Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,establishment of endothelial barrier (GO:0061028),-0.7320884061283719,-2.3749205763794343,0.0,0.0,0.0,21/29,20.44%,TJP1;RAPGEF2;PECAM1;AFDN;RAPGEF6;EZR;F11R;RDX;RAP1A;RAPGEF1;TJP2;PPP1R16B;ICAM1;ROBO4;RAPGEF3;RAP2C;RAB1A;SOX18;RAP2B;MSN;RAB1B
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5708532922315676,-2.355914356154917,0.0,0.0,0.0,48/91,18.24%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;SSR2;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;ARL6IP1;RPL31;RPS23;RPL23A;RPL19;RPL36
prerank,cytoplasmic translation (GO:0002181),-0.5732795674814934,-2.336464782153958,0.0,0.0,0.0,59/91,28.30%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;DRG2;RPL36A;FTSJ1;RPL22L1;RPL34;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;RPL31;RPS23;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;UBA52;RPS11;GSPT1;RPL15;RPL38;RPL13A;RPS25;RPS12;RPL24;RPL18A
prerank,protein targeting to ER (GO:0045047),-0.5601622952869427,-2.2932476665608563,0.0,0.0,0.0,51/99,18.43%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;SEC62;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;SPCS2;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;RPL31;RPS23;RPL23A;SGTB;CHMP4B;CHMP4A;RPL19;RPL36;EDEM1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5678043993650034,-2.2790813979688815,0.0,0.0,0.0,50/87,22.69%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;RPL36A;SRP14;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;SRP68;RPL31;RPS23;RPL23A;RPL19;RPL36;RPL17;RPL23;UBA52;ZFAND2B;RPS11
prerank,collagen fibril organization (GO:0030199),0.6552016056254578,2.1776280405344233,0.0,0.009585983573831027,0.011,25/88,6.84%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;LOXL4;COL23A1;LUM;PLOD1;COL10A1;ADAMTS14;COL22A1;COL7A1;COLGALT1;DPT;LOXL3;LOXL2;COLGALT2;COL12A1;COL26A1;NF1;COL1A2;COL16A1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5189598174676213,-2.1717059057359194,0.0,0.002673375216794763,0.012,61/110,24.79%,RPS14;RPS9;SMG6;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;PPP2R1A;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;HELZ2;RPL36A;PYM1;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;SMG5;RPS8;RPL31;RPS23;PABPC1;EIF3E;RPL23A;RPL19;RPL36;GSPT2;RPL17;RPL23;RBM8A;NCBP2;UBA52;RPS11;GSPT1;MAGOH;RPL15;RPL38
prerank,regulation of cell junction assembly (GO:1901888),-0.6841325912235203,-2.1651457049043787,0.0,0.002643997467159656,0.014,12/27,6.08%,TJP1;RAPGEF2;ROCK2;PRKCH;MEF2C;PDLIM5;OCLN;F11R;CLDN5;RAP1A;RUNX1;RAPGEF1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.6573754532155387,-2.1622392109946524,0.0,0.0026219641549333258,0.016,18/34,15.33%,FLT1;FOXC1;GAS1;NRP1;KDR;NOTCH1;VEGFD;ANXA1;VEGFC;SEMA6A;GAB1;MAPK14;ITGB1BP1;NR4A1;HSPB1;FLT4;RAMP2;ERN1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.8077823538280928,-2.0662828038346404,0.0,0.011927366351853558,0.077,6/12,7.72%,CYP26B1;MBNL1;TGFB2;SKI;MEGF8;LRP6
prerank,muscle cell development (GO:0055001),-0.6359908332309205,-2.0651496168244687,0.0,0.010858016265135655,0.078,11/30,17.03%,NEBL;MYOF;IGF1;CXADR;ANK2;MYH11;DMD;HEY2;RAMP2;DYSF;SDC1
prerank,dopamine metabolic process (GO:0042417),-0.7193490122582377,-2.0609162845472135,0.0,0.010095263056427778,0.08,6/18,8.46%,SNCAIP;MOXD1;TGFB2;MAOB;GCH1;MAOA
prerank,vascular process in circulatory system (GO:0003018),-0.7868998991481037,-2.0335203002228583,0.0,0.014521647627323034,0.135,10/13,18.40%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.7868998991481037,-2.0335203002228583,0.0,0.014521647627323034,0.135,10/13,18.40%,ROCK2;NOS3;GCLC;ACE;ITGB1BP1;NPR1;ADCY6;SCPEP1;AGTR1;ACE2
prerank,extracellular structure organization (GO:0043062),0.5521272329164593,2.0302409370978594,0.0,0.12723214561630272,0.188,47/204,7.01%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP24;MMP28;MMP25;TNR;VCAN;ST7;RECK;APLP1;SPP1;NF1;ADAM19;COLQ;COL1A2;COL16A1;TEX14;ADAMTS12
prerank,external encapsulating structure organization (GO:0045229),0.5513395536940319,2.0255605803038432,0.0,0.09527886703686596,0.203,46/205,7.01%,LAMA1;COL15A1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP24;MMP28;MMP25;TNR;VCAN;ST7;RECK;APLP1;SPP1;NF1;ADAM19;COLQ;COL1A2;COL16A1;ADAMTS12
prerank,extracellular matrix organization (GO:0030198),0.5381675806036036,2.0214475039432775,0.0,0.07864863795802275,0.221,59/276,7.01%,LAMA1;COL15A1;SCUBE1;COL4A6;COL13A1;COL4A5;LAMA2;LAMC3;FLRT2;COL27A1;LAMC1;COL18A1;DCN;ITGA11;LAMB1;COL4A1;LOXL4;GPM6B;COL23A1;NID1;ITGA8;ITGAD;LUM;TGFBI;PLOD1;COL10A1;ADAMTS14;HSPG2;BGN;ITGAV;COL22A1;ADAMTS6;COL7A1;ITGA3;ITGAE;ITGB5;MMP24;MMP28;MMP25;TNR;COLGALT1;DPT;VCAN;ST7;LOXL3;LOXL2;COLGALT2;RECK;KLKB1;APLP1;SPP1;COL12A1;COL26A1;NF1;ADAM19;COLQ;COL1A2;COL16A1;ADAMTS12
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.7273206598404531,1.9602818129846142,0.0,0.18788527804708813,0.515,5/25,6.54%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.7627846078402978,-1.9549574511297303,0.0,0.04864955339573767,0.396,9/14,13.36%,FOXC1;NRP1;KDR;VEGFD;VEGFC;GAB1;PIK3CD;MYO1C;FLT4
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.7176141803989273,-1.9424410481105674,0.0,0.05486588521852638,0.452,10/17,11.41%,DOCK5;IGF1;DOCK4;ADAMTS1;IGFBP5;NRP1;VTN;S100A11;CCN4;MDK
prerank,epithelial cell morphogenesis (GO:0003382),0.7961190280902495,1.9342205873065894,0.0,0.23108030099947216,0.659,4/17,6.13%,COL15A1;COL18A1;COL22A1;SIPA1L3
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7846451919148233,-1.9279581448832808,0.002320185614849188,0.06238732356885472,0.515,10/11,20.44%,TJP1;RAPGEF2;AFDN;RAPGEF6;F11R;TJP2;RAP2C;RAB1A;RAP2B;RAB1B
prerank,positive regulation of wound healing (GO:0090303),-0.5700028999270547,-1.9279222602407933,0.0028735632183908046,0.05879006132860882,0.515,11/36,5.01%,OCLN;PLPP3;MYLK;ITGB1;THBS1;FOXC2;ST3GAL4;ACTG1;VTN;KANK1;ANXA1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.5760422850254906,-1.925943608630727,0.0,0.05696345654247303,0.525,21/36,22.04%,CAV1;NPR3;EGFR;NOS3;ZDHHC21;NOSTRIN;SCARB1;CALM1;APOE;GCH1;PIK3CB;TERT;DDAH1;NOS1AP;DHFR;AKT1;WASL;NOSIP;NUS1;LYPLA1;DDAH2
prerank,cell junction organization (GO:0034330),-0.4925717541113177,-1.9194449177910375,0.0,0.05922554326437629,0.558,17/71,9.03%,SDK1;TJP1;APBB2;LIMS2;OCLN;CXADR;SLC8A3;ACTB;APP;TGFB2;ACTG1;DVL1;CDC42;TJP2;MAPT;SMAD3;PPFIBP1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7725395531456216,-1.9150161048448842,0.0,0.05978078273247982,0.577,6/12,2.44%,DOCK5;MEF2C;DOCK4;ADAMTS1;IGFBP5;TPM1
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.537746061256327,-1.9063449601150813,0.0,0.06333842821329132,0.62,17/44,11.40%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6628449489054047,-1.8959850382065797,0.0,0.0698816542683834,0.678,9/20,15.78%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6670686036736944,1.8777186473003813,0.003048780487804878,0.4540270401787241,0.892,5/32,6.54%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3
prerank,icosanoid secretion (GO:0032309),-0.756548971940168,-1.8718254834097743,0.0022371364653243847,0.09146698484217534,0.774,4/12,6.29%,ABCC4;ANXA1;ACE;BDKRB2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.5978532449590891,-1.8648243432280944,0.0,0.0963957409901958,0.81,13/27,19.39%,HMBOX1;BMPR2;SMG6;DACH1;PDGFA;ACVRL1;NIBAN2;SMG5;ATM;CDKN1A;PARP4;HGF;RGCC
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.652315878560964,-1.8557248123685905,0.0,0.10260825370553192,0.841,7/19,4.27%,TJP1;ROCK2;PRKCH;OCLN;F11R;CLDN5;RUNX1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.5081380282772713,-1.854472075195978,0.0,0.1006549497305626,0.847,19/51,14.88%,ROCK2;PPM1E;SORBS3;CCN2;TPM1;NRP1;LIMCH1;S100A10;RAC1;CDC42;PPM1F;ARHGEF15;RHOC;ITGB1BP1;SFRP1;FHOD1;CCDC88A;RAPGEF3;CX3CL1
prerank,carbohydrate biosynthetic process (GO:0016051),-0.6390226861066228,-1.8530287231855698,0.0,0.09843504644403282,0.852,9/21,15.78%,B4GALT1;ST3GAL6;FUT8;B3GALT1;ST3GAL4;ST3GAL3;MPDU1;FUT9;ST3GAL2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5606312374337322,-1.8529982802669756,0.0029154518950437317,0.09491950907103167,0.852,17/35,18.21%,PLXNA2;SEMA3D;SEMA3C;PLXNA4;SEMA7A;NRP2;NRP1;RAC1;SEMA6A;SEMA4B;PLXNB1;SEMA5B;FLNA;MET;SEMA6C;SEMA3G;SEMA6B
prerank,atrial septum morphogenesis (GO:0060413),-0.7622158281100138,-1.8519890171247835,0.0021551724137931034,0.09253991135058796,0.854,6/10,12.72%,NOTCH2;BMPR2;TGFB2;SOX4;ACVR1;HEY2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4167117497582931,-1.8507379016058274,0.0,0.0909358862205111,0.859,56/168,13.27%,DDX5;CSDE1;RPS14;RPS9;SMG6;RPS16;TUT7;RPLP1;RPL13;SAMD4A;CNOT10;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;PPP2R1A;RPL41;RPS18;RPS20;PARN;RPS19;PAN3;RPS24;NBAS;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;ERI1;CNOT8;RPL10A;RPS5;RPL11;HELZ2;RPL36A;RC3H1;PYM1;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;SMG5;POLR2G;ATM;RPS8
prerank,muscle contraction (GO:0006936),-0.4236232047468997,-1.8485566058100982,0.0,0.09066921206737177,0.868,29/126,13.05%,SORBS1;MYOF;TMOD3;ROCK2;SNTB1;SORBS3;ACTN2;VIM;CALD1;VCL;MYLK;EDNRA;TPM1;SNTA1;MYL6;CRYAB;BDKRB2;CALM1;ITGA1;MYL9;MYH11;DMD;GJC1;LMOD1;KCNJ12;ACTA2;DTNA;NOS1;TMOD1
prerank,regulation of tissue remodeling (GO:0034103),-0.6402776851794412,-1.8447070391630036,0.005076142131979695,0.09219288668302326,0.882,7/18,13.36%,LEPR;IL18;CST3;RUNX1;MDK;CEACAM1;FLT4
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.7992923980074881,1.8426421856947264,0.0055658627087198514,0.6259211547185578,0.966,5/12,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,organophosphate ester transport (GO:0015748),-0.6008759172222753,-1.834164166480194,0.002680965147453083,0.10184998728040469,0.905,11/24,17.77%,PITPNC1;OSBPL8;EPG5;PLTP;SCARB1;PITPNA;ABCA3;TNFAIP8L3;PRELID2;PRELID1;PCTP
prerank,anterograde trans-synaptic signaling (GO:0098916),0.49377593910980266,1.8307239592274245,0.0,0.6445847742524561,0.978,72/224,18.14%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;SLC18A3;CHRNB4;NRXN2;CEL;GRIN2B;NRXN1;NOVA1;GABRA1;ASIC2;GRIK2;KCNQ3;GRIA4;GRIA1;GABRD;SLC12A6;SCN2B;PCDHB16;PDYN;HTR2B;DLG2;GRIK4;CAMKK2;KCNIP2;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;PRKACB;HTR5A;LPAR3;GABRG3;HTR1A;GPR176;PRKACA;NPY;CACNB4;HTR2C;MBP;CAMK4;GLRA3;PLP1;GABRG2;KCND2;GRM5;GLRA1;DLG4;SYT5;CBLN1;HTR4;GLRA2;GABRB1;ATXN3;PRKAR1A;SYN2;APBA2;GLRB;GABBR2;GRM7;HTR6;CDK5;UNC13C;AMPH;GRM1;GRIA2
prerank,lipid catabolic process (GO:0016042),0.7348325998063066,1.8298165138959963,0.004830917874396135,0.5847449980036927,0.979,5/18,5.09%,HSD11B1;CEL;ACADL;LIPC;LIPH
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7307808013711833,-1.8291260291347766,0.002403846153846154,0.10360841055134455,0.915,5/12,9.74%,CAV1;CAMK2D;SRI;CALM1;GJD3
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.7429809121358979,1.8161966157604879,0.009836065573770493,0.6187316670381845,0.993,7/16,12.41%,APOD;PPARA;ABCD2;ADCY7;APPL2;PYCARD;PDCD4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.7091459685938722,1.814626857778137,0.00333889816360601,0.5775555103233194,0.994,5/19,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,negative regulation of hemostasis (GO:1900047),-0.7203457014279903,-1.813755976294035,0.002331002331002331,0.11862735302656323,0.946,7/12,15.36%,THBD;VTN;CD34;APOE;SERPINE1;SERPINE2;EDN1
prerank,myotube cell development (GO:0014904),-0.7537355632452408,-1.8133385975048117,0.006993006993006993,0.1158805334356807,0.947,4/10,5.87%,IGF1;SKI;CAV2;SIX1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.6473508981703647,1.8085115053408434,0.004608294930875576,0.5738183174265286,0.995,9/32,14.70%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;TRPC3;P2RX4;AKAP6;F2R
prerank,negative regulation of vascular permeability (GO:0043116),-0.7267236249396376,-1.8082689641999223,0.0,0.12001842917144723,0.952,7/12,14.58%,PTPRJ;SLIT2;CLDN5;PDE3A;CEACAM1;DDAH1;RAMP2
prerank,myelin maintenance (GO:0043217),0.8207279431621011,1.801980175749375,0.0035714285714285713,0.5719844354541124,0.997,7/10,15.09%,EPB41L3;PTEN;ABCD2;PRX;DEGS1;MYRF;CLU
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.6616190308468742,-1.800483158355923,0.0024154589371980675,0.12815965968448093,0.965,5/17,3.73%,ROCK2;VCL;F11R;CLDN5;ZDHHC21
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7243348472296577,-1.8003354572045966,0.0,0.1250000648704865,0.965,6/11,18.69%,NOS3;CALM1;GCH1;DHFR;AKT1;PRKG2
prerank,platelet degranulation (GO:0002576),-0.4177144018508651,-1.7921397593218689,0.0,0.1331340857963792,0.971,37/118,18.27%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;LHFPL2;ANXA5;APP;PCDH7;SPARC;ECM1;SRGN;TGFB2;VEGFD;VEGFC;CD109;PDGFA;CALM1;ENDOD1;SERPINE1;TAGLN2;CD63;LGALS3BP;ITGB3;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;ALDOA;LAMP2;EGF
prerank,translation (GO:0006412),-0.3864146990594971,-1.7885981759725078,0.0,0.13509322343180144,0.978,102/208,29.75%,RPS14;RPS9;RPS16;RPLP1;RPL13;DRG1;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;EEF1G;RPL35A;RPS15A;RPL10A;RPS5;RPL11;ABCF1;DRG2;RPL36A;FTSJ1;EEF1A1;RPL22L1;RPL34;KARS1;RPLP2;RPS29;RPL32;RPL4;RPLP0;EEF2K;IARS2;RPL30;RPL26;RPS4X;RPS21;GARS1;RPL29;RPS8;EEFSEC;EEF1D;MRPS7;RPL31;APEH;RPS23;NOA1;RPL23A;GTPBP1;SRBD1;MRPS17;AGO2;RPL19;RPL36;MRPL16;EEF1E1;GSPT2;MRPS18A;MRPL2;RARS1;MRPS18B;RPL17;RPL23;GATC;UBA52;MRPL24;RPS11;MRPL57;MRPL55;QARS1;PTCD3;LARS2;GSPT1;RPL15;MRPS34;RPL38;HARS2;TRMT112;MRPL36;MRPL35;RPL13A;RPS25;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A;FASTKD2;MRPS2;MRPL18;GTPBP2;EIF4EBP2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4366380072497659,-1.7864331747966493,0.0,0.13557831456602015,0.981,33/92,13.99%,ANXA3;DOCK5;ROCK2;FOXP1;TEK;DOCK1;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;KDR;TGFB2;RAC1;SCARB1;PPM1F;AAMP;FGF1;ITGB1BP1;ATOH8;HYAL1;PIK3CB;ENPP2;PIK3CD;ETS1;MAPRE2;CTSH;ITGB3;PLCG2;FLT4;PTK2B;RRAS
prerank,cellular response to sterol (GO:0036315),0.7561762531405886,1.783425923839609,0.009852216748768473,0.6499877831758881,1.0,3/13,2.27%,RORA;GRAMD1B;GPLD1
prerank,organic anion transport (GO:0015711),-0.454241709740672,-1.7824177140249,0.0,0.13825032337585513,0.984,29/76,26.05%,ABCG2;ABCC4;SLC4A10;LRRC8C;SLC16A2;SLC26A7;SLCO2A1;SLCO1C1;SLC22A6;SLC39A8;SLC4A3;ABCC6;LRRC8D;CA4;SLC4A8;CYB5R1;SLC35A2;SLC26A6;SLC52A3;SLCO5A1;SLC35C2;SLC35B2;CFTR;SLC4A7;SLC17A9;CYB5R4;SLCO4A1;SLC25A4;SLC52A2
prerank,genitalia development (GO:0048806),0.7966564107323499,1.7821048324908155,0.0054446460980036296,0.6174244874599347,1.0,4/12,4.31%,CHD7;WNT5A;DNAJC19;TBX3
prerank,nerve growth factor signaling pathway (GO:0038180),-0.7429698597714613,-1.7802408941234877,0.0,0.13813684948878674,0.985,5/10,6.67%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5737207643452651,-1.7758245413360707,0.0,0.14153808070866225,0.985,11/24,26.01%,PECAM1;ITGB1;EZR;F11R;ICAM1;NT5E;VCAM1;MSN;GFUS;CERCAM;ITGB2
prerank,chemical synaptic transmission (GO:0007268),0.4687383787798506,1.7697122348367254,0.0,0.6590748171590669,1.0,82/284,16.25%,SLC1A3;PDE7B;HCRT;AKAP5;GRIA3;CACNA1E;UNC119;PTEN;SLC18A3;CHRNB4;NRXN2;GRID2;CEL;PTPRN2;GRIN2B;NRXN1;NOVA1;GRID1;GABRA1;ASIC2;GRIK5;GRIK2;KCNQ3;GRIA4;GRIA1;GABRD;SLC12A6;SCN2B;PCDHB16;PDYN;VAMP2;HTR2B;CHAT;DLG2;GRIK4;CAMKK2;FCHSD2;KCNIP2;NAPB;GRIN2A;GRIK1;PCDHB4;PTCHD1;PCDHB11;PRKACB;SNPH;HTR5A;LPAR3;GABRG3;HTR1A;GPR176;PRKACA;NPY;CACNB4;HTR2C;MBP;CAMK4;GLRA3;ERC2;PLP1;GABRG2;KCND2;GRM5;SHISA6;GLRA1;RIMS1;DLG4;SYT5;DNAJC5;CBLN1;HTR4;GLRA2;UNC13A;GABRB1;ATXN3;PRKAR1A;SYN2;APBA2;GLRB;GABBR2;PDZD11;GRM7
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7577619102607791,1.7641185664739547,0.010169491525423728,0.6589153355547489,1.0,2/12,2.01%,APOD;CBLB
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5983537514874018,1.7636752668962092,0.0029940119760479044,0.6266664764079106,1.0,17/37,18.03%,DYNLL1;TRAF3IP1;WDR35;DYNC2LI1;IFT81;KIFAP3;TTC21B;IFT74;SSX2IP;TNPO1;IFT88;DYNLL2;TRIP11;KIF3C;IFT43;CLUAP1;PCM1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.5208570536935033,-1.7622161300131731,0.0,0.16032204351955487,0.991,15/39,12.98%,SNCAIP;TJP1;RAPGEF2;ROCK2;EZR;TIE1;RDX;RAP1A;HSPA8;NOTCH1;RAPGEF1;APOE;PARP10;NCLN;VPS11
prerank,positive regulation of leukocyte migration (GO:0002687),0.631032904251302,1.757745818322353,0.00946372239747634,0.6321956166941562,1.0,3/27,1.27%,PTN;XCL1;EDN3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5565336905001806,1.7463772899114844,0.0014367816091954023,0.6708528591106163,1.0,11/55,6.00%,CEMIP;DCN;LUM;HSPG2;BGN;GPC4;VCAN;GPC5;HMMR;CEMIP2;SLC9A1
prerank,peptide biosynthetic process (GO:0043043),-0.39006452319330664,-1.7439962207304778,0.0,0.18893893389792382,0.997,76/153,28.65%,RPS14;RPS9;GGTA1;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;RPS19;RPS24;RPS27;RPS15;RPL21;RPL10;RPL35A;RPS15A;RPL10A;RPS5;RPL11;ABCF1;RPL36A;EEF1A1;DMD;RPL34;RPLP2;RPS29;RPL32;RPL4;RPLP0;RPL30;RPL26;RPS4X;RPS21;RPL29;RPS8;FURIN;MRPS7;RPL31;PCSK5;RPS23;RPL23A;SRBD1;MRPS17;AGO2;RPL19;RPL36;GSPT2;MRPS18A;MRPS18B;RPL17;RPL23;MRPL24;RPS11;MRPL55;GSPT1;RPL15;RPL38;HARS2;MRPL36;MRPL35;RPL13A;RPS25;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A;GGT1
prerank,regulation of stress fiber assembly (GO:0051492),-0.443084707478754,-1.7426925059008134,0.0,0.18770178685610925,0.997,27/74,11.67%,PHLDB2;TJP1;ROCK2;ARHGEF18;PPM1E;SORBS3;WASF2;CCN2;TPM1;F11R;NRP1;LIMCH1;S100A10;ACTG1;RAC1;CGNL1;CDC42;PPM1F;ARHGEF15;TMEFF2;RHOC;RHPN2;ITGB1BP1;SFRP1;FHOD1;CCDC88A;ARHGAP28
prerank,lymphocyte chemotaxis (GO:0048247),0.6075660719447606,1.739210438771312,0.00946372239747634,0.6857939405526304,1.0,7/34,10.56%,CYP7B1;XCL1;CXCL10;MSMP;CCL15;GPR183;CCL25
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5024864746127197,-1.7361322835549957,0.005917159763313609,0.19608388835021182,1.0,12/38,10.44%,BCL2L1;NOS3;THBS1;TNFSF10;FAS;GSK3B;CASP8;MADD;GPX1;SFRP1;SERPINE1;ICAM1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.5364387687821182,-1.7338411504136164,0.0053475935828877,0.19650541708926186,1.0,6/31,5.70%,RANBP3L;CRIM1;SMAD6;NOTCH1;SKI;CDK6
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.7885316167573558,1.7313938378233342,0.0035971223021582736,0.7082639958325035,1.0,2/10,0.48%,APOD;LRP1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7436967464971267,1.7313787063058221,0.02030456852791878,0.6788982381815103,1.0,7/13,15.76%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81;BRSK2
prerank,inner ear morphogenesis (GO:0042472),0.6578298843828656,1.7311202969109425,0.006462035541195477,0.6533457822702362,1.0,4/22,7.24%,TBX18;CHD7;ZIC1;MYO6
prerank,cAMP biosynthetic process (GO:0006171),0.7644781462248068,1.7309284115612544,0.01056338028169014,0.6292561385143486,1.0,6/10,8.88%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5074416769658795,-1.7289954917240873,0.0,0.2019426509917275,1.0,15/38,15.36%,ROCK2;CAV1;KLF4;SIRPA;INSR;RAC1;CD34;KLF2;SMAD3;CX3CR1;ASS1;DDAH1;NOS1AP;PTGS2;EDN1
prerank,neuron cell-cell adhesion (GO:0007158),0.7308654433290445,1.7260128422120058,0.016835016835016835,0.6368708009388345,1.0,7/14,8.56%,ASTN2;NRXN2;CEL;NRXN1;CNTN4;ASTN1;NRXN3
prerank,positive regulation of angiogenesis (GO:0045766),-0.4120887518595788,-1.7225504884954954,0.0,0.21160793062167782,1.0,40/108,15.23%,FLT1;ANXA3;TJP1;TEK;ITGB8;BMPER;ITGB1;NOS3;THBS1;KLF4;FOXC2;TIE1;ECM1;KDR;RUNX1;CYP1B1;VEGFD;VEGFC;CD34;GAB1;HIPK1;HK2;FGF1;HYAL1;GATA2;SERPINE1;PIK3CD;ETS1;CTSH;MDK;HSPB1;PKM;HIPK2;SMAD1;GATA6;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.6093195225283327,-1.7225120461220564,0.007751937984496124,0.2076618891188037,1.0,12/17,31.74%,ATP5F1B;ATP5F1C;ATP5MG;VPS9D1;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,hyaluronan catabolic process (GO:0030214),0.6807068289991004,1.7219838096356468,0.017152658662092625,0.6367520712240551,1.0,4/18,6.00%,CEMIP;HMMR;CEMIP2;SLC9A1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6714951524875948,1.72034829082974,0.008264462809917356,0.6239603853511831,1.0,9/21,12.86%,EPHA7;GRIN2B;NGFR;SOX2;DELE1;BIRC2;PYCARD;FYN;PSMB9
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3795264586649226,-1.7199311443529939,0.0,0.20948294006473836,1.0,49/182,12.72%,IGF1;PICALM;SLC24A3;ROCK2;FOXP1;ITGB8;MEF2C;OCLN;ROBO1;NOTCH2;APP;KLF4;NFKB1;KDM4A;CLDN5;KDR;RIN3;WWP2;NOTCH1;RUNX1;TGFB2;WNT4;SMO;CD34;PRKAA2;ADAM10;DICER1;APOE;XDH;CELF1;ACVRL1;MAPT;ATOH8;CITED2;SFRP1;GATA2;TNRC6A;PARP10;OPTN;VHL;PARP9;SLC7A5;TARDBP;MAP2K2;TLE5;TERT;TNRC6C;PTRH2;HEY2
prerank,regulation of glucose metabolic process (GO:0010906),0.5963655789905478,1.7198109112347915,0.006220839813374806,0.6062117915220597,1.0,7/34,7.56%,RORA;OGT;GPLD1;PDK1;IRS1;IRS2;DGKQ
prerank,embryonic digit morphogenesis (GO:0042733),0.6937823920590253,1.7179938963954946,0.011589403973509934,0.5970577862891413,1.0,8/18,11.47%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3;MSX1
prerank,camera-type eye development (GO:0043010),0.6428213606638187,1.7173373777468153,0.012326656394453005,0.5820489401235527,1.0,2/25,1.20%,LAMA1;TENM3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5875245985657445,-1.7173026752942893,0.004728132387706856,0.2112826388120818,1.0,6/20,10.64%,PICALM;BCL2L1;RHOQ;DAB2;PKDCC;TMEM59
prerank,phospholipid transport (GO:0015914),-0.4601836198677364,-1.7132774508512767,0.006688963210702341,0.21568409338354896,1.0,18/52,18.60%,PITPNC1;ATP10A;OSBPL8;ATP8A1;PLTP;ATP11B;SCARB1;PITPNA;APOE;ABCA3;ATP8B1;TNFAIP8L3;MFSD2A;ABCB4;PRELID2;PRELID1;PCTP;ATP8A2
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6371672729789125,1.7119278361023895,0.006622516556291391,0.5924824448002008,1.0,8/26,10.44%,PPARA;SLC30A10;ABCD2;TLR6;ADGRB1;TLR4;CYBA;SLC25A33
prerank,regulation of steroid metabolic process (GO:0019218),0.6529076204983149,1.7116701857074534,0.008,0.5764661940081113,1.0,4/23,7.56%,RORA;NR1H4;ACADL;DGKQ
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6276988062845528,-1.7116064375515185,0.010723860589812333,0.21566669866337024,1.0,7/16,16.72%,ROCK2;GSN;RUFY3;KANK1;PTK2B;CDH5;BCAS3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5857412940547986,-1.7083678629139825,0.0027624309392265192,0.21450437756451543,1.0,5/21,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5857412940547986,-1.7083678629139825,0.0027624309392265192,0.21450437756451543,1.0,5/21,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,positive regulation of cell migration (GO:0030335),-0.35834167230351754,-1.7031375856717943,0.0,0.2216844987465196,1.0,67/253,11.41%,FLT1;PDGFD;FN1;DOCK5;IGF1;TJP1;RAPGEF2;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PECAM1;PODXL;EGFR;MYLK;DOCK1;IGF1R;ITGB1;FER;THBS1;SEMA7A;ITGA6;NRP1;BMPR2;RDX;KDR;INSR;SOD2;NOTCH1;RUFY3;TGFB2;ACTG1;VTN;S100A11;APC;SMO;DAB2;NEDD9;ADAM10;SEMA6A;GAB1;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;RHOC;FGF1;SMURF2;PDGFC;HYAL1;ENPP2;PIK3CD;CCN4;FAM107A;SPAG9;EPHB2;ELP5;SEMA5B;CTSH;MYO1C;CD151;MDK
prerank,blood circulation (GO:0008015),-0.4726687398526585,-1.7001583694163598,0.003278688524590164,0.22415897215021108,1.0,19/49,14.81%,MYOF;ROCK2;NOS3;TBC1D8;GUCY1A1;GCLC;COL4A3;ACE;CYB5R3;BDKRB2;ELN;ACVRL1;ITGB1BP1;NPR1;GPX1;ADCY6;SCPEP1;AGTR1;F5
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.5302695672214247,-1.699741270910258,0.0,0.22133954710564285,1.0,19/30,35.69%,CAV1;INPP5F;PPP2R1A;MVP;SFRP1;PTPN2;PRKCZ;PRKCD;DMTN;SOCS3;HYAL2;PTPN6;NTF3;SOCS1;SAMSN1;SH3BP5L;PPP2CA;NF2;SH3BP5
prerank,steroid catabolic process (GO:0006706),0.7864959723134526,1.6993514557701728,0.0054446460980036296,0.6261763659695494,1.0,2/10,5.26%,HSD11B1;SPP1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.5307375082071777,-1.6926270149731828,0.0055248618784530384,0.23110496379617734,1.0,15/30,26.32%,BCL2L1;NOS3;TNFSF10;FAS;GSK3B;CASP8;GPX1;SERPINE1;ICAM1;TRADD;TNFAIP3;CFLAR;RFFL;BRCA1;PARK7
prerank,triglyceride catabolic process (GO:0019433),0.6709725356883424,1.6908175507852221,0.016339869281045753,0.6557442147260321,1.0,5/19,12.16%,LIPC;LIPH;FABP5;FABP4;FABP3
prerank,cochlea morphogenesis (GO:0090103),0.7615462918505193,1.6897402474377698,0.00528169014084507,0.6434856442767506,1.0,1/10,0.03%,TBX18
prerank,hyaluronan metabolic process (GO:0030212),0.6398954834327731,1.6867062820040908,0.017857142857142856,0.6435222130748144,1.0,4/23,6.00%,CEMIP;HMMR;CEMIP2;SLC9A1
prerank,response to ketone (GO:1901654),-0.5482614346891075,-1.686454216486251,0.0027100271002710027,0.24104718992008362,1.0,9/24,19.15%,CAV1;SLIT2;THBS1;TGFB2;WBP2;ABHD2;ABCB4;CATSPER2;TGFBR3
prerank,actin filament bundle organization (GO:0061572),-0.5048781921004053,-1.6854893499475159,0.005420054200542005,0.2398444676748059,1.0,16/33,23.71%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;LIMA1;SHROOM1;BAIAP2;RFLNA;RFLNB;DMTN;ADD2;CORO1B
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.6257509697935342,-1.6843070540238105,0.009195402298850575,0.23841646251596937,1.0,9/15,23.07%,LEMD3;MAGI2;SKI;ACVR1;ACVR2B;CSNK2B;SMAD7;ACVR2A;FSTL3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.5878870558195283,1.6830903598083362,0.010447761194029851,0.645031673253567,1.0,6/34,7.16%,RORA;ENPP1;WNT5A;LRP3;RUNX1T1;ZFP36L2
prerank,cardiac conduction system development (GO:0003161),0.6350969364440839,1.6825624988311276,0.016474464579901153,0.6318688217995938,1.0,5/24,6.11%,TBX18;MSC;SMAD5;GJA1;CACNA1G
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.4083622211574295,-1.682554158690196,0.0,0.2382833657642304,1.0,37/84,18.27%,ANXA3;ROCK2;FOXP1;TEK;PLPP3;NOS3;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;ATP5F1B;KDR;RAC1;MAPK14;SCARB1;AAMP;FGF1;ITGB1BP1;ATOH8;PIK3CB;GATA2;PIK3CD;ETS1;HSPB1;ITGB3;FLT4;PTK2B;RRAS;TMSB4X;EDN1;MET;SIRT1;BCAS3;AKT1;EGF
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7270588324131404,1.6818816118441744,0.018867924528301886,0.6199857092352045,1.0,6/13,12.94%,SEC16B;SEC16A;SORL1;TMEM30A;SAR1A;CD81
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6918122406138173,-1.681808121310483,0.023752969121140142,0.23648483620239466,1.0,6/10,17.06%,ATP5F1C;ATP5MG;VPS9D1;ATP5MC2;ATP5F1D;ATP5MC1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6405094112729217,-1.6779413613038894,0.011933174224343675,0.2407289442708435,1.0,7/13,23.18%,ACTN2;CAV1;CAB39;NOS1;PTK2B;STK39;CASQ2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6033817765249947,-1.6762941675324192,0.02349869451697128,0.24111494235517958,1.0,12/16,35.07%,ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3;STOML2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.6823003231067157,1.675900836331042,0.010238907849829351,0.6355590104978748,1.0,5/15,6.25%,PPARA;GPLD1;PPARD;IRS1;IRS2
prerank,acylglycerol homeostasis (GO:0055090),0.6321366803094799,1.6746506082875383,0.018272425249169437,0.6275880620102017,1.0,2/20,5.08%,RORA;LIPC
prerank,oogenesis (GO:0048477),0.6971689131146301,1.6736513199294254,0.010362694300518135,0.6187118612869988,1.0,2/15,2.60%,PTN;NANOS3
prerank,basement membrane organization (GO:0071711),0.71136318934746,1.6713667103088579,0.0216998191681736,0.6170662234273775,1.0,4/14,0.96%,FLRT2;LAMB1;COL4A1;NID1
prerank,triglyceride homeostasis (GO:0070328),0.605504845353401,1.6706227177858803,0.016260162601626018,0.6074785558862958,1.0,3/26,5.08%,RORA;NR1H4;LIPC
prerank,regulation of small molecule metabolic process (GO:0062012),0.6037023969214618,1.6685408190736228,0.014218009478672985,0.6057340374728932,1.0,6/28,7.56%,RORA;PPARA;NR1H4;PDK1;ACADL;DGKQ
prerank,histone H3-K9 demethylation (GO:0033169),-0.6768378836209921,-1.665930414332883,0.014084507042253521,0.26069318500848265,1.0,7/11,25.64%,KDM4A;KDM4C;PHF8;HR;KDM4B;KDM3B;KDM1A
prerank,macrophage activation involved in immune response (GO:0002281),-0.6370529990974391,-1.6656496235638352,0.021929824561403508,0.25779220119386936,1.0,8/13,26.76%,LBP;NMI;IFI35;CX3CR1;PLCG2;DYSF;TYROBP;SBNO2
prerank,actomyosin structure organization (GO:0031032),-0.4278203751107707,-1.6656110629105043,0.0,0.25434531251208176,1.0,32/75,24.89%,SORBS1;TJP1;TMOD3;FAM171A1;ROCK2;EPB41L5;ACTN2;PGM5;ITGB1;TPM1;F11R;PHACTR1;CDC42BPB;FRMD5;ZYX;LMOD1;CSRP2;TMOD1;MYH10;CDC42BPG;EPB41L1;CUL3;FHDC1;TNNT3;TNFAIP1;MYO18A;SIX4;MYH9;EPB41;EPB41L4A;SRC;MYOM2
prerank,integrated stress response signaling (GO:0140467),0.6899432461126918,1.6648017015506973,0.020905923344947737,0.6114332477262904,1.0,10/14,23.89%,OMA1;HERPUD1;EIF2AK1;EIF2S1;HSPA5;IMPACT;EIF2AK3;CCL2;DDIT3;ATF4
prerank,catecholamine biosynthetic process (GO:0042423),-0.6726251634102061,-1.6636198610341626,0.01951219512195122,0.2556769370540389,1.0,3/11,8.26%,MOXD1;TGFB2;GCH1
prerank,actin filament bundle assembly (GO:0051017),-0.49501878743496625,-1.6627720250320073,0.013262599469496022,0.25439015986029184,1.0,11/33,14.17%,PAWR;BAIAP2L1;DPYSL3;CALD1;EZR;NEDD9;FAM107A;SHROOM2;LIMA1;SHROOM1;BAIAP2
prerank,central nervous system development (GO:0007417),0.44507819463262893,1.662315559062467,0.0,0.6117244731085195,1.0,70/250,17.24%,APOD;CHST8;ROBO2;CHD7;ADGRL3;EPHA7;COL4A1;ZFHX3;MEIS1;HSPG2;MARCKS;PTEN;SH3GL3;CNTNAP2;ADGRA2;GRIN2B;ZIC4;ASIC2;MEIS2;VCAN;AFF2;POU3F3;LOXL3;TBX3;SOX6;ZIC1;ZBTB16;ADORA2A;NF1;CNTN4;GRIN2A;GRIK1;IER3IP1;SZT2;HAPLN2;RPS6KA6;NPAS2;C1QA;DSCAML1;RELN;DHX30;MBP;ABCB6;CNTN6;AMIGO3;AHI1;SOX10;ALDH5A1;SMARCA1;PLXNB2;SOX9;ANKLE2;ATN1;EML1;ADAM22;MYRF;ARNT2;BPTF;HAPLN3;BAG6;CHD8;PBX2;HAPLN1;TBC1D23;NRCAM;NDUFS4;SMG9;NHEJ1;ZIC5;CDK5
prerank,muscle cell differentiation (GO:0042692),0.5825553358108865,1.6622291158603697,0.007473841554559043,0.5999779973555623,1.0,4/32,2.79%,TBX18;RORA;TMEM204;GLMN
prerank,diol metabolic process (GO:0034311),-0.587060470616771,-1.659665174381727,0.005012531328320802,0.25789412136913853,1.0,8/19,21.49%,PLPP3;NOS3;DEGS2;CALM1;GCH1;AKT1;PRKG2;SPHK2
prerank,arachidonic acid secretion (GO:0050482),-0.7140206860481177,-1.6593230070430511,0.008771929824561403,0.25183510917971974,1.0,3/10,6.29%,ANXA1;ACE;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.7140206860481177,-1.6593230070430511,0.008771929824561403,0.25183510917971974,1.0,3/10,6.29%,ANXA1;ACE;BDKRB2
prerank,regulation of receptor recycling (GO:0001919),0.6605779556130347,1.658163718682052,0.02321724709784411,0.60803500800571,1.0,4/16,8.89%,ECE1;TBC1D16;SCRIB;RAB29
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7477043475429574,1.653685498487725,0.011111111111111112,0.6194690503900177,1.0,5/11,14.94%,PPARA;SLC30A10;ABCD2;FYN;ABCB7
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6680290425703587,1.6518988631633342,0.02456140350877193,0.6165612556629775,1.0,7/17,13.23%,KCNS2;ANK3;VAMP2;KCNG1;KCNAB1;KCNE4;AKAP6
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.708750460584338,1.6506155193950682,0.015625,0.6116632145039455,1.0,2/13,3.16%,ENPP1;TPST1
prerank,cranial nerve development (GO:0021545),0.736123421181014,1.64841662162761,0.033928571428571426,0.6110787247800681,1.0,3/11,7.28%,CHD7;SALL1;TMEM126A
prerank,DNA damage checkpoint signaling (GO:0000077),-0.5153387005250254,-1.6460947713207112,0.015151515151515152,0.27963452705838426,1.0,15/28,27.51%,ATR;ATM;CDC5L;NBN;CLOCK;DONSON;HUS1;E2F1;PRPF19;ATRIP;HINFP;CHEK2;BRIP1;CHEK1;RHNO1
prerank,actin crosslink formation (GO:0051764),-0.657502383685526,-1.6452458908720557,0.01707317073170732,0.27814412688275053,1.0,6/12,19.58%,BAIAP2L1;DPYSL3;FLNA;BAIAP2;GAS2L3;GAS2
prerank,phagosome-lysosome fusion (GO:0090385),0.7373262564653562,1.6448863442929011,0.02071563088512241,0.6179691456175388,1.0,4/10,10.41%,RAB34;RAB20;SYT7;ARL8B
prerank,ribosomal small subunit assembly (GO:0000028),-0.5950293419510843,-1.6444451751414466,0.01,0.2767209925258899,1.0,7/16,14.65%,RPS14;PRKDC;RPS19;RPS27;RPS15;RPS5;MRPS7
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5354425934716955,-1.64346611742926,0.013020833333333334,0.2760096900656642,1.0,10/24,26.31%,PICALM;BCL2L1;RHOQ;DAB2;ITGB1BP1;TMEM59;PID1;DMTN;MRAP2;NUMB
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6187768900135988,1.641960418688115,0.022508038585209004,0.621697665145558,1.0,3/22,8.09%,APOD;CIDEA;BSCL2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5564190164444535,1.6418659759972851,0.020319303338171262,0.6114294914631344,1.0,8/40,4.84%,PDGFRA;NTRK3;NTRK2;TXK;C5AR1;FGFR1;ARHGAP6;HTR2B
prerank,positive regulation of vasculature development (GO:1904018),-0.4014638136328169,-1.639505154193768,0.0,0.2820051595695829,1.0,34/94,15.99%,FLT1;ANXA3;TEK;ITGB8;ITGB1;NOS3;THBS1;TIE1;ECM1;KDR;RUNX1;CYP1B1;VEGFD;VEGFC;CD34;GAB1;HIPK1;HK2;FGF1;HYAL1;GATA2;SERPINE1;PIK3CD;ETS1;CTSH;HSPB1;HIPK2;GATA6;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6;SIRT1
prerank,apical junction assembly (GO:0043297),-0.45245375918901415,-1.63875574712928,0.006666666666666667,0.28060157563972726,1.0,20/53,19.74%,VCL;OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RHOC;RAB13;ARL2;RAMP2;CDH5;CTNNA1;PAK2;PKN2;DLG1;CLDN11;PDCD6IP
prerank,regulation of GTPase activity (GO:0043087),-0.36069983780163345,-1.6333574806307252,0.0,0.2898567764468299,1.0,57/177,15.41%,PKP4;PLXNA2;EPHA4;PICALM;RAPGEF2;LRCH1;FGD5;PLXNA4;CHN2;SIPA1L1;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;RASGRF1;RDX;S100A10;RAP1A;NDEL1;RASIP1;SH3BP4;CAV2;WNK1;SRGAP2;RAPGEF1;EFNA5;GSK3B;RSU1;RALBP1;ITGB1BP1;PLXNB1;NGEF;SGSM2;CPEB2;SFRP1;MAPRE2;ARL2;ARHGAP12;GMIP;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;PRKG1;TBC1D10B;ARHGAP15;RAPGEF3;CX3CL1;EZH2;PLXNA1;RAP1GDS1;RGS10
prerank,positive regulation of signaling (GO:0023056),0.5585767096658902,1.6324745073858804,0.029411764705882353,0.6482576780768412,1.0,9/37,11.37%,ECE1;HCRT;EDN3;GRIK2;SCRIB;RIMS2;RAB29;RIMS1;DLG4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.564281342118742,-1.6304315015868427,0.01201923076923077,0.2936456380794548,1.0,5/20,10.64%,PICALM;BCL2L1;RHOQ;DAB2;TMEM59
prerank,actin filament depolymerization (GO:0030042),-0.6620113330898441,-1.6294864202226298,0.02522935779816514,0.2927806789151782,1.0,6/11,21.45%,MICAL2;GSN;CFL1;DSTN;MICAL3;TWF2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5688472813232001,1.6282278477012653,0.023076923076923078,0.6590363707008832,1.0,7/32,3.78%,APOD;DLC1;CASK;PTEN;CDKN2A;MAP4K4;ARHGAP6
prerank,negative regulation of coagulation (GO:0050819),-0.6193711486092005,-1.6265776892317492,0.01715686274509804,0.29688486105111356,1.0,9/14,24.60%,THBD;VTN;CD34;APOE;SERPINE1;SERPINE2;EDN1;TFPI;PROCR
prerank,ethanol metabolic process (GO:0006067),0.7046493481752926,1.6260378919642897,0.027972027972027972,0.6597613910680544,1.0,2/12,1.50%,ADH1A;ALDH1A1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.6080722395533356,1.625985920438726,0.035830618892508145,0.6494433592798572,1.0,3/24,4.82%,CEMIP;ANK3;MTCL1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.628541414213394,1.6256880956245827,0.02891156462585034,0.6406286540473829,1.0,4/18,5.64%,PTN;IL34;TENM4;NF1
prerank,response to sterol (GO:0036314),0.7178878020170748,1.6215803243234506,0.03305785123966942,0.6522417601847728,1.0,1/11,0.04%,RORA
prerank,negative regulation of viral life cycle (GO:1903901),-0.6142187740069102,-1.6207197418169814,0.020253164556962026,0.30787023391198604,1.0,9/15,20.87%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;PPIA;SNX3;IFITM2
prerank,cellular response to fluid shear stress (GO:0071498),-0.6454165552701423,-1.6203532262114384,0.011337868480725623,0.3054502555394222,1.0,7/12,15.14%,MEF2C;KLF4;SREBF2;KLF2;HDAC3;ASS1;MAP2K5
prerank,anion transport (GO:0006820),-0.4833855599516472,-1.6188395793943604,0.014084507042253521,0.30603931708338766,1.0,7/33,7.77%,ABCG2;SLC13A4;SLC13A3;LRRC8C;SLC26A7;SLC22A6;LRRC8D
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.5415596131923981,-1.6185125507076712,0.01891891891891892,0.3037052597875456,1.0,12/22,30.41%,PDGFD;ACE;PDGFA;CALM1;PDGFC;NBN;RAP2C;NEK10;TAOK2;GREM1;RAD50;RASSF2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6003166232268902,-1.6178310191470457,0.02252252252252252,0.3022439742620422,1.0,4/15,5.61%,PRKCH;IL18;NFKB1;MAPK9
prerank,positive regulation of cell motility (GO:2000147),-0.34971734411169253,-1.6164806480249105,0.0,0.3023101699738144,1.0,56/205,11.41%,FLT1;PDGFD;IGF1;TJP1;SYNE2;ROCK2;SEMA3D;SEMA3C;LEF1;WNT5B;CAVIN1;CAV1;PECAM1;PODXL;EGFR;SPOCK2;MYLK;IGF1R;ITGB1;FER;NTN1;THBS1;SEMA7A;ITGA6;RDX;KDR;INSR;SOD2;NOTCH1;RUFY3;ACTG1;APC;SMO;DAB2;NEDD9;ADAM10;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;RHOC;FGF1;PDGFC;PIK3CD;FAM107A;SPAG9;EPHB2;ELP5;SEMA5B;CTSH;MYO1C;CD151;MDK
prerank,cAMP metabolic process (GO:0046058),0.6766491802479484,1.6135478342172838,0.03270223752151463,0.6824147746965025,1.0,6/13,8.88%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;ADCY7
prerank,polyol metabolic process (GO:0019751),-0.4650573322521318,-1.6133128411459463,0.003125,0.3065571266818144,1.0,17/46,15.70%,PLCE1;PLCB1;ITPKB;INPP4B;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;PLCH1;ITPK1;INPP5B
prerank,tight junction assembly (GO:0120192),-0.4505232669083171,-1.6127769383084407,0.012903225806451613,0.30494471343111806,1.0,19/49,19.74%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;ACTG1;APC;LSR;RAB13;ARL2;CLDN12;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.5835820458461521,1.6107838548527413,0.025974025974025976,0.6861900555763425,1.0,7/30,4.67%,VAMP5;GGA2;RAB34;SEC16A;SPTBN1;ANK3;VAMP2
prerank,regulation of phospholipase activity (GO:0010517),0.7317533099215827,1.6105509178528326,0.02962962962962963,0.6771840553432004,1.0,3/10,3.87%,LRP1;FGFR1;PDPK1
prerank,inositol phosphate metabolic process (GO:0043647),-0.4619251090376553,-1.6103792535723769,0.003134796238244514,0.3079957214476682,1.0,17/46,15.70%,PLCE1;PLCB1;ITPKB;INPP4B;INPP5D;NUDT3;IP6K2;CALM1;NUDT4;INPPL1;MINPP1;PLCB4;PLCG2;SYNJ1;PLCH1;ITPK1;INPP5B
prerank,response to laminar fluid shear stress (GO:0034616),-0.701343674983798,-1.6089685279997554,0.018223234624145785,0.30827751420668653,1.0,6/10,15.14%,SMAD6;KLF4;SREBF2;KLF2;ASS1;MAP2K5
prerank,cilium movement (GO:0003341),0.528785987587605,1.6089312666692106,0.02545968882602546,0.676260383967232,1.0,13/48,15.25%,CFAP251;CCDC63;ODAD4;ADCY10;DNAAF4;RSPH9;DNAI4;DNAH9;SPA17;CABYR;GAS8;ZBBX;CCDC39
prerank,phosphate ion homeostasis (GO:0055062),0.7312054797655546,1.6085784335851598,0.029304029304029304,0.6683034529766388,1.0,1/10,0.11%,ENPP1
prerank,neurotransmitter uptake (GO:0001504),0.688196321671307,1.607451781665107,0.034420289855072464,0.66479418550984,1.0,2/12,1.47%,SLC1A3;ATP1A2
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6249766020087549,1.6063308867767299,0.02348993288590604,0.6607823453018785,1.0,3/18,1.27%,PTN;XCL1;EDN3
prerank,glycogen metabolic process (GO:0005977),-0.5068841794736296,-1.6058882872608893,0.02023121387283237,0.31259171940526553,1.0,11/27,13.48%,PRKAG2;PYGB;PGM2L1;GBE1;CALM1;GSK3B;GYG1;UGP2;GAA;PGM2;PPP1R3C
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6955794560064872,1.6031829263350723,0.03281519861830743,0.6672788641526242,1.0,4/12,3.66%,DCN;BGN;DSE;VCAN
prerank,regulation of protein targeting to membrane (GO:0090313),0.5796166011172956,1.6021924721815697,0.02694136291600634,0.6628773298725893,1.0,3/28,4.82%,CEMIP;ANK3;MTCL1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.643963985498177,-1.6019296789130364,0.018691588785046728,0.31946011263707635,1.0,6/11,9.79%,MLLT3;RSPO3;WNT5B;CSNK1D;DAB2;SFRP1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6171207755903766,1.5976666352449362,0.02533783783783784,0.6765066491183012,1.0,4/20,2.93%,SULF1;SPRY4;SPRY1;FGFBP3
prerank,regulation of nervous system development (GO:0051960),0.5379913987140993,1.5950961496331408,0.01729106628242075,0.6799425294223564,1.0,8/37,9.91%,PTN;GBX1;NPHP3;TENM4;DOCK7;PER2;LGI4;WNT3
prerank,regulation of histone deacetylation (GO:0031063),-0.6115558657703104,-1.5929802013109517,0.02522935779816514,0.3397894513934328,1.0,6/13,22.66%,CAMK2D;SAP30BP;AKAP8;ZBTB7B;SPHK2;APLNR
prerank,nitric oxide metabolic process (GO:0046209),-0.6031808150850952,-1.5918690510342428,0.03398058252427184,0.3393130082854892,1.0,8/14,25.59%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,T cell differentiation in thymus (GO:0033077),0.6672167913505573,1.591259223998967,0.051457975986277875,0.6911998682183425,1.0,4/14,9.85%,MR1;RABL3;ZFP36L2;GLI3
prerank,negative regulation of developmental process (GO:0051093),-0.40287707815515406,-1.5910460703381515,0.011278195488721804,0.33810310135391514,1.0,25/69,20.89%,NFIB;ROCK2;FOXC1;NOS3;CST3;KLF7;NOTCH1;KANK1;TFRC;CDK6;TBX1;ARHGEF15;MAPT;RC3H1;SFRP1;TBX2;ARPIN;HEY2;ADCK1;RAPGEF3;FGFR3;WNT11;VASH1;HOPX;MIF
prerank,Rap protein signal transduction (GO:0032486),-0.6728394648071969,-1.5899267167256041,0.024886877828054297,0.33796050188882676,1.0,7/10,23.30%,RAPGEF2;RAP1A;RAPGEF1;RAPGEF3;RAP2C;RAP2B;RAP1B
prerank,regulation of cell migration (GO:0030334),-0.32378877616322854,-1.5894179519519542,0.0,0.33617546462445974,1.0,119/382,15.36%,FLT1;PDGFD;PLXNA2;CLIC4;EPHA4;IGF1;TJP1;LMO4;SYNE2;ROCK2;DPYSL3;SEMA3D;SEMA3C;LEF1;WNT5B;CAV1;PLXNA4;VCL;PTPRJ;SLIT2;PECAM1;ROBO1;PODXL;EGFR;AFDN;MYLK;IGF1R;ITGB1;FER;PTPRK;THBS1;IGFBP5;SEMA7A;ARID2;TPM1;CDH1;ITGA6;CLDN5;RDX;DACH1;MAGI2;LIMCH1;MCTP1;KDR;INSR;SOD2;NOTCH1;RUFY3;CYP1B1;ACTG1;PHACTR1;AMOT;KANK1;MINK1;ANXA1;APC;RAC1;SMO;DAB2;NEDD9;ACE;ADAM10;SRGAP3;SRGAP2;SEMA6A;SEMA4B;PDGFA;PPM1F;CCN1;SH3RF2;ACVR1;PRR5L;TMEFF2;RHOC;FGF1;ACVRL1;PDGFC;PLXNB1;FRMD5;CITED2;IFITM1;ENPP2;SFRP1;SERPINE1;PIK3CD;FAM107A;CAMK2B;SPAG9;SPATA13;EPHB2;ELP5;ROBO4;SEMA5B;RNF41;CTSH;MYO1C;LMNA;CD151;MDK;DAG1;ARPIN;DLG5;RET;CEACAM1;TRIP6;AMOTL2;ATM;FLNA;MACF1;PTK2B;SERPINE2;CPNE3;TMSB4X;CDH5;CX3CL1;RAP2C;PLXNA1;ARSB;EDN1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.52234854428013,1.5893616141339573,0.020172910662824207,0.6920355815691214,1.0,9/46,2.28%,LAMC3;LAMC1;PIK3R1;LAMB1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,phagolysosome assembly (GO:0001845),0.6845906204346689,1.5886001767955644,0.027124773960216998,0.686861419757557,1.0,4/12,10.41%,RAB34;RAB20;SYT7;ARL8B
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.6187348302721118,-1.5883614753955657,0.023752969121140142,0.33576273495694464,1.0,6/13,20.42%,GOPC;YWHAB;NFKBIA;FLNA;SUFU;GET4
prerank,lamellipodium assembly (GO:0030032),-0.5076719918045107,-1.5883502897186899,0.01977401129943503,0.33265935983074907,1.0,9/26,11.40%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SRGAP2;SPATA13;CCDC88A
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5645363802935465,1.5880467737842638,0.025602409638554216,0.6809467963320935,1.0,13/33,11.54%,GRID2;CEL;GRID1;GRIK5;GRIK2;ABR;GRIK4;FABP5;GRIK1;RELN;LRRC4C;NRG3;PSMC5
prerank,stress fiber assembly (GO:0043149),-0.5890305291307795,-1.5878860488505413,0.032418952618453865,0.3278573030516305,1.0,4/15,4.52%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5890305291307795,-1.5878860488505413,0.032418952618453865,0.3278573030516305,1.0,4/15,4.52%,SORBS1;FAM171A1;ITGB1;PHACTR1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5630174930723973,-1.5878547718719243,0.015706806282722512,0.324944083868507,1.0,11/18,33.53%,ITGB1;JAM2;SLC39A8;CX3CR1;GCNT1;VCAM1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5467702151718897,1.587250237984944,0.04057971014492753,0.6763129274600832,1.0,9/37,12.41%,APOD;PPARA;ABCD2;TLR6;ADCY7;APPL2;TLR4;PYCARD;PDCD4
prerank,presynapse organization (GO:0099172),0.7115263605182733,1.5870853068080941,0.039568345323741004,0.6688993902758658,1.0,3/10,4.15%,WNT5A;C5AR1;LRRTM3
prerank,brain development (GO:0007420),0.4472016556643311,1.5867738682556838,0.004866180048661801,0.6624105944089667,1.0,36/136,16.34%,APOD;ROBO2;ADGRL3;EPHA7;COL4A1;ZFHX3;MEIS1;CTNNA2;HSPG2;PTEN;CNTNAP2;GRIN2B;MEIS2;AFF2;SOX6;ZIC1;NF1;CNTN4;GRIN2A;IER3IP1;DSCAML1;RELN;ABCB6;AMIGO3;SMARCA1;PLXNB2;EML1;ARNT2;BPTF;BAG6;CHD8;PBX2;CENPF;TBC1D23;NDUFS4;SMG9
prerank,positive regulation of neuron projection development (GO:0010976),0.4722803202444656,1.5856978986798371,0.013333333333333334,0.6598684508741866,1.0,22/85,14.06%,ROR1;PTN;NTRK3;ROR2;TENM3;WNT5A;NTRK2;CAPRIN1;PRKCI;PRKD1;RELN;STMN2;P3H1;BMP7;EPHA3;DHX36;PLXNB2;RETREG3;ARHGAP35;LRRC7;CUX2;LYN
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5653310482280769,-1.5848918990456538,0.02617801047120419,0.3294087366922911,1.0,8/18,16.72%,ROCK2;TEK;RUFY3;KANK1;PTK2B;CDH5;LLGL2;BCAS3
prerank,cristae formation (GO:0042407),-0.4905940000048188,-1.5822394092110643,0.015151515151515152,0.33339706395271945,1.0,16/27,31.74%,APOOL;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;ATP5MC2;ATP5F1D;ATP5MC1;CHCHD3;LETM1;APOO;UQCC3;ATP5F1A;ATP5PF;ATP5MF;ATP5MC3
prerank,protein autoprocessing (GO:0016540),0.6401102441915554,1.5819643479225125,0.043993231810490696,0.6703133881735609,1.0,6/17,13.88%,CASP4;OMA1;FXN;HTRA2;SPRTN;MYRF
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.5800414435039709,-1.5810884028583134,0.017582417582417582,0.3331218425349543,1.0,6/16,6.47%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;MAPK14
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6136748696294902,-1.578871775195638,0.03309692671394799,0.33584952622324493,1.0,8/13,25.59%,NOS3;CYP1B1;CYB5R3;GCH1;NOS1;AKT1;DDAH2;NQO1
prerank,sensory perception of sound (GO:0007605),0.47310898416888436,1.5766084492698398,0.013386880856760375,0.6880480680463894,1.0,6/88,1.84%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,modified amino acid transport (GO:0072337),0.6462872576530478,1.5761789586389308,0.05025996533795494,0.6821045436457313,1.0,3/15,1.44%,SLC6A13;SLC6A8;SLC16A12
prerank,negative regulation of chemokine production (GO:0032682),0.6642049574048524,1.5755274081264212,0.03826086956521739,0.6776398900242873,1.0,1/14,0.04%,APOD
prerank,fatty acid metabolic process (GO:0006631),0.4480049993517072,1.573771000429641,0.006321112515802781,0.6784856183651437,1.0,25/115,15.43%,LPIN3;GGT5;PPARA;ACOX2;ACSF2;ABCD2;CEL;PEX2;PPARD;CRAT;LIPC;LIPH;ACADSB;ECHDC3;PER2;HSD17B8;FA2H;ACOT7;ACSL6;ACLY;SGPL1;NDUFAB1;NUDT19;ACOT2;LPIN2
prerank,regulation of stem cell population maintenance (GO:2000036),0.624948413031888,1.5726549049335015,0.040780141843971635,0.6764825670570358,1.0,8/18,17.60%,PTN;LOXL2;REST;NCOA3;KAT2A;CNOT1;MYC;CNOT3
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6181868928419053,1.5713892873223378,0.03993055555555555,0.6749694373379932,1.0,3/17,4.49%,PTN;IL34;TENM4
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5296826952740682,1.571298645828643,0.037267080745341616,0.6680405875393393,1.0,7/38,11.89%,RORA;CCDC22;NR1H4;CARD19;TLE1;PYCARD;TRIM59
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.4066210118298123,-1.569726375673007,0.01680672268907563,0.3587329780877575,1.0,15/75,9.79%,PLCE1;PLCB1;ROCK2;RGS3;RGS6;RGS5;NMT2;MGRN1;RGS12;MGLL;YWHAB;CALM1;FRMPD1;RGS4;GIT1
prerank,regulation of T cell migration (GO:2000404),0.6204552072804491,1.5695976333047519,0.04285714285714286,0.6693517225901143,1.0,3/18,1.10%,APOD;CXCL10;TMEM102
prerank,negative regulation of cell motility (GO:2000146),-0.37739038071754083,-1.5692355130573543,0.0,0.35684240758500285,1.0,33/108,11.76%,CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;TPM1;CDH1;CLDN5;DACH1;MAGI2;LIMCH1;MCTP1;CYP1B1;KANK1;SRGAP3;SRGAP2;TMEFF2;ACVRL1;FRMD5;CITED2;IFITM1;SFRP1;SERPINE1;RNF41;DAG1;ARPIN;DLG5
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.633423761269082,1.5677835107982843,0.04421768707482993,0.6713374459076736,1.0,2/16,3.88%,RORA;PDK1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6938553356088207,1.5672899235405133,0.03130434782608696,0.6663463784842156,1.0,5/11,6.91%,LIG3;TIPIN;FBXO5;MSH3;GMNN
prerank,regulation of actin filament depolymerization (GO:0030834),0.67157636186486,1.5650114477322208,0.0415944540727903,0.6704959783368719,1.0,3/12,5.18%,PLEKHH2;SEMA5A;MTPN
prerank,smooth muscle cell differentiation (GO:0051145),0.6837390894391309,1.5648515643336043,0.03103448275862069,0.6642106231981214,1.0,2/12,0.68%,TBX18;TMEM204
prerank,sodium-independent organic anion transport (GO:0043252),-0.6476667901783901,-1.5641348690055878,0.05228758169934641,0.3677551895860631,1.0,3/10,1.96%,SLC16A2;SLCO2A1;SLCO1C1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.6212207318340369,-1.5634581314692655,0.03818615751789976,0.3664162229996953,1.0,8/12,20.87%,LY6E;GSN;TRIM5;TRIM11;IFITM3;IFITM1;SNX3;IFITM2
prerank,regulation of organelle organization (GO:0033043),-0.3944861479903417,-1.5624772067800397,0.0,0.36606404148263394,1.0,23/80,19.08%,CLIC4;TJP1;EZR;DIAPH1;MTM1;ARMH3;F11R;STX18;RDX;VPS35;SQSTM1;MAVS;MAPT;PLXNB1;CLEC16A;SURF4;VPS11;ARL6IP1;LMAN1;PAK2;CAMSAP2;MSN;MARK2
prerank,epidermis development (GO:0008544),0.5009501025950339,1.562417177310112,0.026200873362445413,0.6688267414596295,1.0,11/56,9.47%,EMP1;EDA2R;PLOD1;HDAC1;COL7A1;SVEP1;FABP5;ATP2A2;FLOT2;GLI1;EVPL
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6601865372458829,-1.562199359751213,0.03579952267303103,0.3607475971184298,1.0,7/10,28.27%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2;NSMAF
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6601865372458829,-1.562199359751213,0.03579952267303103,0.3607475971184298,1.0,7/10,28.27%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;SPHK2;NSMAF
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5692611309853486,-1.5620413434740348,0.05569620253164557,0.35830644582826554,1.0,5/16,12.72%,NOTCH2;BMPR2;NOTCH1;TGFB2;HEY2
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5076877453079036,-1.558966418931112,0.02056555269922879,0.3630072381619216,1.0,5/24,7.45%,LPGAT1;PLA2G4A;CDS2;PGS1;ABCA3
prerank,regulation of T cell chemotaxis (GO:0010819),0.6942310720024801,1.558923775938097,0.04569420035149385,0.67886192763767,1.0,3/11,1.70%,XCL1;CXCL10;WNT5A
prerank,sprouting angiogenesis (GO:0002040),-0.43123150252320575,-1.5581006024659743,0.014285714285714285,0.36266689774138483,1.0,23/51,17.85%,TEK;RSPO3;BMPER;SLIT2;ROBO1;THBS1;NRP1;EFNB2;KDR;OTULIN;VEGFD;EPHB4;VEGFC;CCBE1;ACVRL1;ITGB1BP1;NR4A1;FLT4;PTK2B;RAMP2;ESM1;NAXE;AKT1
prerank,negative regulation of cell junction assembly (GO:1901889),0.5645045219310884,1.557965653469627,0.03486529318541997,0.676397211934573,1.0,5/25,3.78%,APOD;ROBO2;DLC1;PTEN;ARHGAP6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6476873165586721,1.5573771725624341,0.03866432337434095,0.6723173152159,1.0,6/14,15.41%,AUTS2;KMT2E;KMT2A;WDR5;SNW1;PAXIP1
prerank,retina homeostasis (GO:0001895),-0.5109731452581695,-1.5571099091510654,0.0171990171990172,0.362262906300435,1.0,7/23,12.23%,ACTB;POTEF;ACTG1;WHRN;B2M;HSPB1;PRDX1
prerank,response to estrogen (GO:0043627),-0.4776873977765843,-1.5564069634384634,0.01694915254237288,0.36122880951327924,1.0,11/31,16.98%,CAV1;NCOA4;TRIM24;TRIM25;WBP2;CITED2;SFRP1;ARID5A;SFR1;BCAS3;ESR1
prerank,renal system development (GO:0072001),0.50519468561865,1.5548785244154142,0.031724137931034485,0.6774641514549873,1.0,7/52,3.13%,TBX18;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5146606751316366,-1.554661348504537,0.043795620437956206,0.36239697987278546,1.0,14/22,36.55%,AEBP1;HSPA8;APOE;MAPT;GPX1;ARL2;CAMSAP2;PARK7;CAMSAP3;MAP1S;EFEMP2;PIK3CA;AKAP13;PRUNE1
prerank,receptor clustering (GO:0043113),0.5710722207215033,1.5538731575296292,0.051839464882943144,0.6756751434371006,1.0,6/27,5.11%,PTN;NRXN2;NRXN1;SCRIB;DLG3;DLG2
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4676476531738313,-1.552857916231731,0.019886363636363636,0.3646072507213166,1.0,20/36,29.01%,SGMS1;DEPTOR;TPD52L1;TMBIM6;FAS;CRADD;MADD;NR4A2;CX3CR1;CYLD;PPIA;CX3CL1;ING5;TRAF1;QARS1;TRIM39;RB1;ASAH2;BDNF;MAPK8IP2
prerank,neural tube development (GO:0021915),-0.5803243350333517,-1.5524149803485752,0.0387409200968523,0.36283297128405206,1.0,5/15,18.84%,ALDH1A2;DVL1;SOX4;SOX11;ARL13B
prerank,regulation of keratinocyte migration (GO:0051547),0.6815209462140956,1.551988891545814,0.06405693950177936,0.6776858890527075,1.0,4/12,9.11%,PTEN;MAP4K4;IQSEC1;MTOR
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6618103761107222,1.5519624932825242,0.044036697247706424,0.6713205069939219,1.0,5/13,8.63%,ENPP1;ENTPD2;ENTPD5;ENPP3;ITPA
prerank,muscle filament sliding (GO:0030049),-0.4548367556873999,-1.5519041102679716,0.01729106628242075,0.35877229142547035,1.0,20/38,40.32%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,actin-myosin filament sliding (GO:0033275),-0.4548367556873999,-1.5519041102679716,0.01729106628242075,0.35877229142547035,1.0,20/38,40.32%,ACTN2;VIM;TPM1;MYL6;DMD;TMOD1;TPM2;TNNT3;MYL4;TNNI1;TPM4;TTN;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,macrophage differentiation (GO:0030225),-0.6017660647929552,-1.5455531505101896,0.042222222222222223,0.37272085102963076,1.0,6/13,24.09%,IL31RA;CDC42;CASP8;SIRT1;CSF1R;PARP1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6620977930606383,1.5438912766006903,0.043327556325823226,0.7034618023673974,1.0,6/14,15.02%,ENPP1;ENPP3;ITPA;AK4;AK8;AK3
prerank,endoderm development (GO:0007492),0.660386806968134,1.543398570022241,0.043782837127845885,0.699012224155217,1.0,2/13,3.91%,LAMC1;DUSP1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4292502726964867,-1.543122316918773,0.01597444089456869,0.376161983512009,1.0,17/51,15.60%,CRIM1;SMAD6;BMPER;LEMD3;NBL1;FSTL1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SMURF2;HIPK2;SMAD1;GREM2;CHRDL1;RBPMS2
prerank,dendrite morphogenesis (GO:0048813),0.5302743690841311,1.542059840697416,0.02748091603053435,0.698775037100726,1.0,7/35,2.41%,PTN;DOCK10;CTNNA2;PTEN;EPHB1;FARP1;ABITRAM
prerank,sensory perception of mechanical stimulus (GO:0050954),0.4643765146775797,1.5415430045944876,0.021534320323014805,0.6948224289079038,1.0,6/85,1.84%,CEMIP;ROR1;TIMM10;ADGRV1;MYO7A;TSPEAR
prerank,Notch signaling involved in heart development (GO:0061314),-0.6243181773859696,-1.5405876288782638,0.03167420814479638,0.37965304327324306,1.0,7/11,16.71%,RBPJ;NOTCH2;NOTCH1;GALNT11;HEYL;HEY2;SNAI1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.6424258749674505,1.5402666609030187,0.04679376083188908,0.6947079822192656,1.0,5/14,8.25%,PPARA;ABCD2;IRS1;IRS2;TWIST1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3705949571311843,-1.5398799335912743,0.012295081967213115,0.37858648967546216,1.0,30/103,15.58%,PLCE1;IGF1;RAPGEF2;RAPGEF5;ARHGEF18;TIAM2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAC1;PLD2;RASGRP3;MAPK14;NUCB1;RALBP1;ARHGAP18;RRAGC;RGL2;CCDC88A;RALB;CCDC88C;BCR;RAB38;RRAS;GRB2;CDKN1A;GRAP
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.6753005682118762,1.539837485872674,0.0535405872193437,0.6904522532314838,1.0,1/12,0.10%,IL33
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.6274838076284327,-1.5397855521474808,0.06398104265402843,0.37607494169652667,1.0,5/11,23.18%,ACTN2;CAV1;CAB39;STK39;CASQ2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5660262212610565,1.5380330714756592,0.049206349206349205,0.6925774995487943,1.0,9/24,16.56%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,circulatory system development (GO:0072359),-0.35746890706757495,-1.5378223800598485,0.0,0.37850850163806915,1.0,41/118,15.83%,HEG1;PLCE1;FN1;TEK;CACNA1C;MEF2C;MICAL2;PDLIM5;CXADR;FOXC1;OSR1;MEF2A;FOXC2;NXN;RBP4;NOTCH1;TGFB2;GLI2;SOX4;TCF25;TBX1;SH3PXD2B;ACVR1;ACVRL1;SOX17;POU6F1;CRIP1;CASP8;FOXL1;CITED2;ZDHHC16;HEY2;TAB2;FLT4;RAMP2;CDH5;STRA6;CACYBP;CDKN1A;PCSK5;MKKS
prerank,glucose metabolic process (GO:0006006),0.49238343529686285,1.5374970253199904,0.02054794520547945,0.6889614460458134,1.0,10/58,7.97%,APOD;MDH1;PFKFB1;GDPGP1;PPARD;IRS2;CRTC2;OMA1;ALDOB;PER2
prerank,sulfate transport (GO:0008272),-0.5891964373129286,-1.535580041270466,0.03777777777777778,0.3821764222965731,1.0,4/14,4.04%,SLC13A4;SLC26A7;SLC26A2;SLC26A11
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5739025230633407,1.5350801334480824,0.038523274478330656,0.6941470599331914,1.0,2/24,0.66%,RORA;SULF1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4584906756151412,-1.5336375983692363,0.0273972602739726,0.38464646893464527,1.0,8/34,5.89%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;RAC1;NEDD9;CDC42
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4889910389194184,-1.533319520082392,0.02717391304347826,0.3825599935233306,1.0,14/28,24.35%,IRAK2;OTULIN;UBB;AAMP;CASP8;LACC1;TAB2;CYLD;UBE2N;UBC;TNFAIP3;UBA52;IKBKG;NOD2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.49793069379222743,1.5323528953396641,0.027982326951399118,0.7012215783182567,1.0,8/51,9.06%,PTN;IL34;XCL1;CXCL10;EDN3;PTK2;PLA2G7;LGMN
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6269307548135574,-1.5319956126007983,0.04524886877828054,0.3833208772388799,1.0,5/10,22.66%,MGRN1;PDE3A;PDE11A;CDC34;APLNR
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.602321191339485,1.5319877561648487,0.03915171288743882,0.6968290162175541,1.0,4/19,7.78%,ENPP1;TPST1;SLC35B3;PAPSS2
prerank,positive regulation of vascular permeability (GO:0043117),-0.5941743503085979,-1.531030567897916,0.03526448362720403,0.3831934357334206,1.0,5/12,13.30%,TJP1;OCLN;PDE3A;TJP2;TRPV4
prerank,positive regulation of leukocyte activation (GO:0002696),0.6022327503848712,1.5303891549826105,0.054455445544554455,0.6981165325747616,1.0,5/18,9.41%,IL33;WNT5A;TSLP;TLR6;TLR4
prerank,endothelial cell development (GO:0001885),0.5618180108511519,1.530282476464757,0.04107424960505529,0.6925370370716667,1.0,3/25,2.43%,COL15A1;COL18A1;COL22A1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.6326252550564864,-1.5301105911481012,0.044444444444444446,0.3828348090176445,1.0,2/10,4.88%,NFKB1;SREBF2
prerank,dermatan sulfate metabolic process (GO:0030205),0.6607882050434875,1.529879715071642,0.0506108202443281,0.6886768522675787,1.0,4/13,3.66%,DCN;BGN;DSE;VCAN
prerank,negative regulation of nervous system development (GO:0051961),0.6184681230108118,1.529050938062967,0.04195804195804196,0.6866171274884623,1.0,4/17,9.09%,ROBO2;REST;SORL1;APPL2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5099825630255547,1.5276498684178348,0.040061633281972264,0.687104421089411,1.0,13/41,16.56%,XCL1;ITPR1;GRIN2B;RYR2;HTR2B;GRIN2A;TRPV3;HTR2C;TRPM2;RYR3;F2R;CACNA2D1;CHERP
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.5626389981364568,-1.526820909248664,0.03676470588235294,0.38847912044564414,1.0,9/15,28.48%,SMPD3;SIRT3;PLA2G6;PRKCD;TNFRSF1A;ORMDL2;SPHK2;NSMAF;SAMD8
prerank,axonogenesis (GO:0007409),0.40617367010945676,1.5262417821868666,0.002224694104560623,0.6880878066444901,1.0,67/237,16.74%,LAMA1;ROBO2;LAMA2;PIK3R1;ISL2;EPHA7;AUTS2;CTNNA2;WNT5A;PTEN;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;ANK3;EPHA6;UNC5A;ADGRB1;NEFH;DSCAM;RAB8A;CNTN4;IRS2;LLGL1;DAB1;DOCK7;DSCAML1;PTPRO;UNC5C;PTK2;RELN;PALLD;EPHB6;DCC;NRXN3;PRKCA;NEXN;CNTN6;OPHN1;LYPLA2;EPHA3;PPP3CB;PTPRA;DOK5;FYN;USP33;UNC5D;GFRA1;ARHGAP35;SH3KBP1;KIF5C;GFRA2;EPHA5;EVL;GDNF;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;ULK2;TUBB3;EFNA1;CYFIP1;SLITRK1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6287412469895456,1.5247866212551384,0.05821917808219178,0.6889050669109982,1.0,3/14,1.52%,SULF1;SPRY4;SPRY1
prerank,nucleotide catabolic process (GO:0009166),-0.5572910476458595,-1.5246211619128864,0.036057692307692304,0.3913140564016679,1.0,9/16,19.98%,SAMHD1;DERA;NUDT3;XDH;VCP;GPX1;NT5E;GDA;NT5C1A
prerank,negative regulation of cell migration (GO:0030336),-0.35307964668515407,-1.5245080544024625,0.005847953216374269,0.38897186847690973,1.0,38/137,11.76%,PHLDB2;CLIC4;EPHA4;DPYSL3;VCL;PTPRJ;SLIT2;ROBO1;AFDN;PTPRK;IGFBP5;ARID2;TPM1;CDH1;CLDN5;DACH1;MAGI2;LIMCH1;MCTP1;IGFBP3;PTPRG;CYP1B1;KANK1;RAC1;SRGAP3;SRGAP2;ARHGDIB;TMEFF2;ACVRL1;ITGB1BP1;CITED2;IFITM1;SFRP1;SERPINE1;RNF41;DAG1;ARPIN;DLG5
prerank,regulation of lamellipodium organization (GO:1902743),-0.5828202092521886,-1.524315249043072,0.04751131221719457,0.38672030255379947,1.0,9/14,21.82%,FER;RAC1;CAPZB;CDC42;CD44;PDPN;EPHA2;TWF2;DMTN
prerank,positive regulation of chemotaxis (GO:0050921),0.5109222459334041,1.5240163565654543,0.03576982892690513,0.6867120900913322,1.0,9/43,11.17%,PTN;NTRK3;XCL1;EDN3;SEMA5A;DSCAM;PRKD1;LGMN;P2RX4
prerank,leukocyte tethering or rolling (GO:0050901),-0.5492520596290327,-1.5239613199367914,0.02518891687657431,0.3849660312184459,1.0,10/17,33.53%,ITGB1;JAM2;CX3CR1;GCNT1;VCAM1;PODXL2;ADD2;SELPLG;SELP;ITGB7
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5029687024453849,-1.5239162885381872,0.02185792349726776,0.3824734573198753,1.0,14/26,24.35%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TIFA;ALPK1;TNFAIP3;UBA52;IKBKG;NOD2
prerank,bile acid biosynthetic process (GO:0006699),0.5718328946372331,1.523398174658067,0.048701298701298704,0.6839008940764068,1.0,4/24,3.45%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,regulation of neuroblast proliferation (GO:1902692),0.634700968496118,1.5213202991776897,0.06108202443280977,0.6879598975022878,1.0,4/15,5.91%,PTN;LRRK2;NF1;DISC1
prerank,regulation of protein import into nucleus (GO:0042306),0.5220845195493928,1.5209772000753279,0.04142011834319527,0.6842013066557057,1.0,6/36,4.81%,APOD;PIK3R1;JUP;PIK3R2;ZIC1;MDFIC
prerank,protein oxidation (GO:0018158),0.6870305018796301,1.5195176256339518,0.06761565836298933,0.6853394999309388,1.0,3/11,4.22%,LOXL4;LOXL3;LOXL2
prerank,cellular glucan metabolic process (GO:0006073),-0.6183800933547284,-1.5188603280601278,0.05238095238095238,0.39397324925656974,1.0,5/11,13.48%,PRKAG2;GBE1;GSK3B;UGP2;PPP1R3C
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6612465579878317,1.5188297416213263,0.057291666666666664,0.6831102612669815,1.0,4/12,14.06%,IL34;PTK2;IL12A;LYN
prerank,positive regulation of T cell migration (GO:2000406),0.596495095932085,1.518520711003471,0.058823529411764705,0.6791861892384761,1.0,4/20,1.70%,XCL1;CXCL10;TMEM102;WNT5A
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4864878267204428,1.518432497719876,0.027417027417027416,0.6744175170716211,1.0,19/57,24.26%,ADCY5;AKAP5;GPR37L1;ADCY8;ADCY3;ADCY2;HTR5A;HTR1A;ADCY7;LPAR1;HTR4;GPR37;GRM7;ADRA2A;CHRM2;GNAI3;ADCY1;P2RY12;GRM8
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5288956912375974,-1.5177825296398357,0.04473684210526316,0.3942894783576089,1.0,11/20,10.21%,IGF1;SLIT2;IGFBP5;NRP1;IGFBP3;VTN;S100A11;ACE;PDGFA;SERPINE1;CCN4
prerank,supramolecular fiber organization (GO:0097435),0.3997596866345271,1.5169000050015489,0.0,0.6759216051257801,1.0,66/334,12.94%,COL15A1;COL4A6;COL13A1;COL4A5;COL27A1;COL18A1;COL4A1;RND3;LOXL4;COL23A1;GGA2;LUM;TGFBI;PLOD1;COL10A1;ERMN;ADAMTS14;HSPG2;MYO7A;MARCKS;COL22A1;COL7A1;NCKAP5L;COLGALT1;DPT;TNXB;TCHH;ELMO1;LOXL3;LOXL2;COLGALT2;PPP1R9A;RAC3;MFAP4;MYO1B;SORL1;COL12A1;COL26A1;NF1;CLIP3;ACTN1;CAPN3;CALCA;COL1A2;COL16A1;RHOBTB3;MYO6;CALB1;STMN2;CLRN1;COL4A2;P3H1;WDR73;ADAMTS2;STMN4;ZBED3;KATNA1;SLK;TGFBR1;IAPP;MYO1G;TUBGCP4;FIGNL1;CEP126;TRIOBP;CLIP2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6737944606366484,1.5149078014554584,0.060714285714285714,0.680004059289373,1.0,1/10,0.10%,IL33
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5308409826516556,-1.514217882887938,0.04187192118226601,0.4015420399007179,1.0,8/17,16.71%,RBPJ;NOTCH2;NOTCH1;ACVR1;GALNT11;HEYL;HEY2;SNAI1
prerank,inflammatory response (GO:0006954),0.4040085172700107,1.5136282736949962,0.0035335689045936395,0.6806703565278801,1.0,22/195,6.49%,SCUBE1;GGT5;IL1RN;IL2RA;XCL1;CXCL10;PTGFR;CXCL1;HSPG2;CD40;C5AR1;TPST1;MMP25;NFATC3;LOXL3;FOS;TLR6;CCL15;ADORA2A;ADORA1;PRDX5;ADCY8
prerank,response to purine-containing compound (GO:0014074),0.6105927916464835,1.5119671408482043,0.05844155844155844,0.6827054258005834,1.0,10/17,23.93%,P2RY1;RYR2;DGKQ;TRPC3;P2RX4;TRPM2;NDUFS4;ABCC9;STAT1;P2RY6
prerank,pore complex assembly (GO:0046931),-0.5203550394366664,-1.5113135379402467,0.03183023872679045,0.40662722528273176,1.0,9/19,15.31%,ANO6;AFDN;ADAM10;BAD;NUP98;NUP153;TMEM170A;P2RX7;NUP205
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5789004478367549,1.5095539530493127,0.04918032786885246,0.6884737320426764,1.0,8/22,16.91%,DYNLL1;CDKN2A;CDKN2D;BMP7;TP53;ANKLE2;CDKN2C;PRKRIP1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.6141041320279326,1.508718126780761,0.06282722513089005,0.6870061690296081,1.0,4/17,2.66%,CASK;SULF1;TMEM204;ITGA3
prerank,presynapse assembly (GO:0099054),0.6073214979352805,1.5083807264124736,0.05970149253731343,0.6834736317458502,1.0,4/16,4.15%,WNT5A;PTEN;CEL;LRRTM3
prerank,intestinal lipid absorption (GO:0098856),0.6692996923728732,1.5071796872826562,0.0711864406779661,0.683875940126222,1.0,3/11,10.30%,NPC1L1;CEL;SOAT2
prerank,cellular response to glucagon stimulus (GO:0071377),0.5975388070351163,1.5052190697571552,0.05922165820642978,0.687783349891144,1.0,7/17,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,protein hydroxylation (GO:0018126),0.6176258591357524,1.5051084627249816,0.07042253521126761,0.6833499108563273,1.0,8/15,17.94%,PLOD1;HIF1AN;VIPAS39;P3H1;P3H3;ASPH;VPS33B;PLOD2
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.5540038806415151,-1.5048926979714428,0.06005221932114883,0.42185380194209154,1.0,8/15,21.98%,RBPJ;EGFR;FER;CEACAM1;RHBDF2;ERBB2;EGF;MVB12B
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6713825674638827,1.5042295401428498,0.07557117750439367,0.6822550320748288,1.0,4/10,12.54%,ENPP1;APPL2;PRKCB;GSK3A
prerank,cellular response to alcohol (GO:0097306),0.5074008473342857,1.5032773169070512,0.029850746268656716,0.6815560677073959,1.0,14/42,14.53%,PTGFR;GRAMD1B;ADCY5;GPLD1;JUP;ADCY8;ADCY3;ADCY2;ADCY7;GLRA1;SPIDR;GLRA2;MAP4K1;GNG2
prerank,bile acid metabolic process (GO:0008206),0.5533308987531989,1.502778919218017,0.05263157894736842,0.6789228684105488,1.0,4/27,3.45%,CYP7B1;ACOX2;OSBPL3;OSBPL6
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5768536025278856,1.502566498936446,0.04950495049504951,0.6751461486513491,1.0,7/21,8.88%,ADCY5;ADCY10;ADCY8;ADCY3;ADCY2;AMPD2;ADCY7
prerank,ganglioside biosynthetic process (GO:0001574),-0.5771234259035091,-1.5020433638658786,0.0475,0.4271085078369416,1.0,7/15,15.78%,ST8SIA4;B4GALT5;ST3GAL1;ST6GALNAC3;ST8SIA2;ST3GAL5;ST3GAL2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6501047391062684,1.50194922746165,0.07401032702237521,0.6729660969881852,1.0,5/12,12.48%,MYCBP2;PTEN;EPHB1;EPHB6;ARHGAP35
prerank,regulation of protein kinase A signaling (GO:0010738),0.5834138364949929,1.501585411818246,0.04498269896193772,0.670135459402962,1.0,7/20,14.44%,AKAP5;ADGRV1;AKAP7;LRRK2;IAPP;AKAP6;PRKAR1A
prerank,negative regulation of GTPase activity (GO:0034260),-0.5049819541970354,-1.5012523665625774,0.05623471882640587,0.42645080344355996,1.0,8/22,11.17%,LRCH1;F11R;RDX;SH3BP4;WNK1;CPEB2;ARL2;GMIP
prerank,muscle cell migration (GO:0014812),-0.6323386501279358,-1.5000393392340787,0.059770114942528735,0.4270353429347684,1.0,5/10,11.86%,CCN3;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5518654336598364,1.4998379599923763,0.0464,0.6728743930615603,1.0,2/26,0.66%,RORA;SULF1
prerank,regulation of plasminogen activation (GO:0010755),-0.5925434244401286,-1.4981779269579822,0.06607929515418502,0.4296507040241897,1.0,6/12,14.37%,THBS1;RUNX1;SERPINE1;ENO1;SERPINE2;CTSZ
prerank,positive regulation of immune system process (GO:0002684),-0.5517862769507491,-1.4981008442055979,0.05063291139240506,0.42710370154412247,1.0,4/16,9.97%,TGFB2;ANXA1;PIK3CB;PIK3CD
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.45284679182412274,-1.497917761793251,0.029498525073746312,0.4250203895146921,1.0,11/32,14.25%,HMBOX1;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;ATM;MAP3K4
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.31059411273363635,-1.4973334802207465,0.0,0.42404354740698813,1.0,133/306,28.30%,MEF2A;RPS14;RPS9;RPS16;PTMA;ST3GAL4;RPLP1;RPL13;DRG1;TOP1;B4GALT5;RPL27A;RPS2;RPL37A;ALAS1;RPL5;RPL8;RPS7;RPL41;RPS18;RPS20;EXT1;RPS19;RPS24;RPS27;RPS15;APOE;RPL21;TBRG1;RPL10;EEF1G;RPL35A;LARGE1;RPS15A;RPL10A;RPS5;RPL11;ABCF1;RPL36A;PTMS;EEF1A1;RRAGC;RBBP8;ORC6;NR4A2;RECQL5;RPL34;POLR2B;ATR;RPLP2;RPS29;RPL32;RPL4;RPLP0;POLR2H;EEF2K;RPL30;RPL26;RPS4X;TERT;RPS21;RPL29;POLR2G;ATM;RPS8;EEFSEC;FUT9;EEF1D;POLR2C;POLE2;NBN;ING4;MRPS7;KAT5;RPL31;ST3GAL2;GCNT1;RPS23;ING5;RPL23A;GTPBP1;DONSON;SRBD1;MRPS17;AGO2;RPL19;HUS1;RPL36;HOXD3;ORC1;GSPT2;CREBL2;MCM6;MRPS18A;GAL3ST2;TYMS;MRPS18B;RPL17;RPL23;E2F1;MCM9;TOP1MT;MRPL24;RPS11;MRPL55;POLD2;MCM8;GSPT1;RPA2;RPL15;ATRIP;RPL38;RMI2;HARS2;CDC45;NT5M;BRCA1;PCLAF;BRIP1;MRPL36;MRPL35;RPL13A;POLR2I;RPS25;CHEK1;POLR2K;RHNO1;RPS12;MRPS12;FARSB;MRPL34;RPL24;RPL18A
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.416032332796121,-1.496759622461493,0.03225806451612903,0.42310923089282815,1.0,14/41,22.48%,MEF2C;RBPJ;TPM1;CPE;NOTCH1;TGFB2;SOX4;HEYL;HEY2;SOX11;TGFBR3;PKP2;TGFBR2;SMAD7
prerank,lipoprotein transport (GO:0042953),0.6842917070306225,1.494488724174872,0.06972477064220184,0.6913331273977278,1.0,7/10,24.91%,LRP1;UNC119;PRKCB;MIA3;UNC119B;ZDHHC17;VMP1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.45186430101304537,-1.4941947430686993,0.0431266846361186,0.4277728368370614,1.0,15/35,26.88%,PICALM;HIP1R;VTN;RAC1;B2M;RAB21;PIK3CB;SERPINE1;HIP1;HFE;HNRNPK;CCL19;FLOT1;BICD1;ARF1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3712433545235876,-1.4938049692887774,0.0,0.42615757712450036,1.0,29/86,14.55%,PLCE1;IGF1;ARHGEF18;DENND4A;ARHGEF28;KANK2;NOTCH2;RASGRF1;RDX;SHOC2;SQSTM1;NOTCH1;TGFB2;KANK1;DENND3;GABARAP;ARHGAP17;RAPGEF1;NGF;ARHGDIB;EPS8L2;MADD;EPHB2;STK19;MAPKAP1;BCR;DENND1A;DENND4C;GRB2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.5594574116063744,-1.492535287063503,0.046189376443418015,0.42702214931426064,1.0,8/14,28.15%,THBS1;KLF4;NOTCH1;ITGB1BP1;MAP2K5;CARD10;DLL4;HDAC5
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5895078295617306,1.492454739109949,0.07211538461538461,0.695372746203213,1.0,3/18,7.46%,APOD;MDFIC;POLR1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.47952388957956604,-1.492268868404244,0.04461942257217848,0.42510382409339975,1.0,8/24,22.66%,RAPGEF2;MGRN1;PDE3A;PDE11A;PRKAR2A;PRKAR2B;CDC34;APLNR
prerank,regulation of BMP signaling pathway (GO:0030510),-0.38559732693944226,-1.4922183045904602,0.022727272727272728,0.4226838952858912,1.0,17/73,8.17%,CRIM1;SMAD6;RBPJ;BMPER;LEMD3;NBL1;XIAP;FSTL1;BMPR2;FOXD1;SKIL;NOTCH1;SKI;UBE2D3;CCN1;ACVRL1;SMURF2
prerank,interstrand cross-link repair (GO:0036297),0.4814475903342831,1.4917185254766951,0.04016620498614958,0.6939380654401497,1.0,13/53,11.96%,FANCI;ERCC6L2;ERCC1;FAN1;USP1;FANCA;NEIL3;RPA1;ERCC4;RNF168;FAAP100;FAAP20;POLN
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6059244241896591,1.4906562681222753,0.064891846921797,0.694207581052972,1.0,7/18,6.20%,GRID2;GRID1;GRIK5;GRIK2;GRIK4;NAPB;GRIK1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5394962320821988,1.4897838693425522,0.06635071090047394,0.6938027608873133,1.0,9/26,16.56%,XCL1;ITPR1;RYR2;HTR2B;HTR2C;TRPM2;RYR3;F2R;CHERP
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6101704930772703,1.4888201216965833,0.06206896551724138,0.6933804494021949,1.0,6/16,9.37%,SEC16B;SEC16A;RYR2;GBF1;LRRK2;TAPT1
prerank,activation of protein kinase A activity (GO:0034199),0.6079155825020292,1.488396910602734,0.06655290102389079,0.6907170844187658,1.0,7/16,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.42849761410294623,-1.4880885325975852,0.01529051987767584,0.43172071976271914,1.0,20/39,28.61%,RPS14;RPS16;RPS7;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RIOK1;RPS5;RIOK3;MRPS7;NPM1;NOL11;TSR3;PWP2;LTV1;RPS25;RRP36
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.47060311865070803,-1.4876956162106996,0.0423728813559322,0.4301736944202479,1.0,12/26,21.22%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;TRPV4;MET;CDK5RAP2;NUMA1;FES;KATNB1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6481764300730174,1.4867463722643302,0.08540925266903915,0.6933561596924127,1.0,5/12,12.29%,BOD1;CENPE;RMDN1;CENPC;CDT1
prerank,regulation of telomere capping (GO:1904353),-0.4861918916685678,-1.4867458460348832,0.05102040816326531,0.43053921579651194,1.0,8/23,14.36%,SMG6;TNKS2;NEK7;MAP2K7;RTEL1;ATM;MAP3K4;NBN
prerank,positive regulation of hydrolase activity (GO:0051345),-0.34222738917976486,-1.4867448102835084,0.0,0.42802144260471947,1.0,40/137,15.41%,PKP4;CD200;PICALM;RAPGEF2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;RASGRF1;S100A10;RAP1A;NDEL1;CAV2;SRGAP2;RAPGEF1;CALM1;GSK3B;MTMR9;RHOC;RSU1;RALBP1;PLXNB1;SGSM2;SFRP1;MAPRE2;CTSH;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;RAPGEF3;CX3CL1;EZH2;RAP1GDS1;RGS10
prerank,axonemal dynein complex assembly (GO:0070286),0.5346326041370368,1.4864437943815925,0.061611374407582936,0.6902746108785424,1.0,7/28,9.67%,CCDC63;ODAD4;DNAAF4;DNAAF3;TTC12;DNAI4;CCDC65
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5604242303039555,-1.4860681747728508,0.05324074074074074,0.4275128695300999,1.0,7/14,16.72%,NCOA4;TRIM24;WBP2;SFRP1;ARID5A;SFR1;BCAS3
prerank,response to progesterone (GO:0032570),-0.5234827969068997,-1.4827269572191224,0.054404145077720206,0.4345346157183755,1.0,5/18,9.86%,CAV1;THBS1;TGFB2;WBP2;ABHD2
prerank,regulation of kinase activity (GO:0043549),0.4342103960887839,1.4820427479796254,0.026595744680851064,0.7051775895505438,1.0,19/89,10.40%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;NPRL2;EPHA6;ANKRD54;CAMKK2;IRS2;EPHB6;AXL;FGR;EPHA3
prerank,cellular response to interleukin-12 (GO:0071349),-0.4142614178392296,-1.4812965481894869,0.026706231454005934,0.4361785400133843,1.0,20/48,23.30%,PLCB1;SIRPA;SOD2;CDC42;TALDO1;PITPNA;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,peptide catabolic process (GO:0043171),0.5779588238211525,1.4809232956512846,0.05057096247960848,0.7058328480496573,1.0,4/23,4.90%,ECE1;GGT5;GGT7;CPQ
prerank,regulation of nervous system process (GO:0031644),-0.517509444460931,-1.4807731813194853,0.05263157894736842,0.43518788177465456,1.0,4/18,2.48%,ROCK2;SLC8A3;NOS3;APP
prerank,apical protein localization (GO:0045176),-0.6316896293916925,-1.4804347706273755,0.05543237250554324,0.4335424740781598,1.0,6/10,12.33%,ACTB;SHROOM3;GOPC;MAL;ATP8B1;SHROOM2
prerank,neuron migration (GO:0001764),0.48342076188895433,1.4800712727852778,0.049475262368815595,0.7047808048936146,1.0,12/48,8.43%,SH3RF1;ADGRL3;AUTS2;NTRK2;ASTN2;FGFR1;DNAAF4;LRP12;CDKL5;DISC1;ASTN1;RELN
prerank,microvillus organization (GO:0032528),-0.5837827103561177,-1.4787440197644162,0.08293838862559241,0.4359030656620426,1.0,6/13,5.01%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,regulation of fat cell differentiation (GO:0045598),0.4550683360076101,1.4780094483665613,0.031724137931034485,0.7091884938530627,1.0,19/74,18.49%,RORA;ENPP1;WNT5A;LRP3;PTPRQ;PPARD;RUNX1T1;ZBTB16;ZFP36L2;WDFY2;ZFPM2;FTO;CARM1;ASXL1;FERMT2;TAF8;FRZB;BMP2;ALOX5
prerank,regulation of vasculogenesis (GO:2001212),-0.5711401688496519,-1.477515780232391,0.06912442396313365,0.4367329269462505,1.0,8/14,13.99%,RAPGEF2;KDR;RAP1A;CD34;XDH;CEACAM1;HEY2;RRAS
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3713058325004377,-1.4774217804504362,0.012145748987854251,0.4345274437034163,1.0,18/82,10.61%,RANBP3L;CRIM1;SMOC1;IGF1;SMAD6;DDX5;MEF2C;BMPR2;NOTCH1;WNT4;SKI;IL6ST;CDK6;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,nervous system development (GO:0007399),0.3808787777521521,1.4769791899540445,0.0,0.7093086569447279,1.0,110/429,17.45%,CHST8;ROBO2;CHD7;PTN;ADGRL3;RBFOX1;NRG1;GPM6B;MERTK;TEAD1;ADGRV1;CXCL1;UNC119;MARCKS;PTEN;SEMA5A;ERBB4;EPHB1;SH3GL3;FARP1;ADGRA2;NRXN2;BTBD2;NRXN1;ZIC4;ASIC2;WDPCP;PCDHA5;VCAN;POU3F3;TBX3;DPYSL2;PCDHB16;SOX6;ZIC1;DCHS1;PRX;ZBTB16;APLP1;ADGRB2;ADGRB1;DSCAM;ADORA2A;NF1;CNTN4;ADORA1;GRIK1;LIMK1;PCDHB4;SZT2;HAPLN2;PCDHB11;RPS6KA6;NPAS2;DSCAML1;UTP11;NAV2;RELN;DHX30;AXL;NAV3;RAB29;TENM1;LSAMP;MBP;CNTN6;AHI1;LPAR1;OPHN1;SOX10;ALDH5A1;PRPS1;FGF12;RBFOX3;NDUFV2;FKTN;DLG4;TGFBR1;GFRA1;CBLN1;MYT1L;DPF2;ANKLE2;ATN1;SDCBP2;SCN2A;ADAM22;ATXN3;ARNT2;GFRA2;HAPLN3;FGF5;EVL;APBA2;NRSN2;KIRREL3;GDNF;TRIM3;HAPLN1;GLRB;NRCAM;IGF2BP3;CHERP;JAG1;SLITRK1;NHEJ1;ZIC5;CDK5;LDB2;LDB1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4577595130528752,-1.4764626092442559,0.025787965616045846,0.4346839554425803,1.0,13/31,14.07%,PPP1R13B;HIP1R;YWHAB;GSK3B;YWHAG;CASP8;BAD;BAX;PPP3CC;PPP3R1;BID;BOK;ZNF205
prerank,positive regulation of embryonic development (GO:0040019),-0.5122188423551978,-1.4762991000339571,0.047244094488188976,0.4327186705562631,1.0,6/19,10.18%,PLCB1;OSR1;WNT4;B4GALT5;CFL1;NIBAN2
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.38055327377262554,-1.4754074373835893,0.017094017094017096,0.4328020469319806,1.0,17/72,8.73%,HEG1;ARHGEF18;ROBO1;ARHGEF28;NET1;KANK2;F11R;NRP1;GPR4;KANK1;RASIP1;RAC1;PRAG1;APOE;ARHGDIB;RALBP1;EPS8L2
prerank,negative regulation of biosynthetic process (GO:0009890),0.5906549707754855,1.474864831105796,0.06435643564356436,0.7141719142698961,1.0,3/16,2.33%,PPARA;SLC30A10;ABCD2
prerank,sensory perception (GO:0007600),0.4842835327218123,1.4745179786154592,0.049475262368815595,0.7115013195608371,1.0,10/45,11.17%,TRPA1;ADGRV1;MYO7A;NIPSNAP1;C5AR1;PDYN;ADORA2A;PTGES;CLRN1;P2RX4
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5195296618050181,-1.4716470247525115,0.05185185185185185,0.4410563425135673,1.0,5/19,6.17%,SLCO1C1;APP;KLF4;NFKB1;KLF2
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5990222938198769,-1.471446126248553,0.06605922551252848,0.4391622314746381,1.0,5/11,16.47%,MEF2C;EFNB2;TGFB2;GPER1;MYOCD
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.49835008611331266,-1.4703660002237449,0.034574468085106384,0.4398296932559188,1.0,8/22,15.53%,SLIT2;KANK3;HIP1R;GSN;KANK1;SSH1;TMSB4X;PRKCD
prerank,diacylglycerol metabolic process (GO:0046339),-0.4801366135346766,-1.4700262594548188,0.042134831460674156,0.43831412921711466,1.0,6/23,12.52%,PLCE1;DGKH;PGS1;DGKG;LIPE;DGKZ
prerank,microvillus assembly (GO:0030033),-0.5684078940951597,-1.4693078000365947,0.07506053268765134,0.43792987210337775,1.0,6/14,5.01%,RAPGEF2;RAPGEF6;EZR;FXYD5;RAP1A;MINK1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6381268781118278,1.4683425476090166,0.07718696397941681,0.735150355574251,1.0,3/12,8.15%,CDC14B;PTEN;GOLGA2
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.45794448739018384,-1.4682992670834711,0.03763440860215054,0.43845541260194176,1.0,11/29,15.53%,TJP1;SLIT2;SHANK3;KANK3;HIP1R;KANK1;SHANK1;SSH1;ARPIN;LIMA1;PRKCD
prerank,maintenance of blood-brain barrier (GO:0035633),-0.4523079970344259,-1.4680648997989016,0.036827195467422094,0.4368863074068922,1.0,19/30,14.67%,TJP1;VCL;OCLN;PECAM1;ACTB;ITGB1;ESAM;F11R;CLDN5;JAM2;ACTG1;TJP2;LSR;DMD;SLC1A1;CLDN12;GJB6;MFSD2A;CDH5
prerank,epithelial structure maintenance (GO:0010669),-0.581671768535622,-1.4677588683613292,0.04935622317596566,0.43550905788803373,1.0,2/11,4.20%,CXADR;RBP4
prerank,regulation of multicellular organismal development (GO:2000026),0.5362897897718504,1.4675910898044096,0.06688417618270799,0.7338849451980952,1.0,5/25,10.89%,PTN;GBX1;CCSAP;KAT2A;DHX36
prerank,neurotransmitter transport (GO:0006836),0.447322841018815,1.4675680321847382,0.03918918918918919,0.7295741956131397,1.0,17/73,14.58%,SLC1A3;CASK;ATP1A2;SLC18A3;NRXN2;PTPRN2;NRXN1;VAMP2;CHAT;PPFIA2;SNPH;RIMS1;SLC29A1;DNAJC5;UNC13A;PPFIA4;SYN2
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.5605509017547481,-1.4664220297852024,0.06323185011709602,0.4368723619480776,1.0,2/14,0.41%,IGF1;CD200
prerank,smooth muscle contraction (GO:0006939),-0.5542134563649312,-1.4661680244989268,0.056818181818181816,0.4354838258800412,1.0,6/14,12.33%,ROCK2;MYLK;EDNRA;BDKRB2;MYH11;ACTA2
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6357104992456828,1.4661292982270189,0.0831918505942275,0.7316031012798638,1.0,4/12,11.74%,PPARA;ITGAV;NR1H2;ABCA5
prerank,motile cilium assembly (GO:0044458),0.6367632194864203,1.465370923115536,0.08376963350785341,0.7303554660237201,1.0,4/12,15.25%,RSPH9;E2F4;DNAAF3;CCDC39
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6164321671234421,-1.4650363391601327,0.07829977628635347,0.43621300388762124,1.0,7/10,22.28%,TUT7;UBB;NEDD8;ISG15;UBC;CHFR;UBA52
prerank,neutrophil chemotaxis (GO:0030593),0.4686048567032248,1.4645927880594563,0.04341534008683068,0.7296691875370552,1.0,7/53,5.33%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,bicellular tight junction assembly (GO:0070830),-0.4168672441437961,-1.4644912641506103,0.04100946372239748,0.435414593200086,1.0,21/46,27.35%,OCLN;PECAM1;AFDN;ESAM;F11R;CLDN5;PARD3;APC;RAB13;ARL2;RAMP2;CDH5;PAK2;DLG1;CLDN11;PDCD6IP;PATJ;CLDN10;MARVELD2;ECT2;CLDN1
prerank,limb morphogenesis (GO:0035108),-0.4920011463060144,-1.4637194235085607,0.06084656084656084,0.4353393805696959,1.0,6/20,7.72%,CYP26B1;MBNL1;TGFB2;SKI;MEGF8;LRP6
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.4839946850058393,-1.4629331947808608,0.046831955922865015,0.4352586401830614,1.0,11/24,18.21%,SEMA3D;SEMA3C;SEMA7A;NRP1;MEGF8;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.46479223125214186,1.4628212416724433,0.05988857938718663,0.7333123648148,1.0,18/59,15.59%,RUNX2;PTEN;TCF7L2;AGO4;CDKN2A;THRA;CDK8;MED12;MED6;TWIST1;TP53;MED10;AGO3;MED8;SOX9;MED1;MED25;TNRC6B
prerank,melanocyte differentiation (GO:0030318),0.6508118660238471,1.462762458183992,0.059964726631393295,0.7292227408628683,1.0,2/11,1.49%,ENPP1;SLC24A5
prerank,intermediate filament organization (GO:0045109),-0.5225386777322033,-1.4621672824543903,0.055865921787709494,0.43522256243178725,1.0,3/17,3.27%,VIM;MTM1;KLHL24
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4333290112644105,-1.4621476168347785,0.0453257790368272,0.4330805534768897,1.0,8/36,5.89%,RHOBTB1;GULP1;DOCK1;THBS1;GSN;RHOBTB2;RAC1;CDC42
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.48805972710686,-1.4616989291862679,0.04177545691906005,0.4319893268755889,1.0,12/24,24.35%,IRAK2;UBB;AAMP;CASP8;TAB2;CYLD;UBE2N;UBC;TNFAIP3;UBA52;IKBKG;NOD2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.5257443398100382,-1.461417214084079,0.0611764705882353,0.43067457809821297,1.0,8/16,25.48%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;DTX3L;KMT5C
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4890672666680402,1.4608384254991833,0.041968162083936326,0.7335050739610144,1.0,6/48,8.66%,CEMIP;XCL1;CXCL10;PDPK1;CAPN3;PRKACA
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5913158460948288,-1.4605374388082457,0.07991803278688525,0.4309014313269998,1.0,7/11,24.44%,FOXO1;CAV1;FAS;ATP6V0A2;ATP6V1G1;CCDC115;TMEM199
prerank,regulated exocytosis (GO:0045055),-0.3209759975380899,-1.4588253747704898,0.0,0.4333127901847762,1.0,44/173,18.27%,FN1;IGF1;ABCC4;VWF;ACTN2;VCL;PECAM1;APOOL;THBS1;LHFPL2;ANXA5;APP;PCDH7;SPARC;ECM1;SRGN;SYT9;TGFB2;VEGFD;VEGFC;CD109;ARHGAP17;PDGFA;STX1A;CALM1;ENDOD1;RAB31;SERPINE1;TAGLN2;CD63;LGALS3BP;ITGB3;CYB5R1;FLNA;TMSB4X;F5;MANF;CD9;SYNGR2;ALDOA;CPLX2;LAMP2;CPLX1;EGF
prerank,regulation of monooxygenase activity (GO:0032768),-0.478401342279565,-1.45817768748424,0.05511811023622047,0.43295306570861947,1.0,13/23,22.04%,CAV1;EGFR;NOS3;ZDHHC21;NOSTRIN;CALM1;DDAH1;NOS1AP;AKT1;WASL;NOSIP;LYPLA1;DDAH2
prerank,positive regulation of cell projection organization (GO:0031346),0.41740614768179335,1.458029647083584,0.02053915275994865,0.7418382632341154,1.0,28/115,14.06%,ROR1;ROBO2;PTN;NTRK3;PLXNC1;ROR2;TENM3;WNT5A;NTRK2;GRIP1;NGFR;CDKL5;CAPRIN1;PRKCI;CDKL3;CARMIL2;PRKD1;RELN;STMN2;P3H1;EPHA3;DLG4;PLXNB2;RETREG3;ARHGAP35;LRRC7;CUX2;LYN
prerank,protein localization to cell-cell junction (GO:0150105),-0.5548989989024313,-1.457347560731575,0.06835443037974684,0.4329839629970288,1.0,8/15,8.02%,TJP1;ARHGEF18;ACTB;F11R;ACTG1;CGNL1;TJP2;LSR
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6642342869423908,1.4571361572773718,0.07809523809523809,0.7414212384112977,1.0,8/10,27.97%,HERPUD1;EIF2S1;HSPA5;EIF2AK3;CCL2;DDIT3;ATF4;QRICH1
prerank,positive regulation of macrophage activation (GO:0043032),0.5809430339868709,1.457059589691239,0.08542713567839195,0.7375231673777892,1.0,4/17,9.41%,IL33;WNT5A;TLR6;TLR4
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5915528445123351,1.4555539774888941,0.08503401360544217,0.7398438355381365,1.0,6/16,15.41%,AUTS2;KMT2A;BCOR;WDR5;SNW1;PAXIP1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5808390760756438,1.455490461160939,0.0812603648424544,0.7358854827235001,1.0,4/18,4.96%,PPARA;PAG1;TNFAIP8L2;PTPN22
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5066841484895945,-1.4551515082556365,0.058333333333333334,0.43674023072659274,1.0,8/19,12.72%,SMAD6;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;HEYL;HEY2
prerank,heart trabecula morphogenesis (GO:0061384),-0.5081497453162273,-1.4551325174740442,0.05958549222797927,0.4346979978167586,1.0,7/18,4.36%,TEK;RBPJ;ADGRG6;S1PR1;RBP4;NOTCH1;TGFB2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.45357932253688216,-1.455097110079247,0.03550295857988166,0.43266357522021115,1.0,11/28,20.97%,OCLN;DRG1;RAC1;MAPT;GIT1;ARL2;SLAIN2;MET;CDK5RAP2;NUMA1;FES
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6323671895375126,1.4537334803648883,0.10611510791366907,0.7394034357449195,1.0,5/11,11.85%,DLC1;FAP;CIDEA;TP53;PTGIS
prerank,negative regulation of interferon-gamma production (GO:0032689),0.54430644731823,1.4535818222322243,0.07348242811501597,0.7359153260641432,1.0,9/23,22.28%,XCL1;NR1H4;PDCD1LG2;AXL;TLR4;LGALS9;INHBA;DDIT3;HMGB1
prerank,hexose metabolic process (GO:0019318),0.496146948641969,1.4526012778805861,0.058655221745350504,0.7361018689474702,1.0,6/39,6.92%,APOD;GDPGP1;PPARD;IRS2;OMA1;ALDOB
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.3751575130391652,-1.4521014197522952,0.029411764705882353,0.43848494661620263,1.0,23/67,14.88%,FN1;DOCK5;LIMS2;DOCK1;VIT;NRP1;S100A10;RAC1;NEDD9;CDK6;CDC42;PPM1F;GSK3B;RSU1;ECM2;SFRP1;NPNT;ARL2;MDK;PLEKHA2;FLNA;PTK2B;CX3CL1
prerank,ERBB2 signaling pathway (GO:0038128),0.5213403613608537,1.4519058649514622,0.07655502392344497,0.7349093584678895,1.0,7/31,8.66%,PIK3R1;NRG1;ERBB4;PTPRR;NRG2;NRG4;PRKCA
prerank,fatty acid transmembrane transport (GO:1902001),-0.5051753089759966,-1.4496572565899517,0.06266318537859007,0.44328831410408914,1.0,5/19,5.48%,PRKAG2;ABCD3;SLC2A1;ABCD4;PRKAA2
prerank,protein ADP-ribosylation (GO:0006471),-0.4458149725475341,-1.4488047158799522,0.05649717514124294,0.44358639284033896,1.0,13/28,27.96%,ART3;SIRT3;TNKS2;ZC3HAV1;PARP10;PARP9;PARP4;SIRT1;SIRT5;PARP1;PARP2;PARP12;ARF4
prerank,regulation of phospholipase C activity (GO:1900274),0.6115198877003654,1.4467308713022102,0.07625649913344887,0.7541372761712352,1.0,3/15,3.03%,PDGFRA;NTRK3;FGFR1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5725933096573099,1.4466881068524744,0.0859504132231405,0.7502305991831274,1.0,7/19,15.25%,ODAD4;ADCY10;NPHP3;DNAAF4;SPA17;CABYR;CCDC39
prerank,embryonic eye morphogenesis (GO:0048048),-0.5907808358240657,-1.446578413424029,0.06428571428571428,0.4476124811583416,1.0,6/11,22.73%,MFAP5;LRP6;TBX2;EFEMP1;MFAP2;KDM2B
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6087949973253717,1.4462543511452675,0.08888888888888889,0.7482324322848554,1.0,3/15,4.06%,PPARA;PPARD;NR1H2
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.45912152851348215,-1.4436510356085568,0.05099150141643059,0.45394609595600377,1.0,8/26,10.76%,ROCK2;SHANK3;RDX;ACTG1;RAC1;CDC42;SHANK1;FHOD1
prerank,response to glucagon (GO:0033762),0.5535945175877665,1.4415804650087731,0.07131011608623548,0.7649567786346773,1.0,7/19,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5981379543976664,1.441422676035537,0.08605851979345955,0.7614812992608061,1.0,3/14,7.70%,GHR;PIK3R1;PTK2
prerank,positive regulation of cell communication (GO:0010647),0.5159099055161885,1.4411063620252262,0.07266982622432859,0.7586860951807675,1.0,10/28,18.61%,HCRT;EDN3;GRIK2;ANK3;RIMS2;RIMS1;DLG4;NMU;CLSTN1;SYT1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5737352658782536,1.4400477374688887,0.07952622673434856,0.7554760224249601,1.0,5/16,6.74%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5737352658782536,1.4400477374688887,0.07952622673434856,0.7554760224249601,1.0,5/16,6.74%,APOD;DLC1;PTEN;ARHGAP6;DUSP22
prerank,cellular protein metabolic process (GO:0044267),-0.2904696232416553,-1.4399897682005363,0.0,0.46204497083853496,1.0,113/396,18.24%,FN1;ST3GAL6;IGF1;ST8SIA4;IGFBP6;RPS14;RPS9;IGFBP5;MSRB3;APP;FSTL1;PAPPA;CPE;CST3;UBE2G1;RPS16;IGFBP3;PRKDC;RPLP1;RPL13;WWP2;FDX1;DENND3;RPL27A;IGFBP2;RPS2;UBE2D3;GPC3;ST3GAL1;RPL37A;RPL5;RPL8;ADAM10;SERPIND1;RPS7;RPL41;RPS18;PRSS23;RPS20;FBXL2;RPS19;RPS24;LMCD1;RPS27;NUCB1;RPS15;APOE;CCN1;ABCA3;RPL21;RPL10;TNC;RPL35A;MSLN;LAMB2;RPS15A;MANBA;RPL10A;RPS5;RPL11;SPCS2;ABCF1;RPL36A;EEF1A1;SHISA5;RPL34;ST8SIA2;CTSH;RPLP2;RPS29;SEC11C;GALNT11;RPL32;RPL4;RPLP0;APH1A;RPL30;RPL26;RPS4X;RPS21;RPL29;CLN5;APH1B;MMP15;CSNK1G3;RPS8;GOLM1;GATA6;FURIN;MRPS7;USP25;F5;MMP1;RPL31;CHRDL1;FDXR;PARP4;PCSK5;RPS23;UBE2L6;RPL23A;NEDD8;SIAH2;YME1L1;TTF1;SRBD1;MRPS17;AGO2;YES1;RPL19;MFGE8;QPCT;RPL36
prerank,carboxylic acid catabolic process (GO:0046395),-0.5710952298962906,-1.4395035733741726,0.0728476821192053,0.4611197476744313,1.0,4/12,15.34%,ACOT8;PON3;RENBP;NPL
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5038708408021928,1.439398607121545,0.06141732283464567,0.7544719464006385,1.0,3/32,1.71%,CXCL10;HRG;CXCL1
prerank,negative regulation of gene expression (GO:0010629),-0.30131613689960723,-1.4393876633088991,0.0125,0.4592102999404649,1.0,84/302,17.86%,DAPK1;IGF1;PICALM;SLC24A3;ROCK2;FOXP1;ITGB8;MEF2C;OCLN;ROBO1;PPHLN1;NOTCH2;IGFBP5;APP;KLF4;NFKB1;KDM4A;CLDN5;SRGN;KDR;TMBIM6;WWP2;SAMD4A;NOTCH1;RUNX1;TGFB2;WNT4;CNOT10;SMO;LGR4;CD34;PRKAA2;ADAM10;ATP2B1;DICER1;APOE;LSM6;XDH;CELF1;ACVRL1;MAPT;CNOT8;BTG2;PTBP3;ATOH8;RPS6KA5;CITED2;SFRP1;GATA2;PPM1D;TNRC6A;PARP10;CPEB3;VHL;PARP9;SLC7A5;TARDBP;PAIP2;GAPDH;MAP2K2;RBM4;TLE5;TERT;TNRC6C;PTRH2;HEY2;YBX1;LSM2;JARID2;TOB1;DHFR;EZH2;ERN1;TRIM27;SIRT1;GPER1;PRKAA1;HAVCR2;ESR1;RBBP7;TWSG1;AGO2;PPP1R11;DNMT3B
prerank,endocardial cushion development (GO:0003197),-0.4824963743464352,-1.4391758448980259,0.0584958217270195,0.4577012590719667,1.0,8/21,11.62%,NOS3;BMPR2;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5077554653111984,1.4385746315329162,0.07373271889400922,0.7539985185438334,1.0,11/31,15.80%,PDGFRA;EIF4A3;HOXC9;DSCAML1;TWIST1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.41837630236287643,-1.4384079328587935,0.04220779220779221,0.457752722782125,1.0,10/37,13.64%,CAV1;BCL2L1;BECN1;RPS7;NCK1;UBB;BAD;BAX;BID;BOK
prerank,cardiolipin metabolic process (GO:0032048),-0.553358716745101,-1.4380027234392612,0.08791208791208792,0.4567226670657092,1.0,6/13,17.30%,PLA2G4A;PGS1;LCLAT1;PLA2G6;HADHA;PLSCR3
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.5169918989082137,-1.4377956473743965,0.08415841584158416,0.4552343888662104,1.0,5/16,4.82%,IGF1;IGFBP6;IGFBP5;IGFBP3;IGFBP2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4403465493922617,1.437713708132597,0.044897959183673466,0.7538114289419654,1.0,16/68,17.67%,IL33;WNT5A;IL16;TSLP;TLR6;TLR8;TWIST1;MBP;TLR4;CYBA;PYCARD;F2R;DHX9;TIRAP;LGALS9;MYD88
prerank,protein localization to cell junction (GO:1902414),-0.47656259751256214,-1.4376706603271867,0.07238605898123325,0.45350725889211474,1.0,6/22,7.60%,HEG1;TJP1;ARHGEF18;CGNL1;TJP2;SHANK1
prerank,oligosaccharide metabolic process (GO:0009311),-0.4032247526606144,-1.4373247209334021,0.046153846153846156,0.4523819847362951,1.0,14/46,13.54%,B4GALT1;ST3GAL6;FUT8;ST8SIA4;B3GALT1;ST3GAL4;ST6GALNAC3;ST3GAL3;MANBA;MAN2C1;MPDU1;ST8SIA2;NAGA;FUT9
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4847120168025953,-1.4372290259439595,0.07671957671957672,0.4505887779641751,1.0,11/22,17.85%,SLIT2;ROBO1;ID1;NRP1;EFNB2;KDR;EPHB4;NR4A1;CDH5;SOX18;AKT1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4415872436206154,-1.4368564836252036,0.047337278106508875,0.449486683311672,1.0,12/30,23.43%,FLT1;MLLT3;KDR;ACE;SFRP1;FLT4;FLT3;ARMC6;CSF1R;BATF;FSTL3;SP7
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4468021618142714,1.436535551568056,0.044854881266490766,0.7551930874660324,1.0,15/69,8.22%,PDGFRA;PLCL1;PIK3R1;OGT;PTEN;FGFR1;GAB2;PIK3R2;HTR2B;IRS1;NF1;IRS2;PI4KA;RPS6KB1;PLEKHA1
prerank,mesenchyme morphogenesis (GO:0072132),-0.5062157491608914,-1.4364852684786102,0.05913978494623656,0.44851010367918304,1.0,7/17,11.62%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6324514836211526,1.435729460550144,0.10106382978723404,0.7547771677490779,1.0,2/11,0.79%,TARM1;XCL1
prerank,carboxylic acid metabolic process (GO:0019752),-0.4424827738895631,-1.4344526293338113,0.029239766081871343,0.4521596035905202,1.0,8/33,6.16%,DDO;CSGALNACT1;ST6GAL1;SLC2A1;PLA2G4A;PON3;ST3GAL1;CYB5R3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.4032501537423305,-1.434027522598649,0.025936599423631124,0.45126719248343355,1.0,19/46,23.30%,PLCB1;SOD2;CDC42;TALDO1;PITPNA;HNRNPF;CFL1;MTAP;RPLP0;HNRNPDL;PPIA;PAK2;MSN;PSME2;LMNB1;MIF;GSTO1;BOLA2;RAP1B
prerank,cardiac muscle tissue development (GO:0048738),0.4717320873923685,1.4319766769565292,0.06744868035190615,0.767276426017471,1.0,9/50,11.47%,TBX18;MSC;NRG1;SMAD5;GJA1;CACNA1G;BMP7;NDUFV2;MSX1
prerank,aorta development (GO:0035904),0.5989568155110774,1.431817522043587,0.09914529914529914,0.7640509096759829,1.0,2/14,0.48%,ROBO2;LRP1
prerank,positive regulation of chemokine production (GO:0032722),0.4783568156761569,1.4313854603766927,0.05891238670694864,0.7620259752555857,1.0,8/44,10.90%,IL33;WNT5A;TSLP;TWIST1;MBP;TLR4;EIF2AK2;PYCARD
prerank,cholesterol homeostasis (GO:0042632),0.4446189022251854,1.4313039059065198,0.05548216644649934,0.758459041013581,1.0,5/64,5.08%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,lipoprotein localization (GO:0044872),0.6383332002492657,1.431186873379281,0.09747292418772563,0.7551512925712974,1.0,3/11,9.17%,LRP1;UNC119;PRKCB
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.6046252626903573,1.431162475299017,0.10695187165775401,0.75147575320944,1.0,1/13,0.10%,IL33
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5292333055230181,-1.4309553883947803,0.09278350515463918,0.4575466735834622,1.0,5/17,4.26%,PBX1;RBPJ;MAML2;NOTCH3;NOTCH1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.47186998006720987,-1.4308705519902964,0.0453257790368272,0.4557347107933955,1.0,6/24,10.10%,ROCK2;PRKCH;FOXC1;RUNX1;ERRFI1;TRIM16
prerank,regulation of hydrolase activity (GO:0051336),-0.3598099707609662,-1.430806868612973,0.025735294117647058,0.45393857300586227,1.0,23/71,16.03%,PLXNA2;EPHA4;FGD5;CAV1;PLXNA4;CHN2;SIPA1L1;RAPGEF6;RDX;RASIP1;EFNA5;RALBP1;ITGB1BP1;PLXNB1;NGEF;ARHGAP12;ARHGAP27;NOS1;PRKG1;TBC1D10B;ARHGAP15;PLXNA1;ARHGAP44
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5246143739024096,-1.4302418161748025,0.07425742574257425,0.4536547862870215,1.0,5/16,10.60%,CAV1;INPP5F;PPP2R1A;PTPN2;VHL
prerank,positive regulation of synapse assembly (GO:0051965),0.5247149866210423,1.4297623745106884,0.09597523219814241,0.7538372392352549,1.0,10/27,17.98%,SRPX2;EPHB1;GRID2;NRXN1;SYNDIG1;IL1RAP;VSTM5;CUX2;IL1RAPL1;CLSTN1
prerank,cellular response to purine-containing compound (GO:0071415),0.6509333506272468,1.4292196358948104,0.0880281690140845,0.7523616585770756,1.0,4/10,13.68%,P2RY1;RYR2;TRPM2;RYR3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.602656220712075,1.4291003767136696,0.10314685314685315,0.7492006382768197,1.0,5/15,11.50%,PDGFRA;EIF4A3;MTHFD1L;TWIST1;TGFBR1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.49443304139478056,-1.4289837987561778,0.06426735218508997,0.4553818263892857,1.0,9/20,18.21%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5706649459410598,-1.4267405486466842,0.08108108108108109,0.4598914490981633,1.0,3/12,7.21%,PICALM;ROCK2;APOE
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.503274155059457,-1.4266217991325758,0.06377551020408163,0.4583413108564286,1.0,3/18,3.83%,PRKAG2;OCLN;SLC2A1
prerank,epithelium development (GO:0060429),-0.3423898352870833,-1.426429083370639,0.013574660633484163,0.4568360592360251,1.0,25/107,13.88%,ALDH1A2;VCL;OSR1;KANK2;KDR;WNT4;SMO;DVL1;CD34;SIX1;ERRFI1;TOLLIP;PGK1;TBX1;SOX17;BDH2;PTER;TBX2;TAGLN2;TAGLN;DAG1;PCNA;ALDOC;GATA6;MFSD2A
prerank,modulation by symbiont of host process (GO:0044003),-0.5983519252965603,-1.425759796877761,0.0948905109489051,0.45669299456371576,1.0,7/10,22.28%,UBB;B2M;PGK1;ENO1;UBC;MRC1;UBA52
prerank,sterol homeostasis (GO:0055092),0.44300508790363097,1.4252515442158011,0.05220883534136546,0.7624060812710984,1.0,5/65,5.08%,RORA;CYP7B1;GRAMD1B;NR1H2;LIPC
prerank,negative regulation of protein processing (GO:0010955),-0.5602854017022326,-1.4243294677977294,0.07488986784140969,0.45857447256900685,1.0,6/12,14.37%,THBS1;GAS1;SERPINE1;TMEM59;SERPINE2;CTSZ
prerank,sulfur compound catabolic process (GO:0044273),0.48682290067157374,1.4242242875896753,0.084070796460177,0.7631505672394091,1.0,9/38,10.07%,DCN;GGT5;LUM;BGN;GGT7;VCAN;ADO;GNS;TXN2
prerank,acylglycerol catabolic process (GO:0046464),0.5102797868535667,1.4234125632245571,0.07738998482549317,0.763054445328043,1.0,8/30,12.16%,LIPC;LIPH;FABP5;FABP4;ABHD16A;LYPLA2;ABHD12;FABP3
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5259465018292857,-1.4233160895226404,0.08591885441527446,0.4574685892149709,1.0,2/14,2.90%,ABCG2;HMOX2
prerank,heme catabolic process (GO:0042167),-0.5259465018292857,-1.4233160895226404,0.08591885441527446,0.4574685892149709,1.0,2/14,2.90%,ABCG2;HMOX2
prerank,heart morphogenesis (GO:0003007),0.4659159305820635,1.423298621000405,0.06338028169014084,0.7598439127172544,1.0,11/50,12.87%,CHD7;FLRT2;DLC1;RYR2;TBX3;HTR2B;PTK2;MDM4;TGFBR1;SOX9;OLFM1
prerank,cGMP-mediated signaling (GO:0019934),0.6249385335400313,1.4227592030840408,0.10139860139860139,0.7587004341861507,1.0,4/13,9.08%,PDE9A;HTR2B;KCNC2;HTR2C
prerank,ameboidal-type cell migration (GO:0001667),-0.3899427517276331,-1.4226886418015625,0.04666666666666667,0.4573975490008029,1.0,22/51,20.73%,SEMA3D;SEMA3C;SEMA7A;AMOT;CCN3;GPC3;MEGF8;SRGAP2;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B;AMOTL2;SEMA6C;PKN2;AKT1;SEMA3G;SEMA6B;FAT2;AMOTL1;PKN3
prerank,cellular response to interleukin-2 (GO:0071352),0.622745405393428,1.422168769345466,0.10854092526690391,0.7541388722390963,1.0,2/11,3.37%,IL2RA;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.622745405393428,1.422168769345466,0.10854092526690391,0.7541388722390963,1.0,2/11,3.37%,IL2RA;JAK1
prerank,positive regulation of glucose import (GO:0046326),-0.48317700218457044,-1.422155310369579,0.06666666666666667,0.4569569411430172,1.0,6/21,4.57%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.6007850389927769,-1.4214512707962892,0.07555555555555556,0.45684765530487764,1.0,4/10,15.34%,ST6GAL1;ST3GAL1;RENBP;NPL
prerank,negative regulation of viral transcription (GO:0032897),-0.5572068622647904,-1.4201963602249286,0.0784313725490196,0.4585186902346213,1.0,6/13,19.19%,TRIM11;IFITM3;TRIM14;TRIM27;UBP1;HEXIM1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5864803047665902,1.4201345706491257,0.08756567425569177,0.7594734000176933,1.0,3/15,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,negative regulation of response to external stimulus (GO:0032102),0.4112497064633227,1.419417744449319,0.04475703324808184,0.7591835910307482,1.0,14/105,7.85%,RORA;CASK;PPARA;CTNNA2;PTEN;TRAF3IP1;GRID2;NR1H4;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,negative regulation of transferase activity (GO:0051348),0.5087680161786408,1.4190646705409102,0.07317073170731707,0.7571290491773147,1.0,10/28,12.54%,NPRL2;FBXO5;IRS2;LIMK1;ERCC4;TERF1;EIF4A2;PIF1;TP53;GSK3A
prerank,sodium ion export across plasma membrane (GO:0036376),0.5928582944673222,1.4175884769073033,0.10380622837370242,0.7597441730681848,1.0,3/13,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,response to growth factor (GO:0070848),-0.40425357547683466,-1.4174081163306949,0.057926829268292686,0.46414160530292986,1.0,21/41,23.67%,KLF4;BMPR2;ACVR1;ACVRL1;SFRP1;TBC1D7;NOS1;GATA6;CPNE3;PLK5;MAP2K5;EPHA2;ACVR2B;ERBB2;AKT1;CIB1;HDAC6;TGFBR2;TWF2;ACVR2A;EMD
prerank,striated muscle cell development (GO:0055002),-0.5282255473155428,-1.4172655023105332,0.08120649651972157,0.46260347706355937,1.0,5/14,17.03%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.6395419975436993,1.4172556304862536,0.11090573012939002,0.7576656031735782,1.0,5/10,21.42%,CD40;FGR;LYN;BAG6;BTLA
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.538237504226187,1.4170678291181313,0.09446254071661238,0.7550011035658432,1.0,4/21,8.27%,PPARA;SLC30A10;ABCD2;PINK1
prerank,positive regulation of kinase activity (GO:0033674),0.4081875342620543,1.416889715764757,0.033810143042912875,0.7522246205269643,1.0,22/107,10.40%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;TRAF4;ERBB4;EPHB1;FGFR1;EPHA6;CENPE;MRNIP;PTK2;RELN;EPHB6;AXL;JTB;DAXX;CACUL1;EPHA3
prerank,response to organonitrogen compound (GO:0010243),0.48126615247957766,1.4160904159607428,0.08144796380090498,0.7522718535550317,1.0,16/38,19.56%,NR1H4;KYNU;SEL1L;MTOR;DNAJB12;GLRA3;GLRA1;RCN3;TRPM2;GLRA2;MEAK7;GLRB;BRSK2;UBXN6;KAT7;RHBDD1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.41374551607588417,-1.4160309555296333,0.07165109034267912,0.4642204848197631,1.0,15/39,14.24%,FN1;VCL;PLPP3;ACTB;GNAS;MEGF11;ACTG1;TJP2;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,cellular response to ionizing radiation (GO:0071479),-0.40204195549771904,-1.4158775015104648,0.026845637583892617,0.4627747924532249,1.0,22/47,27.76%,NET1;CRYAB;MAPK14;TLK2;INO80;ATR;RPL26;ATM;EEF1D;GRB2;CDKN1A;SIRT1;TMEM109;CLOCK;HUS1;RAD51;KDM1A;LIG4;ECT2;RHOB;RHNO1;GADD45A
prerank,positive regulation of phospholipase activity (GO:0010518),0.5385316144903793,1.4151379982015257,0.08441558441558442,0.7528478938428341,1.0,4/22,3.87%,PDGFRA;NTRK3;FGFR1;PDPK1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.6065429639244828,1.4148701720882089,0.09026548672566372,0.7505112131267012,1.0,2/14,1.27%,ECE1;EDN3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5773221719856211,1.4143516818090367,0.11055276381909548,0.7493313280687413,1.0,4/15,3.66%,DCN;BGN;DSE;VCAN
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5956405242003768,-1.4140763593312677,0.09879518072289156,0.46568181462480485,1.0,2/10,1.30%,CD200;SLIT2
prerank,positive regulation of neuron migration (GO:2001224),-0.5766771777354087,-1.4137721685463334,0.10874704491725769,0.46464986026097366,1.0,3/11,11.41%,RAPGEF2;SEMA6A;MDK
prerank,retinol metabolic process (GO:0042572),0.5922689415712795,1.4134895771936145,0.09771986970684039,0.7495516869323257,1.0,3/14,2.38%,ADH1A;RDH10;RDH11
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5219853047668195,1.4131861653640738,0.0832,0.7474878785304735,1.0,4/25,4.74%,ZFYVE28;PPARA;CBLB;CNRIP1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.4101450903209673,1.4129670807595425,0.04481434058898848,0.7451507158334926,1.0,25/102,11.15%,ENPP1;LPIN3;PIK3R1;ADCY5;CPEB1;SLC30A10;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;ADCY8;ADCY3;ADCY2;PRKACB;RPS6KB1;PRKACA;ADCY7;GCK;SLC25A33;RAB15
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4181744888901291,-1.4121300470251215,0.05234159779614325,0.4672336407628883,1.0,12/32,15.21%,THBS1;KLF4;FOXC2;KDR;JCAD;NOTCH1;ANXA1;ITGB1BP1;GATA2;FGFBP1;MAP2K5;PTGS2
prerank,DNA packaging (GO:0006323),0.5698746818953293,1.4116049963801631,0.09565217391304348,0.7477493231302594,1.0,4/16,10.60%,NAA10;CHAF1B;NOC2L;TP53
prerank,regulation of hippo signaling (GO:0035330),-0.506204605887373,-1.411214523242333,0.07772020725388601,0.4680249201847949,1.0,8/17,18.24%,MAPK14;MOB3B;SCHIP1;DLG5;AJUBA;MARK3;VGLL4;SOX11
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.4808039270151348,-1.4111254744157047,0.06569343065693431,0.46639132160947583,1.0,8/18,18.37%,CTSC;EZR;RDX;VPS35;APOE;VPS11;VGLL4;MSN
prerank,bicarbonate transport (GO:0015701),-0.46778270611762374,-1.41095970666097,0.05965909090909091,0.4650203989741133,1.0,11/25,24.81%,SLC4A10;SLC26A7;SLC39A8;SLC4A3;CA4;SLC4A8;CYB5R1;SLC26A6;CFTR;SLC4A7;CYB5R4
prerank,synapse assembly (GO:0007416),0.4367474795303101,1.410235870135769,0.06694560669456066,0.7502323902153203,1.0,16/67,11.41%,ADGRL3;WNT5A;PTEN;FARP1;NRXN2;GRID2;NRXN1;GABRA1;LRRTM3;PCDHB16;DSCAM;PCDHB4;PCDHB11;RAB29;GABRG2;PLXNB2
prerank,histone H3-K36 demethylation (GO:0070544),-0.590211609201787,-1.4095289886972757,0.10714285714285714,0.46720097114959813,1.0,6/10,22.73%,KDM4A;KDM4C;RIOX2;PHF8;KDM4B;KDM2B
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6462004264165487,1.4082454524051937,0.1068840579710145,0.7555459572280884,1.0,3/10,15.09%,C5AR1;SORL1;CLU
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.40846162315293,-1.4073662406839849,0.0621301775147929,0.47114230562051573,1.0,19/40,26.57%,MAGI2;INSR;VTN;DAB2;B2M;RAB21;SERPINE1;CD63;HIP1;HFE;HNRNPK;WASL;EGF;TBC1D5;CCL19;NTF3;GREM1;ARRB2;BICD1
prerank,outer dynein arm assembly (GO:0036158),0.5771964665564422,1.4071440356216551,0.11347517730496454,0.7569448855442865,1.0,3/15,3.61%,CCDC63;ODAD4;DNAAF4
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.4784386272293506,-1.4063323629288047,0.079155672823219,0.4719849993611374,1.0,8/20,15.66%,ANO6;ENTPD1;IL18;APP;TXNIP;NT5E;P2RX7;PSTPIP1
prerank,regulation of feeding behavior (GO:0060259),-0.579424328909534,-1.4063316056872275,0.10144927536231885,0.470141307957383,1.0,1/11,0.93%,LEPR
prerank,regulation of synapse assembly (GO:0051963),0.46917953915281935,1.4062181645666283,0.08972503617945007,0.7575286415869494,1.0,16/46,18.74%,ROBO2;SRPX2;EPHB1;GRID2;NRXN1;GPC4;SETD5;SYNDIG1;LRFN5;IL1RAP;CUX2;LHFPL4;IL1RAPL1;SLITRK1;CLSTN1;GPC6
prerank,response to ethanol (GO:0045471),0.5917941450378541,1.4060508741457904,0.10869565217391304,0.7549966129865081,1.0,6/14,17.61%,GRIN2B;GRIN2A;ADCY7;GLRA1;GLRA2;GRIN3A
prerank,diterpenoid metabolic process (GO:0016101),0.450649803192592,1.4058305063181689,0.0636237897648686,0.7526939955335563,1.0,7/55,4.65%,LRP1;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.452127168114142,1.4057541321414502,0.06373937677053824,0.7497876885471831,1.0,19/60,15.59%,RUNX2;PTEN;TCF7L2;AGO4;CDKN2A;CDK8;MED12;SRF;MED6;TP53;DHX36;MED10;AGO3;MED8;SOX9;MED1;MED25;PAXIP1;TNRC6B
prerank,morphogenesis of an epithelium (GO:0002009),0.525385344340756,1.4056366695176599,0.10158730158730159,0.7470035720901191,1.0,7/25,12.02%,TBX18;KDF1;TRAF3IP1;PRKX;AHI1;SOX10;SOX9
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.580213632608807,-1.405244176201276,0.1050228310502283,0.47112056866001795,1.0,7/10,34.23%,INPP5F;PPP2R1A;PTPN2;SOCS3;SOCS1;PPP2CA;NF2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.46645166562285434,-1.4049880803446575,0.08031088082901554,0.4698779757161043,1.0,6/23,20.49%,IGF1;GIT1;CX3CR1;CEACAM1;CX3CL1;TNFAIP3
prerank,regulation of secretion (GO:0051046),0.611762399928313,1.4049043515344144,0.09605488850771869,0.7468911280817925,1.0,5/13,15.57%,NRG1;GPLD1;MYO6;POFUT2;SGK1
prerank,potassium ion transport (GO:0006813),0.4027362473636074,1.4047609002799437,0.037267080745341616,0.7443284475651025,1.0,24/120,13.14%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNQ3;SLC9A9;KCNMA1;KCNIP2;SLC9A1;KCNG1;KCNH4;KCNAB1;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNK1;KCNN2;KCNH7;KCNJ8;KCNAB3
prerank,renal water homeostasis (GO:0003091),0.5315186806508132,1.4030477386070725,0.1064516129032258,0.7484193901108038,1.0,7/23,8.88%,ADCY5;ADCY8;ADCY3;ADCY2;PRKACB;PRKACA;ADCY7
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5677609629548152,1.4010563190395213,0.1164021164021164,0.7535752380468271,1.0,5/16,13.17%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,lamellipodium organization (GO:0097581),-0.43813866677999236,-1.399797468987208,0.08192090395480225,0.48216985882191554,1.0,8/29,11.40%,ABLIM1;VCL;ITGB1;PARVB;S1PR1;RAC1;SPATA13;CCDC88A
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.44817469817117056,-1.399181144121399,0.06561679790026247,0.48214717504600174,1.0,8/25,11.74%,ACTN2;ATP1B3;WNK4;WNK1;ANK2;STAC;DMD;TRPC6
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5493959221106103,1.3980647491428586,0.10998307952622674,0.762426219892052,1.0,7/19,5.53%,SCRIB;DLG3;FSCN1;MTCL1;PARD3B;DLG2;PRKCI
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5225510382049897,-1.3980620648041517,0.0979498861047836,0.4834814443798714,1.0,10/16,20.26%,NPR3;SCARB1;APOE;GCH1;PIK3CB;TERT;NOS1AP;DHFR;AKT1;NUS1
prerank,actin cytoskeleton reorganization (GO:0031532),-0.369944093261765,-1.3974576939214023,0.02112676056338028,0.4832796795316711,1.0,20/63,15.13%,CXADR;SIPA1L1;FER;EZR;NRP1;RICTOR;PARVB;S1PR1;GSN;PHACTR1;MINK1;ANXA1;NEDD9;GAB1;CDC42BPB;PTPN1;TRPV4;FLNA;GRB2;CDC42BPG
prerank,pyruvate metabolic process (GO:0006090),-0.38133589020151193,-1.396483522573017,0.04794520547945205,0.4842288674341995,1.0,21/52,20.81%,BSG;ME2;DLAT;HK1;LDHA;PGK1;PFKFB2;SLC16A1;HK2;GLO1;TPI1;ME1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;LDHB;GAPDHS;PGM1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.44782603292077006,-1.3961867973840667,0.07967032967032966,0.4831751805724815,1.0,5/26,5.48%,PRKAG2;ADIPOR2;ERLIN1;LPGAT1;PRKAA2
prerank,response to insulin (GO:0032868),0.4187648278603876,1.3959362860201598,0.05675675675675676,0.7683663547152015,1.0,21/80,13.01%,ENPP1;LPIN3;PIK3R1;OGT;CPEB1;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;ZBED3;RAB15;GSK3A;MEAK7
prerank,positive regulation of reproductive process (GO:2000243),-0.42063960773016495,-1.3957090356306245,0.06287425149700598,0.48266489712382393,1.0,4/31,8.17%,PLCB1;LHFPL2;PDE3A;SMURF2
prerank,regulation of anoikis (GO:2000209),-0.4798542497627713,-1.3949284668897723,0.10101010101010101,0.48305833725006914,1.0,8/19,12.65%,CAV1;ITGB1;MCL1;NOTCH1;SIK1;MYBBP1A;TLE5;PTRH2
prerank,limb development (GO:0060173),0.5101166451303394,1.3946301937338583,0.09295352323838081,0.7706658756290223,1.0,7/28,12.48%,CHD7;KDF1;SALL1;KREMEN1;KAT2A;GLI3;LNPK
prerank,rRNA processing (GO:0006364),-0.3113340869494128,-1.394607989284889,0.0,0.4820116311366655,1.0,84/172,30.70%,NSA2;RPS14;RPS9;RPS16;PRKDC;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;LSM6;RPL21;PDCD11;RIOK1;RPL10;RPL35A;ERI1;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPLP2;ESF1;UTP3;RIOK3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RPL31;IMP3;EXOSC3;RPL23A;SART1;RPL19;RPL36;WDR12;PES1;RRP15;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52;TSR3;WDR74;PWP2;RPL15;RPL38;MRM2;NOP2;RSL1D1;RPL13A;EXOSC4;RPS25;NHP2;RPL24;RPL18A;WDR75;RRP36;BMS1;PIH1D2;NOP53;RRP9;WDR46;RPL22
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.40692217367045913,-1.394577220064217,0.05763688760806916,0.48025912003110616,1.0,11/39,8.29%,TSPAN5;RBPJ;ROBO1;MAML2;NOS3;NOTCH1;TGFB2;CCN3;IL6ST;EPN2;ITGB1BP1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4478557091982477,-1.3944156360597486,0.09295774647887324,0.4789003481725322,1.0,5/26,2.84%,EYA2;BCL2L1;EYA1;EYA4;MCL1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5712390516430889,-1.3939401987866984,0.10657596371882086,0.47845190610728433,1.0,5/11,9.63%,THBS1;SEMA6A;KLF2;EPN2;PIK3CB
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5982074657248818,1.3938519381174812,0.10445205479452055,0.7707260968919806,1.0,3/13,9.31%,APOD;MDFIC;SP100
prerank,granulocyte chemotaxis (GO:0071621),0.44477119653753605,1.3936561054525072,0.07434402332361516,0.7683911250879281,1.0,7/55,5.33%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.48509668697141956,-1.3931624743681368,0.07848101265822785,0.4788763983287646,1.0,5/19,20.49%,IGF1;GIT1;CX3CR1;CX3CL1;TNFAIP3
prerank,bone morphogenesis (GO:0060349),-0.5345409009349648,-1.3931397299795962,0.09198113207547169,0.47714304095589427,1.0,4/14,7.72%,CYP26B1;BMPR2;SKI;LRP6
prerank,steroid biosynthetic process (GO:0006694),0.445166259800472,1.3922541351005386,0.06179775280898876,0.7712467098469707,1.0,6/56,6.24%,HSD11B1;CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D
prerank,negative regulation of macrophage activation (GO:0043031),-0.5139906945581736,-1.3917300841144067,0.09026128266033254,0.47906522312658956,1.0,2/16,0.90%,CD200;IL31RA
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.43375057454577004,-1.3905021832028925,0.05555555555555555,0.480446505202218,1.0,10/27,8.02%,PHLDB2;TJP1;ARHGEF18;WASF2;SHANK3;F11R;CGNL1;SHANK1;TMEFF2;RHPN2
prerank,iron ion homeostasis (GO:0055072),-0.3719175536012597,-1.3898967388391228,0.04377104377104377,0.4802698012547047,1.0,25/58,24.44%,ABCG2;PICALM;NEO1;HMOX2;CUL1;TFRC;SCARA5;B2M;BDH2;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;TMEM199
prerank,positive regulation of locomotion (GO:0040017),-0.4343970745495197,-1.389715983530935,0.07446808510638298,0.4790795681147057,1.0,6/27,10.88%,CAVIN1;SPOCK2;NTN1;THBS1;PPM1F;STX3
prerank,mesenchymal cell differentiation (GO:0048762),-0.3799768488423049,-1.3892750055427074,0.0364963503649635,0.4785972676367063,1.0,12/51,7.72%,RANBP3L;ROCK2;DDX5;MEF2C;RBPJ;LEF1;FOXC1;NOTCH1;TGFB2;WNT4;GSK3B;LRP6
prerank,regulation of muscle contraction (GO:0006937),-0.45006812827524817,-1.3887014366664658,0.0783289817232376,0.47861109546717756,1.0,7/26,13.26%,PLCE1;CAV1;TPM1;SRI;MYL9;PPP1R12B;ENO1
prerank,O-glycan processing (GO:0016266),-0.3789133873607889,-1.3886556454363448,0.057432432432432436,0.47701504984932463,1.0,17/54,20.92%,ST6GAL1;GXYLT2;ST3GAL4;B4GALT5;ST3GAL1;ST6GALNAC2;C1GALT1C1;ST3GAL3;GALNT11;GALNT1;ST3GAL2;GCNT1;B3GNT2;GALNT6;GXYLT1;GALNT3;GALNT12
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4468675759119173,-1.388364798736473,0.08040201005025126,0.4761134372363298,1.0,8/26,9.23%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.576195812460713,-1.3883581622776542,0.09913793103448276,0.47444103826902395,1.0,7/11,18.83%,ARL6IP5;MAP3K5;CYP1B1;PRODH;STK25;PRKCD;GSKIP
prerank,monocarboxylic acid catabolic process (GO:0072329),0.534671100472786,1.3880140016519484,0.12619808306709265,0.7862399440859673,1.0,7/21,15.43%,LPIN3;CEL;PPARD;FAH;HOGA1;NUDT19;LPIN2
prerank,potassium ion transmembrane transport (GO:0071805),0.3936536888409336,1.38771171910562,0.04218362282878412,0.7843184178035113,1.0,27/135,13.14%,SLC1A3;KCNK2;KCNS2;ATP1A2;NALCN;KCNT2;KCNQ3;SLC12A6;SLC9A9;ATP1A3;KCNIP2;SLC9A1;KCNG1;KCNH4;KCNAB1;KCNC2;TMEM175;HCN2;HCN1;KCND2;HCN3;KCNE4;KCNK1;KCNN2;KCNH7;KCNJ8;KCNAB3
prerank,response to axon injury (GO:0048678),0.547563296919748,1.3875045960827497,0.10118043844856661,0.7820972318906574,1.0,1/18,0.04%,APOD
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5710967118455116,-1.38736404172317,0.11510791366906475,0.4753794935422544,1.0,7/11,24.77%,KANK1;CD44;ENPP2;ARPIN;PDPN;CORO1B;SRC
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.4842139411198247,-1.3872234532426493,0.08663366336633663,0.4740485032427198,1.0,11/18,25.05%,EZR;RDX;DAB2;RAB21;MAP2K2;VPS11;MSN;SNX3;MTMR2;SRC;DNAJC13
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6225885769278574,1.3871882073781332,0.14111498257839722,0.7803456344899613,1.0,2/10,0.85%,DCN;HRG
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3637179705886268,-1.3866651381643467,0.039285714285714285,0.4739086164376589,1.0,36/65,34.75%,FOXP1;PIR;IL31RA;LEF1;RUNX1;CDC42;RXRA;MAPK14;OSTM1;GLO1;CASP8;PIK3CD;CDKN1A;SIRT1;PDE1B;EPHA2;E2F1;TGFBR2;CSF1R;BATF;TYROBP;MYH9;CCL19;PARP1;SPI1;SBNO2;SNX10;CEBPA;PPARG;CSF1;MT1G;EFNA2;TREM2;BATF2;PML;DEK
prerank,regulation of platelet activation (GO:0010543),0.5464793480936432,1.3852109871645304,0.11185308848080133,0.7856500657640355,1.0,6/21,9.41%,PDGFRA;HRG;TXK;C1QTNF1;PRKCA;TLR4
prerank,odontogenesis (GO:0042476),0.4793560841840505,1.3850265109425537,0.0951683748169839,0.7832928016280111,1.0,8/35,6.89%,LAMB1;EDA;HDAC1;ANKRD11;TUFT1;BCOR;COL1A2;AMELX
prerank,microtubule-based transport (GO:0099111),0.5930140535159086,1.3849406881099378,0.1359724612736661,0.7804872967691134,1.0,4/13,11.25%,ADCY10;DNAAF4;SPA17;CABYR
prerank,vitamin transport (GO:0051180),-0.4311396396199581,-1.3846728617328004,0.062162162162162166,0.4776704579669905,1.0,21/29,47.78%,ABCG2;SLC25A32;PDPN;CUBN;SLC52A3;AFM;SLC52A2;CD320;TCN2;SLC5A6;TTPA;SLC2A2;SLC23A1;TCN1;SLC27A1;SLC46A1;AMN;SLC2A6;SLC2A10;FOLR2;FOLR1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4316646666573657,1.3841937047343087,0.07005494505494506,0.7806101473459974,1.0,22/65,18.74%,RORA;CPEB1;TBL2;EPAS1;EGLN2;HP1BP3;MDM4;TWIST1;PINK1;MTOR;AK4;BMP7;KCND2;TP53;PTGIS;FAM162A;SCN2A;MYC;TSC1;ADAM8;SUV39H2;HIF1A
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6350529763685588,1.3831734460852472,0.13443830570902393,0.7817314274106684,1.0,7/10,21.52%,GPR37L1;LRRK2;PYCR1;RIPK1;GPR37;STK26;PDE8A
prerank,organelle fission (GO:0048285),0.5296623025367159,1.3828391730316811,0.10050251256281408,0.7800365936506555,1.0,8/24,15.43%,SEC16B;MTFR2;OPA1;DNM1;WASHC5;PEX11A;MTFP1;PEX19
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.4551443965306752,-1.3824009909133084,0.09138381201044386,0.48210058152420293,1.0,6/21,10.59%,FOXP1;PRKCH;ELF1;RUNX1;SLC39A10;ELF2
prerank,regulation of cation transmembrane transport (GO:1904062),0.498917600387071,1.3819300505424665,0.11483253588516747,0.7806263724420373,1.0,10/29,13.14%,DPP6;DPP10;SLC30A5;KCNIP1;KCNIP2;KCNAB1;KCNIP4;FGF12;KCNN2;KCNAB3
prerank,central nervous system myelination (GO:0022010),0.6103481535232969,1.3805511035027704,0.11512027491408934,0.7830877126767782,1.0,7/11,19.41%,PTEN;TENM4;SOX10;PLP1;MYRF;CLU;ABCA2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.532705733453924,1.3802960863886093,0.11783960720130933,0.7810329897772171,1.0,6/23,8.66%,PDE4B;RYR2;APLP1;LRRK2;SLC9A1;PRKACA
prerank,respiratory system development (GO:0060541),0.4927271912278074,1.3796077532378261,0.1013215859030837,0.7808694068918473,1.0,5/32,4.20%,CHD7;BASP1;ITGA3;NPHP3;LOXL3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.42470698723619876,1.3793383005992723,0.08879781420765027,0.7790080964116363,1.0,9/70,2.28%,LAMC3;LAMC1;PIK3R1;LAMB1;ITGA8;ATRNL1;PEAK1;MICALL2;ITGAV
prerank,positive regulation of dendrite development (GO:1900006),0.6306110325221467,1.3790675883791204,0.1289134438305709,0.7771174180985383,1.0,2/10,9.69%,PTN;BMP7
prerank,defense response to fungus (GO:0050832),0.5526929836259091,1.3786207077513744,0.12580645161290321,0.77588816976888,1.0,2/17,0.85%,CLEC4E;HRG
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5938459653438285,1.3783512644828404,0.13945578231292516,0.7740706777622928,1.0,4/12,12.10%,DCN;HRG;ADAMTS12;IL12A
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.49275290726385323,-1.3780249163754803,0.09582309582309582,0.49210596760720327,1.0,7/18,12.36%,SAMHD1;DERA;FUCA1;OGA;MANBA;NGLY1;NAGA
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4877792056409963,-1.3774742192388854,0.09582309582309582,0.4919653037175632,1.0,7/18,19.10%,EZR;RDX;VPS35;VPS11;VGLL4;MSN;WDR91
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5464513778368527,-1.3774042019734363,0.09641255605381166,0.4904551260120019,1.0,4/12,4.87%,PLCB1;SLIT2;NBL1;CCN3
prerank,B cell differentiation (GO:0030183),-0.38817242832631654,-1.3770221542967371,0.04411764705882353,0.4898786350843217,1.0,20/46,28.15%,PTPRJ;FNIP1;TPD52;ITGB1;HDAC4;DNAJB9;PTPN2;IRF2BP2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK;KLF6;CLCF1;JAK3;ADGRG3;MSH2;HDAC5
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.558632777214905,1.3770071665603472,0.11853088480801335,0.7766742173516357,1.0,5/16,10.89%,RBM24;ZC3H12D;DND1;ZFP36L2;DHX36
prerank,Wnt signaling pathway (GO:0016055),-0.33623992810354125,-1.3767391298665592,0.030837004405286344,0.48897113937508146,1.0,33/92,18.81%,LEF1;WNT5B;PLPP3;CPE;NXN;WNT9A;VPS35;WNT4;APC;DVL1;CUL1;WLS;FZD4;UBB;FZD7;ARL6;GSK3B;LRP6;WNT6;SFRP1;NR4A2;BCL9L;PLCG2;FZD3;CSNK1G3;CCDC88C;VPS29;WNT16;FZD8;UBC;CSNK1A1;WNT11;SNX3
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3854743047744925,1.376025462952746,0.04932182490752158,0.7778430895172,1.0,22/138,10.40%,ROR1;PDGFRA;PTN;NTRK3;EPHA7;ROR2;MERTK;PTPRT;NTRK2;ERBB4;EPHB1;CD8B;FGFR1;EPHA6;PTPRU;PTK2;EFS;EPHB6;AXL;AHI1;FGR;EPHA3
prerank,regulation of protein kinase C signaling (GO:0090036),0.5703125589151737,1.3757762586681532,0.125,0.7758903026959307,1.0,3/14,2.15%,ADGRV1;WNT5A;CD40
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.44325942767785176,-1.3753313127257736,0.09809264305177112,0.49148834287310217,1.0,7/25,6.74%,EGFR;THBS1;APP;ITGA6;NRP1;PTGES3;FZD7
prerank,negative regulation of catalytic activity (GO:0043086),-0.4344288905904853,-1.3751302128349636,0.07541899441340782,0.49041310199062904,1.0,13/24,24.20%,NOTCH1;NES;PARP9;NOS1;SIRT1;IFIT1;NOSIP;HDAC6;APBA3;CCAR2;OXA1L;PLN;MT3
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.4384495801699129,-1.3747330702416827,0.07795698924731183,0.48966833091796824,1.0,12/27,24.33%,NFKB1;MAP3K5;CUL1;UBB;MAP2K7;MAP3K8;CCDC88C;UBC;UBA52;IKBKB;TAOK2;IKBKG
prerank,sulfur compound transport (GO:0072348),-0.43618821054438367,-1.3744568852638661,0.10101010101010101,0.4887696705359099,1.0,6/27,7.77%,ABCG2;SLC13A4;SLC26A7;SLC6A6;SLC26A11;LRRC8D
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.4690737690878709,-1.3742633713230816,0.0777479892761394,0.4876561535662718,1.0,5/21,7.72%,CAV1;APC;DVL1;GSK3B;LRP6
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4028098251880412,-1.3742483346139098,0.050746268656716415,0.4860474490892048,1.0,12/35,14.25%,HMBOX1;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;RTEL1;ATM;MAP3K4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.35675248470060994,-1.3739689561233122,0.030303030303030304,0.48512858135187203,1.0,27/70,20.38%,BCL2L1;CASP8AP2;MCL1;FAS;TGFB2;GABARAP;CRADD;NGF;CASP2;GSK3B;HIPK1;IFI27;CASP3;SMAD3;CASP8;BAD;BAX;RNF41;BAG3;BID;BOK;P2RX7;TNFRSF1A;FGFR3;ERBB3;CIB1;TRADD
prerank,activation of phospholipase C activity (GO:0007202),0.4961298210659083,1.3735607207753056,0.11179173047473201,0.7820353920100113,1.0,7/29,12.36%,NTRK2;TXK;C5AR1;ARHGAP6;HTR2B;LPAR1;CD86
prerank,regulation of interleukin-1 production (GO:0032652),-0.5180588416998417,-1.3727565293700605,0.10268948655256724,0.48682802327097274,1.0,4/15,12.30%,FOXP1;SIRPA;ANXA1;CEACAM1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4445499613099354,-1.3726930121571685,0.07816711590296496,0.485386230131155,1.0,6/26,4.57%,SORBS1;IGF1;OCLN;OSBPL8;INSR;RHOQ
prerank,arachidonic acid metabolic process (GO:0019369),-0.40428080336980315,-1.3716643024710318,0.09803921568627451,0.48669639578046325,1.0,14/35,25.42%,PTGDS;PTGS1;PTGES3;PLA2G4A;CYP1B1;MGLL;GPX1;PTGS2;CYP2U1;ALOX12;PLA2G4C;FAAH;CYP2S1;CBR1
prerank,vacuolar acidification (GO:0007035),-0.46017453347242915,-1.3716493189071666,0.09900990099009901,0.48515427431509567,1.0,12/21,27.74%,ATP6V0A4;CLN5;ATP6AP2;ATP6V0E2;TMEM9;ATP6V0A2;ATP6V0D2;ATP6V0A1;CLN6;CCDC115;TMEM199;SLC11A1
prerank,telomere maintenance via recombination (GO:0000722),0.6017409447694468,1.3712337478487737,0.12701252236135957,0.7888714089861568,1.0,3/11,7.73%,TEP1;ERCC1;ERCC4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.49517822569535525,-1.3709240141498988,0.11479591836734694,0.4854344445448136,1.0,7/17,9.90%,SLIT2;ROBO1;NRP1;EFNB2;KDR;EPHB4;NR4A1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.42157907738322803,1.3704543825044893,0.06845637583892618,0.7891807035299032,1.0,20/76,16.07%,FANCI;PRICKLE1;MYCBP2;GNL3;LRRK2;PSMD10;PINK1;TSPYL5;COMMD1;BIRC2;SAE1;NDFIP2;SPRTN;GSK3A;PTTG1IP;DCUN1D5;AXIN1;UBE2D1;PAXIP1;NDFIP1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.3669557909656511,-1.3700831981971155,0.04807692307692308,0.48601312038442124,1.0,27/54,29.78%,NSA2;RPL5;RPL10;RPL35A;RPL10A;RPL11;RPLP0;RPL26;RPL23A;MRPL20;WDR12;PES1;NIP7;NPM1;PAK1IP1;RRP15;LAS1L;GTF3A;WDR74;NOP2;RSL1D1;RPF2;NHP2;LTO1;RPL24;NOP16;NOP53
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3441939546384149,-1.369993340725064,0.03529411764705882,0.48466236238014604,1.0,18/76,11.59%,TSPAN5;RBPJ;EGFR;MAML2;NOTCH3;NOS3;WWP2;NOTCH1;TGFB2;CCN3;SREBF2;IL6ST;EPN2;PRAG1;ITGB1BP1;GATA2;NIBAN2;GALNT11
prerank,negative regulation of defense response to virus (GO:0050687),0.6103210501786482,1.36979759373536,0.10181818181818182,0.7890454599983432,1.0,2/10,2.76%,TRAF3IP1;TSPAN6
prerank,positive regulation of positive chemotaxis (GO:0050927),0.5712616857410489,1.3687584219903322,0.12190812720848057,0.7904986271828601,1.0,2/15,2.18%,NTRK3;IL16
prerank,regulation of cholesterol storage (GO:0010885),0.5646031598543922,1.3685970288116438,0.11824324324324324,0.7882518789118388,1.0,3/15,4.06%,PPARA;PPARD;NR1H2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5812211511641706,1.3684783439817794,0.12937062937062938,0.7858062603162674,1.0,7/13,23.58%,FGFR1;PDPK1;SIRT6;IGF2;SP1;HMGB1;ADAM17
prerank,phasic smooth muscle contraction (GO:0014821),0.6052344592546485,1.367496340317409,0.1413427561837456,0.7870374454808622,1.0,2/10,4.84%,EDN3;HTR2B
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3876151247472807,-1.3666396477695317,0.0410958904109589,0.4920824906968062,1.0,9/47,7.09%,RAPGEF2;ROCK2;CAV1;NFKB1;ERLIN1;SIRPA;WNT4;CD34;SIK1
prerank,regulation of urine volume (GO:0035809),-0.5704737182180779,-1.3660874357858575,0.11325301204819277,0.4919264942270538,1.0,3/10,10.28%,NPR3;NPR1;ADCY6
prerank,Golgi to plasma membrane transport (GO:0006893),0.4483070506671353,1.3652706859134656,0.09142857142857143,0.793325530365087,1.0,12/47,11.20%,VAMP5;CCDC22;GGA2;STXBP6;RAB34;SPTBN1;ANK3;VAMP2;LLGL1;COMMD1;VAMP4;EXOC1
prerank,long-term synaptic potentiation (GO:0060291),0.5302120889288683,1.3648774701145914,0.1212624584717608,0.7919440928558393,1.0,5/21,6.01%,GRIN2B;VAMP2;MPP2;CRHR2;GRIN2A
prerank,negative chemotaxis (GO:0050919),-0.4171386973832772,-1.3641059993237288,0.06470588235294118,0.4955652464810881,1.0,9/33,6.76%,SEMA3D;SEMA3C;SLIT2;ROBO1;NTN1;SEMA7A;SEMA6A;SEMA4B;PDGFA
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3959217709999986,1.3640783385986759,0.056847545219638244,0.7925120813209349,1.0,18/98,11.12%,CEMIP;LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;ANK3;YWHAZ;MTCL1;PRKCI;CLIP3;NECAB2;NKD2;EPHA3;TP53;FYN
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.42962526316448724,-1.3638821115747901,0.09269662921348315,0.4945484600078391,1.0,12/28,25.93%,PRKAG2;ADIPOR2;SIRPA;RAC1;PRKAA2;CX3CR1;NOS1AP;SIRT1;SIRT5;FITM2;PDK4;MFSD12
prerank,cell-cell junction organization (GO:0045216),-0.34475773687573735,-1.3632483285460504,0.03879310344827586,0.4947521978757908,1.0,16/79,9.73%,SDK1;PKP4;TJP1;LIMS2;OCLN;CXADR;AFDN;CDH1;CLDN5;CDH8;TGFB2;CTNND1;TJP2;SMAD3;PVR;GJC1
prerank,peptidyl-amino acid modification (GO:0018193),0.6216484643796373,1.3632154057839914,0.14128440366972478,0.7931485750152681,1.0,4/10,23.24%,METAP1D;ATP7A;FKBP10;FKBP7
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5202183471381084,1.3630960131328576,0.12779552715654952,0.790763420823622,1.0,4/22,9.31%,APOD;MDFIC;LRRK2;SP100
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.45191396151967284,-1.3630858416578762,0.11224489795918367,0.4936096724799465,1.0,4/20,10.18%,IGF1;FOXC1;LAMTOR5;NIBAN2
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4412600535469193,-1.3630036594189288,0.10173697270471464,0.49226091732326654,1.0,12/26,19.39%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;MTBP;ANXA1;HYAL1;CCND1;ANKRD17;AKT1;RGCC
prerank,regulation of nuclear division (GO:0051783),0.530220800124543,1.362719491121729,0.11256117455138662,0.7893765943791393,1.0,6/20,11.27%,L3MBTL1;PKMYT1;FBXO5;CDK13;RCC1;MKI67
prerank,motor neuron axon guidance (GO:0008045),-0.5246294776318796,-1.3627152379005747,0.11383928571428571,0.49153180005935937,1.0,5/15,5.15%,EPHA4;SLIT2;NTN1;TMEFF1;RAC1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.42284326005357087,1.3620680321461343,0.06317204301075269,0.789283462763794,1.0,22/72,20.54%,ENPP1;ERCC1;ANKLE1;FAN1;FEN1;POLK;ERCC5;PDE12;RPA1;ERCC4;RFC3;EDC3;GTF2H3;EDC4;ERCC2;GTF2H1;DXO;FBH1;REXO4;CUL4A;DDX1;DDB1
prerank,positive regulation of bone resorption (GO:0045780),0.5985383516835716,1.361696158771448,0.13043478260869565,0.7879896360952146,1.0,4/11,18.98%,SPP1;PRKCA;ADAM8;ATP6AP1
prerank,glutamate receptor signaling pathway (GO:0007215),0.47351683165433595,1.3613220167523672,0.09197080291970802,0.7866647018239982,1.0,17/37,21.37%,GRIA3;GRID2;GRIN2B;GRIK2;GRIA4;FMR1;GRIK4;GRIN2A;GRIK1;GRM5;GRM7;GRIN3A;GRM1;GRIA2;HOMER3;CDK5R1;HOMER2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.5115300842359267,-1.3611559132907158,0.11386138613861387,0.4938134004078848,1.0,5/15,28.42%,MOXD1;PAOX;SAT2;DDC;SRM
prerank,regulation of smooth muscle contraction (GO:0006940),-0.457925817374843,-1.3611517146782672,0.09669211195928754,0.4922535728858578,1.0,4/20,6.33%,PLCE1;CAV1;ZDHHC21;ATP2B1
prerank,positive regulation of cytokinesis (GO:0032467),0.4856693661500112,1.3606769575554118,0.09009009009009009,0.7863689497363184,1.0,3/32,0.93%,SVIL;CDC14B;RXFP3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.44281279803481566,-1.3599053644311059,0.09809264305177112,0.49381170922726403,1.0,14/26,26.54%,SPTLC2;NOS3;ACER2;CYP1B1;ACER3;CYB5R3;GCH1;NOS1;AKT1;SPHK2;DDAH2;ASAH1;NQO1;ASAH2
prerank,amino acid import across plasma membrane (GO:0089718),0.49938358829481955,1.3596593534487134,0.12050078247261346,0.7876673062427922,1.0,4/24,4.87%,SLC1A3;SLC1A5;SLC6A13;SLC7A8
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6251804536908457,1.358673395915554,0.13701067615658363,0.7889319714202861,1.0,2/10,5.62%,DCN;LRRK2
prerank,carbohydrate catabolic process (GO:0016052),-0.4035589019677353,-1.3581163415387303,0.05660377358490566,0.4970687435973432,1.0,19/38,20.81%,DERA;HK1;LDHA;PGK1;PFKFB2;HK2;TPI1;MANBA;MAN2C1;GAPDH;NAGA;PKM;ALDOC;ENO1;PFKL;ALDOA;MAN2B2;GAPDHS;PGM1
prerank,acidic amino acid transport (GO:0015800),0.5336954040009093,1.3578898858662394,0.11627906976744186,0.7893132509722551,1.0,4/17,8.61%,SLC1A3;SLC6A13;GJA1;SLC25A22
prerank,sulfur amino acid catabolic process (GO:0000098),0.6329685369423994,1.3575613555945145,0.15970961887477314,0.787945911090674,1.0,4/10,10.07%,MTRR;BLMH;ADO;TXN2
prerank,base-excision repair (GO:0006284),0.4488826828325242,1.3572205192448652,0.08115942028985507,0.786533444117888,1.0,13/48,13.74%,POLG;LIG3;FEN1;POLQ;ERCC5;NEIL3;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,kidney development (GO:0001822),0.4249326905454809,1.3567143838588127,0.09126984126984126,0.7860718342047177,1.0,10/65,5.64%,ROBO2;SULF1;ITGA8;TRAF3IP1;SALL1;PYGO1;NPHP3;ZBTB16;PRKX;NF1
prerank,neuron fate commitment (GO:0048663),0.5721381320554476,1.3564501097295334,0.11301369863013698,0.7844705790080017,1.0,3/14,12.13%,ISL2;TGFBR1;MYT1L
prerank,regulation of viral entry into host cell (GO:0046596),-0.43042053512587775,-1.3563680950514811,0.08761329305135952,0.5002975333142479,1.0,16/30,29.49%,LY6E;GSN;TRIM25;TRIM5;TRIM11;IFITM3;TRIM14;IFITM1;TRIM27;CD74;SNX3;IFITM2;TRIM6;P4HB;CIITA;MID2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.44066516192672717,-1.3563485522605208,0.09414758269720101,0.49876014582385014,1.0,16/25,35.25%,CSGALNACT1;B3GALT1;NDST1;NDST3;EXT1;B3GALNT1;FUT9;B3GNT2;HAS1;B3GNT9;NDST4;HAS2;B3GNT3;HAS3;B3GNT6;B4GAT1
prerank,negative regulation of cell differentiation (GO:0045596),0.3715572566670631,1.3561553207979973,0.04009433962264151,0.7829735222768391,1.0,34/181,12.42%,RORA;ENPP1;PPARA;MEIS1;SPRY1;ADGRV1;WNT5A;PTEN;ITGAV;LRP3;NPHP3;MEIS2;NR1H2;SPRED1;REST;TBX3;RUNX1T1;ZBTB16;IL17RD;CNTN4;ADAMTS12;ZFP36L2;SPRED2;TWIST1;SOX2;BMP7;ZFPM2;TGFBR1;IQCB1;ABCA5;SOX9;TWIST2;PDCD4;IGF2
prerank,regulation of synapse organization (GO:0050807),0.5098318221147118,1.3559151600534274,0.10576923076923077,0.7811842915085411,1.0,9/26,8.05%,ARHGAP22;CTNNA2;WNT5A;YWHAZ;CDKL5;NEDD4;SETD5;ABHD17C;ABHD17B
prerank,ribosome assembly (GO:0042255),-0.3826443521253527,-1.3550689397538223,0.07096774193548387,0.5004751197321777,1.0,21/47,29.78%,RPS14;RPL5;RPS19;RPS27;RPS15;RPL10;RPS5;RPL11;RPLP0;MRPS7;RPL23A;MRPL20;NPM1;MPV17L2;PWP2;NOP2;RPF2;RPL24;EIF2A;MRPS2;NOP53
prerank,negative regulation of lyase activity (GO:0051350),0.5491497622629595,1.3548741741832109,0.13058419243986255,0.7825767785585217,1.0,3/16,5.81%,AKAP5;ADGRV1;MTRR
prerank,mesenchymal to epithelial transition (GO:0060231),0.6138822287680812,1.3548016473652273,0.1227106227106227,0.780227086241373,1.0,2/10,2.53%,BASP1;SALL1
prerank,regulation of myoblast differentiation (GO:0045661),-0.41707746833132486,-1.354750000911248,0.07859078590785908,0.49971552129317504,1.0,7/32,6.47%,RANBP3L;PLCB1;MEF2C;BOC;IGFBP3;NOTCH1;MAPK14
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.3944241139486042,-1.3546077560100616,0.07462686567164178,0.49851997461237235,1.0,6/43,2.31%,IGF1;FOXP1;IL18;ADAMTS1;THBS1;IGFBP5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.511745821411489,1.3542205176197872,0.13149847094801223,0.779923804554729,1.0,1/23,0.02%,CEMIP
prerank,alanine transport (GO:0032328),-0.5628389341903197,-1.3538607860940615,0.1345707656612529,0.4990011781178371,1.0,5/10,30.78%,SLC6A6;SLC6A17;SLC36A4;SLC7A10;SLC36A2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.46949934600573734,1.3534605963124193,0.1042296072507553,0.7803404200038466,1.0,6/36,4.67%,VAMP5;GGA2;RAB34;SPTBN1;ANK3;VAMP2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.46767345330154986,-1.353128236391664,0.11140583554376658,0.49931565747869716,1.0,7/18,11.62%,NOS3;NOTCH1;TGFB2;ACVR1;ACVRL1;TBX2;HEYL
prerank,response to light stimulus (GO:0009416),0.4307929588961231,1.3528822406432746,0.09180790960451977,0.7799887549649187,1.0,13/55,15.54%,GPR88;COPS3;TYR;USP1;ERCC5;CDKN2D;ERCC4;UVSSA;GPR52;SPRTN;REV1;ERCC2;CRY2
prerank,purine ribonucleotide transport (GO:0015868),-0.501608900478597,-1.3524443113642945,0.11136890951276102,0.49956366092583043,1.0,4/16,7.77%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,canonical glycolysis (GO:0061621),-0.4371315125563902,-1.3519681794021947,0.09433962264150944,0.49792698233373855,1.0,12/24,20.45%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.4371315125563902,-1.3519681794021947,0.09433962264150944,0.49792698233373855,1.0,12/24,20.45%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,neutrophil migration (GO:1990266),0.4240488617871305,1.3512461257872792,0.09090909090909091,0.7840289993405324,1.0,7/58,5.33%,XCL1;CXCL10;EDN3;CXCL1;PDE4B;GBF1;CCL15
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3845676210614623,1.349482739841581,0.04265402843601896,0.7885743576985055,1.0,26/144,12.94%,CEMIP;SEC16B;PIK3R1;AKAP5;MICALL2;TCF7L2;SEC16A;JUP;ANK3;PIK3R2;YWHAZ;ZIC1;VAMP2;MTCL1;SORL1;PINK1;RAB29;TENM1;TMEM30A;SAE1;SAR1A;TP53;FYN;HTRA2;GSK3A;CD81
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4196834016458313,1.349064614196381,0.07713498622589532,0.7876128565188975,1.0,18/68,16.64%,ENPP1;PDE9A;ACSF2;TPST1;LRRK2;AMPD2;AK4;OPA1;ACOT7;ACSL6;ACLY;MFN1;ENTPD7;AK3;SULT6B1;ACOT2;EFL1;ADSS1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3506800907180272,-1.348815770704925,0.06367041198501873,0.5047525514272578,1.0,22/65,19.03%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;INTS3;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;PSMC1;PABIR1;PSMB10;CHFR;PSME2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5953894195880702,1.3483498642257388,0.13725490196078433,0.7878661802461576,1.0,3/10,11.67%,OGT;DGKQ;PDK2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5464277674911668,-1.3480288191620542,0.14022988505747128,0.5053560492231156,1.0,4/11,4.87%,SLIT2;NBL1;RIN3;CCN3
prerank,protein import (GO:0017038),0.4002566583233829,1.3479828674452872,0.05851063829787234,0.7867339185701285,1.0,27/84,18.83%,PRICKLE1;CSE1L;ABCD2;PEX2;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;SLC25A17;HSPA4;CLU;PEX19;TNPO2;IPO9;PEX12;NUP155;PEX3;ALDH3A2;KPNB1;PEX14
prerank,epiboly involved in wound healing (GO:0090505),-0.5039719733260909,-1.3477992528028175,0.10886075949367088,0.5044565559433789,1.0,9/16,16.26%,CCN1;CD44;TMEFF2;RHOC;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,axon guidance (GO:0007411),0.3648932029862361,1.3472224989466979,0.038946162657502864,0.7872106667196107,1.0,45/201,12.73%,LAMA1;ROBO2;LAMA2;PIK3R1;EPHA7;PLXNC1;CHN1;WNT5A;SEMA5A;EPHB1;NRXN1;GAB2;TNR;SPTBN1;EPHA6;UNC5A;DSCAM;CNTN4;IRS2;DAB1;DSCAML1;PTPRO;UNC5C;PTK2;RELN;PALLD;EPHB6;DCC;NRXN3;PRKCA;NEXN;CNTN6;OPHN1;LYPLA2;EPHA3;PTPRA;DOK5;FYN;USP33;UNC5D;PLXNB2;GFRA1;ARHGAP35;SH3KBP1;KIF5C
prerank,positive regulation of telomerase activity (GO:0051973),-0.4004398071568731,-1.346693904571415,0.06287425149700598,0.5058550271942593,1.0,8/33,14.25%,HMBOX1;KLF4;PTGES3;PARN;NEK7;MAP2K7;CCT4;MAP3K4
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5988041813813405,1.3463543743290638,0.14629629629629629,0.7879891327807454,1.0,2/11,1.20%,COLEC12;UNC93B1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6165834466489044,1.3463377462612243,0.14234234234234233,0.7854543957026618,1.0,3/10,9.11%,MAP4K4;IQSEC1;MTOR
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.559951785500866,-1.3460851890403769,0.1300639658848614,0.5059591779626122,1.0,8/10,25.17%,RDX;CEACAM1;PRKG1;SERPINE2;PRKCD;CD9;ALOX12;ADAMTS18
prerank,intraciliary retrograde transport (GO:0035721),0.5808544302845715,1.345640524777434,0.1503623188405797,0.7857592162957147,1.0,4/12,16.55%,WDR35;DYNC2LI1;TTC21B;IFT43
prerank,regulation of protein metabolic process (GO:0051246),-0.38307500913825543,-1.3455371239908913,0.08304498269896193,0.5058107426814319,1.0,14/44,18.15%,ROCK2;LTBP4;APP;KLF4;VPS35;ACE;KLF2;APOE;SSH1;FURIN;TRAF3;MAP2K5;NEDD8;TMEM9
prerank,amide transport (GO:0042886),-0.44118943039462477,-1.3454804992897988,0.10554089709762533,0.5044514959978238,1.0,13/26,31.25%,ABCG2;SLC25A32;CERT1;PLTP;SLC38A5;TAP2;PDPN;ABCB9;GLTP;DISP1;AQP11;SLC5A6;ABCA13
prerank,regulation of blood coagulation (GO:0030193),-0.42318737444860505,-1.3454401326253715,0.09018567639257294,0.5030561660531743,1.0,11/27,15.36%,CAV1;THBD;THBS1;ST3GAL4;VTN;CD34;APOE;SERPINE1;EPHB2;SERPINE2;EDN1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.42240212763268703,1.3454289145194687,0.10504201680672269,0.7839887837411753,1.0,25/62,21.85%,MEIS1;KMT2E;HDAC1;L3MBTL1;AGO4;MEIS2;KMT2A;ZBTB16;WDR5;PRKCB;AGO3;LYN;TNRC6B;HOXA9;MAFB;ASH2L;AGO1;CBFB;CDC73;KMT2C;HSPA9;RBM15;RBBP5;HOXA5;CREBBP
prerank,negative regulation of lipid storage (GO:0010888),0.5341189726195781,1.3451413511351702,0.13584288052373159,0.7826216130312874,1.0,4/19,4.06%,PPARA;ITGAV;PPARD;NR1H2
prerank,cardiac cell development (GO:0055006),-0.55794777451017,-1.3446877650560998,0.11899313501144165,0.5036888619313232,1.0,3/11,9.16%,CXADR;NOTCH1;MYH11
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5963532419195264,1.3443277937222193,0.15162454873646208,0.7834306351115918,1.0,1/10,0.31%,GHR
prerank,regulation of interferon-gamma production (GO:0032649),0.4135959877735642,1.3441530078018045,0.08423913043478261,0.7816539044835051,1.0,13/71,12.10%,XCL1;TXK;PDE4B;NR1H4;SCRIB;PTPN22;PDCD1LG2;CD276;TLR8;AXL;TLR4;PYCARD;IL12A
prerank,protein import into nucleus (GO:0006606),0.41500363077235036,1.3439153580052101,0.08108108108108109,0.7801303945771683,1.0,25/66,23.31%,PRICKLE1;CBLB;CSE1L;NUP214;FAM53C;NUTF2;POM121;APPL2;FAM53A;TNPO1;KPNA1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;TNPO2;IPO9;NUP54;NUP155;KPNB1;RANBP2;KPNA2;IPO4;IPO8;NUP35
prerank,cellular potassium ion homeostasis (GO:0030007),0.5704109330327857,1.342642245662115,0.13204225352112675,0.782601268143479,1.0,3/13,5.33%,ATP1A2;ATP1A3;KCNMA1
prerank,chloride transmembrane transport (GO:1902476),0.4314482449923842,1.3426086531729715,0.11159420289855072,0.7802242073271596,1.0,13/48,13.84%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;GABRB1;LRRC8A
prerank,sodium ion homeostasis (GO:0055078),0.5119949062332222,1.342579141914597,0.11725293132328309,0.7778428460324615,1.0,3/21,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,positive regulation of synaptic transmission (GO:0050806),0.4141422792823845,1.3425664703315952,0.09497206703910614,0.7754155954238836,1.0,17/72,11.37%,AKAP5;GRIN2B;NRXN1;CACNG3;GRIK2;VAMP2;FMR1;MPP2;CRHR2;GRIN2A;ADCY8;RIMS2;RELN;LGMN;CACNG4;RIMS1;DLG4
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5549481207183338,-1.342409326825606,0.12873563218390804,0.5082976598572018,1.0,7/11,19.18%,EZR;RDX;DAB2;RAB21;VPS11;MSN;MTMR2
prerank,retinal metabolic process (GO:0042574),0.596752938592454,1.3423726798477398,0.1678082191780822,0.7736511210547472,1.0,3/12,11.78%,RDH10;RDH11;ABCA4
prerank,DNA replication initiation (GO:0006270),0.4589528563761376,1.3422339090611766,0.11275964391691394,0.7717875037319768,1.0,13/37,15.55%,MCM7;CDC7;POLA1;GMNN;RPA1;POLE4;NOC3L;MCM4;CDT1;POLE3;MCM10;DBF4;ORC2
prerank,positive regulation of binding (GO:0051099),-0.33489401316739736,-1.3410988772843389,0.043859649122807015,0.5102070284025079,1.0,28/84,18.27%,IGF1;RAPGEF2;CAV1;FOXC1;HMBOX1;APP;CLDN5;HIP1R;VTN;SKI;NGF;B2M;APOE;GSK3B;RPL11;PARP9;RALB;TERT;HIPK2;CLN5;RAN;AMFR;DDX11;MARK3;MET;HFE;HMGB2;EGF
prerank,negative regulation of neurogenesis (GO:0050768),0.46378438345244605,1.3406514012122783,0.11666666666666667,0.7754172763797599,1.0,7/34,9.09%,PTN;PTEN;NGFR;REST;SORL1;NF1;APPL2
prerank,protein trimerization (GO:0070206),0.5643100544827846,1.3406208150122576,0.13310580204778158,0.7706622673398694,1.0,3/14,7.39%,SLC1A5;CLYBL;ASIC1
prerank,protein homotrimerization (GO:0070207),0.5643100544827846,1.3406208150122576,0.13310580204778158,0.7706622673398694,1.0,3/14,7.39%,SLC1A5;CLYBL;ASIC1
prerank,positive regulation of viral genome replication (GO:0045070),0.4797684074793581,1.3405833619586973,0.14463452566096424,0.7683792191306813,1.0,10/29,17.72%,PPARA;PPID;TOP2B;PPIH;PDE12;STAU1;CNOT7;ADAR;HACD3;TOP2A
prerank,neural crest cell migration (GO:0001755),-0.39704933883664006,-1.34017138035472,0.0856269113149847,0.5112097608229746,1.0,10/36,10.81%,FN1;SEMA3D;SEMA3C;SEMA7A;NRP1;SEMA6A;SEMA4B;TBX1;PHACTR4;SEMA5B
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4843294245414124,-1.3394789181444684,0.1377672209026128,0.5115932910912329,1.0,2/15,0.90%,CD200;IL31RA
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3586943158334921,-1.3394182861786743,0.058333333333333334,0.5102305157168234,1.0,19/62,14.66%,IGF1;ROBO1;NET1;NOTCH2;F11R;RASGRF1;GPR4;SHOC2;NOTCH1;RAC1;RAPGEF1;NGF;PRAG1;PIK3CB;MAPRE2;STK19;ALS2;GRB2;ADGRG1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.39041712924753386,1.3392247761715492,0.06351183063511831,0.771078492360381,1.0,38/107,20.41%,HCRT;ATP1A2;PTEN;CHRNB4;GRID2;CEL;GRID1;GRIK5;GRIK2;ABR;FMR1;GRIK4;LRRK2;GRIK1;TMEM108;RIMS2;RELN;OPHN1;GRM5;LRRC4C;DGKI;RIMS1;DLG4;NRG3;PSMC5;UNC13A;DLGAP3;NMU;TPRG1L;GRM7;CDK5;CAMK2A;GRM1;CLSTN1;SYT1;USP46;NPTX2;PXK
prerank,visual system development (GO:0150063),-0.39525411462458415,-1.3389540910613686,0.07692307692307693,0.510077105129389,1.0,12/37,12.80%,SMOC1;PBX1;FOXC1;RBP4;TGFB2;PBX4;ATF6;SH3PXD2B;HIPK1;ZDHHC16;FREM2;HIPK2
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5445763556197764,-1.3386139338262015,0.12155963302752294,0.5095216942121916,1.0,6/11,17.95%,ADIPOR2;KDR;CD34;GATA2;ITGB3;MCAM
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.42913977255699887,-1.3383194056680192,0.09782608695652174,0.5088368001522658,1.0,12/25,20.45%,FOXK1;HK1;PGK1;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5513753812072579,1.3381733728505485,0.1453287197231834,0.7728083555875278,1.0,3/16,6.88%,LRP1;HDAC1;SRF
prerank,regulation of acrosome reaction (GO:0060046),-0.563653772389094,-1.3380579961142323,0.12641083521444696,0.5079949375164257,1.0,1/10,0.46%,PLCB1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4472020875336174,-1.3377136361545532,0.08192090395480225,0.5074717566375885,1.0,10/24,9.87%,SMAD6;SEMA3C;ROBO1;NRP2;NRP1;BMPR2;TGFB2;TBX1;ACVR1;TBX2
prerank,monocyte differentiation (GO:0030224),-0.5573137040403597,-1.33764940618799,0.13876651982378854,0.5061942040397944,1.0,7/10,30.91%,PIR;IL31RA;PDE1B;CSF1R;MYH9;PPARG;MT1G
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5309579458629646,1.337452498099976,0.14659685863874344,0.7733673688490839,1.0,6/17,17.78%,GPLD1;SORL1;CIDEA;BSCL2;ADRA2A;PDE3B
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.5056295838401761,-1.3371502203954801,0.12679425837320574,0.5062394077638678,1.0,4/13,7.21%,DKK3;NFKB1;ERLIN1;APOE
prerank,vascular transport (GO:0010232),0.40763188286209306,1.3368716731188826,0.07901907356948229,0.7731859618550326,1.0,9/81,2.36%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5844894883970144,1.3366919125477004,0.1497326203208556,0.7715309045080477,1.0,4/12,9.80%,TLR6;ADGRB1;TLR4;CYBA
prerank,pulmonary valve development (GO:0003177),-0.4730258176633614,-1.3359710427559328,0.11224489795918367,0.5079283279433151,1.0,8/18,4.36%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;BMPR2;NOTCH1;TGFB2
prerank,ion homeostasis (GO:0050801),-0.41319087294207035,-1.335470029973336,0.11890243902439024,0.5078907614616326,1.0,6/30,6.46%,SLC4A10;FHL1;CAMK2D;WNK4;WNK1;SLC4A3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.35020113967243877,-1.3351187933519468,0.058823529411764705,0.5073612689546195,1.0,28/66,20.91%,PLCB1;EGFR;FHL1;ADAMTS1;KANK2;KLF4;RDX;CCND2;ANXA1;APC;CDK6;HYAL1;INO80;WEE1;FAM107A;PSME3;CCND1;PLK5;CDKN1A;ANKRD17;DCUN1D3;AKT1;DLG1;PSME2;RBL1;RGCC;RBL2;E2F1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.5512222187638695,1.3345360412649843,0.11647254575707154,0.7775686882243155,1.0,11/18,22.93%,LIG3;MCM7;GINS3;POLA1;RFC3;MCM4;POLE3;MCMDC2;POLE;RFC4;GINS1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3653188502704233,-1.3338287742254156,0.06666666666666667,0.5093726218905564,1.0,22/55,24.26%,CAV1;BCL2L1;TPD52L1;BECN1;TNFSF10;FAS;WWOX;CRADD;BAD;BAX;BID;CYLD;BOK;GPER1;ING5;PAK2;AGT;NUPR1;BCL10;TRIM39;HYAL2;BCL2L11
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36148097993387407,1.3334014544598856,0.03484320557491289,0.7794414678267044,1.0,33/214,10.90%,ROR1;PDGFRA;NTRK3;EPHA7;XCL1;ROR2;SPRY1;SLC30A10;NTRK2;PTEN;ERBB4;C5AR1;EPHB1;PTPRR;P2RY1;CNKSR3;YWHAZ;SPRED1;GCNT2;HTR2B;PTPN22;CCL15;RPS6KA6;GLIPR2;NECAB2;SPRED2;GPR183;PRKCA;HTR2C;TLR4;MAP2K1;CCL25;PYCARD
prerank,regulation of response to stress (GO:0080134),0.6202538014278136,1.3322155851245172,0.14535901926444833,0.7815605443402378,1.0,2/10,6.49%,CORO2B;ADCY8
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3633137560112056,-1.3319112177784154,0.05787781350482315,0.5132565832977899,1.0,25/49,30.16%,ACER2;NDRG1;MAPK14;ATR;BID;ATM;CDC5L;NBN;GRB2;CLOCK;DONSON;HUS1;E2F1;PRPF19;BATF;ATRIP;HINFP;CHEK2;BRIP1;CHEK1;RHNO1;GADD45A;SESN2;E2F7;TRIAP1
prerank,inositol lipid-mediated signaling (GO:0048017),0.43911697708378045,1.3304234015940013,0.09285714285714286,0.786138063238708,1.0,12/50,7.87%,PDGFRA;PLCL1;PIK3R1;OGT;FGFR1;GAB2;PIK3R2;IRS1;IRS2;ADAP2;PI4KA;RPS6KB1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5731517679684893,-1.3300237586678,0.15889830508474576,0.5168467327541219,1.0,6/10,13.99%,RAPGEF2;KDR;RAP1A;CD34;CEACAM1;RRAS
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.563082763811292,1.3299669078203362,0.13580246913580246,0.7856281303621847,1.0,11/14,28.49%,SEC24B;SAR1A;SCAP;SEC24A;SEC23A;MIA3;TBC1D20;SEC24C;SEC23B;SEC13;SEC24D
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.45736852245220205,-1.329442690873087,0.10471204188481675,0.5170000651108829,1.0,8/20,23.29%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC;TTBK1;STOX1
prerank,adenine nucleotide transport (GO:0051503),-0.48667965562142096,-1.3291945928048106,0.12264150943396226,0.5162617960792314,1.0,8/17,25.67%,ABCC4;LRRC8C;ABCC6;LRRC8D;SLC25A5;SLC35B2;SLC17A9;SLC25A4
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.502986480357477,-1.3291825378605138,0.14009661835748793,0.5148537028698538,1.0,4/14,11.77%,ACTN2;ATP1B3;ANK2;LRRC38
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3981175082610461,-1.3288147621399773,0.0953757225433526,0.5144322967668067,1.0,12/31,17.82%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD;CDK9
prerank,neuron projection regeneration (GO:0031102),0.6001844255721498,1.3287138791516464,0.15101289134438306,0.7880489396601694,1.0,1/10,0.19%,PTN
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.37084685124893924,1.328670580914637,0.05703883495145631,0.7858354146496934,1.0,22/151,10.90%,ROR1;PDGFRA;NTRK3;XCL1;ROR2;SLC30A10;NTRK2;ERBB4;C5AR1;P2RY1;GCNT2;HTR2B;PTPN22;CCL15;GLIPR2;NECAB2;GPR183;PRKCA;HTR2C;MAP2K1;CCL25;PYCARD
prerank,keratan sulfate metabolic process (GO:0042339),-0.4146520652486986,-1.328577715206754,0.10597826086956522,0.5135801824775119,1.0,9/31,9.34%,B4GALT1;ST3GAL6;OGN;ST3GAL4;B4GALT5;ST3GAL1;ST3GAL3;SLC35D2;HEXB
prerank,cognition (GO:0050890),0.4522868420036001,1.3275485127403217,0.12187958883994127,0.7880421718910772,1.0,17/42,21.05%,CHD7;C5AR1;SOBP;METTL23;NF1;SETD5;PTCHD1;RP9;GRM5;TUSC3;CUX2;LHCGR;CYFIP1;GPR155;MGAT3;BBS4;CTNS
prerank,extracellular transport (GO:0006858),0.5621921605504326,1.3268597477953246,0.16470588235294117,0.7883101690516776,1.0,5/13,13.69%,ADCY10;DNAAF4;SPA17;CABYR;TSG101
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5816800859028943,1.326852192553687,0.1736745886654479,0.785980416539492,1.0,3/11,14.79%,IL34;PRKCA;RIPK1
prerank,muscle organ development (GO:0007517),0.43526336104998525,1.326487553172242,0.10378681626928471,0.7850209897752451,1.0,12/54,11.73%,LAMA2;ITGA11;UTRN;CXCL10;VAMP5;SMTN;SGCE;SOX6;CAPN3;CHD2;FKTN;SPEG
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5412089445251848,-1.3264549844632867,0.12837837837837837,0.5179047549797516,1.0,4/11,15.81%,CAMK2D;NOS1;NOS1AP;CACNB1
prerank,negative regulation of immune effector process (GO:0002698),-0.525098426280423,-1.3262849714281555,0.13975903614457832,0.5168734291410033,1.0,5/13,16.76%,FER;CD55;RPS19;RC3H1;HAVCR2
prerank,negative regulation of defense response (GO:0031348),0.4048112319836575,1.3262618243500166,0.09115281501340483,0.7835423163758015,1.0,10/77,7.85%,RORA;PPARA;TRAF3IP1;NR1H4;TNFAIP8L2;PPARD;DHX58;ENPP3;LYAR;LRFN5
prerank,serine family amino acid catabolic process (GO:0009071),0.6077271335523131,1.3255889190331163,0.15371024734982333,0.7837740464119459,1.0,2/10,2.07%,THNSL2;GLDC
prerank,regulation of response to biotic stimulus (GO:0002831),-0.4238497195934354,-1.325152806348038,0.11382113821138211,0.5185745757868326,1.0,12/28,15.01%,FOXP1;XIAP;SAMHD1;CD55;ERAP1;TRIM5;CASP8;IRF1;ELMOD2;GATA6;CX3CL1;TRAF3
prerank,Notch signaling pathway (GO:0007219),-0.3568607490407366,-1.325057633693407,0.07958477508650519,0.5174213210443306,1.0,16/59,13.76%,PBX1;RBPJ;SORBS2;MAML2;NOTCH3;NOTCH2;NOTCH1;ADAM10;MIB1;MDK;GALNT11;HEYL;APH1A;HEY2;APH1B;YBX1
prerank,regulation of endothelial cell migration (GO:0010594),-0.3238108105314734,-1.324838490857619,0.027777777777777776,0.5164777872868987,1.0,35/85,18.27%,ANXA3;ROCK2;FOXP1;TEK;BMPER;SLIT2;THBS1;NRP2;NRP1;BMPR2;SPARC;FOXC2;KDR;RAC1;SCARB1;APOE;AAMP;FGF1;ACVRL1;ITGB1BP1;ATOH8;PIK3CB;PIK3CD;ETS1;ITGB3;CEACAM1;FLT4;PTK2B;RRAS;EDN1;BCAS3;EPHA2;DNAJA4;AKT1;EGF
prerank,transport across blood-brain barrier (GO:0150104),0.3998231369493372,1.324684641714767,0.08411214953271028,0.7851046509208188,1.0,11/83,5.83%,SLC1A3;SLC1A5;SLC2A13;LRP1;ABCC3;SLC6A13;SLC16A12;ATP1A2;LRP3;SLC7A8;FABP5
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.46278831376938956,-1.3241868686727474,0.1175,0.5167394845283005,1.0,4/20,10.60%,RAPGEF2;ADRA1B;ZDHHC21;LMBRD2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3569101865152195,-1.3241825259219773,0.07586206896551724,0.5153309992303671,1.0,20/56,27.48%,SMAD6;BMPER;BMPR2;TGFB2;DAB2;SNX25;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;SMAD7;INHBB;ACVR2A;GREM1;SMAD4;EMILIN1;TTK
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.38074648298600194,1.3240685096919855,0.06426735218508997,0.7850766761134875,1.0,27/117,17.12%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;CD81;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.5997485364605404,1.3232842498043742,0.16431095406360424,0.7858896514638612,1.0,1/10,0.11%,ENPP1
prerank,prostanoid biosynthetic process (GO:0046457),-0.5002701833950712,-1.3231036762330255,0.1309255079006772,0.5167442097942004,1.0,8/15,20.89%,PTGDS;PTGS1;PTGES3;PLA2G4A;PTGS2;EDN1;CD74;MIF
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.39906782484544207,-1.323027793027415,0.08355795148247978,0.515494246757518,1.0,13/33,12.84%,TJP1;BMPER;THBS1;KLF4;SEMA6A;KLF2;EPN2;PPP1R16B;FGF1;PIK3CB;CEACAM1;PKM;SMAD1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.57889049188122,1.322337039348766,0.1616871704745167,0.7871896574819758,1.0,4/11,14.06%,JAK1;ANK3;PRKCA;LYN
prerank,calcium-ion regulated exocytosis (GO:0017156),0.4869642058674908,1.3222117006877843,0.13687600644122383,0.7853341814485729,1.0,11/27,18.61%,VAMP2;RIMS2;SYT3;SYT7;ARL8B;PPP3CB;RIMS1;SYT5;VAMP7;SYT6;SYT1
prerank,retinoid metabolic process (GO:0001523),0.4094588709634491,1.3217998574282586,0.10427807486631016,0.7845256102128529,1.0,8/71,4.65%,LRP1;ADH1A;RDH10;ALDH1A1;HSPG2;RDH11;GPC4;GPC5
prerank,regulation of establishment of protein localization (GO:0070201),0.567940958539173,1.321460226210526,0.15245901639344261,0.7836661554273466,1.0,5/14,11.64%,CORO2B;CEP295;CEP135;SCFD1;SPIDR
prerank,positive regulation of stem cell differentiation (GO:2000738),0.545075325474338,1.3213462894051469,0.1514629948364888,0.7818168016648616,1.0,7/16,12.56%,PTN;RBM24;SOX6;NUDT21;DHX36;SOX9;HOXB4
prerank,organelle transport along microtubule (GO:0072384),-0.4094661843647405,-1.3207357817780487,0.11142857142857143,0.5201528812994909,1.0,15/31,26.57%,NDEL1;CDC42;UBB;MAPT;TRAK2;BICD2;BORCS5;RAB1A;RAB6A;DYNC1I1;TMEM201;BICDL1;KIF5B;COPG2;BICD1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.5163284818774648,-1.319857236363016,0.12177985948477751,0.5212514761581154,1.0,4/13,7.08%,CAV1;CAMK2D;SRI;CALM1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4138518164690162,-1.3183552313922482,0.12574850299401197,0.5239471760676722,1.0,9/27,15.81%,AHNAK;CAMK2D;CALM1;ANK2;DMD;JPH1;NOS1;JPH2;CACNB1
prerank,amino acid transmembrane transport (GO:0003333),-0.3617416108284059,-1.3183213594590506,0.056962025316455694,0.5226548054114785,1.0,12/45,11.97%,SLC47A1;SLC16A2;SLC6A6;SLC38A11;SLC22A4;SLC7A1;SLC3A2;LRRC8D;SLC38A5;SLC38A10;SLC7A5;SFXN1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5727832971648066,1.3182165590335932,0.15579710144927536,0.7915480903198283,1.0,6/13,12.02%,PPARA;NFATC3;PPARD;REST;SRF;SOX9
prerank,cellular response to growth factor stimulus (GO:0071363),-0.29845220266462297,-1.3180579829483732,0.031088082901554404,0.5219251000173161,1.0,45/151,16.17%,FLT1;RAPGEF2;SOX5;MEF2C;EGFR;FOXC1;GAS1;KLF4;NRP1;BMPR2;MAGI2;IQGAP1;KDR;RAP1A;NOTCH1;WNT4;WWOX;ANXA1;PDE3A;SEMA6A;RAPGEF1;MAPK14;TBX1;CD44;ACVR1;ACVRL1;ITGB1BP1;MAPT;SMAD3;HYAL1;EEF1A1;SFRP1;NR4A1;RAB35;HSPB1;NOS1;NR3C1;FLT4;CPNE3;RAMP2;PLK5;MAP2K5;ERN1;KIDINS220;ZPR1
prerank,rRNA metabolic process (GO:0016072),-0.2955200110689391,-1.3165685169317873,0.02112676056338028,0.524544589843069,1.0,57/160,22.28%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RPL10;RPL35A;MAPT;DDX27;RPL10A;RPL11;RPL36A;DIS3L;RPL34;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RPL31;IMP3;EXOSC3;NIFK;RPL23A;RPL19;RPL36;WDR12;PES1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52
prerank,cellular lipid catabolic process (GO:0044242),0.4843623587938601,1.3160816467176206,0.13230769230769232,0.7978628485916994,1.0,7/27,15.43%,LPIN3;CEL;PPARD;ACADL;ABHD12;NUDT19;LPIN2
prerank,secondary palate development (GO:0062009),0.552008910423947,1.3160635585593228,0.16216216216216217,0.7956166606267795,1.0,2/14,1.70%,CHD7;WNT5A
prerank,intracellular lipid transport (GO:0032365),-0.44475684564005225,-1.313932282703227,0.1218274111675127,0.5301245474514731,1.0,5/21,5.48%,PRKAG2;ABCD3;ABCD4;CERT1;PRKAA2
prerank,synapse organization (GO:0050808),0.3743353770618372,1.3138743241538315,0.07389162561576355,0.8021277169336838,1.0,35/125,17.35%,PDZRN3;ADGRL3;PTEN;C5AR1;FARP1;NRXN2;NRXN1;GPC4;ANK3;REST;PCDHB16;NEDD4;DSCAM;LRRK2;PCDHB4;PCDHB11;C1QA;PPFIA2;LRFN5;C1QC;RAB29;CACNB4;GRM5;LRRC4C;CBLN1;UNC13A;PPFIA4;F2R;KIRREL3;NTNG1;NRCAM;CYFIP1;SLITRK1;CDK5;UNC13C
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3934091984741256,-1.313720339695751,0.09734513274336283,0.5292921957968221,1.0,15/32,24.99%,SORBS1;PRKAG2;ADIPOR2;PRKAA2;APOE;CEACAM1;ASXL3;CREB1;GPER1;AKT1;CREBL2;FITM2;STAR;ASAH1;PDK4
prerank,negative regulation of cyclase activity (GO:0031280),0.5464481664566903,1.3135972233918078,0.1651705565529623,0.8008231478130914,1.0,2/14,1.67%,AKAP5;ADGRV1
prerank,positive regulation of response to wounding (GO:1903036),-0.429616800311073,-1.31351255798723,0.13858695652173914,0.5285264440029619,1.0,8/24,5.80%,OCLN;MYLK;ITGB1;ACTG1;VTN;KANK1;ANXA1;SCARF1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.40270484041262916,-1.3131730850841807,0.10574018126888217,0.5280944274406887,1.0,10/35,9.01%,FLT1;MEF2C;CAV1;THBS1;SPARC;COL4A3;CAV2;APOE;XDH;ATOH8
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5809937580160999,1.3128572509074943,0.1717171717171717,0.8013827801906979,1.0,8/12,20.63%,MBTPS2;H6PD;DGKQ;CLCN2;SREBF1;KPNB1;ABCA2;MBTPS1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5434697998545109,1.3123239745980408,0.17761989342806395,0.8011097567884655,1.0,6/15,15.81%,LRP1;FAP;FSCN1;CARMIL2;CLASP2;CLASP1
prerank,gliogenesis (GO:0042063),-0.48431284185961787,-1.312275097254101,0.16,0.5290808687120775,1.0,4/15,5.70%,NFIB;TGFB2;ANXA1;CDK6
prerank,fibrinolysis (GO:0042730),0.5756829740744094,1.3119833238675935,0.1625,0.8001342206005971,1.0,2/13,8.21%,HRG;PLAU
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.41629823833264057,-1.3119303816234775,0.11444141689373297,0.5286139497500253,1.0,11/28,20.46%,CASP8AP2;GABARAP;CRADD;NGF;CASP8;BAX;BAG3;BID;TNFRSF1A;TRADD;ZDHHC3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.45454350685115896,1.3116953021640325,0.14176829268292682,0.7989407938342177,1.0,11/35,21.17%,CDH6;PCDHB16;DCHS1;CDH11;PCDHB4;PCDHB11;CDH10;PCDHGB4;CDH9;ATP2C1;PCDHB14
prerank,transepithelial transport (GO:0070633),0.5300957584901491,1.3116304034885302,0.17235494880546076,0.7969315766970653,1.0,2/15,2.27%,SLC1A3;GPLD1
prerank,regulation of leukocyte activation (GO:0002694),-0.4968399845047779,-1.3113915613297824,0.15384615384615385,0.5286482095873536,1.0,7/14,22.18%,CD200;GPER1;CD74;MFHAS1;MIF;SHPK;MYO18A
prerank,plasma membrane tubulation (GO:0097320),-0.503589229546677,-1.311278908505742,0.16393442622950818,0.5275517850285805,1.0,3/13,3.98%,FNBP1L;PACSIN2;CAVIN2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.32959395256744123,-1.3108590718082556,0.07931034482758621,0.5272954753775051,1.0,17/74,10.44%,EYA2;IGF1;BCL2L1;EYA1;EYA4;NOS3;THBS1;ITGA6;MCL1;TNFSF10;FAS;GSK3B;ACVR1;CASP8;GPX1;SERPINE1;ICAM1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.36826620469742916,-1.3104472688805775,0.10060975609756098,0.5270501402466282,1.0,11/47,8.29%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;KANK1;RAC1;NEDD9;CDC42;EFNA5;ITGB1BP1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4531853277165061,1.3102366913385926,0.1575037147102526,0.8001086310021179,1.0,10/34,12.54%,GRID2;GRIN2B;GABRA1;MPP2;LRRK2;GRIN2A;GABRG3;GABRG2;GLRA1;GSK3A
prerank,negative regulation of anoikis (GO:2000811),-0.4818780219517522,-1.3093480781767772,0.14157303370786517,0.5286488656974385,1.0,4/14,4.26%,CAV1;ITGB1;MCL1;NOTCH1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5899724163690194,1.3090043357126013,0.1568627450980392,0.8027908280255095,1.0,2/10,8.61%,SLC1A3;SLC25A22
prerank,neuromuscular junction development (GO:0007528),0.49630224476347745,1.3089705788260022,0.14144736842105263,0.8006784416122363,1.0,8/24,17.35%,PDZRN3;ANK3;NEDD4;LRRK2;CACNB4;UNC13A;F2R;UNC13C
prerank,positive regulation of heart contraction (GO:0045823),0.5175647449188303,1.30894109841186,0.16123778501628663,0.7985753699761144,1.0,4/19,5.93%,EDN3;ATP1A2;RYR2;ATP2A2
prerank,negative regulation of synaptic transmission (GO:0050805),0.4874741900672302,1.308253999513591,0.15008431703204048,0.799156244799883,1.0,4/23,12.09%,PTEN;PNKD;LRRK2;CBLN1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5052581322152514,1.3078058452180368,0.15025041736227046,0.7986048731288626,1.0,7/19,11.66%,PTGFR;RYR2;STIMATE;PRKACA;ADGRL1;GRM5;TRPM2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.41963232547464613,-1.3072853593302594,0.11731843575418995,0.5328668657013598,1.0,10/26,17.85%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;NOS1AP;PTGS2;EDN1;AKT1
prerank,negative regulation of T cell activation (GO:0050868),0.45321717909136255,1.3071910995300966,0.13918305597579425,0.7986351073226196,1.0,7/35,12.36%,PAG1;GLMN;TNFAIP8L2;PTPN22;PDCD1LG2;TNFRSF21;CD86
prerank,glycolipid metabolic process (GO:0006664),-0.3668262160125776,-1.3068018735499285,0.08761329305135952,0.5327461322007406,1.0,21/47,28.68%,ST3GAL6;ST3GAL4;SMPD3;FUCA1;ST6GALNAC3;HEXB;UGCG;NAGA;B3GALNT1;ESYT3;SMPD1;ST3GAL2;GM2A;ARSA;PSAP;GLTP;ST8SIA6;ASAH1;PIGW;NEU1;SCCPDH
prerank,positive regulation of histone methylation (GO:0031062),0.4850010400857961,1.3065909332740435,0.14903846153846154,0.7988183979090995,1.0,8/24,19.18%,AUTS2;OGT;KMT2A;WDR5;SNW1;PAXIP1;RIF1;CHTOP
prerank,regulation of actomyosin structure organization (GO:0110020),-0.50008570577125,-1.3055033982344986,0.16247139588100687,0.5348425268182126,1.0,5/13,10.76%,ROCK2;ACTG1;RAC1;CDC42;FHOD1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4263503440452035,-1.305271173200273,0.13559322033898305,0.5341273635636986,1.0,10/25,17.85%,KLF4;INSR;KLF2;SMAD3;ASS1;DDAH1;NOS1AP;PTGS2;EDN1;AKT1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.5093153418962006,1.3051929829211764,0.1563517915309446,0.8019158736887911,1.0,6/21,15.41%,MED12;SRF;TWIST1;DHX36;MED1;PAXIP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5028751726306347,1.3050917705300142,0.14285714285714285,0.8000891426595361,1.0,4/20,6.00%,ATP1A2;ATP1A3;KCNMA1;SLC9A1
prerank,neuron development (GO:0048666),0.3654859667871732,1.305068156993167,0.06561360874848117,0.7979897973219724,1.0,36/141,16.35%,NCDN;LAMB1;ISL2;ETV1;GPM6B;TENM3;NTRK2;MICALL2;CNTNAP2;LRP12;TENM4;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;TENM2;SRF;DOCK7;STMN2;NPY;TENM1;LGI4;OPHN1;PLP1;STMN4;MYT1L;GPRIN1;STMN1;ATP7A;LYN;EPHA5;PBX2;GDNF;TBC1D23;GPRIN3
prerank,positive regulation of secretion (GO:0051047),0.590120444933361,1.304914858324428,0.18641114982578397,0.7964654642591118,1.0,2/11,7.81%,GPLD1;TRH
prerank,regulation of lipid kinase activity (GO:0043550),0.5775146150972721,1.3042658480070808,0.18760757314974183,0.796944997036919,1.0,2/11,4.02%,PIK3R1;PIK3R2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3838910161337207,1.3041881135894906,0.07761966364812418,0.7950807908974042,1.0,16/100,8.25%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;PTEN;PIP4K2A;FGFR1;ENTPD5;NEDD4;IRS2;PTPN13;PTK2;TWIST1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5828630996635603,1.3038724000543866,0.16696914700544466,0.7941896957111705,1.0,3/10,6.25%,GPLD1;IRS1;IRS2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.47487779685435105,-1.3033762104793694,0.14691943127962084,0.537544571550234,1.0,5/15,9.79%,RSPO3;WNT5B;CSNK1D;GPC3;SFRP1
prerank,negative regulation of TOR signaling (GO:0032007),-0.39131685812599637,-1.3033719943835258,0.09850746268656717,0.5361792442481979,1.0,12/36,16.14%,FNIP1;RNF152;DEPTOR;SESN1;PRKAA2;SH3BP4;UBR1;UBR2;TBC1D7;ATM;SIRT1;PRKAA1
prerank,mesoderm development (GO:0007498),-0.4610309155879068,-1.3033377013422813,0.1523809523809524,0.534868097142269,1.0,5/18,7.26%,FOXC2;TIE1;MESD;TBX1;BMX
prerank,response to hexose (GO:0009746),0.48855195845606647,1.3031926504920035,0.14715189873417722,0.7946246266319109,1.0,6/25,10.48%,TCF7L2;GPLD1;VAMP2;EIF2B1;IRS2;ZBED3
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3682931001367731,-1.3031888293899476,0.08,0.5338618851896634,1.0,12/49,12.68%,LRCH1;F11R;CST3;ECM1;RDX;SH3BP4;WNK1;SH3RF2;CPEB2;ARL2;GMIP;NOS1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.552533705434364,1.3029976719812557,0.16606498194945848,0.7932722653443492,1.0,2/13,1.67%,AKAP5;ADGRV1
prerank,positive regulation of dendrite extension (GO:1903861),0.5307479173466965,1.3015308494715931,0.16554054054054054,0.7969065347922285,1.0,7/17,18.61%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,response to glucose (GO:0009749),0.4386920340901572,1.3015261243388263,0.13275613275613277,0.7948046894475069,1.0,11/46,10.48%,ZBTB20;TCF7L2;TRA2B;GPLD1;VAMP2;EIF2B1;IRS2;ADCY8;PRKACA;GCK;ZBED3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.46489159311342587,-1.301461580897825,0.14780600461893764,0.5371542570020169,1.0,6/17,19.39%,EGFR;CCNYL1;CCND2;CCND1;AKT1;RGCC
prerank,dorsal/ventral pattern formation (GO:0009953),-0.44219469767487807,-1.3011777509107243,0.136986301369863,0.5366408982408645,1.0,5/20,9.79%,NBL1;GLI2;ACVR1;ACVRL1;SFRP1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3746215416972098,1.301078459339244,0.08181818181818182,0.7944499771526847,1.0,26/116,17.12%,GGT5;ADORA2B;ADCY5;CALCRL;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4
prerank,regulation of dendrite extension (GO:1903859),0.5230541549764468,1.300679343329344,0.17114093959731544,0.79387754969774,1.0,7/18,18.61%,RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5931254652035496,1.3001063672955622,0.1704745166959578,0.794015918385454,1.0,2/10,1.70%,XCL1;WNT5A
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4656829370676424,1.300071170110943,0.14641744548286603,0.7920772452697861,1.0,8/28,12.54%,ENPP1;PIP4K2A;IRS1;RPS6KB1;APPL2;PRKCB;TNS2;GSK3A
prerank,nucleoside salvage (GO:0043174),-0.5479613817430249,-1.3000554446672903,0.16926503340757237,0.5382395436480123,1.0,7/10,39.15%,UPP2;TK2;DCK;CDA;TK1;UPP1;UCKL1
prerank,energy reserve metabolic process (GO:0006112),-0.4503482617632966,-1.2990159962184196,0.15364583333333334,0.5396747367502533,1.0,11/19,28.49%,PRKAG2;LEPR;GBE1;GSK3B;UGP2;PPP1R3C;PID1;MRAP2;MT3;PHKG2;PYGL
prerank,vasodilation (GO:0042311),-0.4912689747709936,-1.2978509855846698,0.17433414043583534,0.5413569313186724,1.0,6/13,19.69%,NOS3;SOD2;KLF2;NOS1;GPER1;ADRB2
prerank,homeostasis of number of cells (GO:0048872),-0.5038561191772855,-1.2975137705313093,0.15311004784688995,0.5409866209384532,1.0,5/12,11.32%,NOS3;NOTCH1;CCN3;CX3CR1;UBAP2L
prerank,granulocyte differentiation (GO:0030851),-0.4625241204673967,-1.2974619575881126,0.15365239294710328,0.5398161495450964,1.0,6/18,15.10%,LEF1;LBR;RXRA;JAGN1;TAL1;CDKN1A
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.5560677122740347,-1.2972385431743092,0.15698924731182795,0.5390515221811523,1.0,5/10,21.46%,PODXL;DPP4;WNK1;SKAP1;PIEZO1
prerank,epithelial cell migration (GO:0010631),-0.382644918475816,-1.2969327963465347,0.11731843575418995,0.538530105669279,1.0,9/37,5.23%,KANK2;NOS3;FSTL1;NRP1;DPP4;ANLN;CYP1B1;KANK1;GIPC1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.46758539123755694,-1.2966054509529268,0.13414634146341464,0.5380939427581748,1.0,8/17,21.46%,PODXL;FOXC2;TGFB2;RET;SKAP1;CIB1;ADAM9;PIEZO1
prerank,regulation of exocytosis (GO:0017157),0.4274630227260235,1.2965175369793016,0.12573099415204678,0.8036241918403325,1.0,15/46,18.98%,CADPS2;STXBP6;VAMP2;RAB8A;CADPS;RAB3C;RIMS2;RAB15;CLASP2;CLASP1;IL1RAPL1;STXBP5;RAB2B;SYT1;ATP6AP1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.34815489194099003,-1.296188521382869,0.07046979865771812,0.5378004287037964,1.0,20/58,15.78%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;ACER3;SGMS2;CERT1;DEGS2;SPNS2;VAPA;VAPB;ELOVL4;ELOVL7;SPTSSA;KDSR;ST3GAL2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5804446242019875,1.296172277208431,0.18392857142857144,0.8027180504062097,1.0,1/11,1.32%,RTP4
prerank,vasculogenesis (GO:0001570),-0.387466179687738,-1.296128656056001,0.09411764705882353,0.5366614144602064,1.0,13/32,22.66%,ITGB8;CAV1;KDR;NOTCH1;RASIP1;SOX17;HEY2;RAMP2;SOX18;RASA1;TGFBR3;TGFBR2;APLNR
prerank,regulation of focal adhesion assembly (GO:0051893),0.41409369986456246,1.2958289043127715,0.12978142076502733,0.8019421241572633,1.0,15/54,11.12%,APOD;DLC1;HRG;GPM6B;PEAK1;PTEN;MAP4K4;ARHGAP6;SLC9A1;DUSP22;COL16A1;PTK2;EPHA3;PTPRA;SLK
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4554345152583641,-1.295644528811541,0.16209476309226933,0.5366342353518594,1.0,5/19,12.95%,TJP1;AFDN;NOTCH1;PPM1F;DENND6A
prerank,cellular response to cAMP (GO:0071320),-0.4051176233684841,-1.2950548167537121,0.11470588235294117,0.5369315721282222,1.0,11/30,23.30%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5421880724296817,1.2947953126655531,0.176056338028169,0.8037413775465572,1.0,7/13,23.31%,CBLB;KPNA1;NUP54;KPNB1;RANBP2;KPNA2;NUP35
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.47329083387523896,-1.2943428004677346,0.170316301703163,0.5374935792210032,1.0,7/15,27.79%,SAMHD1;PTPN2;NLRC5;ISG15;USP18;YTHDF2;TTLL12
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.36244760504689877,-1.2937003517697783,0.10526315789473684,0.538067922042972,1.0,13/45,11.06%,CAMK2D;NCAM1;TRIM25;TRIM5;B2M;CD44;IRF2;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5170362529783227,-1.293401408003761,0.17312072892938496,0.5375199559723972,1.0,5/11,9.97%,RAPGEF2;MEF2C;ANXA1;PIK3CB;PIK3CD
prerank,transcription preinitiation complex assembly (GO:0070897),0.5695415174745525,1.2931260592521863,0.18706293706293706,0.8080775367112474,1.0,6/12,22.14%,TAF12;TAF1B;BDP1;TAF11;GTF2B;GTF2A2
prerank,cGMP metabolic process (GO:0046068),0.5703306709638679,1.2931113146096955,0.17562724014336917,0.8060623840520758,1.0,1/12,0.28%,PDE9A
prerank,pinocytosis (GO:0006907),0.5866390774078654,1.2920606053318182,0.18248175182481752,0.8080153337394486,1.0,3/10,11.56%,RAB34;PYCARD;MAPKAPK3
prerank,receptor recycling (GO:0001881),0.5828879932626017,1.2917477906549593,0.18989547038327526,0.8071681898066431,1.0,4/10,20.92%,PHETA2;SORL1;PHETA1;ARFGEF2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.4613764932668185,-1.2915534186704436,0.15609756097560976,0.5412346445366017,1.0,7/18,8.88%,FN1;CD200;ITGB8;TGFB2;CD34;SMAD3;LRRC32
prerank,tyrosine metabolic process (GO:0006570),0.56790430668058,1.2910796979488157,0.18324607329842932,0.8075337676004642,1.0,2/11,4.84%,TYR;FAH
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.4524688491624572,-1.2908800416972874,0.1570048309178744,0.5415890824745316,1.0,9/18,26.76%,LBP;NMI;IFI35;KARS1;PLCG2;DYSF;DOCK2;TYROBP;SBNO2
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.442137216414094,-1.2908581126476308,0.13994910941475827,0.5403374801191295,1.0,12/20,31.32%,PTGES3;PSMG2;NDUFAF1;MKKS;PSMG3;HOPX;HSPD1;PFDN6;HSPA1A;PTGES3L;BBS12;BBS10
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3458323005374429,1.2907980753842168,0.06029579067121729,0.8066250099464238,1.0,29/208,10.90%,RORA;ROR1;MAP3K14;EDA2R;CCDC22;WNT5A;TRAF4;CD40;TSPAN6;NR1H4;LURAP1;GJA1;PDPK1;HTR2B;TLR6;CAPN3;CARD19;TNFRSF19;PINK1;PRKD1;TRIM8;PRKCB;TLE1;BIRC2;IRAK1;LPAR1;NDFIP2;DHX36;PYCARD
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.47626366530726255,1.2904967881650977,0.17940199335548174,0.8057678369831618,1.0,4/25,5.93%,TBX18;RYR2;JUP;ATP2A2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4025016914753255,1.2902765982397773,0.1178082191780822,0.8045205544436671,1.0,8/72,3.03%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;ROR2;NTRK2;FGFR1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.409250121752712,-1.2898835315619932,0.11878453038674033,0.5414702445788993,1.0,10/27,16.86%,CSNK1D;GBP5;ARFRP1;OPTN;GAK;BICD2;VPS13A;ARL1;VPS13D;RAB6A
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5001456238122153,-1.2898720622542528,0.17096018735362997,0.5401982018698691,1.0,7/13,28.32%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,regulation of phagocytosis (GO:0050764),0.41493067607108197,1.2890034451991488,0.13237410071942446,0.807381244981535,1.0,9/53,10.90%,IL15RA;MERTK;ITGAV;TUB;LYAR;CYBA;FGR;SYT7;PYCARD
prerank,regulation of hemopoiesis (GO:1903706),0.5824387002428588,1.2887689172871002,0.18552875695732837,0.8061561615121423,1.0,5/10,21.85%,PTN;PRKCB;MAFB;CBFB;CREBBP
prerank,cell-substrate junction assembly (GO:0007044),-0.38370166013418583,-1.2885527346367542,0.12753623188405797,0.5421474434656594,1.0,13/33,13.62%,SORBS1;FN1;ACTN2;PTPRK;THSD1;ITGA6;PLEC;LAMA3;ITGB4;CD151;TRIP6;BCR;DST
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5097777158418726,-1.2885104160088008,0.17727272727272728,0.5409508915435921,1.0,3/12,13.86%,EPHA4;NOTCH1;SERPINE2
prerank,triglyceride metabolic process (GO:0006641),0.42765586323220045,1.2882939912925306,0.14527503526093088,0.8060144481019982,1.0,11/48,15.43%,LPIN3;SEL1L;LIPC;LIPH;FABP5;FABP4;AGMO;GK;FABP3;GPAT3;LPIN2
prerank,negative regulation of phosphorylation (GO:0042326),0.383562934295336,1.2877887646462614,0.10449735449735449,0.8059683192692297,1.0,21/85,14.51%,DYNLL1;NTRK3;PPARA;PTEN;TRAF3IP1;CDKN2A;PFKFB1;NPRL2;LRRK2;IRS2;CBFA2T3;CDKN2D;PTPN13;BMP7;ZBED3;DNAJC10;ANKLE2;PIP5KL1;CDKN2C;LYN;ATG14
prerank,regulation of neuron projection development (GO:0010975),0.3548215926751136,1.287317025063682,0.0861244019138756,0.8058454010446424,1.0,42/163,17.24%,ROR1;PTN;NTRK3;ROR2;CHN1;TENM3;CTNNA2;WNT5A;NTRK2;PTEN;CSMD3;CDKL5;PRKCI;LRRK2;DISC1;PTPRO;PPFIA2;TANC2;PRKD1;RELN;DCC;STMN2;P3H1;RAB29;LPAR1;EPHA3;LRRC4C;PLXNB2;RETREG3;ARHGAP35;GSK3A;LRRC7;LYN;NTNG2;NTNG1;BRSK2;NCS1;DENND5A;IL1RAPL1;CBFA2T2;RTN4RL1;CDK5
prerank,negative regulation of centrosome duplication (GO:0010826),0.574417975393841,1.286831551738837,0.17939609236234458,0.8058570029022498,1.0,4/11,11.22%,MDM1;TRIM37;KAT2A;TMEM67
prerank,response to reactive oxygen species (GO:0000302),0.412368945385544,1.2865702204539873,0.13739376770538245,0.8048482019306493,1.0,6/54,6.14%,APOD;PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5
prerank,negative regulation of lymphocyte migration (GO:2000402),0.5768529244875584,1.2861498080988416,0.18100358422939067,0.8042965648280755,1.0,1/10,0.04%,APOD
prerank,regulation of macrophage differentiation (GO:0045649),0.5278941805020297,1.2857819511047002,0.1735241502683363,0.8036104320552983,1.0,3/15,8.66%,IL34;C1QC;PRKCA
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.47988259379998494,-1.2852090532780942,0.1585081585081585,0.5483203755291807,1.0,7/15,28.32%,OGA;RENBP;LARGE1;EXTL2;CHST1;CHST7;CHST3
prerank,ear morphogenesis (GO:0042471),0.49837219972967706,1.2851410683818567,0.171334431630972,0.8041273275876121,1.0,4/20,8.25%,CHD7;ZIC1;MYO6;TWIST1
prerank,engulfment of apoptotic cell (GO:0043652),-0.47819711854030184,-1.2842302319405632,0.14814814814814814,0.5495766439340073,1.0,4/15,5.15%,RHOBTB1;THBS1;RHOBTB2;RAC1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5174601347319797,-1.28400969398704,0.1774193548387097,0.5489056252821987,1.0,3/12,3.95%,IGF1R;UVRAG;INSR
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4712814392629833,-1.2839417789616658,0.16831683168316833,0.5478040364298479,1.0,12/16,37.31%,NOS3;GUCY1A1;APOE;NOS1;DDAH1;AGT;DDAH2;GUCY1B1;NDNF;MAFA;CD36;NOS2
prerank,establishment of protein localization to organelle (GO:0072594),0.3944168520584959,1.2838556889165373,0.10476190476190476,0.8069698618934634,1.0,21/72,18.72%,PRICKLE1;CSE1L;NUP214;RYR2;FAM53C;NUTF2;POM121;CD68;PINK1;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;PEX19;TNPO2;IPO9;NUP155;KPNB1
prerank,inhibitory synapse assembly (GO:1904862),0.55873276384844,1.2834661246025498,0.20034843205574912,0.8064573588935856,1.0,3/11,10.51%,WNT5A;GABRA1;GABRG2
prerank,positive regulation of GTPase activity (GO:0043547),-0.2839593445908282,-1.2832936708546956,0.01935483870967742,0.5481754420111733,1.0,55/188,15.41%,PKP4;TBC1D4;PICALM;RAPGEF2;SIPA1L1;TIAM2;SNX18;AFDN;RGS6;RAPGEF6;ITGB1;NET1;F11R;ITGA6;SIPA1L2;RASGRF1;S100A10;TBC1D8;RAP1A;RAP1GAP2;NDEL1;ARHGAP42;TBC1D22B;CAV2;SRGAP2;RAPGEF1;GSK3B;ARHGEF15;RANGAP1;RUNDC1;RSU1;RALBP1;PLXNB1;NGEF;SGSM2;SFRP1;MAPRE2;GMIP;APC2;GRTP1;ARHGAP27;TBC1D7;ALS2;TGM2;EVI5L;TBC1D22A;BCR;TBC1D10B;RAPGEF3;TBCK;CX3CL1;EZH2;RAP1GDS1;TBC1D13;RGS10
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5148827028019939,-1.2832087490826578,0.17162471395881007,0.5471157910945006,1.0,4/11,6.95%,MECOM;RUNX1;CD34;ETV6
prerank,aortic valve development (GO:0003176),-0.3779844174575057,-1.2828917882298596,0.11782477341389729,0.5467159020549155,1.0,8/34,4.26%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;BMPR2;TIE1;NOTCH1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.5669735884158241,1.2823826180025641,0.2,0.808604893433977,1.0,5/12,21.51%,TIPIN;GMNN;CDT1;KAT7;WDR18
prerank,female gamete generation (GO:0007292),0.4647242658858216,1.2812535872167186,0.16823899371069181,0.8108558648698847,1.0,3/29,6.86%,PTN;NANOS3;DIAPH2
prerank,eye development (GO:0001654),0.4100083969072366,1.281064293618796,0.14565826330532214,0.8095584211017477,1.0,3/54,3.58%,LAMA1;MEIS1;MEIS2
prerank,protein-containing complex disassembly (GO:0032984),-0.3434474675357341,-1.2804946309832381,0.12171052631578948,0.5516394841011832,1.0,12/54,9.93%,CAV1;UVRAG;HSPA8;GABARAP;EPG5;APC;DVL1;GABARAPL1;GSK3B;LRP6;VCP;PYM1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5105722822435385,-1.2804726526845918,0.16404494382022472,0.5504198620788836,1.0,3/12,3.95%,SORBS1;IGF1;INSR
prerank,negative regulation of nuclear division (GO:0051784),0.5583783349647775,1.2804241667297434,0.19499105545617174,0.8101044702237707,1.0,3/11,9.77%,FBXO5;BMP7;NME6
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.35326082531157216,1.280125534434843,0.08,0.8092915370262599,1.0,34/159,12.68%,ROBO2;ADGRL3;TENM3;CDH6;PTPRT;GRID2;GPC4;MMP24;PCDHB16;TENM4;DCHS1;CDH11;DSCAM;CDH15;CDH3;CNTN4;PCDHB4;TENM2;PCDHB11;DSCAML1;LRFN5;PALLD;ADGRL1;NEXN;TENM1;CNTN6;AMIGO3;LRRC4C;CLDN15;UNC5D;PLXNB2;CBLN1;CDH10;CADM3
prerank,mitotic recombination (GO:0006312),0.5276629511028101,1.279769180701836,0.19550173010380623,0.8087105631025312,1.0,4/15,13.20%,TEP1;ERCC1;MSH3;RAD52
prerank,regulation of complement activation (GO:0030449),0.43417845290376167,1.2791740569383079,0.12705530642750373,0.8089316094116367,1.0,9/40,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.4494935140351333,-1.2791676750768384,0.14047619047619048,0.5526966071515054,1.0,8/19,9.79%,TEK;PTPRJ;NRP1;S100A10;KDR;RAC1;PPM1F;SFRP1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5312465474162756,1.278790347123983,0.18592964824120603,0.808437030973301,1.0,5/15,12.04%,GGT5;GGT7;ABHD16A;HOGA1;ABHD12
prerank,negative regulation of epithelial cell migration (GO:0010633),0.44629111979825187,1.2787724297714762,0.18153846153846154,0.8065361453119891,1.0,6/33,5.41%,DCN;PTEN;NR2F2;PTPRR;MCC;ADGRB1
prerank,cell projection organization (GO:0030030),-0.40030368861148796,-1.27796172071871,0.12238805970149254,0.5546311839510364,1.0,8/30,6.76%,ITGB1;PACSIN2;PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.30523753945746157,-1.277550581520023,0.07109004739336493,0.554442776403633,1.0,24/108,9.82%,DAPK1;ROBO1;CASP8AP2;ARL6IP5;TNFSF10;ACER2;HIP1R;GSN;MAP3K5;FAS;UACA;COL4A3;EGLN3;CRADD;NGF;CASP2;PPM1F;XDH;VCP;MAPT;SMAD3;CASP8;BAD;BAX
prerank,positive regulation of cellular component movement (GO:0051272),-0.4206726277728375,-1.2772097281657862,0.1532258064516129,0.5541002946211655,1.0,10/24,23.89%,CAVIN1;SPOCK2;NTN1;RPS19;ETS1;PDPN;CCDC25;TUBB2B;CSF1R;CCL19
prerank,insulin receptor signaling pathway (GO:0008286),-0.32906697061655643,-1.2768821039699987,0.07482993197278912,0.553633439015587,1.0,14/69,7.28%,SORBS1;FOXO1;IGF1R;FER;ATP6V0A4;FOXC2;INSR;RHOQ;GRB14;APC;GRB10;CAV2;GAB1;GSK3B
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5070616806966882,1.2760483605066604,0.18989547038327526,0.8149563076827842,1.0,4/17,6.86%,PPARA;PFKFB1;PDE12;CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),0.5737434948059553,1.2751816508087868,0.2003610108303249,0.8142080361300479,1.0,3/10,6.86%,PPARA;PFKFB1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5737434948059553,1.2751816508087868,0.2003610108303249,0.8142080361300479,1.0,3/10,6.86%,PPARA;PFKFB1;CBFA2T3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5419617463946582,-1.2743689728308365,0.18550106609808104,0.5593437845421325,1.0,3/10,19.39%,NOTCH1;PPM1F;RGCC
prerank,negative regulation of bone mineralization (GO:0030502),0.5400664905296813,1.2740840386557675,0.18821603927986907,0.8165934066613244,1.0,2/13,6.36%,ENPP1;BCOR
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4669989454832675,-1.273303050145828,0.16381418092909536,0.560930067117142,1.0,5/16,8.91%,CAV1;TRIM25;TRIM5;TRIM14;EXOC2
prerank,membrane lipid catabolic process (GO:0046466),-0.5301553514770145,-1.272676736119848,0.19103773584905662,0.561349092358287,1.0,4/10,12.36%,CYP1B1;FUCA1;ENPP2;NAGA
prerank,regulation of mitotic nuclear division (GO:0007088),0.4113898054399378,1.2724701396397002,0.14042553191489363,0.8208920566170199,1.0,13/55,12.42%,EDN3;L3MBTL1;PHIP;DUSP1;PKMYT1;FBXO5;CDK13;BMP7;NME6;RCC1;MKI67;NUSAP1;IGF2
prerank,glucan biosynthetic process (GO:0009250),-0.502971547875442,-1.2724383885870856,0.2028301886792453,0.5594589484651097,1.0,6/12,13.48%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),-0.502971547875442,-1.2724383885870856,0.2028301886792453,0.5594589484651097,1.0,6/12,13.48%,PGM2L1;GBE1;GYG1;UGP2;PGM2;PPP1R3C
prerank,peptidyl-arginine modification (GO:0018195),-0.48353021354049563,-1.2715102602288082,0.17215189873417722,0.5607819805667223,1.0,13/15,47.90%,ART3;PRMT7;PRMT8;KRTCAP2;PADI2;PARK7;PRMT1;PRMT5;NDUFAF5;ART1;PADI1;PADI4;ART4
prerank,aromatic amino acid family catabolic process (GO:0009074),0.5258099734905012,1.2712377384973508,0.19223985890652556,0.8237128525455008,1.0,2/15,4.84%,KYNU;FAH
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.5372161197959006,-1.2704226925248028,0.19375,0.5623327861181633,1.0,5/10,17.67%,TSN;DICER1;DROSHA;TERT;AGO2
prerank,regulation of fibrinolysis (GO:0051917),0.5355148897460433,1.2702520508849227,0.18739352640545145,0.8254261880985723,1.0,3/13,5.10%,HRG;FAP;KLKB1
prerank,chondrocyte differentiation (GO:0002062),-0.3863412668195111,-1.269506892586938,0.16147308781869688,0.5635251980552828,1.0,9/32,5.50%,NFIB;SOX5;MEF2C;WNT5B;OSR1;BMPR2;RUNX1;CCN3;SULF2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.37385109615989803,1.268971608047147,0.11528497409326424,0.8283348000781924,1.0,11/95,4.65%,CEMIP;DCN;LUM;HSPG2;BGN;DSE;GPC4;VCAN;B4GALT2;GCNT2;GPC5
prerank,neuromuscular process controlling balance (GO:0050885),0.5474708009341531,1.2686545842574282,0.203125,0.8276340743486145,1.0,3/12,8.62%,MYO7A;NRXN1;CLRN1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4976917788973153,-1.2685361597622336,0.18243243243243243,0.5648215552879204,1.0,3/13,3.95%,SORBS1;IGF1;INSR
prerank,clathrin-dependent endocytosis (GO:0072583),-0.40280886970667434,-1.2683948139051486,0.1440443213296399,0.5639268883527666,1.0,7/26,12.68%,PICALM;FNBP1L;INPP5F;GPR107;AP2A1;CLTB;GAK
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4141335025177961,1.2683145729793177,0.15244755244755245,0.8268871082830345,1.0,13/50,16.20%,RORA;RAB34;PTCH2;ZIC1;IFT81;GLI1;GLI3;GAS8;TXNDC15;HERC4;EVC;FGFR2;PDCL
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5384134569934269,-1.2680726209709345,0.20945945945945946,0.563524791086591,1.0,6/10,22.71%,FN1;LAPTM4B;GATA6;FURIN;TSKU;TYROBP
prerank,regulation of lymphocyte activation (GO:0051249),0.5386641602898845,1.2662677425294795,0.20812182741116753,0.8328083326569099,1.0,2/12,9.77%,PAG1;KAT2A
prerank,negative regulation of viral process (GO:0048525),-0.333710682368085,-1.2661271376584071,0.12267657992565056,0.5675725524514706,1.0,18/57,20.87%,MAVS;TRIM5;TRIM11;IFITM3;TRIM14;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;PPIA;TRIM35;TRIM27;ISG15;UBP1;IFIT1;HEXIM1;IFITM2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.48022020714594965,-1.265533532758061,0.19376391982182628,0.5678532416056393,1.0,5/13,18.69%,NOS3;CALM1;GCH1;AKT1;PRKG2
prerank,phosphate ion transport (GO:0006817),-0.45342022428848144,-1.2653130176942455,0.16990291262135923,0.5672176678648623,1.0,4/16,12.21%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.4512163679676834,-1.265098663020281,0.1783132530120482,0.5665517460560705,1.0,6/17,17.38%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,peptide cross-linking (GO:0018149),-0.4057713346143239,-1.2650823987015147,0.1388888888888889,0.5653201767165732,1.0,3/25,5.01%,FN1;THBS1;ANXA1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.35542383015391493,1.264995274550091,0.10037641154328733,0.8357049792034118,1.0,33/152,17.33%,ADGRL3;CXCL10;PTGFR;ADCY5;AKAP5;CALCRL;GPR3;GPR37L1;ADGRB2;ADGRB1;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;LPAR3;ADGRB3;ADGRL1;ADCY7;GNA11;LPAR1;GPR26;IAPP;GNAO1;S1PR2;LGR5;LHCGR;GPR37;ADGRE5;PTGER4;ADRA2A
prerank,negative regulation of protein binding (GO:0032091),-0.3229528304171142,-1.2649236193783995,0.10144927536231885,0.5644962134026149,1.0,23/71,18.22%,CAV1;ACTB;TMBIM6;DAB2;DVL1;MITD1;PTPRF;B2M;GSK3B;ITGB1BP1;NES;STYX;BAX;RALB;TLE5;ATP2A3;CTSZ;CDKN1A;DDX11;PRKCD;HFE;AKT1;IFIT1
prerank,response to ATP (GO:0033198),0.5076486837664446,1.2646510891584006,0.1778846153846154,0.8350857784412233,1.0,6/18,13.68%,P2RY1;DGKQ;TRPC3;P2RX4;HSP90B1;RYR3
prerank,plasma membrane repair (GO:0001778),-0.4926410652021797,-1.2641984237204493,0.1762114537444934,0.5650279510799434,1.0,4/13,15.85%,MYOF;AHNAK2;SMPD1;DYSF
prerank,regulation of chemokine production (GO:0032642),0.43218967803346403,1.2637899045489425,0.16455696202531644,0.836384226642303,1.0,6/36,10.90%,IL33;WNT5A;TSLP;TLR4;EIF2AK2;PYCARD
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.4223194482014013,1.263637337856258,0.1722689075630252,0.8350581522149711,1.0,16/46,18.61%,ATP1A2;NRXN1;CACNG3;LRRK2;GRIK1;RELN;OPHN1;CACNG4;GRM5;DGKI;UNC13A;TPRG1L;GRM7;CDK5;GRM1;SYT1
prerank,electron transport chain (GO:0022900),0.5288034284825902,1.2633182004093022,0.19256756756756757,0.8342615534494653,1.0,2/15,4.16%,POR;SDHB
prerank,embryonic heart tube development (GO:0035050),-0.4720663999291214,-1.263054751464866,0.17073170731707318,0.5669639321312347,1.0,5/14,9.87%,MEGF8;ACVR1;SOX17;CITED2;TBX2
prerank,response to chemokine (GO:1990868),-0.48221624009243047,-1.263025293883178,0.16985645933014354,0.565783409518019,1.0,3/13,5.92%,LRCH1;FOXC1;WNK1
prerank,cell junction assembly (GO:0034329),-0.3020837180475256,-1.2624924224852876,0.06511627906976744,0.565992114440105,1.0,17/100,8.10%,SDK1;PKP4;FN1;TJP1;LIMS2;SPOCK2;ACTB;SHANK3;CDH1;ITGA6;CLDN5;CDH8;ACTG1;CTNND1;CDC42;DNER;DNM3
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3854569728177501,-1.2624352407735944,0.1392757660167131,0.5649033858510446,1.0,13/33,19.39%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;ANXA1;HYAL1;PLCG2;CCND1;EZH2;ANKRD17;AKT1;RGCC
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4586349106449585,1.2621087352387363,0.16614906832298137,0.8370174527717583,1.0,5/29,8.14%,SPRY1;PTEN;SPRED1;IL17RD;SPRED2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5397780347041248,1.2620496276505129,0.2222222222222222,0.8352978836765743,1.0,7/12,18.61%,RIMS2;SYT7;RIMS1;SYT5;UNC13A;UNC13C;SYT1
prerank,import into nucleus (GO:0051170),0.3851185207191678,1.2618661163305116,0.13019390581717452,0.8340493166397116,1.0,21/73,18.72%,PRICKLE1;CSE1L;GEMIN2;NUP214;FAM53C;NUTF2;POM121;SNUPN;APPL2;FAM53A;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;SNRPF;TNPO2;IPO9;GEMIN8;NUP155;KPNB1
prerank,leukotriene biosynthetic process (GO:0019370),0.5269086499228361,1.2618071791779668,0.20954003407155025,0.832324406673696,1.0,2/14,2.23%,GGT5;GGT7
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5435975082696749,1.2617184350383852,0.20945945945945946,0.8307000432673379,1.0,3/13,3.66%,DCN;BGN;VCAN
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3055628463330168,-1.2616903187836161,0.07623318385650224,0.5656729694155662,1.0,26/104,12.84%,CRIM1;SMAD6;CAV1;BMPER;LEMD3;NBL1;BMPR2;MAGI2;SKIL;NOTCH1;CCN3;SKI;UBE2D3;CD109;UBB;ASPN;SNX25;ACVR1;SMURF2;SMAD3;SNX6;PRDM16;BCL9L;SPRED3;HIPK2;SMAD1
prerank,development of primary male sexual characteristics (GO:0046546),-0.37592947831869505,-1.2610511416014394,0.1323943661971831,0.5661788381368837,1.0,6/34,4.38%,KITLG;CSDE1;LHFPL2;TGFB2;WNT4;NCOA4
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32118955433443036,-1.2610339643158262,0.07380073800738007,0.5649805114035896,1.0,22/67,14.61%,FLT1;ROCK2;DOCK1;WASF2;NRP2;NRP1;KDR;CLEC14A;VEGFD;RAC1;VEGFC;CDC42;NCK1;MAPK14;AAMP;PIK3CB;HSPB1;ITGB3;FLT4;PTK2B;BAIAP2;ELMO2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.4110304928582646,1.2605213723178716,0.18328445747800587,0.8334966534450227,1.0,12/48,11.03%,ADCY5;ADCY10;SLC35B3;GMPS;COASY;ADCY8;ADCY3;ADCY2;PAPSS2;AMPD2;ADCY7;ACOT7
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.47780226815410964,-1.2603602888071501,0.1875,0.5656260775554813,1.0,7/15,16.70%,EGFR;IGF1R;KDR;BMX;PTK2B;TEC;AATK
prerank,regulation of transmembrane transport (GO:0034762),-0.3778606322609293,-1.259905756157646,0.12023460410557185,0.5655414366917272,1.0,8/31,12.29%,OCLN;ACTB;SLC2A1;WWP2;KCNJ13;CTTNBP2NL;KCNJ2;KCNJ12
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4962842381558594,1.2597795324521148,0.2,0.8343732256318617,1.0,8/19,17.84%,CDKL5;CAPRIN1;CDKL3;RELN;DHX36;CUX2;IL1RAPL1;CUL7
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.48330044401879796,1.2590366711543564,0.20330578512396694,0.8352097994257819,1.0,8/22,15.41%,MED12;SRF;PSMC4;TP53;DHX36;PSMC5;MED1;PAXIP1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3339891703507254,1.2589141867271831,0.07631874298540965,0.8338310080424928,1.0,47/268,13.68%,SLC1A3;KCNK2;KCNS2;TRPA1;SLC6A13;SLC6A8;ATP1A2;SLC24A5;SLC30A10;NALCN;MCOLN2;ITGAV;ASIC2;KCNQ3;SCN2B;SLC30A5;SLC39A7;SLC9A9;ATP1A3;ATP2A2;SLC9A1;CACNA1G;TRPV3;KCNG1;KCNH4;ASIC1;KCNAB1;TRPC3;KCNC2;TMEM175;HCN2;SLC30A3;HCN1;KCND2;HCN3;P2RX4;TRPM2;TRPC7;KCNK1;KCNN2;KCNH7;KCNJ8;ATP6V0E1;KCNAB3;SCN1A;SCN2A;RYR3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5600046974414026,1.2581692533874893,0.2118491921005386,0.8347246883696697,1.0,4/10,17.28%,SCRIB;PDCD1LG2;PRKAR1A;LGALS9
prerank,filopodium assembly (GO:0046847),-0.4494700313201835,-1.257771420087594,0.1725,0.5700539183999138,1.0,5/16,10.41%,FGD5;EZR;SRGAP2;DNM3;SPATA13
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.39657138982533713,1.257664421839797,0.15521978021978022,0.8348579792355033,1.0,11/59,11.95%,CYP7B1;ACOX2;OSBPL3;OSBPL6;LIPC;LIPH;PER2;HSD17B8;HOGA1;GAMT;ACLY
prerank,gene expression (GO:0010467),-0.25513306674921943,-1.2573530629611835,0.0,0.5699653844314909,1.0,136/348,28.46%,TSPAN5;MEF2A;RPS14;AGFG1;RPS9;SMG6;RPS16;PTMA;RPLP1;RPL13;DRG1;THOC2;RPL27A;THOC1;RPS2;RPL37A;RPL5;WDR33;RPL8;RPS7;RPL41;RPS18;NUP50;RPS20;RPS19;RPS24;RPS27;DROSHA;RPS15;RPL21;RPL10;RPL35A;HNRNPF;RPS15A;RPL10A;RPS5;RPL11;TSPAN17;ABCF1;ALKBH5;RPL36A;EEF1A1;SRSF3;RRAGC;LMF1;NR4A2;SNRNP40;RPL34;POLR2B;NUP98;RPLP2;RPS29;NUP153;RPL32;RPL4;THOC3;RPLP0;POLR2H;SRSF4;RBM4;RPL30;RPL26;RPS4X;HNRNPH1;RPS21;RPL29;SMG5;POLR2G;NOX4;ATXN1;RPS8;POLR2C;RNASEL;NUP43;MRPS7;RAE1;NUP205;RPL31;RPS23;SRSF7;RPL23A;SRSF2;NUFIP1;ALYREF;SRBD1;HNRNPK;HHEX;MRPS17;AGO2;RPL19;RPL36;HOXD3;SEH1L;GSPT2;CREBL2;CLP1;RBM15B;MRPS18A;MRPS18B;RPL17;RPL23;E2F1;RBM8A;NCBP2;DDX20;DDX39A;MRPL24;DDX25;RPS11;NXT1;MRPL55;HSPD1;GSPT1;MAGOH;RPL15;RPL38;HARS2;DUSP11;MRPL36;MRPL35;BICD1;RPL13A;POLR2I;RPS25;POLDIP3;U2AF2;POLR2K;RPS12;MRPS12;RBMS2;FARSB;TSPAN33;MRPL34;RPL24;RPL18A;FASTKD2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4185035174076217,-1.257350035611663,0.16032608695652173,0.5675033432239288,1.0,8/23,12.21%,PPP1R13B;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4185035174076217,-1.257350035611663,0.16032608695652173,0.5675033432239288,1.0,8/23,12.21%,PPP1R13B;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID
prerank,vesicle organization (GO:0016050),-0.34998057240313285,-1.257338329419709,0.13666666666666666,0.5663042834218184,1.0,10/46,7.28%,CAV1;FNBP1L;LAPTM4B;SRGN;SQSTM1;CHMP2B;CD34;CAV2;VPS18;HOOK1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.45483540624549706,-1.2572420622933809,0.17571059431524547,0.5653603561092846,1.0,6/17,20.76%,LPGAT1;PLA2G4A;LCLAT1;PLAAT3;PLA2G4E;PLA2G4C
prerank,negative regulation of blood coagulation (GO:0030195),0.4361418947933826,1.2569471721521748,0.16559485530546625,0.8357888360065447,1.0,6/38,9.62%,PDGFRA;HRG;KLKB1;C1QTNF1;PLAU;F8
prerank,response to ionizing radiation (GO:0010212),-0.31749530254547464,-1.2565593716528145,0.07317073170731707,0.5660125731955246,1.0,33/70,29.73%,EYA1;NET1;ANXA1;MAPK14;RNF8;INTS3;INO80;BRCC3;ATM;EEF1D;GRB2;KAT5;CDKN1A;SMPD1;SIRT1;PRKAA1;CLOCK;DCUN1D3;HUS1;EYA3;FANCD2;RFWD3;RAD51;BRSK1;LIG4;BRCA1;ECT2;RHOB;RHNO1;GADD45A;MSH2;UIMC1;TANK
prerank,integrin-mediated signaling pathway (GO:0007229),-0.31358944202598216,-1.2563854293975858,0.11206896551724138,0.5652321898613852,1.0,24/73,13.81%,FN1;ITGB8;PLPP3;DOCK1;ADAMTS1;ITGB1;SEMA7A;ITGA10;ITGBL1;NRP1;FYB1;LAMA3;DAB2;NEDD9;ADAM10;CDC42;ITGB4;LAMA5;ITGB1BP1;ZYX;ITGB3;CEACAM1;DST;PTK2B
prerank,amino sugar metabolic process (GO:0006040),-0.513308836766029,-1.2562526177721178,0.19198312236286919,0.5643573905609405,1.0,3/10,5.10%,CSGALNACT1;ST6GAL1;ST3GAL1
prerank,activation of protein kinase activity (GO:0032147),0.3654993910732238,1.2559535022190815,0.13613861386138615,0.8375118330643911,1.0,19/106,10.04%,NTRK3;GHR;NRG1;ADCY5;WNT5A;MAP4K4;PDPK1;PRR5;TLR6;ADCY8;ADCY3;CALCA;ADCY2;PRKACB;PINK1;PRKACA;ADCY7;MTOR;IRAK1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4986815356969563,1.2558633643786397,0.18974358974358974,0.8359186667384116,1.0,7/18,24.53%,C5AR1;GPLD1;LYN;BAG6;CMKLR1;SPG21;BCAR1
prerank,membrane assembly (GO:0071709),0.44061741080836503,1.2552582936898211,0.1687116564417178,0.8363096914961324,1.0,7/34,6.91%,PTEN;NRXN2;CEL;NRXN1;SPTBN1;ANK3;FLOT2
prerank,positive regulation of lipid localization (GO:1905954),0.56143909208095,1.2548764957283989,0.2036697247706422,0.8358530173461975,1.0,1/11,0.48%,LRP1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.4874436317811509,-1.253896438767643,0.19954648526077098,0.5692997344064533,1.0,8/13,17.67%,BTG2;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,regulation of synapse maturation (GO:0090128),0.5731256339697646,1.2535604291005238,0.21015761821366025,0.8389860405892262,1.0,4/10,8.81%,NRXN1;YWHAZ;RELN;ADGRL1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.35105376223332924,1.2534745093139033,0.11616766467065869,0.8374468438258628,1.0,17/138,7.64%,RORA;PPARA;TEAD1;HDAC1;TAF9B;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;NR2C1;TAF3
prerank,myotube differentiation (GO:0014902),-0.4490408598589123,-1.2530217667792345,0.16458852867830423,0.5703773401692358,1.0,4/17,4.92%,IGF1;MEF2C;JAM2;SKI
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.47784871782165184,1.2530106076677778,0.19769357495881384,0.8372987210234947,1.0,9/20,21.61%,MEIS1;MEIS2;ZBTB16;HOXA9;MAFB;LDB1;CDC73;HSPA9;HOXA5
prerank,negative regulation of apoptotic process (GO:0043066),-0.249680475085401,-1.252990877816174,0.0,0.5692556549602876,1.0,108/444,16.68%,IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;PRKCH;MEF2C;IL31RA;LEF1;CAV1;BCL2L1;FNIP1;EGFR;IGF1R;ITGB1;RETREG1;OSR1;XIAP;THBS1;NOTCH2;ANXA5;FSTL1;KLF4;NFKB1;MCL1;PTMA;KDR;SQSTM1;PRKDC;TMBIM6;CCND2;FAS;ARHGAP10;SOD2;NOTCH1;GCLC;SOCS2;ANXA1;DAB2;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;SIX1;HIPK3;CD38;BNIP2;UBB;NGF;CASP2;NRBP2;CAT;CARD14;TBX1;APOE;GSK3B;CD44;SH3RF2;GLO1;RPL10;CASP3;LAMTOR5;SNX6;CFL1;CITED2;GPX1;SFRP1;NFKBIA;KLHL20;BNIP3L;NIBAN2;RNF144B;NR4A2;CX3CR1;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;MDK;HSPB1;BAG3;BID;FOXQ1;PTRH2;FZD3;FLT4;GATA6;FLNA;PTK2B;TPT1;CX3CL1;ARL6IP1;MAP2K5;PRELID1;PRKCD;TRIM27;SIRT1;ANXA4;PRKAA1;PDPN;PRDX3;PAK2;SIAH2;YME1L1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.47959619059465153,1.2528168989068416,0.21462639109697934,0.8361650391768327,1.0,4/21,8.15%,CDC14B;PTEN;FBXO5;GOLGA2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.39704619899919025,-1.2524167897284393,0.14025974025974025,0.5696319457527883,1.0,5/25,15.70%,TMTC2;CAV1;CNNM2;CNNM4;JPH2
prerank,regulation of cell communication (GO:0010646),0.4301470940660837,1.2523133401438575,0.18636363636363637,0.8361368834866778,1.0,3/35,3.83%,TBX18;MTCH1;RYR2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4262714039198789,1.2521916855448398,0.15522388059701492,0.8347551958585584,1.0,13/41,17.33%,IL34;NTRK2;UNC119;DLG3;DOCK3;RELN;GRM5;FYN;DLG4;CASS4;AREG;EFNA1;ADRA2A
prerank,excitatory postsynaptic potential (GO:0060079),0.4924689178380951,1.2516166065271483,0.20941558441558442,0.8351090156737766,1.0,5/19,6.01%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.48248000395296775,-1.2513257213454472,0.21052631578947367,0.571407811371985,1.0,7/13,36.65%,STX3;TYROBP;GPD1L;ABCA7;STX4;RANGRF;RIC3
prerank,positive regulation of hemostasis (GO:1900048),-0.5368667844558839,-1.2510709673681524,0.20279720279720279,0.5696710087090878,1.0,6/10,28.40%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,positive regulation of coagulation (GO:0050820),-0.5368667844558839,-1.2510709673681524,0.20279720279720279,0.5696710087090878,1.0,6/10,28.40%,THBS1;ST3GAL4;SERPINE1;DMTN;ENPP4;HPSE
prerank,protein import into mitochondrial matrix (GO:0030150),0.49288147898242674,1.250844759755172,0.19745222929936307,0.8360724438471945,1.0,6/18,20.82%,DNAJC19;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.336728911186157,-1.2504357107889903,0.09797297297297297,0.5701861249431427,1.0,16/51,14.32%,HMBOX1;SMG6;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;STN1;SMG5;ATM;HNRNPC;MAP3K4;TEN1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3798311089840858,1.250406746729199,0.1296551724137931,0.8359504780434284,1.0,23/75,17.63%,ISL2;CTNNA2;FARP1;ABITRAM;ANK3;ADGRB1;NEFH;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;OPHN1;SDC2;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;SLITRK1;CDK5;CDHR1
prerank,regulation of immune effector process (GO:0002697),0.4230765176719454,1.2501295718738088,0.15853658536585366,0.8351572244937355,1.0,9/41,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,negative regulation of secretion (GO:0051048),0.559257439947823,1.2498435495644826,0.23407917383820998,0.8344287467786992,1.0,2/10,6.45%,NRG1;SPX
prerank,substantia nigra development (GO:0021762),0.4284100391409167,1.2498266847038546,0.16395864106351551,0.8326619248575211,1.0,9/37,14.38%,DYNLL1;GNB4;BASP1;SEC16A;MBP;PLP1;S100A1;HSPA5;NDRG2
prerank,midbody abscission (GO:0061952),-0.45586166947178314,-1.2494403903997742,0.2,0.5718240718240056,1.0,13/17,38.37%,CHMP2B;MITD1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.38219782762340604,-1.2493270609932858,0.14285714285714285,0.5708968848304351,1.0,14/30,28.67%,DKK3;LTBP4;XIAP;FSTL1;SMURF2;SMAD3;TWSG1;SOX11;TGFBR3;SMAD7;FSTL3;SMAD4;TRIM33;FKBP1A
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5035523573790116,1.2491759642284794,0.20242214532871972,0.8332216249391369,1.0,7/18,13.86%,PTEN;NRXN1;RIMS2;RELN;RIMS1;DLG4;CUX2
prerank,metanephros development (GO:0001656),0.4554490840589035,1.2483848633160315,0.2113323124042879,0.8343401880125122,1.0,4/26,9.69%,ROBO2;BASP1;NF1;BMP7
prerank,signal peptide processing (GO:0006465),-0.5120459165381387,-1.2471659335072938,0.19310344827586207,0.5754769270990259,1.0,5/11,15.69%,SPCS2;SEC11C;CLN5;FURIN;PCSK5
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.47485019444619875,-1.2470708412627622,0.22350230414746544,0.574543409527642,1.0,4/13,13.26%,NOS3;PRODH;NOS1;DDAH1
prerank,protein-containing complex subunit organization (GO:0043933),0.3587540160544129,1.2468901378927055,0.12129032258064516,0.8381327884071513,1.0,22/109,12.05%,LAMC1;WIPF1;TEAD1;PPID;CD40;EPRS1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;LLGL1;CAPN3;WASF3;MDM4;KIFAP3;IL1RAP;TP53;RIMS1;DLG4;SOX9;TUBGCP4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.40179475417916244,1.2467565528696936,0.17455621301775148,0.8368393158270367,1.0,13/52,10.40%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3;EPB41L2;GPSM2;NKD2;EPHA3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.39468721371796434,1.246611348520983,0.15469613259668508,0.8355344416583987,1.0,15/64,11.12%,CASK;UTRN;GPM6B;PEAK1;CDKN2A;MAP4K4;JUP;NF1;SLC9A1;PTK2;PLAU;EPHA3;CCL25;PTPRA;SLK
prerank,transition metal ion homeostasis (GO:0055076),-0.40090611939858045,-1.245777632741219,0.15343915343915343,0.5768064085544009,1.0,6/28,8.27%,PICALM;XIAP;NEO1;HMOX2;B2M;BDH2
prerank,muscle tissue morphogenesis (GO:0060415),-0.45609865261056365,-1.2456888632648913,0.1761904761904762,0.5758534868869878,1.0,5/16,19.15%,MYLK;NOTCH1;TBX1;HEY2;TGFBR3
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.48038730816434283,-1.2456181399704582,0.17633410672853828,0.5748302825313576,1.0,7/14,13.59%,MEF2C;SLIT2;IGFBP5;TPM1;IGFBP3;SERPINE1;PRKG1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4260957754769801,-1.2455207845112908,0.18457300275482094,0.5739441535668544,1.0,11/21,36.20%,OSBPL8;MBOAT1;PLA2G4A;PLAAT3;PLA1A;PLA2G4E;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4
prerank,positive regulation of DNA binding (GO:0043388),-0.380167140876436,-1.2451465177709131,0.1497005988023952,0.5737754927710244,1.0,11/31,26.33%,IGF1;FOXC1;SKI;NGF;NIBAN2;HMGB2;EGF;TXN;TRIM6;PARK7;RB1
prerank,carnitine metabolic process (GO:0009437),0.5418864294864392,1.244914953552372,0.23734729493891799,0.8401807141754014,1.0,7/12,26.27%,ACADL;CRAT;TMLHE;ALDH9A1;CPT1A;CPT1C;CROT
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4214720483305737,1.2440315283373533,0.17262830482115085,0.8416561336592276,1.0,7/39,7.26%,CASK;SPRY4;CORO2B;CDKN2A;MAP4K4;GCNT2;PTPRO
prerank,cell differentiation in hindbrain (GO:0021533),0.5722335388893175,1.2439128611674384,0.20738137082601055,0.840302361814662,1.0,8/11,28.29%,GRID2;OPHN1;CBLN1;ATP7A;FAIM2;PROX1;AGTPBP1;KNDC1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.523864682420504,1.2436849097172757,0.19508196721311474,0.8393404757172693,1.0,2/14,1.70%,XCL1;WNT5A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5355302434436642,1.2434883052410217,0.20623916811091855,0.8383153953330028,1.0,2/13,2.72%,XCL1;MR1
prerank,positive regulation of cell division (GO:0051781),0.43334442726586625,1.2434185372855846,0.17559523809523808,0.8367983313275206,1.0,4/38,4.84%,SVIL;CDC14B;RXFP3;HTR2B
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4774536398906977,-1.243032165718217,0.19907407407407407,0.5783013044304853,1.0,4/13,2.72%,PLXNA2;PLXNA4;NRP2;NRP1
prerank,mRNA methylation (GO:0080009),-0.45948236888560245,-1.2429896785868308,0.2,0.5772256308551352,1.0,4/15,8.66%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,axon development (GO:0061564),0.3781620251897082,1.2425057896689722,0.14937759336099585,0.83822052519634,1.0,23/78,17.24%,ISL2;CTNNA2;SEMA5A;ANK3;ADGRB1;NEFH;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;PLP1;ARHGAP35;NTNG2;NTNG1;FGFR2;BRSK2;NRCAM;GRM7;SLITRK1;RTN4RL1;CDK5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3505023054075561,-1.2423823352027477,0.14779874213836477,0.5776846720639619,1.0,24/48,29.16%,BCL2L1;MCL1;PRKDC;CASP2;HIPK1;FNIP2;CRIP1;DYRK2;BAX;HIPK2;ATM;BOK;SIRT1;TMEM109;EPHA2;E2F1;IKBKE;BCL2L11;CHEK2;BRCA1;MSH2;SFN;DDIT4;TNFRSF1B
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.43696111563820667,-1.2421690825495133,0.1920374707259953,0.5770268018769709,1.0,4/17,5.48%,PRKAG2;CAV1;ADIPOR2;PRKAA2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.5095184197273634,-1.2417237013031064,0.2013888888888889,0.5758979016469352,1.0,8/11,39.74%,SRI;CALM1;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.5095184197273634,-1.2417237013031064,0.2013888888888889,0.5758979016469352,1.0,8/11,39.74%,SRI;CALM1;GSTO1;CASQ2;FKBP1A;TRDN;FKBP1B;CALM3
prerank,regulation of protein binding (GO:0043393),-0.2916910210524646,-1.2415403068740263,0.06701030927835051,0.5751697881828628,1.0,32/114,15.53%,RAPGEF2;CAV1;ACTB;HDAC4;APP;CLDN5;HIP1R;TMBIM6;VTN;DAB2;DVL1;MITD1;B2M;PRMT7;GSK3B;ITGB1BP1;RPL11;NES;STYX;BAX;PRMT8;RALB;TLE5;TERT;HIPK2;RAN;AMFR;CTSZ;CDKN1A;DDX11;MARK3;PRKCD
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4249718247945957,-1.241299483429635,0.1937799043062201,0.5745700273634284,1.0,8/20,21.30%,GLYR1;PRKAA2;SOX4;RPS6KA5;NOS1;PRKAA1;TADA2B;RUVBL2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.46713738174141295,1.2404714072833898,0.19966722129783693,0.8443395277800756,1.0,3/23,3.59%,GHR;ERBB4;TSLP
prerank,regulation of cholesterol metabolic process (GO:0090181),0.49001365363506844,1.240092863224303,0.1821138211382114,0.8440004268677835,1.0,10/20,20.63%,MBTPS2;NR1H4;ACADL;DGKQ;SREBF1;LDLRAP1;ARV1;KPNB1;ABCA2;MBTPS1
prerank,activation of adenylate cyclase activity (GO:0007190),0.4345394098104248,1.2400757326787384,0.18816388467374812,0.8422714013410444,1.0,7/35,8.88%,ADORA2B;ADCY5;ADCY8;ADCY3;ACR;ADCY2;ADCY7
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4173730558756769,-1.239975209639025,0.17215189873417722,0.5769284707205445,1.0,9/20,23.65%,ACTN2;OSR1;CAMK2D;GOPC;CAB39;TCAF2;STK39;CASQ2;PLN
prerank,establishment of protein localization to extracellular region (GO:0035592),0.42068382699626994,1.2396489518454272,0.19230769230769232,0.8420507431500358,1.0,16/39,21.59%,STEAP3;SEL1L;RAB8A;RAB3C;RCN3;RAB15;TMEM167A;MTTP;TVP23B;LTBP2;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4492485149802218,1.2395431503419718,0.19905956112852666,0.8406647816490074,1.0,7/27,12.54%,ENPP1;PIP4K2A;IRS1;RPS6KB1;PRKCB;TNS2;GSK3A
prerank,regulation of cellular component organization (GO:0051128),-0.2862097184008895,-1.2394646821174062,0.0625,0.577249230554847,1.0,30/135,14.68%,PLCE1;SNCAIP;TJP1;PICALM;RAPGEF2;ROCK2;MLLT3;LTBP4;NET1;PACSIN2;MARK4;HIP1R;CAMK2D;RAP1A;HSPA8;SOCS2;TFRC;RAPGEF1;APOE;RAB5A;RAB5C;STK38L;FAM107A;PTPN1;NCLN;CEACAM1;SNX17;HIP1;AGTR1;ARHGEF11
prerank,blood vessel morphogenesis (GO:0048514),0.40166619983707036,1.2394600642990203,0.17222222222222222,0.8391725190653206,1.0,3/54,2.79%,LAMA1;COL4A1;GLMN
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40039656716712224,-1.2390711302289494,0.1724137931034483,0.5770477289629565,1.0,11/24,16.47%,CDON;MEF2C;BOC;MEF2A;CDC42;MAPK14;BNIP2;SPAG9;RBM4;CTNNA1;MYOCD
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.5180229174566187,1.2388718065520852,0.23022847100175747,0.8395890593032423,1.0,4/14,8.14%,ZEB1;SPRY1;SPRED1;SPRED2
prerank,positive regulation of organelle organization (GO:0010638),-0.38547451944850675,-1.2386901715346785,0.14835164835164835,0.5768744038297661,1.0,18/32,32.92%,SORBS3;STX18;UVRAG;ANXA1;GSK3B;SURF4;P2RX7;SYNJ1;ATL3;LMAN1;ADRB2;SHCBP1L;PFDN2;LIG4;IRGM;AKT2;DOC2B;TREM2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4409426016234552,-1.2386475603760356,0.18719211822660098,0.5758254089464272,1.0,7/16,19.47%,SIK3;LAMTOR5;CLEC16A;PIP4P1;GPR137;SEH1L;RRAGB
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.43681116827716926,-1.2384000836658298,0.18434343434343434,0.5753380962394307,1.0,5/18,16.98%,TMBIM6;NRDE2;PTBP3;TERT;ESR1
prerank,positive regulation of transferase activity (GO:0051347),0.3465966151420605,1.238347727916735,0.11497005988023952,0.8398537251068078,1.0,30/142,15.70%,ROR1;PDGFRA;NTRK3;EPHA7;ROR2;MERTK;NTRK2;ERBB4;EPHB1;FGFR1;SERINC1;EPHA6;SORL1;HNRNPA2B1;PARM1;PINK1;EPHB6;AXL;RFC3;EPHA3;POLG2;IGF2;GSK3A;DCUN1D5;AXIN1;SERINC5;EPHA5;HNRNPD;MYC;FGFR2
prerank,skeletal system morphogenesis (GO:0048705),0.4106089304559369,1.238221921341717,0.1943620178041543,0.8385278385267423,1.0,11/42,15.80%,PDGFRA;ANKRD11;FGFR1;HOXC9;DSCAML1;TGFBR1;HOXB9;HOXB4;HOXC4;FGFR2;HOXA9
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5700218151909252,1.2376152683435355,0.22201492537313433,0.8389886912879463,1.0,1/10,0.33%,SH3RF1
prerank,triglyceride biosynthetic process (GO:0019432),0.49351498979137554,1.2375974024078353,0.22833333333333333,0.8373171991021581,1.0,5/18,15.43%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5556066092938714,1.2375746169516038,0.21254355400696864,0.8356454093583756,1.0,3/12,5.51%,MYO7A;NKD1;DSCAM
prerank,negative regulation of inflammatory response (GO:0050728),0.341360414029211,1.236814242281818,0.10011918951132301,0.8367235645220105,1.0,29/182,12.45%,RORA;GGT5;ADORA2B;PPARA;ADCY5;CALCRL;NR1H4;TNFAIP8L2;PPARD;ADORA2A;CRHR2;ADCY8;ADCY3;CALCA;ENPP3;ADCY2;PRKACB;LRFN5;CD200R1;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;PTGIS;GPR27;HTR4;FNDC4
prerank,positive regulation of cell adhesion (GO:0045785),-0.3195409424639498,-1.2363102801876646,0.11067193675889328,0.5796027479041248,1.0,21/74,13.12%,EPHA4;PTPRJ;AFDN;VIT;TPM1;FOXC2;TGFB2;RAC1;PPM1F;RSU1;ECM2;FRMD5;HYAL1;CITED2;NPNT;STX3;ARL2;MDK;RET;TGM2;ATM
prerank,plasma membrane invagination (GO:0099024),-0.3838813256964539,-1.2362519185299008,0.18207282913165265,0.5785842030735694,1.0,5/29,5.89%,GULP1;SNX18;DOCK1;GSN;CDC42
prerank,metal ion export (GO:0070839),0.43645286822024326,1.2357944284067484,0.19314641744548286,0.8388115305817824,1.0,7/31,14.03%,ATP1A2;KCNT2;ATP1A3;KCNIP2;SLC9A1;KCNE4;ATP7A
prerank,T-helper cell differentiation (GO:0042093),-0.4597054986424894,-1.2354474885850881,0.2106537530266344,0.5798158027773139,1.0,2/14,0.98%,FOXP1;LEF1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.5159103499081391,-1.2354008167969945,0.2013888888888889,0.5787935177840772,1.0,5/10,28.79%,APC;CDC42;RCC2;ECT2;SPAG5
prerank,presynaptic endocytosis (GO:0140238),0.46833709232146514,1.23539800107477,0.20426829268292682,0.8385759972667113,1.0,9/24,19.48%,CEL;VAMP2;OPHN1;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.34011732474632106,1.234609876168127,0.12237762237762238,0.8398916873907838,1.0,50/173,20.27%,SEC16B;DYNLL1;KDELR3;COL7A1;COPA;SEC16A;KDELR2;DCTN3;GRIA1;SPTBN1;ANK3;GBF1;TMEM115;COPZ2;DCTN2;IER3IP1;TRAPPC2L;COPB1;CNIH4;GOLGA2;RAB29;COG6;DCTN4;F8;SEC24B;SAR1A;VAMP4;SCFD1;RAB2A;VAMP7;MCFD2;BGLAP;COG1;DYNLL2;TRIP11;AREG;ERGIC2;SEC24A;TMED3;SEC23A;TMED9;COPG1;MIA3;TRAPPC12;TBC1D20;CNIH3;TRAPPC2;TRAPPC5;COPB2;ACTR10
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4235203343039262,1.234516157492413,0.1924198250728863,0.8385139236049818,1.0,5/37,9.69%,CEMIP;SPRED1;DGKQ;SPRED2;BMP7
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.43410169141559146,1.234364989239416,0.19389312977099238,0.8373480376557451,1.0,10/35,14.69%,PDE9A;PDE7B;HTR2B;RIMS2;DGKQ;ADCY2;HTR2C;SOX9;AKAP6;EPHA5
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4003943829838381,-1.234356707352743,0.1628498727735369,0.5803558671046853,1.0,8/24,8.02%,PHLDB2;TJP1;ARHGEF18;WASF2;F11R;CGNL1;TMEFF2;RHPN2
prerank,regulation of glucose import (GO:0046324),-0.38146490630511865,-1.2335443505675143,0.17039106145251395,0.5813440468001235,1.0,8/30,5.46%,SORBS1;PRKAG2;IGF1;OCLN;OSBPL8;INSR;RHOQ;GRB10
prerank,regulation of protein kinase B signaling (GO:0051896),0.33677046477592354,1.2333687804964537,0.11641443538998836,0.8392898136456359,1.0,43/193,17.40%,PDGFRA;NTRK3;PIK3R1;NRG1;PPARA;NTRK2;PTEN;SEMA5A;TCF7L2;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PLEKHA1;PINK1;AXL;TSPYL5;RCN3;FYN;P2RX4;TGFBR1;IAPP;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;PIK3CG;MAZ;ADAM8;RHOG
prerank,"base-excision repair, gap-filling (GO:0006287)",0.4325363465369734,1.2332445491116977,0.19311377245508982,0.8380217558762761,1.0,10/35,13.74%,POLG;LIG3;FEN1;RPA1;POLL;RFC3;MUTYH;XRCC1;POLB;MBD4
prerank,pulmonary valve morphogenesis (GO:0003184),-0.44497317540227793,-1.2330471823567095,0.19518072289156627,0.5815440142579946,1.0,7/17,4.36%,SMAD6;SLIT2;ROBO1;NOS3;NOTCH2;NOTCH1;TGFB2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.4744284734234166,-1.232740736414634,0.1926605504587156,0.5812116050151249,1.0,6/14,23.89%,IL18;NFKBIZ;ANXA1;PRKCZ;SOCS5;CCL19
prerank,embryonic axis specification (GO:0000578),-0.46196832976950164,-1.2324700881353865,0.1970074812967581,0.5807417884465339,1.0,3/15,9.95%,SMAD6;COBL;CXXC4
prerank,negative regulation of programmed cell death (GO:0043069),-0.25359219996927257,-1.232309729047273,0.02857142857142857,0.5800212191667836,1.0,115/355,22.65%,MECOM;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;IL31RA;LEF1;BCL2L1;EGFR;IGF1R;OSR1;KANK2;XIAP;THBS1;NOTCH2;ANXA5;FSTL1;NFKB1;MCL1;PTMA;KDR;SQSTM1;PRKDC;TMBIM6;CCND2;FAS;ARHGAP10;GCLC;SOCS2;ANXA1;DAB2;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;HIPK3;CD38;BNIP2;UBB;NGF;CASP2;CAT;CARD14;GSK3B;CD44;SH3RF2;GLO1;RPL10;CASP3;CFL1;CITED2;SFRP1;NFKBIA;KLHL20;BNIP3L;NIBAN2;RNF144B;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;HSPB1;BAG3;BID;FLT4;GATA6;FLNA;PTK2B;TPT1;CX3CL1;ARL6IP1;PRELID1;MET;SIRT1;ANXA4;PRKAA1;PDPN;PRDX3;PAK2;SIAH2;YME1L1;CD74;LAPTM5;UBC;HNRNPK;RASA1;AKT1;NUAK2;WNT11;HGF;NPM1;DCPS;DNAJC3;CIB1;SON;PIM2;ASNS;MIF;NAA35;CFLAR;BIRC3;MGMT;DDAH2;HIGD1A;NUPR1;MYO18A;UBA52;SIX4;UFM1;PPIF
prerank,blood vessel diameter maintenance (GO:0097746),-0.364182359189066,-1.2320232690216681,0.16071428571428573,0.5795749800890826,1.0,15/34,16.10%,ROCK2;EDNRA;NOS3;GCLC;ACE;KLF2;BDKRB2;ITGB1BP1;NPR1;ADCY6;SCPEP1;NOS1;AGTR1;EDN1;GPER1
prerank,carnitine shuttle (GO:0006853),-0.5082680991309207,-1.2319885806136732,0.2014218009478673,0.5785280742907372,1.0,2/11,5.48%,PRKAG2;PRKAA2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.38301412939855306,-1.2319752647920084,0.1772853185595568,0.5774224861225193,1.0,10/30,14.55%,IGF1;NOTCH2;RASGRF1;SHOC2;NOTCH1;RAPGEF1;NGF;STK19;TGM2;GRB2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.507471896015611,1.231234349831364,0.20689655172413793,0.8436004146361716,1.0,5/15,11.17%,SEMA5A;FGFR1;PRKD1;LGMN;P2RX4
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3352399543516203,-1.2311773825668222,0.13595166163141995,0.5784202339181452,1.0,20/47,24.23%,APOOL;MICOS10;ATP5F1B;ATP5F1C;ATP5MG;ATP5F1E;TIMM9;ATP5MC2;GHITM;ATP5F1D;ATP5MC1;TIMM13;CHCHD3;TIMM8B;ROMO1;LETM1;NDUFA13;APOO;UQCC3;TIMM10B
prerank,regulation of angiogenesis (GO:0045765),-0.27293519930546856,-1.2309389294845987,0.03870967741935484,0.5778555249308072,1.0,58/192,17.67%,FLT1;ANXA3;ROCK2;TEK;ITGB8;BMPER;ADAMTS1;FOXC1;ITGB1;NOS3;THBS1;KLF4;SPARC;TIE1;ECM1;CLDN5;KDR;RUNX1;TGFB2;CYP1B1;AMOT;COL4A3;VEGFD;VEGFC;CD34;SEMA6A;GAB1;PGK1;HIPK1;HK2;PPP1R16B;FGF1;NPR1;HYAL1;STAB1;SFRP1;GATA2;SERPINE1;PIK3CD;NIBAN2;ETS1;CTSH;HSPB1;CEACAM1;HIPK2;GATA6;GTF2I;RRAS;RAMP2;CDH5;RAPGEF3;PIK3R6;SIRT1;EPHA2;NAXE;HHEX;ERBB2;AGO2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4648871951080549,1.2307993482524946,0.208,0.8435718899239805,1.0,3/21,4.96%,PAG1;TNFAIP8L2;PTPN22
prerank,negative regulation of proteolysis (GO:0045861),-0.36976448251410615,-1.2300585127062345,0.16666666666666666,0.5790885996020515,1.0,12/34,22.17%,EPHA4;PTPN3;GAS1;CST3;ECM1;TMEM59;SERPINE2;AKT1;CLN8;TIMP3;HDAC6;CAMK2N1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3459422685099929,-1.2289106234218732,0.1266233766233766,0.5809374121590981,1.0,9/48,5.89%,DOCK5;LIMS2;DOCK1;NRP1;S100A10;PRKDC;RAC1;NEDD9;CDC42
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.3033323773269744,-1.2288874076738727,0.1,0.5798761271899646,1.0,20/88,9.97%,TEK;CAV1;THBS1;NRP2;NRP1;BMPR2;SPARC;TIE1;ECM1;KDR;VEGFD;VEGFC;CAV2;APOE;XDH;PPP1R16B;ACVRL1;ATOH8;NR4A1;PIK3CD
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4807536573318688,1.228863201227967,0.23164763458401305,0.8488591675349315,1.0,11/19,26.38%,PRDX5;MTOR;TENM1;ZC3H8;DHX36;CHD8;AR;MAF1;POLR3F;RPTOR;ELL
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5196091573391999,-1.2285914277201306,0.23974082073434125,0.579511058005152,1.0,3/10,7.12%,RARB;RXRA;TBX1
prerank,neuron projection morphogenesis (GO:0048812),0.34345348748985244,1.2285683325682188,0.14232209737827714,0.848180650433906,1.0,35/137,17.24%,EPB41L3;ISL2;DOCK10;CTNNA2;PTEN;EPHB1;CNTNAP2;FARP1;ABITRAM;MAP4K4;ANK3;ADGRB1;NEFH;LRRK2;RAB8A;CNTN4;LLGL1;DOCK7;DSCAML1;DCC;BMP7;DLG4;ATP7A;CTTN;SDC2;SGK1;NTNG2;NTNG1;TNIK;FGFR2;BRSK2;NRCAM;IMPACT;SLITRK1;CDK5
prerank,regulation of response to oxidative stress (GO:1902882),0.5522028872756172,1.22781363675051,0.24436741767764297,0.8492354184693368,1.0,5/11,18.49%,ACOX2;GGT7;PINK1;AIFM2;ALOX5
prerank,negative regulation of neuron differentiation (GO:0045665),0.4638593718898855,1.227318871680011,0.21052631578947367,0.8493209671614359,1.0,9/22,21.72%,REST;CNTN4;SOX2;BMP7;SOX9;MED1;CALR;HEY1;DTX1
prerank,alpha-amino acid catabolic process (GO:1901606),0.4438586256894268,1.227309177627338,0.18769230769230769,0.847642137963323,1.0,7/29,10.21%,THNSL2;KYNU;FAH;ACADSB;MTRR;BLMH;HOGA1
prerank,protein localization to synapse (GO:0035418),0.5350129626967461,1.2253346172077022,0.22145328719723184,0.853231601351904,1.0,5/12,18.59%,NRXN2;NRXN1;DLG4;PCLO;MPP4
prerank,skeletal muscle organ development (GO:0060538),0.4516076584454358,1.2249959741642225,0.21003134796238246,0.8527474965115037,1.0,3/26,2.11%,SVIL;MSC;BASP1
prerank,positive regulation of neuron death (GO:1901216),0.40795661634681396,1.224957658449235,0.18641618497109827,0.8511698948819963,1.0,13/46,15.09%,EPHA7;WNT5A;GRIN2B;REST;FOS;TLR6;NF1;C1QA;TLR4;DAXX;FYN;EIF2S1;CLU
prerank,protein localization to cell periphery (GO:1990778),-0.2868820151398007,-1.224897105247037,0.0851063829787234,0.5883728057325286,1.0,28/133,9.20%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;LIN7A;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;PACS1;RAMP1;TTC7B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;TTC7A
prerank,regulation of gastrulation (GO:0010470),-0.463365424953542,-1.2246978654076777,0.22518159806295399,0.5878097130747044,1.0,2/14,2.04%,PHLDB2;OSR1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.36553596426025187,1.2244872668785205,0.18181818181818182,0.8511913321038613,1.0,23/83,19.99%,DYNLL1;ATF5;DCTN3;HAUS3;HAUS1;HMMR;DCTN2;HAUS8;PRKACA;CEP192;CEP135;TP53;SSNA1;CEP250;CEP152;CSNK1E;CENPF;CLASP1;ALMS1;PCM1;ATAD5;TUBA1A;CEP43
prerank,negative regulation of cellular protein localization (GO:1903828),-0.36185318494724183,-1.223794439124475,0.17295597484276728,0.5890877202936851,1.0,6/34,8.29%,PICALM;ROCK2;ACTN2;GOPC;GSK3B;MAPT
prerank,axoneme assembly (GO:0035082),0.43388804084348365,1.2237199881103116,0.20565149136577707,0.8524048313522026,1.0,8/31,18.52%,RSPH9;DNAAF3;TTC12;DNAI4;CCDC65;GAS8;CCDC39;SPEF1
prerank,macrophage activation (GO:0042116),-0.3637931658939831,-1.223614287403791,0.17543859649122806,0.5884614738981803,1.0,11/34,18.26%,FOXP1;APP;LBP;NMI;CD93;IFI35;MAPT;PLCG2;CX3CL1;DYSF;IFNGR1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4744229364040379,-1.223554781172629,0.2119047619047619,0.5874665217779573,1.0,7/13,17.38%,SEMA7A;TGFB2;CUEDC2;PLCG2;SIRT1;CD74;LAPTM5
prerank,regulation of DNA binding (GO:0051101),-0.3497691762241443,-1.2235497183144086,0.14285714285714285,0.5863456180374348,1.0,16/44,25.64%,IGF1;LEF1;FOXC1;SKI;SMO;NGF;NFKBIA;SUMO3;HMGB2;CSNK2B;EGF;E2F1;ILRUN;TXN;SUMO1;KDM1A
prerank,positive regulation of ATPase activity (GO:0032781),0.40896678563285765,1.2234258789228898,0.18958031837916064,0.8517575174165951,1.0,11/41,19.18%,DYNLL1;RYR2;DNAJC24;MSH3;ALDOB;DNAJC10;DYNLL2;DHX9;MSH6;SSBP1;CHTOP
prerank,meiosis I (GO:0007127),0.4624566675968433,1.2234235531727313,0.19063004846526657,0.8500659971810173,1.0,7/23,15.63%,SGO1;MEIKIN;ZCWPW1;SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3614474211688391,1.223027319908214,0.1568627450980392,0.8497758740576961,1.0,26/95,18.20%,MORF4L1;LIG3;MCM7;FAN1;FEN1;POLQ;ERCC5;CDC7;RPA1;ERCC4;POLL;MMS22L;BRCA2;ZFYVE26;REV3L;MCM4;RECQL;SPIDR;POLN;XRCC1;RAD52;PSMD14;MCMDC2;HELQ;WRN;FBH1
prerank,negative regulation of kinase activity (GO:0033673),-0.32604833785768084,-1.2221876082035483,0.14285714285714285,0.5889141060736235,1.0,24/62,23.72%,PRKAG2;PPM1E;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;LRP6;ITGB1BP1;MAPT;YWHAG;HSPB1;CEACAM1;PPIA;TRIM27;PRDX3;PAK2;AKT1;GSKIP;DUSP19;CAMK2N1;WWTR1;QARS1;DBNDD2
prerank,fat cell differentiation (GO:0045444),-0.3264825291834221,-1.2218146108250372,0.12666666666666668,0.5887630057671414,1.0,12/57,10.39%,SMAD6;FOXO1;WNT5B;BBS9;OSBPL8;KLF4;OSBPL11;ERAP1;PRDM16;NR4A1;FAM120B;NR4A2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.3085750093165493,-1.2218114985173958,0.13178294573643412,0.5876577589746336,1.0,34/73,28.33%,ACTB;PPHLN1;HDAC4;DDX21;SF3B1;PRMT7;WBP2;GPX1;PPM1D;SMARCA5;MYO1C;MYBBP1A;POLR2H;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;CTCF;POLR1H;TAF1C;POLR1G;HDAC6;SPHK2;POLR1C;PHF2;PHF1;MTF2;CGGBP1;SPI1;ZFP57;POLR2K;HDAC5;BMI1
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.37756812985318555,-1.2217777462759276,0.16101694915254236,0.5866246043882749,1.0,15/33,28.65%,GCLC;PRODH;SLC39A8;GOT2;RIMKLB;OAT;NIT2;DDAH1;DDAH2;CAD;GLUL;PYCR2;FPGS;PYCR3;GGT1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.40031862603114793,-1.2217090527615273,0.18635170603674542,0.5857122065886708,1.0,8/24,13.81%,EPHA4;CTSC;UBB;APOE;TMF1;GPX1;PSME3;PTK2B
prerank,selective autophagy (GO:0061912),-0.3283112667386947,-1.2212032989422412,0.16,0.5858435305315319,1.0,25/56,22.49%,VIM;RETREG1;BECN1;SQSTM1;ATG13;WDFY3;UBB;USP30;ATG2B;DYNC1H1;ATM;UBE2N;DYNC1I1;ATG2A;UBC;LGALS8;AMBRA1;ARL13B;DYNC1LI1;HDAC6;KLHL3;MAP1LC3B;CFTR;UBA52;UFM1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.3457831974459726,-1.2207627567227068,0.17717717717717718,0.5859161577102372,1.0,11/44,13.97%,ANO6;ACTN2;ATP1B3;WNK4;WNK1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,synaptonemal complex assembly (GO:0007130),0.5102905752131742,1.2199054124477997,0.22876949740034663,0.8579567465803305,1.0,4/15,19.98%,STAG3;TEX11;BAG6;TRIP13
prerank,synaptonemal complex organization (GO:0070193),0.5102905752131742,1.2199054124477997,0.22876949740034663,0.8579567465803305,1.0,4/15,19.98%,STAG3;TEX11;BAG6;TRIP13
prerank,regulation of microtubule-based process (GO:0032886),-0.36512433064543554,-1.2194711258078632,0.14893617021276595,0.5882494362302434,1.0,16/36,19.08%,PHLDB2;DIAPH1;MARK4;APC;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;CYLD;MACF1;BICD2;PRKAA1;ERBB2;MARK2
prerank,nucleotide-excision repair (GO:0006289),0.3570359721105626,1.2191469417361025,0.15451174289245984,0.8589960957903305,1.0,32/101,21.65%,COPS3;ERCC1;ISY1;LIG3;FAN1;POLK;ERCC5;POLA1;RPA1;ERCC4;POLL;UVSSA;XPC;COMMD1;BRCA2;RFC3;TP53;GTF2H3;XRCC1;POLB;COPS4;ATXN3;ERCC2;GTF2H1;MMS19;CUL4A;POLE;POLR2L;USP45;DDB1;CDK7;RFC4
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.4990696736701952,-1.2187400712813077,0.22877358490566038,0.5891986004843626,1.0,5/11,16.47%,MEF2C;EFNB2;FZD7;FRS2;MYOCD
prerank,cellular response to chemokine (GO:1990869),0.3959130480067588,1.218702865171213,0.17914831130690162,0.8589966019316437,1.0,5/46,5.33%,XCL1;CXCL10;CXCL1;DUSP1;CCL15
prerank,receptor catabolic process (GO:0032801),-0.3988654159131083,-1.2178899893349542,0.21508379888268156,0.5902715251008623,1.0,5/24,8.78%,BECN1;RNF43;UVRAG;SNX25;AP2A1
prerank,chromatin disassembly (GO:0031498),-0.45431255576184737,-1.2177527580320522,0.2222222222222222,0.5884523594022147,1.0,11/14,42.39%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,nucleosome disassembly (GO:0006337),-0.45431255576184737,-1.2177527580320522,0.2222222222222222,0.5884523594022147,1.0,11/14,42.39%,ARID2;SMARCA4;SMARCC2;SMARCD3;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,regulation of inclusion body assembly (GO:0090083),-0.5001714183061094,-1.2166033591125662,0.21481481481481482,0.5904230503195076,1.0,7/11,32.31%,SNCAIP;DNAJA4;DNAJB1;HSPA1A;DNAJB2;HSPA1B;HSPA2
prerank,positive regulation of response to stimulus (GO:0048584),0.41507806885802645,1.216546252254137,0.19247467438494936,0.8654094909405072,1.0,6/40,6.31%,ACOX2;WNT5A;CDKN2A;ANKLE1;FMR1;ECHDC3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2970542745377636,-1.2164697669535895,0.08482142857142858,0.5896544350112648,1.0,30/87,22.48%,SMAD6;ARHGEF18;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;SKI;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;ZYX;PRKCZ;SMAD1;FURIN;CDH5;SIRT1;UBC;USP9X;TWSG1;TGFBR3;ADAM9;TGFBR2;NRROS;UBA52;SMAD7
prerank,aortic valve morphogenesis (GO:0003180),-0.3735357548792964,-1.2163721202582516,0.18208955223880596,0.588799233228513,1.0,7/30,4.26%,SMAD6;ROCK2;SLIT2;ROBO1;NOS3;TIE1;NOTCH1
prerank,regulation of stem cell differentiation (GO:2000736),0.3630424327291348,1.2161943075030035,0.15958815958815958,0.8650498411348214,1.0,27/89,19.21%,PDGFRA;PTN;PSMD1;RBM24;KMT2A;PSMD10;ZFP36L2;PSMA5;PSMB5;PSMC4;NUDT21;OCIAD1;EIF2AK2;PSMA4;PSMC5;HOXB4;PSMB9;SMYD5;PUS7;GDNF;PSMA7;JAG1;PSMD14;LDB1;PSMA2;PSMD11;CBFB
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.359395455663887,-1.2159094779740156,0.17543859649122806,0.5888766099065096,1.0,6/37,4.25%,IGF1;MEF2C;ADAMTS1;IGFBP5;TPM1;SOD2
prerank,regulation of stem cell proliferation (GO:0072091),0.49364383622789704,1.2156544087797394,0.22727272727272727,0.865381929236364,1.0,4/17,11.21%,KDF1;GJA1;EIF2AK2;AGO3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3649256184650038,1.215534324951429,0.1753681392235609,0.8641079478696254,1.0,10/87,4.55%,PDGFRA;DLC1;LRP1;RND3;HRG;GPM6B;IQGAP3;CORO2B;FSCN1;RAC3
prerank,negative regulation of immune response (GO:0050777),0.338869549500765,1.2155272060945685,0.138442521631644,0.8624508740553078,1.0,31/154,17.39%,GGT5;ADORA2B;ADCY5;CALCRL;TRAF3IP1;ADORA2A;DHX58;CRHR2;ADCY8;ADCY3;CALCA;ENPP3;LYAR;ADCY2;PRKACB;GPR176;PRKACA;ADCY7;FGR;FYN;IAPP;GPR27;HTR4;LYN;PRKAR1A;GNG2;LHCGR;DPEP1;HTR6;PTGER4;COL3A1
prerank,regulation of dendrite development (GO:0050773),0.4287651057475025,1.214818770269026,0.21666666666666667,0.8632821180905883,1.0,10/37,16.69%,PTN;CSMD3;CDKL5;NEDD4;ADGRB3;DCC;BMP7;SDC2;TNIK;HECW1
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.508602003085473,-1.21433365009894,0.22448979591836735,0.5919104072952707,1.0,6/10,18.24%,NOTCH1;LRP6;PHACTR4;ARHGAP12;LIN7C;SOX11
prerank,regulation of chemotaxis (GO:0050920),0.43476759960404887,1.2140650932419061,0.21766561514195584,0.8643440975988813,1.0,6/30,11.17%,PDGFRA;MYCBP2;ADGRA2;ZSWIM8;GPR183;P2RX4
prerank,sodium ion transmembrane transport (GO:0035725),0.3626095352607153,1.2140625315642068,0.18488529014844804,0.8626742202545356,1.0,16/84,13.61%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;SLC9A9;ATP1A3;SLC9A1;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,GPI anchor metabolic process (GO:0006505),0.45197799299216357,1.2139780361728978,0.2098360655737705,0.8613300103162909,1.0,6/26,13.17%,PIGV;GPLD1;PIGQ;PIGP;PIGA;PIGL
prerank,positive regulation of nervous system development (GO:0051962),0.41447459891761035,1.2135707882017044,0.21481481481481482,0.8611085504621137,1.0,12/42,17.98%,SRPX2;EPHB1;GRID2;NRXN1;SERPINF1;SYNDIG1;IL1RAP;NAP1L1;SNW1;CUX2;IL1RAPL1;CLSTN1
prerank,endodermal cell differentiation (GO:0035987),0.43210676487632066,1.2133715977102932,0.21461897356143078,0.8601561269824844,1.0,7/31,8.64%,LAMB1;ITGAV;COL7A1;ITGB5;COL12A1;RTF1;COL4A2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.524803649168598,1.2127407805755208,0.2483108108108108,0.8608310637117268,1.0,4/12,14.34%,KDELR3;KDELR2;TAPT1;HSPA5
prerank,negative regulation of JNK cascade (GO:0046329),-0.370145787683848,-1.212690573313829,0.1794871794871795,0.5952249203721293,1.0,8/31,16.20%,MECOM;SIRPA;HIPK3;SH3RF2;HDAC3;CYLD;MAPK8IP1;PER1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.4931731289294045,1.212612888868254,0.2376068376068376,0.8596716772496682,1.0,7/17,15.14%,ATP1A2;GJA1;RYR2;ATP1A3;PRKACA;GJC3;GJA5
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5320635757680708,1.212609938625781,0.24869565217391304,0.8580299989157165,1.0,2/12,1.10%,CXCL10;TMEM102
prerank,T cell differentiation (GO:0030217),0.40971203420044167,1.211273484816675,0.20763358778625954,0.8612593886865175,1.0,7/40,11.91%,CHD7;MR1;RABL3;PTPN22;ZFP36L2;GLI3;LMBR1L
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5259390856234633,1.2109045394088045,0.23519163763066203,0.8610089456062671,1.0,2/13,2.01%,ZFYVE28;CBLB
prerank,positive regulation of T cell proliferation (GO:0042102),-0.32813158569195516,-1.2108494304046278,0.12080536912751678,0.5990803933874054,1.0,8/55,6.17%,IGF1;IL18;IGFBP2;ANXA1;IL6ST;SLC7A1;TFRC;NCK1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.41650477034334343,-1.2104489407251098,0.19743589743589743,0.5990746413353066,1.0,6/21,8.82%,TUT7;SAMD4A;CNOT10;PARN;PAN3;CNOT8
prerank,extracellular matrix assembly (GO:0085029),0.46291750609502735,1.2100175399594715,0.2359375,0.8626038122989422,1.0,4/23,4.93%,LAMB1;GPM6B;TNXB;MFAP4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4584235328164116,1.209760220158042,0.2300163132137031,0.8619035866252882,1.0,5/22,9.69%,IL1RN;GCNT2;FLOT2;MBP;BMP7
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.4222402793764416,-1.2092236845796258,0.22193877551020408,0.6012690014601167,1.0,8/19,15.14%,ELF1;KLF4;IRAK2;RUNX1;MAVS;PARP9;TLE5;MAP2K5
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.372948091704469,-1.2086031007566058,0.1762820512820513,0.6018388319036293,1.0,6/30,6.75%,ROBO1;NET1;F11R;GPR4;RAC1;PRAG1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.424799033065649,1.2085830060339675,0.22406015037593985,0.8645858033048031,1.0,4/35,2.23%,GGT5;ACSS3;PAM;GGT7
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.4759111442028643,1.2085239517786548,0.22330097087378642,0.8631304274766016,1.0,8/19,23.41%,IL34;PTK2;JAM3;AKIRIN1;CMKLR1;RARRES2;MAPK1;CAMK1D
prerank,regulation of secretion by cell (GO:1903530),0.3862890092322872,1.2083560324815155,0.19742489270386265,0.8620816308971366,1.0,14/54,12.83%,HCRT;CHRNB4;DNAJC1;VAMP2;FMR1;RAB8A;LLGL1;RAB3C;RIMS2;HTR1A;P3H1;RIMS1;RAB15;ARFIP1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5182947992218911,1.2082445535087913,0.2421602787456446,0.8608358216915747,1.0,6/13,19.01%,MBTPS2;NR1H2;USP19;CLU;ALOX5;EIF2AK3
prerank,clathrin coat assembly (GO:0048268),-0.4521351536953878,-1.208143065148198,0.23155216284987276,0.6019342712350833,1.0,7/15,23.01%,PICALM;HIP1R;CLTB;HIP1;CALY;AP2S1;PIK3C2A
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.34130097373959184,1.2080024935437694,0.15925925925925927,0.8601126527310005,1.0,31/124,17.24%,NCDN;LAMB1;GPM6B;MICALL2;CNTNAP2;WDPCP;LRP12;PPP1R9A;NEDD4;UNC5A;CNTN4;TMEM108;DOCK7;FAM161A;PLEKHA1;KIFAP3;STMN2;NPY;OPHN1;PLP1;STMN4;GPRIN1;FAM161B;STMN1;LYN;CTTN;GDNF;TBC1D23;GPRIN3;CYFIP1;CDK5
prerank,myeloid cell development (GO:0061515),-0.4336699205849327,-1.2079371593142563,0.21393034825870647,0.6013684428047958,1.0,9/18,29.04%,FOXP1;APP;ALAS1;ABCB10;NRROS;DMTN;SRC;NCKAP1L;ALAS2
prerank,regulation of peptide hormone secretion (GO:0090276),0.3796053092453393,1.2078198440751018,0.19099590723055934,0.8591969101823156,1.0,11/67,10.49%,CHD7;RAPGEF4;CACNA1E;ITPR1;PER2;PRKCA;KCNC2;HTR2C;SYT7;GCK;PPP3CB
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.48850369713422304,1.2075123873903304,0.2226027397260274,0.8586941276865238,1.0,6/18,15.31%,POR;EDN3;FXN;PDP1;ATP7A;GDNF
prerank,multivesicular body assembly (GO:0036258),-0.3759591363853876,-1.2073291532225798,0.14713896457765668,0.6019507333317345,1.0,14/30,28.52%,VPS37A;CHMP2B;VPS37B;IST1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;VPS28;VPS36;CHMP4C;CHMP2A;RAB11A
prerank,regulation of protein ubiquitination (GO:0031396),0.35250367838415236,1.2072536212049207,0.17848101265822786,0.8579659673121961,1.0,24/108,16.42%,FANCI;PRICKLE1;OGT;MYCBP2;PRMT3;ADGRB1;LRRK2;PSMD10;PER2;PINK1;TSPYL5;COMMD1;BIRC2;DAXX;NDFIP2;TGFBR1;SPRTN;GSK3A;PTTG1IP;AXIN1;UBE2D1;PAXIP1;NDFIP1;USP4
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3948553224144125,1.2071574989200993,0.21807747489239598,0.8566807805780474,1.0,9/48,12.10%,TXK;PDE4B;SCRIB;PTPN22;CD276;TLR8;TLR4;PYCARD;IL12A
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.432120404375693,-1.2070967637177819,0.24317617866004962,0.6014655979555956,1.0,6/17,14.60%,CAV1;OSR1;KLF7;CEACAM1;APOLD1;MAFG
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.301339219997963,-1.2070143268366467,0.11895910780669144,0.6005873897530013,1.0,13/80,5.89%,PLCE1;DPYSL3;OCLN;FNBP1L;WASF2;NRP1;MARK4;ANLN;NDEL1;RHOQ;APC;RAC1;CDC42
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5088189719235424,1.2070140998715837,0.25207296849087896,0.8556170398801725,1.0,4/14,15.43%,LPIN3;CHKA;SELENOI;LPIN2
prerank,intracellular protein transmembrane transport (GO:0065002),0.4059255838515213,1.206989427629691,0.20923520923520925,0.8541231676831693,1.0,17/42,22.21%,DNAJC19;PEX2;PEX7;SEC63;SEC61B;TIMM44;DNAJC15;HSPA5;RTN2;PAM16;PEX12;PEX14;PEX6;GRPEL1;TIMM21;CHCHD4;C2CD5
prerank,actin filament organization (GO:0007015),-0.2722008864388107,-1.2068477761808367,0.05555555555555555,0.599972130393651,1.0,37/151,14.61%,NEBL;TMOD3;RHOBTB1;BAIAP2L1;DPYSL3;SHROOM4;SHROOM3;TPM1;MYO1D;HIP1R;GSN;RUFY3;RHOBTB2;RAC1;NEDD9;CGNL1;ARHGAP17;COBL;CDC42;VILL;INPPL1;RHOC;FHOD1;MYO1C;MYO1E;ARHGAP12;CD2AP;LMOD1;SHROOM2;TMOD1;TRPV4;FLNA;DSTN;SHROOM1;HIP1;BAIAP2;ELMO2
prerank,regulation of humoral immune response (GO:0002920),0.40467634341284375,1.2065453573436433,0.2073732718894009,0.8541327199024484,1.0,9/44,15.09%,C7;C5AR1;SUSD4;C1QA;C1QC;CR2;C8G;CD81;CLU
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.30744434641513896,-1.2058147115096673,0.15162454873646208,0.6017195385533859,1.0,22/73,13.95%,ROBO1;CASP8AP2;TNFSF10;ACER2;HIP1R;FAS;COL4A3;EGLN3;CRADD;NGF;CASP2;XDH;VCP;MAPT;SMAD3;CASP8;BAD;BAX;BID;ATP2A3;BOK;HIP1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2925192910743624,-1.2054190609213593,0.11214953271028037,0.6017693610825551,1.0,29/94,16.13%,PLCB1;NFKB1;IRAK2;PSMC6;SQSTM1;IL1R1;PELI1;PSMD9;PSMF1;PSMB7;CUL1;TOLLIP;UBB;PSMD8;RPS6KA5;PSMD12;NFKBIA;MAP3K8;TAB2;PSMA3;PSMA6;PSMD4;IRAK4;PSME3;PSMD7;UBE2N;PSMB6;PSMC1;PSMB10
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3153448264388102,-1.20526159754173,0.12686567164179105,0.6011352551841912,1.0,17/68,10.92%,LEF1;WNT5B;CAV1;PLPP3;WNT9A;WNT4;APC;DVL1;FZD4;FZD7;GSK3B;LRP6;RAB5A;WNT6;SFRP1;NR4A2;BCL9L
prerank,embryonic skeletal system development (GO:0048706),0.41733889516345807,1.205078278368661,0.20268256333830104,0.8579746862796966,1.0,8/35,13.51%,PDGFRA;SULF1;WNT5A;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4
prerank,lymphocyte migration (GO:0072676),0.42208367969373395,1.2047507776664728,0.23863636363636365,0.8576860340974451,1.0,8/32,20.39%,XCL1;MSMP;CCL15;CCL25;MYO1G;ADAM8;CCL2;CCL14
prerank,superoxide metabolic process (GO:0006801),-0.38043130810712594,-1.2041999044496234,0.2238372093023256,0.6028711221740707,1.0,14/29,27.11%,SH3PXD2A;NOS3;SOD2;SH3PXD2B;PRDX1;NOX4;SOD3;ALOX12;NRROS;CYBB;MT3;CYB5R4;NCF2;NOXO1
prerank,negative regulation of reproductive process (GO:2000242),0.4906740393404151,1.2040618868420272,0.24598930481283424,0.8585345675690635,1.0,3/17,3.91%,SULF1;GJA1;DUSP1
prerank,regulation of aerobic respiration (GO:1903715),0.4988929496311419,1.2039339092890102,0.2408026755852843,0.8574276515653234,1.0,7/15,19.90%,CBFA2T3;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.42989710908340617,1.2038451026582109,0.21686746987951808,0.8561672511204304,1.0,7/33,8.22%,PIK3R1;PTEN;PIK3R2;HTR2B;IRS1;NF1;PLEKHA1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.44676317439357016,-1.2037476523071666,0.21707317073170732,0.602996276071505,1.0,6/17,13.64%,BCL2L1;SOD2;BAD;BAX;BID;BOK
prerank,sensory perception of pain (GO:0019233),0.45421380816596557,1.2037219921668827,0.23102310231023102,0.8550045764175547,1.0,4/21,11.17%,TRPA1;NIPSNAP1;PTGES;P2RX4
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3854337875560058,-1.2036359303017863,0.19830028328611898,0.6021839516784329,1.0,11/26,16.72%,FOXP1;KANK2;SMARCA4;DAB2;VPS18;SFRP1;HEYL;VPS11;SIRT1;PER1;CLOCK
prerank,phosphate ion transmembrane transport (GO:0035435),-0.48258669481100613,-1.2034992184942155,0.2555831265508685,0.6014519318386756,1.0,4/12,12.21%,XPR1;SLC37A3;SLC25A3;SLC20A1
prerank,neuron projection development (GO:0031175),0.3305691206488872,1.2034691146042464,0.1359338061465721,0.8542963202019299,1.0,39/168,16.35%,NCDN;EPB41L3;LAMB1;DOCK10;GPM6B;ADGRV1;MICALL2;PTEN;EPHB1;CNTNAP2;MAP4K4;LRP12;PPP1R9A;NEDD4;UNC5A;NEFH;LRRK2;CNTN4;TMEM108;DOCK7;STMN2;NPY;BMP7;OPHN1;PLP1;STMN4;DLG4;IFT88;GPRIN1;STMN1;ATP7A;LYN;CTTN;GDNF;SGK1;TNIK;TBC1D23;GRM7;GPRIN3
prerank,oxoacid metabolic process (GO:0043436),0.4453031053175541,1.2033212624874365,0.22698412698412698,0.8532420818708171,1.0,3/27,5.28%,ENPP1;TPST1;GRHPR
prerank,negative regulation of T cell proliferation (GO:0042130),0.4278478427721246,1.202847590414025,0.22325581395348837,0.8533887561144059,1.0,7/28,17.28%,GLMN;SCRIB;PDCD1LG2;TNFRSF21;CD86;PRKAR1A;LGALS9
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5086714954344496,1.2026774058792171,0.24036697247706423,0.8508864420867694,1.0,2/13,3.37%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.5086714954344496,1.2026774058792171,0.24036697247706423,0.8508864420867694,1.0,2/13,3.37%,IL15RA;JAK1
prerank,dendrite self-avoidance (GO:0070593),0.49512572688920276,1.2021116446143976,0.24377224199288255,0.8513334393500457,1.0,6/16,9.95%,DSCAM;CNTN4;DSCAML1;PALLD;NEXN;CNTN6
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3492170227031696,1.201431459162221,0.17057291666666666,0.8523238654413559,1.0,27/110,17.33%,ADGRL3;CXCL10;PTGFR;ADCY5;CALCRL;GPR3;ADGRB2;ADGRB1;ADORA2A;ADCY8;ADCY3;CALCA;ADCY2;LPAR3;ADGRB3;ADGRL1;ADCY7;LPAR1;GPR26;IAPP;GNG2;S1PR2;LGR5;LHCGR;ADGRE5;PTGER4;ADRA2A
prerank,tRNA 5'-leader removal (GO:0001682),0.5150566645386715,1.2013148973698546,0.24315068493150685,0.8511834653850319,1.0,4/13,9.76%,RPP40;POP5;PRORP;POP7
prerank,neurotrophin signaling pathway (GO:0038179),-0.4049158646183506,-1.2010311003884686,0.22422680412371135,0.6070706475509817,1.0,10/21,19.23%,RAPGEF2;MAGI2;RAP1A;RAPGEF1;NGF;CASP3;FRS2;GRB2;KIDINS220;SOS1
prerank,ncRNA processing (GO:0034470),-0.26447894092496615,-1.2008848718498957,0.06451612903225806,0.6064140390804029,1.0,68/200,22.28%,RPS14;RPS9;DGCR8;RPS16;TUT7;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;DICER1;RPS27;DROSHA;RPP30;RPS15;RPL21;PDCD11;RPL10;RPL35A;INTS3;SMAD3;DDX27;RPL10A;RPL11;RPL36A;RPL34;KARS1;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;SMAD1;RPL29;EXOSC2;INTS9;INTS10;INTS1;RPL31;IMP3;EXOSC3;ADAT1;RPL23A;AGO2;RPL19;RPL36;WDR12;PES1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.45103800402283173,1.1999692986708377,0.23274478330658105,0.8545591769649475,1.0,7/25,12.54%,GRID2;GRIN2B;MPP2;LRRK2;GRIN2A;GLRA1;GSK3A
prerank,regulation of developmental growth (GO:0048638),-0.38105500600366465,-1.1997508606845546,0.18051575931232092,0.6084100529377634,1.0,7/29,7.28%,IGF1;PLCB1;APP;INSR;SIX1;APOE;GSK3B
prerank,cytoskeleton organization (GO:0007010),-0.28363888565980533,-1.1995491802498883,0.07981220657276995,0.607909277671751,1.0,25/114,9.15%,PLCE1;RHOBTB1;MICAL2;MARK1;FGD5;SYNE3;LARP4;DIAPH1;TPM1;PACSIN2;LRCH3;BRWD3;ARHGAP10;RHOBTB2;RAC1;NEDD9;PLD2;CAPZB;ARAP3;SEMA6A;APOE;CDC42BPB;RHOC;MAST3;CFL1
prerank,myelin assembly (GO:0032288),0.5406757434143075,1.1992453500554734,0.26691042047531993,0.8555651865752415,1.0,2/10,4.49%,EPB41L3;TENM4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.29325777887501225,-1.1991123324071526,0.1271186440677966,0.6079450294551035,1.0,29/94,16.97%,DDX5;BCL2L1;PPP1R13B;ARL6IP5;MCL1;PRKDC;MAP3K5;CYP1B1;PRODH;CUL1;JMY;CASP2;PPM1F;FNIP2;CRIP1;BAD;BAX;MYBBP1A;HIPK2;ATP2A3;ATM;BOK;HINT1;CDKN1A;ERN1;PRKCD;CUL3;AIFM1;EPHA2
prerank,SNARE complex assembly (GO:0035493),0.5462704631607891,1.1990404946925386,0.2545126353790614,0.8548403884770528,1.0,3/10,10.81%,STXBP6;VAMP2;VAMP4
prerank,RNA catabolic process (GO:0006401),0.3919286364738072,1.1989942484729712,0.21052631578947367,0.853452443535761,1.0,13/46,17.91%,RNASEH2C;AGO4;FEN1;ZC3H12D;ZFP36L2;AGO3;MTREX;RNASEH2B;DIS3L2;HNRNPD;RNASEH1;PPP1R8;DXO
prerank,digestive tract morphogenesis (GO:0048546),0.5073998877446464,1.1989693181359273,0.24558303886925795,0.8519973925683595,1.0,1/14,0.14%,PDGFRA
prerank,glycolytic process (GO:0006096),-0.372073216078322,-1.1989430510420311,0.20718232044198895,0.6073287184405844,1.0,14/28,20.81%,HK1;LDHA;PGK1;PFKFB2;HK2;TPI1;GAPDH;PKM;ALDOC;ENO1;PFKL;ALDOA;GAPDHS;PGM1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4400275325189319,1.1988277276549235,0.24098360655737705,0.8509543485946709,1.0,10/26,13.86%,PTEN;NRXN1;LRRK2;TMEM108;RIMS2;RELN;RIMS1;DLG4;CBLN1;CUX2
prerank,recombinational repair (GO:0000725),0.36505092393777805,1.198530208212773,0.19436997319034852,0.8505209997324301,1.0,22/77,18.20%,MORF4L1;LIG3;FAN1;FEN1;POLQ;ERCC5;RPA1;ERCC4;POLL;MMS22L;BRCA2;ZFYVE26;REV3L;RECQL;SPIDR;POLN;XRCC1;RAD52;PSMD14;HELQ;WRN;FBH1
prerank,negative regulation of type I interferon production (GO:0032480),-0.3532460616728161,-1.198434052829267,0.1955128205128205,0.6077300712710259,1.0,17/40,22.93%,NPLOC4;SIRPA;MAVS;TRIM25;PCBP2;RNF125;CYLD;NLRX1;NLRC5;UBE2L6;TBK1;HAVCR2;ISG15;TNFAIP3;ILRUN;REL;IKBKE
prerank,endochondral bone morphogenesis (GO:0060350),0.513937975274565,1.19813690037784,0.2542372881355932,0.8504181397641637,1.0,1/11,0.07%,COL13A1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.43151971551526913,-1.1980921637344648,0.20297029702970298,0.6075719324588214,1.0,6/16,14.00%,THBS1;JCAD;PPP1R16B;GATA2;FGFBP1;AGTR1
prerank,magnesium ion transport (GO:0015693),-0.46719590737095806,-1.197787392721224,0.2255125284738041,0.6072816075497197,1.0,4/12,12.38%,SLC41A1;NIPAL2;MRS2;CNNM4
prerank,dendritic spine morphogenesis (GO:0060997),0.4936876447359656,1.1976520025975939,0.2616984402079723,0.850594200896387,1.0,3/15,2.25%,DOCK10;PTEN;EPHB1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3361458616903295,1.1975930410446558,0.17391304347826086,0.8492876981533319,1.0,37/150,17.40%,PDGFRA;PIK3R1;NRG1;SEMA5A;TCF7L2;ERBB4;FLT3LG;NRG2;FGFR1;GAB2;PDPK1;PIK3R2;GCNT2;IRS1;IRS2;NRG4;PTK2;PINK1;AXL;TSPYL5;FYN;P2RX4;TGFBR1;IAPP;CD86;IGF2;CASS4;MYDGF;FERMT2;FGF5;AREG;FGFR2;HAX1;PIK3CG;MAZ;ADAM8;RHOG
prerank,synaptic vesicle exocytosis (GO:0016079),0.39945632018561333,1.1971797628518532,0.2195845697329377,0.8492837206952403,1.0,14/40,18.61%,VAMP2;SNAP23;RIMS2;SNPH;SNAP29;SYT7;RIMS1;SYT5;DNAJC5;UNC13A;PCLO;CDK5;UNC13C;SYT1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.4612226372060427,1.1970596525614734,0.23164763458401305,0.8467247992464713,1.0,9/21,20.54%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.4612226372060427,1.1970596525614734,0.23164763458401305,0.8467247992464713,1.0,9/21,20.54%,ERCC1;ERCC5;RPA1;ERCC4;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1
prerank,positive regulation of cellular component organization (GO:0051130),-0.28771874684526233,-1.1970250899856971,0.08133971291866028,0.6082565825735383,1.0,31/107,16.08%,TRABD2B;ATP10A;FNIP1;IGF1R;SHANK3;INSR;RUNX1;TGFB2;GPC3;DAB2;TFRC;APOE;GSK3B;VCP;RHOC;FNIP2;HYAL1;GPX1;BAX;CAMK2B;CD151;AJUBA;BID;SURF4;ABCB4;CDH5;TAL1;RAPGEF3;SMPD1;MMP1;LMAN1
prerank,negative regulation of binding (GO:0051100),-0.30172616109479683,-1.1970089277791716,0.14583333333333334,0.6072331284304884,1.0,22/81,15.53%,LEF1;CAV1;ACTB;TMBIM6;SMO;DAB2;DVL1;MITD1;GSK3B;ITGB1BP1;NES;STYX;BAX;NFKBIA;ARHGAP28;SUMO3;RALB;TLE5;CTSZ;CDKN1A;DDX11;PRKCD
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3933403636733523,-1.196972596027097,0.22193877551020408,0.6062717116144075,1.0,11/25,25.14%,RBPJ;AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;AGT;RTN4;DOK1;CNOT9
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.46841702922365624,-1.1967367000234617,0.2447058823529412,0.6058322747457068,1.0,4/12,3.37%,PODXL;PROM1;MAGI2;IQGAP1
prerank,regulation of cholesterol transport (GO:0032374),0.46460780204034924,1.1965724554496608,0.24433656957928804,0.846896584832754,1.0,3/20,4.06%,LRP1;OSBPL6;NR1H2
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5084823228891997,1.1964252490154883,0.2547332185886403,0.8458868367402661,1.0,2/14,6.08%,CCDC22;PSMD10
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.45304717163079555,1.19602516330365,0.22132471728594508,0.8457659360097409,1.0,3/20,2.62%,PTEN;NR2F2;CDKN2A
prerank,positive regulation of blood coagulation (GO:0030194),-0.42713558594144574,-1.1958473954170916,0.23222748815165878,0.607271057886454,1.0,5/17,9.85%,ANO6;THBD;THBS1;ST3GAL4;SERPINE1
prerank,cellular response to lipid (GO:0071396),0.3242519894607236,1.1952329891941393,0.15057471264367817,0.8470431612158086,1.0,35/191,14.06%,RORA;CXCL10;ADCY5;ATP1A2;WNT5A;CXCL1;GPLD1;PDE4B;NR1H4;NCOA3;PDCD1LG2;SPP1;ATP1A3;IRS1;ADCY8;ADCY3;CD68;ADCY2;AXL;TLR4;WNT3;PLAA;IRAK1;EPHA3;PYCARD;SNW1;SOX9;HTRA2;CD86;PDCD4;TESC;NRIP1;MED1;MAP4K1;LYN
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.48252542212535776,1.1950602678262778,0.22338568935427575,0.8460798312257862,1.0,4/16,11.46%,TRA2B;PRDX6;CELF4;SNW1
prerank,protein localization to phagophore assembly site (GO:0034497),0.5404213442995079,1.194404454437196,0.26607142857142857,0.8468841915553781,1.0,6/11,21.07%,ATG9B;WDR45B;ATG9A;WIPI2;PACS2;MFN2
prerank,positive regulation of cell differentiation (GO:0045597),-0.25944736516554856,-1.1942372319624734,0.0234375,0.6103779665338513,1.0,50/237,12.30%,RANBP3L;IGF1;PLCB1;RAPGEF2;KITLG;CDON;SOX5;PRKCH;MEF2C;LEF1;BOC;IL18;FOXC1;CCN2;NBL1;MEF2A;SLC6A6;NFKB1;BMPR2;IGFBP3;KDR;RAP1A;CDS1;TGFB2;WNT4;DAB2;CD34;IL6ST;MAPK9;CDC42;MAPK14;BNIP2;NGF;CCN1;PKDCC;ACVR1;ACVRL1;SMAD3;IFITM1;SFRP1;CCN4;SPAG9;VHL;NPNT;BCL9L;RPS6KA1;MDK;HEYL;RBM4;CEACAM1
prerank,cell part morphogenesis (GO:0032990),-0.4685374881993225,-1.1941513398942736,0.2511013215859031,0.6095660924836303,1.0,2/13,2.52%,MTM1;PACSIN2
prerank,endoderm formation (GO:0001706),0.41570225135401023,1.1940772173536722,0.24042879019908117,0.846536515336913,1.0,7/35,8.64%,LAMB1;ITGAV;COL7A1;ITGB5;DUSP1;COL12A1;COL4A2
prerank,tRNA 5'-end processing (GO:0099116),0.4917032362314357,1.1940541182325806,0.2470389170896785,0.8451373029180808,1.0,8/15,23.78%,RPP40;POP5;PRORP;POP7;RPP21;POP4;TRMT10C;SSB
prerank,peptidyl-glutamic acid modification (GO:0018200),0.45157579836138795,1.1931527277539073,0.22899505766062603,0.8469170101235226,1.0,6/24,14.60%,NAA10;TTLL6;GGCX;AGBL4;TPGS1;VKORC1L1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.46621930346592577,-1.1923765562129256,0.24608501118568232,0.6132332917362463,1.0,5/12,25.14%,TNKS2;PARP10;PARP1;PARP2;PARP12
prerank,protein targeting to mitochondrion (GO:0006626),0.38465195794240825,1.1922456513966744,0.2211267605633803,0.8486783705714239,1.0,19/52,24.45%,TIMM10;DNAJC19;IMMP2L;PMPCA;PITRM1;TIMM44;AGK;DNAJC15;PAM16;HSPA4;IMMP1L;GRPEL1;TIMM21;MFN2;GDAP1;CHCHD4;FIS1;TOMM34;SAMM50
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.41119058283167537,1.1919477945323937,0.22427035330261136,0.8482511829914722,1.0,7/34,10.09%,PDGFRA;PIK3R1;PIK3R2;IRS1;PTK2;PRKD1;FGR
prerank,skeletal system development (GO:0001501),0.33458561627977623,1.1916779775195367,0.1652593486127865,0.8476878012230009,1.0,44/148,20.87%,COL13A1;CHD7;SULF1;TRPS1;COL10A1;WNT5A;ANKRD11;FGFR1;VCAN;GJA1;TBX3;SOX6;ZBTB16;CDH11;CREB3L2;HAPLN2;COL1A2;ALX4;PAPSS2;P3H1;BMP7;TGFBR1;SOX9;IGF2;BGLAP;ATP7A;TRIP11;EVC;HAPLN3;FBN1;HAPLN1;FGFR2;STC1;PTGER4;FRZB;BMP2;HHIP;EIF2AK3;DDRGK1;TRAPPC2;BMP5;PLS3;CMKLR1;RAB33B
prerank,inorganic anion transport (GO:0015698),-0.3226797809727527,-1.190812589437427,0.15673981191222572,0.6164400529944143,1.0,8/53,4.04%,CLIC4;SLC13A4;SLC4A10;ANO6;XPR1;SLC26A7;ANO1;SLC26A11
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.3673503862009117,-1.1907277653833264,0.21635883905013192,0.6155983713451614,1.0,13/29,24.22%,CAV1;THBS1;TNFSF10;WWOX;SFRP1;RET;BID;CYLD;GPER1;PAK2;AGT;BCL10;HYAL2
prerank,regulation of cellular response to heat (GO:1900034),-0.30474515227832827,-1.1903334486958925,0.17012448132780084,0.6156305659606934,1.0,22/77,15.99%,PTGES3;CAMK2D;HSPA8;HSPH1;CD34;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;ATR;CAMK2G;NUP98;NUP153;BAG3;ATM;NUP43;HIKESHI;RAE1;NUP205;SIRT1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.44450538612245705,-1.1901818055098148,0.23130841121495327,0.6149380996884528,1.0,9/15,17.67%,BTG2;TENT4A;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;AGO2
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3455916581452196,-1.1901601529985608,0.17647058823529413,0.6139289180883558,1.0,19/38,28.33%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;RHNO1;YAF2;BMI1
prerank,response to hydrogen peroxide (GO:0042542),-0.33456077508974535,-1.1901103228068208,0.16326530612244897,0.6130442609216954,1.0,21/45,27.34%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;CAT;GPX1;STK25;ANKZF1;PRKCD;SIRT1;PRDX3;APTX;TNFAIP3;ADAM9;HDAC6;PPIF;OSER1;PARK7;ECT2;RHOB
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3931977065202099,1.1898225571191106,0.21568627450980393,0.8528066754211414,1.0,4/42,5.33%,XCL1;CXCL10;CXCL1;CCL15
prerank,sphingosine metabolic process (GO:0006670),-0.43532257955798764,-1.1896801740342164,0.24806201550387597,0.6130742626429101,1.0,4/17,4.52%,SPTLC2;PLPP3;ACER2;ACER3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3392511490700576,1.189679506992438,0.17565872020075282,0.8518348045630142,1.0,28/125,15.81%,DYNLL1;BUB1B;CENPU;EFHC1;DCTN2;SGO1;CENPE;SUN2;GPSM2;NSL1;PTPA;TBCE;SPDL1;RCC1;NUSAP1;RMDN1;CENPC;INCENP;CEP126;NUP107;EML1;BUB1;STMN1;DYNLL2;CLASP2;KIF2A;CENPF;CLASP1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.43950370343489376,1.1893182843009795,0.24143556280587275,0.8516293766049986,1.0,14/25,28.99%,HTATSF1;SETD5;ZNF326;EAF2;CCNK;THOC5;LDB1;KAT7;DDX39B;CCNT2;EAF1;ELL;WDR43;HMGN1
prerank,regulation of cell aging (GO:0090342),-0.47832250444027236,-1.188588886355307,0.24608501118568232,0.6148734779863297,1.0,6/11,26.03%,NEK6;LMNA;VASH1;MIF;PNPT1;RSL1D1
prerank,zinc ion transmembrane transport (GO:0071577),0.45453999886745655,1.1885834113466833,0.23986486486486486,0.8527077965133041,1.0,7/22,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A13;SLC39A14
prerank,zinc ion transport (GO:0006829),0.4536600894592409,1.187572575554772,0.2683333333333333,0.8548969440944891,1.0,7/21,17.97%,SLC30A10;SLC30A5;SLC39A7;SLC30A3;TRPM2;SLC39A13;SLC39A14
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.39309573752341287,-1.187449041014853,0.23645320197044334,0.6169158400703397,1.0,6/22,17.38%,PTPRJ;EZR;PTPN2;CEACAM1;DGKZ;LAPTM5
prerank,multivesicular body organization (GO:0036257),-0.3690675532918841,-1.1872397765484497,0.18282548476454294,0.6164202135974652,1.0,14/31,28.52%,VPS37A;CHMP2B;VPS37B;IST1;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;VPS28;VPS36;CHMP4C;CHMP2A;RAB11A
prerank,ribosome biogenesis (GO:0042254),-0.26256051560346383,-1.1867874002928658,0.07352941176470588,0.6166000618823408,1.0,86/187,30.70%,RPS14;RPS9;RPS16;RPLP1;RPL13;RPL27A;RPS2;RPL37A;RPL5;RPL8;FCF1;RPS7;RPL41;DDX52;RPS19;RPS24;RPS27;RPS15;RPL21;PDCD11;RIOK1;RPL10;RPL35A;DDX27;RPL10A;RPL11;RPL36A;RPL34;RPLP2;ESF1;UTP3;RPL32;RPL4;RPLP0;RPL30;RPL26;NOLC1;RPL29;EXOSC2;RAN;RPL31;IMP3;EXOSC3;RPL23A;RPL19;RPL36;WDR12;PES1;NIP7;NPM1;PAK1IP1;LAS1L;RPL17;RPL23;NOL11;SENP3;EXOSC1;RRP12;UBA52;GTF3A;GLUL;WDR74;PWP2;RPL15;RPL38;MRM2;LTV1;LSG1;RPF2;MRPL36;RPL13A;EXOSC4;RPS25;LTO1;RPL24;RPL18A;WDR75;RRP36;NOP16;BMS1;EIF2A;PIH1D2;NOP53;RRP9;WDR46;RPL22
prerank,regulation of cholesterol esterification (GO:0010872),-0.4994674375745968,-1.1867601713719242,0.2727272727272727,0.6156316133167872,1.0,4/10,20.22%,APOE;STARD4;AGTR1;AGT
prerank,microtubule depolymerization (GO:0007019),0.48029003741342924,1.1865729750845058,0.2711571675302245,0.8569003851320828,1.0,6/17,15.36%,NCKAP5L;STMN2;CCSAP;STMN4;STMN1;KIF2A
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.44554981377500247,-1.1864346818638503,0.25925925925925924,0.6155226103547679,1.0,10/16,28.49%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;AOAH;PHKA2;PHKG2;PYGL
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5358076021698959,1.1861424188000271,0.26017699115044246,0.8569059147673421,1.0,6/11,27.34%,REST;PINK1;NONO;HIF1A;ATF4;NR4A3
prerank,regulation of cell motility (GO:2000145),-0.27690998819030727,-1.1859489125439309,0.10204081632653061,0.6158203780378266,1.0,37/121,18.66%,PLXNA2;LMO4;ROCK2;CAVIN1;PLXNA4;EGFR;SPOCK2;NTN1;DIAPH1;AMOT;MINK1;RAC1;INPP5F;CDK6;PRAG1;FGF1;PLXNB1;FRMD5;ARHGAP18;ENPP2;SPATA13;ROBO4;LMNA;CEACAM1;AMOTL2;FLNA;MACF1;SERPINE2;TMSB4X;PLXNA1;PKN2;CCDC25;ERBB2;AKT1;EGF;SPINT2;ERBB3
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.27028937833659294,-1.1858907394448983,0.09659090909090909,0.6149418271823206,1.0,36/150,12.75%,PRKAG2;SMAD6;PPM1E;CAV1;OCLN;SLIT2;PLPP3;TRIB2;DEPTOR;SIRPA;PARD3;IGFBP3;PRKDC;NIBAN1;DVL1;ERRFI1;NCK1;CEP85;CALM1;PPM1F;MVP;SNX25;XDH;PRR5L;LRP6;ITGB1BP1;YWHAG;DMD;SFRP1;PPEF2;EPHB2;TARDBP;HSPB1;CEACAM1;SPRED3;PRKCZ
prerank,protein localization to plasma membrane (GO:0072659),-0.2775684699677172,-1.1858651877104562,0.10160427807486631,0.613997353383865,1.0,27/129,9.20%,TSPAN5;RAPGEF2;ROCK2;ACTN2;BSG;AFDN;RAPGEF6;EZR;CDH1;F11R;RDX;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;PACS1;RAMP1;TTC7B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;TTC7A
prerank,sensory perception of taste (GO:0050909),0.5401778761598551,1.1858072698798314,0.27060931899641577,0.8565935838557145,1.0,2/10,7.39%,ASIC2;ASIC1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4960523275915133,1.1852649722314574,0.26573426573426573,0.8570807802907271,1.0,2/14,4.72%,ACOX2;CRAT
prerank,protein-containing complex assembly (GO:0065003),0.31423392039267417,1.1849494866824335,0.13125695216907676,0.8567290646758425,1.0,75/259,19.85%,SEC16B;LAMC1;WIPF1;TEAD1;HDAC1;PPID;TCF7L2;CD40;COL7A1;PYGO1;SEC16A;EPRS1;RSPH9;GRIA1;TEAD2;KMT2A;VAMP2;FANCA;PPIH;BCL9;LRRK2;TLE2;NOL3;SLC9A1;LLGL1;ADCY8;CAPN3;COL16A1;WASF3;TRAPPC2L;MDM4;GOLGA2;KIFAP3;OPA1;TLE1;IL1RAP;F8;SEC24B;DNAJB12;PPP6C;GSDMD;TP53;RIMS1;SCFD1;DLG4;WDCP;MCFD2;SOX9;TUBGCP4;CAND1;AXIN1;RIPK1;FERMT2;TFAP4;DHX9;AREG;MYC;DET1;PDZD11;FERMT3;TRAPPC10;PPP6R3;SEC24A;DNAJB14;SEC23A;ASH2L;TSPAN4;MDN1;PEX14;TBC1D20;ST13;CNIH3;TRAPPC2;TRAPPC5;CDC73
prerank,positive regulation of histone modification (GO:0031058),-0.35852990434092546,-1.184727638471381,0.19533527696793002,0.6160573647974502,1.0,13/33,25.88%,GLYR1;RPS6KA5;SAP30BP;AKAP8;NOS1;UBE2N;CDK9;ZBTB7B;TADA2B;RUVBL2;APLNR;KDM1A;BRCA1
prerank,regulation of fibroblast migration (GO:0010762),-0.4058200029595955,-1.184527673397748,0.24310776942355888,0.6155511459092196,1.0,9/20,24.22%,ITGB1;THBS1;RAC1;PRR5L;ITGB1BP1;HAS1;RFFL;DMTN;HYAL2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5467384453225785,1.1835856810086063,0.28545780969479356,0.8601063474344157,1.0,2/10,4.06%,ABCD2;NR1H2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.33273068061140676,1.1825322147790622,0.17490952955367914,0.8622197995899314,1.0,22/142,11.67%,PDGFRA;PTGFR;ADCY5;ATP1A2;WNT5A;C5AR1;P2RY1;ACKR2;CCR9;RYR2;ADCY8;CALCA;C1QTNF1;CALB1;LPAR3;TRPC3;PRKACA;CCKBR;LPAR1;DLG4;IAPP;TRPC7
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.3147466041918632,-1.1824892191636307,0.17845117845117844,0.6198906959570788,1.0,23/55,27.96%,THBS1;CYP1B1;RAC1;MAPK14;XDH;RNF41;AGTR1;GRB2;CDKN1A;ACE2;PID1;SIRT5;MPV17;AGT;ROMO1;TGFBR2;SPHK2;MT3;CBR1;BRCA1;NOXO1;GADD45A;ARF4
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.3909860834128782,-1.181784417053393,0.23848238482384823,0.6206695920908387,1.0,10/25,25.16%,EPHA4;PSMF1;RPL5;RPS7;RPL11;HIPK2;HFE;RPL23;TRIM39;ALAD
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3942946649093751,1.1817736244967367,0.2383808095952024,0.863319983528496,1.0,10/40,15.90%,CCDC22;PTEN;GLMN;PDCL3;PTK2;COMMD1;AXIN1;CLU;ARAF;CSNK2A2
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3486101664451702,-1.1817551661886379,0.19584569732937684,0.6197006587013635,1.0,18/36,28.33%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;RBBP7;E2F1;PCGF2;APAF1;RNF2;RAD51;BRCA1;CHEK1;YAF2;BMI1
prerank,regulation of neuron differentiation (GO:0045664),0.3594244932325607,1.1816466325481203,0.22418478260869565,0.8622968869624233,1.0,18/76,18.46%,ZEB1;ZFHX3;TCF4;FGFR1;REST;LRRK2;CNTN4;BEND6;SOX2;BMP7;MED1;NRCAM;IMPACT;BRINP1;CALR;BMP2;HEY1;RHOA
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.26984299852101246,-1.1812216081546414,0.08904109589041095,0.6199936381208426,1.0,44/152,16.13%,RSPO3;WNT5B;CAV1;EGFR;XIAP;NFKB1;RNF146;SMARCA4;CSNK1D;PSMC6;PSMD9;RSPO2;KANK1;TBL1X;SKI;PSMF1;GPC3;PSMB7;LGR4;SULF2;WNK1;WLS;SOX4;TNKS2;VCP;SMURF2;PSMD8;PSMD12;SFRP1;GID8;TERT;PSMA3;DKK2;PSMA6;PSMD4;CSNK1G3;PSME3;MACF1;PSMD7;PSMB6;PSMC1;FAM53B;ATP6AP2;PSMB10
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.39690019182626657,1.1807289133916616,0.2273381294964029,0.8640464384929678,1.0,9/43,6.88%,PPARA;TEAD1;GNL3;NFATC3;NGFR;PPARD;REST;FOS;SRF
prerank,cytoplasmic translational initiation (GO:0002183),-0.4226106477125129,-1.1804738516329243,0.24154589371980675,0.6209871665469276,1.0,6/17,16.94%,EIF5;EIF2S2;MCTS1;RBM4;EIF3D;EIF4H
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.43672064477024225,1.1804488871293972,0.24881141045958796,0.8635216517524825,1.0,13/26,23.89%,GPR37L1;REST;LRRK2;NOL3;PYCR1;PINK1;FYN;HTRA2;GPR37;PDE8A;BAG5;MAPK7;ATF4
prerank,protein catabolic process (GO:0030163),-0.32011691700623807,-1.1800887087731111,0.17424242424242425,0.6210154157773614,1.0,25/59,25.43%,DDI2;UBE2G1;HSPA8;DENND3;TRIM24;OGA;APOE;VCP;MANBA;NGLY1;RNF41;CEACAM1;CLPX;CLN5;USE1;SIAH2;LAMP2;CLN8;STT3B;PRPF19;RNF5;PSMA8;CLN6;TPP1;CHEK2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.36912583907744156,-1.1800712033010998,0.1952662721893491,0.620033857588735,1.0,15/29,40.32%,TPM1;S1PR1;NOTCH1;TGFBR3;PKP2;SMAD7;FKBP1A;TTN;TNNC1;TNNI3;TBX20;NOG;TCAP;MYL3;MYH6
prerank,fluid transport (GO:0042044),-0.4608777779803367,-1.1799033524389624,0.2644230769230769,0.6194908062206215,1.0,8/12,53.64%,PDPN;SLC26A6;AQP11;AQP1;SLC4A11;AQP9;AQP6;AQP7
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.4297132907580953,-1.1798863582235677,0.24111675126903553,0.6185047935444713,1.0,4/16,4.38%,DDX5;RBFOX2;PPARGC1B;NCOA4
prerank,cGMP biosynthetic process (GO:0006182),-0.49500521167556927,-1.1797567419976303,0.29130434782608694,0.6178167056695572,1.0,4/10,27.99%,GUCY1A1;NPR1;GUCY2C;GUCY1B1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.38958422600133324,1.179362725432024,0.22189349112426035,0.8659627509811385,1.0,11/43,12.54%,ENPP1;OGT;PIP4K2A;SORL1;IRS1;RPS6KB1;PRKCB;TNS2;ERFE;IGF2;GSK3A
prerank,xenobiotic transport (GO:0042908),-0.4259296185911499,-1.1793546329884186,0.2375,0.6178806125109103,1.0,6/17,10.68%,ABCG2;SLC47A1;SLC22A4;ABCA3;SLC22A18;SLC7A5
prerank,visual perception (GO:0007601),0.35230319793795317,1.1784195085802958,0.23423423423423423,0.8679158917139765,1.0,7/84,3.76%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,ERBB signaling pathway (GO:0038127),0.3685016667357083,1.1779305859959088,0.22641509433962265,0.8682103680362108,1.0,13/64,13.05%,PIK3R1;NRG1;SLC30A10;ERBB4;PTPRR;NRG2;PDPK1;NRG4;PTK2;PRKCA;SOX9;CUL5;GAREM1
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.32828000506723115,1.1775396529631856,0.16568742655699178,0.868111994743302,1.0,43/161,18.28%,TBX18;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CHD8;AMER2;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LZTS2;PSMA2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4984579796383931,1.1773690357761324,0.26678765880217786,0.8672505172632957,1.0,3/14,6.25%,GPLD1;IRS1;IRS2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.5217146030128387,1.1772091393884836,0.28390596745027125,0.866375890906009,1.0,6/10,22.12%,CDC7;WIZ;CDT1;DBF4;SSBP1;ATRX
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.4370311661894113,-1.1762108245414358,0.26150121065375304,0.6251517140781427,1.0,5/15,7.89%,RAI2;RICTOR;TGFB2;STOX2;CELF1
prerank,mammary gland development (GO:0030879),0.45978929610697405,1.1761148141945927,0.2546689303904924,0.8687383086016112,1.0,5/21,12.48%,NRG1;ERBB4;TBX3;WNT3;ARHGAP35
prerank,calcium-mediated signaling (GO:0019722),0.3461564990530121,1.1760132921009483,0.22018348623853212,0.8676927322463587,1.0,20/93,11.66%,PTGFR;ACKR2;CCR9;RYR2;PDPK1;PPP1R9A;HTR2B;CAMKK2;LRRK2;STIMATE;ATP2A2;SLC9A1;PRKACA;ADGRL1;KSR2;PPP3CB;GRM5;RCAN3;P2RX4;TRPM2
prerank,regulation of embryonic development (GO:0045995),-0.35424004230575024,-1.1758340835764998,0.21629213483146068,0.6251625843983989,1.0,9/34,11.50%,PHLDB2;PLCB1;INSR;B4GALT5;TRIP12;SOX17;CFL1;NIBAN2;DAG1
prerank,negative regulation of blood pressure (GO:0045776),-0.45263230327660786,-1.1757565550749176,0.26401869158878505,0.6243359352453001,1.0,4/13,12.68%,NOS3;BMPR2;SCPEP1;NOS1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.34632462644283724,-1.1756106229250405,0.22551928783382788,0.6236418859101707,1.0,10/36,18.04%,MECOM;FOXO1;EZR;SIRPA;SH3RF2;HDAC3;CYLD;PPIA;PER1;DLG1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.39345916617014187,1.1751682684061509,0.23580786026200873,0.8693606948382103,1.0,10/46,9.97%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,phospholipid biosynthetic process (GO:0008654),-0.35356484195452015,-1.1751116776324593,0.2215568862275449,0.6239530114741942,1.0,14/36,29.94%,SGMS1;MBOAT1;SGMS2;AGPAT4;CPNE3;FDPS;NUS1;PIP5K1A;DOLPP1;SPHK2;FITM2;AGPAT5;SAMD8;MVD
prerank,tryptophan metabolic process (GO:0006568),0.5217471189462642,1.1749334420542399,0.3053016453382084,0.8687272280846804,1.0,3/11,17.55%,KYNU;ATP7A;KMO
prerank,regulation of cation channel activity (GO:2001257),0.34835718841194724,1.1745299479735591,0.21059431524547803,0.8687144061733302,1.0,20/89,11.37%,KCNS2;GRIA3;GRIN2B;CACNG3;GRIA4;GRIA1;DLG3;ANK3;VAMP2;DLG2;GRIN2A;KCNG1;KCNAB1;RELN;PRKACA;CACNB4;CACNG4;SHISA6;FGF12;DLG4
prerank,ceramide transport (GO:0035627),-0.4683539162600835,-1.174514253022454,0.27586206896551724,0.6243743671210523,1.0,5/12,20.98%,CERT1;PLTP;ABCB4;PSAP;GLTP
prerank,negative regulation of wound healing (GO:0061045),-0.3605568152610257,-1.1744203283763721,0.23746701846965698,0.6236008664459196,1.0,7/28,9.85%,PHLDB2;THBD;VTN;CD34;CD109;APOE;SERPINE1
prerank,peroxisome organization (GO:0007031),0.4429622140676186,1.1743625269907425,0.2623762376237624,0.8678244024542076,1.0,10/25,18.90%,SEC16B;ABCD2;PEX2;PEX7;PEX11A;PEX19;PEX12;PEX3;PEX14;PEX6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.3757067906707468,1.1741453130315798,0.24182076813655762,0.8671145123431092,1.0,22/52,22.83%,RBFOX1;TRA2B;NOVA1;RBM24;REST;FMR1;KHDRBS3;WTAP;CELF4;SMU1;DDX17;RBFOX3;ZBTB7A;RBM5;HNRNPL;SRSF6;KHDRBS1;FXR1;RBM15;RBM25;SRSF12;CELF6
prerank,T cell mediated immunity (GO:0002456),-0.4494950019772591,-1.1741407705325841,0.25471698113207547,0.6233419880493123,1.0,5/13,20.48%,CD55;CTSH;GNL1;BTN3A3;CD46
prerank,positive regulation of transmembrane transport (GO:0034764),-0.458999173411196,-1.1736416200150124,0.2576112412177986,0.6236093032062014,1.0,5/13,18.42%,ANO6;AZIN1;P2RX7;ACSL5;SLC26A6
prerank,maturation of LSU-rRNA (GO:0000470),-0.3834582774775665,-1.1735690474321694,0.232,0.6227946081659103,1.0,11/26,27.54%,NSA2;RPL10A;NIFK;WDR12;PES1;RRP15;LAS1L;NOP2;RSL1D1;RPF2;NHP2
prerank,mitotic cytokinetic process (GO:1902410),-0.40693480154940886,-1.173139140968059,0.233502538071066,0.6229255166506233,1.0,14/20,38.37%,CHMP2B;MITD1;KLHDC8B;CHMP4B;CHMP4A;CHMP7;PDCD6IP;CHMP1A;CHMP4C;CHMP2A;CHMP6;VPS4A;KIF20A;CHMP3
prerank,axon extension (GO:0048675),-0.38347778950955563,-1.1729873445056542,0.2178477690288714,0.6223729674287725,1.0,4/23,2.72%,ALCAM;SLIT2;NRP2;NRP1
prerank,regulation of cellular component size (GO:0032535),-0.3622078604422667,-1.1729525996799022,0.21467391304347827,0.6214602487510344,1.0,7/30,8.25%,PICALM;EZR;RDX;RIN3;RAP1GAP2;RAC1;LAMTOR5
prerank,positive regulation of signal transduction (GO:0009967),-0.2506375786422541,-1.1729171952501858,0.06896551724137931,0.6205285218484162,1.0,60/238,16.38%,SORBS1;TSPAN5;IGF1;VWF;TEK;LIMS2;RBPJ;RSPO3;ROBO1;MAML2;NOS3;TPD52L1;SHANK3;NRP1;SMARCA4;VPS35;FAS;JCAD;NOTCH1;RSPO2;TGFB2;VTN;KANK1;CCN3;SKI;SMO;GRB10;SULF2;IL6ST;CAV2;CRADD;KLF2;EPN2;WLS;SHANK1;CCBE1;FGF1;ITGB1BP1;CITED2;SFRP1;BAX;TRIM16;MYO1C;CD63;DLG5;ITGB3;TERT;PRKCZ;TTC23;GKAP1;FLNA;MACF1;PTK2B;CDKN2AIP;ERN1;ESM1;SIRT1;ATP6AP2;GPER1;ING5
prerank,positive regulation of TOR signaling (GO:0032008),-0.3365445103035087,-1.1729062951221723,0.21604938271604937,0.6195599389589025,1.0,12/40,19.47%,FNIP1;RICTOR;SIK3;LAMTOR5;RRAGC;CLEC16A;PIP4P1;HDAC3;LAMTOR3;GPR137;SEH1L;RRAGB
prerank,telomere maintenance via telomere trimming (GO:0090737),0.5299573489208824,1.1728472439920772,0.2846580406654344,0.8674139819345407,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,t-circle formation (GO:0090656),0.5299573489208824,1.1728472439920772,0.2846580406654344,0.8674139819345407,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.5299573489208824,1.1728472439920772,0.2846580406654344,0.8674139819345407,1.0,4/10,18.07%,ERCC1;TERF1;SMARCAL1;WRN
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.343974416494729,1.1725802908847625,0.19946808510638298,0.8669283648906764,1.0,10/101,6.08%,CEMIP;IL34;EDN3;WNT5A;CD40;FGFR1;HTR2B;LRRK2;MTCP1;PSMD10
prerank,cellular defense response (GO:0006968),0.39461920927933003,1.1723640774429436,0.22840409956076135,0.866267192200286,1.0,5/40,5.63%,ADORA2B;CLEC5A;C5AR1;CCR9;ADORA2A
prerank,vesicle coating (GO:0006901),0.3754219091299762,1.1723018846606676,0.2356164383561644,0.8622182087294696,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,COPII vesicle coating (GO:0048208),0.3754219091299762,1.1723018846606676,0.2356164383561644,0.8622182087294696,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3754219091299762,1.1723018846606676,0.2356164383561644,0.8622182087294696,1.0,20/61,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;PPP6C;SCFD1;MCFD2;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,neuropeptide signaling pathway (GO:0007218),0.3673731045693449,1.1722839035118793,0.21584699453551912,0.8608778132549062,1.0,11/58,16.07%,RXFP3;SORCS3;PDYN;SORL1;NPY;GLRA3;GLRA1;GLRA2;NMU;GLRB;GPR37
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.29687237315929227,-1.1720281577516731,0.15384615384615385,0.6209806171692336,1.0,23/86,18.28%,RBPJ;THBS1;BMPR2;FOXD1;NOTCH1;TGFB2;DAB2;GIPC1;CCN1;ACVR1;ACVRL1;CITED2;SH2B1;HIPK2;CDH5;TGFB1I1;GDF11;HFE;ACVR2B;TWSG1;CSNK2B;SOX11;SDCBP
prerank,regulation of cellular pH (GO:0030641),-0.36621607179059745,-1.171822161735812,0.20754716981132076,0.6204912819234882,1.0,9/29,18.67%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;LACC1;SLC4A8;SLC9A5;SLC26A6;SLC9B1
prerank,nuclear membrane organization (GO:0071763),-0.4051185747427139,-1.1716998249896295,0.24932975871313673,0.6198111005659712,1.0,12/19,36.77%,TARDBP;TOR1A;GPER1;CHMP4B;CHMP7;TOR1AIP1;EMD;CHMP2A;UBXN2A;NSFL1C;VPS4A;PLK1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.4341671646312757,1.1714177630154767,0.2659235668789809,0.8625628140375264,1.0,6/23,12.54%,PPARA;PFKFB1;CBFA2T3;GCK;ERFE;GSK3A
prerank,cellular response to copper ion (GO:0071280),-0.4248733699008151,-1.1713699814740741,0.2620192307692308,0.6196797269716728,1.0,12/16,37.34%,MT2A;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;HSF1;AQP1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.47558078372784907,1.171281917988063,0.2569444444444444,0.8616095938272132,1.0,7/16,18.60%,MCM7;RPA1;MCM4;RECQL;MCMDC2;WRN;SSBP1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.43108714908955403,-1.1712635741810646,0.26024096385542167,0.6189832527661112,1.0,6/17,18.80%,COX15;COX6C;COX5B;AFG1L;COX4I1;COX6B1
prerank,protein localization to chromatin (GO:0071168),-0.410042577127611,-1.1712278922755848,0.24096385542168675,0.6180955371700103,1.0,8/18,28.38%,PPHLN1;ESR1;CHMP7;MCM9;RUVBL2;MCM8;MSH2;SGF29
prerank,negative regulation of axon extension (GO:0030517),-0.3648871248961212,-1.1710201908751052,0.21082621082621084,0.617606834982235,1.0,14/30,28.07%,SEMA3D;SEMA3C;SEMA7A;SEMA6A;SEMA4B;SEMA5B;SEMA6C;SEMA3G;SEMA6B;RTN4;MT3;SEMA3F;RTN4R;RNF6
prerank,regulation of actin filament-based process (GO:0032970),0.36307107018519474,1.1707934175444918,0.22589531680440772,0.8619080282984816,1.0,9/70,4.55%,DLC1;LRP1;RND3;HRG;GPM6B;IQGAP3;CORO2B;FSCN1;RAC3
prerank,negative regulation of transposition (GO:0010529),-0.4291324984209891,-1.1706679519253467,0.23515981735159816,0.6175664021236409,1.0,4/16,11.78%,TUT7;MYBL1;TEX15;UBR2
prerank,endocrine system development (GO:0035270),-0.3876684286335146,-1.1700548814143181,0.2540106951871658,0.6181391012665367,1.0,9/21,18.76%,DKK3;WNT4;GLI2;SIX1;TBX1;MDK;STRA6;HOXD3;WNT11
prerank,positive regulation of RNA splicing (GO:0033120),0.41738946604805044,1.169948514178474,0.24186046511627907,0.8634012772022653,1.0,8/29,17.90%,PIK3R1;TRA2B;PRDX6;CELF4;SNW1;RBM20;HNRNPLL;HABP4
prerank,regulation of viral transcription (GO:0046782),-0.32984269003952577,-1.1696510692868793,0.1974921630094044,0.6182019171680709,1.0,17/39,29.49%,TRIM11;IFITM3;TRIM14;POLR2B;POLR2H;POLR2G;POLR2C;TRIM27;UBP1;CDK9;NELFCD;HEXIM1;GTF2F2;CTDP1;POLR2I;POLR2K;MID2
prerank,positive regulation of biosynthetic process (GO:0009891),0.3978687125465034,1.1692237055909893,0.24774774774774774,0.8645081767119545,1.0,10/40,9.80%,ZBTB20;PPARA;TLR6;MTPN;LARP6;ADGRB1;AMELX;MTOR;TLR4;CYBA
prerank,protein localization to lysosome (GO:0061462),0.423995597095811,1.1691452280345835,0.25862068965517243,0.8633822724478445,1.0,8/28,12.94%,SORL1;NEDD4;SZT2;SNX16;AP3M1;RNF128;HGS;CD81
prerank,regulation of interleukin-6 production (GO:0032675),0.34335133621150943,1.1690689589820245,0.22804718217562253,0.8622221050212865,1.0,13/96,10.90%,IL33;WNT5A;IL16;TSLP;PTPN22;TLR6;TLR8;TWIST1;CD200R1;MBP;TLR4;CYBA;PYCARD
prerank,cellular response to estradiol stimulus (GO:0071392),-0.41304215088675256,-1.16892941881651,0.25,0.6191419491098132,1.0,8/18,21.30%,EGFR;LCOR;SFRP1;KAT5;GPER1;ESR1;CCDC62;RUVBL2
prerank,autonomic nervous system development (GO:0048483),-0.4128449342128499,-1.168462548249181,0.2623762376237624,0.6193261676197279,1.0,4/17,10.02%,FN1;NRP1;SOX4;PHACTR4
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5100790653400368,1.168394587031184,0.2948717948717949,0.8630509557776431,1.0,1/11,0.79%,XCL1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.45191148680284265,-1.1678728248813606,0.24700239808153476,0.6198456019941112,1.0,5/12,26.93%,TMEFF2;AP2A1;EDN1;SELENOS;TAF7
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4096524976078727,1.1678447582529394,0.2484375,0.8636239627074271,1.0,2/33,1.89%,APOD;PTEN
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3877486631938714,-1.1675695110054964,0.2394736842105263,0.618662878639896,1.0,9/23,26.15%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3877486631938714,-1.1675695110054964,0.2394736842105263,0.618662878639896,1.0,9/23,26.15%,THBS1;DAB2;GIPC1;CITED2;HIPK2;TGFB1I1;SDCBP;RNF111;SMAD4
prerank,secretion (GO:0046903),-0.4496794116002284,-1.1674515147317008,0.27842227378190254,0.617972298296782,1.0,4/14,9.38%,TPD52;SLC22A4;SLC22A6;NPR1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.33079825259611223,1.1673558232322494,0.19875776397515527,0.8639772698134971,1.0,20/117,11.03%,GGT5;ADH1A;PPARA;SLC6A8;ACSF2;PPARD;MCCC1;KYNU;GRHPR;ACADSB;ABAT;ECHDC3;MTHFD1L;PER2;FA2H;PDHX;CKM;HOGA1;GAMT;ACOT7
prerank,regulation of transferase activity (GO:0051338),-0.41004987611609595,-1.167282356817615,0.2560386473429952,0.6174022320342518,1.0,6/17,20.35%,HMBOX1;SMG6;ATM;NLRC5;PARP4;JMJD8
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.3998627674833219,1.1671839524684797,0.25748502994011974,0.8631651850591333,1.0,10/37,16.58%,ENTPD2;RNASEH2C;ENTPD5;NUDT9;MTREX;RNASEH2B;ENTPD7;HNRNPD;RNASEH1;PPP1R8
prerank,regulation of platelet aggregation (GO:0090330),-0.4130550846384746,-1.1670249559169807,0.26401869158878505,0.6171031978516194,1.0,10/17,25.17%,F11R;CEACAM1;PRKG1;SERPINE2;PRKCD;PDPN;CD9;ALOX12;DMTN;ADAMTS18
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.3826327762572688,-1.166713699448492,0.24396782841823056,0.6169192046281735,1.0,11/24,29.54%,CAMK2D;SRI;CALM1;DMD;JPH1;NOS1;JPH2;GSTO1;CASQ2;FKBP1A;JPH3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.40839860262816274,1.1665223970713827,0.2679938744257274,0.8640457012230421,1.0,10/32,23.10%,LPIN3;CHAT;CHKA;STARD10;LPIN2;CSNK2A2;SLC44A1;PCYT1A;ABHD3;SLC44A5
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4952038855205454,1.1663751429181168,0.2972972972972973,0.8631693836004091,1.0,5/13,14.93%,WNT5A;TSLP;AXL;TRIM44;DHX9
prerank,mitotic spindle organization (GO:0007052),0.32726953583582125,1.1661990842300243,0.1890909090909091,0.862397156277224,1.0,34/153,15.81%,DYNLL1;BUB1B;CENPU;CCDC61;LSM14A;EFHC1;AAAS;DCTN2;SGO1;CENPE;SUN2;GPSM2;GOLGA2;CEP192;NSL1;PTPA;TBCE;SPDL1;RCC1;RMDN1;CENPC;INCENP;CEP126;NUP107;EML1;BUB1;MAP9;STMN1;DYNLL2;CLASP2;KIFC2;KIF2A;CENPF;CLASP1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.455252092302292,1.165403158421196,0.28821656050955413,0.863816407931892,1.0,4/19,9.78%,CORO2B;CCT5;CEP295;CEP135
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4947028821368544,-1.1650870027921434,0.2863741339491917,0.6201728460669617,1.0,5/11,21.49%,VCPIP1;STX18;VAPB;ARL6IP1;RTN4
prerank,dendritic spine organization (GO:0097061),0.4279312146440638,1.164971387774264,0.265139116202946,0.8639281242239403,1.0,7/26,11.37%,DOCK10;PTEN;EPHB1;ITGA3;LGMN;FYN;DLG4
prerank,cyclooxygenase pathway (GO:0019371),-0.4842919660870851,-1.1649243165427745,0.26014319809069214,0.6196086881071409,1.0,3/10,3.06%,PTGDS;PTGS1;PTGES3
prerank,transport along microtubule (GO:0010970),-0.45254933314337625,-1.1647535044063906,0.2641509433962264,0.619109812326593,1.0,10/13,31.52%,APP;CDC42;BAG3;BORCS5;DYNC1I1;SPG11;COPG2;APBA1;CAMSAP3;DYNC1I2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2982154753158294,-1.164725042870045,0.15447154471544716,0.618243484176113,1.0,22/80,12.46%,EPHA4;PICALM;ROCK2;VIM;LARP4;THBS1;ELAVL1;PRKDC;NIBAN1;SAMD4A;SMPD3;LARP4B;RPL5;SIRT3;SOX4;CASP3;PYM1;CPEB3;PLA2G6;RPL26;EIF3D;RPS4X
prerank,eye morphogenesis (GO:0048592),0.4560746672711028,1.1646349876208635,0.27330173775671407,0.8637480813613275,1.0,3/19,5.64%,TENM3;NKD1;NF1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.4749674377901904,-1.164297163783699,0.2882882882882883,0.6183489052107987,1.0,4/11,20.55%,NRP1;RAC1;HGF;MST1R
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.49061515112467174,-1.1641831656519286,0.30068337129840544,0.6176703793117867,1.0,4/10,10.35%,SHANK3;APP;RAB5A;CAMK2B
prerank,positive regulation of growth (GO:0045927),-0.30790411813187724,-1.1637800467047212,0.20676691729323307,0.6177916657521659,1.0,21/64,20.47%,PLCB1;EGFR;INSR;TGFB2;ADAM10;CDC42;PPM1F;HYAL1;SFRP1;INO80;RPS6KA1;EXOSC2;MFSD2A;CDKN2AIP;PABIR1;ZPR1;ERBB2;AKT1;SDCBP;CIB1;LGI1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.45047620584719905,-1.163613073578985,0.2529832935560859,0.6173090140098241,1.0,2/13,3.21%,CAV1;ADRA1B
prerank,cardiac muscle cell differentiation (GO:0055007),-0.3883637485841902,-1.1633279130612755,0.22762148337595908,0.6170681433409808,1.0,7/21,16.47%,MEF2C;CXADR;SIK1;ACVR1;MYH11;CBY1;MYOCD
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.294277350955997,-1.163035300451871,0.17573221757322174,0.6168775230485871,1.0,21/73,16.13%,KITLG;FOXC1;PSMC6;PRKDC;LMO2;PSMD9;RUNX1;PSMF1;PSMB7;PSMD8;PSMD12;GATA2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;TAL1;PSMB6;PSMC1;PSMB10
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5049756811731616,1.1628461883466645,0.30685920577617326,0.8685339602179817,1.0,4/11,15.73%,TLR6;CYBA;LYN;TIRAP
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4079701240280231,1.1627642342928788,0.26403641881638845,0.8674798870660583,1.0,16/34,22.62%,PTPRT;PTPRQ;DUSP1;PTPN22;DUSP22;PTPRO;PTPN13;TNS2;UBASH3B;DUSP8;PTPN18;PTPN11;DUSP10;DUSP6;PTPRZ1;DUSP7
prerank,positive regulation of autophagy (GO:0010508),-0.2909683414086626,-1.1626500914227678,0.11065573770491803,0.6169555564910529,1.0,23/81,16.44%,DAPK1;FOXO1;RNF152;KDR;SESN1;ATF6;PRKAA2;SH3BP4;TRIM5;TRIM14;GSK3B;BAD;PIK3CB;BNIP3L;OPTN;TMEM59;PAFAH1B2;TICAM1;KAT5;TRIM27;SIRT1;PRKAA1;TBK1
prerank,platelet aggregation (GO:0070527),-0.36228114565259917,-1.1623813122219342,0.2415902140672783,0.6167258325867461,1.0,12/33,14.24%,FN1;VCL;ACTB;GNAS;ACTG1;MYL9;CLIC1;PIK3CB;HSPB1;ITGB3;FLNA;PPIA
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3300529637331995,-1.1621526071316126,0.2116564417177914,0.6163736174248429,1.0,12/46,9.64%,MAP3K1;PIEZO2;CASP8AP2;NFKB1;F11R;FAS;CRADD;MAP2K4;CASP2;CASP8;BAD;IRF1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31608430353219685,-1.1620987819168296,0.17716535433070865,0.615579653653906,1.0,18/55,16.13%,FBXL7;FHL1;PSMC6;PSMD9;PSMF1;PSMB7;AVEN;CUL1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;PSMC1;PSMB10
prerank,negative regulation of protein secretion (GO:0050709),-0.3401340318764775,-1.1620343355315301,0.22580645161290322,0.6147748948893231,1.0,12/38,22.57%,CD200;PSMD9;CCN3;APOE;KCNB1;SFRP1;RHBDF2;CYP51A1;CHGA;RAB11FIP1;RAB11FIP5;INHBB
prerank,regulation of lymphocyte migration (GO:2000401),-0.4877059758022256,-1.1618577174199245,0.2830188679245283,0.6142593671204584,1.0,6/10,31.45%,JAM2;AKT1;WASL;MSN;SLC8B1;STK10
prerank,positive regulation of lipid transport (GO:0032370),0.5033592192936283,1.1615418116959744,0.2943201376936317,0.870302569193802,1.0,2/12,5.26%,LRP1;SPP1
prerank,positive regulation of lipid storage (GO:0010884),-0.3958854317952497,-1.1614711568449927,0.24561403508771928,0.6142540297888452,1.0,4/21,6.66%,NFKB1;OSBPL11;SREBF2;SCARB1
prerank,COPII-coated vesicle budding (GO:0090114),0.3649883212067364,1.1612773028509213,0.2543741588156124,0.8697952328168238,1.0,23/68,19.82%,SEC16B;COL7A1;SEC16A;GRIA1;TRAPPC2L;GOLGA2;F8;SEC24B;SAR1A;PPP6C;SCFD1;MCFD2;SCAP;AREG;TRAPPC10;PPP6R3;SEC24A;SEC23A;MIA3;TBC1D20;CNIH3;TRAPPC2;TRAPPC5
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3961283824268107,-1.1607173492141587,0.2729528535980149,0.6153659588788174,1.0,14/20,37.20%,SLC8A3;MICU1;MCUB;SMDT1;YME1L1;MCUR1;LETM1;MCU;SLC8B1;MICU2;PMPCB;STOML2;SLC25A23;SPG7
prerank,organic cation transport (GO:0015695),-0.4064722998668721,-1.160615719447372,0.25190839694656486,0.6146772287191494,1.0,4/20,8.10%,SLC47A1;SLC22A4;SLC22A18;RALBP1
prerank,positive regulation of translational initiation (GO:0045948),0.4565954943879944,1.1605984615844191,0.29697986577181207,0.8708008325865337,1.0,8/18,24.63%,BOLL;RPS6KB1;MTOR;HABP4;KHDRBS1;YTHDF1;EIF2B5;POLR2D
prerank,regulation of microtubule polymerization (GO:0031113),-0.33679937694444845,-1.160355786456604,0.21766561514195584,0.6143900043475591,1.0,13/40,20.97%,OCLN;DRG1;RAC1;MAPT;ARL2;SLAIN2;CDH5;MET;CDK5RAP2;CAMSAP2;EML2;NUMA1;FES
prerank,mitochondrion distribution (GO:0048311),-0.47439920044798856,-1.1600948803811237,0.2891304347826087,0.6140924176934727,1.0,5/12,17.35%,MEF2A;MTM1;MAPT;TRAK2;MSTO1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.5149820924147857,1.1600446179133788,0.27177700348432055,0.8713162463497904,1.0,4/11,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,heart development (GO:0007507),0.32325665739386683,1.159126241219701,0.18856447688564476,0.8732082514956638,1.0,24/150,12.50%,SCUBE1;CHD7;ECE1;FLRT2;DLC1;NTRK3;PTEN;ERBB4;SALL1;DNAAF4;HTR2B;NF1;BCOR;ADAP2;SRF;PTK2;BMP7;KAT2A;FGF12;ZFPM2;NDUFV2;TGFBR1;SOX9;RBM20
prerank,epithelial tube morphogenesis (GO:0060562),-0.3586908542994992,-1.158892375225104,0.23563218390804597,0.6161438162243249,1.0,9/32,8.00%,MEF2C;SLIT2;PODXL;RASIP1;GLI2;MEGF8;ACVR1;ACVRL1;SOX17
prerank,regulation of wound healing (GO:0061041),-0.32500990879907526,-1.15874585006652,0.20909090909090908,0.6155700769759636,1.0,11/42,10.44%,CAV1;OCLN;MYLK;ITGB1;ACTG1;VTN;KANK1;ANXA1;CD109;SERPINE1;EPHB2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.38752954177673216,-1.1578179573462228,0.2275132275132275,0.6169718830852564,1.0,10/24,16.26%,CCN1;CD44;TMEFF2;RHOC;ACVRL1;CD151;CEACAM1;FLNA;TOR1A;PDPN
prerank,positive regulation of multicellular organismal process (GO:0051240),0.30387717923979485,1.157754059741889,0.15738758029978586,0.8766749515979835,1.0,47/308,12.02%,IL33;PTN;GHR;LRP1;HCRT;OGT;WNT5A;TXK;GPR3;PLA2R1;THRA;GLMN;LURAP1;GJA1;LOXL2;REST;ACADL;FBXO5;GCNT2;SOX6;NCOA3;HTR2B;ZBTB16;SORL1;SIRT6;EPAS1;FABP5;FABP4;OMA1;GLIPR2;HMCES;PER2;BSCL2;TWIST1;G0S2;APPL2;MTOR;TAPT1;KAT2A;KSR2;FGR;EIF2AK2;ZBED3;SMTNL2;TGFBR1;VAMP7;SOX9
prerank,regulation of macrophage migration (GO:1905521),-0.49623324315027484,-1.1577356400326348,0.26811594202898553,0.6162720752979477,1.0,4/10,13.81%,CD200;MTUS1;CX3CR1;PTK2B
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.46015029848904665,-1.1576842560939404,0.2713347921225383,0.6154926131947489,1.0,3/12,4.21%,DPYSL3;CTPS1;CTPS2
prerank,negative regulation of ossification (GO:0030279),-0.3717560849499109,-1.1575972083979738,0.24858757062146894,0.6148268215476206,1.0,6/23,4.26%,SMAD6;MEF2C;RBPJ;ECM1;SRGN;NOTCH1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2679108880786,-1.1574154339592009,0.13529411764705881,0.6143631155696201,1.0,41/129,19.03%,CAV1;EGFR;XIAP;NFKB1;RNF146;CSNK1D;PSMC6;PSMD9;KANK1;TBL1X;PSMF1;GPC3;PSMB7;LGR4;WNK1;WLS;SOX4;TNKS2;VCP;SMURF2;PSMD8;PSMD12;SFRP1;GID8;PSMA3;DKK2;PSMA6;PSMD4;CSNK1G3;PSME3;PSMD7;PSMB6;PSMC1;FAM53B;ATP6AP2;PSMB10;HHEX;TMEM9;EGF;GSKIP;PSME2
prerank,histone deacetylation (GO:0016575),0.38038712097174865,1.1571140182580681,0.2635431918008785,0.8774456535454954,1.0,8/43,7.97%,MIER2;HDAC1;MORF4L1;REST;SIRT6;BRMS1L;BRMS1;PER2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.42851337643909004,-1.1570357827621696,0.27450980392156865,0.6143854668164183,1.0,7/16,10.43%,PDGFD;PTPRJ;FER;NRP1;PDGFA;PDGFC;PTPN1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4293580846842633,-1.157025807516682,0.26520681265206814,0.6134934346539239,1.0,6/15,12.84%,TJP1;BMPER;KLF4;FGF1;PKM;SMAD1
prerank,homologous chromosome segregation (GO:0045143),0.4496711236770115,1.156990005701373,0.291866028708134,0.8765471778863755,1.0,4/20,12.24%,SGO1;MEIKIN;ZCWPW1;CENPC
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.31990541049850413,1.1564014174009627,0.21261682242990654,0.8772016560230379,1.0,30/166,15.28%,RORA;PPARA;TEAD1;HDAC1;TAF9B;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;TAF15;POLR1A;NR2C1;TAF3;TBPL1;TAF1D;TAF1B;SNW1;GTF2H3;ESR2;HDAC10;MED1;ERCC2;NRBF2;GTF2H1;AR
prerank,embryonic limb morphogenesis (GO:0030326),0.4056494553750514,1.1560027339587606,0.2606060606060606,0.8771805181049569,1.0,7/34,9.85%,ECE1;HDAC1;SALL1;WDPCP;TBX3;TWIST1;GLI3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4056225075311547,-1.1558982741661146,0.24700239808153476,0.6154775556894083,1.0,8/20,13.64%,BCL2L1;MCL1;FAS;CASP2;GSK3B;CASP3;BAX;BOK
prerank,stem cell differentiation (GO:0048863),-0.33922451925134556,-1.1555878089624068,0.23003194888178913,0.6152974101724904,1.0,7/39,9.79%,MLLT3;MEF2C;OSR1;TGFB2;ACE;LRP6;SFRP1
prerank,negative regulation of protein kinase activity (GO:0006469),-0.2862225093875177,-1.1552123110168848,0.16091954022988506,0.6153163969407868,1.0,30/88,24.22%,PRKAG2;PTPRB;PPM1E;CAV1;SLC8A3;TRIB2;DEPTOR;DVL1;CEP85;PPM1F;MVP;LRP6;ITGB1BP1;YWHAG;PTPN1;HSPB1;CEACAM1;PPIA;CDKN1A;TRIM27;PAK2;AKT1;GSKIP;NPM1;DUSP19;CAMK2N1;WWTR1;QARS1;DBNDD2;HYAL2
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.340162689437985,-1.1550160323231382,0.24503311258278146,0.6149001692843741,1.0,17/36,27.51%,ATR;ATM;CDC5L;NBN;CLOCK;DONSON;SETMAR;HUS1;E2F1;PRPF19;ATRIP;CDC45;HINFP;CHEK2;BRIP1;CHEK1;RHNO1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.27223969716921415,-1.154761050463105,0.1282051282051282,0.6146905172440036,1.0,31/112,17.61%,SMAD6;SOX5;ARHGEF18;MEF2C;ITGB1;PTPRK;ID1;F11R;CLDN5;PARD3;TGFB2;WNT4;WWOX;SKI;PDE3A;UBB;ACVR1;ACVRL1;SMAD3;LRRC32;SFRP1;ZYX;PRKCZ;SMAD1;NR3C1;FURIN;CDH5;SIRT1;UBC;USP9X;TWSG1
prerank,histone H3-K4 methylation (GO:0051568),0.4285390012754337,1.1547186829684584,0.2794348508634223,0.8802758377256579,1.0,13/26,24.08%,OGT;KMT2A;CXXC1;WDR5;DYDC2;PAXIP1;ASH2L;SETD4;MEN1;KMT2C;RBBP5;KDM6A;TET2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2993319282511501,-1.1545306256628398,0.19157088122605365,0.6142727919674725,1.0,24/72,22.16%,SLIT2;SHANK3;KANK3;HIP1R;ATXN7;HSPA8;KANK1;APC;CRYAB;APOE;SHANK1;SSH1;APC2;ARPIN;LIMA1;CDH5;PRKCD;CAMSAP2;EML2;CHADL;CIB1;KATNB1;TWF2;PFDN4
prerank,amyloid fibril formation (GO:1990000),-0.31788040664882944,-1.1543906874157577,0.20962199312714777,0.6136680256622477,1.0,17/51,18.00%,TSPAN5;SNCAIP;APP;CST3;GSN;ADAM10;UBB;B2M;MAPT;APH1A;APH1B;FURIN;UBE2L6;SIAH2;UBC;USP9X;MFGE8
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.44340902516497394,-1.1540172354130258,0.25609756097560976,0.6137622921199755,1.0,4/13,26.01%,MAPT;PRKCD;TYROBP;ITGB2
prerank,positive regulation of mRNA processing (GO:0050685),0.43725391236416966,1.153932127591008,0.26776859504132233,0.8815767695616249,1.0,5/21,11.46%,TRA2B;PRDX6;CELF4;DHX36;SNW1
prerank,regulation of protein phosphorylation (GO:0001932),-0.2500070727701861,-1.15386047287786,0.05660377358490566,0.6132548390166133,1.0,42/256,8.10%,PLCE1;FN1;ROCK2;TEK;LEPR;OCLN;BMPER;SLIT2;PECAM1;FNIP1;EGFR;KRAS;PLPP3;FER;APP;CSNK1D;SIRPA;LIMCH1;IGFBP3;KDR;PRKDC;NIBAN1;CCND2;INSR;FAS;VEGFD;RAC1;DAB2;VEGFC;MAVS;TFRC;EFNA5;PDGFA;CARD14;TBX1;CCN1;XDH;PRR5L;LRP6;FGF1;FNIP2;RALBP1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.40840791688409456,-1.1533816582505574,0.2826086956521739,0.6136133166085712,1.0,3/18,4.82%,IGF1;IL18;IGFBP2
prerank,keratinocyte differentiation (GO:0030216),-0.3566456052279545,-1.153327328574581,0.25066666666666665,0.6128658926248797,1.0,13/29,25.19%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;BCR;WNT16;EPHA2;ADAM9;PIP5K1A;ASAH1;DSP;EXPH5
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.517824949547247,1.1533102603443302,0.29642857142857143,0.8823664502965293,1.0,2/10,9.91%,WNT5A;WNT3
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.47837997822596334,-1.1531797799116823,0.28982300884955753,0.6123692545520231,1.0,4/10,24.20%,HDAC6;AOC3;OXA1L;MT3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.42413339952266704,-1.153097804663968,0.2577565632458234,0.6116838314575145,1.0,2/17,3.21%,RAPGEF2;ADRA1B
prerank,modification-dependent protein catabolic process (GO:0019941),-0.25197408829504764,-1.1529971610558383,0.1092436974789916,0.6110619307569469,1.0,67/193,23.96%,FBXL7;NPLOC4;RNF146;UBE2G1;ASB2;SQSTM1;RNF43;RNF185;PSMD9;ARIH1;CDC23;PSMF1;TRIP12;TRIM25;ANAPC10;PTTG1;TOLLIP;UBB;RNF8;UBE2H;MIB1;SMURF2;UBA6;KCTD21;RC3H1;UBE2A;RNF125;RNF11;RNF144B;RNF114;SPSB4;RCHY1;KCTD6;FBXL4;AMFR;ELOC;UBE2L6;FBXL14;NEDD8;SIAH2;CUL3;ANAPC16;ISG15;ANAPC11;UBC;ANAPC15;PPP1R11;BUB3;CHFR;ANKIB1;WDR91;KLHL25;FZR1;CDC34;KLHL3;ANAPC2;RNF166;RNF5;RFFL;FBXO22;UBA52;ADRM1;FBXO10;SMURF1;RLIM;RNF111;RNF20
prerank,atrioventricular valve development (GO:0003171),-0.4366415498674523,-1.1529685118399469,0.26683291770573564,0.6102485515710807,1.0,5/14,11.62%,BMPR2;NOTCH1;TGFB2;ACVR1;HEYL
prerank,protein localization to cilium (GO:0061512),0.41247094005243945,1.1529448838619796,0.2830188679245283,0.882235094952535,1.0,7/32,10.58%,ODAD4;WDR35;ZNF423;TUB;RAB29;TTC21B;TCTN2
prerank,catecholamine metabolic process (GO:0006584),-0.4421531379974664,-1.1528447837208384,0.2807017543859649,0.609654018315818,1.0,1/14,0.20%,SNCAIP
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.4532522720790997,-1.1528433439282446,0.28634361233480177,0.6087640124496635,1.0,7/12,36.41%,GCLC;BDH2;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,regulation of macrophage activation (GO:0043030),0.40948834463173106,1.1528041985426656,0.265625,0.8813604512950224,1.0,5/30,9.41%,IL33;WNT5A;TLR6;LRFN5;TLR4
prerank,histone lysine demethylation (GO:0070076),-0.37343586386922156,-1.1525994582863681,0.25405405405405407,0.6084899368196698,1.0,10/25,25.64%,KDM4A;KDM4C;RIOX2;PHF8;HR;KDM4B;KDM3B;PHF2;KDM2B;KDM1A
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.457402129838107,-1.1523171238325554,0.29711751662971175,0.6083531565726386,1.0,4/11,25.14%,PARP10;PARP9;PARP4;PARP12
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5085410020977537,1.1518579863975829,0.28975265017667845,0.8832854778917126,1.0,2/11,8.61%,MERTK;AXL
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.39036931274276443,-1.1517504539126655,0.2878787878787879,0.6088857155498483,1.0,3/21,2.31%,IGF1;ADAMTS1;IGFBP5
prerank,embryonic organ morphogenesis (GO:0048562),0.3855257655643567,1.1516571871464494,0.24351585014409222,0.8826210582042209,1.0,10/42,15.80%,PDGFRA;RYR2;HOXC9;DSCAML1;HOXB9;HOXB4;HOXC4;FBN1;FGFR2;HOXA9
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4899064965279043,-1.1513189632266574,0.3239130434782609,0.6090299144941926,1.0,1/10,0.26%,EPHA4
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5234867665163547,1.1510637683017677,0.29945553539019965,0.88336960373387,1.0,5/10,19.12%,TLR6;CD68;TLR4;MYD88;MIA3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4492073747836601,-1.1508097659416363,0.3078817733990148,0.6094526563627698,1.0,12/14,54.23%,IL18;PAEP;IL17D;CD84;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,synaptic membrane adhesion (GO:0099560),0.4902971110349345,1.1498774577110293,0.3174872665534805,0.8860619200501677,1.0,6/14,18.74%,GPC4;LRFN5;LRRC4C;NTNG1;SLITRK1;GPC6
prerank,negative regulation of cellular senescence (GO:2000773),0.49631447968753006,1.1498021955893802,0.30579964850615116,0.8849986087966095,1.0,4/13,8.25%,SLC30A10;FBXO5;ZKSCAN3;TWIST1
prerank,establishment of protein localization to membrane (GO:0090150),-0.292854484940981,-1.1495588562470966,0.19047619047619047,0.6117258657043864,1.0,14/66,12.72%,SYNE3;EGFR;AFDN;VPS37A;NACA;PARD3;ZDHHC21;VPS37B;ARL6;FRMPD1;MYO1C;RAB3IP;BID;ZDHHC14
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.4364143615793309,-1.1493908408002573,0.2702702702702703,0.6112697990145274,1.0,7/13,25.13%,NBL1;FSTL1;GREM2;CHRDL1;CD46;NRROS;GREM1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.29589969617971545,-1.1493529577895754,0.1814516129032258,0.6104856616446032,1.0,28/71,23.08%,CTSC;DDI2;UBB;VCP;NGLY1;CASP8;CTSO;RNF41;CTSH;CLPX;PSMA6;CTSZ;NEDD8;YME1L1;ISG15;CTSS;CHMP4B;UBC;USP9X;CHFR;CLPP;PDCD6IP;TNFAIP3;HDAC6;PRPF19;UBA52;PSMA8;CHMP4C
prerank,amyloid-beta metabolic process (GO:0050435),-0.4067946240715153,-1.149042869242258,0.3112745098039216,0.6103758318077437,1.0,7/16,25.69%,ACE;APH1A;APH1B;APEH;MME;BACE2;PSEN2
prerank,endothelial cell differentiation (GO:0045446),0.5030659343292964,1.1487557417945307,0.28862478777589134,0.8874709988638468,1.0,1/12,0.06%,SCUBE1
prerank,regulation of bone mineralization (GO:0030500),0.3702430119809994,1.1487300901291213,0.2754237288135593,0.8862038918448838,1.0,4/55,1.67%,ENPP1;PTN;GPM6B;ADGRV1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4782743606171482,-1.148473381169584,0.30969267139479906,0.6109054425955697,1.0,5/11,21.66%,RNF185;VCP;TOR1A;RNF5;UGGT1
prerank,protein heterooligomerization (GO:0051291),0.4609408097270341,1.1484218085407398,0.27121464226289516,0.8859449444623165,1.0,4/17,10.19%,GRIN2B;KCNC2;HSD17B8;NUDT21
prerank,negative regulation of multicellular organismal process (GO:0051241),0.31116059343784713,1.1482541348187782,0.21160409556313994,0.8851854014040207,1.0,27/199,9.97%,TBX18;PLCL1;HOXC10;ALDH1A1;SPRY1;PTEN;PTPRR;NR1H4;NOVA1;MCC;GJA1;NR1H2;SPRED1;LOXL2;ZNF423;IL17RD;TRPV3;SPX;SRF;DOCK7;RPS6KA6;PTPRO;CIDEA;SPRED2;TLR4;BRCA2;NRDC
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.2349992785032876,-1.1481789102240836,0.05970149253731343,0.6108059619995589,1.0,108/341,23.64%,FBXL7;WWP1;NPLOC4;VPS37A;RNF146;UBE2G1;ASB2;PSMC6;SQSTM1;RNF43;RNF185;PELI1;PSMD9;WWP2;ARIH1;CDC23;TBL1X;UBE2D3;PSMF1;PSMB7;TRIP12;TRIM25;ANAPC10;PTTG1;TOLLIP;VPS37B;IFI27;RNF8;VCP;UBE2H;MIB1;SMURF2;PCBP2;UBA6;KCTD21;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;KLHL20;RNF11;GID8;RNF144B;RNF114;SPSB4;RCHY1;KCTD6;PSMA3;PSMA6;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;PSMB6;KAT5;UCHL1;ELOC;PSMC1;SIAH3;UBE2L6;SIRT1;PSMB10;HECTD3;TGFB1I1;FBXL14;NEDD8;SIAH2;CUL3;CLOCK;ANAPC16;ANAPC11;USP9X;ANAPC15;PPP1R11;RAD23B;BUB3;CHFR;ANKIB1;PSME2;WDR91;KLHL25;KCTD2;FZR1;CDC34;TNFAIP3;MAEA;KLHL3;ANAPC2;PSMC3;RNF166;KBTBD7;RNF5;VPS28;TNFAIP1;RFFL;FBXO22;MVB12B;ZFAND2B;PSMA8;ADRM1;FBXO10;SMURF1;RLIM;RNF111
prerank,sensory organ development (GO:0007423),0.3743422127180164,1.147574936775249,0.2725988700564972,0.8862108049936467,1.0,8/51,10.06%,CHD7;ECE1;MEIS1;MYO7A;MEIS2;SIPA1L3;SOX2;AHI1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4238259508824398,1.14714571187845,0.2740157480314961,0.8864092494653988,1.0,2/24,2.16%,GHR;ERBB4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.351907460279276,1.14702101674179,0.24234354194407456,0.885508533591172,1.0,18/80,16.07%,FANCI;PRICKLE1;MYCBP2;LRRK2;PSMD10;PINK1;TSPYL5;COMMD1;BIRC2;NDFIP2;SPRTN;GSK3A;PTTG1IP;DCUN1D5;AXIN1;UBE2D1;PAXIP1;NDFIP1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.46490718996672586,1.146984869760072,0.2897822445561139,0.8842994039672285,1.0,5/15,11.17%,HRG;SEMA5A;PRKD1;LGMN;P2RX4
prerank,gland development (GO:0048732),-0.3061964009462884,-1.1469394561672093,0.2,0.6130523504543168,1.0,20/59,19.15%,DKK3;CAV1;EZR;ARID5B;WNT4;ANXA1;COBL;GLI2;SIX1;TBX1;LSR;CITED2;MDK;STRA6;MET;EPHB3;MSN;HOXD3;WNT11;TGFBR3
prerank,regulation of TORC1 signaling (GO:1903432),-0.3421768723812633,-1.1467831201795782,0.23391812865497075,0.6125523430950992,1.0,11/33,19.47%,RNF152;SIK3;SESN1;LAMTOR5;RRAGC;CLEC16A;PIP4P1;ATM;GPR137;SEH1L;RRAGB
prerank,negative regulation of hippo signaling (GO:0035331),-0.4595519722796516,-1.1467769216782866,0.28132387706855794,0.6116936682907382,1.0,5/12,16.76%,MAPK14;DLG5;AJUBA;MARK3;VGLL4
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.43023070658921486,1.1466452018801523,0.2878535773710483,0.8841193984926589,1.0,7/25,12.03%,TRA2B;GEMIN2;BCAS2;MPHOSPH10;SLU7;DBR1;SRSF10
prerank,sterol metabolic process (GO:0016125),-0.308578232009661,-1.1460664744048052,0.21631205673758866,0.6125789598413303,1.0,20/60,21.55%,PRKAG2;CYP26B1;LBR;CYP39A1;CYP1B1;FDX1;RXRA;APOE;LIPA;PIP4P1;SOAT1;PMVK;FDXR;CYP51A1;INSIG1;INSIG2;CLN8;OSBPL1A;EBP;TSKU
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.3708250189079664,1.145847690314234,0.2653352353780314,0.8855119689778784,1.0,12/53,20.38%,CALCRL;HTR2B;HTR5A;LPAR3;HTR1A;NPY;HTR2C;HTR4;LHCGR;HTR6;CHRM2;CCL2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4777603391735855,-1.14568213765191,0.2950108459869848,0.6126925398371377,1.0,2/10,8.32%,ANO6;RAB31
prerank,ceramide catabolic process (GO:0046514),-0.43620264115716584,-1.1453956416289257,0.286697247706422,0.6125351191995669,1.0,8/14,28.37%,ACER2;ACER3;HEXB;NAGA;GM2A;ASAH1;ASAH2;NEU1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.40547991254282806,1.144733254777184,0.2822966507177033,0.8879739121373477,1.0,8/29,11.21%,AGO4;SPOUT1;ZC3H7B;LIN28B;HNRNPA2B1;MRPL44;SRRT;AGO3
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.33677654844166827,-1.1446362767885234,0.2344213649851632,0.6136646661886558,1.0,11/37,16.14%,PHLDB2;PRKAA2;EFNA5;GSK3B;MAPT;TRIM36;FAM107A;MAPRE2;CYLD;BICD2;PRKAA1
prerank,negative regulation of metabolic process (GO:0009892),0.37351239032601424,1.1440083247412245,0.2586705202312139,0.8890485410859142,1.0,10/54,9.97%,PLCL1;HOXC10;ALDH1A1;NOVA1;NR1H2;ZNF423;DOCK7;CIDEA;TLR4;NRDC
prerank,renal absorption (GO:0070293),-0.4640691034122595,-1.1438150837403873,0.3089622641509434,0.6148646155305543,1.0,6/10,28.60%,GSN;WNK4;KCNQ1;KLHL3;HYAL2;HAS2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.46194320860116483,-1.1434590283183226,0.2853828306264501,0.6148517975694828,1.0,5/12,15.08%,CYP26B1;DHRS3;KLF2;TRIM16;EZH2
prerank,cytosolic calcium ion transport (GO:0060401),-0.3551999383740426,-1.1431559607084658,0.27823691460055094,0.6147184256671644,1.0,9/28,15.70%,CACNA1C;SLC35G1;ATP2B1;MICU1;MCUB;SMDT1;JPH1;ATP2A3;JPH2
prerank,cell differentiation in spinal cord (GO:0021515),0.5072374785544964,1.14309879412403,0.32616487455197135,0.890906344248377,1.0,2/10,4.52%,MDGA2;SOX6
prerank,postsynaptic membrane organization (GO:0001941),0.4632992031685946,1.1427791046290816,0.2961730449251248,0.8906772803667228,1.0,5/17,15.66%,NRXN2;CEL;NRXN1;DLG4;LHFPL4
prerank,regulation of protein autophosphorylation (GO:0031952),0.39320283487400987,1.142752244331341,0.276218611521418,0.8894287282230463,1.0,2/36,0.66%,ENPP1;EPHA7
prerank,sarcomere organization (GO:0045214),-0.36604877052113,-1.1426085719687813,0.26795580110497236,0.6152573380016271,1.0,15/27,41.16%,ACTN2;TPM1;CSRP2;TNNT3;SIX4;MYOM2;KRT19;TTN;CASQ1;MYPN;MYLK3;TCAP;OBSCN;MYH6;CSRP1
prerank,endothelial cell proliferation (GO:0001935),-0.41447523003397835,-1.1426075494774794,0.2904761904761905,0.6143900732099364,1.0,6/17,8.29%,TEK;BMPER;BMPR2;CD34;ACVRL1;ITGB1BP1
prerank,organophosphate biosynthetic process (GO:0090407),-0.3421274489045891,-1.1426033742781154,0.24778761061946902,0.6135287354430029,1.0,7/37,7.94%,MBOAT1;TPK1;ITPKB;AGPAT4;NFS1;IP6K2;TPI1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.47993230683281424,1.142131301327073,0.3153310104529617,0.8902003650614938,1.0,6/14,21.50%,IL34;PTK2;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.48814342693587814,1.1420043326009413,0.3103448275862069,0.889325643793053,1.0,4/13,16.57%,PRICKLE1;TBX3;SOX9;SRA1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4592402666117617,-1.141613326287669,0.29723502304147464,0.6150593522070008,1.0,9/12,50.62%,IL18;PAEP;IL17D;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,peptide metabolic process (GO:0006518),-0.2869204188399529,-1.1411177621023822,0.1952191235059761,0.6154645985959949,1.0,29/75,30.39%,AEBP1;CPE;CPD;ERAP1;ACE;SPCS2;DMD;GPX1;SEC11C;ETHE1;CLN5;FURIN;GSTA4;APEH;PCSK5;GSTT1;TRHDE;ABCB9;GSTM5;MME;BACE2;TPP1;PSEN2;GGT1;CARNMT1;THOP1;GSTK1;SPPL3;CPZ
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.26112177868463476,-1.1411104680992896,0.15428571428571428,0.6146244434249126,1.0,46/153,19.89%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;CAMK2D;PRKDC;TOP1;VRK3;TLK1;MAPK9;WNK1;HIPK3;MAPK14;GSK3B;HIPK1;TLK2;STK38L;MAST3;DYRK2;RPS6KA5;CAB39;ATR;RPS6KA1;MAP2K2;PRKCZ;HIPK2;ATM;CSNK1G3;ERN1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;STK32B;AKT1;CSNK1A1;SBK1;VRK2;MARK2;ULK3;MKNK1
prerank,cellular response to virus (GO:0098586),0.40959402441027054,1.140932489561847,0.274294670846395,0.891525044597504,1.0,9/30,19.67%,CXCL10;GBF1;FMR1;IL12A;MAPK11;LGALS9;RRP1B;HIF1A;GSDME
prerank,early endosome to late endosome transport (GO:0045022),-0.39028846637295067,-1.140638431657676,0.28717948717948716,0.6150360851546398,1.0,4/20,7.80%,EEA1;BECN1;HOOK1;RAB5A
prerank,nuclear migration (GO:0007097),-0.4410054376462846,-1.1403779408225796,0.2924107142857143,0.6148261848781239,1.0,3/13,3.79%,SYNE2;SYNE3;CLMN
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5170030836533184,1.1401896597902645,0.32786885245901637,0.8927673414006949,1.0,3/10,10.89%,CPEB1;NUDT21;DHX36
prerank,cytosolic transport (GO:0016482),-0.2750441415445779,-1.1400190933098506,0.1625615763546798,0.6149292208999004,1.0,31/108,19.92%,ERC1;VTI1A;EEA1;BECN1;MYO1D;VPS35;DOP1B;HOOK1;RAB5A;SNX32;AP2A1;ARFRP1;SNX6;KLHL20;SPAG9;MON2;GAK;CLN5;TBC1D10B;VPS51;VPS29;VPS13A;TRIM27;ARL1;TMEM87B;RAB6A;LAPTM5;VPS54;WDR91;PLEKHJ1;TBC1D5
prerank,water transport (GO:0006833),-0.44382192474017984,-1.139934439716568,0.30120481927710846,0.6142926837862456,1.0,8/12,55.32%,PDPN;CFTR;AQP11;AQP1;AQP9;AQP6;AQP7;SLC5A1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.3069773683034015,-1.1397120688971631,0.1984732824427481,0.6139986549573786,1.0,17/60,19.55%,HMBOX1;KLF4;PTGES3;PARN;TNKS2;CCT3;NEK7;MAP2K7;ATR;CCT4;CCT7;PCNA;ATM;MAP3K4;HGF;RGCC;HNRNPA1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.29799313047416665,-1.139463168249453,0.22108843537414966,0.6137776211257456,1.0,16/53,15.99%,EYA2;DDX5;EYA1;EGFR;EYA4;RNF8;ATR;SPRED3;PCNA;BRCC3;ATM;SMCHD1;UBE2N;NSMCE4A;PRKCD;SIRT1
prerank,cellular response to fatty acid (GO:0071398),0.4866778065345506,1.1387306267620183,0.3141263940520446,0.8965167152834465,1.0,2/12,5.40%,NR1H4;IRS1
prerank,regulation of receptor binding (GO:1900120),-0.48357064471900874,-1.1386929050046624,0.3034188034188034,0.614907761430555,1.0,5/10,17.14%,PTPRF;B2M;ATP2A3;GREM2;HFE
prerank,heme biosynthetic process (GO:0006783),-0.38752819668023647,-1.1386194039325066,0.2656641604010025,0.6142011012503487,1.0,7/22,12.56%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5062276395289589,1.1380460344083108,0.31001890359168244,0.8948159865812686,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5062276395289589,1.1380460344083108,0.31001890359168244,0.8948159865812686,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5062276395289589,1.1380460344083108,0.31001890359168244,0.8948159865812686,1.0,4/11,21.63%,COASY;ACOT7;PANK2;SLC25A16
prerank,regulation of myelination (GO:0031641),0.41408870843234147,1.1377682264146365,0.27941176470588236,0.8944377873207912,1.0,5/25,13.88%,PTN;TENM4;LGI4;TNFRSF21;MYRF
prerank,regulation of neuron projection arborization (GO:0150011),0.4747552127411308,1.1377585445794203,0.3017543859649123,0.8931532614285901,1.0,8/15,20.74%,WNT5A;GRIP1;DLG4;NTNG2;NTNG1;DVL3;MAP3K13;DVL2
prerank,negative regulation of cell aging (GO:0090344),0.47128410130574,1.1372228552339807,0.3152542372881356,0.8936013074260101,1.0,6/16,15.64%,SLC30A10;FBXO5;ZKSCAN3;TWIST1;FOXM1;MAP3K3
prerank,positive regulation of telomere capping (GO:1904355),-0.40709924866244873,-1.1371929796777485,0.279126213592233,0.616884825231052,1.0,5/17,14.25%,TNKS2;NEK7;MAP2K7;RTEL1;MAP3K4
prerank,protein import into peroxisome membrane (GO:0045046),0.4311924437850497,1.1370072265982825,0.2939244663382594,0.8930317675964259,1.0,10/22,23.26%,ABCD2;PEX2;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;GDAP1;FIS1
prerank,cellular response to amyloid-beta (GO:1904646),0.3971899291289142,1.1365604853556879,0.29256965944272445,0.8931485221318461,1.0,11/35,11.12%,LRP1;GJA1;NGFR;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;GRM5;FYN
prerank,glucan catabolic process (GO:0009251),-0.4319444453055572,-1.1360577699655503,0.29055690072639223,0.6188040480238439,1.0,9/15,28.49%,PYGB;PGM2L1;CALM1;GAA;PGM2;PHKG1;PHKA2;PHKG2;PYGL
prerank,negative regulation of heart contraction (GO:0045822),0.5013521559984419,1.1353957156340666,0.3182608695652174,0.8958435153039253,1.0,2/11,6.45%,ATP1A2;SPX
prerank,positive regulation of phospholipid transport (GO:2001140),-0.46299821309037975,-1.1352145931727016,0.2964705882352941,0.6200848164039112,1.0,5/10,19.84%,APOE;ABCA3;ABCB4;PRELID1;DBI
prerank,regulation of actin filament polymerization (GO:0030833),-0.29102286327284405,-1.133607316313047,0.2089041095890411,0.623168534890325,1.0,17/69,15.53%,BAIAP2L1;SLIT2;FER;ESAM;KANK3;HIP1R;KANK1;NCK1;SSH1;ARHGAP18;COTL1;ARHGAP28;LMOD1;PTK2B;PLEKHG2;BAIAP2;PRKCD
prerank,regulation of ion transmembrane transport (GO:0034765),-0.3347907604861988,-1.1335665311341114,0.2648809523809524,0.6224281239234792,1.0,8/33,14.64%,ANO6;WWP2;KCNJ13;WNK1;KCNJ2;KCNQ1;KCNJ12;P2RX7
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3484358031213474,1.133547681605944,0.2699868938401048,0.9008604459385396,1.0,15/72,15.08%,COPS3;ERCC1;ISY1;LIG3;POLK;ERCC5;RPA1;ERCC4;UVSSA;RFC3;GTF2H3;XRCC1;COPS4;ERCC2;GTF2H1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.44978366386284824,1.1335391546937206,0.31552587646076796,0.8995701536405235,1.0,5/17,15.28%,ATP1A2;ATP1A3;BMP7;MED1;AR
prerank,neutrophil activation (GO:0042119),0.4926887817799763,1.133535693354998,0.3126079447322971,0.8982645457057389,1.0,2/12,13.18%,KMT2E;PREX1
prerank,"transcription, DNA-templated (GO:0006351)",-0.24137409731779244,-1.1333795497510428,0.14166666666666666,0.6220177637286389,1.0,61/207,24.09%,SOX5;PIR;MLLT3;DDX5;GLIS3;KLF13;TSC22D1;MEF2A;NFKB1;PTMA;ELOA;DDX21;GTF2H5;DRG1;TRIM24;HIPK3;AFF4;SNAPC3;CRCP;RRAGC;UBTF;RBMX;NR4A2;NFYA;MAF;SMARCA5;POLR2B;RPAP1;POLR2H;POLR3G;POLR2G;POLR2C;ELOC;CEBPD;GTF2E2;BTF3;TTF1;GMEB2;MLLT1;PMF1;CDK9;NELFCD;HOXD3;GTF3C6;CREBL2;ZBTB7B;TAF1C;GTF2H4;LEO1;E2F1;POLRMT;POLR1C;NCBP2;POLR3K;GTF3A;TAF2;TWNK;GTF2F2;CTDP1;HSF2BP;PARP1
prerank,monocyte chemotaxis (GO:0002548),0.39480105576740115,1.1333042547414112,0.308411214953271,0.8977592472164029,1.0,6/32,10.56%,XCL1;MSMP;CCL15;CALCA;PTPRO;CCL25
prerank,Rho protein signal transduction (GO:0007266),0.3648204796433317,1.1332957535391637,0.26308345120226306,0.8964943253874439,1.0,19/53,19.37%,ARHGEF3;RHOJ;ARHGAP6;NGFR;CTNNAL1;LIMK1;COL1A2;EPS8L1;ARHGAP4;ARHGAP1;RTKN;CDC42EP1;CDC42EP4;ADRA2A;RHOG;ARHGAP29;CDC42EP3;RHOA;PLEKHG5
prerank,regulation of ruffle assembly (GO:1900027),-0.3586526213515124,-1.1330112955196094,0.26975476839237056,0.6220871432684173,1.0,5/23,8.73%,CAV1;RDX;NDEL1;KANK1;EPS8L2
prerank,regulation of gene expression (GO:0010468),-0.2228973716576587,-1.1327515355123785,0.1,0.6219207452512601,1.0,225/903,18.76%,BNC2;PRDM6;FN1;IGF1;PICALM;APBB2;SLC24A3;ROCK2;FOXP1;ITGB8;ERC1;MEF2C;DENND4A;RBPJ;LEF1;OCLN;ROBO1;LARP4;KRAS;MBNL1;AFDN;FOXC1;HDAC4;OSR1;EZR;FOXN3;NOS3;NOTCH2;PPARGC1B;APP;CDH1;GTF2IRD1;AHNAK;KLF4;NFKB1;ZNF462;GPBP1L1;KDM4A;KAT6B;FOXD1;ESRRG;CLDN5;RDX;PRRX2;SIRPA;SMARCA2;KDR;VPS35;GSN;YBX3;AHNAK2;INSR;WWP2;NOTCH1;RUNX1;TGFB2;WNT4;ACTG1;NFKBIZ;TDRD7;TAPBP;ASCC2;SMO;DVL1;RPL5;CD34;PRKAA2;MAPK9;NFYC;TFRC;CDK6;ADAM10;PRDM2;SLC39A8;SIX1;MEGF8;RPS7;PPP2R1A;TRIM5;TRIM11;MOG;AFF4;MAPK14;SOX4;NGF;PRDM11;FZD7;CRABP2;DICER1;NOVA2;TRIM14;PPM1F;APOE;GSK3B;PLAG1;IRF2;XDH;CELF1;FGF1;ACVRL1;SOX17;HNRNPF;PCBP2;LAMTOR5;MAPT;SMAD3;ANK2;WNT6;CRIP1;GZF1;RPL11;VSX1;ACTR8;PTBP3;ATOH8;CASP8;RPS6KA5;RC3H1;CITED2;PIK3CB;GPX1;MYBL1;SFRP1;GATA2;HMG20B;PIK3CD;RFX3;MYCBP;CCN4;ETS1;EPHB2;CASZ1;NFYA;TNRC6A;PARP10;VHL;PARP9;SLC7A5;UBAP2;MBNL2;CTSH;GCFC2;TARDBP;MZF1;MAP2K2;AJUBA;MYBBP1A;FASTK;ACTA2;TLE5;FUS;TERT;TNRC6C;HNRNPH1;PTRH2;PLCG2;HNRNPDL;HEY2;SMAD1;NR3C1;TMEM119;ATM;ATXN1;ACTR5;YBX1;MSL3;HINT1;NOS1AP;ZNF205;PTHLH;WNT16;RAMP2;TICAM1;P2RX7;CDH5;CIAO3;CAVIN4;TOB1;ZNF219;TRAF3;EZH2;NFYB;POGZ;CHD3;TRIM27;SRRM4;SIRT1;MATR3;GPER1;PRKAA1;ZPR1;PER1;MED23;TRRAP;NFKB2;CLOCK;HAVCR2;BTN3A3;FAM50A;ESR1;DNAJA4;HFE;CD74;HNRNPK;ACVR2B;BHLHE40;AGO2;SOX18;AKT1;DNMT3B;SOX11;OGG1;IFNGR1;EGF;SLC22A2;MSN;ACE2;PQBP1;SUFU;HOXD3;CTCF;EFEMP1;PID1;APBB1;WNT11
prerank,cartilage development (GO:0051216),-0.31645039901087635,-1.1326691649141065,0.24528301886792453,0.6212741208944411,1.0,10/49,7.33%,NFIB;SOX5;ITGB8;MEF2C;WNT5B;OSR1;RUNX1;CCN3;SULF2;CD44
prerank,chromatin assembly or disassembly (GO:0006333),0.49577243919689706,1.1324204273190657,0.30347349177330896,0.8981628348859833,1.0,5/11,21.09%,CHAF1B;NOC2L;TP53;SUV39H2;HIRIP3
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3646569428941966,1.132371427368925,0.2683658170914543,0.8970211558668124,1.0,9/52,6.24%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,regulation of protein kinase activity (GO:0045859),-0.27640534676088596,-1.132238697743537,0.2037914691943128,0.6215386100711409,1.0,30/106,17.97%,PRKAG2;PLCE1;RAPGEF2;PPM1E;TRIB2;DEPTOR;IQGAP1;RAP1A;UVRAG;DVL1;CEP85;PPM1F;CCN1;LRP6;ITGB1BP1;YWHAG;HSPB1;ALS2;CEACAM1;TAB2;PTK2B;PPIA;RAP2C;CDKN1A;TRIM27;SIRT1;PAK2;AKT1;RAP2B;LCP2
prerank,negative regulation of protein transport (GO:0051224),-0.35988506860826924,-1.1322239062024508,0.2810810810810811,0.6207254861731815,1.0,7/25,18.81%,WWP2;PPM1F;APOE;PKDCC;RHBDF2;CYP51A1;SNX3
prerank,base conversion or substitution editing (GO:0016553),0.491811796765537,1.1318031780456577,0.3015267175572519,0.8976661073805363,1.0,2/11,15.51%,ADARB2;ADAR
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4507006208965356,-1.1314322171186313,0.32054176072234764,0.6219406854451328,1.0,5/12,16.95%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2813892557519061,-1.1314149290273787,0.1810344827586207,0.621139331486232,1.0,29/74,23.29%,RBPJ;PSMC6;PSMD9;NOTCH1;EGLN3;PSMF1;HIF3A;PSMB7;UBB;PSMD8;CITED2;PSMD12;VHL;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;ELOC;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;PSMA8;STOX1
prerank,prostaglandin metabolic process (GO:0006693),-0.3568677846971487,-1.1306821405270107,0.26485148514851486,0.6220934603726083,1.0,4/26,4.08%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,regulation of phosphatase activity (GO:0010921),0.4185730860985588,1.1304294526364604,0.27768860353130015,0.9010420992141116,1.0,9/24,18.02%,GPATCH2;PPP6R2;PTPA;PPP1R26;HSP90B1;ZCCHC9;TSC1;PPP6R3;BMP2
prerank,carbohydrate transport (GO:0008643),-0.4626269674971648,-1.1302897247076302,0.3215130023640662,0.6222627054853369,1.0,9/11,46.94%,SLC26A6;AQP11;SLC2A2;SLC23A2;SLC23A1;AQP1;SLC50A1;SLC2A5;AQP9
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3906219668417017,1.130118617062449,0.2852852852852853,0.9008230349448185,1.0,5/35,5.15%,DLC1;SPRY4;SPRY1;ITGA3;ARHGAP24
prerank,mRNA splice site selection (GO:0006376),0.4052579430132709,1.1300352311435196,0.29675425038639874,0.8998287204523678,1.0,13/30,22.83%,ISY1;NOL3;CELF4;SLU7;LUC7L2;SRSF10;SRSF9;SF3A3;SRSF6;PRPF39;LUC7L3;SRSF12;CELF6
prerank,urogenital system development (GO:0001655),-0.46855708284685826,-1.1295704637855102,0.3371824480369515,0.6232613322892181,1.0,4/11,17.96%,OSR1;ANXA1;EPHB2;EPHB3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.45460727032017184,1.1293412872264028,0.33620689655172414,0.9008639648290547,1.0,8/17,25.07%,CTNNA2;FCHSD2;WASF3;ARFIP1;CYFIP1;GMFB;ARFIP2;ABI2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.270989207228468,-1.1289590278035087,0.18025751072961374,0.6239341337306165,1.0,25/108,9.46%,PHLDB2;CLIC4;TJP1;RHOBTB1;ROCK2;SORBS3;EZR;DIAPH1;F11R;RICTOR;IQGAP1;HIP1R;RHOQ;RHOBTB2;RAC1;PRKAA2;ARHGAP17;EFNA5;PDGFA;GSK3B;RHOC;MAPT;TRIM36;PLXNB1;ARHGAP18
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3443601095034404,-1.1284962850968558,0.2594594594594595,0.624374389047668,1.0,11/32,16.30%,DDX5;PPP1R13B;JMY;HIPK1;DYRK2;MYBBP1A;HIPK2;BOK;HINT1;SIRT1;TMEM109
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.39784471926479,-1.1282803505904613,0.32914572864321606,0.6240888282199525,1.0,7/19,14.14%,CSGALNACT1;NDST1;NDST3;EXT1;UGDH;GLCE;HS3ST3B1
prerank,mitotic spindle assembly (GO:0090307),0.38706518366431203,1.1278134430629119,0.29253731343283584,0.904737543202081,1.0,20/42,25.51%,CCDC61;LSM14A;AAAS;GOLGA2;CEP192;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;RHOA;KPNB1;SMC3;KIF11;KIF23;TPX2;TOGARAM1;STAG1;KIFC1
prerank,epithelial cell differentiation (GO:0030855),0.33274645703169003,1.1275658508537845,0.2559055118110236,0.904231456552471,1.0,9/88,9.06%,SCUBE1;HDAC1;BASP1;ERBB4;SCRIB;CASP6;E2F4;EDF1;GLI1
prerank,T cell migration (GO:0072678),0.4740211966592707,1.1274885933338223,0.3194444444444444,0.9031866962368112,1.0,4/13,16.96%,CXCL10;GPR183;MYO1G;PIK3CG
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.28450417584154536,-1.1274681240769775,0.2028301886792453,0.6252329888003743,1.0,30/87,19.39%,FBXL7;FHL1;KANK2;KLF4;PSMC6;PSMD9;PSMF1;APC;PSMB7;AVEN;CUL1;CDK6;PSMD8;PSMD12;WEE1;FAM107A;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;CDKN1A;PSMC1;PSMB10;DCUN1D3;DLG1;PSME2;RBL1;RGCC
prerank,sphingolipid metabolic process (GO:0006665),-0.2707376375072526,-1.127381050674875,0.15833333333333333,0.6245990266711821,1.0,35/108,21.49%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;SMPD3;ACER3;SGMS2;CERT1;PPP2R1A;DEGS2;SPNS2;VAPA;ST6GALNAC3;VAPB;HEXB;ENPP2;ELOVL4;UGCG;B3GALNT1;ELOVL7;ESYT3;SPTSSA;KDSR;SMPD1;GM2A;CLN8;ARSA;ORMDL2;CERS2;PSAP;GLTP;SPHK2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4623687256072084,1.1272239831887674,0.3158783783783784,0.9027729250413106,1.0,7/16,19.90%,PDE12;PINK1;AK4;SLC25A33;ATP7A;COX7A2L;UQCC2
prerank,steroid metabolic process (GO:0008202),0.34603790663816286,1.1268829133536622,0.28243243243243243,0.9026533155191291,1.0,2/72,0.29%,HSD11B1;CYP7B1
prerank,proteoglycan metabolic process (GO:0006029),0.4129111326974223,1.1265879334087954,0.3114503816793893,0.9023784311219814,1.0,2/26,0.66%,CHST8;SULF1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.31813534362226886,-1.126462116622649,0.24846625766871167,0.6260902857659626,1.0,8/46,3.64%,IGF1;FOXP1;OGN;IL18;THBS1;IGFBP5;IGFBP3;PRKDC
prerank,acylglycerol metabolic process (GO:0006639),-0.3334308471907101,-1.1262027599435622,0.28434504792332266,0.6258504511565023,1.0,10/37,14.45%,CAV1;DGKH;MGLL;PGS1;APOE;DGKG;ABHD2;LMF1;DGKZ;PLAAT3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.317485494800103,-1.1260749496443418,0.23452768729641693,0.6253492306903756,1.0,18/47,25.13%,FOXO1;EGFR;IGF1R;ARL6IP5;FAS;TGFB2;MAPK8IP3;MAP2K2;PPIA;MAPK8IP1;STK25;PER1;TGFBR3;MID1;QARS1;TAOK2;NOD2;GREM1
prerank,muscle tissue development (GO:0060537),-0.4366996272891067,-1.1259920540538897,0.29256594724220625,0.6247052667930617,1.0,4/13,14.79%,PGM5;SMO;CSRP2;STRA6
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.2941554700358953,-1.1259447962552203,0.23487544483985764,0.6239935623829307,1.0,19/65,18.27%,AFAP1L2;PTPRJ;EGFR;FER;PTPN3;HIP1R;CDC42;ERRFI1;MVP;ITGA1;PTPN2;CCDC88A;CEACAM1;RHBDF2;HIP1;GRB2;GPER1;AKT1;EGF
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4019904041744402,1.1257313674358058,0.29249617151607965,0.9039827412050301,1.0,12/31,22.09%,DNAJC19;PEX2;PEX7;TIMM44;DNAJC15;PAM16;PEX12;PEX14;PEX6;GRPEL1;TIMM21;CHCHD4
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.46706560844049444,1.1251522471930264,0.3092436974789916,0.9045819233960386,1.0,6/15,17.33%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.32691033492823374,-1.125095621489335,0.25825825825825827,0.625383151734301,1.0,9/39,10.61%,SLIT2;NRP1;TIE1;KDR;RASIP1;GLI2;SIX1;LRP6;NPNT
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4688782998989075,-1.1249554750851343,0.32608695652173914,0.6248489461620564,1.0,4/10,23.42%,KLF4;TLE5;MAP2K5;SIGIRR
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.41651676354106437,1.1246179540401509,0.29430379746835444,0.9050814709419501,1.0,3/22,2.62%,PTEN;NR2F2;CDKN2A
prerank,cellular response to hypoxia (GO:0071456),0.3221145534295354,1.124415087772502,0.2735961768219833,0.9044692393928544,1.0,35/126,19.13%,RORA;CPEB1;HIF1AN;PSMD1;TBL2;EPAS1;PSMD10;EGLN2;HP1BP3;PSMA5;PSMB5;MDM4;TWIST1;PINK1;MTOR;AK4;BMP7;PSMC4;KCND2;TP53;PSMA4;PSMC5;PTGIS;FAM162A;PSMB9;SCN2A;MYC;PSMA7;PSMD14;ADAM8;SUV39H2;PSMA2;HIF1A;PSMD11;ARNT
prerank,negative regulation by host of viral transcription (GO:0043922),0.4928186456779404,1.1243593489657504,0.3159722222222222,0.9033507060829895,1.0,2/12,4.28%,HDAC1;REST
prerank,focal adhesion assembly (GO:0048041),-0.3825037529898145,-1.1240493882500782,0.30512820512820515,0.6263226398841752,1.0,4/21,2.45%,SORBS1;ACTN2;PTPRK;THSD1
prerank,protein phosphorylation (GO:0006468),-0.22639844538154394,-1.1239831437755559,0.024390243902439025,0.6256339617351777,1.0,122/479,19.17%,FLT1;PRKAG2;DAPK1;EPHA4;MAP3K1;ROCK2;TEK;ERC1;PRKCH;MARK1;ERG;DCLK1;EGFR;TRIB2;IGF1R;FER;APP;BMPR2;RICTOR;CSNK1D;MARK4;NEK6;IGFBP3;KDR;CAMK2D;PRKDC;MAP3K5;INSR;GTF2H5;TOP1;TGFB2;SIK3;MINK1;WNK4;EPHB4;VRK3;PRKAA2;TLK1;MAPK9;CDK6;ADAM10;CDK17;SNRK;WNK1;HIPK3;MAPK14;PRAG1;NRBP2;SIK1;BMX;GSK3B;PKDCC;HIPK1;ACVR1;CDC42BPB;ACVRL1;FNIP2;TLK2;NEK7;STK38L;MAST3;DYRK2;RPS6KA5;LIPE;CDK19;PIK3CD;CAB39;CAMK2B;EPHB2;STK19;ATR;CDKL2;RPS6KA1;RET;EEF2K;FASTK;SRPK1;PRKCZ;HIPK2;PRKAG3;ATM;CSNK1G3;FLT4;BCR;PRKG1;PTK2B;RNASEL;STK25;TBCK;STK17B;CDC42BPG;CREB1;ERN1;MARK3;PRKCD;FLT3;TEC;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;AATK;MAP3K10;ACVR2B;ERBB2;STK32B;CDK9;AKT1;CSNK2B;EPHB3;FGFR3;NUAK2;EFEMP1;CSNK1A1;PRKG2;SBK1;WNT11;VRK2;MARK2;TGFBR3;MAP4K3
prerank,positive regulation of protein modification process (GO:0031401),-0.2494790642709637,-1.1239049109918118,0.16417910447761194,0.625001335406809,1.0,50/203,16.10%,TRABD2B;ROCK2;TEK;LEPR;PECAM1;FNIP1;EGFR;KRAS;APP;CSNK1D;LIMCH1;KDR;NIBAN1;CCND2;INSR;FAS;VEGFD;RAC1;DAB2;VEGFC;MAVS;ACE;TFRC;PPP1R7;EFNA5;RAMP1;CARD14;CALM1;TBX1;CCN1;PPP1R16B;FGF1;RALBP1;HDAC3;ITGB3;CAMTA1;RALB;TMEM119;FLT4;NOS1AP;PPIA;UBE2N;CCND1;CDH5;KAT5;RAPGEF3;SMPD1;PRKCD;SIRT1;GPER1
prerank,chromatin assembly (GO:0031497),0.379099652617255,1.1234289947638727,0.2971768202080238,0.9051977880589877,1.0,10/38,12.74%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;NOC2L;DAXX;TP53;NAP1L1;SOX9;POLE3
prerank,embryonic digestive tract development (GO:0048566),0.4481834288874964,1.121980840789546,0.325,0.9089218355890256,1.0,2/18,2.53%,PDGFRA;SALL1
prerank,cellular response to interleukin-7 (GO:0098761),0.4446611051879092,1.1216199041119017,0.30666666666666664,0.9075267836587467,1.0,4/17,6.25%,JAK1;TSLP;IRS1;IRS2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4446611051879092,1.1216199041119017,0.30666666666666664,0.9075267836587467,1.0,4/17,6.25%,JAK1;TSLP;IRS1;IRS2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2636844761305669,-1.1214002982585949,0.1902439024390244,0.6304576800901412,1.0,34/118,19.62%,PHLDB2;EPHA4;MEF2C;PDLIM5;BMPER;SIPA1L1;LARP4;SHANK3;SPARC;RUFY3;CAPZB;EFNA5;TBX1;GSK3B;MAPT;CFL1;RC3H1;SFRP1;ETS1;BCL9L;DAG1;CEACAM1;FLT4;LFNG;LZTS3;ARHGAP44;PAK2;EPHA2;ERBB2;EPHB3;PID1;MARK2;VASH1;SARM1
prerank,regulation of cytoplasmic translation (GO:2000765),0.4654220401988816,1.1210445021126365,0.32229965156794427,0.9081534996493151,1.0,5/14,14.93%,CPEB1;RBM24;FMR1;DHX36;DHX9
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.3361819107461174,-1.1202940125991545,0.28313253012048195,0.6324060381829123,1.0,7/35,7.65%,NR3C2;DDX5;RBFOX2;PPARGC1B;NCOA4;TMF1;WBP2
prerank,receptor metabolic process (GO:0043112),-0.30059610602878317,-1.119816191049853,0.25675675675675674,0.6327144382712065,1.0,11/53,8.32%,PICALM;CAV1;ITGB1;BECN1;UVRAG;ACKR3;TFRC;RAMP1;SNX25;DNM3;RAB31
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.29905900531948093,-1.1197955554127312,0.24232081911262798,0.631917262375638,1.0,24/59,22.72%,ROCK2;CAMK2D;PRKDC;WNK1;HIPK3;GSK3B;HIPK1;ACVR1;CDC42BPB;DYRK2;HIPK2;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;AKT1;CSNK2B;SBK1;MARK2;TGFBR2;TTBK1;STK39;CAD
prerank,potassium ion homeostasis (GO:0055075),0.41839146085885714,1.119652616378558,0.33003300330033003,0.9116894245947558,1.0,4/23,5.33%,ATP1A2;SLC12A6;ATP1A3;KCNMA1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.39883637978127046,-1.119117392096177,0.30455635491606714,0.6327755098765857,1.0,4/18,4.08%,PTGDS;PTGS1;PTGES3;PLA2G4A
prerank,positive regulation of cytokine production (GO:0001819),0.2931919432814854,1.1189869218106634,0.21618625277161863,0.912636552586818,1.0,34/292,10.90%,RORA;IL33;SULF1;XCL1;WNT5A;TXK;PLA2R1;CD40;IL16;PDE4B;GLMN;NR1H4;LURAP1;TSLP;SCRIB;SPTBN1;HTR2B;PTPN22;TLR6;SORL1;CD276;DHX58;TLR8;TWIST1;MBP;TLR4;DDX41;KAT2A;CYBA;IRAK1;FGR;EIF2AK2;DHX36;PYCARD
prerank,central nervous system neuron differentiation (GO:0021953),0.3940823618876048,1.1184272565057707,0.3296875,0.913257131750257,1.0,7/33,14.03%,NTRK2;GRID2;MDGA2;NPY;OPHN1;CBLN1;ATP7A
prerank,mitochondrial protein processing (GO:0034982),0.5023977553818372,1.1182069459330144,0.34285714285714286,0.9127591945256579,1.0,4/11,17.56%,OMA1;IMMP2L;PMPCA;IMMP1L
prerank,male gonad development (GO:0008584),-0.3310882200707747,-1.117878453564307,0.27932960893854747,0.6349810811903586,1.0,5/34,4.38%,KITLG;CSDE1;TGFB2;WNT4;NCOA4
prerank,nucleoside catabolic process (GO:0009164),-0.45848678258398806,-1.1177082636482354,0.31990521327014215,0.6345421840433332,1.0,4/11,10.80%,UPP2;DERA;UPB1;NT5E
prerank,sensory perception of light stimulus (GO:0050953),0.33236577405685286,1.1172469928048505,0.30859375,0.9147904733914678,1.0,7/87,3.76%,COL18A1;RDH10;ADGRV1;MYO7A;UNC119;DNAJC19;TYR
prerank,regulation of dendritic spine development (GO:0060998),-0.3883982667621722,-1.1170059918441615,0.3085399449035813,0.6354651093007436,1.0,7/19,11.76%,MEF2C;SHANK3;APOE;SHANK1;CAMK2B;CPEB3;DLG5
prerank,regulation of phospholipid metabolic process (GO:1903725),0.5125059141011158,1.1169456442876788,0.33098591549295775,0.9144792209473738,1.0,3/10,6.30%,DNAJC19;MTMR4;MTMR1
prerank,activation of protein kinase B activity (GO:0032148),0.40593429334696424,1.1168638270907099,0.30434782608695654,0.9135149430678859,1.0,7/29,9.11%,NTRK3;NRG1;WNT5A;PDPK1;PRR5;PINK1;MTOR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5065279280292905,1.1166853707019748,0.3629764065335753,0.9128397898068804,1.0,7/11,23.89%,MBTPS2;TP53;HSPA5;CREB3L1;ATF6B;DDIT3;ATF4
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.49964845215881404,1.1166806768350819,0.3596330275229358,0.9115823137856214,1.0,3/11,5.40%,GHR;PIK3R1;IRS1
prerank,cation transport (GO:0006812),-0.24938390845438804,-1.1163490375539957,0.1390728476821192,0.6363028069394262,1.0,25/167,12.29%,TRPM3;TRPM6;SLC47A1;ANO6;PIEZO2;SLC8A3;KCNK5;SLC6A6;ANO1;SLC9B2;SLC22A4;KCNJ13;KCNQ4;SLC7A1;SLC3A2;SLC41A1;SLC22A18;SLC38A5;KCNK9;KCNJ2;SCN7A;SLC6A17;TRPC6;SLC1A1;KCNJ12
prerank,positive regulation of cellular process (GO:0048522),0.28239635486015174,1.1159913053038388,0.18666666666666668,0.912614684663786,1.0,97/565,15.70%,PDGFRA;PTN;COLEC12;NTRK3;IL34;IL15RA;LRP1;ZFHX3;NRG1;MERTK;TMEM102;HOXC10;PTGFR;EDN3;MEIS1;ACOX2;HDAC1;WNT5A;NTRK2;TAF9B;PTEN;PHIP;ERBB4;ITGAV;FLT3LG;FGFR1;ANKLE1;GAB2;MEIS2;TSLP;TIPIN;RYR2;POU3F3;TBX3;FBXO5;TENM4;GCNT2;HTR2B;CDC7;FMR1;TUB;MTPN;IRS1;CDH3;PSMD10;IRS2;ECHDC3;SRF;FXN;LYAR;PTK2;TRPC3;HTR1A;CDK13;PRKCA;CCKBR;GLI1;LGMN;TSPYL5;TLR4;CYBA;CACUL1;SLC25A33;DHX36;PYCARD;POFUT2;RTKN2;NAP1L1;P2RX4;TGFBR1;ACLY;SOX9;IL12A;EXOSC9;CD86;IGF2;FAM98B;CD81;GAREM1;AKAP6;DHPS;MYRF;LYN;DOT1L;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;AREG;AR;GDNF;CNOT7;MYC;N6AMT1;FGFR2
prerank,regulation of microtubule-based movement (GO:0060632),0.49375984749485313,1.1159466682714632,0.329608938547486,0.9115229711476254,1.0,3/11,9.67%,NEFH;TTC21B;CCDC65
prerank,positive regulation of transport (GO:0051050),0.3355563866841619,1.1155858863770725,0.27873183619550856,0.9114614376514453,1.0,14/85,10.90%,IL15RA;LRP1;MERTK;GPLD1;KMT2A;FMR1;TUB;CDH3;CLIP3;LYAR;CYBA;PLAA;KCTD7;PYCARD
prerank,positive regulation of nervous system process (GO:0031646),0.437065878155914,1.1153593926531038,0.31494661921708184,0.911061376851439,1.0,5/18,13.88%,HCRT;TENM4;RIMS2;RIMS1;MYRF
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.4524634617768927,1.1142014978781265,0.3018867924528302,0.9136848225923028,1.0,5/16,17.72%,TOP2B;ERCC4;HFM1;EME2;TOP2A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.4497749955006284,1.1139030028169299,0.3261231281198003,0.9134017970872256,1.0,5/16,22.59%,VAMP2;ARL8B;VAMP7;PLEKHM2;ULBP1
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3157745909672757,-1.1138982571059566,0.271875,0.6418565008529121,1.0,16/47,20.22%,APP;KLF4;NFKB1;VPS35;APOE;RPL10;SSH1;TCOF1;NFKBIA;EIF2B4;NOLC1;AGTR1;EDN1;AKT1;WDR91;AGT
prerank,nuclear pore complex assembly (GO:0051292),-0.46716311074346245,-1.1138821411986706,0.3395784543325527,0.6410530313919925,1.0,5/10,21.49%,NUP98;NUP153;TMEM170A;NUP205;RTN4
prerank,positive regulation of cell death (GO:0010942),0.3530490094497643,1.1136580175927069,0.28966521106259097,0.9129647063029206,1.0,13/59,15.09%,LRP1;SLC6A13;ACOX2;WNT5A;GRIN2B;FOS;LRRK2;C1QA;DAXX;FYN;EIF2S1;RIPK1;CLU
prerank,in utero embryonic development (GO:0001701),0.4133545569030023,1.1131497598200804,0.3209302325581395,0.9134338345501897,1.0,7/25,18.02%,CHD7;PTPRR;TGFBR1;IGF2;ARNT2;FGFR2;BMP2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.4494078793522561,-1.112892201760908,0.3365617433414044,0.642821277781754,1.0,5/11,22.48%,TGFB2;ACVR1;TGFBR3;TGFBR2;SMAD7
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4856006006011047,1.1120618432510099,0.3257443082311734,0.915706826734509,1.0,5/11,14.92%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,extracellular matrix disassembly (GO:0022617),0.35886619063761926,1.1118275088158784,0.30939226519337015,0.9152229472351469,1.0,2/53,0.41%,SCUBE1;LAMC1
prerank,neuron remodeling (GO:0016322),-0.4522051527018327,-1.1114945293244036,0.3378684807256236,0.6455442095185273,1.0,3/10,5.80%,ANKS1A;APP;SCARF1
prerank,positive regulation of hormone secretion (GO:0046887),0.44196307652763545,1.1114505945238002,0.3436426116838488,0.9152740092060822,1.0,3/17,11.81%,EDN3;SPP1;VAMP7
prerank,cell-matrix adhesion (GO:0007160),0.32560395531821623,1.1113713181248865,0.2789473684210526,0.9142758498229158,1.0,12/95,7.55%,COL13A1;DLC1;ITGA11;ITGA8;PEAK1;ITGAV;ITGA3;ITGB5;SGCE;ACTN1;ADAMTS12;PPFIA2
prerank,positive regulation of MAPK cascade (GO:0043410),0.2968844233339478,1.1111277066135445,0.2491506228765572,0.9138554338044524,1.0,33/245,10.90%,ROR1;PDGFRA;NTRK3;IL34;XCL1;ROR2;EDN3;SLC30A10;NTRK2;CD40;ERBB4;C5AR1;P2RY1;FGFR1;GPR37L1;GCNT2;HTR2B;PTPN22;CCL15;LRRK2;GLIPR2;NECAB2;GPR183;PRKCA;SOX2;HTR2C;TENM1;MAP2K1;IRAK1;LPAR1;EIF2AK2;CCL25;PYCARD
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2654675270181856,-1.1110840120310335,0.22123893805309736,0.6458051946786364,1.0,25/101,12.98%,VIM;LARP4;EZR;THBS1;KLF4;ELAVL1;RDX;VPS35;PRKDC;NIBAN1;SAMD4A;LARP4B;RPL5;SOX4;CASP8;BAD;NFKBIA;PYM1;PERP;IST1;CPEB3;RPL26;EIF3D;RPS4X;VPS11
prerank,protein K48-linked ubiquitination (GO:0070936),-0.29989544114635425,-1.1110628984104298,0.2798507462686567,0.6450136522515229,1.0,17/54,21.80%,RNF152;RNF146;UBE2G1;PELI1;UBE2D3;IFI27;RNF8;UBE2H;UBE2A;AMFR;CUL3;CDC34;TNFAIP3;KLHL3;KBTBD7;RNF5;RFFL
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.4343948439077172,-1.1108765844746358,0.3062200956937799,0.644671389732615,1.0,3/13,6.45%,DDO;ACOT8;GOT2
prerank,regulation of intracellular protein transport (GO:0033157),-0.3433516024305474,-1.1106137183075446,0.2833333333333333,0.6445308429827461,1.0,10/32,17.59%,PTPN14;RUFY3;NDEL1;IFI27;PRR5L;CEP290;PTPN1;OAZ1;BCAS3;OAZ2
prerank,protein modification process (GO:0036211),-0.28150483294663503,-1.1102392299944683,0.2585551330798479,0.644734026151239,1.0,31/76,27.55%,ST3GAL6;ST8SIA4;CPE;PRKDC;WWP2;UBE2D3;ST3GAL1;FBXL2;MANBA;ST8SIA2;MMP15;CSNK1G3;USP25;PARP4;UBE2L6;NEDD8;YES1;QPCT;MCRS1;CDC34;ICMT;FBXO22;UBA52;PHEX;FBXW2;PARP1;BAP1;ADPRH;NAGPA;PHKA2;RABGGTA
prerank,positive regulation of protein binding (GO:0032092),-0.3023188583729409,-1.1101396713681984,0.2791519434628975,0.6441338677948502,1.0,16/56,15.41%,RAPGEF2;CAV1;APP;CLDN5;HIP1R;VTN;B2M;APOE;GSK3B;RPL11;RALB;TERT;HIPK2;RAN;AMFR;MARK3
prerank,phosphorylation (GO:0016310),-0.22676100083883458,-1.1100338584995664,0.08928571428571429,0.6435656728119005,1.0,101/385,19.17%,PRKAG2;DAPK1;MAP3K1;ROCK2;PRKCH;MARK1;ERG;DCLK1;TRIB2;FER;APP;BMPR2;CSNK1D;MARK4;NEK6;IGFBP3;CAMK2D;PRKDC;MAP3K5;DGKH;INSR;TOP1;TGFB2;SIK3;MINK1;WNK4;HK1;PRKAA2;TLK1;MAPK9;CDK6;ADAM10;CDK17;SNRK;WNK1;HIPK3;TOLLIP;PRAG1;NRBP2;SIK1;PGK1;BMX;GSK3B;HIPK1;ACVR1;CDC42BPB;ACVRL1;FNIP2;TLK2;DGKG;NEK7;STK38L;DYRK2;RPS6KA5;LIPE;CDK19;PIK3CB;PIK3CD;GNPTAB;CAMK2B;EPHB2;STK19;CDKL2;RET;FASTK;SRPK1;DGKZ;PRKCZ;HIPK2;PRKAG3;ATM;BCR;PRKG1;PTK2B;RNASEL;STK25;TBCK;STK17B;CDC42BPG;CREB1;ERN1;MARK3;PRKCD;TEC;PRKAA1;DYRK1B;TBK1;PAK2;PKN2;AATK;ACVR2B;ERBB2;CDK9;AKT1;NUAK2;CSNK1A1;PRKG2;WNT11;VRK2;MARK2;MAP4K3
prerank,brain morphogenesis (GO:0048854),0.4898053549761222,1.1097178706289286,0.3481349911190053,0.9172905316020338,1.0,2/12,1.89%,CTNNA2;PTEN
prerank,cellular component disassembly (GO:0022411),0.3592035087958657,1.1093403094380658,0.3185595567867036,0.9173159403846288,1.0,2/53,0.41%,SCUBE1;LAMC1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.43577062594505345,-1.1088935033811473,0.3182844243792325,0.6455801580721052,1.0,4/12,10.59%,ELF1;RUNX1;RC3H1;ELF2
prerank,glutamate metabolic process (GO:0006536),-0.39223176409130595,-1.108862557062983,0.31527093596059114,0.6448216139391069,1.0,4/19,9.04%,GCLC;PRODH;GOT2;OAT
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.44946985774725057,-1.1088147919442715,0.3436807095343681,0.6441048834047943,1.0,5/11,26.23%,ANXA1;RC3H1;SOCS5;SMAD7;JAK3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.42990992863242444,1.1086537751761867,0.3355048859934853,0.9184000658448013,1.0,7/22,17.43%,CASK;CDH3;PRKD1;MED1;AREG;FGFR2;SRSF6
prerank,negative regulation of myotube differentiation (GO:0010832),-0.4423274181001681,-1.108302129831948,0.3402777777777778,0.6445633687714802,1.0,5/12,12.99%,HDAC4;NOTCH1;CCN3;HDAC3;TMEM119
prerank,response to thyroid hormone (GO:0097066),-0.4295314429738904,-1.10782606321549,0.33774834437086093,0.6448998299789281,1.0,5/13,16.95%,RDX;LMO2;KLF9;CTSH;CTSS
prerank,response to amyloid-beta (GO:1904645),0.3703965057461259,1.1077787705832065,0.31845238095238093,0.920060240614198,1.0,11/44,11.12%,LRP1;GJA1;NGFR;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;GRM5;FYN
prerank,B cell receptor signaling pathway (GO:0050853),-0.3419446828077006,-1.1076718984877871,0.29714285714285715,0.6444414319009808,1.0,9/32,18.48%,MEF2C;CD38;BMX;BAX;PIK3CD;PLCG2;TEC;SH2B2;BLNK
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.22870170611958865,-1.106655986577956,0.12857142857142856,0.6460903476531152,1.0,91/348,18.76%,FN1;IGF1;SLC24A3;ROCK2;ITGB8;MEF2C;RBPJ;LEF1;OCLN;ROBO1;KRAS;AFDN;PPHLN1;OSR1;EZR;NOS3;APP;KLF4;FOXD1;CLDN5;RDX;MAGI2;VPS35;GSN;INSR;NOTCH1;ACTG1;SMO;INPP5F;RPL5;CD34;MAPK9;TFRC;RPS7;KLF2;MAPK14;NGF;PPM1F;GSK3B;CELF1;FGF1;LAMTOR5;SMAD3;ANK2;WNT6;RPL11;CITED2;PIK3CB;GATA2;PIK3CD;ETS1;PTPN1;EPHB2;TNRC6A;ATF7IP;CTSH;CD63;ACTA2;TNRC6C;PLCG2;HEY2;SMAD1;TMEM119;ATM;NOS1AP;WNT16;RAMP2;TICAM1;P2RX7;CDH5;MAP2K5;GPER1;PRKAA1;ZPR1;MED23;DNAJA4;HFE;CD74;LAPTM5;AGO2;AKT1;DNMT3B;SOX11;IFNGR1;EGF;SLC22A2;MSN;HOXD3;CTCF;PID1;WNT11
prerank,cellular response to ketone (GO:1901655),0.3793108801047457,1.1064295545611194,0.33781763826606875,0.9233027351210013,1.0,10/35,17.12%,PTGFR;ADCY5;SPP1;ADCY8;ADCY3;ADCY2;MAP4K1;GNG2;AR;PTGER4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.467913640445118,1.1057396097537195,0.33104631217838765,0.9243483631038505,1.0,5/15,11.47%,EDA;HDAC1;ANKRD11;AMELX;MSX1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.37286447536302625,-1.1057153033092841,0.2991913746630728,0.6475512964890411,1.0,5/21,7.53%,MEF2C;MAGI2;CALM1;MTMR9;ITGA1
prerank,protein heterotetramerization (GO:0051290),0.47038371114434624,1.105326095035953,0.3443478260869565,0.9244501334526072,1.0,3/13,10.19%,GRIN2B;HSD17B8;NUDT21
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.29319594160885004,-1.1052707584135821,0.2806451612903226,0.6478695465472266,1.0,27/57,29.30%,RPS16;RPL5;RPS7;RPS19;RPS24;RPS15;RIOK1;RPL35A;RPL11;RPL26;WDR12;PES1;NIP7;NPM1;PAK1IP1;GTF3A;GLUL;WDR74;RPL38;LTV1;RPF2;MRPL36;RPS25;LTO1;RRP36;NOP16;TGS1
prerank,type I interferon signaling pathway (GO:0060337),-0.3215767108930305,-1.1049588741538143,0.2905405405405405,0.6469068377494801,1.0,10/41,9.69%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IRF1;IFITM1
prerank,cellular response to type I interferon (GO:0071357),-0.3215767108930305,-1.1049588741538143,0.2905405405405405,0.6469068377494801,1.0,10/41,9.69%,SAMHD1;IFITM3;IP6K2;IRF2;IFI27;IFNAR1;IFI35;GBP2;IRF1;IFITM1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4585796411594809,1.1048067492161084,0.33503401360544216,0.9237225945464006,1.0,6/15,15.59%,NANOS3;ZFP36L2;DHX36;CNOT1;CNOT7;TNRC6B
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4585796411594809,1.1048067492161084,0.33503401360544216,0.9237225945464006,1.0,6/15,15.59%,NANOS3;ZFP36L2;DHX36;CNOT1;CNOT7;TNRC6B
prerank,glucose homeostasis (GO:0042593),-0.27253601876285183,-1.1045727948998316,0.21428571428571427,0.6470576548155704,1.0,16/83,10.30%,FOXO1;LEPR;IGF1R;FOXK1;ADIPOR2;KLF7;INSR;RBP4;HK1;PRKAA2;SOX4;HK2;KCNB1;LRRC8D;BAD;PTPN2
prerank,regulation of cartilage development (GO:0061035),0.43746292406855875,1.1044444527578474,0.3239202657807309,0.9237284906461457,1.0,6/18,12.02%,TRPS1;SOX6;ZBTB16;TAPT1;KAT2A;SOX9
prerank,positive regulation of programmed cell death (GO:0043068),-0.2316206105157268,-1.1041822632058558,0.11494252873563218,0.6472490061526677,1.0,79/272,22.61%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;ITGA6;MCF2L;TNFSF10;MARK4;HIP1R;IGFBP3;SQSTM1;MAP3K5;FAS;CYP1B1;UNC13B;APC;ATF6;CRADD;JMY;UBB;SOX4;IP6K2;NGF;CASP2;CASP3;NGEF;CASP8;BAD;SFRP1;BAX;BNIP3L;TNFAIP8;ADAMTSL4;BID;APH1A;TGM2;GADD45B;APH1B;ATM;BOK;PLEKHG2;ING4;ARHGEF11;STK17B;TRIM35;SMPD1;SIRT1;GPER1;ING5;AIFM1;DCUN1D3;LAPTM5;UBC;MAP3K10;TFPT;APBB1;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;RASGRF2;GADD45G;TRADD;ARHGEF12;HDAC6;E2F1;SPHK2;CCAR2;DDX20;UBA52;TIAM1;ARHGEF1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.43818699675019024,1.1041738192954502,0.3344947735191638,0.9233531834697757,1.0,7/18,18.02%,COLGALT1;FSCN1;IER3IP1;CARMIL2;CLASP2;CLASP1;BMP2
prerank,positive regulation of phosphorylation (GO:0042327),0.2946010468063568,1.1037735247973193,0.273972602739726,0.9234239821726743,1.0,31/240,10.56%,ROR1;PDGFRA;NTRK3;IL34;ZBTB20;EPHA7;ROR2;MERTK;NTRK2;CD40;ERBB4;EPHB1;PFKFB1;GLMN;P2RY1;FGFR1;ENTPD5;EPHA6;FMR1;DSCAM;CAMKK2;LRRK2;CLIP3;PTK2;PINK1;EPHB6;AXL;RB1CC1;DAXX;EPHA3;WDFY2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4018365731632779,-1.103361631029168,0.3015075376884422,0.6485086961227641,1.0,5/16,27.35%,CLDN5;CLDN12;CLDN11;CLDN10;CLDN1
prerank,heterochromatin organization (GO:0070828),-0.41433272726527254,-1.1033589029400808,0.3237410071942446,0.6476867610525944,1.0,6/14,16.92%,MECOM;PRDM16;SMCHD1;SIRT1;SNAI1;BAHD1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.32665564537927294,1.103273764977083,0.30039525691699603,0.923863057538696,1.0,16/90,9.82%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;SIRT6;EPAS1;FABP5;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.3748279491238159,1.1030387522388874,0.3020527859237537,0.9234084756894534,1.0,11/37,13.50%,TENM3;GRID2;TENM4;DCHS1;TENM2;ADGRL1;TENM1;AMIGO3;CBLN1;CADM3;NECTIN3
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4677943381685592,-1.1027997229226538,0.3363431151241535,0.6482936207234591,1.0,3/10,7.28%,MARK4;APC;GSK3B
prerank,sodium ion transport (GO:0006814),0.327784810958427,1.1027424446323117,0.30286493860845837,0.9232175967859081,1.0,14/85,13.61%,SLC6A13;SLC6A8;ATP1A2;NALCN;ASIC2;SCN2B;CATSPER3;ASIC1;HCN2;HCN1;HCN3;KCNK1;SCN1A;SCN2A
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3194999108701501,-1.1020798147070203,0.24861878453038674,0.6493906073522504,1.0,15/33,27.34%,NET1;SIRPA;MAP3K5;CYP1B1;ANXA1;ANKZF1;PRKCD;SIRT1;TNFAIP3;HDAC6;PPIF;OSER1;PARK7;ECT2;RHOB
prerank,regulation of potassium ion transport (GO:0043266),0.39039380057662804,1.1019324689200516,0.3302325581395349,0.9247013967510397,1.0,9/31,13.14%,DPP6;DPP10;ANK3;KCNIP1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3
prerank,positive regulation of endocytosis (GO:0045807),-0.31026739523931635,-1.101708982712759,0.27936507936507937,0.6495324380197939,1.0,16/45,17.51%,ANO6;VTN;GPC3;DAB2;CDC42;B2M;RAB21;APOE;RAB31;SERPINE1;CD151;HIP1;TOR1A;SMPD1;HFE;HNRNPK
prerank,pre-miRNA processing (GO:0031054),0.45267447005842926,1.1013524424650694,0.33094812164579607,0.9252806943632914,1.0,6/14,17.42%,AGO4;LIN28B;MRPL44;AGO3;ADAR;AGO1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.3750101676828739,-1.1012843024339252,0.340153452685422,0.6497910487506484,1.0,6/21,16.21%,SNTA1;ANK2;KCNQ1;FLNA;NOS1AP;SCN4B
prerank,purine nucleotide catabolic process (GO:0006195),-0.4269922936128998,-1.099668427304353,0.3219178082191781,0.6531079312817366,1.0,6/13,19.98%,XDH;GPX1;NT5E;HINT1;GDA;NT5C1A
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2733357771846525,-1.099556339264129,0.26666666666666666,0.652580861049781,1.0,20/79,15.79%,ST3GAL6;IGF1;CSGALNACT1;ST8SIA4;B3GALT1;BMPR2;ST3GAL4;B4GALT5;ST6GALNAC2;CHST11;ST3GAL3;MGAT1;LARGE1;FOXL1;ST8SIA2;B3GALNT1;FUT9;ST3GAL5;ST3GAL2;GCNT1
prerank,regulation of ossification (GO:0030278),0.37995406486998134,1.099340098600706,0.32781954887218046,0.9307153455259848,1.0,4/36,5.18%,ENPP1;PTN;WNT5A;ZBTB16
prerank,positive regulation of protein secretion (GO:0050714),-0.27996654812300253,-1.0992004184386688,0.22932330827067668,0.6526370440734774,1.0,16/69,14.24%,IGF1;MYRIP;EZR;PSMD9;RBP4;TGFB2;UNC13B;WLS;SOX4;NNAT;BAD;CD2AP;ACSL4;MYH10;GOLPH3L;PPIA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4950300084271759,1.0989279580786062,0.33634719710669075,0.930838342247313,1.0,5/10,14.92%,RPS6KA6;SP100;TP53;FOXM1;TFAP4
prerank,lipoxygenase pathway (GO:0019372),-0.4084236226893355,-1.097987098265246,0.31221719457013575,0.6548640050770769,1.0,4/14,19.42%,PON3;GPX1;PTGS2;ALOX12
prerank,cellular response to osmotic stress (GO:0071470),-0.3763997980840375,-1.0978450166108416,0.29473684210526313,0.6544484611995828,1.0,5/21,13.30%,MYLK;YBX3;LRRC8D;CAB39;TRPV4
prerank,ESCRT complex disassembly (GO:1904896),-0.46923102443479153,-1.0976426712819423,0.3579418344519016,0.6533526739896593,1.0,5/10,27.10%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,ESCRT III complex disassembly (GO:1904903),-0.46923102443479153,-1.0976426712819423,0.3579418344519016,0.6533526739896593,1.0,5/10,27.10%,CHMP2B;IST1;CHMP7;CHMP1A;CHMP2A
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3574568054419093,-1.0974652054225926,0.30446927374301674,0.6530039802971171,1.0,3/26,0.60%,EPHA4;PICALM;ROCK2
prerank,regulation of membrane repolarization (GO:0060306),-0.42386709715702486,-1.0972668007585655,0.3325526932084309,0.6527040315575288,1.0,3/13,10.97%,CAV1;KCNJ2;KCNQ1
prerank,protein localization to membrane (GO:0072657),-0.2450552687716864,-1.0970969727841426,0.19148936170212766,0.6523554780704023,1.0,35/187,9.20%,TSPAN5;RAPGEF2;ROCK2;ACTN2;CAV1;BSG;SYNE3;LIN7A;RAPGEF6;EZR;SHANK3;CDH1;F11R;CPE;RDX;MAGI2;EFR3B;S100A10;RAP1A;FYB1;ATP1B3;DVL1;PACS1;RAMP1;TTC7B;SH3PXD2B;LRP6;KCNB1;ITGB1BP1;ANK2;EHD4;KCNIP3;TSPAN17;FRMPD1;TTC7A
prerank,neutrophil degranulation (GO:0043312),-0.21837667999432386,-1.097047998127421,0.057692307692307696,0.6516504206064092,1.0,119/425,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,cellular amino acid catabolic process (GO:0009063),0.3262337803728856,1.0969429878112928,0.3097686375321337,0.9362963440999331,1.0,15/87,10.90%,GLDC;SLC25A21;MCCC1;KYNU;FAH;ACADSB;MTRR;ABAT;BLMH;HNMT;ASPA;DLST;HOGA1;ALDH5A1;BCAT1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3717414216764228,-1.096723388399832,0.3423180592991914,0.6516071317307618,1.0,7/22,6.94%,IGF1;ROCK2;MEF2A;CAMK2D;NOTCH1;IL6ST;LMCD1
prerank,regulation of inflammatory response (GO:0050727),0.2989827369169894,1.0960027594102695,0.28157589803012745,0.9382713966815732,1.0,21/190,9.55%,RORA;IL33;XCL1;PPARA;WNT5A;IL16;NR1H4;TSLP;TNFAIP8L2;PPARD;VAMP2;CASP4;ADAMTS12;ENPP3;BCL6;LRFN5;PTGES;PLA2G7;CD200R1;TLR4;BIRC2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3786949002300222,1.0959728006350764,0.3234375,0.9371599188358406,1.0,5/36,5.41%,DCN;HRG;NR2F2;JUP;ADGRB1
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.38555730407623323,-1.095524729656279,0.3299492385786802,0.6538319275788143,1.0,10/20,28.59%,ROCK2;RHOQ;RAB13;FHOD1;LLGL2;DLG1;STRIP1;IKBKB;FMNL1;NCKAP1L
prerank,neutrophil mediated immunity (GO:0002446),-0.216924309699744,-1.0940838960529142,0.07692307692307693,0.6564901014578627,1.0,121/432,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;ACE;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;IRAK4;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,cellular response to interleukin-4 (GO:0071353),0.493133391821136,1.09397219371702,0.3531468531468531,0.9428106291082249,1.0,1/10,0.79%,XCL1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.42680659041159846,1.0938495790593807,0.35331230283911674,0.9419519902847748,1.0,6/20,18.74%,EPAS1;PINK1;DAXX;TGFBR1;DCUN1D5;HIF1A
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2509722130863704,-1.0936302906608972,0.22388059701492538,0.6567827656118524,1.0,49/166,19.47%,SORBS1;IGF1;VIM;LARP4;EGFR;THBS1;KLF4;LPGAT1;ELAVL1;PRKDC;NIBAN1;INSR;SAMD4A;GIPC1;LARP4B;RPL5;GLI2;KLF2;SOX4;SCARB1;SMAD3;DYRK2;PYM1;STARD4;PTPN2;CPEB3;RPL26;EIF3D;RPS4X;PTH1R;PCNA;STN1;ASS1;DDAH1;MFSD2A;NOS1AP;ZNF205;PTGS2;EDN1;SIRT1;EIF3E;EPM2AIP1;ERBB2;AKT1;ABCB10;EGF;HGF;RGCC;NPM1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.45198135420756425,1.0934219184772291,0.3777038269550749,0.9421386007914567,1.0,5/15,13.81%,ENTPD2;ENTPD5;AK4;ENTPD7;AK8
prerank,regulation of viral release from host cell (GO:1902186),-0.3767508926808212,-1.092656923676955,0.3252032520325203,0.658446345579689,1.0,5/21,6.68%,CHMP2B;TRIM25;TRIM5;TRIM11;VPS37B
prerank,retinoic acid metabolic process (GO:0042573),-0.4149831664164808,-1.092587499400944,0.36829268292682926,0.6578031986827726,1.0,2/14,1.57%,ALDH1A2;CYP26B1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.36334406603158564,-1.0922018608330928,0.32717678100263853,0.6580366498260942,1.0,11/23,36.20%,MBOAT1;PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;PLA2G4C;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4598902404083084,-1.0916668689534466,0.36486486486486486,0.6586935221096544,1.0,2/10,1.78%,ROCK2;IL18
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2253972344097745,-1.0916506207483005,0.136986301369863,0.6579290655336049,1.0,85/348,18.28%,PDGFD;PRKAG2;IGF1;RAPGEF2;ROCK2;TEK;LEPR;CAV1;PTPRJ;PECAM1;FNIP1;EGFR;KRAS;APP;NRP1;BMPR2;CSNK1D;IQGAP1;LIMCH1;CSPG4;KDR;NIBAN1;RAP1A;CCND2;INSR;FAS;TGFB2;VTN;VEGFD;RAC1;DAB2;VEGFC;MAVS;TFRC;EFNA5;NGF;PDGFA;CARD14;CALM1;TBX1;CCN1;CD44;ACVR1;FGF1;ACVRL1;FNIP2;RALBP1;PDGFC;RPS6KA5;ENPP2;CAB39;CX3CR1;HDAC3;ITGB3;RALB;ALS2;PLCG2;NOS1;TAB2;TMEM119;FLT4;PTK2B;PPIA;NBN;CCND1;RAPGEF3;CX3CL1;RAP2C;CDKN1A;TEC;SIRT1;GPER1;TBK1;PAK2;GDF11;HFE;CD74;TWSG1;ERBB2;CDK9;AKT1;CSNK2B;LCP2;EGF;SDCBP
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3029572177724507,-1.0913390038921547,0.29102167182662536,0.6579028577956992,1.0,22/48,27.47%,ACTB;DDX21;SF3B1;WBP2;SMARCA5;MYO1C;MYBBP1A;POLR2H;SERTAD1;ARID1B;POLR1H;TAF1C;POLR1G;SPHK2;POLR1C;PHF2;SMARCD1;ELOF1;PADI2;CDCA4;CHEK1;POLR2K
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.2828116506693588,-1.0912292446353862,0.30935251798561153,0.657373747274602,1.0,15/66,9.79%,NFIB;CAV1;ROBO1;PTPRK;THBS1;SPARC;TGFB2;CAV2;CDK6;B2M;APOE;XDH;ATOH8;KLF9;SFRP1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4352795872104394,-1.0903182906797202,0.36792452830188677,0.6589251458987031,1.0,5/12,21.36%,CSGALNACT1;FUT8;UGP2;EXTL2;GFUS
prerank,kinetochore organization (GO:0051383),0.4678022077455116,1.089750257892556,0.36042402826855124,0.9534501162648951,1.0,5/13,15.58%,CENPE;CENPC;CDT1;CENPW;CENPF
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.30594737092642715,1.0896928388706253,0.309265944645006,0.9523695921551673,1.0,19/140,11.57%,PDGFRA;PTGFR;ADCY5;C5AR1;P2RY1;ACKR2;CCR9;RYR2;ADCY8;CALCA;C1QTNF1;LPAR3;TRPC3;CCKBR;HTR2C;LPAR1;P2RX4;DLG4;IAPP
prerank,primary neural tube formation (GO:0014020),0.39364641022679053,1.0896543739267621,0.3619344773790952,0.9512368723898019,1.0,4/30,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,positive regulation of cell cycle process (GO:0090068),0.3300521279434691,1.0896473392280053,0.3258278145695364,0.950015518189952,1.0,13/91,12.42%,SVIL;CDC14B;RXFP3;EDN3;PHIP;FEN1;CDC7;CEP295;GPSM2;WIZ;NUSAP1;USP19;IGF2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.4169320350120561,-1.0896225601766978,0.36551724137931035,0.6599315902534223,1.0,5/13,24.32%,PARP10;PARP9;PTGS2;NAXE;NAPRT
prerank,cell-cell junction assembly (GO:0007043),-0.28378877094316474,-1.089523267171534,0.26666666666666666,0.659332296648657,1.0,24/63,19.86%,PKP4;TJP1;VCL;ACTB;CLDN5;CDH8;ACTG1;GJB2;CTNND1;RHOC;GJC1;GJD3;CLDN12;GJB6;TRPV4;RAMP2;CDH5;CTNNA1;PAK2;PKN2;CD9;CLDN11;PKP2;CNTNAP1
prerank,regulation of NMDA receptor activity (GO:2000310),0.3880497500796768,1.0893294638838389,0.33890577507598785,0.9497786120572395,1.0,10/32,12.92%,GRIA3;GRIN2B;GRIA4;GRIA1;DLG3;DLG2;GRIN2A;RELN;DLG4;LRRC7
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.43535873476649567,1.0891364751822323,0.35537190082644626,0.9492088219416079,1.0,4/18,10.50%,NRXN1;CACNG3;RELN;CACNG4
prerank,neurotransmitter secretion (GO:0007269),0.3626391964359948,1.0889145762046086,0.3269513991163476,0.9486553518127689,1.0,14/44,18.61%,NRXN2;PTPRN2;NRXN1;VAMP2;RIMS2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4039603844914615,1.0886720800350882,0.32896890343698854,0.9481819303125012,1.0,5/24,6.84%,PIK3R1;HRG;MAP4K4;IQSEC1;COL16A1
prerank,positive regulation of macrophage migration (GO:1905523),0.42816199812020217,1.088556782192949,0.342668863261944,0.9473434160709842,1.0,7/19,21.50%,IL34;PTK2;P2RX4;AKIRIN1;CMKLR1;RARRES2;MAPK1
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.3871483060941056,-1.0881313778358823,0.34366925064599485,0.6621109689930189,1.0,13/19,38.37%,DRG1;CHMP2B;CHMP4B;PDCD6IP;CHMP1A;CHMP4C;HSPA1A;CHMP2A;HSPA1B;TPR;PLK1;HNRNPU;CHMP3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4149205629407243,1.0880354907433,0.32792207792207795,0.9478648280691307,1.0,3/23,4.06%,TXK;JAK1;NR1H2
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2180711891814838,-1.0879217123038187,0.058823529411764705,0.6617898691742202,1.0,119/428,21.33%,ANXA3;B4GALT1;PTPRB;AMPD3;ANO6;CTSC;VCL;PTPRJ;PECAM1;DIAPH1;ATP8A1;NFKB1;CST3;HMOX2;BRI3;PYGB;SIRPA;IQGAP1;GSN;KCMF1;RAP1A;CD55;HSPA8;STOM;DERA;S100A11;FUCA1;RAC1;PSMB7;PLEKHO2;CD93;ADAM10;CYB5R3;TOLLIP;VAPA;MAPK14;ATP11B;YPEL5;B2M;CAT;MVP;CD44;VCP;RAB5C;PGLYRP1;CEP290;RAB31;GYG1;MANBA;HEXB;PSMD12;EEF1A1;SRP14;CAP1;CAB39;IST1;GAA;CTSH;CD63;COTL1;DYNC1H1;PGM2;TMC6;CMTM6;CEACAM1;PAFAH1B2;SURF4;PGRMC1;PKM;NIT2;ALDOC;LAMTOR3;GCA;OSTF1;GHDC;NBEAL2;HGSNAT;PFKL;PSMD7;PPIA;CPNE3;IGF2R;CTSZ;RAP2C;ARSB;PRKCD;RAB3D;APEH;KCNAB2;CYSTM1;ATP6AP2;FTL;RAB6A;CTSS;ALDOA;RAP2B;CSNK2B;LAMP2;GM2A;QPCT;SDCBP;MLEC;STK11IP;DYNC1LI1;ARSA;RAB37;LRG1;DNAJC3;APRT;GALNS;DOK3;AGPAT2;PGM1;PSAP;MIF;FAF2;PSMC3;IQGAP2;DOCK2
prerank,negative regulation of endocytosis (GO:0045806),-0.35953262940527875,-1.0872151976692397,0.32299741602067183,0.6626717436719536,1.0,4/24,5.15%,PICALM;CAV1;MCTP1;RAC1
prerank,response to retinoic acid (GO:0032526),-0.2938677885637044,-1.0868239643155924,0.2857142857142857,0.6629126868943543,1.0,16/59,15.29%,WNT5B;ACER2;WNT9A;RBP4;RXRA;FZD4;FZD7;TBX1;WNT6;TRIM16;CTSH;RET;ATM;GATA6;PTK2B;CREB1
prerank,tube closure (GO:0060606),0.39075822221434187,1.0866651328338315,0.35893416927899685,0.9512363946194881,1.0,4/31,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,inorganic anion transmembrane transport (GO:0098661),0.3363929314983423,1.0865096878651814,0.32303370786516855,0.9505071027765116,1.0,16/63,15.70%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;GLRA3;GABRG2;GLRA1;GLRA2;SLC25A30;GABRB1;LRRC8A;SLC25A14;GLRB
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4490251276359139,1.0864369691792182,0.36593591905564926,0.9495160057679912,1.0,3/16,5.15%,AUTS2;OGT;ARHGAP24
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.44855012456481674,1.0864067919115017,0.3565365025466893,0.9483861935357304,1.0,4/16,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2799003619430317,-1.0858868104844135,0.25862068965517243,0.6643944315050618,1.0,14/79,6.23%,CRIM1;SMAD6;BMPER;SLIT2;LEMD3;NBL1;THBS1;BMPR2;SKIL;NOTCH1;SKI;UBE2D3;SULF2;EPN2
prerank,receptor internalization (GO:0031623),-0.3079718792321137,-1.0858226218207963,0.2739273927392739,0.6637550068622643,1.0,12/44,14.58%,PICALM;CAV1;ITGB1;ACKR3;TFRC;RAMP1;RAB5A;DNM3;RAB31;CEACAM1;GRB2;RAMP2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2244632113235242,-1.0855801174863138,0.20202020202020202,0.6635344307036821,1.0,47/260,11.90%,ABLIM1;RAPGEF2;ABCC4;ANO6;FGD5;ACTN2;VCL;FNBP1L;BBS9;EXOC6;MYLK;RAPGEF6;ITGB1;NTN1;EZR;CDC14A;NRP1;PARVB;S1PR1;EXOC4;FXYD5;GSN;RAP1A;RAB23;NOTCH1;EXOC5;MINK1;OFD1;RAC1;SRGAP2;ARL6;KIF24;CYS1;DNM3;CEP290;CEP162;EHD4;EXOC2;RFX3;IFT140;SPATA13;RAB3IP;CCDC88A;GALNT11;RP2;CD2AP;TMEM237
prerank,cellular protein modification process (GO:0006464),-0.20346346862924355,-1.0854885428260916,0.16666666666666666,0.6629635709836217,1.0,298/983,24.42%,PRKAG2;FN1;DAPK1;ST3GAL6;PTPRB;FBXL7;MAP3K1;ROCK2;PRKCH;PPM1E;MARK1;PTPRJ;ERG;ST8SIA4;B3GALT1;DCLK1;TRIB2;FER;PTPRK;LMO7;THBS1;PTPN3;IGFBP5;GAN;MTM1;APP;FSTL1;CPE;PTP4A2;CST3;BMPR2;KLHL13;CSNK1D;ASB2;PTPN4;MARK4;PSMC6;NEK6;IGFBP3;CAMK2D;PPM1L;ST3GAL4;PRKDC;MAP3K5;PTPN14;INSR;PSMD9;WWP2;PTPRG;TGFB2;ART3;SOCS2;B4GALT5;EGLN3;UBE2D3;SIK3;MINK1;ANXA1;PSMF1;HIF3A;WNK4;GPC3;ST3GAL1;PSMB7;PRKAA2;TLK1;MAPK9;CUL1;CDK6;ADAM10;CDK17;SERPIND1;SNRK;WNK1;PPP2R1A;HIPK3;OGA;PTPRF;ST6GALNAC2;PRSS23;FBXL2;SIRT3;PRAG1;NRBP2;NUCB1;SIK1;PPM1F;TNKS2;APOE;CCN1;BMX;GSK3B;HIPK1;ACVR1;ZC3HAV1;RAB5A;UBE2F;CDC42BPB;UST;ACVRL1;TNC;FNIP2;MSLN;ST3GAL3;MGAT1;LARGE1;LAMB2;TLK2;NEK7;MANBA;NGLY1;STK38L;KLHL11;CTTNBP2NL;DCAF8;PSMD8;DYRK2;SSH1;PIGU;RPS6KA5;LIPE;FBXL19;CDK19;PSMD12;PPM1D;PIK3CD;ASB5;KLHL20;PPEF2;SHISA5;RAB13;CAMK2B;PTPN1;PARP10;VHL;PARP9;PPP3CC;ST8SIA2;STK19;CUL9;CDKL2;NEURL2;SPSB4;UGCG;GPAA1;LHPP;RET;FASTK;SRPK1;TGM2;KCTD6;B3GALNT1;PRKCZ;PSMA3;LOXL1;HIPK2;PSMA6;PRKAG3;ATM;MMP15;PSMD4;CSNK1G3;PSME3;FBXL4;GOLM1;BCR;FUT9;PRKG1;RAB38;PPP2R5D;PTK2B;PSMD7;RNASEL;ST3GAL5;USP25;PSMB6;F5;STK25;TBCK;STK17B;CDC42BPG;ELOC;CREB1;ERN1;PSMC1;MARK3;PRKCD;CHRDL1;FBXO32;PARP4;TEC;ST3GAL2;SBF1;UBE2L6;SIRT1;PSMB10;PRKAA1;RAB1A;DYRK1B;TBK1;PAK2;PKN2;FBXL14;NEDD8;CUL3;AATK;FNTB;ISG15;DCUN1D3;OARD1;ASB7;ACVR2B;RBBP7;ERBB2;MAN2A1;NAA80;YES1;B3GNT2;CDK9;AKT1;MFGE8;PPP1CB;QPCT;NUAK2;PPP2R5B;CSNK1A1;PRKG2;CCDC8;WNT11;SIRT5;VRK2;PSME2;STT3B;MARK2;MAP4K3;MTMR2;KLHL25;PTPN5;MCRS1;MKNK1;DNAJC3;MACROD1;NUS1;CDC34;RAB1B;ASB8;GPS1;PKN3;PIM2;SOCS5;KLHL3;ASB6;TGFBR2;PSMC3;WDR45;ICMT;PIGK;KBTBD7;PENK;FBXO22;NEK10;B3GNT9;CDKL4;FBXL8;UBA52;TTBK1;PHEX;FBXW2;PASK;STK39;CISH;FBXL18;PSMA8;IKBKE;ACVR2A;FSTL3;FBXO10;SOCS3;CTDP1;ST8SIA6;BRD2;F13A1;CDK16;PLK4;IKBKB;FN3K;PAK4;PTPRE;MPI;COQ8A;GRK4;TAOK2;PARP1;MT3;PARP2;BAP1;RSKR;PTPN6
prerank,bone development (GO:0060348),-0.31721634509589175,-1.085299576609234,0.3096774193548387,0.6626127186424478,1.0,8/39,7.72%,RANBP3L;CYP26B1;GNAS;RPL13;SKI;SULF2;SH3PXD2B;LRP6
prerank,response to interleukin-4 (GO:0070670),0.48590757951257174,1.0852415646688267,0.3673469387755102,0.9512971160082158,1.0,1/10,0.79%,XCL1
prerank,regulation of postsynapse organization (GO:0099175),0.389837750337071,1.085159475828085,0.3566009104704097,0.9503359001782801,1.0,8/28,8.22%,ARHGAP22;WNT5A;CDKL5;LRRK2;PPFIA2;ABHD17C;ABHD17B;TANC2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4051361044671957,1.0849193362099527,0.347682119205298,0.9499344927365642,1.0,8/26,17.33%,ADCY5;GPLD1;NR1H4;ADCY8;PPP3CB;EPHA5;BRSK2;ADRA2A
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.34762315618382666,1.084570135427013,0.3581267217630854,0.9498737067614775,1.0,14/57,13.79%,GRIA3;GRIN2B;CACNG3;GRIA4;GRIA1;DLG3;DLG2;GRIN2A;RELN;CACNG4;SHISA6;DLG4;LRRC7;DLGAP3
prerank,ncRNA transcription (GO:0098781),-0.4209390333949531,-1.084366395610821,0.3674832962138085,0.664008075665271,1.0,5/13,22.51%,CAVIN1;SNAPC3;NIFK;POLR1G;GTF3A
prerank,regulation of DNA repair (GO:0006282),-0.309912423536969,-1.0841575608774505,0.3106796116504854,0.6637046093961435,1.0,12/44,17.82%,EYA2;EYA1;EGFR;EYA4;TRIP12;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;SIRT1;CDK9
prerank,fatty acid beta-oxidation (GO:0006635),0.34912053743337845,1.0841207093151553,0.33994334277620397,0.9501690705151111,1.0,7/51,6.33%,ACOX2;ABCD2;PEX2;PPARD;ACADL;CRAT;ACADS
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3917857300458174,-1.0839261175008588,0.31695331695331697,0.6634943796355869,1.0,6/17,16.10%,MEF2C;TPM1;SOD2;PRKG1;CDKN1A;GPER1
prerank,miRNA metabolic process (GO:0010586),-0.3734317842734855,-1.0837031824942136,0.3661616161616162,0.6632667755679106,1.0,5/20,6.98%,DGCR8;TUT7;PARN;DICER1;DROSHA
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3841109751567515,-1.0834115224594396,0.337468982630273,0.6631885584201413,1.0,3/18,4.84%,FLT1;MEF2C;COL4A3
prerank,GTP metabolic process (GO:0046039),0.4472609629485025,1.0830758785326333,0.3596638655462185,0.9525116447523341,1.0,9/15,21.60%,LRRK2;AK4;OPA1;MFN1;ENTPD7;AK3;EFL1;IMPDH2;GNAI3
prerank,chordate embryonic development (GO:0043009),0.34910684057022245,1.0830504744225424,0.34854771784232363,0.9513769462940062,1.0,5/55,3.03%,CHD7;SULF1;WNT5A;PTPRR;FGFR1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.43587115012198213,1.0827507055307264,0.3602693602693603,0.9511401064218784,1.0,6/17,19.03%,ERCC5;NEIL3;TERF1;MUTYH;MBD4;TERF2IP
prerank,neuronal action potential (GO:0019228),0.40677648223683155,1.0824987829789714,0.35081967213114756,0.9507720386261462,1.0,6/22,21.35%,ANK3;CACNA1G;SCN1A;SCN2A;SCN8A;CACNA1I
prerank,peptidyl-asparagine modification (GO:0018196),0.3834549179704185,1.082383369164825,0.3580060422960725,0.9499228804553252,1.0,7/31,12.21%,HIF1AN;RPN2;OSTC;DAD1;ALG5;MCFD2;TUSC3
prerank,cellular response to interferon-gamma (GO:0071346),-0.26926895538435175,-1.0822216310890593,0.28879310344827586,0.6654697400175212,1.0,20/88,11.59%,DAPK1;GBP7;SIRPA;CAMK2D;NCAM1;TRIM25;GBP5;TRIM5;B2M;CD44;IRF2;GBP4;GBP2;MT2A;IRF1;CAMK2B;ICAM1;CAMK2G;GAPDH;GBP6
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.361231481847884,1.0819681904244711,0.3435672514619883,0.9501390221925714,1.0,6/44,7.97%,CYP7B1;ACOX2;OSBPL3;OSBPL6;SC5D;PER2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3913605466830191,1.0814571182258526,0.37318255250403876,0.9506473221280872,1.0,7/28,15.09%,CCDC22;PTEN;FMR1;PTK2;PSMC5;AXIN1;CLU
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4393220500183877,1.0810703391680903,0.36824324324324326,0.9507041487396255,1.0,6/17,18.55%,GJA1;N4BP2L2;FERMT2;KAT7;LTBP3;CCNE1
prerank,protein polyubiquitination (GO:0000209),-0.22420999335458547,-1.0808514622787866,0.2,0.6683393498106595,1.0,88/297,23.59%,FBXL7;WWP1;RNF152;LMO7;UNKL;RNF146;UBE2G1;PSMC6;PELI1;PSMD9;WWP2;ARIH1;CDC23;UBE2D3;PSMF1;PSMB7;TRIP12;CUL1;ANAPC10;TRIM5;UBB;TRIM14;TNKS2;IFI27;HERC6;RNF8;UBE2H;SMURF2;TRIM36;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;KLHL20;ZFP91;RNF144B;RNF41;RNF114;UBR2;PSMA3;PSMA6;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;UBE2N;PSMB6;TRAF3;PSMC1;FBXO32;TRIM27;ANAPC13;UBE2L6;PSMB10;FBXL14;SIAH2;CUL3;ANAPC11;UBC;CHFR;ANKIB1;PSME2;FZR1;CDC34;TNFAIP3;KLHL3;ANAPC2;PSMC3;RNF166;PRPF19;KBTBD7;RNF5;TRAF1;RFFL;FBXO22;FBXL8;MKRN1;UBA52;FBXW2;FBXL18;PSMA8;FBXO10;SMURF1;RLIM
prerank,spindle assembly (GO:0051225),0.3366082025792423,1.0807584571004976,0.3507362784471218,0.9505521258899786,1.0,21/67,18.72%,CCDC61;HAUS3;HAUS1;LSM14A;AAAS;STARD9;HAUS8;GOLGA2;CEP192;RCC1;TUBGCP4;MAP9;CLASP2;TUBGCP6;KIFC2;KIF2A;CLASP1;GOLGA8B;SMC1A;RHOA;KPNB1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3801193001727116,1.0806824062533147,0.35222052067381315,0.9495889076351325,1.0,6/31,13.42%,CDC14B;PTEN;GOLGA2;PINK1;DCUN1D5;AXIN1
prerank,regulation of telomerase activity (GO:0051972),-0.30027875687632977,-1.0805855116194663,0.3300653594771242,0.668218242566837,1.0,11/45,15.67%,HMBOX1;KLF4;PTGES3;SMG6;PARN;NEK7;MAP2K7;CCT4;ATM;MAP3K4;PARP4
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.391457886079612,-1.0804846958339687,0.3564356435643564,0.6677063810931626,1.0,2/17,4.08%,LPGAT1;PLA2G4A
prerank,positive regulation of response to external stimulus (GO:0032103),0.30787088347204666,1.0804323420361086,0.3266832917705736,0.9491906507360809,1.0,13/128,9.80%,IL33;PTN;HRG;WNT5A;IL16;TSLP;DHX58;TLR8;AKIRIN2;PLA2G7;PRKCA;TLR4;CYBA
prerank,positive regulation of cell population proliferation (GO:0008284),0.2780038649327993,1.0801772507022478,0.27899686520376177,0.948870817983539,1.0,86/423,17.40%,PDGFRA;PTN;NTRK3;IL34;LAMC1;LAMB1;NRG1;HOXC10;PTGFR;EDN3;MEIS1;HDAC1;WNT5A;NTRK2;PTEN;TCF7L2;PHIP;ERBB4;C5AR1;ITGAV;FLT3LG;FGFR1;GAB2;MEIS2;TSLP;TIPIN;GJA1;POU3F3;TBX3;FBXO5;GCNT2;HTR2B;CDC7;IRS1;PRKCI;SIRT6;IRS2;FXN;PTK2;HTR1A;CDK13;CCKBR;GLI1;LGMN;TSPYL5;CACUL1;SLC25A33;ZFPM2;RTKN2;NAP1L1;TGFBR1;SOX9;CD86;IGF2;FAM98B;CD81;GAREM1;DHPS;PIM1;LYN;NME1;DOT1L;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;DHX9;AREG;AR;GDNF;CNOT7;MYC;MAP3K3;FGFR2;NDUFS4;GDF9;NOX1;CCPG1;STAMBP;MAZ;CALR;ADRA2A;ASH2L;RHOG
prerank,potassium ion export across plasma membrane (GO:0097623),0.45300697535458706,1.0800686444206717,0.3703071672354949,0.948026052420698,1.0,3/13,10.97%,KCNT2;KCNIP2;KCNE4
prerank,regulation of telomere maintenance (GO:0032204),0.4035437420776188,1.0800675878790575,0.373015873015873,0.9468282256532089,1.0,8/26,15.40%,GNL3;ERCC1;SIRT6;ERCC4;PIF1;DHX36;HNRNPD;MYC
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.26423071586222857,-1.0798170322099472,0.27705627705627706,0.668657448662421,1.0,36/95,23.64%,SMAD6;DKK3;CAV1;LEMD3;LTBP4;THBS1;SKIL;SKI;DAB2;GIPC1;CD109;UBB;ASPN;SNX25;SMURF2;SMAD3;SNX6;PRDM16;CITED2;BCL9L;SPRED3;HIPK2;SIRT1;TGFB1I1;UBC;HTRA4;SOX11;SDCBP;TGFBR3;VASN;ADAMTSL2;TGFBR2;UBA52;SMAD7;SMURF1;RNF111
prerank,cardiac myofibril assembly (GO:0055003),0.44436342269106477,1.0797873331464172,0.36971830985915494,0.946519202814262,1.0,1/15,0.14%,PDGFRA
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.40471359426471903,-1.0797226617717792,0.36553524804177545,0.6680753584146,1.0,4/16,4.26%,IGF1;MEF2C;RBPJ;NOTCH1
prerank,negative regulation of signal transduction (GO:0009968),0.2854879859847261,1.079719164282941,0.3129251700680272,0.9455452670322811,1.0,39/249,14.69%,APOD;ENPP1;DCN;LRP1;SULF1;HRG;SPRY4;PTPRT;SPRY1;PTEN;HIF1AN;PIP4K2A;NKD1;PTCH2;NEDD4;IRS1;LRRK2;ADAMTS12;RPS6KB1;LRRC14;BEND6;DCC;LGMN;PRKCB;TLE1;NKD2;GLI3;TNS2;UBASH3B;CBLN1;IL12A;HGS;GSK3A;CNOT1;HERC4;LYN;CTNNBIP1;CREB3L1;ASXL1
prerank,negative regulation of protein modification process (GO:0031400),-0.27058257052668644,-1.079627896314628,0.25390625,0.6675300827028169,1.0,24/79,16.14%,OCLN;SLIT2;PLPP3;SNTA1;SIRPA;IGFBP3;PRKDC;NIBAN1;PRKAA2;YWHAB;GSK3B;XDH;PRR5L;LRP6;PPP1R16B;MAPT;DMD;EPHB2;TARDBP;CRTAP;PPIA;CDYL;SIRT1;PRKAA1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.486400252288438,1.0795309087638902,0.3805147058823529,0.9450001731870021,1.0,4/10,17.18%,GALNT13;POGLUT3;POGLUT2;GALNT2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.47796131178706025,1.0791087313294259,0.3591549295774648,0.9451665658813231,1.0,4/11,18.96%,REST;PINK1;FYN;STK26
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2993788942920015,-1.0790917449206734,0.29491525423728815,0.6680843533918776,1.0,10/49,13.64%,SGMS1;CAV1;BCL2L1;BECN1;MCL1;BAD;BAX;BID;CYLD;BOK
prerank,maturation of SSU-rRNA (GO:0030490),-0.3212422887372858,-1.0790776985184094,0.33815028901734107,0.6673224541296344,1.0,9/34,13.27%,RPS14;RPS16;DDX52;RPS19;LSM6;RIOK1;UTP3;RIOK3;RPS8
prerank,skeletal muscle tissue development (GO:0007519),0.3779242586289708,1.0784826479897973,0.343701399688958,0.9460658759423239,1.0,2/32,0.73%,SVIL;MSC
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.33106981691255766,-1.0782374564454613,0.3373493975903614,0.6687109735463354,1.0,8/30,11.62%,FOXP1;DDX5;KDM4C;SMARCA4;DAB2;KLK2;SFRP1;HEYL
prerank,pancreas development (GO:0031016),0.4810816513599478,1.0778603837744773,0.38178633975481613,0.9469059973364472,1.0,2/12,3.13%,TCF7L2;NPHP3
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2609225377676709,-1.0775326119836188,0.29523809523809524,0.6698126916804461,1.0,18/99,10.97%,RAPGEF2;MEF2C;SLIT2;ACTB;EZR;DIAPH1;IGFBP5;CDH1;RAP1A;SH3BP4;PDE3A;RAPGEF1;LAMTOR5;SSH1;SFRP1;RRAGC;CPEB3;KCNQ1
prerank,sterol transport (GO:0015918),0.4279508922896708,1.0771732234799185,0.3717948717948718,0.9479441057641441,1.0,8/19,26.01%,NPC1L1;LDLRAP1;ARV1;OSBP;NPC2;OSBPL5;MSR1;LCAT
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3650655757141907,1.077009836636749,0.3613569321533923,0.9473207938872091,1.0,9/44,14.06%,SPRY4;SPRY1;DUSP1;PTPN22;SORL1;NF1;BMP7;PDCD4;LYN
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.24544573888650165,-1.0768363416364963,0.25842696629213485,0.6707709442702088,1.0,40/151,17.88%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ST3GAL4;PLA2G4A;ACER3;B4GALT5;SGMS2;CERT1;ALAS1;NFS1;DEGS2;SPNS2;VAPA;APOE;LARGE1;GCH1;VAPB;DMD;ELOVL4;ASS1;ELOVL7;MFSD2A;FURIN;MOCS1;CHKB;SPTSSA;KDSR;GSTA4;PCSK5;ST3GAL2;GCNT1;GSTT1;ESD;PCTP;CSNK2B
prerank,striated muscle tissue development (GO:0014706),-0.33889956384513975,-1.0761887402794745,0.3240223463687151,0.6716389968192824,1.0,7/29,5.87%,MEF2C;CAV1;PGM5;BMPR2;MYL6;RBP4;SIX1
prerank,B cell activation (GO:0042113),-0.2795226143916969,-1.0758533342926815,0.30689655172413793,0.671670703660927,1.0,17/68,18.48%,MEF2C;PTPRJ;TPD52;ITGB1;HDAC4;CTPS1;CASP8;DNAJB9;PIK3CD;PTPN2;EPHB2;PLCG2;SLC25A5;FLT3;VCAM1;HHEX;BLNK
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42317527351174794,1.0755853386455565,0.36593591905564926,0.9507956350612019,1.0,3/21,3.66%,DCN;BGN;VCAN
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2853831854285769,-1.0755303317796991,0.31986531986531985,0.6717096449975245,1.0,18/54,20.15%,FIGN;EZR;HOOK1;MAPT;TUBGCP5;KATNAL2;FIGNL2;CRIPT;CCDC88A;SLAIN2;DYNC1H1;TRPV4;CCDC88C;DST;DLG1;CAMSAP2;NUMA1;CIB1
prerank,metanephric mesenchyme development (GO:0072075),-0.4445724345522613,-1.0755241274111416,0.3722943722943723,0.6709264039074414,1.0,3/10,5.87%,OSR1;WNT4;SIX1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.469126286669593,1.0754555774458934,0.3953488372093023,0.9500494029413498,1.0,3/12,5.31%,NUP214;AAAS;NEDD4
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3888110533711876,-1.0754400487335454,0.35279187817258884,0.670355034108107,1.0,6/17,20.48%,IL18;CD55;BACH2;GNL1;BTN3A3;CD46
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4538604550608548,1.0749988188271327,0.3787610619469027,0.9503505601440592,1.0,2/13,3.59%,PTPRT;TSLP
prerank,regulation of myotube differentiation (GO:0010830),-0.3575171890988048,-1.0749586188757605,0.35543766578249336,0.6707887127840257,1.0,12/24,28.15%,HDAC4;NOTCH1;CCN3;MAPK14;SIK1;HDAC3;TMEM119;PIEZO1;FBXO22;BHLHE41;BDNF;HDAC5
prerank,sphingolipid biosynthetic process (GO:0030148),-0.28123982208331577,-1.074924471905567,0.2825278810408922,0.6700951753721027,1.0,21/71,15.28%,SGMS1;SPTLC2;PLPP3;HACD4;ACER2;HACD1;PPM1L;ACER3;SGMS2;CERT1;DEGS2;SPNS2;VAPA;LARGE1;VAPB;ELOVL4;ELOVL7;ST3GAL5;SPTSSA;KDSR;SMPD1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.41975630141696063,-1.0748550030578843,0.3485576923076923,0.6694890173929471,1.0,6/12,15.99%,FOXP1;SMARCA4;DAB2;SFRP1;HEYL;SIRT1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.4472472058027278,-1.074598768946748,0.35516372795969775,0.6693458965197735,1.0,3/11,4.00%,PICALM;ACTN2;GOPC
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3005331288443267,1.0742304156938136,0.3281437125748503,0.9517343063475222,1.0,33/149,17.82%,ROR1;EDA2R;EDA;WNT5A;CD40;IL18RAP;TLR6;MTPN;PRKCI;CAPN3;FLOT2;TRIM37;PRKD1;TRIM8;PRKCB;TLR4;IL1RAP;IRAK1;EIF2AK2;PYCARD;RTKN2;RNF31;UBE2V1;RIPK1;DHX9;CLU;AR;TIRAP;ZBTB7A;LGALS9;ADAM8;MYD88;CAMK2A
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.3854262634917684,-1.074115769950256,0.35278514588859416,0.6697540742669558,1.0,5/19,4.27%,MEF2C;RBPJ;RBP4;NOTCH1;RUNX1
prerank,cilium assembly (GO:0060271),0.2815593216441321,1.0739466954642196,0.3025027203482046,0.9514498377634011,1.0,77/297,20.83%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;DCTN3;HAUS3;DYNC2LI1;RSPH9;HAUS1;GBF1;CCDC57;DCTN2;RAB8A;DISC1;E2F4;DNAAF3;IFT81;HAUS8;FAM161A;KIFAP3;PRKACA;CEP192;TTC21B;SNAP29;CCDC65;CEP135;AHI1;RPGRIP1;TCTN2;IFT74;SSNA1;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;IQCB1;GAS8;SSX2IP;RFX2;TNPO1;IFT88;RAB11FIP3;CEP126;SCLT1;TXNDC15;ACTR2;DYNLL2;TRIP11;CEP250;KIF3C;CEP152;CCDC39;CSNK1E;PTPDC1;CLASP1;IFT43;CLUAP1;ALMS1;BBS1;PCM1;ATP6V0D1;WDR90;MKS1;CEP19;TUBA1A;CEP43;NUDCD3;DZIP1L;UNC119B;KIF3A;TTC39C;BBS4;ABLIM3
prerank,neuromuscular process (GO:0050905),0.4469341997775713,1.0734290366826535,0.38294314381270905,0.9519909223010048,1.0,2/16,3.00%,MYCBP2;NRXN1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.4133257204820028,1.0734090434371064,0.3822525597269625,0.9508786906563959,1.0,7/19,16.74%,CAMKK2;PINK1;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,regulation of vasoconstriction (GO:0019229),-0.34470169562322084,-1.0734069319997783,0.35843373493975905,0.6708245689583708,1.0,7/27,6.33%,CAV1;BMPR2;ADRA1B;ZDHHC21;ACE;BDKRB2;ATP2B1
prerank,determination of left/right symmetry (GO:0007368),-0.315172634046732,-1.0730756938606398,0.3128654970760234,0.670885788893964,1.0,15/37,21.05%,NOTCH1;OFD1;SMO;MEGF8;ARL6;TBX1;CITED2;RFX3;GALNT11;ZIC3;MKKS;DNAH11;ENKUR;BBS7;DNAH5
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4178513185153012,-1.073016787014238,0.3696682464454976,0.6702591371544092,1.0,5/13,29.18%,ITGB1;SREBF2;CD9;ITGB2;PPARG
prerank,fatty acid catabolic process (GO:0009062),0.33075733353116643,1.072206622110569,0.3310344827586207,0.9536918388338083,1.0,17/67,18.89%,LPIN3;ABCD2;CEL;PEX2;PPARD;ACADL;ACADS;ACAT2;SLC25A17;NUDT19;LPIN2;PECR;MMAA;MMUT;MCEE;ALDH3A2;ECI2
prerank,cholesterol biosynthetic process (GO:0006695),0.37831210985488484,1.0719801314838184,0.36793893129770994,0.953248693912926,1.0,7/31,11.95%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.3407874386528855,1.0718361977679824,0.34911242603550297,0.9525337775411077,1.0,17/56,18.46%,CECR2;UNC119;DCTN3;SPTBN1;ANK3;EFHC1;SEPTIN9;JTB;NUSAP1;INCENP;RTKN;STMN1;CEP55;STAMBP;SPIRE1;CUL7;RHOA
prerank,regulation of receptor internalization (GO:0002090),-0.3176835457251507,-1.0717362647108046,0.33043478260869563,0.6727308814775335,1.0,14/35,26.88%,MAGI2;RIN3;INSR;CD63;EGF;SDCBP;MTMR2;TBC1D5;ANKRD13D;NTF3;GREM1;FLOT1;ARRB2;ARF1
prerank,cardiac muscle cell development (GO:0055013),0.4097723327539146,1.0715917772839858,0.3842443729903537,0.9521954934250343,1.0,1/20,0.14%,PDGFRA
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4860509852809738,1.0715740542150838,0.3890845070422535,0.9510705092275364,1.0,2/11,8.18%,LIPC;PLA2G7
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2965871550971976,1.0708734313324686,0.3218116805721097,0.9521758236065319,1.0,36/158,20.19%,ROR1;MAP3K14;EDA2R;CCDC22;CD40;TSPAN6;LURAP1;GJA1;HTR2B;TLR6;TNFRSF19;PINK1;PRKD1;TRIM8;PRKCB;BIRC2;IRAK1;LPAR1;NDFIP2;DHX36;LGALS1;RNF31;UBE2V1;F2R;RIPK1;MAP3K3;TIRAP;NDFIP1;LGALS9;MYD88;RHOA;ATP2C1;TERF2IP;PLEKHG5;GPR89A;DDX1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.40368463001793914,1.070675618221511,0.3629160063391442,0.9516911260484434,1.0,4/22,9.11%,ZBTB20;PPARA;PPARD;MTOR
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.42721587266451994,-1.0705822555485027,0.381057268722467,0.6749100058005452,1.0,5/12,22.72%,UPP2;TK2;DCK;CDA;CAD
prerank,neuromuscular synaptic transmission (GO:0007274),0.4279238024969747,1.0703511498325289,0.3723228995057661,0.9515967198225229,1.0,4/18,10.19%,CHRNB4;CHAT;FCHSD2;ERC2
prerank,import into cell (GO:0098657),0.36127265986786394,1.0703252861254833,0.3514774494556765,0.9505143991559418,1.0,5/41,4.87%,SLC1A3;SLC6A13;ATP1A2;SLC12A6;SLC7A8
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.32069999469281335,1.0698741522839619,0.35157318741450067,0.9507745267294806,1.0,28/84,22.86%,RBFOX1;TRA2B;NOVA1;RBM24;REST;PRDX6;FMR1;KHDRBS3;WTAP;CELF4;SMU1;DDX17;CWC22;RBFOX3;SNW1;SRSF10;ZBTB7A;SRSF9;RBM5;HNRNPL;SRSF6;KHDRBS1;FXR1;RBM15;RBM25;SRSF12;CELF6;DAZAP1
prerank,organelle fusion (GO:0048284),-0.3586692772800365,-1.06984641138368,0.3525,0.6760906173661804,1.0,8/22,20.96%,EEA1;VPS18;MIEF1;USP30;BAX;VPS11;CHCHD3;MIGA1
prerank,nucleic acid-templated transcription (GO:0097659),-0.309666421332765,-1.0693815844759738,0.3409090909090909,0.676457404507005,1.0,13/42,20.91%,MEF2A;PTMA;DRG1;RRAGC;NR4A2;POLR2B;POLR2H;TERT;POLR2G;POLR2C;HOXD3;CREBL2;E2F1
prerank,gastrulation (GO:0007369),-0.39190369763241084,-1.069218928926239,0.3681592039800995,0.6760620469666198,1.0,4/15,15.83%,GPC3;MEGF8;UGDH;MKKS
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3837275097154809,1.068861932727974,0.3630769230769231,0.952979834702407,1.0,4/30,3.66%,DCN;BGN;DSE;VCAN
prerank,negative regulation of receptor binding (GO:1900121),-0.44772204183214304,-1.0685794631522059,0.3841059602649007,0.6769402119843593,1.0,4/10,17.14%,PTPRF;B2M;ATP2A3;HFE
prerank,cellular iron ion homeostasis (GO:0006879),-0.28831170686298424,-1.0680957901840848,0.3110367892976589,0.6774466074027006,1.0,21/55,24.44%,ABCG2;HMOX2;CUL1;TFRC;SCARA5;ACO1;CYB561A3;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;TMEM199
prerank,protein-DNA complex disassembly (GO:0032986),-0.3877665453058279,-1.0680915766942107,0.3829787234042553,0.6766707262553573,1.0,12/16,42.39%,ARID2;SMARCA4;SMARCC2;SMARCD3;RPL23;SMARCD1;SET;ARID1A;GRWD1;NFE2;SMARCB1;HMGA1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.4649725726102905,1.0676803710274798,0.37630662020905925,0.9556672031758158,1.0,3/13,7.03%,GPR37L1;LRRK2;PYCR1
prerank,positive regulation of axon extension (GO:0045773),-0.35298499534719563,-1.067476772941321,0.3544973544973545,0.6774135971839518,1.0,8/22,13.68%,NTN1;SEMA7A;NRP1;RUFY3;MEGF8;MAPT;GOLGA4;MACF1
prerank,cellular response to pH (GO:0071467),0.4299974502084672,1.0674528070877067,0.38747884940778343,0.9552457134281298,1.0,5/17,17.53%,GPLD1;SLC9A1;ASIC1;IMPACT;MCOLN1
prerank,positive regulation of ossification (GO:0045778),0.3644003669258243,1.0672343978723464,0.3720588235294118,0.9548688788143073,1.0,5/39,5.18%,PTN;GPM6B;ADGRV1;WNT5A;ZBTB16
prerank,regulation of autophagy (GO:0010506),-0.23368485427843852,-1.0671758110655492,0.2706766917293233,0.6773878668311487,1.0,52/216,16.14%,PRKAG2;DAPK1;FOXO1;LEPR;RNF152;FOXK1;KDM4A;MCL1;ACER2;EXOC4;VPS35;ATG13;RASIP1;SREBF2;ATF6;PRKAA2;SH3BP4;TRIM5;FBXL2;TRIM14;GSK3B;MTMR9;SNX32;CASP3;DAPL1;LAMTOR5;MAPT;TLK2;SNX6;BAD;EEF1A1;PIK3CB;RRAGC;OPTN;TMEM59;PIP4K2C;GAPDH;HSPB1;TAB2;PRKAG3;LAMTOR3;ATM;BOK;VPS29;RAB39B;TICAM1;KAT5;UCHL1;ERN1;MET;TRIM27;PRKAA1
prerank,positive regulation of histone acetylation (GO:0035066),-0.35179901280884784,-1.0670341222989832,0.37468354430379747,0.6769770587671822,1.0,9/23,26.15%,GLYR1;WBP2;RPS6KA5;NOS1;TADA2B;RUVBL2;SPHK2;BRCA1;SMAD4
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.3034700546416068,-1.066520085856244,0.34551495016611294,0.6775517272228899,1.0,15/44,17.67%,ROCK2;PRR5L;ZC3HAV1;CELF1;CNOT8;BTG2;RC3H1;TNRC6A;CPEB3;TNRC6C;POLR2G;TOB1;PABPC1;GTPBP1;AGO2
prerank,DNA methylation (GO:0006306),0.39828031770619526,1.0661028025118624,0.3836065573770492,0.9572975542906006,1.0,9/23,22.92%,KMT2E;FOS;MTRR;DMAP1;N6AMT1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,cellular response to ATP (GO:0071318),0.45078965908254354,1.0660663919904478,0.3935810810810811,0.9562472386126414,1.0,4/14,13.68%,P2RY1;P2RX4;HSP90B1;RYR3
prerank,regulation of macroautophagy (GO:0016241),-0.254607830890125,-1.065994513685325,0.3076923076923077,0.6781449940406207,1.0,33/105,22.24%,PRKAG2;EXOC4;KDR;VPS35;ATG13;SESN1;PRKAA2;NRBP2;SNX32;CASP3;LAMTOR5;SNX6;RRAGC;CLEC16A;BNIP3L;GAPDH;PAFAH1B2;PRKAG3;LAMTOR3;UCHL1;ERN1;SIRT1;PRKAA1;TBK1;ATP6V0E2;AKT1;ATP6V0A2;RRAGB;EXOC8;HDAC6;ATG101;ATP6V0D2;ATP6V0A1
prerank,histone H4-K16 acetylation (GO:0043984),0.42118612636241703,1.0659562477341322,0.3947826086956522,0.9554231726005741,1.0,6/19,11.31%,OGT;KMT2A;WDR5;MSL1;KANSL1;JADE1
prerank,mesonephric tubule development (GO:0072164),0.4422549075057226,1.0658951390628848,0.37434094903339193,0.9544189829032717,1.0,2/15,2.53%,ROBO2;SALL1
prerank,regulation of lipid metabolic process (GO:0019216),0.3129100800525911,1.0654934100497382,0.34183673469387754,0.9545594263075884,1.0,25/88,21.85%,RORA;PPARA;NCOA2;PPARD;C1QTNF2;SC5D;IRS2;CHD9;EDF1;NCOA1;HMGCS1;MBOAT7;CARM1;MED1;SREBF1;ELOVL6;IDI1;NR1D2;PANK2;NPC2;SP1;BBS4;RARRES2;ACACA;CREBBP
prerank,cellular response to insulin stimulus (GO:0032869),0.2989294607814877,1.0654273549897761,0.3446969696969697,0.9535935760968425,1.0,22/124,13.09%,ENPP1;LPIN3;PIK3R1;CPEB1;PHIP;GPLD1;EPRS1;PDPK1;PIK3R2;VAMP2;IRS1;PRKCI;RAB8A;IRS2;RPS6KB1;GCK;SLC25A33;RAB15;PDK2;IGF2;GSK3A;ATP6V0E1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4682867741389648,1.0653035219765077,0.3912280701754386,0.9528357949485589,1.0,2/12,5.48%,GNL3;CCT5
prerank,protein deneddylation (GO:0000338),0.47769443433027736,1.0652130622719345,0.4052173913043478,0.9519544498934902,1.0,2/10,12.53%,COPS3;COPS4
prerank,regulation of axon regeneration (GO:0048679),0.45910668878071065,1.0642312125070703,0.3992673992673993,0.9540284912568868,1.0,1/12,0.19%,PTN
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.4357595191895778,-1.0641561258014725,0.3967889908256881,0.6820447337260962,1.0,4/11,18.30%,FOXO1;NOTCH1;LMNA;GLRX3
prerank,cellular response to drug (GO:0035690),-0.34300729435167543,-1.063955244066299,0.32941176470588235,0.6817568259998704,1.0,7/25,10.97%,PPM1E;MEF2C;ACER2;TFRC;PPM1F;RBM22;KCNQ1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.28463138465035437,-1.0638905830878576,0.3389830508474576,0.681151895224088,1.0,23/59,24.33%,ROCK2;ERC1;IRAK2;UBB;AZI2;NFKBIA;NKIRAS1;TAB2;TICAM1;TBK1;TNFRSF1A;UBC;AKT1;TIFA;LY96;TRADD;BIRC3;TLR7;UBA52;REL;BCL10;IKBKB;IKBKG
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.27197680257092066,-1.0637247149158702,0.32280701754385965,0.680786343625087,1.0,18/67,13.71%,CAV1;TBC1D19;PODXL;FER;RABEP2;RDX;TBC1D8;RAC1;TBC1D22B;CAPZB;CDC42;PPP1R16B;RAB5A;ATP8B1;IFT140;TBC1D22A;CYLD;TBC1D10B
prerank,negative regulation of insulin secretion (GO:0046676),-0.3799460447773725,-1.0630702583771194,0.3674540682414698,0.6816385161316115,1.0,5/17,9.79%,KLF7;PSMD9;CCN3;KCNB1;SFRP1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3103292190161202,-1.0627339841691334,0.3371757925072046,0.681688773163521,1.0,5/41,4.78%,PTGS1;PLA2G4A;CYP1B1;ACOT8;MGLL
prerank,toxin transport (GO:1901998),0.4892669272810508,1.0625770346263932,0.39399293286219084,0.9582451508384369,1.0,3/10,8.89%,ANTXR2;RAB40B;RAB29
prerank,positive regulation of cell development (GO:0010720),-0.32736701591126705,-1.0624361957911017,0.3638814016172507,0.6817318564637517,1.0,13/31,26.31%,PDE3A;BAD;RFX3;NIBAN2;CX3CR1;TGM2;GPER1;SOX11;TYROBP;MME;SPEN;LIG4;NUMB
prerank,cellular biogenic amine metabolic process (GO:0006576),0.46124899675812236,1.062241768429012,0.4017094017094017,0.9581479316489107,1.0,4/12,14.03%,ODC1;HNMT;TRH;ATP7A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.45441142872188556,1.0620749085798797,0.39482758620689656,0.9575601642162619,1.0,7/13,16.16%,LRRK2;AK4;OPA1;MFN1;ENTPD7;AK3;EFL1
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.3641335010077687,-1.0618391390647983,0.3647342995169082,0.6823586359286166,1.0,6/21,11.64%,PGM2L1;DERA;HK1;TALDO1;HK2;PGM2
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.38884372821869334,1.0608892489774633,0.38827258320126784,0.9603444057460371,1.0,8/29,15.31%,RBM24;FMR1;DND1;TAF15;PAIP1;TENT5A;EIF4ENIF1;GDNF
prerank,cellular response to gamma radiation (GO:0071480),-0.37617321346086996,-1.0608599115939914,0.3588516746411483,0.6840826317395046,1.0,6/17,16.30%,CRYAB;TLK2;ATR;RPL26;ATM;TMEM109
prerank,positive regulation of exocytosis (GO:0045921),0.36898549637703243,1.0607533656345414,0.3698630136986301,0.9596424271862986,1.0,12/35,18.98%,CADPS2;CADPS;RAB15;HGS;TSG101;CLASP2;SNF8;CLASP1;STXBP5;VPS4B;RAB2B;ATP6AP1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3378449178557287,-1.0606788288090252,0.3532608695652174,0.6837767366843118,1.0,10/25,19.65%,RBPJ;BMPR2;FOXD1;NOTCH1;CCN1;ACVRL1;CDH5;ACVR2B;SOX11;NUMA1
prerank,cellular response to cadmium ion (GO:0071276),-0.3607878085396413,-1.059909654005408,0.3803191489361702,0.6850075463726947,1.0,16/24,33.24%,EGFR;MAPK9;MT2A;AKT1;MT3;SUMO1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;JUN;HSF1
prerank,response to zinc ion (GO:0010043),0.3993481602772707,1.0598135044341677,0.3707865168539326,0.9615303684914709,1.0,6/25,12.98%,PAM;SLC30A5;SLC30A3;GLRA1;P2RX4;GLRA2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3984288144928425,1.0596827865986491,0.39123630672926446,0.960795253999642,1.0,5/23,13.64%,ENPP1;PTCH2;GLI3;HERC4;RFX4
prerank,innate immune response in mucosa (GO:0002227),-0.44233798682682757,-1.0595920897775581,0.3930131004366812,0.6850227458242909,1.0,8/10,53.59%,RPL39;RNASE3;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,response to lipid (GO:0033993),-0.25020470097678665,-1.0590666284766481,0.32547169811320753,0.685580531120962,1.0,21/105,13.46%,SMAD6;FOXO1;FOXP1;FER;NOS3;LBP;ACER2;PELI1;RBP4;SOCS2;ANXA1;RXRA;ALPL;IFNAR1;PAQR7;GCH1;TRIM16;CTSH;NOS1;TAB2;GATA6
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4113761729728655,-1.058694858752055,0.3897058823529412,0.6858121275833108,1.0,3/13,4.26%,RBPJ;CPE;NOTCH1
prerank,vasoconstriction (GO:0042310),0.46851540264833025,1.0586319514297824,0.4194107452339688,0.9631171958772913,1.0,2/11,4.84%,EDN3;HTR2B
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4031848948590543,-1.0583144048840967,0.3632183908045977,0.6860222147767314,1.0,5/14,19.69%,RAPGEF2;PRKAR2A;PRKAR2B;SIRT1;ADRB2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.40564944391400487,1.0583138168105612,0.3734513274336283,0.9629920633330937,1.0,5/20,11.21%,AGO4;SPOUT1;ZC3H7B;MRPL44;AGO3
prerank,nucleus organization (GO:0006997),-0.29527235485489384,-1.057865747684635,0.3546325878594249,0.6864316480516033,1.0,16/47,20.04%,LEMD3;ATXN7;CHMP2B;RPS19;NUP98;REEP3;TOR1A;TMEM170A;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;NUMA1;PDCD6IP;CHMP1A
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.32059814572207657,-1.0575056933527656,0.34688346883468835,0.6866293929161409,1.0,7/33,8.29%,MEF2C;THBS1;KLF4;NOTCH1;APOE;ACVRL1;ITGB1BP1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3874642024601429,1.05750013743441,0.38351822503961963,0.964500943927371,1.0,3/27,3.66%,DCN;BGN;VCAN
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.29570301705269875,-1.0574632018941277,0.34615384615384615,0.685953922771486,1.0,14/44,22.66%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;ACVR1;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,phosphatidylcholine metabolic process (GO:0046470),0.325589714514036,1.0568951581166375,0.3788487282463186,0.9652666870552227,1.0,13/70,15.90%,LPIN3;GPLD1;NR1H2;CHAT;LIPC;PLA2G7;CHKA;MBOAT7;STARD10;PLA2G12A;LPIN2;ABHD4;CSNK2A2
prerank,amino acid import (GO:0043090),0.40392064376343034,1.0568937589649126,0.3758169934640523,0.9641217098232624,1.0,3/21,4.87%,SLC1A3;SLC6A13;SLC7A8
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3256880032952988,1.0566583618187508,0.35802469135802467,0.9637804462224421,1.0,7/68,6.65%,ENPP1;MMAB;PDXK;MCCC1;GSTO2;MTRR;MTHFD1L
prerank,regulation of cellular protein localization (GO:1903827),-0.302386368391827,-1.0564435570180706,0.3395061728395062,0.6876947886208659,1.0,16/45,18.27%,VCPIP1;NDEL1;GPC3;DVL1;PRKAA2;PPM1F;VCP;MAPT;PTPN1;SUMO3;RALB;TOR1A;KCNAB2;PRKAA1;HFE;EGF
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3478241883037455,1.056428912273452,0.3641703377386197,0.9633892792102743,1.0,8/46,9.41%,SPRY1;PTEN;PTPRR;CNKSR3;SPRED1;RPS6KA6;SPRED2;TLR4
prerank,cellular response to peptide (GO:1901653),0.33825263166338065,1.0563766612566843,0.3665223665223665,0.9624139365237271,1.0,13/56,11.12%,LRP1;GJA1;NGFR;PTPN22;TLR6;ATP1A3;GRIN2A;CASP4;LGMN;TLR4;TP53;GRM5;FYN
prerank,response to cholesterol (GO:0070723),0.4296284698839954,1.0563660116698608,0.41390205371248023,0.9613015138885195,1.0,2/17,2.27%,GRAMD1B;GPLD1
prerank,response to cAMP (GO:0051591),-0.31597918997299684,-1.056319945544621,0.3542319749216301,0.6872561196903929,1.0,11/37,23.30%,RAPGEF2;EZR;IGFBP5;RAP1A;RAPGEF1;KCNQ1;RAPGEF3;SLC26A6;DMTN;CFTR;RAP1B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4042565052346866,-1.0561986171992686,0.38497652582159625,0.6868226072174817,1.0,5/14,13.58%,LIMS2;ITGB1BP1;PHACTR4;CD63;FLNA
prerank,cellular response to organic cyclic compound (GO:0071407),0.29813526473577323,1.056180867090386,0.3450789793438639,0.9607919439416329,1.0,28/141,13.82%,RORA;ADCY5;ATP1A2;NR1H4;P2RY1;JUP;NCOA3;CASP6;SPP1;ATP1A3;LRRK2;PDE12;ADCY8;ADCY3;ADCY2;HCN2;HCN1;GABRG2;HCN3;P2RX4;SPIDR;TRPM2;HSP90B1;AKAP6;NRIP1;RYR3;MED1;GABRB1
prerank,regulation of cell projection organization (GO:0031344),0.45449001476633416,1.0561779049966429,0.3674911660777385,0.9596696471871843,1.0,4/13,18.88%,ERMN;NTNG2;NTNG1;SPRY2
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.4426539145665439,-1.0561346168961139,0.413953488372093,0.686223519004171,1.0,3/10,4.26%,CST3;DPP4;NOTCH1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.38831936426681457,1.0557925743409782,0.39206349206349206,0.9597774426225156,1.0,3/29,7.14%,STAG3;ZCWPW1;TEX11
prerank,ventricular septum morphogenesis (GO:0060412),-0.33160525221278303,-1.0557287176687074,0.3638888888888889,0.6865615739128625,1.0,15/27,22.66%,SLIT2;ROBO1;BMPR2;NOTCH1;TGFB2;SOX4;ACVR1;CITED2;HEYL;HEY2;SOX11;TGFBR3;TGFBR2;SMAD7;APLNR
prerank,cellular component assembly (GO:0022607),0.28086994248884056,1.055459571209742,0.3614190687361419,0.9597585820244894,1.0,40/253,12.05%,LAMC1;GPM6B;WIPF1;TEAD1;PPID;WNT5A;CD40;STAG3;RHOJ;EPRS1;RSPH9;SPTBN1;ANK3;FSCN1;TEAD2;YWHAZ;LRRTM3;RAC3;KMT2A;VAMP2;FANCA;PPIH;MYO1B;NEFH;LLGL1;CAPN3;WASF3;TEX11;MDM4;CHAF1B;KIFAP3;NOC2L;IL1RAP;OPHN1;TP53;RIMS1;DLG4;GAS8;SOX9;TUBGCP4
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.286296465972005,-1.0553327366212784,0.38275862068965516,0.6859918615327404,1.0,21/51,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,mitotic nuclear membrane organization (GO:0101024),-0.286296465972005,-1.0553327366212784,0.38275862068965516,0.6859918615327404,1.0,21/51,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,regulation of neuroinflammatory response (GO:0150077),0.4130808942248248,1.0551623734917717,0.36633663366336633,0.959602222029768,1.0,1/19,0.10%,IL33
prerank,negative regulation of cell death (GO:0060548),-0.2619122994369615,-1.0547823599523087,0.3504273504273504,0.6865915647447168,1.0,26/88,19.90%,MECOM;CD200;CCN2;KANK2;BECN1;VPS35;CCN3;CD34;SRGAP2;NCK1;SOX4;CCN5;CCN1;GSK3B;BNIP3L;CCN4;NENF;WNT16;TMEM109;CHMP4B;CHMP4A;AKT1;SOX11;WNT11;CHGA;DCPS
prerank,regulation of chondrocyte differentiation (GO:0032330),0.3965602054333799,1.05455860121154,0.3675496688741722,0.9603289606208166,1.0,7/24,12.02%,TRPS1;LOXL2;SOX6;ZBTB16;ADAMTS12;TGFBR1;SOX9
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.4077558824929155,1.0540174639821858,0.37777777777777777,0.9608379200447807,1.0,4/22,9.77%,IL2RA;FANCA;BCL6;KAT2A
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3495644393365712,-1.0539508658851102,0.3435897435897436,0.6879904207248001,1.0,11/22,20.81%,DDX5;RPS7;RPS20;UBB;RPS15;ATR;SPRED3;ATM;EEF1E1;HEXIM1;RPL23
prerank,regulation of interleukin-4 production (GO:0032673),-0.352629965067197,-1.0535646459819383,0.36828644501278773,0.6882239735590274,1.0,4/21,16.76%,LEF1;SLC7A5;PRKCZ;HAVCR2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.37764403081730147,-1.0534656858001485,0.38071065989847713,0.6877023641262124,1.0,8/18,14.28%,HIP1R;GSK3B;BAX;BID;BOK;SLC25A5;ZNF205;ACAA2
prerank,regulation of cytokine production (GO:0001817),0.29659068978161035,1.0532357461993402,0.3711217183770883,0.9622212291093627,1.0,17/126,11.37%,IL33;TXK;PLA2R1;GLMN;LURAP1;ICOSLG;DTX4;HTR2B;CD276;TRIM56;POLA1;BCL6;CIDEA;KAT2A;FGR;EIF2AK2;ASB1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.34256456018594583,-1.0527222794976585,0.35733333333333334,0.6888201939477039,1.0,8/25,23.08%,LAPTM4B;CHMP2B;VCP;CHMP4B;CHMP4A;CHMP7;CHMP1A;CHMP4C
prerank,determination of heart left/right asymmetry (GO:0061371),-0.3030804275630449,-1.0526835645418535,0.3581081081081081,0.6881396965441258,1.0,13/43,22.66%,MEF2C;MICAL2;NOTCH1;SMO;MEGF8;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,regulation of cellular response to stress (GO:0080135),-0.25095564862445924,-1.0523713705342688,0.3300970873786408,0.6881428388965991,1.0,29/115,15.99%,ROCK2;MCL1;PTGES3;NEK6;CAMK2D;ARMT1;HSPA8;HSPH1;CRYAB;NUP50;GSK3B;MAPT;HSPB8;CAMK2B;ATR;CAMK2G;NUP98;NUP153;AJUBA;BAG3;CHCHD2;ATM;AMFR;NUP43;HIKESHI;RAE1;NUP205;MANF;SIRT1
prerank,regulation of apoptotic process (GO:0042981),-0.20646434069851868,-1.0521148963408649,0.125,0.6880253296408988,1.0,192/676,22.65%,PAWR;DAPK1;IGF1;TJP1;SMAD6;FOXO1;TEK;ERC1;ARHGEF18;MEF2C;IL31RA;ANO6;LEF1;ACTN2;SLIT2;TIAM2;BCL2L1;EGFR;IGF1R;ITGB1;NET1;OSR1;PPP1R13B;XIAP;THBS1;ARL6IP5;NOTCH2;ANXA5;FSTL1;GAS1;NFKB1;ITGA6;MCL1;MCF2L;TNFSF10;ACER2;PTMA;HIP1R;IGFBP3;KDR;SQSTM1;PRKDC;MAP3K5;TMBIM6;CCND2;FAS;NDRG1;ARHGAP10;CYP1B1;GCLC;SOCS2;UNC13B;EGLN3;ANXA1;APC;DAB2;TRIM24;ATF6;AVEN;PRKAA2;IL6ST;TFRC;ADAM10;CRYAB;CRADD;HIPK3;JMY;CD38;DDX42;BNIP2;UBB;SOX4;IP6K2;NGF;CASP2;CAT;CARD14;GSK3B;CD44;SH3RF2;VCP;GLO1;RPL10;CASP3;NGEF;CFL1;CASP8;MADD;BAD;CITED2;SFRP1;BAX;NFKBIA;KLHL20;PERP;BNIP3L;NIBAN2;RNF144B;VHL;HDAC3;CTSH;RPS6KA1;TNFAIP8;TARDBP;HSPB1;ADAMTSL4;BAG3;BID;APH1A;TGM2;GADD45B;APH1B;ATM;FLT4;GATA6;FLNA;BOK;PTK2B;PLEKHG2;TPT1;HIP1;PPIA;ING4;ARHGEF11;CX3CL1;PLK5;ARL6IP1;STK17B;TRIM35;PRELID1;SMPD1;FLT3;SIRT1;GPER1;ANXA4;PRKAA1;PDPN;ING5;PRDX3;PAK2;SIAH2;YME1L1;AIFM1;DCUN1D3;CD74;PLSCR3;UBC;MAP3K10;HNRNPK;RASA1;AKT1;NUAK2;TFPT;APBB1;WNT11;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;HGF;NPM1;DNAJC3;CIB1;RASGRF2;AGT;GADD45G;TRADD;SON;ARHGEF12;PIM2;ASNS;MIF;E2F1;NAA35;CFLAR;RTN4;SPHK2;CCAR2;BIRC3;DDX20;MGMT;DDAH2;HIGD1A;NUPR1;MYO18A;UBA52;SIX4;TIAM1;UFM1;ARHGEF1;PPIF
prerank,histone H4 deacetylation (GO:0070933),0.48054912764811286,1.0519978115468853,0.4129263913824057,0.9650377109444218,1.0,2/10,4.28%,HDAC1;REST
prerank,positive regulation of protein polymerization (GO:0032273),-0.2771478667658366,-1.0517467080504568,0.3655913978494624,0.6881080194742929,1.0,14/65,15.68%,BAIAP2L1;OCLN;FER;DRG1;RAC1;NCK1;MAPT;ARL2;SLAIN2;LMOD1;PTK2B;BAIAP2;TPPP3;MET
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.45128690907487423,-1.0515846306552836,0.3755868544600939,0.6877473192891709,1.0,5/10,20.94%,PRKCH;FOXC1;TRIM16;NUMA1;ETV4
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.37237185801337463,-1.0512371132322185,0.395,0.6878560955842412,1.0,7/18,12.99%,HDAC4;NOTCH1;CCN3;FZD7;FRS2;HDAC3;TMEM119
prerank,positive regulation of chromosome organization (GO:2001252),0.4469176631229062,1.051157382037379,0.39464882943143814,0.9666618492077155,1.0,4/15,10.89%,GNL3;FEN1;SIRT6;DHX36
prerank,cellular protein catabolic process (GO:0044257),-0.27460405134419574,-1.050637261698202,0.3597122302158273,0.6886102267705292,1.0,19/59,22.87%,CTSC;UBE2G1;DENND3;AP2A1;CASP8;BNIP3L;CTSO;CTSH;CLPX;PSMA6;CTSZ;AFG1L;SIAH2;YME1L1;CTSS;CLPP;AP2S1;RNF5;AP2B1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.45156530226976843,1.050392350115333,0.4103019538188277,0.9679580689363713,1.0,3/12,13.83%,CLIP3;STMN2;STMN1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.4307178903032302,-1.0503186947691656,0.4033816425120773,0.6886564567596527,1.0,6/11,25.67%,YBX3;PELI1;CASP8;BIRC3;NUPR1;SLC25A4
prerank,regulation of immune response (GO:0050776),0.296713739375835,1.0503183545551387,0.370595382746051,0.9670532844838532,1.0,17/135,10.09%,COLEC12;TREML4;CD40;CD8B;PIANP;PTPN22;CD276;DHX58;SH2D1A;COL1A2;OSCAR;BCL6;CD200R1;ADCY7;APPL2;BIRC2;FGR
prerank,N-terminal protein amino acid modification (GO:0031365),0.44472462014310954,1.0501955579892956,0.37340619307832423,0.9663275460056433,1.0,3/14,9.92%,NAA10;METAP1D;NAA50
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.35851158749803796,1.0499006903982366,0.39741750358680056,0.9661651700155504,1.0,10/39,15.08%,ERCC1;FAN1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,regulation of protein localization to membrane (GO:1905475),0.38100526094591997,1.0498673393409492,0.3918918918918919,0.9651509944773322,1.0,10/28,18.74%,GPC4;SPTBN1;GPC5;NECAB2;FYN;AR;LDLRAP1;ZDHHC2;CDK5;GPC6
prerank,DNA-dependent DNA replication (GO:0006261),0.30235889331238774,1.0493752200814679,0.3753056234718826,0.9656145677705453,1.0,36/128,18.81%,POLG;PSMD1;MCM7;CDC7;GINS3;PSMD10;POLA1;GMNN;PSMA5;RPA1;PSMB5;POLE4;RFC3;PSMC4;NOC3L;REV3L;MCM4;PSMA4;RECQL;TEFM;PSMC5;CDT1;POLG2;POLB;POLE3;PSMB9;MCM10;DBF4;ORC2;PSMA7;PSMD14;MCMDC2;WRN;PSMA2;SSBP1;PSMD11
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.24295311651386142,-1.0493237361124945,0.3567567567567568,0.6904689462119602,1.0,42/128,23.64%,SMAD6;DDX5;ARHGEF18;ITGB1;PTPRK;ID1;F11R;BMPR2;CLDN5;PARD3;TGFB2;SKI;MEGF8;UBB;ACVR1;ACVRL1;SMURF2;SMAD3;LRRC32;ZYX;SLC33A1;PRKCZ;SMAD1;FURIN;CDH5;SIRT1;TGFB1I1;HFE;UBC;USP9X;ACVR2B;TWSG1;TGFBR3;ADAM9;TGFBR2;NRROS;UBA52;SMAD7;INHBB;ACVR2A;SMURF1;RNF111
prerank,heterochromatin assembly (GO:0031507),0.4072585275120627,1.0492676506566516,0.4076335877862595,0.964840228431547,1.0,3/20,5.03%,HDAC1;CDKN2A;RRP8
prerank,vasculature development (GO:0001944),0.42924083404232005,1.0485904707888043,0.4013605442176871,0.9658479975653367,1.0,1/16,0.14%,PDGFRA
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.32939645048621063,-1.0485638463741584,0.3804034582132565,0.6916054108259722,1.0,13/29,27.79%,SAMHD1;MAVS;PTPN2;PTPN1;RNASEL;NLRC5;ISG15;USP18;PTPN6;YTHDF2;TRIM6;ZBP1;TTLL12
prerank,positive regulation of developmental process (GO:0051094),0.29377921811648955,1.0479743641635466,0.38452380952380955,0.9667484125210349,1.0,25/164,9.69%,PTN;DCN;EDN3;WNT5A;BASP1;NRXN1;FGFR1;PHLDB1;GRIP1;GJA1;REST;FBXO5;SOX6;NCOA3;FOXO6;FMR1;ZBTB16;SORL1;SRF;HMCES;PINK1;RELN;ADGRL1;TAPT1;BMP7
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.2665721977668478,-1.0478237253742322,0.35661764705882354,0.6926945290851141,1.0,27/69,25.76%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFS6;NDUFA8;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;COA6;NDUFA1;NDUFS2;NDUFS8
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.36789264024132906,1.0477326716219768,0.3826219512195122,0.9664041156825428,1.0,4/33,3.87%,PPARA;SEMA5A;TCF7L2;PDPK1
prerank,tetrapyrrole metabolic process (GO:0033013),0.4190996867934737,1.047703705930013,0.4079601990049751,0.9653876315085939,1.0,5/18,17.19%,MMAB;MTRR;ABCB6;MMAA;MMUT
prerank,response to gamma radiation (GO:0010332),-0.34366702217026746,-1.047651302782782,0.3793103448275862,0.6923885711904666,1.0,11/24,25.78%,CRYAB;TLK2;ATR;RPL26;ATM;PRKAA1;TMEM109;DCUN1D3;FANCD2;KDM1A;LIG4
prerank,myelination in peripheral nervous system (GO:0022011),-0.40284394667116,-1.0476226088856375,0.39775280898876403,0.6917239732544462,1.0,4/13,6.77%,ADGRG6;PARD3;SKI;DICER1
prerank,cell chemotaxis (GO:0060326),0.3322888602605939,1.0475794755377121,0.3709449929478138,0.9646884657799981,1.0,5/60,3.26%,PDGFRA;SEMA5A;EPHB1;ACKR2;CCR9
prerank,carboxylic acid transport (GO:0046942),-0.28260808886798666,-1.047288796673873,0.3464285714285714,0.6918396188415431,1.0,17/55,16.17%,SLC13A3;SLC16A2;SLC6A6;SLC16A6;SLC16A11;SLC7A1;SLC3A2;SLC16A1;SLC16A4;SLC38A5;SLC7A5;SLC6A17;SLC1A1;SLC6A7;SLC16A9;SLC36A4;LLGL2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4635041786465359,1.0472159296746042,0.4332129963898917,0.9647055647013997,1.0,5/11,15.70%,WNT5A;SOX9;CTNNBIP1;MYC;FGFR2
prerank,negative regulation of developmental growth (GO:0048640),0.36877696010557504,1.0466557885843426,0.3968253968253968,0.9653772179916603,1.0,4/30,8.53%,PTEN;NKD1;CDKL3;DCC
prerank,negative regulation of cell adhesion (GO:0007162),0.3206763681569494,1.0463310557568186,0.37950138504155123,0.9652841772896549,1.0,12/72,8.21%,PLXNC1;HRG;TGFBI;SEMA5A;CORO2B;SIPA1;DUSP1;GCNT2;DSCAM;PTPRO;PTK2;JAM3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3410263730012657,1.046212668602519,0.39067055393586003,0.9645432698711578,1.0,15/49,21.55%,KMT2E;HDAC1;L3MBTL1;AGO4;KMT2A;WDR5;AGO3;TESC;TNRC6B;ASH2L;AGO1;CBFB;KMT2C;RBM15;RBBP5
prerank,regulation of centriole replication (GO:0046599),0.4200759650617224,1.0460901810445213,0.39572192513368987,0.9638240741356462,1.0,4/18,9.77%,MDM1;CEP295;TRIM37;KAT2A
prerank,response to cadmium ion (GO:0046686),-0.34549353920197695,-1.0459643677621242,0.38320209973753283,0.6945296226810099,1.0,16/26,33.24%,EGFR;MAPK9;MT2A;AKT1;MT3;SUMO1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;JUN;HSF1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.42667035949436066,1.045807988890081,0.41421143847487,0.963557245049215,1.0,6/15,22.76%,TLR6;TLR4;EIF2AK2;MYD88;DHX33;NLRP2B
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.23469539580578452,-1.0457721725478364,0.3401360544217687,0.6942527269754595,1.0,35/170,15.93%,PRDM6;IGF1;ROCK2;FOXP1;APP;CDH1;ZNF462;SIRPA;YBX3;NFKBIZ;TAPBP;CDK6;PRDM2;MEGF8;TRIM5;TRIM11;AFF4;PRDM11;NOVA2;TRIM14;APOE;MTMR9;PCBP2;CRIP1;HMG20B;UBAP2;TARDBP;HNRNPDL;YBX1;PTHLH;CIAO3;CAVIN4;TOB1;POGZ;TRIM27
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4179475193194482,-1.04572168962312,0.3897550111358575,0.693618697175787,1.0,5/12,12.68%,ATP1B3;WNK4;WNK1;DMD;NOS1
prerank,cellular response to hormone stimulus (GO:0032870),0.3234929301292191,1.0455482279396162,0.3969571230982019,0.9632550910467413,1.0,7/69,6.46%,ROBO2;GHR;ATP1A2;NCOA2;NCOA3;ATP1A3;BRD8
prerank,positive regulation of immune effector process (GO:0002699),-0.3429407287999988,-1.0455196176190553,0.3776041666666667,0.6933811598860696,1.0,4/27,6.56%,PTPRJ;DDX60;LBP;RPS19
prerank,mRNA modification (GO:0016556),-0.3549092675693182,-1.0453737555490046,0.3765281173594132,0.6930107867793179,1.0,4/22,8.66%,VIRMA;NSUN2;TRMT61B;CMTR1
prerank,cellular glucose homeostasis (GO:0001678),0.3552172653499804,1.0452070055125553,0.4005805515239477,0.9632148649706664,1.0,8/41,10.39%,PIK3R1;ZBTB20;TRA2B;NGFR;PIK3R2;ADCY8;PRKACA;GCK
prerank,regulation of ATP metabolic process (GO:1903578),0.3336399277791733,1.0449999641636454,0.39196675900277006,0.9627733644627391,1.0,20/54,23.31%,OGT;NUP214;AAAS;POM121;PINK1;AK4;GCK;SLC25A33;NUP42;NUP107;ATP7A;COX7A2L;ZBTB7A;NUP54;NUP155;HIF1A;UQCC2;RANBP2;FIS1;NUP35
prerank,endothelial cell migration (GO:0043542),-0.30804475456220903,-1.0449392840451128,0.3764705882352941,0.6933583973689078,1.0,10/37,10.25%,NOS3;ID1;FSTL1;NRP1;DPP4;CYP1B1;CCN3;GIPC1;NR4A1;RAB13
prerank,DNA alkylation (GO:0006305),0.40690828046963134,1.0449157290931073,0.39800995024875624,0.9608351200061662,1.0,8/19,22.92%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,DNA methylation or demethylation (GO:0044728),0.40690828046963134,1.0449157290931073,0.39800995024875624,0.9608351200061662,1.0,8/19,22.92%,KMT2E;FOS;MTRR;DMAP1;DNMT3A;EHMT2;ATRX;EHMT1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.424749068309631,-1.0448434259354373,0.391304347826087,0.6928356308454652,1.0,10/12,54.23%,SLC11A1;CCR2;ZBTB1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,mitochondrion localization (GO:0051646),-0.3602735385486938,-1.0447649254987335,0.3877068557919622,0.6922535842199948,1.0,3/19,2.47%,MARK1;MEF2A;MTM1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.37015332977461873,1.0444640834438772,0.3964968152866242,0.9611918731294706,1.0,4/30,10.90%,XCL1;TSLP;TLR4;PYCARD
prerank,central nervous system neuron development (GO:0021954),0.4332858835220666,1.04438038280195,0.4013605442176871,0.9604057054082443,1.0,5/15,14.03%,NTRK2;PTEN;NPY;ARHGAP35;ATP7A
prerank,positive regulation of protein import (GO:1904591),0.3664531032017111,1.0439312315284346,0.3972602739726027,0.9607532231120961,1.0,4/30,4.57%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,regulation of fatty acid oxidation (GO:0046320),0.42386771302707954,1.0438166325607638,0.40316901408450706,0.9600445144344846,1.0,5/16,12.16%,PPARA;ACADL;APPL2;SOX9;FABP3
prerank,antibacterial humoral response (GO:0019731),-0.37667458227416784,-1.0431555224271045,0.3960880195599022,0.6956506779432156,1.0,6/16,36.37%,PLA2G6;RNASE7;RPL39;SLPI;RNASE3;JCHAIN
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3090504456615777,1.0429862897763456,0.37944162436548223,0.9615723638309724,1.0,33/107,21.56%,PIK3R1;ITPR1;MBTPS2;SEC16A;PIK3R2;SEL1L;CREB3L2;ATP2A2;CASP4;HERPUD1;TMX1;DNAJB12;TP53;RCN3;DNAJC10;USP19;HSP90B1;EIF2S1;HSPA5;CREB3L1;BAK1;BAG6;BRSK2;UBXN6;BBC3;EIF2AK3;DDRGK1;RHBDD1;MBTPS1;TNFRSF10B;ATG10;ATF6B;DDIT3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.43019887871868934,1.0428584095836988,0.4178321678321678,0.9608811103951764,1.0,8/16,17.43%,CDK13;CELF4;DDX17;SLU7;RBM17;DHX9;SRSF9;SRSF6
prerank,DNA replication (GO:0006260),0.3060413101650746,1.0427543551932217,0.3917910447761194,0.9601056557052323,1.0,21/105,14.03%,RBMS1;POLG;TIPIN;MCM7;FEN1;CDC7;POLA1;RPA1;PIF1;POLL;RFC3;REV3L;MCM4;TOP3A;NAP1L1;POLG2;POLB;POLE3;REV1;MCM10;DBF4
prerank,positive regulation of calcium ion transport (GO:0051928),-0.30727545158535996,-1.0427265966774393,0.39779005524861877,0.6959791757707491,1.0,7/36,14.64%,CAV1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.34517528797556346,-1.0426400681258852,0.375,0.6954424522330389,1.0,9/21,22.58%,SLC8A3;MICU1;MCUB;SMDT1;TGM2;RAP1GDS1;MCUR1;LETM1;MCU
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.27234943066442135,-1.042617437995142,0.36752136752136755,0.6947317710231544,1.0,20/70,16.13%,FOXC1;PSMC6;PRKDC;LMO2;PSMD9;RUNX1;PSMF1;PSMB7;PSMD8;PSMD12;GATA2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;TAL1;PSMB6;PSMC1;PSMB10
prerank,response to muscle stretch (GO:0035994),0.43487047734164774,1.042362017437465,0.3880070546737213,0.9602408248305757,1.0,3/15,7.70%,RYR2;SLC9A1;PTK2
prerank,chloride transport (GO:0006821),0.3166795208202999,1.0423355421780782,0.3892709766162311,0.9592376852430443,1.0,16/74,13.84%,SLC1A3;ANO4;GABRA1;GABRD;SLC12A6;GABRG3;CLCN3;CLCN2;GLRA3;GABRG2;GLRA1;SLC4A1;CLCN6;GLRA2;GABRB1;LRRC8A
prerank,negative regulation of MAPK cascade (GO:0043409),0.31328794072046445,1.0421605222009218,0.3780487804878049,0.9587024994614901,1.0,15/87,9.69%,SPRY4;SPRY1;PTEN;PTPRR;DUSP1;CNKSR3;PIK3R2;SPRED1;SORL1;NF1;PSMD10;RPS6KA6;SPRED2;TLR4;BMP7
prerank,dephosphorylation (GO:0016311),0.29130382362151713,1.041915637169898,0.3791866028708134,0.9584168046639014,1.0,23/147,10.69%,CDC14B;PTPRT;THNSL2;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;PLPPR3;PTPRU;PTPRO;PTPN13;SSH2;PLPPR2;PPP2R2A;PPP2R3A;PPP6C;PPP3CB;PLPP6;PDP1;PTPRA
prerank,cell projection assembly (GO:0030031),-0.3481534439267204,-1.0416121634545292,0.3858267716535433,0.6964770055310744,1.0,6/22,6.76%,PARVB;GSN;RHOQ;RAC1;CDC42;PDGFA
prerank,chromosome organization (GO:0051276),0.30527773442118994,1.0415710069874777,0.3816300129366106,0.9583719168262406,1.0,25/99,20.54%,HDAC1;L3MBTL1;TCF7L2;COPS3;TOP2B;MSH3;SOX2;XPC;HMGN3;CDT1;COPS4;POLE3;CENPW;HDAC10;DOT1L;MYC;ZBTB7A;LDB1;TOP2A;SAFB;MSH6;NUP155;CUL4A;GATAD1;DDB1
prerank,cellular response to light stimulus (GO:0071482),0.3253639893533671,1.0414949215342486,0.39473684210526316,0.9575682802922273,1.0,12/66,15.40%,GPR88;POLK;FMR1;NEDD4;ERCC4;NOC2L;GPR52;TP53;DHX36;EIF2S1;BAK1;MYC
prerank,detection of calcium ion (GO:0005513),0.44072903241665656,1.0414185379200354,0.4172661870503597,0.9567341716171889,1.0,4/13,18.61%,RYR2;KCNIP2;STIM1;SYT1
prerank,nuclear pore organization (GO:0006999),-0.39103224665564257,-1.0413504009678505,0.4151376146788991,0.6964310289919895,1.0,6/14,21.49%,NUP98;NUP153;TMEM170A;NUP205;SEH1L;RTN4
prerank,sympathetic nervous system development (GO:0048485),-0.3874938872490918,-1.041215541832521,0.38676844783715014,0.6959960710614933,1.0,5/15,18.24%,NRP2;NRP1;SOX4;FZD3;SOX11
prerank,apoptotic DNA fragmentation (GO:0006309),0.42617183852852064,1.0410117903355975,0.4099485420240137,0.957020558415335,1.0,1/16,0.46%,CECR2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3954511902652611,-1.0407029761029332,0.4146919431279621,0.6965376970750398,1.0,6/14,15.11%,ELAVL1;YBX3;MAPK14;TARDBP;HNRNPC;ANGEL2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3760012926793636,1.0405034994386317,0.4003215434083601,0.9575610062135025,1.0,6/28,9.06%,PTN;AKAP5;ADCY8;CALB1;RELN;LGMN
prerank,cellular response to starvation (GO:0009267),-0.24230092304094314,-1.0403257897818146,0.3111111111111111,0.6967258127378685,1.0,44/147,23.54%,PRKAG2;FOXO1;XPR1;FNIP1;RNF152;BMPR2;BECN1;MAP3K5;FAS;HSPA8;SREBF2;GABARAP;SESN1;PRKAA2;GABARAPL1;SIK1;DAPL1;LAMTOR5;SFRP1;RRAGC;CLEC16A;MYBBP1A;RALB;PRKAG3;LAMTOR3;MFSD2A;CDKN1A;SIRT1;PRKAA1;ATP6V0E2;MAP1LC3A;LAMP2;NUAK2;SEH1L;RRAGB;HNRNPA1;ASNS;MAP1LC3B;WDR45;ATP6V0D2;INHBB;KLF10;NPRL3;ATP6V1G1
prerank,negative regulation of growth (GO:0045926),-0.2444322767382445,-1.0402952715180034,0.3380281690140845,0.6960674821735033,1.0,60/121,30.91%,APBB2;PTPRJ;SLIT2;FHL1;NOTCH2;BMPR2;SMARCA4;OSGIN2;SMARCA2;NOTCH1;TGFB2;CCN3;SH3BP4;PPP2R1A;IP6K2;PRDM11;ACVRL1;SOX17;SMAD3;MT2A;NPR1;HYAL1;SFRP1;ENO1;CDKN2AIP;ING4;CDKN1A;SIRT1;ING5;VGLL4;DCUN1D3;RBBP7;FGFR3;APBB1;WNT11;RERG;RTN4;SPHK2;CCAR2;BTG1;NDUFA13;CDA;PNPT1;MT3;HYAL2;HSPA1A;SMAD4;RB1;DNAJB2;SESN2;HSPA1B;MINAR1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,heart looping (GO:0001947),-0.3004926144659089,-1.040283282500443,0.36245954692556637,0.6953535176793398,1.0,12/40,22.66%,MEF2C;MICAL2;NOTCH1;SMO;SOX17;TBX2;ZIC3;MKKS;SOX18;BBS7;TGFBR2;APLNR
prerank,DNA strand elongation (GO:0022616),0.42191393942400063,1.040266194491288,0.41412520064205455,0.9572414640401321,1.0,5/18,10.71%,MCM7;GINS3;POLA1;RFC3;MCM4
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.4753083845308219,1.0399924547540904,0.43006993006993005,0.9560180393614536,1.0,2/11,8.79%,PTEN;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),0.4753083845308219,1.0399924547540904,0.43006993006993005,0.9560180393614536,1.0,2/11,8.79%,PTEN;INPP5J
prerank,mitotic sister chromatid cohesion (GO:0007064),0.4329015022024155,1.0396986641770483,0.4395973154362416,0.9558110677435647,1.0,5/16,21.23%,BOD1;SGO1;NAA50;SMC1A;MAU2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4340395549200571,-1.0396764459077374,0.4033816425120773,0.695431476294646,1.0,3/10,22.87%,AP2A1;AP2S1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4340395549200571,-1.0396764459077374,0.4033816425120773,0.695431476294646,1.0,3/10,22.87%,AP2A1;AP2S1;AP2B1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4493853178745288,1.0390139343380895,0.43838028169014087,0.9568243972724566,1.0,1/13,0.10%,IL33
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3832415768491766,-1.0389929256702128,0.39816933638443935,0.6964026723533949,1.0,8/15,33.07%,JMY;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4;WHAMM;ACTR3
prerank,regulation of insulin secretion (GO:0050796),0.30699935968400477,1.0389001529248256,0.3879093198992443,0.9561264938869687,1.0,17/101,10.49%,RAPGEF4;ADCY5;CACNA1E;TCF7L2;ITPR1;NR1H4;REST;IRS1;TM7SF3;IRS2;TRH;PER2;PRKCA;KCNC2;SYT7;GCK;PPP3CB
prerank,nitrogen compound transport (GO:0071705),0.2929845260469101,1.0388501785430415,0.37758830694275275,0.9552006587608225,1.0,19/141,12.95%,SLC1A5;SLC48A1;HRG;SLC6A13;SLC6A8;LRP1B;CALCRL;SLC7A11;SLC43A1;VAMP2;SLC7A8;RUFY1;ABCB6;TMEM30A;SEC14L1;RCN3;SLC7A3;HSP90B1;SLC25A29
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.26664952793818353,1.0383132821531822,0.39400428265524623,0.9558050650249931,1.0,59/390,14.06%,ROR1;COL4A6;PDGFRA;FLRT2;NTRK3;GHR;PIK3R1;EPHA7;SULF1;NRG1;ROR2;CHN1;MERTK;PTPRT;NTRK2;PHIP;ERBB4;EPHB1;GPLD1;ITGAV;CD8B;GRIN2B;FGFR1;NGFR;PIK3R2;ELMO1;SPRED1;EPHA6;IRS1;IRS2;ANKS1B;PTK2;EFS;SPRED2;PRKD1;EPHB6;AXL;COL4A2;ITSN1;CYBA;AHI1;FGR;EPHA3;FYN;MAPKAPK3;PDK2;UBASH3B;DNM1;IGF2;GSK3A;CASS4;MTSS1;ATP6V0E1;ACTR2;CRK;STMN1;GFRA2;SH2D2A;LYN
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.4055490974253093,1.0381993142816577,0.43134087237479807,0.9551077145034159,1.0,4/19,8.47%,NAT10;TERF1;PIF1;TENT4B
prerank,positive regulation of neuron differentiation (GO:0045666),0.3564560270160216,1.0377536340638809,0.40713224368499257,0.9554281211966499,1.0,15/40,25.26%,ZEB1;TCF4;FGFR1;REST;BEND6;NRCAM;IMPACT;BRINP1;BMP2;RHOA;MMD2;TRIM32;ZC4H2;CPNE1;VWC2
prerank,DNA biosynthetic process (GO:0071897),0.42415784061849165,1.0376204314382973,0.39008264462809916,0.9547838222863962,1.0,7/16,19.87%,POLA1;CDKN2D;POLL;RFC3;POLH;WRN;POLE
prerank,positive regulation of protein import into nucleus (GO:0042307),0.37178328554010504,1.0374992843721624,0.40249609984399376,0.954117836883953,1.0,4/28,4.57%,PIK3R1;JUP;PIK3R2;ZIC1
prerank,generation of neurons (GO:0048699),0.281305981276327,1.037322310434311,0.3798358733880422,0.95363511483434,1.0,26/190,11.41%,SH3RF1;ADGRL3;RUNX2;AUTS2;WNT5A;NTRK2;ASTN2;FGFR1;DNAAF4;MYEF2;LRP12;CDKL5;MTPN;DISC1;DOCK7;ASTN1;SNPH;PER2;RELN;OLIG2;BHLHE22;WNT3;MAP2K1;OPHN1;SMARCA1;PLXNB2
prerank,protein localization to kinetochore (GO:0034501),-0.3953468666440765,-1.0372623221627362,0.4354066985645933,0.70013675713517,1.0,7/14,27.48%,MTBP;ZW10;CENPT;BUB3;RCC2;IK;TTK
prerank,regulation of cell development (GO:0060284),-0.30770519943209484,-1.0367631928792673,0.41346153846153844,0.7006587632363532,1.0,15/36,26.24%,FOXO1;NOTCH2;RPS19;CX3CR1;HEYL;HEY2;CX3CL1;CLOCK;BHLHE40;HMGB2;AKT1;FBXO22;BHLHE41;YTHDF2;HES6
prerank,regulation of dendrite morphogenesis (GO:0048814),0.37796935752954663,1.0366043648067633,0.4110612855007474,0.9547791447233875,1.0,11/32,17.84%,CDKL5;NEDD4;CAPRIN1;CDKL3;ADGRB3;CUX2;SDC2;TNIK;IL1RAPL1;HECW1;CUL7
prerank,regulation of superoxide anion generation (GO:0032928),-0.3924245334675152,-1.036245004976535,0.3888888888888889,0.7011915180310834,1.0,9/14,50.89%,MAPT;PRKCD;TYROBP;ITGB2;AATF;CRP;GSTP1;F2RL1;CD177
prerank,regulation of axonogenesis (GO:0050770),0.3340619072156737,1.0361812741351293,0.3924963924963925,0.9550760746722537,1.0,6/51,3.83%,ROBO2;PLXNC1;CHN1;NTRK2;PTEN;NGFR
prerank,regulation of microtubule nucleation (GO:0010968),-0.4362114331866232,-1.0360017599366704,0.41898148148148145,0.7010752575344052,1.0,6/10,35.55%,GIT1;EML2;HSPA1A;HSPA1B;RANGRF;MECP2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.32937923201543096,1.0358157161043036,0.4117647058823529,0.9541702267092371,1.0,24/56,25.64%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFV2;NDUFAF7;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFAF2;NDUFB6;DMAC1;NDUFB8
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.32937923201543096,1.0358157161043036,0.4117647058823529,0.9541702267092371,1.0,24/56,25.64%,TIMMDC1;DMAC2;NDUFS7;TMEM126A;NDUFS5;BCS1L;NDUFV2;NDUFAF7;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;TMEM126B;TIMM21;NDUFA10;NDUFS1;NDUFAF2;NDUFB6;DMAC1;NDUFB8
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.38497039512364273,1.0355866996062735,0.428343949044586,0.9538450640612419,1.0,5/24,8.47%,NAT10;ERCC4;TERF1;PIF1;TENT4B
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.4168194227358849,-1.0350153515258613,0.3971631205673759,0.7027482183385274,1.0,6/12,25.88%,SMCHD1;CDYL;PCGF5;RBM15B;RLIM;BRCA1
prerank,neutral amino acid transport (GO:0015804),0.37199532470503816,1.0347687920765767,0.40998487140695916,0.9552176546434481,1.0,3/28,4.87%,SLC1A5;SLC43A1;SLC7A8
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3101220622939729,1.0347574131435433,0.4103896103896104,0.9542143662893452,1.0,26/83,20.52%,CDK14;CDKN2A;FBXO5;CDC7;POLA1;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CDT1;CUL5;CDKN2C;DBF4;MYC;KLF11;CDK5;CAMK2A;CCNE1;KHDRBS1;CUL4A;TFDP1;POLE;LATS2;INHBA
prerank,positive regulation of heart rate (GO:0010460),0.42120279678252903,1.034476439099246,0.4184873949579832,0.9540217986846354,1.0,3/17,5.93%,EDN3;RYR2;ATP2A2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.3398329861848719,-1.0340508486051425,0.38461538461538464,0.7045595301019008,1.0,12/26,30.23%,ST3GAL4;B4GALT5;TPI1;LARGE1;RRM2B;ST3GAL2;GCNT1;GAL3ST2;ST8SIA6;SCCPDH;RRM1;GK5
prerank,regulation of phosphorylation (GO:0042325),0.29148245462726996,1.0336664110217388,0.4146341463414634,0.955569700873934,1.0,30/120,17.45%,DYNLL1;OGT;PHIP;SRPX2;CDKN2A;GLMN;NUP214;MCM7;AAAS;DSCAM;POM121;CDKN2D;PTK2;BMP7;GCK;GRM5;NUP42;PLXNB2;ANKLE2;NUP107;CDKN2C;LYN;ATG14;AR;NDUFS4;ZBTB7A;PRKRIP1;NUP54;LDB2;LDB1
prerank,positive regulation of cell junction assembly (GO:1901890),0.32941203844419714,1.0335193452915117,0.40611353711790393,0.9549945755472877,1.0,10/56,9.52%,HRG;SRPX2;EPHB1;CNTNAP2;GRID2;NRXN1;MAP4K4;COL16A1;SYNDIG1;IL1RAP
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2501295464225805,-1.033122751994838,0.3662551440329218,0.7061622188449165,1.0,25/82,18.28%,EPHA4;ROCK2;ANKS1A;SIPA1L1;ACTB;ARHGEF28;EFNB2;ACTG1;EPHB4;RAC1;CDC42;EFNA5;EFNB1;AP2A1;NGEF;GIT1;EPHB2;APH1A;APH1B;EPHA2;YES1;RASA1;WASL;EPHB3;SDCBP
prerank,positive regulation of interleukin-2 production (GO:0032743),0.38006653787788114,1.0327832289874863,0.4272,0.9561265477989316,1.0,3/25,3.80%,PDE4B;GLMN;SPTBN1
prerank,positive regulation of protein transport (GO:0051222),-0.27181104657429633,-1.0326388057117433,0.3861003861003861,0.7066810494191141,1.0,19/67,22.18%,IGF1;EZR;CNST;RUFY3;TGFB2;UNC13B;PRR5L;CEP290;CD2AP;MYH10;GOLPH3L;PPIA;OAZ1;BCAS3;OAZ2;APBB1;ADAM9;VPS28;MYO18A
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.33613205496777643,-1.0325770255764157,0.4095744680851064,0.7061037555704495,1.0,14/23,44.39%,TPM1;TGFBR3;PKP2;HOPX;SMAD7;DSG2;FKBP1A;TNNC1;TNNI3;IRX3;MYL3;MYH6;ID2;ISL1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4093600532980761,1.0321504683821487,0.4157119476268412,0.9569769610725358,1.0,3/17,9.06%,CXCL10;PLA2G7;LGMN
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.3516189056570926,-1.0321352522523237,0.42296918767507,0.7065181804488219,1.0,7/23,16.47%,IGF1;MEF2C;EFNB2;MAPK14;NIBAN2;EDN1;MYOCD
prerank,protein transport (GO:0015031),0.26655440802734576,1.0320495146112965,0.3899782135076253,0.956283649112876,1.0,78/332,20.54%,LRP1;VAMP5;STEAP3;UNC93B1;GGA2;LRP1B;CALCRL;UNC119;RAB34;RAB20;RABGAP1L;TBC1D16;RABL3;COPA;SPTBN1;NGFR;ANK3;VAMP2;SEL1L;COPZ2;RAB8A;NAPB;RUFY1;RAB3C;MYO6;SYNDIG1;VIPAS39;TBC1D1;TRIM23;VPS26C;RAB29;PRKCB;TBC1D8B;SLU7;RAB24;SAR1A;VAMP4;RCN3;RAB15;SCFD1;HSP90B1;ARHGAP1;ARFIP1;ATP6V0E1;AP3D1;TBC1D9;CTTN;TMEM167A;CLU;CENPF;VPS33B;MTTP;SCAMP2;USP6NL;TMED3;TMED9;TBC1D17;MCOLN1;BBS1;TVP23B;ATP6V0D1;LTBP2;ATP6V1G2;COPG1;ATP6AP1;MIA3;SVBP;VPS45;CANX;RAB3GAP2;SCAMP3;ARL5C;COPB2;ARL4A;SCG2;UNC119B;NAPG;KIF3A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.24377474048626166,-1.0315744014658053,0.35784313725490197,0.7071304005643911,1.0,34/109,19.23%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;RAC1;PSMB7;MAPK9;CUL1;MAP2K4;CALM1;MAP2K7;PSMD8;PSMD12;PIK3CB;PPP3R1;PLCG2;TAB2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;GRB2;PSMB6;PSMC1;TEC;PSMB10;PAK2;LCP2;VAV1;PSME2;SOS1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3557399440176527,1.0315123932831165,0.4212962962962963,0.9568696597524464,1.0,3/34,4.96%,XCL1;WNT5A;PTPN22
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.38380799493264445,1.0315123847699588,0.4084967320261438,0.9558307133249193,1.0,8/24,16.57%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1;ACTR2;AKIRIN1;CYFIP1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24828660968970623,-1.0311348766359403,0.38028169014084506,0.7075741982225323,1.0,34/110,23.51%,FOXO1;ROCK2;WWP1;IL18;APP;KLF4;WWP2;GPC3;APC;KLF2;APOE;GSK3B;VCP;SMURF2;NFKBIA;ASB5;RNF41;APC2;AGTR1;MAP2K5;OAZ1;PAEP;RAB1A;OAZ2;AKT1;ABCB10;FZR1;AGT;RAB1B;TNFAIP3;VPS28;NDUFA13;BCL10;SMURF1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4016431350692356,1.0310691454659195,0.43285939968404424,0.9561484589978364,1.0,7/21,19.98%,BUB1B;FBXO5;TEX14;BUB1;CENPF;KLHL22;TRIP13
prerank,gene silencing by miRNA (GO:0035195),0.35887625833046727,1.0310472241267283,0.3911671924290221,0.9551871332471574,1.0,11/32,19.89%,AGO4;SPOUT1;ZC3H7B;AGO3;CNOT1;CNOT7;WTIP;ADAR;TNRC6B;AGO1;ZC3H7A
prerank,membrane depolarization during action potential (GO:0086010),0.37518153320319075,1.0310253469247035,0.4028662420382166,0.9542212863710847,1.0,9/26,21.35%,ATP1A2;SCN2B;CACNA1G;HCN2;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I
prerank,cellular metal ion homeostasis (GO:0006875),0.29877589627359824,1.0308331783616567,0.4190231362467866,0.9537775733096586,1.0,13/102,9.08%,EDN3;ATP1A2;SLC24A5;CD40;RYR2;HTR2B;ATP1A3;KCNMA1;CCL15;ATP2A2;SLC9A1;ATP13A3;HTR2C
prerank,Fc receptor signaling pathway (GO:0038093),-0.24409525187740833,-1.030278689501721,0.3622448979591837,0.7090174538420151,1.0,34/110,19.23%,MAP3K1;FER;NFKB1;PSMC6;PSMD9;PSMF1;RAC1;PSMB7;MAPK9;CUL1;MAP2K4;CALM1;MAP2K7;PSMD8;PSMD12;PIK3CB;PPP3R1;PLCG2;TAB2;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;GRB2;PSMB6;PSMC1;TEC;PSMB10;PAK2;LCP2;VAV1;PSME2;SOS1
prerank,protein export from nucleus (GO:0006611),0.380491384434495,1.0302217110101064,0.4304,0.9546419981700274,1.0,9/27,17.09%,CSE1L;ANKLE1;NUP214;NUTF2;NUP42;RANBP3;STRADB;CALR;XPO6
prerank,regulation of neurotransmitter secretion (GO:0046928),0.3619003008207393,1.0299294877606457,0.4158730158730159,0.9545099546604793,1.0,6/32,6.62%,HCRT;CHRNB4;PNKD;FMR1;LRRK2;RIMS2
prerank,chromatin organization (GO:0006325),-0.2354661757390819,-1.0295621590602242,0.3532608695652174,0.710060270724365,1.0,43/132,26.33%,MECOM;HDAC4;PBRM1;KDM4A;KDM4C;SMARCA4;SMARCA2;CBX3;TOP1;PRDM16;INO80;HDAC8;HDAC3;SMARCA5;SMARCC2;JARID2;EZH2;DDX11;SIRT1;SNAI1;BAZ1A;FAM50A;ESR1;BAZ2B;INO80C;CHD1;HMGB2;KDM4B;TADA2B;NPM1;CHD1L;SMARCD3;RUVBL2;PHF1;MTF2;HDAC11;SMARCD1;MYSM1;TAF6L;PADI2;ACTL6B;SPI1;RB1
prerank,hepaticobiliary system development (GO:0061008),-0.3580119600809681,-1.0291341506097393,0.42297650130548303,0.7103238646867621,1.0,8/20,22.23%,ARID5B;WNT4;COBL;LSR;CITED2;MET;TGFBR3;PHF2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.4609765735655368,1.0291150582163233,0.43079584775086505,0.9560131092660614,1.0,8/12,29.19%,AMPD2;PRPS1L1;PRPS1;MTHFD1;HPRT1;PRPSAP2;GART;PRPSAP1
prerank,peptidyl-serine modification (GO:0018209),-0.23134439500196202,-1.0290229709252936,0.37158469945355194,0.7098445035599348,1.0,49/166,21.18%,ROCK2;PRKCH;MARK1;RICTOR;CSNK1D;NEK6;CAMK2D;PRKDC;TOP1;VRK3;TLK1;MAPK9;WNK1;HIPK3;MAPK14;NTMT1;GSK3B;HIPK1;TLK2;STK38L;MAST3;DYRK2;RPS6KA5;CAB39;ATR;RPS6KA1;PRKCZ;HIPK2;ATM;CSNK1G3;GALNT1;MARK3;PRKCD;DYRK1B;TBK1;PAK2;PKN2;MAP3K10;STK32B;AKT1;CSNK1A1;SBK1;VRK2;MARK2;ULK3;MKNK1;GALNT3;PKN3;TGFBR2
prerank,determination of bilateral symmetry (GO:0009855),-0.34029547663430004,-1.0289305896895264,0.41935483870967744,0.7093427731105069,1.0,10/25,21.05%,NOTCH1;ARL6;TBX1;CITED2;GALNT11;ZIC3;MKKS;DNAH11;BBS7;DNAH5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.2534873038435995,-1.0288871107716102,0.3943089430894309,0.7087188410205478,1.0,21/80,16.65%,DAPK1;FNIP1;XIAP;THBS1;ARL6IP5;KLF4;TNFSF10;MAP3K5;UACA;NGF;PPM1F;CD44;LAMTOR5;BAD;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIRT1;GPER1;SIAH2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3683246311664578,1.028882159278137,0.40062111801242234,0.9556913250809888,1.0,8/31,12.92%,SCRIB;DLG3;MTCL1;PARD3B;DLG2;PRKCI;OPHN1;LRRC7
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2825657913120746,1.0287476850816948,0.40993071593533487,0.9550816226467792,1.0,42/185,18.28%,DYNLL1;CDC14B;BUB1B;PSMD1;DCTN3;HAUS3;HAUS1;FBXO5;HMMR;DCTN2;CENPE;CDC16;PSMD10;ZFP36L2;PSMA5;PSMB5;HAUS8;PRKACA;CEP192;APPL2;XPC;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;CEP250;TFAP4;CEP152;CSNK1E;CENPF;CLASP1;PSMA7;PSMD14;ALMS1;CDC26;PCM1;PSMA2
prerank,sulfur compound biosynthetic process (GO:0044272),0.2950687944370119,1.028723270986421,0.41410256410256413,0.9541222150678932,1.0,13/104,7.78%,DCN;GGT5;LUM;BGN;GGT7;DSE;SLC35B3;VCAN;B4GALT2;GSTO2;B4GALT3;GSTA3;PAPSS2
prerank,regulation of establishment of planar polarity (GO:0090175),0.30957365834226985,1.0285243624139386,0.39588688946015427,0.9537043817661078,1.0,22/88,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;NPHP3;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMA7;PSMD14;PSMA2;RHOA;SPEF1;PSMD11
prerank,T cell activation involved in immune response (GO:0002286),-0.41087295339121227,-1.028522052974485,0.43448275862068964,0.70893866988565,1.0,5/12,35.38%,ICAM1;MDK;CD74;SLC11A1;LILRB1
prerank,acute inflammatory response (GO:0002526),-0.34205442992526114,-1.0284403659128278,0.40583554376657827,0.7083617863364762,1.0,2/23,2.85%,ANO6;LBP
prerank,apoptotic cell clearance (GO:0043277),0.36210378062226306,1.0283737445855934,0.40536277602523657,0.9531436030158442,1.0,5/30,7.90%,LRP1;ITGAV;TXNDC5;ADGRB1;XKR6
prerank,response to glucocorticoid (GO:0051384),0.3735423926903148,1.0282836514371305,0.4087237479806139,0.9523852889951193,1.0,3/26,7.16%,IL1RN;REST;ZFP36L2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.44936483567850155,1.0282304919660463,0.4342560553633218,0.9515232770419308,1.0,1/12,0.21%,COLEC12
prerank,ceramide metabolic process (GO:0006672),-0.28374443128250726,-1.0282054461492105,0.4105960264900662,0.7082594819639157,1.0,9/49,7.43%,SGMS1;SPTLC2;PLPP3;ACER2;ACER3;SGMS2;PPP2R1A;DEGS2;ST6GALNAC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4660521693091183,1.0278656388538476,0.45454545454545453,0.9505683406782948,1.0,3/10,10.49%,NFATC3;ADGRB2;PPP3CB
prerank,calcineurin-mediated signaling (GO:0097720),0.4660521693091183,1.0278656388538476,0.45454545454545453,0.9505683406782948,1.0,3/10,10.49%,NFATC3;ADGRB2;PPP3CB
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.33389214995192873,-1.0278562714461508,0.4,0.7084067489497713,1.0,11/23,20.45%,IGF1;APP;NFKB1;INSR;PRKAA2;PFKFB2;P2RX7;PRKAA1;EGF;PRXL2C;GAPDHS
prerank,regulation of cell morphogenesis (GO:0022604),-0.3260444859683203,-1.027790959476641,0.4084507042253521,0.7078425573414563,1.0,10/30,16.26%,LARP4;SPARC;CAPZB;EFNA5;CD44;CFL1;BCL9L;MACF1;MFSD2A;PDPN
prerank,error-prone translesion synthesis (GO:0042276),0.39965274972332565,1.0277798254746366,0.4129746835443038,0.9498206511604284,1.0,7/21,14.01%,POLK;RPA1;RFC3;REV3L;POLH;REV1;POLI
prerank,proteoglycan biosynthetic process (GO:0030166),-0.31850299747957744,-1.0275864119703044,0.3901734104046243,0.7076431290036684,1.0,10/31,14.14%,IGF1;CSGALNACT1;BMPR2;NDST3;EXT1;UGDH;CHST11;FOXL1;GLCE;HS3ST3B1
prerank,phospholipid homeostasis (GO:0055091),0.4538240341227173,1.0275089604039491,0.43838028169014087,0.9495849899255515,1.0,3/11,21.46%,RCN3;FABP3;TLCD1
prerank,response to fatty acid (GO:0070542),0.4156317935276487,1.0274610294071533,0.4058219178082192,0.94872683387303,1.0,4/17,12.02%,GLDC;NR1H4;IRS1;SOX9
prerank,mammary gland epithelium development (GO:0061180),0.42598039653286646,1.0270216986048974,0.4362657091561939,0.9490790524700113,1.0,3/14,9.91%,ERBB4;SCRIB;WNT3
prerank,sensory perception of chemical stimulus (GO:0007606),0.4190885004669224,1.02676743281173,0.411371237458194,0.9488421536801862,1.0,2/15,6.49%,C5AR1;ADCY3
prerank,UV-damage excision repair (GO:0070914),0.4492613523146596,1.026625593088184,0.4388984509466437,0.9482425748777185,1.0,3/12,9.10%,ERCC1;POLA1;XPC
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3094182765994466,-1.0265367636864868,0.3693181818181818,0.7094816694064139,1.0,4/34,0.60%,EPHA4;IGF1;PICALM;ROCK2
prerank,response to interferon-gamma (GO:0034341),0.3161049964935487,1.0260458468442628,0.417910447761194,0.9489976034185571,1.0,10/67,10.56%,XCL1;WNT5A;CD40;EPRS1;KYNU;CCL15;PDE12;SP100;TLR4;CCL25
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.40721579184263434,1.025665067403511,0.42549668874172186,0.9491746761766594,1.0,2/19,0.85%,DCN;HRG
prerank,synaptic vesicle recycling (GO:0036465),0.3689192316009586,1.0252978688966727,0.4170337738619677,0.9493034722918137,1.0,10/31,19.48%,CEL;VAMP2;OPHN1;SYT7;SYT5;CDK5;AMPH;FCHO2;SYT1;CANX
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.37296973022850854,-1.025206207369291,0.41044776119402987,0.7120999251369602,1.0,5/17,16.21%,SNTA1;ANK2;KCNQ1;NOS1AP;SCN4B
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.47135724865553325,1.0250165742116253,0.4460694698354662,0.9491301626061854,1.0,3/10,15.04%,ADGRV1;IFT88;PDZD7
prerank,cellular response to glucose stimulus (GO:0071333),0.36389696774147096,1.024734394351025,0.3930722891566265,0.9489728458754709,1.0,5/30,8.66%,ZBTB20;TRA2B;PTPRN2;ADCY8;PRKACA
prerank,renal filtration (GO:0097205),0.47169057110705104,1.0246005320832023,0.4362657091561939,0.9483870213029225,1.0,3/10,9.55%,SULF1;ITGA3;TBC1D8B
prerank,placenta development (GO:0001890),0.4463665318261484,1.0243403032240503,0.42955326460481097,0.9481647710511646,1.0,3/12,17.84%,ADAM19;PTK2;CUL7
prerank,7-methylguanosine RNA capping (GO:0009452),-0.3113964916922538,-1.0242011480497712,0.42702702702702705,0.7131742501418645,1.0,12/31,28.24%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;POLR2K;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.3113964916922538,-1.0242011480497712,0.42702702702702705,0.7131742501418645,1.0,12/31,28.24%,GTF2H5;CMTR1;POLR2B;POLR2H;POLR2G;POLR2C;GTF2H4;NCBP2;GTF2F2;POLR2I;POLR2K;CMTR2
prerank,negative regulation of catabolic process (GO:0009895),0.33652634307703694,1.023939488213136,0.4005805515239477,0.9483718420706131,1.0,7/47,8.09%,PPARA;PFKFB1;ADGRB1;CBFA2T3;MDM4;CIDEA;BSCL2
prerank,regulation of hormone secretion (GO:0046883),0.4182033918540611,1.0235576165600482,0.43898305084745765,0.9485546778785121,1.0,2/15,4.67%,EDN3;VAMP2
prerank,cellular response to calcium ion (GO:0071277),0.31779564859538484,1.0235564230822483,0.4163265306122449,0.9475620857287512,1.0,22/67,18.99%,ADGRV1;WNT5A;GPLD1;ADCY8;CAPN3;RASGRP2;SYT3;LGMN;SYT7;CPNE7;TRPM2;SYT5;CPNE4;RYR3;CPNE8;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1
prerank,glycerolipid metabolic process (GO:0046486),-0.41809625022619634,-1.0234103624248794,0.44549763033175355,0.714508158773945,1.0,5/11,20.57%,DGKG;DGKZ;PGP;PNPLA3;PIP5K1A
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.29754887936642227,-1.023399754988642,0.43243243243243246,0.7137879797027774,1.0,8/39,7.10%,PODXL;CDH1;KLF4;RDX;FXYD5;NOTCH1;WNK1;PPM1F
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.376165956496344,-1.0232950231156028,0.4245939675174014,0.7132971247129525,1.0,3/16,4.37%,VIM;RUNX1;WNT4
prerank,activin receptor signaling pathway (GO:0032924),-0.38612895845564954,-1.0227675600084598,0.40966921119592875,0.7138928329422657,1.0,5/15,22.98%,ACVR1;SMAD3;ACVR2B;INHBB;ACVR2A
prerank,positive regulation of cyclase activity (GO:0031281),-0.3958976997065198,-1.0227622829443277,0.44341801385681295,0.713162754500703,1.0,5/14,12.68%,CACNA1C;NOS3;MAPK14;ORAI1;NOS1
prerank,regulation of water loss via skin (GO:0033561),0.41737330104827874,1.0225465516871701,0.4098639455782313,0.9486145167090156,1.0,3/15,13.83%,KDF1;FA2H;STMN1
prerank,establishment of skin barrier (GO:0061436),0.41737330104827874,1.0225465516871701,0.4098639455782313,0.9486145167090156,1.0,3/15,13.83%,KDF1;FA2H;STMN1
prerank,autophagy of nucleus (GO:0044804),0.4289510562279444,1.0224723196590948,0.43686006825938567,0.9478273435082085,1.0,6/16,17.76%,ATG9B;WDR45B;RB1CC1;ATG9A;ULK2;WIPI2
prerank,mitotic DNA replication (GO:1902969),0.47501759016585754,1.0220977713354704,0.4234875444839858,0.9479733686551213,1.0,7/10,27.85%,GINS3;POLA1;MCM4;MCMDC2;GINS1;MCM3;MCM2
prerank,positive regulation of viral process (GO:0048524),0.32884463750357074,1.0214295781696845,0.4177215189873418,0.94899690961106,1.0,17/60,22.34%,PPARA;PPID;MDFIC;PPIH;PDE12;STAU1;AXL;NELFA;DHX9;CNOT7;ADAR;HACD3;TBC1D20;POLR2L;DDB1;NELFB;KPNA2
prerank,calcium ion transport (GO:0006816),0.2933701133201031,1.021386056747578,0.4392059553349876,0.9481318336554142,1.0,18/113,11.67%,TRPA1;SLC24A5;CACNA1E;NALCN;CALCRL;MCOLN2;ITGAV;ITPR1;CACNG3;RYR2;ATP2A2;CACNA1G;TRPV3;TRPC3;FYN;P2RX4;TRPM2;TRPC7
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.40547546935181206,-1.0211010373700193,0.4188861985472155,0.7167584571185458,1.0,7/12,38.41%,SETMAR;HUS1;ORC1;CHEK2;HUS1B;CDC6;TICRR
prerank,positive regulation of macroautophagy (GO:0016239),-0.2847252487402093,-1.0210035502802965,0.3924050632911392,0.7162321461105982,1.0,16/48,16.59%,SPTLC2;KDR;UVRAG;SESN1;PRKAA2;HSPB8;BNIP3L;OPTN;PIP4K2C;BAG3;RALB;PAFAH1B2;SLC25A5;SIRT1;TBK1;VPS13D
prerank,tryptophan catabolic process (GO:0006569),0.4475131739934214,1.0209910769064805,0.44525547445255476,0.9483388132210346,1.0,2/11,17.55%,KYNU;KMO
prerank,telomere capping (GO:0016233),-0.37258258369055763,-1.0209617633105772,0.45121951219512196,0.7155897742124812,1.0,6/16,15.81%,PRKDC;DCLRE1A;STN1;TEN1;NBN;DCLRE1B
prerank,signal release from synapse (GO:0099643),0.3409988941835374,1.0207359870101453,0.42773722627737226,0.9480964866264537,1.0,13/43,18.61%,NRXN2;PTPRN2;NRXN1;VAMP2;SNPH;RIMS1;DNAJC5;UNC13A;PCLO;SYN2;PDZD11;CDK5;SYT1
prerank,regulation of neuron death (GO:1901214),0.3103063254148459,1.0207205426485737,0.410427807486631,0.947157139037092,1.0,19/82,13.29%,WNT5A;EPHB1;GRID2;GRIN2B;REST;FOS;SORL1;DHCR24;LRRK2;EGLN2;C1QA;CD200R1;DCC;RAB29;DAXX;FYN;HTRA2;EIF2S1;TRIM2
prerank,response to cytokine (GO:0034097),-0.23127978252845643,-1.0203871823677626,0.43617021276595747,0.7163695801392896,1.0,23/141,10.30%,ALDH1A2;DPYSL3;LEF1;BCL2L1;HDAC4;APP;MCL1;IRAK2;PTPN4;PTPN14;IL1R1;ANXA1;IL6ST;ADAM10;IFITM3;CASP3;GCH1;SMAD3;MAP2K7;CASP8;IFITM1;KLHL20;PTPN2
prerank,response to peptide hormone (GO:0043434),-0.29473814540861665,-1.0201530268824732,0.43843843843843844,0.7161769526550322,1.0,13/43,19.15%,ROCK2;CAV1;IGFBP5;ANXA1;TRIM16;EIF2B4;CREB1;SIRT1;GPER1;EPM2AIP1;AKT1;ZBTB7B;TGFBR3
prerank,aerobic electron transport chain (GO:0019646),-0.259517105479562,-1.0198526942385968,0.3888888888888889,0.716164977592372,1.0,26/68,25.76%,SDHC;NDUFA6;COX15;NDUFB7;COX6C;NDUFAF1;NDUFV1;COX5B;NDUFS6;NDUFA8;SDHA;NDUFC1;AFG1L;CYC1;UQCRB;COX4I1;COX6B1;NDUFB4;UQCRQ;UQCRC2;NDUFA13;NDUFB2;UQCC3;NDUFA1;NDUFS2;NDUFS8
prerank,negative regulation of protein polymerization (GO:0032272),-0.33101391289380927,-1.019243839391033,0.4262295081967213,0.7170140699646749,1.0,9/27,21.45%,SLIT2;KANK3;HIP1R;KANK1;SSH1;CDH5;PRKCD;EML2;TWF2
prerank,Golgi localization (GO:0051645),-0.4197508216640403,-1.0192024557946335,0.43805309734513276,0.7163843272857713,1.0,4/11,14.83%,UVRAG;CDC42;ARCN1;STK25
prerank,positive regulation of bone mineralization (GO:0030501),0.3552184675889732,1.018766426336499,0.4260089686098655,0.9520013763339922,1.0,3/35,1.67%,PTN;GPM6B;ADGRV1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4181770021728217,-1.0185784713121782,0.43287037037037035,0.717289666096902,1.0,7/11,20.48%,CD200;THBS1;CD34;GATA6;PTGS2;ATP6AP2;CD46
prerank,regulation of osteoclast differentiation (GO:0045670),0.3568551343563061,1.0183740802110803,0.4418960244648318,0.9522631468129964,1.0,9/33,17.82%,MTOR;TLR4;CAMK4;UBASH3B;BGLAP;LRRC17;FBN1;MAFB;GPR137B
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4000668289545445,1.0183676060817384,0.4316309719934102,0.9512926007074275,1.0,5/20,8.66%,ATP1A2;RYR2;ATP2A2;SLC9A1;PRKACA
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.38336800426182754,-1.018256504619147,0.43424317617866004,0.7173398103590802,1.0,7/14,17.38%,SEMA7A;MAVS;PLCG2;TICAM1;SIRT1;CD74;LAPTM5
prerank,protein deacylation (GO:0035601),0.3804206473890696,1.0182239609047874,0.4519230769230769,0.9507661054173582,1.0,6/23,13.60%,HDAC1;SIRT6;ABHD17C;ABHD17B;LYPLA2;HDAC10
prerank,response to organophosphorus (GO:0046683),0.4213984553656615,1.0175406430882175,0.4307178631051753,0.9518322048332933,1.0,7/16,23.88%,DGKQ;TRPC3;RFC3;P2RX4;NDUFS4;ABCC9;STAT1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.2996127712444569,-1.0173455171461452,0.4276923076923077,0.7189988024605123,1.0,14/42,14.88%,TEK;PTPRJ;NRP1;S100A10;KDR;RAC1;CDK6;PPM1F;GSK3B;SFRP1;PLEKHA2;PTK2B;RRAS;CX3CL1
prerank,regulation of endopeptidase activity (GO:0052548),-0.2744420036423599,-1.017149735484129,0.4075342465753425,0.7187884642592485,1.0,21/59,22.78%,PICALM;SPOCK2;VTN;SERPIND1;SERPINE1;SERPINI1;SERPINA2;GAPDH;APH1A;PSMA3;APH1B;PSME3;SERPINE2;FURIN;PRELID1;AKT1;PSME2;TIMP3;AGT;BIRC3;SERPINB8
prerank,protein K11-linked ubiquitination (GO:0070979),-0.32289989977431155,-1.0168617680665977,0.42934782608695654,0.7188281015864508,1.0,9/27,21.18%,CDC23;UBE2D3;ANAPC10;UBE2H;UBE2A;ANAPC13;ANAPC11;FZR1;ANAPC2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4270217723239961,1.0164497077344958,0.44582593250444047,0.9541429636277599,1.0,5/14,19.47%,XCL1;PTPN22;CD81;LGALS9;RASAL3
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3604361922464874,-1.0162421544637348,0.4332493702770781,0.7195953868478238,1.0,4/16,10.80%,DPYSL3;UPP2;UPB1;NT5E
prerank,positive regulation of neurogenesis (GO:0050769),0.3141933593939498,1.0159225493954331,0.43989071038251365,0.9547734968765351,1.0,12/68,11.46%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;CAPRIN1;SERPINF1;DISC1;CDKL3;NAP1L1;PLXNB2;SNW1
prerank,synaptic vesicle endocytosis (GO:0048488),0.35773257209126275,1.0159195504947933,0.4273255813953488,0.9538053655961871,1.0,13/33,21.14%,CEL;VAMP2;ITSN1;OPHN1;SYT5;DNM1;CDK5;DNAJC6;AMPH;FCHO2;SYT1;CANX;SNAP91
prerank,glutathione biosynthetic process (GO:0006750),-0.4124147939217405,-1.0158085419187968,0.44298245614035087,0.719925921825588,1.0,6/11,36.41%,GCLC;CHAC2;GGT1;GSS;GGCT;MGST2
prerank,monocarboxylic acid transport (GO:0015718),0.33747519992817426,1.0157200351393232,0.4155455904334828,0.9534118206287567,1.0,6/51,3.46%,ABCC3;SLC6A13;SLC6A8;SLC16A12;NR1H4;NCOA2
prerank,regulation of intracellular signal transduction (GO:1902531),0.26090902058209825,1.0148640527335846,0.4435146443514644,0.9549520615362292,1.0,90/420,18.88%,DLC1;NTRK3;CHN1;ARHGAP22;ARHGAP32;AKAP5;TAGAP;FBXO9;HDAC1;L3MBTL1;WNT5A;NTRK2;TAF9B;PTEN;TRAF4;ARHGEF3;ITGAV;PIP4K2A;RHOJ;TAF12;AKAP7;ABR;MAP4K4;ARHGAP6;PDPK1;PIK3R2;SPRED1;ENTPD5;RAC3;PRR5;PTPN22;ARHGAP24;ANKRD54;CHD4;LRRK2;CAPN3;MBD3;TAF15;ARHGEF6;RPA1;TAF3;PTPN13;MDM4;NOC2L;MTOR;ITSN1;BIRC2;DAXX;RFC3;ARAP2;OPHN1;ARHGAP4;TP53;PYCARD;RCN3;TOP3A;ARHGAP31;ARHGAP35;SSRP1;ARHGAP1;FAM13B;PREX1;AKAP6;CRK;LYN;ARHGEF19;GPAT3;PRKAR1A;RRS1;ARAF;SGK1;TNIK;CSNK2A2;FGD2;MAPK11;CDK5;PAK5;RHOG;A2M;CASTOR1;WRN;TTI1;TAF10;SYDE1;ARHGAP29;BRD7;RHOA;WWC1;ULK4;KALRN
prerank,substrate-dependent cell migration (GO:0006929),-0.3837264844233194,-1.0148006632043098,0.44724770642201833,0.721752253872896,1.0,6/14,11.76%,ANKS1A;NTN1;NRP1;VEGFC;ITGB1BP1;CD2AP
prerank,indolalkylamine catabolic process (GO:0046218),0.45479126122757363,1.014248973036779,0.44403669724770645,0.955829053336547,1.0,2/10,17.55%,KYNU;KMO
prerank,regulation of cellular respiration (GO:0043457),-0.36427489936298063,-1.0142405028298909,0.44415584415584414,0.7224213376551881,1.0,6/17,16.30%,IL10RB;IFNAR1;VCP;PRDM16;PRELID1;NOA1
prerank,phospholipid dephosphorylation (GO:0046839),0.34898766433614237,1.0141630955222563,0.4418960244648318,0.9550910719986135,1.0,8/37,10.68%,PTEN;SACM1L;MTMR4;PLPPR3;MTMR1;INPP5J;PLPPR2;PLPP6
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.24405485195752324,-1.0140932637475408,0.41836734693877553,0.7220545706321744,1.0,33/108,18.83%,TRABD2B;RSPO3;APP;SMARCA4;NXN;RNF43;RUNX1;RSPO2;OTULIN;KANK1;WWOX;SKI;GPC3;GRB10;SULF2;PPP2R1A;WLS;FZD7;FOXL1;SFRP1;CXXC4;TMEM237;TERT;MACF1;CBY1;FAM53B;ATP6AP2;VGLL4;ESR1;HHEX;TAX1BP3;SNX3;GSKIP
prerank,regulation of cell growth (GO:0001558),-0.21646307692539668,-1.0140696255225647,0.4028776978417266,0.721371626519235,1.0,68/204,24.37%,PLCE1;APBB2;PTPRJ;SLIT2;EGFR;FHL1;LTBP4;NET1;BMPR2;SMARCA4;OSGIN2;SMARCA2;CAMK2D;TGFB2;SOCS2;CCN3;SH3BP4;TFRC;ADAM10;CDC42;PPP2R1A;IP6K2;PRDM11;ACVRL1;SOX17;SMAD3;NPR1;HYAL1;SFRP1;INO80;FAM107A;RPS6KA1;CEACAM1;ENO1;EXOSC2;MFSD2A;AGTR1;CDKN2AIP;ARHGEF11;CDKN1A;SIRT1;PABIR1;VGLL4;OGFR;DCUN1D3;RBBP7;ERBB2;AKT1;SDCBP;APBB1;WNT11;RERG;CIB1;AGT;LGI1;RTN4;SPHK2;CCAR2;BTG1;NDUFA13;CDA;CISH;NUBP1;PAK4;TAOK2;MT3;HYAL2;BAP1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.28973696525470954,-1.0140348616321941,0.41839762611275966,0.7207476313926253,1.0,10/43,10.61%,IGF1;MEF2C;BMPR2;WNT4;IL6ST;CCN1;ACVR1;IFITM1;CCN4;NPNT
prerank,protein localization to nucleus (GO:0034504),0.29499563710432813,1.0137830466692501,0.438058748403576,0.9552752164108413,1.0,26/102,18.72%,PRICKLE1;CSE1L;NUP214;FAM53C;NUTF2;POM121;TAF3;APPL2;FAM53A;BMP7;MSX1;TNPO1;PTTG1IP;NUP107;EIF4ENIF1;NXT2;RRS1;ZBTB7A;TNPO2;CALR;TAF8;IPO9;CTDNEP1;WRN;NUP155;KPNB1
prerank,peptidyl-lysine modification (GO:0018205),0.2961603689538161,1.0137827923491038,0.44740177439797213,0.9542964508202565,1.0,25/99,19.67%,LOXL4;PLOD1;NUP214;LOXL3;LOXL2;AAAS;VCPKMT;POM121;VIPAS39;PIAS2;SAE1;NUP42;NUP107;P3H3;HDAC10;ATP7A;SENP6;NDUFAB1;VPS33B;NUP54;PLOD2;NUP155;USPL1;ATPSCKMT;SUMO2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.33747968384460947,1.0136265351918325,0.4309623430962343,0.9537754846573463,1.0,6/46,5.31%,PIK3R1;TCF7L2;JUP;PIK3R2;ZIC1;NEDD4
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.37368157064219293,-1.013530738849674,0.43675417661097854,0.7212850092751657,1.0,3/15,7.21%,PLTP;SCARB1;APOE
prerank,negative regulation of cytokine production (GO:0001818),0.27921266299020003,1.0135043851071097,0.45696969696969697,0.9531522213352076,1.0,23/163,12.41%,APOD;XCL1;PPARA;TRAF3IP1;ABCD2;NR1H4;PTPN22;PDCD1LG2;TLR6;DHX58;TLR8;CIDEA;CD200R1;AXL;NAV3;ADCY7;APPL2;TLR4;TNFRSF21;PYCARD;ASB1;IL12A;PDCD4
prerank,protein kinase A signaling (GO:0010737),-0.3995795200082373,-1.0131436244452523,0.44243792325056436,0.7215328146043407,1.0,3/12,10.25%,EZR;RDX;RAB13
prerank,P-body assembly (GO:0033962),0.4375322474069956,1.0130596114691437,0.4432234432234432,0.9534791270429502,1.0,4/12,13.86%,LSM14A;LSM4;EDC3;EIF4ENIF1
prerank,metal ion homeostasis (GO:0055065),-0.2903535953129062,-1.012697724161294,0.41786743515850144,0.7219310770750601,1.0,3/40,1.13%,TMTC2;SLC12A7;CAV1
prerank,defense response to tumor cell (GO:0002357),0.4695888921625254,1.0126632984174135,0.45251396648044695,0.9537111063885039,1.0,2/10,4.92%,DLEC1;RBMS3
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3981716914273913,1.0123256539828827,0.434991974317817,0.9538013681051222,1.0,10/21,18.46%,GPM6B;PEAK1;SLC9A1;PTK2;EPHA3;PTPRA;SLK;CLASP1;LDB1;RHOA
prerank,hippo signaling (GO:0035329),-0.31799732107756495,-1.01221121640066,0.3978201634877384,0.7223846197698894,1.0,10/26,20.19%,TJP1;AMOT;TEAD4;YWHAB;TJP2;CASP3;AMOTL2;MOB1B;NPHP4;AMOTL1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3769288425122312,-1.0121678647287888,0.4665012406947891,0.7217490549783463,1.0,6/16,23.08%,CHMP4B;CHMP4A;CHMP7;VPS28;VPS36;CHMP4C
prerank,cardiac ventricle development (GO:0003231),0.39351769937114933,1.0120708956856992,0.42995169082125606,0.9535835089128455,1.0,7/20,18.37%,SALL1;TMEM65;MDM4;HECTD1;DAND5;GJA5;HEY1
prerank,protein-DNA complex assembly (GO:0065004),0.29177153523235316,1.0118580370664982,0.45006165228113443,0.9532543909553719,1.0,32/116,18.81%,TCF4;PSMD1;MCM7;NAP1L3;ERCC5;PSMD10;ASF1A;GMNN;PSMA5;RPA1;PSMB5;CHAF1B;SPTY2D1;XPC;DAXX;PSMC4;MCM4;PSMA4;NAP1L1;PSMC5;GTF2H3;SOX9;CDT1;PSMB9;ERCC2;GTF2H1;ORC2;PSMA7;PSMD14;PSMA2;CUL4A;PSMD11
prerank,protein O-linked mannosylation (GO:0035269),-0.36304528588752755,-1.0116735741141236,0.41968911917098445,0.722262813747224,1.0,4/18,8.22%,TMTC2;TMTC1;TMTC4;LARGE1
prerank,calcium import into the mitochondrion (GO:0036444),-0.4212962776716777,-1.0114244089051083,0.45495495495495497,0.7221753796191879,1.0,5/10,22.58%,MICU1;MCUB;SMDT1;MCUR1;MCU
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2890168519892432,-1.0112830163400301,0.40059347181008903,0.7218423413687077,1.0,13/40,20.68%,LBP;GBP7;DROSHA;GBP4;GBP2;PGLYRP1;GBP6;RNASE7;MPEG1;HMGB2;PPP1R11;CHGA;ROMO1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.35196658067974446,-1.0110336980821923,0.4511627906976744,0.7217344244541339,1.0,7/18,15.21%,FOXC2;KDR;JCAD;ANXA1;GATA2;FGFBP1;PTGS2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.30387089422925934,1.0109282362905119,0.43557422969187676,0.9549123943718051,1.0,19/77,17.00%,SH3RF1;TCF7L2;PHIP;ITGAV;NOL3;PSMD10;HERPUD1;FXN;PINK1;NOC2L;OPA1;RTKN2;BCL2L2;TGFBR1;RIPK1;CLU;AR;CSNK2A2;MAZ
prerank,bile acid and bile salt transport (GO:0015721),0.3812974740136403,1.010661666592704,0.4430379746835443,0.9547621945057487,1.0,4/24,9.04%,ABCC3;NR1H4;NCOA2;NCOA1
prerank,anion transmembrane transport (GO:0098656),0.3120215536041807,1.0102106756874496,0.45454545454545453,0.9551576203323076,1.0,6/67,4.87%,SLC1A3;SLC6A13;SLC6A8;SLC16A12;SLC25A21;SLC7A8
prerank,regulation of store-operated calcium entry (GO:2001256),0.4617748254525694,1.0102030982155108,0.46234676007005254,0.9542075407382965,1.0,4/10,21.37%,GRAMD2A;STIM1;HOMER3;HOMER2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3073365059764924,1.009942076365635,0.435656836461126,0.9539976497716652,1.0,22/76,19.81%,PRICKLE1;CCDC22;PTEN;RNF180;LRRK2;PSMD10;CBFA2T3;PTK2;NKD2;ZYG11B;HECTD1;GSK3A;AXIN1;DDA1;CLU;CSNK1E;DET1;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,membrane repolarization (GO:0086009),0.4126621249162492,1.0099322500680832,0.4567901234567901,0.9530647626736938,1.0,3/15,10.97%,ATP1A2;KCNIP2;KCNE4
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.32531103101904524,1.0097570788718302,0.4408759124087591,0.9526363861484326,1.0,4/49,3.59%,GHR;CD40;ERBB4;TSLP
prerank,lipid transport (GO:0006869),0.30000190960037554,1.0093698328644396,0.4560723514211886,0.9528341043488432,1.0,8/97,4.00%,ABCA9;NPC1L1;ABCC3;ABCA6;ABCD2;NR1H4;NCOA2;PPARD
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2655325671691037,-1.0091739343232116,0.4627450980392157,0.7256751905091844,1.0,22/61,19.03%,PRKAG2;CAV1;PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;SIRT1;PSMB10;OAZ2;SIRT5;PSME2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.352160188386625,-1.0089769649578304,0.4400921658986175,0.7254361751390109,1.0,8/19,23.78%,RENBP;UGDH;UAP1;UGP2;UAP1L1;PMM1;NANS;MPI
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2486677798871089,-1.0089658406227804,0.4080717488789238,0.7247364846235038,1.0,19/86,15.68%,BAIAP2L1;OCLN;FER;APP;DRG1;RAC1;NCK1;APOE;MAPT;GPX1;ARL2;SLAIN2;LMOD1;TRPV4;PTK2B;BAIAP2;CX3CL1;EDN1;MET
prerank,cholesterol transport (GO:0030301),0.3378765807847247,1.0086570885570048,0.44710860366713684,0.9539353807692926,1.0,11/45,19.35%,NPC1L1;CEL;LIPC;SOAT2;ABCA5;RELCH;SERAC1;CLU;LDLRAP1;OSBP;NPC2
prerank,coenzyme A metabolic process (GO:0015936),0.41652105138332696,1.0083217959229689,0.46402877697841727,0.9539216470960986,1.0,5/14,21.63%,COASY;ACOT7;ACLY;PANK2;SLC25A16
prerank,cell-cell junction maintenance (GO:0045217),-0.40544837378668785,-1.0082187716367685,0.4225352112676056,0.7259847134121789,1.0,1/11,0.33%,TJP1
prerank,glycogen catabolic process (GO:0005980),-0.37763262025781996,-1.0074534960264212,0.45169082125603865,0.7271650508725886,1.0,5/15,11.64%,PYGB;PGM2L1;CALM1;GAA;PGM2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.402347156254654,-1.007356780703537,0.45023696682464454,0.726671579869323,1.0,4/12,22.66%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,embryonic organ development (GO:0048568),0.318847321636515,1.007347777563772,0.4489795918367347,0.9558314501068076,1.0,6/61,4.58%,COL13A1;TEAD1;FLT3LG;SALL1;TEAD2;KMT2A
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.28078471094031604,1.00722930129169,0.4464500601684717,0.9552202725366644,1.0,25/140,13.18%,DLC1;CHN1;ARHGAP22;ARHGAP32;TAGAP;ARHGEF3;ITGAV;RHOJ;RABL3;ABR;ARHGAP6;PIK3R2;RAC3;ARHGAP24;ARHGEF6;RELN;ITSN1;ARAP2;OPHN1;ARHGAP4;ARHGAP31;ARHGAP35;ARHGAP1;FAM13B;PREX1
prerank,protein deacetylation (GO:0006476),0.33199140315168607,1.006808065178429,0.4469026548672566,0.9554502769797945,1.0,6/41,7.08%,MIER2;HDAC1;MORF4L1;SIRT6;BRMS1L;BRMS1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.34486342086401744,1.0065658124363426,0.45603576751117736,0.9551702341427849,1.0,9/34,16.96%,PDE4B;RYR2;ATP2A2;SLC9A1;PRKACA;P2RX4;GJA5;STC1;PIK3CG
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.3773988407489886,1.0057986103741052,0.456,0.9565140302934019,1.0,5/23,8.79%,PTEN;SACM1L;MTMR4;MTMR1;INPP5J
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25758953834931236,1.0057379805524689,0.4722222222222222,0.9557510873507991,1.0,120/497,19.42%,ENPP1;ZEB1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;HDAC1;L3MBTL1;WNT5A;NR2F2;TCF7L2;BASP1;EIF4A3;SALL1;NANOS3;CDKN2A;THRA;EPRS1;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;LSM14A;SCML4;MDFIC;RUNX1T1;ZNF423;FMR1;ZBTB16;CAPRIN1;TLE2;FOXS1;BCOR;CAPN3;CALCA;CBFA2T3;GMNN;BRMS1;PAX9;BCL6;TERF1;ZKSCAN3;PER2;TWIST1;L3MBTL4;TLE1;DAXX;BMP7;GLI3;EIF2AK2;EIF2AK1;TP53;ZC3H8;MPHOSPH8;DHX36;ZFPM2;SNW1;DAP;EPC1;ZNF318;SOX9;TWIST2;PDCD4;GSK3A;DPF2;HIC2;BTAF1;CNOT1;PHC1;PRDM5;ZMYND15;MALSU1;HDAC10;EIF4ENIF1;PUS7;KDM5C;TSPYL2;CREB3L1;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;CNOT7;CRY2;CENPF;ZHX3;SPINDOC;TSC1;ZBTB7A;CBFA2T2;IGF2BP3;NONO;MBTD1;CIART;NR1D2;CALR;CDK5;MBD2;LDB1;SUV39H2;BMP2;MBD1;KAT7;HEY1;BRD7;ILF3;KHDRBS1;DEDD2;PEX14;THAP7;EIF2AK3;CREBZF;FXR1;NACC1;IKZF4
prerank,lipoprotein catabolic process (GO:0042159),0.44145444375915677,1.0055075393312372,0.45768566493955093,0.9554245253671125,1.0,3/11,10.31%,ABHD17C;ABHD17B;LYPLA2
prerank,regulation of endocytosis (GO:0030100),-0.26841087715966655,-1.0054023047755016,0.42857142857142855,0.730823944744499,1.0,18/61,19.99%,PICALM;PACSIN2;HIP1R;MCTP1;GPC3;DAB2;APOE;RAB5A;RAB5C;PTPN1;CD151;SNX17;HIP1;SMPD1;MTMR2;RAB4A;CALY;AP2S1
prerank,neural tube closure (GO:0001843),0.35430859399739734,1.0050180358806082,0.45412130637636083,0.9559204457063155,1.0,4/34,6.65%,DLC1;PRICKLE1;SCRIB;MTHFD1L
prerank,hemopoiesis (GO:0030097),-0.24682984431410468,-1.0049058066482959,0.42292490118577075,0.7313279420235612,1.0,13/87,7.46%,FLT1;MECOM;KITLG;TEK;NOTCH2;KDR;RUNX1;TGFB2;CD34;SNRK;MFAP5;ETV6;HIPK1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.2544585066378396,-1.004631972996318,0.4552238805970149,0.7313160054055747,1.0,22/75,18.27%,TEK;NRP2;NRP1;BMPR2;ECM1;KDR;JCAD;VEGFD;VEGFC;PPP1R16B;GATA2;NR4A1;PIK3CD;FGFBP1;MDK;ITGB3;FLT4;AGTR1;SIRT1;HMGB2;AKT1;EGF
prerank,peroxisomal membrane transport (GO:0015919),0.36443355024235363,1.003730921787152,0.4458804523424879,0.9587122898679667,1.0,12/27,23.26%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;PEX6;GDAP1;FIS1
prerank,atrial septum development (GO:0003283),-0.38581589011946704,-1.0031886466227637,0.4412470023980815,0.7344090137467704,1.0,5/13,12.72%,NOTCH2;BMPR2;TGFB2;ANK2;HEY2
prerank,regulation of monocyte differentiation (GO:0045655),0.4172581346590088,1.003130248036553,0.4358974358974359,0.959502826602749,1.0,1/14,0.31%,IL34
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.44917181448560206,1.0030998338535522,0.47593582887700536,0.9586313406659537,1.0,4/10,11.54%,THRA;PSMC4;TP53;PSMC5
prerank,Ras protein signal transduction (GO:0007265),-0.23748387928576378,-1.0025296079251151,0.47761194029850745,0.7353887348917897,1.0,31/137,16.26%,PLCE1;IGF1;RAPGEF2;ROCK2;MRAS;KRAS;RAPGEF6;NTN1;RRAS2;SHOC2;RAP1A;RAC1;RASGRP3;RAPGEF1;MAPK14;ARHGDIB;EPS8L2;CFL1;PHACTR4;RGL2;RALB;RRAS;AGTR1;GRB2;ADGRG1;ARHGEF11;RAPGEF3;RAP2C;CDKN1A;GRAP;PDPN
prerank,response to calcium ion (GO:0051592),0.2934907663316928,1.002495944495879,0.4454428754813864,0.9595166347783706,1.0,29/102,19.43%,ADGRV1;WNT5A;GPLD1;RYR2;NEDD4;KCNMA1;KCNIP2;ADCY8;CAPN3;RASGRP2;SYT3;TRPC3;LGMN;SYT7;CPNE7;TRPM2;SYT5;CPNE4;RYR3;CPNE8;STIM1;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1;TRPC1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3811766662917384,-1.0024146061253962,0.45742092457420924,0.7349255709799398,1.0,5/15,5.51%,IGF1;ROCK2;MEF2A;CAMK2D;IL6ST
prerank,ganglioside metabolic process (GO:0001573),-0.34969801562684066,-1.0023943367514752,0.44559585492227977,0.7342540095779555,1.0,8/20,23.36%,ST8SIA4;ST6GALNAC3;HEXB;ST8SIA2;ST3GAL5;GM2A;ST8SIA6;CLN6
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.34390687733261055,-1.0022342073545008,0.45454545454545453,0.733922511468398,1.0,9/21,25.69%,ERAP1;ADAM10;RBMX;DAG1;APH1A;ADAM9;MYH9;BACE2;PSEN2
prerank,positive regulation of filopodium assembly (GO:0051491),0.3669390183743863,1.0019556800149856,0.453781512605042,0.9601974650712729,1.0,5/24,9.15%,PIK3R1;FSCN1;FMR1;TENM2;TENM1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4337038987016492,1.00195183875176,0.45143884892086333,0.9592517308234063,1.0,1/12,0.79%,XCL1
prerank,protein processing (GO:0016485),0.2952626537381582,1.001931530207089,0.4653846153846154,0.9583666615319314,1.0,15/102,12.41%,ECE1;ECE2;OGT;PCSK2;KLKB1;ADAM19;CASP4;OMA1;CPM;FXN;LGMN;PITRM1;SEC11A;HTRA2;SPRTN
prerank,regulation of lamellipodium assembly (GO:0010591),0.34524617860215606,1.001817212677663,0.4354587869362364,0.9577493600091883,1.0,6/34,8.62%,PIK3R1;HRG;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,negative regulation of cell population proliferation (GO:0008285),0.2591872226262952,1.0016718308912091,0.4865735767991407,0.9571962670763992,1.0,69/351,16.56%,APOD;DLC1;COL18A1;KDF1;ATF5;HRG;ROR2;WNT5A;CXCL1;PTEN;ERBB4;GPLD1;CDKN2A;GLMN;FAP;PEX2;MCC;DLG3;REST;TBX3;TMEM115;ADGRB1;NF1;CBFA2T3;CDKN2D;PTPRU;MDM4;PER2;IFNLR1;P3H1;SOX2;APPL2;TENM1;MAP2K1;TNS2;EIF2AK2;TP53;FKTN;GAS8;SPEG;SOX9;IL12A;FABP3;HGS;ST18;DIS3L2;MTSS1;TESC;BNIPL;P3H3;CDKN2C;B4GALT7;LYN;NME1;MED25;THAP12;WNK2;CTNNBIP1;F2R;TFAP4;AR;CNOT7;MYC;KLF11;MN1;CDK10;TSC1;RBM5;CHERP
prerank,positive regulation of apoptotic process (GO:0043065),-0.20795428245012623,-1.0014702527937576,0.40298507462686567,0.7351114011401816,1.0,85/293,22.61%,PAWR;DAPK1;FOXO1;ARHGEF18;ANO6;SLIT2;TIAM2;ITGB1;NET1;ARL6IP5;TPD52L1;ITGA6;MCF2L;TNFSF10;HIP1R;IGFBP3;SQSTM1;MAP3K5;FAS;TGFB2;CYP1B1;UNC13B;APC;ATF6;CRADD;JMY;UBB;SOX4;IP6K2;NGF;PRDM11;CASP2;SIK1;CASP3;NGEF;CASP8;BAD;SFRP1;BAX;BNIP3L;TNFAIP8;ADAMTSL4;MYBBP1A;BID;APH1A;TGM2;TLE5;GADD45B;PTRH2;APH1B;ATM;BOK;PLEKHG2;ING4;ARHGEF11;STK17B;TRIM35;SMPD1;SIRT1;GPER1;ING5;AIFM1;DCUN1D3;UBC;MAP3K10;TFPT;APBB1;EEF1E1;STPG1;VAV1;ITGB3BP;SOS1;RASGRF2;GADD45G;TRADD;ARHGEF12;E2F1;SPHK2;CCAR2;BTG1;DDX20;NUPR1;UBA52;TIAM1;ARHGEF1
prerank,cellular response to UV-A (GO:0071492),0.44069141525641853,1.0014681695433267,0.460573476702509,0.9568261442522874,1.0,1/11,1.67%,PPID
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.41123598147855056,1.0010512211220566,0.4469565217391304,0.9571551209054041,1.0,6/16,20.07%,NECAB2;PRKCA;GSK3A;MRAP;SLC39A14;PDE6H
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3525802217412605,-1.0009997362021685,0.4623376623376623,0.7354875663202067,1.0,4/19,5.89%,EZR;CYTH1;PARD3;CDC42
prerank,positive regulation of cation channel activity (GO:2001259),-0.2851781529095491,-1.000951573653505,0.47109826589595377,0.7348656541318291,1.0,12/40,22.01%,ACTN2;SHANK3;CALM1;ANK2;STAC;EPHB2;LRRC38;TMSB4X;JPH2;CTSS;ADRB2;GSTO1
prerank,negative regulation of viral genome replication (GO:0045071),-0.28638103492935774,-1.000787032453687,0.45569620253164556,0.7345519136379378,1.0,12/40,25.63%,MAVS;IFITM3;ZC3HAV1;IFITM1;PARP10;SRPK1;RNASEL;ISG15;IFIT1;IFITM2;BANF1;TRIM6
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3933683781438011,1.0006908583844303,0.4578512396694215,0.9572744025486661,1.0,6/18,15.40%,PEX2;NF1;TP53;B4GALT7;MED25;MYC
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.27793486693331515,-1.000644077328507,0.44551282051282054,0.7342022870655924,1.0,15/44,20.63%,FNIP1;XIAP;THBS1;KLF4;NGF;CD44;LAMTOR5;GPX1;RPS6KA1;ARL6IP1;MAP2K5;SIAH2;AKT1;HGF;CAST
prerank,telomere organization (GO:0032200),-0.28507162455111584,-1.0004823616834702,0.4507936507936508,0.7338898183431831,1.0,27/43,37.09%,PTGES3;PRKDC;ATR;RTEL1;TERT;PCNA;STN1;ATM;NBN;RAD51D;DCLRE1B;HUS1;POLD2;PARP1;RPA2;ACD;LTO1;POLD4;POLD1;CTC1;RAD50;H3-3A;TINF2;HUS1B;MRE11;RPA3;APEX1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3331247464191102,-1.0004232863529998,0.48186528497409326,0.7333095746850765,1.0,6/23,14.38%,NMI;UACA;CCN3;IFI35;CYLD;TMSB4X
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2917651673587464,-1.0003993433118894,0.47337278106508873,0.7326346261243416,1.0,15/41,25.90%,TJP1;PODXL;PLPP3;AFDN;CD44;CITED2;MDK;DENND6A;CX3CL1;SKAP1;PIEZO1;SMAD7;FSTL3;MAGI1;FLOT1
prerank,negative regulation of peptidase activity (GO:0010466),0.3263218315027663,1.0002270724769868,0.44165435745937964,0.9577071376443486,1.0,4/47,5.46%,LRP1;HRG;SPOCK3;SERPINF1
prerank,regulation of vacuole organization (GO:0044088),-0.34079033731863706,-1.0001664274164732,0.43882978723404253,0.7324712760568968,1.0,8/20,25.09%,MTM1;LAPTM4B;RAB5A;ENO1;TBC1D14;RAB1B;NPRL3;ADPRH
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2966206817110224,-0.999978228250162,0.42857142857142855,0.7322283298934229,1.0,20/35,38.37%,DRG1;CHMP2B;DYNC1H1;RAE1;CHMP4B;NUMA1;PDCD6IP;CHMP1A;CHMP4C;TACC3;HSPA1A;CHMP2A;FSD1;HSPA1B;NUP62;TPR;PLK1;HNRNPU;PSRC1;CHMP3
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.39905129815550144,0.9998722199227494,0.4606164383561644,0.957865134815073,1.0,2/19,6.58%,CHRNB4;COLQ
prerank,negative regulation of DNA binding (GO:0043392),-0.3133318457825909,-0.9998229094101765,0.46355685131195334,0.7319060217400849,1.0,10/28,25.64%,LEF1;SMO;NFKBIA;SUMO3;HEY2;SOX11;E2F1;ILRUN;SUMO1;KDM1A
prerank,cell cycle G1/S phase transition (GO:0044843),0.31366539389995396,0.9997686153490553,0.4567901234567901,0.9572139821604682,1.0,21/61,21.60%,CDKN2A;CDC7;CDKN2D;RPS6KB1;CACUL1;PPP6C;BCAT1;RCC1;CUL5;CDKN2C;DBF4;CCNA2;MYC;CAMK2A;CCNE1;KHDRBS1;CUL4A;POLE;LATS2;INHBA;CDK7
prerank,mRNA stabilization (GO:0048255),0.33807630289964696,0.99933936432843,0.4711964549483013,0.957516110377315,1.0,12/40,17.67%,RBM24;DND1;BOLL;ELAVL4;TAF15;PAIP1;TENT5A;EIF4ENIF1;DHX9;GDNF;TIRAP;MYD88
prerank,lipid translocation (GO:0034204),-0.33563066877612824,-0.9988408224372948,0.47668393782383417,0.7336460241970909,1.0,4/21,8.53%,ATP10A;ATP8A1;ATP11B;ATP8B1
prerank,response to organic cyclic compound (GO:0014070),0.3273266945025363,0.998592334207579,0.45248868778280543,0.9587747024997494,1.0,7/52,7.11%,GGT5;GLDC;GGT7;KYNU;SPP1;LRRK2;CDKN2D
prerank,adipose tissue development (GO:0060612),-0.41002034300903933,-0.9985062895540183,0.47344110854503463,0.7337974303857099,1.0,3/11,7.13%,SPTLC2;ARID5B;SH3PXD2B
prerank,androgen metabolic process (GO:0008209),0.403757670873971,0.9982250253557033,0.45791245791245794,0.9588959684352656,1.0,3/18,17.23%,SPP1;MED1;HSD17B11
prerank,protein prenylation (GO:0018342),0.4527971440449408,0.9979626474111611,0.4654205607476635,0.9587025900030678,1.0,3/10,14.64%,PTAR1;PGGT1B;CHML
prerank,regulation of dephosphorylation (GO:0035303),-0.3664685404842012,-0.9976182937412076,0.4452380952380952,0.7353524696259259,1.0,5/15,12.95%,SMG6;PPP1R16A;MTMR9;PPP1R16B;SMG5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.4487620784832963,0.9975684673887165,0.47183098591549294,0.9579903867116794,1.0,2/10,9.27%,IL1RN;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.4487620784832963,0.9975684673887165,0.47183098591549294,0.9579903867116794,1.0,2/10,9.27%,IL1RN;MBP
prerank,regulation of osteoblast proliferation (GO:0033688),-0.3578212735227474,-0.9968841620555422,0.4659949622166247,0.7364899699938682,1.0,5/17,12.99%,NPR3;CCN1;PLXNB1;SFRP1;TMEM119
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.33745830706173247,-0.9963700122390969,0.4583333333333333,0.7370992028325043,1.0,3/21,6.90%,FOXP1;PRKCH;SLC39A10
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.41796018337339835,0.9962617582735456,0.46551724137931033,0.9608447129046697,1.0,2/13,10.09%,GAB2;FGR
prerank,regulation of catabolic process (GO:0009894),0.39779980984984636,0.9962144936718871,0.4609250398724083,0.960050211784466,1.0,8/18,22.97%,FAP;ODC1;HGS;SNF8;ZDHHC2;CENATAC;RARRES2;FAF1
prerank,positive regulation of metabolic process (GO:0009893),0.28786766358738397,0.996182219421196,0.4576923076923077,0.959208799618669,1.0,16/103,9.82%,HCRT;OGT;GPR3;THRA;GJA1;ACADL;SIRT6;EPAS1;FABP5;FABP4;OMA1;PER2;BSCL2;G0S2;APPL2;KSR2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.30098443762552385,0.9960099972154032,0.44623655913978494,0.9588268377642263,1.0,8/75,5.46%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;ADGRB1;SERPINF1
prerank,cellular response to oxidative stress (GO:0034599),0.28325336296510506,0.995784483457436,0.4769038701622971,0.9585618700595944,1.0,23/118,14.60%,PDGFRA;ETV5;PLA2R1;ERCC6L2;FOS;PRDX6;ALDH3B1;CAMKK2;LRRK2;PRDX5;CCS;PYCR1;PINK1;PRKD1;CYBA;TP53;ERMP1;PDK2;HTRA2;EIF2S1;RAD52;LONP1;VKORC1L1
prerank,histone H3-K4 trimethylation (GO:0080182),0.4372628089393119,0.9957507779893834,0.4603448275862069,0.9577311429158204,1.0,2/11,4.58%,OGT;KMT2A
prerank,membrane organization (GO:0061024),-0.21783542516167867,-0.9957206047700546,0.5206611570247934,0.7379742248250591,1.0,68/227,23.26%,MYOF;PICALM;FNBP1L;LEMD3;EGFR;ACTB;AGFG1;PACSIN2;STX18;HIP1R;SYT9;HSPA8;ACTG1;CERT1;DAB2;CHMP2B;TFRC;MITD1;EPN2;FZD4;VAPA;UBB;RAB5A;DNM3;ANK2;AP2A1;VAPB;NAPA;CLTB;GAPVD1;CCDC88A;USO1;GAK;GCA;HIP1;REEP3;TOR1A;IGF2R;GRB2;TMEM170A;SYNJ1;DYSF;CHMP4B;CHMP4A;CHMP7;UBC;SYNGR2;WASL;REPS1;EGF;SNX3;ADRB2;PDCD6IP;AP2S1;CHMP1A;GLTP;A4GALT;TOR1AIP1;COX18;CFTR;UBA52;TMEM33;AP2B1;ARPC5;PIK3C2A;CHMP4C;ARPC4;OXA1L
prerank,regulation of multicellular organism growth (GO:0040014),0.41465765255678766,0.9956242407905461,0.48353552859618715,0.9571645672788095,1.0,1/15,0.31%,GHR
prerank,histone methylation (GO:0016571),-0.31867285113693766,-0.9956230596397734,0.43131868131868134,0.7375367859726627,1.0,6/26,15.08%,SMYD3;NTMT1;PRMT7;SMYD2;PRMT8;EZH2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3189119159171609,0.9954650610087256,0.4704184704184704,0.9567276945691804,1.0,10/56,12.46%,CLEC4E;UNC93B1;TLR6;TLR8;LGMN;TLR4;IRAK1;MAPKAPK3;S100A1;HSP90B1
prerank,cellular response to organic substance (GO:0071310),-0.2346719695553311,-0.9953906578671037,0.45098039215686275,0.7374194668640679,1.0,42/116,23.67%,DPYSL3;LEF1;SLIT2;IL18;ARL6IP5;IGFBP5;KLF4;BMPR2;PTPN4;PTPN14;CYP1B1;SOCS2;RAMP1;ACVR1;ACVRL1;SMAD3;SFRP1;PTPN2;SLC1A1;NOS1;CPNE3;RAMP2;PLK5;MAP2K5;FLT3;TBK1;ACVR2B;ERBB2;CDK9;NDOR1;PID1;PTPN5;DCPS;CIB1;HDAC6;TGFBR2;TWF2;CSF1R;ACVR2A;MME;SIGIRR;EMD
prerank,membrane depolarization (GO:0051899),0.351348688405174,0.9953083839962424,0.45131375579598143,0.9562654665741993,1.0,12/32,22.80%,CACNA1E;CACNA1G;CACNB4;CACNG4;P2RX4;SCN1A;SCN2A;SCN1B;SCN8A;CACNA1I;CACNA1A;ABL1
prerank,protein modification by small protein conjugation (GO:0032446),-0.20032298983169072,-0.995249628843918,0.5102040816326531,0.7370553628656522,1.0,78/361,17.48%,FBXL7;WWP1;EYA1;RNF152;LMO7;GAN;MGRN1;VCPIP1;KLHL13;UBE2G1;ASB2;KLHL24;RNF43;PRKDC;WWP2;ARIH1;OTULIN;CDC23;UBE2D3;HIF3A;TRIM24;HLTF;CUL1;TRIM5;NUP50;TRIM11;FBXL2;UBB;STX1A;VPS18;TRIM14;RANGAP1;RNF8;VCP;MSL2;UBE2F;UBE2H;MIB1;SMURF2;UBR1;UBA6;FBXO25;TSPAN17;UBE2A;ASB5;KLHL20;VHL;CUL9;RNF41;NUP98;NUP153;SPSB4;UBR2;SUMO3;RCHY1;PCNA;HERC2;VPS11;TRIM63;AMFR;NUP43;UBE2N;CAND2;RAE1;TRIM35;ELOC;NUP205;FBXO32;TRIM27;SIRT1;NEDD8;CUL3;ANAPC16;ISG15;DCUN1D3;ANAPC11;UBC;USP9X
prerank,positive regulation of biomineral tissue development (GO:0070169),0.3424968468109066,0.9952153407917123,0.4658753709198813,0.9556056930256629,1.0,6/40,9.69%,PTN;GPM6B;ADGRV1;FBXO5;AMELX;BMP7
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.36758932842458436,0.9952102465112103,0.4511627906976744,0.9547000180277676,1.0,2/25,1.70%,XCL1;WNT5A
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.35739587165845765,0.9951154033629466,0.4670846394984326,0.9540480913979512,1.0,13/29,24.05%,COPA;COPZ2;COPB1;COG6;COG1;TRAPPC10;GOLGA5;COPG1;COPB2;NAPG;RAB33B;COPZ1;GOSR1
prerank,response to amino acid (GO:0043200),0.35400130168231747,0.9949512456803314,0.4539781591263651,0.953606236468808,1.0,10/31,18.69%,CPEB1;MTOR;GLRA3;GLRA1;GLRA2;MEAK7;GLRB;RRAGA;RRAGD;CAPN2
prerank,glial cell differentiation (GO:0010001),-0.31407662249172263,-0.9948117810694507,0.4613259668508287,0.7374406706496814,1.0,3/28,1.55%,NFIB;SLC8A3;ADGRG6
prerank,manganese ion transport (GO:0006828),0.41661319724813695,0.9947834938715509,0.4809688581314879,0.9531576640033609,1.0,6/14,19.43%,SLC30A10;TRPC3;TRPC7;SLC39A14;ATP2C1;TRPC1
prerank,regulation of cellular metabolic process (GO:0031323),0.3269641322144733,0.9942975828595448,0.4540059347181009,0.953618385553654,1.0,12/45,19.52%,PPARA;TBC1D16;PINK1;PDK2;ACLY;MBOAT7;FOXM1;PANK2;COQ7;NPC2;ABCA2;PDK3
prerank,negative regulation of chemotaxis (GO:0050922),0.35874629774583777,0.9941762276381789,0.4704968944099379,0.9530648823668897,1.0,3/31,1.98%,ROBO2;HRG;SEMA5A
prerank,histone monoubiquitination (GO:0010390),0.3700747604743471,0.9940108328228032,0.4696485623003195,0.952579544002596,1.0,4/24,9.24%,RNF40;BCOR;TRIM37;RNF168
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.33788700462199805,-0.9939474907511889,0.4430051813471503,0.7388664171884137,1.0,4/21,6.14%,ROCK2;KLF7;RUNX1;ERRFI1
prerank,histone lysine methylation (GO:0034968),0.34929624034866746,0.9938773195219099,0.46238244514106586,0.9520465387149397,1.0,14/33,23.21%,KMT2A;CXXC1;WDR5;DYDC2;PRDM5;DOT1L;PAXIP1;N6AMT1;ASH2L;SUV39H2;EHMT2;MEN1;RBBP5;KDM6A
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.36722817038744543,0.9935197975459655,0.4767255216693419,0.9521357084275551,1.0,5/26,9.06%,MEIS2;CCDC57;RPS6KB1;PRKCA;LGMN
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3254131811159503,-0.9934701889929484,0.4838709677419355,0.7393604147206834,1.0,5/24,10.49%,ERAP1;TAPBP;ACE;B2M;TAP2
prerank,positive regulation of phagocytosis (GO:0050766),0.3226371048809435,0.9933493781918553,0.46402349486049926,0.9517061840597786,1.0,7/47,10.90%,IL15RA;MERTK;TUB;LYAR;APPL2;CYBA;PYCARD
prerank,regulation of filopodium assembly (GO:0051489),0.33573589653270514,0.9932295339241891,0.4722662440570523,0.951134608471307,1.0,8/38,11.66%,PIK3R1;ABITRAM;MYO10;FSCN1;FMR1;TENM2;TENM1;TRPM2
prerank,regulation of T cell activation (GO:0050863),0.3335586061218831,0.9932014152023844,0.4650817236255572,0.9502995199840233,1.0,5/42,10.90%,PAG1;TNFAIP8L2;PTPN22;KAT2A;PYCARD
prerank,proteolysis (GO:0006508),0.265488086860718,0.9931034695313878,0.4881623449830891,0.9496711756381823,1.0,31/252,12.41%,ECE1;GGT5;PGPEP1L;ECE2;OGT;ADGRV1;ATG4A;FAP;MMP24;MMP25;PCSK2;CAPN5;HTRA3;CASP6;CPQ;KLKB1;ADAM19;CASP4;CAPN3;CPM;ADAMTS12;PSMB5;PLAU;LGMN;CAPN6;PSMC4;PITRM1;ERMP1;HTRA2;ENDOU;SPRTN
prerank,positive regulation of cilium assembly (GO:0045724),0.3950396223071987,0.9930892634454694,0.45016611295681064,0.94880992343482,1.0,5/18,12.99%,SEPTIN9;TAPT1;CEP135;ARHGAP35;ENTR1
prerank,replication fork processing (GO:0031297),-0.2956115730859621,-0.9930182617305691,0.47720364741641336,0.7397650666179767,1.0,16/38,27.97%,SAMHD1;THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;ALYREF;CDK9;SETMAR;RFWD3;ZRANB3;RAD51;CENPX;GEN1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3595851590650433,-0.9925931653795341,0.4473684210526316,0.7400591528205074,1.0,3/18,0.60%,EPHA4;PICALM;ROCK2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3588282083770297,0.9921294137573055,0.4558139534883721,0.9507244835784278,1.0,4/29,4.06%,ZBTB20;PPARA;GPLD1;NR1H2
prerank,response to tumor necrosis factor (GO:0034612),0.2892865555210886,0.9920789023228104,0.480719794344473,0.9499387084467845,1.0,11/91,10.90%,GGT5;XCL1;CD40;GGT7;CCL15;SMPD4;ADAMTS12;ZFP36L2;TNFRSF21;CCL25;PYCARD
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.25769108430269744,-0.992001146255017,0.4474708171206226,0.7408736361673836,1.0,28/72,24.72%,ELF1;IRAK2;RUNX1;OTULIN;HIPK1;CASP8;MADD;PTPN2;PTPN1;CYLD;RNASEL;TNFRSF1A;CD74;IFNGR1;VRK2;TRADD;TNFAIP3;AGPAT2;USP18;CFLAR;TRAF1;BIRC3;SOCS3;IKBKB;SIGIRR;IKBKG;PTPN6;SUMO1
prerank,cAMP-mediated signaling (GO:0019933),0.36634082588043754,0.9917270840905917,0.43573667711598746,0.9500890212407376,1.0,7/24,14.69%,PDE7B;RIMS2;DGKQ;ADCY2;SOX9;AKAP6;EPHA5
prerank,negative regulation of hormone secretion (GO:0046888),0.4480673151582069,0.9916700378112943,0.4484629294755877,0.9493460158349583,1.0,2/10,12.63%,GJA1;RAB11FIP3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.29520665168529275,0.9913205036927151,0.47313237221494103,0.9493954483193582,1.0,20/88,14.46%,CCDC22;STXBP6;TXNDC5;GBF1;VAMP2;MYO1B;SORL1;EPS15;LLGL1;SNAP23;COMMD1;AP1S1;SCFD1;EXOC1;VAMP7;HGS;ACBD3;CLVS1;RABIF;SH3D19
prerank,DNA double-strand break processing (GO:0000729),-0.35143015926310994,-0.9908255057314244,0.4879807692307692,0.7431586106072752,1.0,10/18,32.44%,RBBP8;ATM;NBN;UBE2N;KAT5;SETMAR;BRCA1;RNF138;RAD50;BARD1
prerank,cellular response to cytokine stimulus (GO:0071345),0.2547762362234192,0.9906171527709338,0.49420442571127504,0.950475288343612,1.0,54/416,12.54%,RORA;GHR;IL34;PIK3R1;ZEB1;IL1RN;IL2RA;XCL1;CXCL10;PTPRT;WNT5A;CXCL1;IL1R2;CD40;IL16;FLT3LG;EPRS1;GAB2;JAK1;DUSP1;FSCN1;YWHAZ;FOS;CCL15;SMPD4;PDE12;COL1A2;ADAMTS12;ZFP36L2;BCL6;PTPN13;IL5;UBE2G2;TWIST1;PLP2;AXL;PRKACA;IFNLR1;SOX2;TLR4;IL1RAP;IRAK1;TNFRSF21;CCL25;TP53;PYCARD;FYN;PTGIS;SOX9;IL12A;HTRA2;CD86;HSP90B1;GSK3A
prerank,regulation of MAPK cascade (GO:0043408),0.27646656580621565,0.9905778375675772,0.4874251497005988,0.949683549901681,1.0,15/157,6.08%,ROR1;NTRK3;EPHA7;ROR2;NTRK2;EPHB1;FGFR1;MAP4K4;GPR37L1;DUSP1;PIK3R2;YWHAZ;SPRED1;NF1;PSMD10
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.39512336574214696,-0.9903213669701668,0.4874141876430206,0.7437043894584153,1.0,1/12,0.01%,SORBS1
prerank,regulation of glycolytic process (GO:0006110),0.3036972169027438,0.9902095843312244,0.4697986577181208,0.9498466206115829,1.0,9/68,6.86%,ZBTB20;PPARA;OGT;PFKFB1;NUP214;ENTPD5;AAAS;POM121;CBFA2T3
prerank,digestive tract development (GO:0048565),0.35084870498031917,0.9898342996231481,0.470125786163522,0.9499812974397848,1.0,8/33,15.70%,CLMP;SALL1;NPY;GLI1;GLI3;CHD8;CCDC39;FGFR2
prerank,nucleosome assembly (GO:0006334),0.34456590092403866,0.9897625615047931,0.46570972886762363,0.9492847028880737,1.0,8/31,12.02%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;UBN1;SOX9
prerank,negative regulation of endopeptidase activity (GO:0010951),0.32631509161891653,0.9893031071321337,0.48439821693907875,0.9496917279388698,1.0,5/47,5.46%,HRG;RECK;SPOCK3;SORL1;SERPINF1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.35589323754153884,0.9889608265437547,0.4815950920245399,0.9497438013237556,1.0,12/29,21.85%,HDAC1;TCF7L2;PYGO1;BCL9;TLE2;TLE1;MYC;ASH2L;CDC73;MEN1;RBBP5;CREBBP
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3790883362270959,-0.9882818342106293,0.48758465011286684,0.7481218852569228,1.0,4/13,13.54%,ZDHHC21;ETS1;MDK;FUT9
prerank,cellular response to interleukin-1 (GO:0071347),-0.22666385221276972,-0.988150159549698,0.4819277108433735,0.7477058579988091,1.0,35/143,15.38%,PLCB1;NFKB1;IRAK2;PSMC6;SIRPA;SQSTM1;IL1R1;PELI1;PSMD9;PSMF1;PSMB7;CUL1;TOLLIP;UBB;GBP2;PSMD8;RPS6KA5;RC3H1;HYAL1;PSMD12;SFRP1;NFKBIA;RBMX;MAP3K8;TAB2;PSMA3;PSMA6;PSMD4;IRAK4;PSME3;PSMD7;UBE2N;PSMB6;CX3CL1;PSMC1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.3561047765154433,0.9881339972262996,0.47919876733436056,0.9512078759274777,1.0,5/27,15.67%,LPIN3;CHKA;SELENOI;LPIN2;ABHD4
prerank,regulation of AMPA receptor activity (GO:2000311),-0.32177044637573027,-0.9879039589727353,0.4946524064171123,0.7476667224841164,1.0,5/25,8.64%,MEF2C;SHANK3;MINK1;SHANK1;CACNG2
prerank,cellular biogenic amine catabolic process (GO:0042402),0.45729655715016587,0.9878365404951908,0.4878048780487805,0.9511260585235359,1.0,3/10,18.50%,HNMT;DMGDH;SLC44A1
prerank,ion transport (GO:0006811),0.28503625551212863,0.9876843700932807,0.4845758354755784,0.9506715021461014,1.0,17/111,14.33%,SLC1A3;SLC15A1;VDAC2;TRPA1;SLC24A5;CHRNB4;SLC12A6;SLC9A9;SLC9A1;PLP2;SLC25A22;GLRA1;SLC4A1;KCNN2;GABRB1;LRRC8A;SLC25A26
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.3186073571695296,0.9875809059013767,0.47801418439716314,0.9500684567453718,1.0,14/54,16.88%,DPP6;DPP10;KCNIP1;NEDD4;KCNMA1;KCNIP2;KCNAB1;KCNIP4;KCNN2;KCNAB3;AKAP6;GNG2;GABBR2;KCNJ10
prerank,RNA transport (GO:0050658),0.3064557125731153,0.9875258282233152,0.4539385847797063,0.9493337374936078,1.0,17/71,19.18%,RBFOX1;EIF4A3;NUP214;FMR1;POM121;THOC7;HNRNPA2B1;SRSF11;SLU7;CASC3;KIF5C;SLBP;SRSF9;THOC5;SRSF6;NUP155;CHTOP
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.24260452027309817,-0.9874714702609068,0.5,0.74803065376656,1.0,24/86,17.88%,IGF1;PTPRJ;PECAM1;EGFR;APP;NRP1;CSPG4;VTN;EFNA5;PDGFA;CD44;ACVR1;ENPP2;SFRP1;ITGB3;PLCG2;PRKCZ;PTK2B;RAP2C;PRKCD;TEC;PAK2;CD74;RAP2B
prerank,primary alcohol metabolic process (GO:0034308),0.369599049866572,0.9873682416502039,0.4725274725274725,0.9488714998196359,1.0,3/25,2.38%,ADH1A;RDH10;RDH11
prerank,regulation of protein sumoylation (GO:0033233),0.3914585289329935,0.9873054204985051,0.4596774193548387,0.9481818340459395,1.0,3/17,10.22%,GNL3;CAPN3;SAE1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.28868941686198335,0.9872323441206239,0.4690721649484536,0.947514717156768,1.0,24/95,19.99%,DYNLL1;DCTN3;HAUS3;HAUS1;DCTN2;HAUS8;PRKACA;CEP192;CEP135;AHI1;TCTN2;SSNA1;TMEM67;IQCB1;SCLT1;CEP250;CEP152;CSNK1E;CLASP1;ALMS1;PCM1;MKS1;TUBA1A;CEP43
prerank,signal transduction by p53 class mediator (GO:0072331),-0.3081446015556522,-0.9868162462992343,0.48258706467661694,0.7489362189543931,1.0,9/30,14.36%,DDX5;PPP1R13B;ACER2;NDRG1;JMY;MYBBP1A;BOK;HINT1;NBN
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3361288332623691,-0.9867913677351959,0.49732620320855614,0.7482761261354043,1.0,6/21,9.65%,CACNA1C;CAMK2D;SRI;CALM1;ANK2;DMD
prerank,calcium ion transmembrane transport (GO:0070588),0.29223714783770227,0.9866952059512765,0.4915032679738562,0.9480935503006613,1.0,16/86,11.67%,TRPA1;SLC24A5;NALCN;MCOLN2;ITGAV;GRIN2B;ATP2A2;GRIN2A;CACNA1G;TRPV3;TRPC3;MICU3;PMPCA;P2RX4;TRPM2;TRPC7
prerank,thymus development (GO:0048538),-0.3812043591682699,-0.9865319490660636,0.47706422018348627,0.7482247756964544,1.0,3/13,17.96%,SIX1;TBX1;EPHB3
prerank,cellular response to superoxide (GO:0071451),-0.4136341713964863,-0.9859294707491111,0.4965197215777262,0.7490083014283588,1.0,4/10,16.03%,NOS3;SOD2;PRDX1;SOD3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2824309778740728,-0.9857150055258739,0.4713804713804714,0.7488313112037585,1.0,18/47,26.01%,THBS1;MAPK14;XDH;MAPT;RNF41;PLCG2;AGTR1;GRB2;CDKN1A;PRKCD;ACE2;PID1;AGT;ROMO1;TGFBR2;TYROBP;CBR1;ITGB2
prerank,aminoglycan catabolic process (GO:0006026),0.3590477196614639,0.9855882325963627,0.46614173228346456,0.9503326088639584,1.0,7/28,15.44%,HSPG2;GPC4;GPC5;GNS;GUSB;IDUA;SDC2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.24873161373454616,0.9852632694132022,0.557013118062563,0.9503590907804401,1.0,141/834,16.89%,RORA;IL33;LPIN3;DCN;PIK3R1;ZFHX3;ATF5;ETV1;CXCL10;RUNX2;PPARA;HOXC10;AUTS2;MEIS1;TEAD1;OGT;ETV5;HDAC1;GNL3;WNT5A;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;SALL1;THRA;SMAD5;NR1H4;CDK8;MAML3;NCOA2;MEIS2;PGR;NFATC3;NGFR;MED12;THAP3;METTL23;JUP;PPARD;PIK3R2;NR1H2;REST;TBX3;FOS;NCOA3;KMT2A;MYCN;BCL9;EPAS1;HLF;SSBP4;SLC9A1;E2F4;BRD8;CRTC2;GLIS1;SRF;CSRNP3;NPAS2;MYO6;AKIRIN2;FIZ1;CSRNP2;MED6;TWIST1;PRKD1;PFKM;CDK13;SOX2;NCOA1;GLI1;TLR4;DDX17;KAT2A;GLI3;AHI1;ZBED3;PPP3CB;TP53;SMARCA1;DHX36;ZFPM2;MED10;SNW1;EPC1;FOXJ2;SOX9;IGF2;TFEB;HOXB4;ST18;DPF2;KDM1B;CD81;ACTR2;NRIP1;NFIX;HOXC4;MYDGF;RFX4;PEG3;MED1;SREBF1;ZFP64;ARNT2;MED25;DOT1L;SSBP2;ELK1;BPTF;ASXL1;RIPK1;CHD8;FOXM1;DHX9;EAF2;PBX2;AR;GDNF;ATF2;MYC;PAXIP1;LPIN2;PRDM10;LAGE3;FOXJ3;FGFR2;PLAC8;AKIRIN1;ONECUT2;DVL3;CCNK;USP16;JAG1;HAX1;TOX2;ATMIN
prerank,stress-activated MAPK cascade (GO:0051403),-0.26377427072899784,-0.9849028865452041,0.48639455782312924,0.750253852443487,1.0,22/61,24.35%,NFKB1;IRAK2;MAP3K5;MINK1;MAPK9;CUL1;MAP2K4;MAPK14;UBB;MAP2K7;MAP3K8;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKB;TAOK2;IKBKG;NOD2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2690447130207297,0.9848572066736274,0.4988207547169811,0.9505598138084459,1.0,26/198,10.49%,ENPP1;EPHA7;PLA2G2C;THNSL2;PTEN;PIP4K2A;PFKFB1;DUSP12;HTR2B;LRRK2;IPMK;NADK;GFPT2;PLPPR3;ALDOB;ENPP3;PI4KA;PFKM;INPP5J;MTOR;PLPPR2;ACYP2;PLAA;GCK;GK;PPP3CB
prerank,protein autophosphorylation (GO:0046777),0.27438147289873105,0.9847712354419749,0.4897713598074609,0.9498960320862585,1.0,35/157,16.05%,PDGFRA;NTRK2;PEAK1;TXK;ERBB4;EPHB1;FGFR1;PDPK1;CDKL5;PRKX;CAMKK2;LRRK2;PTK2;PINK1;PRKD1;MTOR;IRAK1;FGR;CAMK4;EIF2AK2;EIF2AK1;SLK;MAPKAPK3;STK16;MAP4K1;MELK;PIM1;LYN;WNK2;RIPK1;VRK1;TNIK;MAP3K3;FGFR2;ULK2
prerank,mRNA destabilization (GO:0061157),0.33651289362587233,0.9843479629159875,0.47496206373292865,0.950191924535665,1.0,10/38,15.33%,RBM24;ZC3H12D;DND1;PDE12;ZFP36L2;DHX36;DIS3L2;CNOT1;FTO;RC3H2
prerank,establishment of spindle localization (GO:0051293),0.40856824076743214,0.9842121266622397,0.48324514991181655,0.9496856585998086,1.0,6/14,18.72%,LLGL1;ZBED3;NUSAP1;CLASP2;CLASP1;KPNB1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3289660681010808,0.9841769172031131,0.4900763358778626,0.9488882282627341,1.0,12/40,19.24%,ANKLE1;USP1;FBXO5;FMR1;NPAS2;UBE2V2;POLH;UBE2V1;MYC;WDR76;FEM1B;FXR1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.38038690220354937,-0.9832368881201285,0.47877358490566035,0.7536010050533803,1.0,4/13,10.97%,CACNA1C;ANK2;GJC1;KCNQ1
prerank,protein targeting to peroxisome (GO:0006625),0.35441957965696974,0.983214711427692,0.4697452229299363,0.9507042087114776,1.0,12/29,23.26%,ABCD2;PEX2;PEX7;SLC25A17;PEX19;PEX12;PEX3;ALDH3A2;PEX14;PEX6;GDAP1;FIS1
prerank,mesoderm formation (GO:0001707),0.3982261983688735,0.9831591248913983,0.4991652754590985,0.9499696763256851,1.0,2/17,2.66%,ITGA8;ITGA3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4229247914586935,0.9831085400725027,0.4737762237762238,0.949207378624102,1.0,3/12,10.49%,GPLD1;ADCY8;PPP3CB
prerank,L-amino acid transport (GO:0015807),0.354814417020581,0.9830730021648703,0.486404833836858,0.948436794427878,1.0,4/28,12.38%,SLC1A3;SLC7A8;SLC25A22;SLC7A3
prerank,organic hydroxy compound transport (GO:0015850),-0.2932284318011672,-0.983003408251947,0.463768115942029,0.753493069096748,1.0,7/36,8.53%,ABCC4;SLCO1C1;RBP4;RXRA;SLC16A1;RALBP1;ATP8B1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.4473222178960921,0.9828349894396068,0.4864406779661017,0.9482087632560692,1.0,5/10,16.07%,CORO2B;TERF1;NDFIP2;SNX12;NDFIP1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3371008738125002,-0.9826303568467315,0.48320413436692505,0.7537695996976411,1.0,8/21,13.93%,AMPD3;NUDT3;NUDT4;XDH;NUDT7;NT5E;ACAT1;HINT1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.3936786208012947,-0.9816536516269031,0.4701670644391408,0.7555389217688524,1.0,6/11,27.34%,CYC1;UQCRB;UQCRQ;UQCRC2;UQCC3;UQCRC1
prerank,cellular response to metal ion (GO:0071248),0.2787686754502477,0.9816251723660455,0.49876237623762376,0.9506883071327438,1.0,32/123,18.99%,ADGRV1;WNT5A;GPLD1;ANK3;FOS;DLG2;LRRK2;ADCY8;CAPN3;RASGRP2;SYT3;ADCY7;LGMN;DAXX;SYT7;GLRA1;CPNE7;P2RX4;DLG4;TRPM2;SYT5;GLRA2;CPNE4;RYR3;CPNE8;CPNE9;DPEP1;MCOLN1;SYT6;SYT1;CARF;KCNH1
prerank,regulation of interleukin-10 production (GO:0032653),0.3228221586762577,0.9815453866259987,0.47305389221556887,0.9500345777594541,1.0,6/44,10.90%,XCL1;TSLP;PDCD1LG2;TLR4;TNFRSF21;PYCARD
prerank,negative regulation of response to stimulus (GO:0048585),0.30686771478030855,0.9812518348052875,0.48409405255878285,0.949979670588987,1.0,16/60,18.73%,CASK;SLC30A10;GGT7;NR1H2;FBXO5;ZKSCAN3;TWIST1;APPL2;UBASH3B;LYN;CLU;MAP3K3;ADRA2A;COL3A1;ALOX5;HHIP
prerank,nucleic acid metabolic process (GO:0090304),0.29889006854962136,0.980660525488292,0.4746666666666667,0.9508156298479653,1.0,7/69,8.80%,ENPP1;POLG;ANKLE1;FEN1;PDE12;HNRNPA2B1;WTAP
prerank,smooth muscle tissue development (GO:0048745),-0.4084156861107656,-0.980576368681015,0.4638949671772429,0.7575617399398746,1.0,3/10,14.79%,MYLK;SMO;STRA6
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.29801933837056965,0.9800954236048854,0.4967234600262123,0.9515801054039393,1.0,25/84,19.24%,NTRK2;EIF4A3;NANOS3;EPRS1;LSM14A;FMR1;SORL1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;EIF4ENIF1;PUS7;RTN2;CLU;CNOT7;TSC1;IGF2BP3;RTN3;CALR;ORMDL3;ILF3;EIF2AK3;FXR1
prerank,peripheral nervous system development (GO:0007422),0.35991080818657284,0.9800408898702588,0.4666666666666667,0.9508500554529186,1.0,8/23,20.24%,ASIC2;ADGRB2;ADGRB1;NF1;SOX10;GDNF;ALDH3A2;SCN8A
prerank,positive regulation of defense response (GO:0031349),0.29151515123179167,0.9799775161761175,0.5019867549668874,0.9501711014403292,1.0,10/89,9.80%,IL33;WNT5A;IL16;TSLP;TLR8;NPAS2;AKIRIN2;PLA2G7;TLR4;CYBA
prerank,tRNA metabolic process (GO:0006399),0.39076587061124224,0.9798814502202717,0.47892074198988194,0.9495687568986955,1.0,8/17,23.78%,POP5;DTD1;POP7;SARS1;RPP21;DTD2;AARS1;SSB
prerank,male meiosis I (GO:0007141),0.39522655776680654,0.9798782427821078,0.47855917667238423,0.9487015982722858,1.0,4/16,15.63%,SYCP3;FOXJ2;TDRD9;FOXJ3
prerank,ureteric bud development (GO:0001657),0.39956622937941993,0.9797463472034875,0.4939550949913644,0.948198537487827,1.0,2/17,2.53%,ROBO2;SALL1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2583724629515932,-0.9797372343214235,0.46691176470588236,0.7589960068163153,1.0,12/66,14.88%,IGF1;FOXP1;APP;SIRPA;GBP5;CASP8;GIT1;TRIM16;CX3CR1;HSPB1;P2RX7;CX3CL1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.36006566006242696,-0.979732032876831,0.47101449275362317,0.7582840913054769,1.0,3/17,4.37%,VIM;RUNX1;WNT4
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.4475317504268945,0.9796914571484808,0.5037593984962406,0.947474938745679,1.0,3/10,10.51%,GABRA1;GABRG3;GABRG2
prerank,negative regulation of cell projection organization (GO:0031345),-0.27593035396600185,-0.9795901322049416,0.490625,0.757913861753939,1.0,10/48,13.30%,EPHA4;RAPGEF2;DPYSL3;EFNB2;KANK1;PRAG1;APOE;ADCY6;GAK;TRPV4
prerank,fatty acid transport (GO:0015908),0.3960635599563633,0.9795829066239733,0.510752688172043,0.9469020356206157,1.0,5/17,14.47%,PPARD;FABP5;FABP4;FABP3;SLC25A17
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4240093113143959,0.9792849879760687,0.47593582887700536,0.9468568841628417,1.0,4/12,17.83%,MCM7;CDC7;MCM4;MCMDC2
prerank,phospholipid translocation (GO:0045332),-0.30472422013669287,-0.9791157049636853,0.5013927576601671,0.7583552260522753,1.0,10/28,18.60%,ATP10A;ANO6;ATP8A1;ATP11B;ATP8B1;MFSD2A;ABCB4;P2RX7;PLSCR3;ATP8A2
prerank,positive regulation of protein depolymerization (GO:1901881),0.42363278130783066,0.9789395769357465,0.5034364261168385,0.946933005501815,1.0,2/11,8.58%,SEMA5A;STMN2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.33171893194950186,-0.978864436465488,0.45257452574525747,0.7583054775481897,1.0,3/22,0.60%,EPHA4;PICALM;ROCK2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.29449550415539416,0.978848656855252,0.47644683714670255,0.9454573228649543,1.0,28/78,26.42%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.29449550415539416,0.978848656855252,0.47644683714670255,0.9454573228649543,1.0,28/78,26.42%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,regulation of lipid catabolic process (GO:0050994),0.3813289815861696,0.97840241868469,0.4618055555555556,0.9458191662750559,1.0,6/19,22.61%,CIDEA;BSCL2;ADRA2A;PDE3B;RARRES2;TYSND1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3477983820877371,0.9782748010408944,0.4790996784565916,0.9453192240922965,1.0,5/27,10.09%,PDGFRA;IRS1;PTK2;PRKD1;FGR
prerank,regulation of MAP kinase activity (GO:0043405),0.2918179271933476,0.9781041262227498,0.49320652173913043,0.9449257510719264,1.0,11/92,5.64%,IL34;SPRY4;EDN3;SPRY1;CD40;FGFR1;DUSP1;HTR2B;SORL1;LRRK2;NF1
prerank,positive regulation of innate immune response (GO:0045089),-0.31058474691241267,-0.978071480699449,0.4629080118694362,0.7596016461200235,1.0,10/30,15.89%,LBP;NMI;MAVS;GBP5;RPS19;IFI35;RIOK3;POLR3G;NLRC5;POLR3D
prerank,regulation of cell differentiation (GO:0045595),0.27844972051680295,0.977944243996677,0.503015681544029,0.9445139632861231,1.0,34/148,17.13%,ZFHX3;TRPS1;RUNX2;EDN3;PTPRQ;FGFR1;PHLDB1;ST7;REST;NF1;SRF;FLOT2;BCL6;PTK2;PRKACA;PRKCB;DDX17;BIRC2;OCIAD1;EPHA3;EIF2AK2;MCRIP1;TGFBR1;IGF2;SMYD5;CLASP2;AR;GDNF;FGFR2;CLASP1;MAFB;TRIP4;NR1D2;TAF8
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.29420796748857475,0.977810466871939,0.4825268817204301,0.944039545801591,1.0,28/79,26.42%,DYNLL1;DCTN3;DCTN2;CENPE;ACTR1B;KIFAP3;LGMN;DCTN4;AP1S1;SEC24B;DYNLL2;KIF3C;KIF2A;SEC24A;SEC23A;CANX;ACTR10;KIF3A;KIF11;KIF15;KIF23;SEC24C;SH3GL2;SAR1B;AP1B1;RAB7A;KLC2;CAPZA2
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.23257185235913141,-0.9776884534256404,0.5113122171945701,0.7598397651486477,1.0,38/109,23.01%,PLCB1;PITPNM2;MTM1;LPGAT1;PLA2G4A;CDS1;PIK3C2B;INPP5F;INPP4B;INPP5D;BMX;MTMR9;RAB5A;INPPL1;PIK3CB;LCLAT1;PIK3CD;PIP4P1;PIP4K2C;PLEKHA2;PLCG2;VAC14;PLAAT3;SYNJ1;PIK3R6;INPP5B;SBF1;MTMR14;MTMR2;RAB4A;PLA2G4E;PIP5K1A;PLA2G4C;PIP5K1B;CSF1R;PITPNM1;MTMR11;PIK3C2A
prerank,carbohydrate derivative transport (GO:1901264),-0.3591862544701411,-0.9776054804781725,0.46733668341708545,0.7593440997495341,1.0,4/18,13.88%,LBP;PLTP;SCARB1;MFSD2A
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.30370421211161064,-0.9774147966100641,0.4746192893401015,0.7591040496868406,1.0,5/29,7.67%,IL31RA;FER;NMI;SOCS2;IFNAR1
prerank,leukotriene metabolic process (GO:0006691),0.3750115336735332,0.9769307245062978,0.4935064935064935,0.9456175853072355,1.0,1/19,0.52%,GGT5
prerank,myelination (GO:0042552),0.3259119267501787,0.9768684626824585,0.48180494905385735,0.94491290681977,1.0,12/46,13.88%,EPB41L3;ABCD2;NF1;SBF2;MBP;DEGS1;LGI4;SOX10;PLP1;TNFRSF21;SCN2A;MYRF
prerank,aerobic respiration (GO:0009060),0.38220837546057546,0.9767155562690443,0.47896440129449835,0.9444718110796247,1.0,6/20,15.03%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14
prerank,regulation of ATP biosynthetic process (GO:2001169),0.38332259839740745,0.9763148328442423,0.4802065404475043,0.9446795786975493,1.0,3/16,9.12%,PPARA;PINK1;AK4
prerank,histone H3 deacetylation (GO:0070932),0.40241582136115106,0.9763148085930684,0.48925619834710743,0.9438246650516691,1.0,3/15,7.97%,HDAC1;SIRT6;PER2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.2837962401091754,-0.9759312786325145,0.49851632047477745,0.7619421444160758,1.0,13/39,20.49%,TEK;ANO6;THBS1;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5;GPER1;RGCC;ECSCR;TNFAIP3
prerank,negative regulation of interleukin-17 production (GO:0032700),0.45072777728231106,0.9757876334476372,0.4943820224719101,0.9443856357239901,1.0,3/10,21.56%,TLR4;IL12A;DDIT3
prerank,RNA metabolic process (GO:0016070),0.2767999386841841,0.9754955133565082,0.49559748427672956,0.9442961360174658,1.0,35/127,21.15%,RBMS1;RNASEH2C;AGO4;NOVA1;ADARB2;ELAVL4;PCBP3;HNRNPA2B1;MRPL44;MPHOSPH10;WTAP;DDX17;NOL9;DHX36;AGO3;MTREX;TENT2;RNASEH2B;FTO;HNRNPUL1;HNRNPD;DHX9;RNASEH1;ADAR;LAGE3;RBM5;PPP1R8;HNRNPL;AGO1;DEDD2;RBM6;POLR2L;TFIP11;DDX39B;RBPMS
prerank,dopaminergic neuron differentiation (GO:0071542),-0.34596135984021065,-0.975343605641138,0.4641975308641975,0.7626600330281564,1.0,3/19,15.35%,LRP6;NR4A2;MANF
prerank,iron ion transmembrane transport (GO:0034755),0.43760858429030597,0.9752384684509208,0.4974182444061962,0.9440998325061745,1.0,4/10,17.97%,SLC25A37;ABCB6;ABCB7;SLC39A14
prerank,plasma membrane organization (GO:0007009),0.3058275287246817,0.9750807590214055,0.4930167597765363,0.9436594989748642,1.0,9/61,10.41%,PLSCR4;EPB41L3;ABCD2;SPTBN1;ANK3;DEGS1;FA2H;SYT7;ARL8B
prerank,regulation of autophagosome maturation (GO:1901096),-0.37708664305127515,-0.9750699007732977,0.5,0.7625926501694998,1.0,6/13,32.17%,UVRAG;CLEC16A;TMEM39A;ADRB2;IRGM;PHF23
prerank,regulation of mRNA catabolic process (GO:0061013),-0.22890317245816283,-0.9750638886239826,0.5084745762711864,0.7618835520875643,1.0,34/121,18.20%,VIM;ELAVL1;PSMC6;PSMD9;SAMD4A;HSPA8;PSMF1;PSMB7;YWHAB;PARN;UBB;PRR5L;ZC3HAV1;CNOT8;PSMD8;RC3H1;PSMD12;HSPB1;PSMA3;PSMA6;PSMD4;PSME3;EXOSC2;PSMD7;PSMB6;PSMC1;PRKCD;EXOSC3;PABPC1;PSMB10;GTPBP1;UBC;AKT1;SERBP1
prerank,autophagy of peroxisome (GO:0030242),-0.3814547500754505,-0.9750273583602281,0.5056947608200456,0.7612602798748079,1.0,5/12,26.78%,SQSTM1;USP30;ATM;MAP1LC3B;PEX5
prerank,endothelial tube morphogenesis (GO:0061154),-0.4119437557869474,-0.9748134700978133,0.48672566371681414,0.7610614137649724,1.0,3/10,17.88%,RBPJ;ACVRL1;CSNK2B
prerank,regulation of protein localization (GO:0032880),-0.2599014108976945,-0.974612610785179,0.4777777777777778,0.7608201737874275,1.0,8/58,8.31%,PICALM;AFDN;DVL1;TRIM25;TRIM5;TRIM14;PPM1F;CEP290
prerank,protein homotetramerization (GO:0051289),-0.26601575585728,-0.9743707692500077,0.4936708860759494,0.7607352053911608,1.0,13/49,17.60%,ALDH1A2;SAMHD1;SOD2;GBP5;B2M;UPB1;KCNJ2;CBR4;KCNJ12;ACOT13;CBY1;ACACB;ALDOA
prerank,regulation of phosphate metabolic process (GO:0019220),0.40136479369393724,0.9740314577196275,0.47334410339256866,0.9456262683912591,1.0,2/16,3.65%,SRPX2;MCM7
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.33529792816351833,0.9739091449884023,0.4963820549927641,0.9450794614748319,1.0,9/37,15.08%,ERCC1;POLK;ERCC5;RPA1;ERCC4;RFC3;GTF2H3;ERCC2;GTF2H1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.24641206188247725,0.9732723488646343,0.5779153766769866,0.945923887767376,1.0,61/532,12.57%,RORA;IL33;GHR;IL34;IL15RA;PIK3R1;ZEB1;IL1RN;MAP3K14;IL2RA;XCL1;CXCL10;EDA2R;EDA;CXCL1;IL1R2;CD40;IL16;FLT3LG;IL18RAP;GAB2;JAK1;PSMD1;TSLP;FSCN1;YWHAZ;FOS;CCL15;IRS1;IFIT2;PSMD10;IRS2;COL1A2;PSMA5;BCL6;HNRNPA2B1;PSMB5;IL5;TWIST1;PLP2;PRKACA;IFNLR1;SOX2;TRIM8;APPL2;SP100;IL1RAP;BIRC2;IRAK1;PSMC4;CCL25;TP53;PSMA4;PYCARD;FYN;PSMC5;IL12A;CD86;PDCD4;HSP90B1;ST18
prerank,glycine metabolic process (GO:0006544),0.4257275432984057,0.9731810605189863,0.49914236706689535,0.9453245536154675,1.0,2/12,13.26%,GLDC;AMT
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.34366511048364384,0.9729098883315456,0.4933135215453195,0.9451972243160798,1.0,6/33,10.60%,TEAD1;GNL3;NGFR;FOS;SRF;TP53
prerank,regulation of ERAD pathway (GO:1904292),0.4313707094142522,0.9726313097601418,0.4785714285714286,0.9451060757332825,1.0,5/11,16.69%,HERPUD1;USP19;ATXN3;BAG6;USP13
prerank,glycerophospholipid metabolic process (GO:0006650),0.2976591773849008,0.9723461298414245,0.4973544973544973,0.9450072817800945,1.0,15/75,13.98%,PIGV;GPLD1;PIGQ;SERINC1;PRDX6;SMPD4;PIGP;ENPP6;PLA2G7;CPNE7;ABHD12;AGK;PIGA;PIGL;SERINC5
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2487564719777564,0.9723446006831125,0.5683453237410072,0.9441659401834364,1.0,107/509,19.20%,ROR1;PDGFRA;NTRK3;DCN;PIK3R1;MAP3K14;NRG1;ROR2;EDA2R;CCDC22;ADGRV1;WNT5A;NTRK2;SEMA5A;TCF7L2;CD40;ERBB4;ITGAV;FLT3LG;NRG2;TSPAN6;FGFR1;GAB2;LURAP1;GPR37L1;GJA1;PDPK1;PIK3R2;GCNT2;HTR2B;TLR6;NEDD4;IRS1;DHX58;IRS2;NRG4;WDR24;PTK2;TNFRSF19;PINK1;PRKD1;RELN;AXL;SOX2;TRIM8;PRKCB;TSPYL5;TLR4;BIRC2;IRAK1;LPAR1;FGR;NDFIP2;EIF2AK2;TP53;DHX36;RTKN2;FYN;RPL37;P2RX4;TGFBR1;IAPP;SOX9;CD86;PDCD4;IGF2;CASS4;LGALS1;TRIM44;MYDGF;RNF31;LYN;UBE2V1;F2R;RIPK1;FERMT2;FGF5;AREG;MIOS;MAP3K3;FGFR2;TIRAP;GPR37;NDFIP1;ZCCHC3;HAX1;PIK3CG;RRAGA;MAZ;HTR6;LGALS9;ADAM8;ADRA2A;RHOG;MYD88;BMP2;RRAGD;NFAT5;RHOA;BBC3;WWC1;SPRY2;ATP2C1;TERF2IP;RNF13;KSR1;PDGFRB
prerank,intracellular protein transport (GO:0006886),0.25306325559825665,0.9722928078749729,0.5565312843029637,0.9434336712204029,1.0,72/304,20.16%,PRICKLE1;UNC93B1;GGA2;RAB20;CSE1L;RABGAP1L;TBC1D16;CACNG3;RABL3;ANKLE1;COPA;SEC16A;NUP214;NGFR;COPZ2;FAM53C;SORL1;NUTF2;POM121;NAPB;CLIP3;MYO6;SYNDIG1;VIPAS39;TBC1D1;TRIM23;VPS26C;RAB29;APPL2;FAM53A;TBC1D8B;BCS1L;SLU7;RAB24;SRPRA;SAR1A;NUP42;SCFD1;RANBP3;TNPO1;PTTG1IP;ARFIP1;NUP107;AKAP6;AP3D1;EIF4ENIF1;NXT2;TBC1D9;STRADB;SNF8;RTN2;CTTN;VPS33B;USP6NL;TNPO2;CALR;XPO6;TMED3;IPO9;TMED9;TBC1D17;NUP155;LTBP2;KPNB1;KIF13B;HOMER3;VPS45;RAB3GAP2;XPO1;ARL5C;COPB2;ARL4A
prerank,regulation of JNK cascade (GO:0046328),-0.23282671076782313,-0.9720882971195501,0.5248868778280543,0.7657011722843023,1.0,35/101,24.82%,MECOM;PLCB1;EGFR;IGF1R;CCN2;TPD52L1;APP;SIRPA;MAP3K5;MAPK8IP3;MINK1;FZD7;SH3RF2;HDAC3;GADD45B;HIPK2;CYLD;FLT4;PTK2B;WNT16;MAPK8IP1;TRAF3;PER1;MAP3K10;SDCBP;TGFBR3;MFHAS1;GADD45G;DUSP19;TRAF1;CCL19;EDAR;TAOK2;NOD2;CD27
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.34064917031248987,-0.9719996139513372,0.5144927536231884,0.7652005166427198,1.0,5/18,16.98%,DDX5;EGFR;MAP2K2;TERT;ESR1
prerank,regulation of gluconeogenesis (GO:0006111),0.35380239038332667,0.9715982322511684,0.4713584288052373,0.9444331566986919,1.0,5/27,11.67%,OGT;DGKQ;GCK;ERFE;PDK2
prerank,negative regulation of axonogenesis (GO:0050771),0.3537491178150414,0.9714779183785723,0.5094339622641509,0.943874691216901,1.0,9/27,22.35%,PTEN;NGFR;CDKL3;DCC;ULK2;RHOA;EFNB3;MCF2;GDI1
prerank,activation of GTPase activity (GO:0090630),0.28616199566303413,0.9714382520993471,0.4953519256308101,0.943125984414977,1.0,12/89,7.41%,NTRK3;ARHGAP22;RABGAP1L;TBC1D16;SIPA1;ABR;SCRIB;GARNL3;ARHGAP24;SIPA1L3;DOCK7;TBC1D1
prerank,regulation of cell population proliferation (GO:0042127),0.24384636054135828,0.9706018310757674,0.5872210953346856,0.9445471477870747,1.0,131/691,17.40%,PDGFRA;PTN;DLC1;NTRK3;IL34;COL18A1;ATF5;CXCL10;NRG1;HRG;ROR2;HOXC10;PTGFR;EDN3;MEIS1;HDAC1;GNL3;CXCL1;NTRK2;PTEN;TCF7L2;PHIP;ERBB4;GPLD1;ITGAV;FLT3LG;CDKN2A;GLMN;FGFR1;GAB2;MEIS2;TSLP;TIPIN;DLG3;JUP;POU3F3;REST;TBX3;FBXO5;GCNT2;TMEM115;HTR2B;CDC7;IRS1;ADGRB1;IRS2;DUSP22;CBFA2T3;AMELX;FXN;HP1BP3;CDKN2D;PTPRU;BCL6;PTK2;MDM4;HTR1A;CDK13;IFNLR1;P3H1;CCKBR;GLI1;LGMN;TENM1;TSPYL5;BIRC2;CACUL1;MAP2K1;TNS2;SLC25A33;EIF2AK2;TP53;RTKN2;FKTN;NAP1L1;AGO3;TGFBR1;GAS8;SPEG;SOX9;FABP3;HGS;CD86;IGF2;ST18;DIS3L2;FAM98B;CD81;MEAK7;TESC;GAREM1;BNIPL;P3H3;CDKN2C;DHPS;LYN;NME1;DOT1L;THAP12;WNK2;CLEC11A;F2R;S1PR2;FOXM1;CIAO1;FGF5;TFAP4;CLU;AREG;AR;GDNF;CNOT7;MYC;SGK1;FGFR2;KLF11;CDK10;TSC1;RBM5;CHERP;GDF9;JAG1;NOX1;CCPG1;STAMBP;IGFBP7;MAZ;CALR;ADRA2A;ASH2L;RHOG
prerank,regulation of biomineral tissue development (GO:0070167),0.36065178233805995,0.9704198355371163,0.4968152866242038,0.9442182180156079,1.0,3/26,8.25%,ENPP1;FBXO5;TWIST1
prerank,regulation of T cell differentiation (GO:0045580),0.34617347136272436,0.9702415745777581,0.4931714719271624,0.9439038291822924,1.0,4/33,10.11%,IL2RA;FANCA;KAT2A;CAMK4
prerank,positive regulation of axonogenesis (GO:0050772),0.3251480542895293,0.9698252479973597,0.4933135215453195,0.9441709679639025,1.0,6/43,6.34%,ROBO2;PLXNC1;NTRK2;NGFR;CDKL5;LIMK1
prerank,protein insertion into ER membrane (GO:0045048),0.333381668264834,0.9694679364662382,0.5,0.9442836187926313,1.0,16/37,24.06%,VAMP2;UBL4A;EMC2;SEC61B;EMC9;TRAM2;EMC8;BAG6;GET3;ALDH3A2;EMC10;TRAM1L1;SERP1;UBE2J2;CCDC47;EMC4
prerank,positive regulation of ion transport (GO:0043270),-0.2719918865914278,-0.9693854460322979,0.4983388704318937,0.771109529219375,1.0,12/48,19.73%,ANO6;ACTN2;FHL1;MYLK;ATP2B1;ORAI1;ANK2;TRPC6;P2RX7;SCN4B;DLG1;PKP2
prerank,defense response to virus (GO:0051607),0.28263915746988333,0.9691588385214258,0.5212355212355212,0.9442793089181352,1.0,12/100,11.68%,MAP3K14;CXCL10;RTP4;CD40;IFIT2;TLR8;PDE12;TRIM56;IFNLR1;EIF2AK2;PYCARD;AGBL4
prerank,Golgi organization (GO:0007030),0.28264103291446296,0.9684754895271737,0.5153452685421995,0.9453473265756922,1.0,29/112,19.53%,SEC16B;SEC16A;YWHAZ;GBF1;DNAJC28;LRRK2;GOLGA2;PRKD1;RAB30;RAB29;VAMP4;RAB2A;SYNE1;COG1;TRIP11;CLASP2;VRK1;HACE1;CLASP1;USP6NL;UBXN2B;TMED3;TMED9;GOLGA8B;GOLGA5;CUL7;TRAPPC12;TBC1D20;PLEKHM2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.338991237921376,-0.9684599822891751,0.46522781774580335,0.7726792242662371,1.0,3/19,4.37%,VIM;RUNX1;WNT4
prerank,snRNA 3'-end processing (GO:0034472),0.3796050361218088,0.9681299343896708,0.5088282504012841,0.9454509173144124,1.0,5/19,15.88%,INTS8;INTS14;EXOSC9;EXOSC8;EXOSC5
prerank,organic acid transport (GO:0015849),0.28705836588278555,0.9680885969731128,0.5274151436031331,0.9447168043397434,1.0,9/94,4.87%,SLC1A5;ABCC3;SLC6A13;NR1H4;NCOA2;PPARD;SLC7A11;SLC43A1;SLC7A8
prerank,negative regulation of stem cell differentiation (GO:2000737),0.41683077965464493,0.9679842513830654,0.49222797927461137,0.9441473388213151,1.0,5/12,21.32%,REST;ZFP36L2;N4BP2L2;JAG1;NELFB
prerank,artery development (GO:0060840),0.365589647713337,0.967978644346541,0.49673202614379086,0.9433240640897859,1.0,5/23,15.14%,ROBO2;NF1;TGFBR1;HECTD1;GJA5
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.4014182916887469,0.9677770942978691,0.5034722222222222,0.9430068085565658,1.0,1/15,0.79%,XCL1
prerank,regulation of cytoplasmic transport (GO:1903649),0.43014826480403556,0.9673249172739606,0.5043478260869565,0.9434078701854182,1.0,5/11,21.55%,LRRK2;MAP2K1;ATP9A;MAPK1;DENND10
prerank,positive regulation of potassium ion transport (GO:0043268),-0.28703668562972445,-0.9672748995765874,0.49855907780979825,0.7749226692017207,1.0,8/38,13.97%,ACTN2;FHL1;ANK2;KCNJ2;KCNQ1;KCNJ12;FLNA;NOS1AP
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.36780098173018916,0.9669957287795239,0.5017241379310344,0.9434680896773827,1.0,4/22,8.58%,NTRK3;NTRK2;TMEM108;STMN2
prerank,endodermal cell fate commitment (GO:0001711),0.4353522512458814,0.9669178338754808,0.47358834244080145,0.9428416270208677,1.0,2/10,8.78%,RTF1;SOX2
prerank,nuclear membrane reassembly (GO:0031468),-0.25877101909004524,-0.9666601126776442,0.5426621160409556,0.7758018187984038,1.0,21/54,27.10%,LBR;CHMP2B;PPP2R1A;RANGAP1;IST1;NUP98;LMNA;RAN;REEP3;NUP43;NUP205;CHMP4B;CHMP4A;CHMP7;SEH1L;CHMP4C;EMD;SUMO1;BANF1;REEP4;CHMP2A
prerank,cellular response to oxygen-containing compound (GO:1901701),0.25290891776494023,0.9660737193415723,0.5393743257820928,0.9442826141039776,1.0,47/291,14.06%,RORA;PDGFRA;CXCL10;CPEB1;WNT5A;CXCL1;GPLD1;ERCC6L2;PDE4B;NR1H4;P2RY1;FOS;NCOA3;PDCD1LG2;IRS1;CAMKK2;PRDX5;CD68;PRKD1;AXL;KCNC2;MTOR;TLR4;HCN2;WNT3;HCN1;PLAA;IRAK1;EPHA3;HCN3;GLRA1;DHX36;PYCARD;P2RX4;SNW1;PDK2;SOX9;HTRA2;CD86;PDCD4;HSP90B1;GLRA2;TESC;AKAP6;NRIP1;RYR3;LYN
prerank,mitochondrion morphogenesis (GO:0070584),-0.3998527356347863,-0.9658013151989655,0.5031982942430704,0.7771953560985352,1.0,7/11,43.10%,MTM1;PID1;PNPT1;DNM1L;NUBPL;WASF1;SLIRP
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.29031878003573824,-0.9656662858677217,0.5154320987654321,0.7768002366064589,1.0,12/33,19.23%,IGF1;BCL2L1;TFRC;MAPT;GPX1;SLC25A5;ACAA2;ADCK1;PRELID1;GHITM;AKT1;HGF
prerank,ganglion development (GO:0061548),-0.4014597152441707,-0.9653622169802575,0.49019607843137253,0.7768808540486347,1.0,3/11,13.10%,NRP2;NRP1;FZD3
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3135593160053911,-0.9653439708082904,0.5040650406504065,0.7762020202241674,1.0,6/26,12.66%,IGF1;LMCD1;GSK3B;DYRK2;CAMTA1;PLCG2
prerank,organic substance transport (GO:0071702),0.27672090221099516,0.9651875297884182,0.5376884422110553,0.9458474217314122,1.0,7/121,2.33%,ABCA9;SLC48A1;HRG;ABCA6;LRP1B;CALCRL;ABCD2
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.22852097862047047,-0.965041764729493,0.5081967213114754,0.776316173852041,1.0,32/98,21.18%,SLCO1C1;THBS1;KLF4;MAGI2;INSR;IL10RB;INPP5F;MAPK14;APOE;XDH;IFNAR1;NFKBIA;STARD4;RNF41;CD63;CHCHD2;AGTR1;GRB2;CDKN1A;PRELID1;RAB1A;ACACB;GHITM;AKT1;EGF;ACE2;PID1;TBC1D5;AGT;RAB1B;ROMO1;TGFBR2
prerank,defense response to bacterium (GO:0042742),-0.23296602720222515,-0.9646758492314854,0.5282051282051282,0.7765499644536752,1.0,23/105,17.80%,ANXA3;LBP;GBP7;MAVS;RPS19;DROSHA;GBP4;GBP2;PGLYRP1;STAB1;SERPINE1;OPTN;PLA2G6;GBP6;RPL30;RNASE7;PRKCD;ANKRD17;MPEG1;RAB1A;ISG15;HMGB2;PPP1R11
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3767247259056837,-0.9644087883020229,0.4963325183374083,0.7764594617291994,1.0,5/13,17.21%,PRR5L;ZC3HAV1;CNOT8;RC3H1;GTPBP1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.34333608856981834,0.964249868045999,0.4869831546707504,0.9475724487485365,1.0,6/30,11.95%,NPC1L1;DHCR24;ACAT2;PLPP6;HMGCS1;ACLY
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4314420032802758,0.9641791516673539,0.5106761565836299,0.94695222821665,1.0,4/10,12.02%,LOXL2;SOX6;ZBTB16;SOX9
prerank,lytic vacuole organization (GO:0080171),0.34265405362034157,0.9639491711940111,0.49382716049382713,0.9467119210545606,1.0,8/32,15.60%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,hemidesmosome assembly (GO:0031581),-0.3966874531428159,-0.9639431016424805,0.4852216748768473,0.776957006646036,1.0,7/11,17.04%,ITGA6;PLEC;LAMA3;ITGB4;CD151;DST;LAMC2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.24760631183467227,0.9638380557552697,0.5754422476586889,0.9462125828737211,1.0,97/417,18.84%,ZEB1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;HDAC1;L3MBTL1;WNT5A;NR2F2;TCF7L2;BASP1;SALL1;CDKN2A;THRA;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;SCML4;MDFIC;RUNX1T1;ZNF423;ZBTB16;TLE2;FOXS1;BCOR;CAPN3;CALCA;CBFA2T3;GMNN;BRMS1;PAX9;BCL6;ZKSCAN3;EIF4A2;PER2;TWIST1;L3MBTL4;TLE1;DAXX;BMP7;GLI3;TP53;ZC3H8;MPHOSPH8;ZFPM2;SNW1;DAP;EPC1;ZNF318;SOX9;TWIST2;PDCD4;DPF2;HIC2;BTAF1;PHC1;PRDM5;ZMYND15;HDAC10;KDM5C;CREB3L1;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;CNOT7;CRY2;CENPF;ZHX3;SPINDOC;ZBTB7A;CBFA2T2;NONO;MBTD1;CIART;NR1D2;CALR;CDK5;MBD2;LDB1;SUV39H2;BMP2;MBD1;KAT7;HEY1;BRD7;ILF3;KHDRBS1;DEDD2;PEX14;THAP7
prerank,regulation of protein export from nucleus (GO:0046825),-0.3184792430103501,-0.963431504918834,0.5156695156695157,0.7774570483401972,1.0,7/23,14.82%,PTPN14;RBM22;GSK3B;IFI27;RANGAP1;BAG3;RAPGEF3
prerank,chromatin remodeling (GO:0006338),-0.23293218617719116,-0.9633177216469856,0.5087719298245614,0.7770532289484418,1.0,30/100,21.30%,ACTB;HDAC4;PBRM1;KDM4A;KDM4C;SMARCA4;SMARCA2;CBX3;TOP1;ACTR8;INO80;SMARCA5;HNRNPC;ACTR5;SMARCC2;JARID2;CHD3;SIRT1;ARID1B;BAZ1A;BAHD1;ESR1;BAZ2B;INO80C;KDM4B;TADA2B;NPM1;CHD1L;SMARCD3;RUVBL2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.4099706560663575,0.9631243791939201,0.5043478260869565,0.9472061863371961,1.0,4/14,12.97%,ENTPD2;ENTPD5;NUDT9;ENTPD7
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2467952383281976,-0.9630990600968431,0.5527272727272727,0.7768978352605931,1.0,28/69,28.08%,MEF2C;RETREG1;SOD2;SIX1;NGF;NRBP2;APOE;SNX6;CX3CR1;MDK;FOXQ1;PTK2B;CX3CL1;ZPR1;RASA1;ERBB3;SIX4;KDM2B;CLCF1;MT3;NTF3;CRLF1;LIG4;PARK7;VSTM2L;BDNF;NDNF;MSH2
prerank,sphingoid biosynthetic process (GO:0046520),-0.396144492810087,-0.9630471126858475,0.49534883720930234,0.7756092045474438,1.0,3/11,4.52%,SPTLC2;ACER2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),-0.396144492810087,-0.9630471126858475,0.49534883720930234,0.7756092045474438,1.0,3/11,4.52%,SPTLC2;ACER2;ACER3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.39033221120724026,0.9623396169048659,0.5107438016528926,0.9484898066818362,1.0,6/17,15.21%,UBL4A;EMC2;EMC9;EMC8;BAG6;GET3
prerank,regulation of cellular senescence (GO:2000772),0.35442604152057666,0.9621193124541192,0.5,0.9482474739687239,1.0,5/28,8.25%,SLC30A10;CDKN2A;FBXO5;ZKSCAN3;TWIST1
prerank,diol biosynthetic process (GO:0034312),-0.36509704949646044,-0.9619269833327124,0.5,0.7777578741013976,1.0,4/15,8.26%,SPTLC2;ACER2;ACER3;GCH1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3416889552112849,0.9616490714293237,0.5045871559633027,0.9486519298767001,1.0,5/27,12.95%,SLC1A3;SLC7A8;SLC25A22;SLC7A3;SLC25A29
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3532090769557124,-0.9614160185128704,0.5295566502463054,0.7782861241588164,1.0,6/17,24.35%,ARL6IP5;TGFB2;STK25;MID1;TAOK2;NOD2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.32462490767000657,-0.9611454270665071,0.5076923076923077,0.778266026466742,1.0,7/24,12.56%,ABCG2;ALAS1;COX15;PPOX;FECH;FLVCR1;PGRMC1
prerank,MAPK cascade (GO:0000165),0.2539076931330447,0.9610260590742161,0.553030303030303,0.9494651950988019,1.0,69/295,19.20%,PDGFRA;PIK3R1;IL2RA;NRG1;ERBB4;ITGAV;FLT3LG;NRG2;GRIN2B;FGFR1;JAK1;PSMD1;MAP4K4;SPTBN1;DLG3;PIK3R2;SPRED1;HTR2B;DLG2;IRS1;IL17RD;CAMKK2;LRRK2;NF1;PSMD10;IRS2;NRG4;ZFP36L2;PSMA5;ABHD17C;PTK2;PSMB5;IL5;ABHD17B;MBP;MAP2K1;PSMC4;PTPRA;PSMA4;FYN;DLG4;PSMC5;GFRA1;SOX9;PSMB9;LRRC7;GFRA2;FGF5;AREG;GDNF;MYC;ARAF;TNIK;MAP3K3;FGFR2;MAPK11;PSMA7;PTGER4;PSMD14;LGALS9;CAMK2A;CCM2;RASA3;PSMA2;ZDHHC9;MAPK12;PSMD11;KSR1;PDGFRB
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2639872281886386,-0.9609477697071979,0.5176056338028169,0.7780504905572089,1.0,18/50,19.03%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;PSMB10;OAZ2;PSME2
prerank,regulation of translational initiation (GO:0006446),0.30103029713110824,0.9609325390143462,0.5272206303724928,0.9488878805161051,1.0,23/63,24.63%,EIF4G3;EIF3H;FMR1;BOLL;RPS6KB1;EIF4A2;GLE1;PAIP1;IMPACT;EIF5B;MTIF2;HABP4;KHDRBS1;YTHDF1;EIF2AK3;CTIF;DDX1;NCK2;EIF4B;EIF2B5;ATF4;MIF4GD;POLR2D
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.39764034567551765,0.960453730879297,0.5069686411149826,0.9492725203687956,1.0,1/16,0.79%,XCL1
prerank,positive regulation of DNA repair (GO:0045739),-0.2715957869157022,-0.959882781537116,0.547945205479452,0.7801393924574105,1.0,11/46,15.99%,EYA2;EYA1;EGFR;EYA4;RNF8;PCNA;BRCC3;SMCHD1;UBE2N;DDX11;SIRT1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.31251672653260243,-0.9597412074734868,0.5248041775456919,0.7797759179672749,1.0,4/23,8.34%,DKK3;LTBP4;SMURF2;SMAD3
prerank,protein polymerization (GO:0051258),-0.26085694224740597,-0.9596191029067165,0.5581395348837209,0.77935000556101,1.0,15/56,17.92%,DIAPH1;GSN;RAC1;COBL;ARL6;MAPT;GAS7;FAM107A;MAP7D3;TRPV4;TPPP3;PSTPIP1;CHMP4B;CHMP4A;WASL
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4051051144983093,-0.9593158725584641,0.5084745762711864,0.7793594251820235,1.0,5/10,25.88%,JARID2;SIRT1;DNMT3B;KDM1A;BRCA1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3199425191427149,-0.959277592841304,0.5108108108108108,0.7787367105809502,1.0,2/22,4.15%,ALDH1A2;RBP1
prerank,camera-type eye morphogenesis (GO:0048593),0.4381371743615854,0.9592535164412294,0.5061511423550088,0.9516380997447124,1.0,2/10,5.64%,TENM3;NF1
prerank,myoblast differentiation (GO:0045445),0.4109983981321038,0.9591961445596455,0.5044091710758377,0.9509725753314775,1.0,5/14,9.54%,NRG1;TCF7L2;REST;EPAS1;DDX17
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.39412036776282244,-0.959039392153444,0.5305164319248826,0.7786758760400361,1.0,3/10,9.79%,MLLT3;ACE;SFRP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.42133526015730527,0.9589758904491616,0.49642857142857144,0.9507711657765348,1.0,3/10,10.97%,ANK3;KCNAB1;KCNE4
prerank,cellular response to nutrient levels (GO:0031669),-0.2545230047510886,-0.958751076513199,0.5224913494809689,0.7786735334684438,1.0,22/62,22.74%,FOXO1;FNIP1;BMPR2;HSPA8;SREBF2;PRKAA2;KCNB1;SFRP1;RRAGC;CLEC16A;FAM107A;RALB;MFSD2A;SIRT1;PRKAA1;MAP1LC3A;LAMP2;RRAGB;MAP1LC3B;WDR45;INHBB;KLF10
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.36115519533928275,0.9585800454659327,0.502262443438914,0.9509721984096772,1.0,6/24,12.35%,LIG3;POLK;RPA1;RFC3;XRCC1;POLB
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.24075648762666269,0.9585201097077142,0.6408450704225352,0.9503082260081606,1.0,196/1082,17.02%,RORA;IL33;LPIN3;DCN;PIK3R1;ZFHX3;ATF5;ETV1;CXCL10;RUNX2;PPARA;HOXC10;AUTS2;MEIS1;TEAD1;RGMB;OGT;ETV5;KMT2E;HDAC1;WNT5A;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;ERBB4;SALL1;THRA;SMAD5;NR1H4;CDK8;MAML3;NCOA2;MEIS2;PGR;NFATC3;MED12;THAP3;METTL23;JUP;POU3F3;PPARD;PIK3R2;NR1H2;TEAD2;REST;TBX3;FOS;NCOA3;ZIC1;KMT2A;MDFIC;ZNF423;ZBTB16;CXXC1;SPP1;MYCN;CAMKK2;BCL9;EPAS1;HLF;CREB3L2;SSBP4;SLC9A1;SERTAD2;E2F4;BRD8;CRTC2;ASF1A;CAPN3;GLIS1;TRIM56;TAF15;SRF;CSRNP3;NPAS2;MYO6;AKIRIN2;LYAR;SPIN1;FIZ1;CSRNP2;ZKSCAN3;MED6;TWIST1;PRKD1;PFKM;SOX2;BICRAL;EDF1;NCOA1;GLI1;XPC;MTOR;SP100;TLR4;DDX17;BRCA2;BMP7;KAT2A;NSD1;GLI3;ENY2;MAP2K1;AHI1;CAMK4;SOX10;ZBED3;PPP3CB;TP53;ZC3H8;SMARCA1;DHX36;ZFPM2;MED10;SNW1;TGFBR1;PSMC5;EPC1;ZNF318;FOXJ2;ESR2;SOX9;UTP15;CD86;IGF2;TFEB;HOXB4;ST18;DPF2;KDM1B;HIVEP3;CD81;TESC;ACTR2;TRIM44;NRIP1;NFIX;AXIN1;HOXC4;MYDGF;RFX4;PEG3;BICRA;MED1;SREBF1;MYRF;ZFP64;ARNT2;MED25;DOT1L;SSBP2;ELK1;BPTF;UBE2V1;ASXL1;F2R;RIPK1;CHD8;FOXM1;HNRNPD;TFAP4;DHX9;EAF2;PBX2;GTF2H1;PRMT2;AR;GDNF;ATF2;MYC;LPIN2;PRDM10;LAGE3;FOXJ3;FGFR2;MAFB;MMS19;PLAC8;AKIRIN1;ONECUT2;TRIP4;DVL3;CCNK;THOC5;USP21;USP16;JAG1;HAX1;TOX2;ATMIN;MAZ;NR1D2
prerank,RNA splicing (GO:0008380),0.2806417789482455,0.957939177127846,0.5205843293492696,0.9510857530191014,1.0,28/95,22.42%,TRA2B;GEMIN2;NOVA1;SNRNP35;ZRSR2;NOL3;LSM4;BCAS2;SRSF11;MPHOSPH10;SMU1;RP9;SLU7;DBR1;SNRNP48;SRSF10;PRPF18;SNRPF;NONO;SF3A3;PPIG;ZCRB1;LUC7L3;PRPF8;DDX39B;DHX15;WBP4;HNRNPH3
prerank,apoptotic process (GO:0006915),0.2576774586357307,0.9577094689389097,0.5751708428246014,0.9508872040348234,1.0,42/203,15.40%,DLC1;IL2RA;MAGI3;OGT;FAP;NGFR;PPARD;ELMO1;CASP6;ZBTB16;IFIT2;DHCR24;ADORA2A;CASP4;CAPN3;ARHGEF6;KREMEN1;TNFRSF19;DCC;MTOR;DDX41;TNFRSF21;PYCARD;JADE1;IAPP;DAP;CASP12;PDCD4;FAM162A;DPF2;MRPS30;BNIPL;ATN1;SCN2A;MELK;ERCC2;BAK1;RIPK1;BAG6;YARS1;AIFM2;MYC
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2395355632535518,-0.9576526751590041,0.5686274509803921,0.7806207026218586,1.0,24/84,20.53%,FOXO1;WWP1;EZR;RDX;VPS35;WWP2;GPC3;APC;APOE;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2;VPS11;FURIN;OAZ1;VGLL4;OAZ2;MSN;FZR1;TNFAIP3;ADAM9
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.38318683476235227,-0.9576096138136536,0.5118483412322274,0.7800159149628693,1.0,4/12,7.34%,ACTB;ACTG1;LAMA3;LAMA5
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2875989960294659,0.9574937615920532,0.5412719891745602,0.9506257294166534,1.0,34/87,25.64%,TIMMDC1;DMAC2;OMA1;IMMP2L;NDUFS7;TMEM126A;NDUFS5;BCS1L;SLC25A33;NDUFV2;NDUFAF7;COX16;NDUFV3;NDUFC2;SURF1;NDUFA12;NDUFAB1;FOXRED1;NDUFAF6;NDUFS4;NDUFB3;UQCC2;TMEM126B;TIMM21;NDUFA10;CHCHD4;LYRM7;NDUFS1;NDUFAF2;COX17;NDUFB6;SAMM50;DMAC1;NDUFB8
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.27480524654568605,-0.9574519343736567,0.5677966101694916,0.7797223707835287,1.0,13/40,19.23%,IGF1;BCL2L1;TNFSF10;BAD;GPX1;BAX;BID;PRELID1;GPER1;GHITM;PLSCR3;AKT1;HGF
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2221601359445558,-0.9573766204838375,0.5763546798029556,0.7791910874746533,1.0,46/132,27.61%,RPS14;PTGES3;PRKDC;EIF5;SF3B1;RPL5;EIF2S2;SCAF11;RPS19;DICER1;PRMT7;RPS27;KHDC4;RPS15;MCTS1;CELF1;RPL10;RPS5;RPL11;SNRPC;GCFC2;SNRPE;RPLP0;SRPK1;SNRNP200;MRPS7;SNRPD1;RPL23A;SART1;EIF4H;MRPL20;CLP1;PRPF19;DDX20;PUF60;SF3A2;USP39;CELF5;PWP2;RPL38;SMN1;NOP2;RPF2;CPSF6;CPSF7;STRAP
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.25783979053109185,-0.9569272240132448,0.5703971119133574,0.7796107536481973,1.0,18/53,19.03%,PSMC6;PSMD9;PSMF1;PSMB7;AZIN1;PSMD8;PSMD12;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;OAZ1;PSMC1;PSMB10;OAZ2;PSME2
prerank,regulation of interleukin-2 production (GO:0032663),0.3225288517338205,0.9568295171444278,0.5070202808112324,0.9515477152019736,1.0,4/43,3.80%,XCL1;PDE4B;GLMN;SPTBN1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.2599137378869784,-0.9565262743314547,0.5639344262295082,0.7798666336741309,1.0,18/56,23.51%,PLCB1;EGFR;ADAMTS1;RDX;CCND2;CDC23;ANXA1;HYAL1;CCND1;RAD51C;ANKRD17;CUL3;ANAPC11;AKT1;RGCC;RCC2;STOX1;LSM10
prerank,nucleotide metabolic process (GO:0009117),0.3591712253050102,0.9564430136210789,0.5224358974358975,0.9517575637087192,1.0,7/23,13.81%,NMNAT3;ENPP3;AK4;FHIT;DCTD;RNASEH2B;AK8
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.2615806033567543,-0.9551599050860394,0.5259938837920489,0.7826265971114952,1.0,18/48,20.26%,NOS3;THBS1;FOXC2;ATP5F1B;KDR;JCAD;ANXA1;MAPK14;GATA2;ETS1;FGFBP1;HSPB1;TMSB4X;PTGS2;SIRT1;AKT1;CIB1;NUS1
prerank,protein modification by small protein removal (GO:0070646),0.2567393272272727,0.955014415603618,0.5689084895259096,0.9546655498588861,1.0,57/252,18.81%,IL33;STAMBPL1;OGT;TAF9B;PTEN;COPS3;MBD6;PSMD1;USP1;PSMD10;UCHL3;OTULINL;PSMA5;USP42;PSMB5;MDM4;BIRC2;KAT2A;RNF128;PSMC4;TP53;PSMA4;USP33;JOSD1;TGFBR1;PSMC5;USP19;HGS;POLB;COPS4;PSMB9;KDM1B;ATXN3;UBE2D1;SENP6;CCNA2;ASXL1;RIPK1;AR;MYC;YOD1;USP34;USP4;PSMA7;USP21;USP16;USP13;STAMBP;PSMD14;USP49;INO80E;TAF10;PSMA2;USP14;RHOA;HIF1A;PSMD11
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.37452151251924587,-0.954944981164366,0.5211581291759465,0.7824200740812398,1.0,2/12,10.91%,PPHLN1;ATF7IP
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.38257799498054046,0.9549210536099452,0.5115511551155115,0.9540984770663603,1.0,2/17,5.08%,NR1H2;LIPC
prerank,RNA polyadenylation (GO:0043631),-0.3008875644456198,-0.9545459450719853,0.49101796407185627,0.7819480653534695,1.0,10/26,26.25%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,mRNA polyadenylation (GO:0006378),-0.3008875644456198,-0.9545459450719853,0.49101796407185627,0.7819480653534695,1.0,10/26,26.25%,APP;WDR33;PAPOLG;PABPC1;CLP1;LEO1;PNPT1;AHCYL1;MTPAP;SSU72
prerank,regulation of double-strand break repair (GO:2000779),0.3267645104771465,0.9543463408383589,0.5130057803468208,0.9547960622243385,1.0,13/39,20.56%,SIRT6;ZCWPW1;MRNIP;TWIST1;SLF1;SPIDR;FIGNL1;ACTR2;FOXM1;SLF2;SPIRE1;TERF2IP;PPP4R2
prerank,protein targeting to lysosome (GO:0006622),0.3691103003009653,0.9540447596729867,0.5066666666666667,0.9547603672427788,1.0,6/20,15.09%,SORL1;NEDD4;SNX16;AP3M1;HGS;CLU
prerank,regulation of extracellular matrix organization (GO:1903053),0.39495765471325883,0.9539709615199933,0.5083056478405316,0.9541295401422251,1.0,2/15,2.80%,LRP1;FAP
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.43657927567813176,0.9537946484256801,0.5387323943661971,0.9537414091704701,1.0,3/10,17.28%,XCL1;CD81;LGALS9
prerank,response to exogenous dsRNA (GO:0043330),0.3763518183004514,0.9536842207648273,0.528830313014827,0.9532201617026654,1.0,1/18,0.21%,COLEC12
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2347683583297239,-0.9534323877980188,0.6024590163934426,0.7839681160179595,1.0,24/88,19.74%,TRABD2B;FNIP1;STX18;SMPD3;TFRC;GSK3B;VCP;RHOC;FNIP2;SMAD3;HYAL1;BAX;SDC4;AJUBA;BID;CDH5;TAL1;CX3CL1;MMP1;SDC1;SDCBP;RGCC;CHGA;PDCD6IP
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.24455048203777052,0.9531881716579627,0.6148225469728601,0.9537004477265819,1.0,95/476,17.02%,RORA;ZFHX3;ATF5;RUNX2;PPARA;TEAD1;RGMB;KMT2E;HDAC1;WNT5A;NR2F2;TCF4;PHIP;ERBB4;SALL1;SMAD5;NR1H4;MED12;POU3F3;PPARD;NR1H2;TEAD2;REST;FOS;ZIC1;KMT2A;MDFIC;ZNF423;ZBTB16;CXXC1;SPP1;MYCN;CAMKK2;CREB3L2;CAPN3;TRIM56;TAF15;NPAS2;SPIN1;ZKSCAN3;SOX2;BICRAL;EDF1;NCOA1;GLI1;XPC;SP100;BRCA2;BMP7;KAT2A;NSD1;GLI3;ENY2;MAP2K1;CAMK4;SOX10;PPP3CB;TP53;SMARCA1;TGFBR1;PSMC5;EPC1;ZNF318;ESR2;SOX9;CD86;TFEB;HIVEP3;TESC;TRIM44;AXIN1;BICRA;MED1;MYRF;ARNT2;ELK1;UBE2V1;F2R;CHD8;FOXM1;HNRNPD;TFAP4;GTF2H1;PRMT2;AR;MYC;MAFB;MMS19;TRIP4;DVL3;USP21;USP16;ATMIN;MAZ;NR1D2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.30881532086099456,0.953114150104142,0.5120910384068279,0.9530958177771715,1.0,13/52,19.63%,KDELR3;FKBP14;CXXC1;EXTL3;SRPRA;GSK3A;TATDN2;MYDGF;HSPA5;TSPYL2;CUL7;ATP6V0D1;SSR1
prerank,regulation of cardiac conduction (GO:1903779),0.3106904482687286,0.9528967137388016,0.5426917510853835,0.9528821024609363,1.0,12/54,15.14%,ATP1A2;ITPR1;RYR2;TMEM65;ATP1A3;ATP2A2;PRKACA;FXYD4;RYR3;ASPH;STIM1;GJA5
prerank,T cell homeostasis (GO:0043029),-0.3969683523197455,-0.9528224385942153,0.503370786516854,0.7847961989327366,1.0,7/10,35.61%,FAS;AKT1;PPP2R3C;JAK3;NCKAP1L;FADD;PMAIP1
prerank,cellular response to alkaloid (GO:0071312),0.3863211381077472,0.9527758112512523,0.5168141592920354,0.9523819922776485,1.0,4/17,13.68%,RYR2;CASP6;SPIDR;RYR3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.41256934699233067,0.952668014866851,0.5164644714038128,0.951848503255733,1.0,1/13,0.70%,COL4A1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.429955400724498,0.9523977037901454,0.5241502683363148,0.9517553689538467,1.0,2/10,7.93%,SEMA5A;CARMIL2
prerank,positive regulation of integrin activation (GO:0033625),-0.3906454000276357,-0.9522378074697493,0.5647058823529412,0.785507394998381,1.0,5/11,24.77%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC
prerank,positive regulation of ATP metabolic process (GO:1903580),0.330767860380764,0.952010664990935,0.516566265060241,0.95197590852802,1.0,5/32,8.27%,ZBTB20;PPARA;PFKFB1;ENTPD5;PINK1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3107551010462108,-0.951942575755668,0.5092838196286472,0.7854967267718694,1.0,6/24,9.10%,SORBS1;IGF1;INSR;PPP1R3B;GSK3B;DYRK2
prerank,cellular response to hexose stimulus (GO:0071331),0.36470517268199637,0.9517373061293358,0.5239616613418531,0.951885793540904,1.0,4/23,8.66%,ZBTB20;TRA2B;ADCY8;PRKACA
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.2561311111750222,0.951666033363564,0.5756578947368421,0.9512648018258074,1.0,59/248,18.28%,PRICKLE1;HDAC1;WNT5A;LYPD6;CDK14;SEMA5A;TCF7L2;BICC1;ADGRA2;RNF220;NKD1;NPHP3;PSMD1;MCC;JUP;GPC5;RBMS3;CDH3;LRRK2;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;ZBED3;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;WNK2;DAAM2;LGR5;CHD8;CSNK1E;AMER2;FGFR2;USP34;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LRRK1;LZTS2;PSMA2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.28847844143301,-0.9514085528435943,0.5420289855072464,0.7861639283955137,1.0,7/31,10.35%,EPHA4;PDLIM5;SIPA1L1;SHANK3;NGEF;CFL1;CAMK2B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.2371904975309213,0.9513427158967267,0.719,0.9513229100479238,1.0,289/1667,17.45%,TBX18;RORA;IL33;GBX1;ZNF367;LPIN3;DCN;PIK3R1;ZEB1;ZBTB20;ISL2;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;PKNOX2;CXCL10;RUNX2;ARID3A;PPARA;HOXC10;AUTS2;MEIS1;MIER2;TEAD1;OGT;ETV5;TEF;HDAC1;PPID;WNT5A;TAF9B;PTEN;TXK;NR2F2;TCF7L2;TCF4;PHIP;RGMA;CD40;SALL1;AGO4;CDKN2A;THRA;SMAD5;NR1H4;PEX2;CDK8;ZFHX4;MAML3;ZIC4;PER3;HTATSF1;NCOA2;MEIS2;PGR;NFATC3;ZNF740;MED12;THAP3;METTL23;MYT1;JUP;POU3F3;PPARD;PIK3R2;NR1H2;TEAD2;LOXL2;REST;TBX3;FOS;ZBTB24;SOX6;NCOA3;ZIC1;KMT2A;FOXO6;HOXC9;ZBTB16;CHD4;IFRD1;MYCN;DMRTA2;BCL9;ZFP37;RTF1;SIRT6;EPAS1;HLF;CREB3L2;SSBP4;SLC9A1;FOXS1;PSMD10;BCOR;E2F4;ZBTB46;BRD8;CRTC2;GLIS1;DUSP22;TENM2;SRF;CSRNP3;BRMS1L;BRMS1;NPAS2;PAX9;ZBTB2;TRIM37;MYO6;AKIRIN2;LYAR;BCL6;FIZ1;DGKQ;ALX4;NR2C1;TAF3;CSRNP2;ZKSCAN3;MDM4;PER2;MED6;PIAS2;TWIST1;PRKD1;PFKM;CDK13;CHD2;SOX2;MXI1;NOC2L;NCOA1;PHF6;GLI1;OLIG2;PRKCB;TTC21B;SP100;TLR4;WIZ;DDX17;BHLHE22;KAT2A;NSD1;GLI3;ZBTB43;ENY2;HOXC8;AHI1;SOX10;ZBED3;PPP3CB;TP53;N4BP2L2;SMARCA1;DHX36;ZFPM2;MED10;AGO3;ZNF292;ZBTB39;ZNF25;MED8;SNW1;MSX1;PSMC5;HOXB9;ZBTB26;EPC1;RFX2;GTF2H3;FOXJ2;ESR2;PROX2;SOX9;MYT1L;ZNF112;TWIST2;IGF2;TFEB;HOXB4;ST18;SAP30;DPF2;ELP4;PPIL4;KDM1B;HIVEP3;CD81;HIC2;CNOT1;DMRTA1;ACTR2;PRDM5;ATN1;NRIP1;NFIX;HOXC4;MYDGF;ZFP1;HDAC10;RFX4;CRK;PEG3;MED1;SREBF1;CUX2;ZFP64;ARNT2;UBE2D1;MED25;DOT1L;SSBP2;ELK1;BPTF;ZSCAN18;PRKAR1A;SNF8;CREB3L1;ASXL1;ZBTB32;MYNN;RIPK1;CHD8;FOXM1;CIAO1;HOXC5;TFAP4;DHX9;EAF2;DMAP1;PBX2;GTF2H1;ZBTB25;SAFB2;AR;GDNF;ATF2;MYC;LPIN2;PRDM10;CRY2;ORC2;TNRC6B;LAGE3;FOXJ3;ZHX3;DCAF1;FGFR2;KLF11;HOXA9;MAFB;ZKSCAN5;KDM2A;IMPACT;PLAC8;EFNA1;AKIRIN1;ZBTB7A;AASS;ZNF467;ONECUT2;ZNF3;DVL3;CCNK;SRA1;USP16;ZFP62;JAG1;HAX1;TOX2;ATMIN;ZIC5;MAZ;NR1D2;CALR;ZBTB12;DNMT3A;SARS1;CREG1;MBD2;AGO1;LDB2;LDB1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2388731404529817,-0.9512138768816761,0.5583333333333333,0.7859280495050264,1.0,23/80,19.92%,ERC1;VTI1A;VPS35;SNX32;ARFRP1;SNX6;SGSM2;SPAG9;SURF4;CLN5;TBC1D10B;VPS51;VPS29;TRIM27;LMAN1;ARL1;TMEM87B;RAB6A;SNX3;VPS54;PLEKHJ1;TBC1D14;TBC1D5
prerank,response to X-ray (GO:0010165),-0.3605422832223318,-0.9509410907638887,0.5159817351598174,0.7858893926701419,1.0,8/14,40.73%,ANXA1;BRCC3;ATM;LIG4;MSH2;XRCC4;XRRA1;XRCC5
prerank,covalent chromatin modification (GO:0016569),0.4075991266885425,0.9508655375163985,0.5400340715502555,0.9517000327552055,1.0,2/14,5.93%,HDAC1;SETD5
prerank,natural killer cell activation (GO:0030101),-0.3129736477420605,-0.9504191195149561,0.5177304964539007,0.7864207912549191,1.0,5/23,12.23%,PBX1;ELF4;CASP8;PIK3CD;PRDX1
prerank,aorta morphogenesis (GO:0035909),-0.33423868056748274,-0.9503768210513871,0.5025773195876289,0.7858155973701973,1.0,6/17,12.72%,RBPJ;MYLK;TBX1;ACVRL1;TBX2;HEY2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3183931890361151,0.9502742167668852,0.5111111111111111,0.9524752530428805,1.0,6/42,7.70%,FBLN2;CORO2B;GCNT2;NF1;PTPRO;PTK2
prerank,cellular response to dsRNA (GO:0071359),0.3950797558879441,0.9497126908340698,0.5265866209262435,0.9531789394200114,1.0,2/15,6.47%,COLEC12;PDE12
prerank,protein localization to organelle (GO:0033365),-0.2208430326194156,-0.9497028742375156,0.5562130177514792,0.7867783509756381,1.0,32/133,17.90%,BBS9;APP;PACSIN2;CSNK1D;VPS35;DVL1;GBP5;SIX1;TOLLIP;VAPA;ARL6;STX1A;UBAC2;GBP2;ANK2;RPL11;ARFRP1;TSPAN17;IFT140;OPTN;RAB35;LMNA;GAK;YBX1;TOR1A;BICD2;CROCC;ARL1;RAB6A;ISG15;HHEX;LAMP2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3237975652196398,-0.9496317687483736,0.5300261096605744,0.7862356118187651,1.0,9/22,22.28%,RNF185;UBB;AMFR;UBC;EDEM1;MAN1A2;RNF5;UGGT1;UBA52
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.2933060415195624,0.9493985057851826,0.5430183356840621,0.9531879632643132,1.0,10/67,11.12%,PDGFRA;GHR;TXK;ERBB4;FGFR1;PTK2;RELN;FGR;EPHA3;FYN
prerank,cilium-dependent cell motility (GO:0060285),0.36569522194346854,0.949150210789253,0.5337620578778135,0.9530228287953213,1.0,5/22,15.25%,RSPH9;EFHC1;CCDC65;GAS8;CCDC39
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.4133450282429273,0.9488935259159009,0.5166959578207382,0.9529073708266959,1.0,1/11,1.70%,WNT5A
prerank,cellular protein localization (GO:0034613),0.2501582505556194,0.948702110011628,0.5997757847533632,0.952588056915963,1.0,38/285,10.36%,EPB41L3;UNC93B1;GGA2;RTP4;WNT5A;MYO7A;ATG9B;RAB20;CNTNAP2;RABGAP1L;TBC1D16;GRID2;RABL3;COPA;WDR45B;GJA1;NGFR;COPZ2;LRRK2;SEPTIN9;NAPB;CAPN3;CEP68;MYO6;PTPRU;SYNDIG1;VIPAS39;TBC1D1;TRIM23;JAM3;VPS26C;RAB29;ITSN1;TBC1D8B;SLU7;RAB24;AHI1;SAR1A
prerank,regulation of membrane depolarization (GO:0003254),-0.3375506323889945,-0.9486752008956012,0.5347222222222222,0.7878775957661809,1.0,3/18,3.59%,FHL1;PTPN3;CAMK2D
prerank,positive regulation of peptidase activity (GO:0010952),-0.3218394384387404,-0.9484894072038599,0.5360824742268041,0.7876471596673924,1.0,10/20,29.73%,VCP;CTSH;APH1A;APH1B;PSME3;PRELID1;PSME2;NDUFA13;VSIR;TANK
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.30569317905815985,-0.9484472031303972,0.5245901639344263,0.7870666414515837,1.0,4/25,5.15%,PICALM;APP;RIN3;RAC1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.2756984826253517,0.9483937530942772,0.5603015075376885,0.9525739965452796,1.0,27/113,15.73%,NRG1;ERCC1;FSCN1;ERCC5;TLR6;RPA1;ERCC4;TERF1;IL5;MPP7;TLR4;PSMC4;SLF1;TP53;ASAP1;PSMC5;SPIDR;GTF2H3;CDT1;ERCC2;MED25;BAK1;FERMT2;GTF2H1;CLU;SLF2;TIRAP
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3102614469036068,-0.9483799678424134,0.5163043478260869,0.7865113065783857,1.0,10/25,21.66%,RNF185;VCP;NGLY1;TOR1A;CUL3;YME1L1;CLPP;HDAC6;RNF5;UGGT1
prerank,carbohydrate homeostasis (GO:0033500),-0.24242461459974446,-0.9483240366706265,0.5814814814814815,0.7859317332728312,1.0,11/67,10.30%,LEPR;IGF1R;ADIPOR2;KLF7;INSR;RBP4;PRKAA2;SOX4;KCNB1;BAD;PTPN2
prerank,RNA stabilization (GO:0043489),0.3366318266254671,0.9481907945319877,0.5350609756097561,0.9522819774125897,1.0,9/33,15.31%,RBM24;DND1;TAF15;PAIP1;TENT5A;DHX36;TENT2;EIF4ENIF1;GDNF
prerank,peptidyl-threonine modification (GO:0018210),-0.24802252438772174,-0.9481208466558481,0.5476190476190477,0.7857476757053706,1.0,27/66,22.72%,ROCK2;CAMK2D;PRKDC;WNK1;HIPK3;GSK3B;HIPK1;ACVR1;CDC42BPB;DYRK2;GALNT11;HIPK2;GALNT1;CDC42BPG;PRKCD;DYRK1B;TBK1;MAP3K10;AKT1;CSNK2B;SBK1;MARK2;GALNT3;TGFBR2;TTBK1;STK39;CAD
prerank,protein localization to cell surface (GO:0034394),-0.3043472349549884,-0.9481143266662938,0.5216216216216216,0.7850789381959618,1.0,10/26,23.51%,VCL;PTPRK;MESD;ANK2;PIGU;FLNA;UNC50;WNT11;PIGK;SMURF1
prerank,regulation of cell killing (GO:0031341),-0.34777098699739184,-0.9480699322273511,0.5049261083743842,0.7844715482722583,1.0,5/16,10.44%,CD55;TGFB2;RAC1;FZD7;ICAM1
prerank,response to interferon-beta (GO:0035456),-0.31409842369833163,-0.9480322321073257,0.517948717948718,0.7838685129776972,1.0,10/22,29.08%,IFITM3;IRF1;IFITM1;CDC34;IFITM2;NDUFA13;IKBKE;PNPT1;TRIM6;IRGM
prerank,oligodendrocyte differentiation (GO:0048709),0.37612668767149576,0.9479325485200489,0.5201342281879194,0.9521660639440933,1.0,9/19,23.37%,SOX6;EIF2B1;SOX10;SOX9;MYRF;CDK5;PTPRZ1;NSUN5;EIF2B5
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3489898264414034,0.947864475244421,0.5337620578778135,0.9515547848620538,1.0,8/26,19.60%,OGT;KMT2A;VCPKMT;SETD5;SMYD5;SUV39H2;SETD4;ATPSCKMT
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.4062409278830478,-0.9473849263205073,0.49878934624697335,0.7847537350819996,1.0,2/10,5.23%,RAPGEF2;GIPC1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.39747435323161945,-0.94735693664499,0.518348623853211,0.7841438800044026,1.0,5/10,34.72%,TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,actin filament capping (GO:0051693),0.38116206892490423,0.946837597107403,0.5498281786941581,0.952656498767532,1.0,1/18,0.32%,SVIL
prerank,barbed-end actin filament capping (GO:0051016),0.38116206892490423,0.946837597107403,0.5498281786941581,0.952656498767532,1.0,1/18,0.32%,SVIL
prerank,sphingolipid catabolic process (GO:0030149),-0.35012561633370576,-0.9464979916459376,0.5358024691358024,0.7855668385077144,1.0,7/15,26.54%,ACER2;ACER3;ENPP2;SMPD1;SMPDL3A;ASAH1;ASAH2
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.28844671894539053,0.9464188049822965,0.5496688741721855,0.9529251247821501,1.0,19/74,16.15%,SPRY1;PTEN;PHLDB1;SPRED1;LOXL2;GCNT2;IL17RD;GLIPR2;SPRED2;TWIST1;MTOR;EPHA3;MCRIP1;TGFBR1;OLFM1;CLASP2;FERMT2;CLASP1;EFNA1
prerank,ncRNA catabolic process (GO:0034661),0.3459899192375609,0.9462818702392465,0.5363636363636364,0.9524703814705131,1.0,10/28,19.04%,LIN28B;TENT4B;MTREX;EXOSC9;DIS3L2;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,positive regulation of lipid kinase activity (GO:0090218),0.33642234978804425,0.9460910514636208,0.5414710485133021,0.9521808952254541,1.0,7/29,14.51%,PDGFRA;IRS1;PTK2;PRKD1;FGR;CD81;ATG14
prerank,regulation of translation (GO:0006417),0.2613704656601219,0.9459890818638138,0.5839243498817966,0.9516289243816607,1.0,44/173,19.24%,EIF4G3;PRR16;PLD1;NAT10;EIF4A3;NANOS3;EPRS1;EIF3H;LSM14A;FMR1;MTPN;LARP6;CAPRIN1;RPS6KB1;EIF4A2;GLE1;PAIP1;MTOR;MTRF1;EIF2AK2;GRM5;DHX36;PLXNB2;CNOT1;MALSU1;EIF4ENIF1;RBM4B;PUS7;HNRNPD;DHX9;CNOT7;IMPACT;TSC1;IGF2BP3;CYFIP1;EIF5B;CALR;MTIF2;EIF3C;ILF3;YTHDF1;EIF2AK3;CTIF;FXR1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.38416539928198123,-0.9459436876508831,0.5254988913525499,0.7862075431681014,1.0,2/11,1.60%,DDX5;EGFR
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.35050978046493525,-0.9458783659054919,0.5255474452554745,0.785666567528495,1.0,7/16,21.96%,RBM22;SNRPC;CWC15;SNRNP200;SART1;DCPS;NCBP2
prerank,histone modification (GO:0016570),-0.22126847382214992,-0.9457900649396115,0.6089108910891089,0.7851830746699303,1.0,24/109,16.62%,EYA2;EYA1;HDAC4;EYA4;KDM4A;KAT6B;SIN3B;ATXN7;TBL1X;NTMT1;PRMT7;MIER1;PHF20;RPS6KA5;UBE2A;PRMT8;MIER3;MSL3;UBE2N;KAT5;EZH2;PRKCD;SIRT1;TRRAP
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.3006585217293649,-0.9454424816072174,0.5521126760563381,0.7854020854106761,1.0,7/27,15.33%,KHNYN;NYNRIN;PARN;DICER1;RPP30;RNASE4;ERN1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.3808485833500723,0.9452722305455544,0.5269565217391304,0.9526521865154307,1.0,4/17,9.46%,ATP1A2;SCN2B;CACNA1G;HCN2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3827320421777645,0.9452427791959002,0.5236427320490368,0.9519432272123318,1.0,3/17,12.02%,KDF1;AHI1;SOX9
prerank,sensory perception of smell (GO:0007608),0.41847913351689864,0.9449517174376452,0.525089605734767,0.9518759277348688,1.0,3/11,22.63%,ADCY3;BBS4;UBR3
prerank,positive regulation of cell growth (GO:0030307),-0.23115457051278948,-0.9449104909482213,0.6129032258064516,0.7859820804829216,1.0,24/96,18.28%,IGF1;EGFR;NTN1;SEMA7A;RUFY3;TGFB2;ADAM10;CDC42;NGF;MAPT;HYAL1;SFRP1;INO80;RPS6KA1;GOLGA4;EXOSC2;MACF1;MFSD2A;CDKN2AIP;EDN1;PABIR1;ERBB2;AKT1;SDCBP
prerank,positive regulation of RNA metabolic process (GO:0051254),0.315050420668519,0.9448214858218783,0.5333333333333333,0.9514265244533686,1.0,13/45,17.91%,PIK3R1;MYCN;LIN28B;NMD3;MAP2K1;TP53;UTP15;RBM20;DIMT1;RIPK1;HNRNPLL;HABP4;DXO
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.32955537138785795,0.9447042921037825,0.5235849056603774,0.9509676875022796,1.0,6/33,16.74%,IL34;PRKCA;TESC;CTNNBIP1;RIPK1;HAX1
prerank,amide biosynthetic process (GO:0043604),0.3088945475622602,0.9446654281860412,0.5604551920341394,0.9502893905003946,1.0,12/47,17.21%,PAM;CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;CERS6;SLC25A2;SLC25A15
prerank,heart process (GO:0003015),-0.35684114895873664,-0.9446642110625578,0.5400943396226415,0.7858801533104218,1.0,3/14,12.99%,ACE;GPX1;NOX4
prerank,regulation of mononuclear cell migration (GO:0071675),0.3540546251181516,0.9446505711305615,0.5189456342668863,0.949529435953557,1.0,8/23,21.50%,IL34;PTK2;LYN;AKIRIN1;BMP5;CMKLR1;RARRES2;MAPK1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.30846841728584257,-0.9446298100669545,0.5173333333333333,0.7852790091633042,1.0,7/24,14.67%,TEK;KDR;GATA2;SERPINE1;ICAM1;RAMP2;CDH5
prerank,cellular senescence (GO:0090398),0.34630245259615056,0.9445997911501423,0.5376,0.9488469355945389,1.0,5/27,9.96%,CDKN2A;TBX3;SRF;OPA1;MAP2K1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3389747112939626,0.9445726602824204,0.5245398773006135,0.9481300457190165,1.0,10/31,23.40%,REST;CACNA1G;SYT3;SYT7;SYT5;ADRA2A;SYT6;SYT1;CACNA1I;SYT4
prerank,glucose import (GO:0046323),-0.3627955217491181,-0.9436769449468501,0.5437352245862884,0.7869485827439555,1.0,8/13,48.84%,SLC2A1;SLC2A4;RAB4B;SLC27A4;SLC27A1;SLC2A3;SLC2A10;TRARG1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.2596699445920192,-0.9436523748394183,0.5874587458745875,0.7863194397854962,1.0,7/56,3.95%,FLT1;EPHA4;TEK;EGFR;FER;KDR;INSR
prerank,apoptotic nuclear changes (GO:0030262),0.351645185489841,0.9436002938151469,0.5120385232744783,0.9499026612582431,1.0,5/24,18.80%,CECR2;KPNA1;TOP2A;KPNB1;DEDD2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.35426032891384795,-0.9435385819679976,0.5367088607594936,0.7859139698355829,1.0,3/15,7.21%,APP;CRYAB;APOE
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.380713000704663,-0.9433878387462,0.5276497695852534,0.7856074436293315,1.0,4/12,17.21%,FOXP1;KLF4;MAP2K5;CD74
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3546892738311078,-0.9432599361814065,0.528604118993135,0.7852162475621736,1.0,4/14,22.66%,SAP30BP;AKAP8;ZBTB7B;APLNR
prerank,regulation of protein polymerization (GO:0032271),-0.2835788148530264,-0.9429438144608698,0.5565749235474006,0.7852977287652532,1.0,16/35,31.12%,ESAM;MAPT;ARHGAP18;ARL2;COTL1;ARHGAP28;PLEKHG2;TPPP3;RASA1;CAMSAP2;TTBK1;FCHSD1;TPPP;HCLS1;CAMSAP3;PFN2
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.4080480262459059,0.9429420657547257,0.5350877192982456,0.9507820604475997,1.0,2/12,8.42%,DOCK10;GPR183
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2967712668563929,0.942820738379175,0.5473251028806584,0.9503054510352248,1.0,12/59,13.50%,ROBO2;TENM3;PTPRT;DSCAM;CNTN4;DSCAML1;PALLD;NEXN;CNTN6;PLXNB2;CADM3;NECTIN3
prerank,regulation of interleukin-13 production (GO:0032656),-0.3690809826270257,-0.9426176160785115,0.5426008968609866,0.7853683010527542,1.0,2/13,1.78%,LEF1;IL18
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2535732036094566,0.9425450910140536,0.590221187427241,0.9502415128156855,1.0,25/190,11.89%,RORA;PPARA;CCDC22;PTEN;ITPR1;TSPAN6;NR1H4;DUSP1;PIK3R2;SPRED1;NPRL2;NF1;PSMD10;HERPUD1;CARD19;PLEKHA1;TWIST1;PINK1;NOC2L;TLE1;BMP7;PYCARD;RTKN2;BCL2L2;TRIM59
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.285465569583136,-0.9423175846055771,0.5344827586206896,0.7854387502848281,1.0,14/33,22.33%,FHL1;KANK2;KLF4;APC;CDK6;WEE1;FAM107A;PLK5;CDKN1A;DCUN1D3;DLG1;RBL1;RBL2;CDK2AP2
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3558632941050008,0.942083241699294,0.5480769230769231,0.9506513120266848,1.0,3/23,6.74%,ZFYVE28;CBLB;DUSP22
prerank,negative regulation of platelet activation (GO:0010544),0.37905230800574974,0.9419813046969392,0.5254833040421792,0.950131267587343,1.0,1/16,0.14%,PDGFRA
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3861100031953129,0.941873598776017,0.5339966832504146,0.9496344283866245,1.0,4/15,17.70%,GPLD1;NR1H2;SREBF1;CTDNEP1
prerank,Golgi inheritance (GO:0048313),0.42091124927015955,0.9406619763799832,0.5259259259259259,0.9519853971145138,1.0,4/11,15.36%,YWHAZ;GBF1;GOLGA2;VRK1
prerank,respiratory chain complex IV assembly (GO:0008535),-0.32128053598046546,-0.9406303480908639,0.5523809523809524,0.7888882345215645,1.0,9/21,24.35%,COX15;PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L;COA6
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.31843172393933983,-0.9405666378371144,0.5429292929292929,0.7883305109564116,1.0,6/20,31.03%,FDX1;FDXR;STAR;HSD17B10;CYP46A1;TSPO
prerank,regulation of acute inflammatory response (GO:0002673),0.37306027990820206,0.939894067583168,0.5218093699515347,0.9530796344623226,1.0,4/18,21.69%,KLKB1;PTGES;ADAM8;OSMR
prerank,positive regulation of behavior (GO:0048520),-0.3914947859488872,-0.9398337906161903,0.5408388520971302,0.78937241784282,1.0,1/10,0.87%,MEF2C
prerank,inorganic ion transmembrane transport (GO:0098660),0.4143195264749011,0.9396594190765836,0.519327731092437,0.9528943664071649,1.0,3/12,21.24%,ASIC2;KCNJ8;ABCC9
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.34921264289582665,0.939342460728799,0.5317460317460317,0.9529098452091092,1.0,2/27,1.70%,PDGFRA;WNT5A
prerank,fatty acid elongation (GO:0030497),-0.36631356884894045,-0.9392776002342574,0.5294117647058824,0.7900008684652076,1.0,4/13,13.29%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.27490769345727495,0.9391778895194939,0.5712435233160622,0.9525347956601617,1.0,27/100,19.94%,PRICKLE1;OGT;GLMN;EIF3H;RNF180;LRRK2;PSMD10;HERPUD1;CBFA2T3;COMMD1;NKD2;FHIT;ZYG11B;HECTD1;GSK3A;DDA1;BAG6;CLU;CSNK1E;DET1;ARAF;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A;XPO1
prerank,response to interleukin-6 (GO:0070741),-0.3908094447752918,-0.9390651571662237,0.5384615384615384,0.7898227880583243,1.0,2/10,2.62%,ST3GAL6;NFKB1
prerank,long-term memory (GO:0007616),-0.32773481668207904,-0.9389124396491993,0.5365239294710328,0.7894973379410584,1.0,4/19,10.54%,RASGRF1;APOE;SHANK1;CPEB3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.2679835407093652,-0.9389029834807309,0.5454545454545454,0.7888345822839982,1.0,12/41,20.84%,ACTN2;ANK2;STAC;KCNJ2;KCNQ1;KCNJ12;NOS1;FLNA;NOS1AP;CTSS;ACE2;KCNJ15
prerank,mitotic cell cycle phase transition (GO:0044772),0.2549825874130889,0.9387219960636417,0.5756541524459613,0.9529493333181948,1.0,53/204,21.66%,DYNLL1;CDK14;CDKN2A;CCNJ;DCTN3;HAUS3;PKMYT1;HAUS1;CDC7;CCDC57;DCTN2;CDC16;CDKN2D;HAUS8;RPS6KB1;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;CACUL1;PPP6C;BCAT1;SSNA1;RCC1;CUL5;CDKN2C;MELK;DBF4;CLASP2;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;MYC;BRSK2;CLASP1;ALMS1;CAMK2A;PCM1;CCNE1;KHDRBS1;CUL4A;TUBA1A;POLE;CEP43;LATS2;INHBA;FBXL22;CCND3;CDK7;BTRC
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.41014093077000224,0.9387124764586582,0.5314183123877917,0.9521900241656087,1.0,4/11,19.24%,FMR1;DHX9;WTIP;FXR1
prerank,autophagy of mitochondrion (GO:0000422),-0.27245989915712204,-0.9386632631513148,0.55,0.7886739984222855,1.0,15/38,21.26%,BECN1;SQSTM1;ATG13;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;AMBRA1;MARK2;MAP1LC3B;WDR45
prerank,positive regulation of interleukin-1 production (GO:0032732),0.30257845624337504,0.938138891447688,0.5576102418207681,0.9528626639173233,1.0,7/51,10.90%,WNT5A;IL16;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,protein acetylation (GO:0006473),-0.2899920426149867,-0.9379251095663345,0.5561643835616439,0.7897560967334831,1.0,12/30,22.75%,FOXO1;NAA40;MAPT;ESCO1;ING4;KAT5;SIRT1;ING5;CLOCK;NAA80;NAA35;NAT9
prerank,positive regulation of protein sumoylation (GO:0033235),0.4247604806881663,0.9377615865102223,0.5432098765432098,0.9530111842432274,1.0,2/10,10.22%,GNL3;SAE1
prerank,positive regulation of cellular respiration (GO:1901857),-0.3806642845176957,-0.9377232151153841,0.546875,0.789521409963241,1.0,6/11,26.32%,IL10RB;IFNAR1;VCP;PRELID1;NUPR1;PARK7
prerank,T cell activation (GO:0042110),0.2862473352701472,0.9376293006134953,0.5366528354080221,0.9525889772711162,1.0,9/69,11.91%,CHD7;CD8B;SCRIB;ICOSLG;PTPN22;CD276;RAB29;PPP3CB;LMBR1L
prerank,entry into host (GO:0044409),-0.3615661363503697,-0.9376068467400244,0.5355450236966824,0.7891283669031233,1.0,5/13,15.68%,CDH1;CTNND1;PPIA;GRB2;MET
prerank,regulation of type I interferon production (GO:0032479),-0.23229613413734324,-0.9374353082387284,0.6217391304347826,0.7888743994246515,1.0,28/84,22.93%,NPLOC4;NFKB1;PRKDC;POLR3E;MAVS;TRIM25;CRCP;PCBP2;IRF1;RNF125;GAPDH;POLR2H;POLR3G;CYLD;NLRX1;TRAF3;NLRC5;POLR3D;UBE2L6;TBK1;NFKB2;ISG15;PQBP1;TNFAIP3;POLR1C;ILRUN;POLR3K;IKBKE
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2672975923767401,0.937337225606841,0.5853365384615384,0.9525517589514723,1.0,30/124,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;TCF7L2;AGO4;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PPP3CB;PSMA4;AGO3;PSMC5;GNAO1;PSMB9;ARHGEF19;GNG2;TNRC6B;DVL3;PSMA7;PSMD14;AGO1;CAMK2A;FRZB;PSMA2;RHOA;PSMD11
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.33641131219689946,0.9372380767456759,0.5327868852459017,0.9520242754310101,1.0,9/30,17.08%,ACOX2;ABCD2;PEX2;ELOVL2;ACSL6;ACOT2;ELOVL6;ELOVL1;HACD3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2825221152206202,0.9372153954183002,0.5873221216041398,0.9513015426287925,1.0,20/85,18.81%,PRICKLE2;ROR2;PRICKLE1;WNT5A;PSMD1;PSMD10;DAAM1;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;PSMB9;ARHGEF19;DVL3;PSMA7;PSMD14;PSMA2;RHOA;PSMD11
prerank,cation transmembrane transport (GO:0098655),-0.2613995860609558,-0.9371591400702276,0.5375,0.7888718976266456,1.0,7/44,11.97%,TRPM3;TRPM6;SLC7A1;SLC3A2;SLC38A5;SLC7A5;SFXN1
prerank,osteoclast differentiation (GO:0030316),-0.31025613503438987,-0.9371156202042127,0.5404040404040404,0.788305074063983,1.0,13/22,32.92%,FOXP1;MAPK14;OSTM1;GLO1;EPHA2;CSF1R;TYROBP;SRC;SBNO2;SNX10;CSF1;EFNA2;TREM2
prerank,positive regulation of translation (GO:0045727),-0.2307604005348948,-0.9366609375703805,0.62882096069869,0.788784082931652,1.0,20/94,13.78%,VIM;LARP4;THBS1;RPS9;ELAVL1;PRKDC;NIBAN1;YBX3;SAMD4A;LARP4B;RPL5;SOX4;PYM1;CPEB3;RPL26;EIF3D;RPS4X;PKM;POLR2G;NGRN
prerank,regulation of signal transduction (GO:0009966),0.2567778828245316,0.9366049645672377,0.6011428571428571,0.9520485646966645,1.0,28/190,11.70%,RORA;SULF1;TMEM204;MTCH1;OGT;TSPEAR;SEMA5A;ITGA3;RGS20;ZIC1;MDFIC;ANKRD54;LRRK2;TMEM108;LLGL1;IFT81;KCTD8;DGKQ;PRKD1;RGS8;GLI1;SP100;IRAK1;DOK5;FYN;USP33;SNW1;UBASH3B
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.34200894035281465,0.9360786904925106,0.5564263322884012,0.9526071176494583,1.0,9/27,15.59%,FMR1;MYCN;MAP2K1;TP53;EIF4ENIF1;RIPK1;DHX9;WTIP;TNRC6B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.37381939417827903,-0.9357432505321828,0.5511627906976744,0.7902531798001382,1.0,2/12,1.54%,FOXP1;FNIP1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.2649255104703019,-0.9356212228708733,0.5654952076677316,0.7898721342858712,1.0,12/45,22.98%,BMPR2;TGFB2;DAB2;ACVR1;ACVRL1;GDF11;HFE;TWSG1;CSNK2B;SDCBP;INHBB;ACVR2A
prerank,cellular response to glucose starvation (GO:0042149),-0.2712310299019231,-0.9354546856676235,0.5539358600583091,0.7895574078712425,1.0,11/41,20.88%,PRKAG2;BECN1;SESN1;PRKAA2;SIK1;MYBBP1A;PRKAG3;PRKAA1;NUAK2;HNRNPA1;ASNS
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.32223573233596947,0.935105329600763,0.5449010654490106,0.9542133479026506,1.0,7/36,14.79%,WNT5A;TXK;TSLP;CASP4;AXL;TRIM44;RIPK1
prerank,regulation of coagulation (GO:0050818),0.4200365290947603,0.9349763988520037,0.5427574171029669,0.9537698250965068,1.0,3/11,14.71%,HRG;F2R;HS3ST5
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.3723395620937077,-0.9349377422978158,0.5555555555555556,0.790150101845289,1.0,4/12,10.44%,NFIB;EPHA4;GLI2;EPHB2
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.22824512927864873,-0.934608053408699,0.635,0.7902268764714481,1.0,35/86,27.18%,PSMC6;PSMD9;EGLN3;PSMF1;HIF3A;PSMB7;KLF2;UBB;PSMD8;PSMD12;INO80;VHL;BAG3;PSMA3;PSMA6;PSMD4;PSME3;PSMD7;PSMB6;ELOC;PSMC1;PSMB10;UBC;PSME2;PSMC3;HIGD1A;UBA52;PSMA8;STOX1;DNAJB1;BACH1;HSPA1A;LIMD1;ATF3;CHEK1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2331364023501272,0.9345569076717614,0.801,0.9540060057650847,1.0,341/1645,19.90%,TBX18;RORA;CHD7;GBX1;ZNF367;ZEB1;ZBTB20;ISL2;BHLHA9;ZFHX3;TRPS1;MSC;ATF5;ETV1;XCL1;PKNOX2;NRG1;RUNX2;ARID3A;PRICKLE1;PPARA;HOXC10;MEIS1;TEAD1;RGMB;OGT;ETV5;TEF;KMT2E;HDAC1;L3MBTL1;WNT5A;CDK14;NR2F2;TCF7L2;TCF4;PHIP;BASP1;ERBB4;SALL1;CDKN2A;THRA;SMAD5;NR1H4;ZFHX4;ZIC4;HTATSF1;NCOA2;MEIS2;PGR;NFATC3;ZNF740;MED12;MYT1;POU3F3;PPARD;NR1H2;TEAD2;LOXL3;LOXL2;REST;TBX3;FOS;FBXO5;ZBTB24;SCML4;SOX6;ZIC1;KMT2A;FOXO6;MDFIC;RUNX1T1;HOXC9;ZNF423;RRP8;ZBTB16;FOXN2;CXXC1;SPP1;CHD4;IFRD1;MYCN;DMRTA2;CAMKK2;ZFP37;EPAS1;HLF;TLE2;CREB3L2;SETD5;FOXS1;BCOR;E2F4;ZBTB46;CAPN3;GLIS1;TRIM56;CALCA;TAF15;POLA1;CBFA2T3;SRF;GMNN;CSRNP3;HP1BP3;BRMS1;NPAS2;PAX9;ZBTB2;SPIN1;BCL6;DGKQ;ALX4;NR2C1;CSRNP2;ZKSCAN3;MDM4;PER2;MED6;PIAS2;TWIST1;SPTY2D1;CHD2;SOX2;MXI1;BICRAL;L3MBTL4;EDF1;NCOA1;PHF6;GLI1;XPC;OLIG2;TENM1;PRKCB;TTC21B;SP100;TLE1;WIZ;DDX17;BHLHE22;DAXX;SRRT;BRCA2;BMP7;KAT2A;NSD1;GLI3;ZBTB43;ENY2;MAP2K1;HOXC8;CAMK4;SOX10;PPP3CB;TP53;ZC3H8;NFXL1;MPHOSPH8;SMARCA1;DHX36;ZFPM2;ZNF292;ZBTB39;ZNF25;MED8;SNW1;MSX1;TGFBR1;PSMC5;DAP;HOXB9;ZBTB26;EPC1;RFX2;ZNF318;FOXJ2;ESR2;PROX2;SOX9;SRSF10;MYT1L;ZNF112;CDT1;TWIST2;CD86;PDCD4;IGF2;TFEB;HOXB4;ST18;SAP30;DPF2;ELP4;HIVEP3;HIC2;BTAF1;NUP107;TESC;PHC1;DMRTA1;TRIM44;ZNF628;PRDM5;ZMYND15;NFIX;AXIN1;CARM1;HOXC4;ZFP1;HDAC10;RFX4;CRK;PEG3;BICRA;MED1;SREBF1;CUX2;MYRF;ARNT2;SSBP2;ZNF326;ELK1;BPTF;ZSCAN18;TGFBRAP1;KDM5C;PRKAR1A;UBE2V1;SNF8;CREB3L1;F2R;ZBTB32;MYNN;CHD8;FOXM1;CIAO1;HOXC5;HNRNPD;TFAP4;DHX9;DMAP1;PBX2;GTF2H1;ZBTB25;SAFB2;PRMT2;MLF1;AR;ATF2;CNOT7;MYC;WTIP;CRY2;CENPF;FOXJ3;ZHX3;KLF11;HOXA9;MAFB;ZKSCAN5;MMS19;KDM2A;SPINDOC;ZBTB7A;ZNF467;ONECUT2;TRIP4;ZNF3;CBFA2T2;DVL3;CCNK;NONO;SRA1;USP21;USP16;USP13;ZFP62;MBTD1;TOX2;ATMIN;ZIC5;CIART;MAZ;NR1D2;CALR;ZBTB12;CREG1;CDK5;MBD2;ZBTB11;RHOG;LDB1;SMARCAL1;SAFB;PHF20L1;ZNF32;MLF2;RAI1;SUV39H2;ZXDB;BMP2;MBD1;KAT7;NFAT5;RNF187;SKOR2;HDGFL2;HEY1;BRD7;CCNE1;ILF3;REXO4;KHDRBS1;HIF1A;WWC1;DEDD2;PEX14;THAP7;ZNF711;CARF;TERF2IP;CREBZF;ARNT;CBFB;NR2C2;TFDP1;NACC1;ABCA2;IKZF4;SP1;E2F5;OLIG1;TASP1;MTA3;TRAPPC2;CNBP;HIVEP2;LRRFIP1;HOXB2;MAP3K2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.423012555035821,0.9343454388176006,0.5195729537366548,0.9537684636754115,1.0,1/10,1.47%,ATP1A2
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2586345116570205,0.9342589596208949,0.6068476977567887,0.9532150607418922,1.0,23/175,12.86%,MAP3K14;XCL1;EDA2R;EDA;CD40;PSMD1;CCL15;SMPD4;PSMD10;ADAMTS12;ZFP36L2;PSMA5;PSMB5;BIRC2;PSMC4;TNFRSF21;CCL25;TP53;PSMA4;PYCARD;PSMC5;ST18;PSMB9
prerank,regulation of protein processing (GO:0070613),-0.3154041228523735,-0.9340443631168374,0.5495049504950495,0.7908507305255259,1.0,5/21,13.86%,GAS1;RUNX1;CCBE1;TMEM59;SERPINE2
prerank,endoplasmic reticulum organization (GO:0007029),0.28451712293039655,0.9337777121686446,0.5606860158311345,0.9536494959445803,1.0,10/72,12.48%,SEC16B;REEP2;SEC16A;VAMP2;LRRK2;SMPD4;ZBED3;SEC61B;TRAM2;LNPK
prerank,regulation of cholesterol efflux (GO:0010874),-0.28158070889606757,-0.9335724777237606,0.5545977011494253,0.7913933001613457,1.0,7/30,9.83%,CAV1;SREBF2;PLTP;RXRA;APOE;ABCA3;NFKBIA
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.34382095387264433,0.9334906129179875,0.5682539682539682,0.9536011298483806,1.0,3/26,7.50%,TRAF3IP1;DHX58;LYAR
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.38751397048220565,0.9334287668517415,0.5310924369747899,0.952986963663268,1.0,5/16,8.66%,PDE9A;MTPN;SLC9A1;TRPC3;PRKCA
prerank,neuron maturation (GO:0042551),-0.32776688490172323,-0.9330861857131911,0.5476772616136919,0.7918221016380788,1.0,7/18,15.95%,ANKS1A;APP;B4GALT5;SCARF1;CLN5;CX3CL1;SRRM4
prerank,phospholipid catabolic process (GO:0009395),-0.30195873983844107,-0.9328668992582321,0.5887323943661972,0.7916716975178519,1.0,8/24,20.76%,GPCPD1;PLA2G4A;GDPD3;ENPP2;SMPD1;SMPDL3A;PLA2G4E;PLA2G4C
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3600778687212206,-0.9325074790293566,0.5446009389671361,0.7918205413548676,1.0,1/13,0.01%,SORBS1
prerank,microtubule polymerization (GO:0046785),-0.2880064823614493,-0.9321015040417575,0.5612535612535613,0.7921058769440857,1.0,8/29,15.48%,CSNK1D;NDEL1;MAPT;TUBGCP5;MAP7D3;SLAIN2;TRPV4;TPPP3
prerank,transcription by RNA polymerase I (GO:0006360),-0.2732581169252902,-0.931617379324389,0.5555555555555556,0.7924863667819642,1.0,11/34,21.86%,CAVIN1;GTF2H5;TCOF1;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,negative regulation of complement activation (GO:0045916),0.4206107346279008,0.9314088305842156,0.5435540069686411,0.957336057990427,1.0,3/10,17.51%,SUSD4;CR2;A2M
prerank,protein secretion (GO:0009306),0.2947136762154782,0.9313419604576011,0.5571227080394923,0.9567353969685038,1.0,17/56,21.59%,STEAP3;SEL1L;RAB8A;RAB3C;RIMS2;RCN3;RAB15;TMEM167A;MTTP;TVP23B;LTBP2;COPG1;MIA3;SVBP;CANX;SCG2;TANGO6
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.275477811458433,0.9311179403036326,0.577020202020202,0.9565280389579559,1.0,12/113,8.66%,PTN;LAMC1;LAMB1;WNT5A;SEMA5A;TCF7L2;C5AR1;HTR2B;CDH3;PDCL3;PRKD1;PRKCA
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.41592464354596237,0.9309897984476706,0.5368043087971275,0.956093282387676,1.0,5/12,17.70%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.26922419965555333,0.9309129461127039,0.6088560885608856,0.9555169219342943,1.0,16/114,12.86%,MAP3K14;EDA2R;EDA;CD40;PSMD1;PSMD10;PSMA5;PSMB5;BIRC2;PSMC4;TP53;PSMA4;PYCARD;PSMC5;ST18;PSMB9
prerank,protein deubiquitination (GO:0016579),0.251202663186236,0.9308158139006801,0.6255555555555555,0.9550154042041631,1.0,55/242,18.81%,IL33;STAMBPL1;OGT;TAF9B;PTEN;MBD6;PSMD1;USP1;PSMD10;UCHL3;OTULINL;PSMA5;USP42;PSMB5;MDM4;BIRC2;KAT2A;ENY2;RNF128;PSMC4;TP53;PSMA4;USP33;JOSD1;TGFBR1;PSMC5;USP19;HGS;POLB;PSMB9;KDM1B;ATXN3;UBE2D1;CCNA2;ASXL1;RIPK1;AR;MYC;YOD1;USP34;USP4;PSMA7;USP21;USP16;USP13;STAMBP;PSMD14;USP49;INO80E;TAF10;PSMA2;USP14;RHOA;HIF1A;PSMD11
prerank,histone H4-K5 acetylation (GO:0043981),0.38670778823994034,0.9307616714809569,0.528169014084507,0.9535853939789871,1.0,4/15,11.31%,OGT;WDR5;KANSL1;JADE1
prerank,histone H4-K8 acetylation (GO:0043982),0.38670778823994034,0.9307616714809569,0.528169014084507,0.9535853939789871,1.0,4/15,11.31%,OGT;WDR5;KANSL1;JADE1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.25177419559096426,-0.9307523008466275,0.5963636363636363,0.7938480508738807,1.0,9/57,10.07%,DAPK1;ARL6IP5;TNFSF10;MAP3K5;UACA;PPM1F;CASP8;BAD;PERP
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3024277629945583,-0.9305604810342873,0.5743073047858942,0.7935853477145295,1.0,13/24,32.92%,PPHLN1;PPM1D;JARID2;EZH2;TRIM27;RBBP7;DNMT3B;PHF1;MTF2;SPI1;BMI1;H3-3A;PHF19
prerank,regulation of organelle assembly (GO:1902115),-0.2379949314074042,-0.9305081405403025,0.594488188976378,0.7930201282265871,1.0,21/73,20.44%,TBC1D19;EZR;RABEP2;STX18;RDX;GSN;TBC1D8;TBC1D22B;RAB5A;IFT140;VPS11;TBC1D22A;CYLD;TBC1D10B;TBC1D13;MSN;NPM1;TBC1D14;PDCD6IP;TBC1D5;RAB1B
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.40049622994231426,0.9302814070787198,0.5678571428571428,0.9540690486107629,1.0,1/13,1.01%,VDAC2
prerank,neuron projection organization (GO:0106027),0.38160004115138413,0.929774552696384,0.5393634840871022,0.9545757806133199,1.0,3/15,9.06%,ABCD2;ATP1A3;LGMN
prerank,cobalamin metabolic process (GO:0009235),0.3723211081790384,0.929712935165473,0.5391014975041597,0.9539620588843283,1.0,4/17,17.19%,MMAB;MTRR;MMAA;MMUT
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3402659890064881,-0.9294324141797167,0.5561097256857855,0.7948869394932331,1.0,5/16,9.65%,CACNA1C;CAMK2D;CALM1;ANK2;DMD
prerank,positive regulation of receptor internalization (GO:0002092),-0.30872093895086794,-0.9293240097666924,0.5951742627345844,0.794497392820068,1.0,8/22,26.26%,MAGI2;INSR;CD63;EGF;TBC1D5;NTF3;GREM1;ARRB2
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.24575741130057635,-0.9291860875138388,0.599290780141844,0.7941534692902819,1.0,16/61,19.39%,EYA2;EYA1;EGFR;EYA4;RNF8;RTEL1;PCNA;BRCC3;SMCHD1;NBN;UBE2N;SIRT1;USP9X;PPP1R10;HGF;RGCC
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3724341775053554,-0.9286181563144462,0.5487528344671202,0.7948005638185237,1.0,8/11,34.43%,ITM2A;SOAT1;AGO2;ITM2B;BACE2;NECAB3;ITM2C;ABCA7
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3677039618414239,0.9285701405866145,0.5448613376835236,0.9560491470480275,1.0,2/18,2.66%,DLC1;ITGA3
prerank,negative regulation of angiogenesis (GO:0016525),0.2763329105167275,0.928108160714761,0.5746367239101717,0.9564179748469595,1.0,8/84,5.46%,DCN;SULF1;CXCL10;HRG;HSPG2;SPRED1;ADGRB1;SERPINF1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3502747282647038,0.928024191874341,0.5663865546218487,0.95585810613239,1.0,3/22,5.64%,AKAP5;ADGRV1;NF1
prerank,response to prostaglandin E (GO:0034695),-0.379864744363442,-0.9280119398263181,0.544468546637744,0.7955206788716009,1.0,4/10,23.89%,SFRP1;ADCY6;TGFBR3;CCL19
prerank,RNA interference (GO:0016246),-0.3385156898926703,-0.9274121474312422,0.5915841584158416,0.7962990273164957,1.0,8/17,19.18%,TSN;DICER1;DROSHA;NRDE2;CELF1;TERT;AGO2;CLP1
prerank,AMP metabolic process (GO:0046033),-0.35702281563462623,-0.9270800935981144,0.5580808080808081,0.7964653809379879,1.0,4/13,10.80%,AMPD3;ADSS2;XDH;NT5E
prerank,protein ubiquitination (GO:0016567),-0.18438967145492843,-0.927042896604065,0.8461538461538461,0.7958807221361098,1.0,101/471,17.48%,FBXL7;WWP1;RNF152;LMO7;UNKL;GAN;MGRN1;VCPIP1;RNF146;KLHL13;UBE2G1;ASB2;KLHL24;PSMC6;RNF43;PRKDC;RNF185;PELI1;PSMD9;WWP2;ARIH1;OTULIN;CDC23;UBE2D3;PSMF1;HIF3A;PSMB7;TRIM24;HLTF;TRIP12;TRIM25;CUL1;TRIM5;TRIM11;FBXL2;UBB;VPS18;TRIM14;TNKS2;SH3RF2;HERC6;RNF8;VCP;MSL2;UBE2H;MIB1;SMURF2;UBR1;TRIM36;UBA6;FBXO25;TSPAN17;PSMD8;RC3H1;FBXL19;PSMD12;UBE2A;RNF125;ASB5;KLHL20;RNF11;RNF144B;VHL;CUL9;RNF41;RNF114;SPSB4;UBR2;RCHY1;PCNA;HERC2;PSMA3;VPS11;PSMA6;TRIM63;PSMD4;PSME3;FBXL4;UBE3D;AMFR;PSMD7;UBE2N;CAND2;PSMB6;TRIM35;ELOC;PSMC1;FBXO32;TRIM27;UBE2L6;SIRT1;PSMB10;FBXL14;NEDD8;SIAH2;CUL3;ANAPC16;ISG15;ANAPC11;UBC;USP9X
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2918431811030425,-0.9269202177737635,0.5498575498575499,0.79553945285829,1.0,8/28,18.27%,EGFR;NOTCH3;WWP2;GATA2;NIBAN2;LFNG;AKT1;EGF
prerank,cardiac muscle cell action potential (GO:0086001),0.32702120592763995,0.9267543903109166,0.5614035087719298,0.9582699027443551,1.0,8/30,15.77%,ATP1A2;SCN2B;KCNIP2;CACNA1G;HCN2;FGF12;SCN1A;CACNA2D1
prerank,negative regulation of cellular component movement (GO:0051271),0.3922504750938447,0.9254596921672323,0.5511265164644714,0.9607776882932082,1.0,5/15,18.39%,SPOCK3;ACTN1;SP100;CRK;FBLN1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2539583741413302,0.9248151770240025,0.6115023474178404,0.9616711189857778,1.0,31/172,15.90%,LPIN3;PIK3R1;PLD1;PTEN;PIP4K2A;SACM1L;PIK3R2;MTMR4;CHAT;LIPH;MTMR1;RUFY1;PI4KA;DGKQ;PTPN13;CDIPT;PLEKHA1;INPP5J;CHKA;CPNE7;AGK;PTDSS2;MBOAT7;SELENOI;TAMM41;STARD10;GPAT3;PLA2G12A;LPIN2;ABHD4;CSNK2A2
prerank,response to steroid hormone (GO:0048545),-0.27738658114174225,-0.9247996780860642,0.6098265895953757,0.7998099020544145,1.0,7/31,12.90%,CAV1;THBS1;TGFB2;WBP2;PAQR7;ABHD2;NR3C1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.2614524703545689,0.9247660835507178,0.5866834170854272,0.9610091451066161,1.0,33/122,19.24%,IL33;SLC25A37;PRR16;PLD1;NAT10;EIF4A3;FMR1;MTPN;LARP6;IRS1;IRS2;RPS6KB1;NMD3;GLI1;MTOR;TLR4;GCK;PLXNB2;CDT1;IGF2;HNRNPD;DHX9;AR;MYC;NOX1;PPP1R3E;LDB1;EIF3C;KAT7;YTHDF1;ATAD5;PDGFRB;FXR1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.32175263939222826,0.9243758784349906,0.5557228915662651,0.9612203791963359,1.0,5/32,8.62%,PIK3R1;AUTS2;FSCN1;CARMIL2;CLRN1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.26658914577849463,0.9242985831682972,0.6047678795483061,0.9606029778225912,1.0,17/119,8.79%,PIK3R1;PIGV;PTEN;PIP4K2A;PIGQ;SACM1L;PIK3R2;MTMR4;EFR3A;MTMR1;RUFY1;PIGP;PI4KA;PTPN13;CDIPT;PLEKHA1;INPP5J
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.31469891378865106,-0.9235610305105486,0.5525,0.8020644954039455,1.0,4/20,6.79%,IL18;IL1R1;CD55;B2M
prerank,pharyngeal system development (GO:0060037),-0.33584018017355305,-0.9232685434903857,0.5880952380952381,0.8020457725199341,1.0,3/15,7.12%,BMPR2;TGFB2;TBX1
prerank,second-messenger-mediated signaling (GO:0019932),0.27949018116378666,0.9231123926415545,0.5809906291834003,0.9628624265473745,1.0,12/82,11.17%,EDN3;ACKR2;CCR9;RYR2;PDPK1;PPP1R9A;HTR2B;CAMKK2;LRRK2;KSR2;RCAN3;P2RX4
prerank,regulation of adaptive immune response (GO:0002819),-0.3297599024853618,-0.923093000103538,0.5846153846153846,0.8017875660382825,1.0,10/18,35.60%,IL6ST;IRF1;TRIM27;SIRT1;SKAP1;FCGR2B;IRF7;SAMSN1;FADD;IL4I1
prerank,glycerophospholipid catabolic process (GO:0046475),0.34115229707017825,0.9228603026304546,0.5718799368088467,0.9627110042433268,1.0,7/27,12.04%,PRDX6;LIPC;SMPD4;ENPP6;PLA2G7;ABHD16A;ABHD12
prerank,positive regulation of T cell differentiation (GO:0045582),-0.27835656060561775,-0.922819301515028,0.5770392749244713,0.8017670351308993,1.0,22/36,43.15%,LEF1;GLI2;SOX4;MDK;SART1;SOX12;CD46;RHOH;PNP;VSIR;NCKAP1L;IL7;SOCS1;NKAP;IL4I1;VNN1;ZBTB1;ZAP70;GATA3;TESPA1;IL12RB1;IL4
prerank,myeloid cell differentiation (GO:0030099),-0.2584553735142408,-0.9225066726983097,0.6,0.8018158918487577,1.0,24/47,32.46%,RPS14;RUNX1;SNRK;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;PRDX3;MFHAS1;KAT8;NCOA6;SPI1;JAK3;RASGRP4;KAT6A;ALAS2;CEBPA;HCLS1;EPO;ATP5IF1;CDKN2B
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.35830824544584283,-0.9222157447167774,0.5318627450980392,0.8017974401257616,1.0,3/13,13.12%,RNF152;SESN1;ATM
prerank,positive regulation of ERAD pathway (GO:1904294),-0.3537499489346759,-0.9220258264658339,0.5571095571095571,0.8015878424972219,1.0,2/13,3.70%,CAV1;RNF185
prerank,regulation of cell adhesion (GO:0030155),0.260062512117323,0.9218578395422695,0.5801242236024845,0.9644388287948733,1.0,15/129,8.66%,EPHA7;PLXNC1;ZFHX3;HRG;TMEM102;TGFBI;SEMA5A;ITGAV;SIPA1;DUSP1;PRKX;DSCAM;PTK2;PLAU;PRKCA
prerank,negative regulation of response to wounding (GO:1903035),-0.32741404724861134,-0.9217819010946449,0.5799522673031027,0.8014539698692166,1.0,6/19,11.41%,EPHA4;INPP5F;CD109;GIT1;SERPINE1;MDK
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.30652456556480345,-0.9216327968189767,0.5826330532212886,0.8011511288513863,1.0,9/22,29.85%,MINK1;XDH;GADD45B;MAP3K4;MFHAS1;GADD45G;SPI1;GADD45A;AGER
prerank,negative regulation of cell activation (GO:0050866),0.3894912645038862,0.9213883360110058,0.5478260869565217,0.9648143987002679,1.0,1/14,0.14%,PDGFRA
prerank,mononuclear cell differentiation (GO:1903131),-0.29964731826754465,-0.9209906057398111,0.5911458333333334,0.8019074236186822,1.0,2/24,0.90%,PIR;IL31RA
prerank,lymphocyte differentiation (GO:0030098),-0.24247726757936305,-0.9209515765991917,0.6136363636363636,0.8013358959036785,1.0,20/68,21.23%,PBX1;LEPR;PTPRJ;TPD52;ITGB1;HDAC4;SOX4;DNAJB9;PIK3CD;PTPN2;PLCG2;SLC25A5;LFNG;FLT3;VCAM1;HHEX;BLNK;NFIL3;KLF6;RHOH
prerank,regulation of cell cycle (GO:0051726),-0.1958171266627812,-0.9207730976121539,0.8,0.8011121210858934,1.0,76/271,22.17%,MECOM;APBB2;AFAP1L2;PTPRK;PPP1R13B;XIAP;THBS1;CDC14A;NOTCH2;MAGI2;IQGAP1;NEK6;NOTCH1;TGFB2;APC;CDK6;ADAM10;JMY;PRCC;PRDM11;SIK1;LRP6;TBRG1;PLAGL1;SMAD3;RPS15A;NEK7;MADD;CITED2;IRF1;SFRP1;NR4A1;PHACTR4;TARDBP;LIN52;MYBBP1A;GADD45B;HIPK2;ZBTB49;ATM;CYLD;GATA6;NBN;ING4;CCND1;CDKN1A;ERN1;ANKRD17;TRNP1;SIRT1;GPER1;DCUN1D3;CDK9;SETMAR;SDCBP;JUNB;WDR12;APBB1;PES1;RGCC;TXLNG;GADD45GIP1;CHMP1A;HBP1;GADD45G;SON;PIM2;RPL23;MIF;MAEA;RPRD1B;ZBTB17;BIRC3;FBXL8;NUPR1;CAMK2N1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3269436131617548,-0.9205972173476673,0.558974358974359,0.8008403928279882,1.0,4/17,5.89%,BAIAP2L1;TEK;NRP1;CDC42
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.26883377752293264,-0.9205881661887956,0.6323529411764706,0.8001951561771556,1.0,11/41,22.01%,IGF1;LBP;SIRPA;CD34;DICER1;CX3CL1;TRIM27;HAVCR2;TNFAIP3;SELENOS;ILRUN
prerank,C-terminal protein amino acid modification (GO:0018410),0.40675324880655717,0.9205288302663853,0.5663716814159292,0.966237610511044,1.0,3/11,15.83%,GPLD1;AGBL4;FOLH1
prerank,lipid droplet formation (GO:0140042),-0.3930348653235432,-0.9195120929413557,0.5849056603773585,0.8019448153529144,1.0,4/10,23.41%,CDS1;CDS2;PLA2G4C;FITM2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.2712280357749082,-0.9193171769354118,0.5568862275449101,0.8017161501381207,1.0,18/40,23.63%,LEF1;FOXC1;NOTCH1;TGFB2;DAB2;SMAD3;BCL9L;MDK;EZH2;PDPN;TGFB1I1;SNAI1;SDCBP;RGCC;TGFBR2;TIAM1;WWTR1;AXIN2
prerank,UV protection (GO:0009650),0.4278380931451856,0.919304916364543,0.5743879472693032,0.9684974544542145,1.0,3/10,4.93%,FEN1;ERCC5;MFAP4
prerank,cellular amide metabolic process (GO:0043603),-0.2219892530196947,-0.9191112462347211,0.6877828054298643,0.8015575515208248,1.0,12/102,6.65%,AEBP1;ST6GAL1;PLPP3;CPE;CPD;SLC25A32;PCCA;SMPD3;ACOT8;ST3GAL1;PPP2R1A;AASDHPPT
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.225880063783383,-0.9188482199822882,0.6367521367521367,0.8015159469802821,1.0,46/91,33.10%,ABCG2;APP;HMOX2;CUL1;TFRC;SLC39A8;SLC31A2;SCARA5;SLC39A10;MT2A;ACO1;CYB561A3;SLC30A9;FLVCR1;NEDD8;FTL;HFE;GLRX3;ATP6V0A2;SLC40A1;BOLA2;NUBP1;ATP6V1G1;FTH1;CCDC115;SLC11A2;MT3;TMEM199;SMAD4;ARF1;ATOX1;SLC11A1;ALAS2;LCN2;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;IREB2;HMOX1;BMP6;SLC30A1
prerank,regulation of cellular component movement (GO:0051270),0.3011393037415722,0.9187293780942303,0.5788712011577424,0.9691201666332873,1.0,11/49,14.06%,NRG1;MYCBP2;ERBB4;NRG2;ZSWIM8;ACTN1;NRG4;SP100;TGFBR1;MEMO1;LYN
prerank,gas transport (GO:0015669),0.4127181442883304,0.9187124222935317,0.5551782682512734,0.9683932130376912,1.0,2/10,15.40%,MB;MYC
prerank,regulation of mast cell activation (GO:0033003),0.42139449964653025,0.918648741678051,0.5748709122203098,0.9677814407750044,1.0,5/10,28.66%,TSLP;LYN;NECTIN2;MILR1;PLSCR1
prerank,cilium organization (GO:0044782),0.24788194997919863,0.9184779286406106,0.6394948335246843,0.9674599715023199,1.0,52/210,20.83%,DYNLL1;CDC14B;TRAF3IP1;DZIP1;NPHP3;WDPCP;WDR35;GBF1;CCDC57;RAB8A;DISC1;IFT81;FAM161A;KIFAP3;SNAP29;CCDC65;AHI1;TCTN2;IFT74;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;IQCB1;SSX2IP;RFX2;IFT88;RAB11FIP3;CEP126;SCLT1;TXNDC15;ACTR2;FAM161B;DYNLL2;CEP250;PTPDC1;IFT43;CLUAP1;BBS1;PCM1;ATP6V0D1;WDR90;MKS1;CEP19;NUDCD3;DZIP1L;UNC119B;KIF3A;TTC39C;BBS4;ABLIM3
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3407460015794461,-0.9183331702262229,0.5863874345549738,0.8020453044211069,1.0,7/18,22.28%,RNF185;UBB;AMFR;UBC;RNF5;UGGT1;UBA52
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3675631749774348,0.9181689525839747,0.5684575389948007,0.9674488152612809,1.0,8/18,23.86%,CRTC2;ADCY8;PRKD1;RELN;EPHA5;CRTC3;CAMK1D;ADCY1
prerank,regulation of centrosome cycle (GO:0046605),0.3525656843210869,0.917734726695091,0.5678807947019867,0.9677920491953176,1.0,2/21,2.23%,ATF5;NAT10
prerank,receptor-mediated endocytosis (GO:0006898),0.26168719726937845,0.9176589822712176,0.6171497584541062,0.9671930200541136,1.0,12/132,6.29%,COLEC12;LRP1;LRP1B;HSPG2;CALCRL;MASP1;LRP3;SORL1;NEDD4;FCHSD2;EPS15;TMEM108
prerank,regulation of innate immune response (GO:0045088),-0.2506029878822451,-0.917325059905483,0.6212624584717608,0.8037125802008265,1.0,14/57,15.89%,XIAP;SAMHD1;ERAP1;NMI;GBP5;IFI35;CASP8;IRF1;PTPN1;PARP9;RIOK3;POLR3G;RNASEL;POLR3D
prerank,endosome organization (GO:0007032),-0.2599949411897963,-0.9173096605013317,0.5891238670694864,0.8030830046310937,1.0,15/41,26.06%,EEA1;LAPTM4B;SQSTM1;CHMP2B;VPS18;HOOK1;ALS2;VPS11;TMEM9;SNX3;PLEKHJ1;EXOC8;DNAJC13;WASHC4;ALS2CL
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2603751253634338,-0.9171458599356475,0.6401273885350318,0.8027688051741972,1.0,13/41,21.65%,RNF152;UBE2G1;PELI1;WWP2;TRIM5;RNF8;ZFP91;UBE2N;TRAF3;TRIM27;PRPF19;RNF5;TRAF1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2515386450578713,-0.9171374785734153,0.6496598639455783,0.8021237149044038,1.0,12/52,12.98%,PPP1R13B;ATG13;SREBF2;UBE2D3;YWHAB;YWHAG;CASP8;BAD;PPP3CC;PPP3R1;BID;VPS11
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.3786670663656079,-0.9168814054235936,0.5586854460093896,0.8020696224018821,1.0,2/11,3.97%,GSN;FAS
prerank,ncRNA metabolic process (GO:0034660),-0.26927056151099293,-0.9166086825173951,0.6158536585365854,0.8020319078141789,1.0,10/37,19.80%,DGCR8;TUT7;PARN;DICER1;DROSHA;MAPT;RAN;NIFK;AGO2;MEPCE
prerank,regulation of cell cycle phase transition (GO:1901987),0.27308834180384883,0.9162882825609757,0.603112840466926,0.9698122923537533,1.0,24/91,18.81%,BUB1B;PSMD1;FBXO5;CDC16;PSMD10;PSMA5;PSMB5;XPC;PSMC4;TP53;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;DBF4;ERCC2;TFAP4;MN1;PSMA7;PSMD14;CDC26;PSMA2;PSMD11
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.38561687165077785,-0.9162643760755717,0.5951807228915663,0.802125474410893,1.0,5/10,25.65%,UPP2;UPB1;NT5E;NT5C1A;NT5M
prerank,positive regulation of insulin secretion (GO:0032024),0.3157488020293851,0.9162522278570622,0.5893939393939394,0.9691348919577972,1.0,8/36,10.49%,TCF7L2;GPLD1;TM7SF3;IRS2;ADCY8;TRH;GCK;PPP3CB
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.30708915976403567,0.9162243163916541,0.5885885885885885,0.9684400038397459,1.0,11/41,18.74%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.3841374231248588,0.9161727721309163,0.5621716287215411,0.9677922214196705,1.0,4/14,14.26%,ANK3;SLC9A1;TESC;WNK2
prerank,isotype switching (GO:0045190),-0.37387128206907055,-0.9159747199812989,0.5661252900232019,0.8021081032225801,1.0,6/10,28.08%,RNF8;EXOSC3;BATF;HSPD1;LIG4;MSH2
prerank,positive regulation of type 2 immune response (GO:0002830),0.3856943681127326,0.9159017635101037,0.5618181818181818,0.9676896026493653,1.0,3/14,12.94%,XCL1;CD86;CD81
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.33015705090837133,-0.9157385284222512,0.575197889182058,0.8020186582013162,1.0,6/17,16.14%,ERLIN1;SREBF2;APOE;FGF1;RAN;PRKAA1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.29436346319811135,0.9153586884404862,0.5852981969486823,0.9682481058144092,1.0,15/53,20.27%,GLMN;DNAAF4;FMR1;PINK1;PRKACA;COMMD1;OPHN1;PSMC5;USP19;ARAF;PSMD14;USP14;DDRGK1;XPO1;PRKCG
prerank,cellular response to unfolded protein (GO:0034620),-0.2904220053685854,-0.9151403693260579,0.6025974025974026,0.8027380698258816,1.0,12/26,25.76%,TMBIM6;HSPA8;HSPB8;BAX;PTPN1;OPTN;BAG3;ERN1;ABCB10;HSPD1;HSPA14;HSPA1A
prerank,response to estradiol (GO:0032355),0.32403064386791863,0.9146843939304327,0.5795795795795796,0.9691119725863626,1.0,3/31,4.54%,GGT5;GGT7;NCOA3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3680572461688664,-0.9144446406799147,0.5817307692307693,0.803700639017051,1.0,5/11,26.10%,MAVS;TICAM1;TYROBP;ITGB2;SPI1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),-0.2907682147903017,-0.9137354043296938,0.591044776119403,0.8046363019885988,1.0,11/27,25.60%,CTPS1;CTPS2;DTYMK;AK2;RRM2B;GUK1;TYMS;AK6;AK5;TXNRD1;AK7
prerank,glycerolipid catabolic process (GO:0046503),-0.3215766091634418,-0.9136097488146643,0.574468085106383,0.8042667229009147,1.0,5/19,9.86%,GPCPD1;PLA2G4A;MGLL;GDPD3;ABHD2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.22112790508667815,-0.9135498330755314,0.6785714285714286,0.803766272210909,1.0,32/93,24.82%,PLCB1;CCN2;ARL6IP5;TPD52L1;APP;MAP3K5;TGFB2;MINK1;FZD7;SH3RF2;XDH;GADD45B;HIPK2;FLT4;PTK2B;WNT16;MAP3K4;MAPK8IP1;STK25;TRAF3;MAP3K10;SDCBP;MFHAS1;GADD45G;DUSP19;TRAF1;MID1;CCL19;EDAR;TAOK2;NOD2;CD27
prerank,metallo-sulfur cluster assembly (GO:0031163),0.34710377928075886,0.9135074122356558,0.5662650602409639,0.9712888496698755,1.0,6/22,16.72%,NUBP2;FXN;CIAO1;ABCB7;MMS19;ISCA1
prerank,negative regulation of transport (GO:0051051),0.2990982862429128,0.9133434609142878,0.5887323943661972,0.9709245614647664,1.0,10/51,16.07%,NRG1;PTEN;ITGAV;NR1H2;PRKD1;EPHA3;NDFIP2;SNX12;PACSIN3;NDFIP1
prerank,histone H4 acetylation (GO:0043967),0.2970698574479963,0.9132895750921726,0.5683139534883721,0.9702901816265219,1.0,12/47,15.32%,OGT;MORF4L1;KMT2A;BRD8;WDR5;MSL1;BRCA2;KANSL1;JADE1;EPC1;DMAP1;ATF2
prerank,linoleic acid metabolic process (GO:0043651),0.36955397853474903,0.9131098941393392,0.5795847750865052,0.9699798347454491,1.0,4/17,21.94%,ELOVL2;ELOVL1;ALOX5;ELOVL5
prerank,gonad development (GO:0008406),0.30597185398132043,0.9128957962409032,0.5652818991097923,0.9697300270674718,1.0,4/41,2.53%,WNT5A;NR2F2;BASP1;SALL1
prerank,spermatid development (GO:0007286),0.325646163332835,0.9124556224847121,0.5587301587301587,0.9700540782566525,1.0,5/32,13.34%,CCDC63;SYCP3;RFX2;DPY19L2;ZMYND15
prerank,positive regulation of cell killing (GO:0031343),0.39120599312899434,0.9123654433567826,0.5583482944344704,0.9695313798030113,1.0,4/13,20.74%,WNT5A;CYBA;NOX1;DVL2
prerank,proteasome assembly (GO:0043248),-0.3836199175182535,-0.9122535121281048,0.5750577367205543,0.8061092813978642,1.0,5/11,22.97%,PSMD9;PSMG2;PSMD4;POMP;ADRM1
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.35558708996043453,-0.911851849569,0.5687645687645687,0.8064149001555982,1.0,7/12,31.26%,ACO1;ACO2;ASS1;IDH3B;IDH3A;IDH2;IREB2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4154843172221534,0.9112384398765034,0.5754385964912281,0.9715952626689289,1.0,2/10,6.33%,ACADL;ACADS
prerank,cellular response to lipopolysaccharide (GO:0071222),0.26763334974593317,0.911184029536757,0.6088082901554405,0.9709674123358666,1.0,14/101,12.41%,CXCL10;WNT5A;CXCL1;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,positive regulation of proteolysis (GO:0045862),0.2910857152789868,0.9110562334793832,0.5945558739255015,0.9705281554061304,1.0,15/55,19.56%,OGT;GPLD1;CAPN3;PINK1;NKD2;NRDC;RCN3;ASPH;SH3D19;BAK1;PACSIN3;ADAM8;ADRA2A;MAPK12;RHBDD1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.35193869750934764,0.9106535821467547,0.5669421487603306,0.9707919078059337,1.0,3/20,5.53%,PLA2R1;CD40;PRKCI
prerank,cellular response to interleukin-6 (GO:0071354),-0.2946029188943592,-0.9106355554250603,0.6195372750642674,0.808561232954228,1.0,4/26,5.51%,ST3GAL6;FER;NFKB1;IL6ST
prerank,RNA processing (GO:0006396),0.24837499223660317,0.9105936150888884,0.6431980906921241,0.9701783667102555,1.0,49/176,22.68%,RBMS1;GEMIN2;NOVA1;ADARB2;SNRNP35;ZRSR2;NOL3;LIN28B;LSM4;ELAVL4;BCAS2;HNRNPA2B1;MRPL44;SRSF11;MPHOSPH10;TENT4B;PRKACA;SMU1;DDX17;RP9;SLU7;NUDT21;NOL9;SNRNP48;TENT2;PRPF18;HNRNPUL1;HNRNPD;SNRPF;ADAR;SRSF9;RBM5;NONO;HNRNPL;SF3A3;PPIG;DEDD2;ZCRB1;RBM6;LUC7L3;PRPF8;TFIP11;DDX39B;RBPMS;DHX15;RNGTT;WBP4;HNRNPH3;LSM3
prerank,regulation of defense response (GO:0031347),-0.23194128511889112,-0.9105474360534438,0.6679841897233202,0.8081012476588817,1.0,38/76,30.15%,FOXP1;XIAP;SEMA7A;SAMHD1;IL1R1;ERAP1;MGLL;ANXA1;APOE;CELF1;CASP8;IRF1;LACC1;ELMOD2;PSMA6;CYLD;AGTR1;TMSB4X;TRAF3;PTGS2;ACE2;USP18;SHPK;BIRC3;BCL6B;NOD2;PIK3AP1;TKFC;HCK;PARK7;SBNO2;ZBP1;CASP1;FCGR2B;GGT1;LRP8;LRRC19;CCR2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3520903713665708,0.9099398139007018,0.5945945945945946,0.9710414862555932,1.0,6/21,16.20%,RAB34;GLI1;GAS8;TXNDC15;EVC;PDCL
prerank,positive regulation of gene expression (GO:0010628),0.23418945277665504,0.9097650623346032,0.7212249208025343,0.9707255143205606,1.0,96/442,19.53%,IL33;SEC16B;NTRK3;PIK3R1;PRR16;WNT5A;NTRK2;PLD1;TXK;PLA2R1;NAT10;LRP3;EIF4A3;AGO4;GLMN;LURAP1;GJA1;POU3F3;RBM24;ANK3;HTR2B;RBMS3;PTPN22;FMR1;TLR6;LARP6;MYCN;CDH3;ADAM19;RIMS2;ELAVL4;PDCL3;C1QTNF1;POLR1A;DGKQ;RPS6KB1;TWIST1;TENT4B;MTOR;TLE1;TLR4;BMP7;KAT2A;WNT3;MAP2K1;FGR;TAF1D;EIF2AK2;TP53;TAF1B;DHX36;RIMS1;AGO3;PLXNB2;TGFBR1;SOX9;HGS;RBM20;GSK3A;FAM98B;OLFM1;TESC;MED1;CUX2;ACTG2;SNF8;RIPK1;FGF5;HNRNPD;CLU;AR;ATF2;MYC;TNRC6B;HNRNPLL;MAPK11;PIK3CG;MAZ;PTGER4;LGALS9;ADRA2A;AGO1;EIF3C;MYD88;HABP4;BMP2;HEY1;YTHDF1;HIF1A;SPRY2;MBIP;EIF2AK3;FXR1;PIK3R3;SP1;DDRGK1
prerank,positive regulation of catabolic process (GO:0009896),-0.2386201023983923,-0.9091639974807022,0.6444444444444445,0.8105942253889815,1.0,11/65,11.30%,FOXO1;WWP1;WWP2;GPC3;APC;GSK3B;VCP;SMURF2;ASB5;RNF41;APC2
prerank,nuclear membrane disassembly (GO:0051081),0.3861571143761061,0.9090828703240408,0.5763888888888888,0.9716105666321182,1.0,5/14,17.70%,CCNB2;PRKCA;PRKCB;VRK1;CTDNEP1
prerank,glutathione metabolic process (GO:0006749),0.3097168305315541,0.9090434268158241,0.6106060606060606,0.9709705549855218,1.0,3/38,7.44%,GGT5;GGT7;GSTA3
prerank,negative regulation of translation (GO:0017148),0.2733045913852939,0.90870549371489,0.6179921773142112,0.9710163943592033,1.0,23/87,19.24%,CPEB1;EIF4A3;NANOS3;EPRS1;RBM24;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;FTO;MALSU1;EIF4ENIF1;PUS7;CNOT7;TSC1;IGF2BP3;CALR;ILF3;YTHDF1;EIF2AK3;FXR1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.32088269176426476,-0.9084470314244925,0.5700712589073634,0.811548352532141,1.0,3/17,7.53%,MAGI2;CALM1;ITGA1
prerank,negative regulation of RNA splicing (GO:0033119),-0.3149422193168568,-0.9083341275712141,0.6307277628032345,0.8111302980046423,1.0,5/19,16.15%,TMBIM6;PTBP3;RBMX;SRSF4;SRSF7
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.31461138334127864,0.9082779230964549,0.5949926362297496,0.9713060344096943,1.0,10/38,16.74%,MICALL2;LRRK2;PINK1;SAE1;HTRA2;GSK3A;RNF31;SREBF1;CSNK2A2;HAX1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3277405335063943,0.9082425751629405,0.5516693163751988,0.970636694898468,1.0,5/30,13.17%,PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,ATP transport (GO:0015867),-0.3829453626092541,-0.9082314795960418,0.603448275862069,0.8107028765831763,1.0,4/10,25.67%,ABCC6;SLC25A5;SLC17A9;SLC25A4
prerank,regulation of fibroblast proliferation (GO:0048145),0.30363719850081367,0.9081573221318916,0.5768115942028985,0.9700756368998709,1.0,10/45,16.18%,PDGFRA;WNT5A;PEX2;NF1;TP53;B4GALT7;MED25;DHX9;MYC;NDUFS4
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2769459002012404,-0.9078162048286119,0.6158357771260997,0.8109979971684834,1.0,11/33,22.71%,PICALM;ACTN2;GOPC;STX3;TOR1A;KCNAB2;HFE;EGF;TAX1BP3;RAB11FIP5;TYROBP
prerank,neuron differentiation (GO:0030182),0.24940903795084077,0.9076968500039114,0.6560283687943262,0.9705183254268892,1.0,21/165,12.13%,ISL2;RUNX2;TENM3;WNT5A;NTRK2;MYO7A;MYEF2;TENM4;MTPN;TENM2;SRF;SNPH;OLIG2;TENM1;BHLHE22;WNT3;MAP2K1;OPHN1;SMARCA1;TGFBR1;MYT1L
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3035678653357808,0.9074220729487718,0.5848527349228612,0.9704336865475334,1.0,11/42,14.01%,POLK;POLA1;CDKN2D;RPA1;RFC3;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3424057312145404,-0.9072430968131963,0.5900900900900901,0.8117069358058229,1.0,8/13,27.18%,SERTAD1;ARID1B;SMARCD1;ELOF1;PADI2;SPI1;CDCA4;CHEK1
prerank,ether lipid metabolic process (GO:0046485),0.3796711423569551,0.9070318599214469,0.5627118644067797,0.9706634398327494,1.0,3/14,9.68%,PEX7;PLA2G7;AGMO
prerank,glycolipid biosynthetic process (GO:0009247),0.3153872555379158,0.9063704316441054,0.5828313253012049,0.9715154971455391,1.0,6/38,13.17%,ST8SIA1;PIGV;PIGQ;PIGP;PIGA;PIGL
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.35616920380283884,0.9062161932195413,0.5917065390749602,0.9696206619613127,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.35616920380283884,0.9062161932195413,0.5917065390749602,0.9696206619613127,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.35616920380283884,0.9062161932195413,0.5917065390749602,0.9696206619613127,1.0,8/20,24.60%,BUB1B;TEX14;BUB1;CENPF;KLHL22;TRIP13;MAD2L1;KNTC1
prerank,lipid homeostasis (GO:0055088),0.28697615825856576,0.9059309391626565,0.6127247579529738,0.969588721067925,1.0,10/57,19.41%,ZBTB20;ACOX2;TLCD3B;IRS2;RCN3;FABP3;ABHD4;NR1D2;ORMDL3;ABCA2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.3181448320907095,0.9056493552814912,0.5881458966565349,0.969516639281883,1.0,2/35,0.27%,PDGFRA;NTRK3
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.2786066939579068,0.9047561057403661,0.625170998632011,0.9709017752056249,1.0,13/73,17.31%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;CD86;RIPK1;DHX9;CLU;TIRAP;LGALS9;ADAM8
prerank,protein import into peroxisome matrix (GO:0016558),0.3891697069067277,0.9046595424347316,0.5796064400715564,0.970394073024745,1.0,5/12,18.90%,PEX2;PEX7;PEX12;PEX14;PEX6
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3801832210348558,0.9045974024535212,0.5707317073170731,0.9698016081242979,1.0,5/14,20.85%,XCL1;HMCES;PAXIP1;RIF1;NECTIN2
prerank,nuclear export (GO:0051168),0.27288866924931166,0.9044041779401993,0.6112565445026178,0.9695526224158526,1.0,22/80,20.64%,CSE1L;EIF4A3;ANKLE1;NUP214;NUTF2;POM121;THOC7;SRSF11;SLU7;NUP42;RANBP3;CASC3;STRADB;SRSF9;THOC5;CALR;XPO6;SRSF6;NUP155;CHTOP;XPO1;DDX39B
prerank,B cell homeostasis (GO:0001782),0.408744651626441,0.9038767543824695,0.5813953488372093,0.9700953987987444,1.0,1/10,0.78%,DOCK10
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.2713470397199961,0.9038331129659467,0.6161335187760779,0.9694685173750459,1.0,9/78,6.24%,LRP1;PIK3R1;AKAP5;ITGA3;DPP10;SPTBN1;PDPK1;PRKCI;CLIP3
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.2362028262176647,-0.9038188158247621,0.6777777777777778,0.8189418810710468,1.0,22/62,27.47%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;GTF2F2;CTDP1;ELOF1;TCEA1;POLR2I;POLR2K
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2838130677642258,0.9037714456472554,0.610719322990127,0.9688645806864918,1.0,14/70,14.06%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2445644474165053,-0.9037688842382033,0.6498422712933754,0.818416365990932,1.0,12/48,20.68%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;PLA2G6;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,cortical cytoskeleton organization (GO:0030865),0.3096124150336048,0.903335334548077,0.5805970149253732,0.9691589836371259,1.0,6/41,7.23%,EPB41L3;RND3;RAC3;LLGL1;FMNL2;RHOBTB3
prerank,response to metal ion (GO:0010038),0.2803640437860978,0.9028408246163006,0.6108843537414966,0.969546069504861,1.0,9/67,9.59%,PAM;LOXL2;SLC30A5;NEDD4;KCNMA1;CAPN3;FXN;TRPC3;SLC30A3
prerank,copper ion transport (GO:0006825),0.3996850055923352,0.9026183681423593,0.5611015490533563,0.9693628964576897,1.0,5/11,25.21%,STEAP3;ATP7A;STEAP2;COX17;CUTC
prerank,glycoprotein metabolic process (GO:0009100),-0.24772750641337232,-0.9025522992670186,0.6168831168831169,0.8205045360776018,1.0,17/53,20.54%,FUT8;ST8SIA4;ST3GAL4;B4GALT5;OGA;ST6GALNAC3;LARGE1;MANBA;NGLY1;MGAT4B;ST8SIA2;ST3GAL2;GCNT1;MAN2A1;STT3B;GAL3ST2;MAN1A2
prerank,negative regulation of cell development (GO:0010721),-0.2915957046945258,-0.9022313185247939,0.6082191780821918,0.8205905396780176,1.0,4/25,7.28%,IGF1;NOTCH1;B2M;GSK3B
prerank,lipid droplet organization (GO:0034389),0.33974423414027105,0.9021010607649114,0.5746753246753247,0.9698017099981117,1.0,3/22,8.09%,PPID;CIDEA;BSCL2
prerank,dicarboxylic acid transport (GO:0006835),0.3154308859301541,0.9020338857215517,0.5975422427035331,0.9692203944332718,1.0,2/28,3.75%,SLC1A3;GJA1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.35844108707740074,0.9018766263212721,0.5882352941176471,0.9688654538066863,1.0,4/19,10.49%,EDN3;NFATC3;ADGRB2;PPP3CB
prerank,calcium ion transport into cytosol (GO:0060402),0.34149583522399046,0.9018354726599512,0.5849673202614379,0.9682201268617375,1.0,5/21,15.77%,GRIN2B;RYR2;GRIN2A;TRPM2;CACNA2D1
prerank,ketone body metabolic process (GO:1902224),-0.3728988196410939,-0.9015129884431412,0.5853658536585366,0.8215456047881223,1.0,6/10,17.18%,BDH2;BDH1;ACAT1;OXCT1;HMGCLL1;HMGCS2
prerank,inositol phosphate catabolic process (GO:0071545),0.3968419740094937,0.9014943882474552,0.5941780821917808,0.9682989012745817,1.0,2/12,8.79%,PTEN;INPP5J
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2829756423517999,0.901395537400712,0.6175637393767706,0.9678111446612451,1.0,14/71,14.06%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.38642192290103605,0.9007711364884955,0.5789473684210527,0.9685671720018536,1.0,4/13,9.06%,AKAP5;ADCY8;RELN;LGMN
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34913815342019505,0.9006943032936419,0.5748407643312102,0.9680026505935178,1.0,2/20,2.78%,RUNX2;SMAD5
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2666503381868975,0.9000857627257888,0.6390685640362225,0.9687336204564811,1.0,13/95,12.41%,CXCL10;WNT5A;CXCL1;PDE4B;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;CD86;PDCD4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2602287497172718,-0.8996891950533848,0.6697247706422018,0.8250397293871239,1.0,11/43,22.01%,IGF1;LBP;SIRPA;CD34;DICER1;CX3CL1;TRIM27;HAVCR2;TNFAIP3;SELENOS;ILRUN
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.33124063569174644,0.8995549380679189,0.5881435257410297,0.9692279736053269,1.0,7/27,12.81%,PLA2R1;SPRED1;PSMD10;SPRED2;TWIST1;MSX1;PTTG1IP
prerank,dendritic cell migration (GO:0036336),0.36671485064412374,0.8994026935809627,0.60580204778157,0.9688731975677612,1.0,6/16,25.54%,GPR183;TRPM2;PIK3CG;ALOX5;HMGB1;CCR5
prerank,erythrocyte differentiation (GO:0030218),-0.2559316547214028,-0.899011419676172,0.6323529411764706,0.8259148436231138,1.0,13/44,21.82%,RPS14;ALAS1;RPS19;CASP3;PTPN2;FLVCR1;HIPK2;SLC25A5;TAL1;ABCB10;TGFBR3;MFHAS1;DMTN
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3420071828456719,0.8989221153771325,0.603448275862069,0.9692830436712297,1.0,2/26,2.01%,ZFYVE28;CBLB
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3365156490111891,-0.8986583104152834,0.6044776119402985,0.8260400521987948,1.0,2/15,2.98%,LEF1;SMARCA4
prerank,positive regulation of vacuole organization (GO:0044090),0.41350828343163504,0.89832717702555,0.5968028419182948,0.9699660806942559,1.0,1/10,2.30%,PIP4K2A
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.37322542918837315,-0.8981963456027201,0.5908045977011495,0.8257704459352745,1.0,2/10,5.89%,APC;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.37322542918837315,-0.8981963456027201,0.5908045977011495,0.8257704459352745,1.0,2/10,5.89%,APC;CDC42
prerank,regulation of lipase activity (GO:0060191),-0.3550180156141656,-0.8981118730999845,0.6083916083916084,0.8252830095741316,1.0,4/13,15.69%,RHOC;LMF1;FURIN;PCSK5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.348005305251218,-0.8974788901775314,0.5871121718377088,0.8260222760155734,1.0,4/13,9.87%,MEF2C;RBPJ;NOTCH1;TBX2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.39022138059971745,0.8973714123827978,0.5956678700361011,0.9715044126605838,1.0,1/12,0.55%,PIK3R1
prerank,negative regulation of B cell activation (GO:0050869),-0.3094750417371879,-0.8973503122797813,0.5956416464891041,0.8256277379108398,1.0,10/21,33.49%,RC3H1;SFRP1;ATM;LAPTM5;TNFAIP3;TYROBP;FCGR2B;BANK1;SAMSN1;FOXJ1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.25403250388330106,0.8972390230347244,0.6505441354292624,0.9710635534920328,1.0,22/132,13.02%,DCN;ZBTB20;PPARA;GPLD1;ABCD2;PFKFB1;TPCN1;NPRL2;ENTPD5;ZSWIM8;IRS1;LRRK2;LIN28B;IRS2;TWIST1;PRKD1;TRIM8;NRDC;TFEB;GSK3A;PTTG1IP;CNOT1
prerank,ruffle organization (GO:0031529),-0.33011244239537374,-0.8972225585280198,0.6048780487804878,0.8252497037642764,1.0,6/16,23.71%,TPM1;RAC1;LIMA1;PIP5K1A;CSF1R;CORO1B
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.22700689486936645,-0.8971938864843192,0.7258064516129032,0.8246463159934461,1.0,12/76,14.38%,NR3C2;EGFR;EZR;APP;NMI;UACA;CCN3;IFI35;NFKBIA;TRIP6;CYLD;TMSB4X
prerank,telomere maintenance (GO:0000723),-0.25070325194182747,-0.8969196206742667,0.6772151898734177,0.8245776475418624,1.0,24/50,30.56%,PTGES3;PRKDC;ATR;RTEL1;TERT;PCNA;STN1;ATM;TEN1;NBN;RAD51D;DCLRE1B;HUS1;POLD2;PARP1;RPA2;ACD;RAD51;LTO1;POLD4;POLD1;CTC1;RAD50;XRCC3
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2923532397585328,0.8967543549411896,0.6106870229007634,0.9714751105457854,1.0,11/45,16.57%,NANOS3;SPOUT1;GCNT2;MTPN;ZC3H7B;NUDT21;GRM5;RBM4B;ATG14;TSC1;CYFIP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2794684452575469,0.8966836147627109,0.6284916201117319,0.9708925388080565,1.0,14/73,14.06%,PIK3R1;WIPF1;MYO10;PIK3R2;ELMO1;LIMK1;PTK2;WIPF2;FGR;FYN;MYO1G;ACTR2;CRK;LYN
prerank,DNA metabolic process (GO:0006259),0.2378387607869184,0.8966366197211897,0.7087912087912088,0.9702806806166601,1.0,72/270,22.46%,TCF7L2;POLG;ERCC1;LIG3;MCM7;FAN1;FEN1;POLK;POLQ;TOP2B;ERCC5;FANCA;CDC7;MSH3;ASF1A;NEIL3;POLA1;GMNN;RPA1;ERCC4;TERF1;POLL;XPC;SP100;POLE4;RFC3;UBE2V2;NOC3L;MCM4;POLH;RECQL;TOP3A;GTF2H3;MUTYH;CDT1;XRCC1;POLB;POLE3;RAD52;ALKBH3;MBD4;LONP1;POLI;MCM10;DBF4;DOT1L;RNASEH1;GTF2H1;CSNK1E;ORC2;MMS19;SMARCAL1;TOP2A;SMC1A;MSH6;WRN;REXO4;RIF1;TERF2IP;CNBP;POLE;USP45;MEN1;DDB1;ORC5;RFC4;TOPBP1;RAD54L;PWWP3A;HMGB1;KPNA2;FANCC
prerank,regulation of cilium assembly (GO:1902017),-0.2372520639368459,-0.8966312172136811,0.6618181818181819,0.824580330855956,1.0,14/62,15.40%,TBC1D19;RABEP2;MARK4;TBC1D8;TBC1D22B;IFT140;CCDC88A;TBC1D7;EVI5L;TBC1D22A;CYLD;TBC1D10B;CROCC;TBC1D13
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.2413011092947301,0.8963937993641968,0.6863636363636364,0.970124470646757,1.0,45/234,17.82%,ROR1;EDA2R;EDA;WNT5A;PTEN;CD40;MBTPS2;IL18RAP;TAF12;JUP;TLR6;MTPN;PRKCI;CRTC2;ADCY8;CAPN3;SRF;FLOT2;TRIM37;PRKD1;RELN;TRIM8;PRKCB;TLR4;IL1RAP;IRAK1;EIF2AK2;PYCARD;RTKN2;ESR2;RNF31;UBE2V1;EPHA5;RIPK1;DHX9;CLU;AR;ATF2;TIRAP;ZBTB7A;TRIM26;LGALS9;ADAM8;MYD88;CAMK2A
prerank,modulation by host of viral genome replication (GO:0044827),-0.35434445248841506,-0.8962944704093322,0.6173708920187794,0.8247174695701198,1.0,3/13,7.47%,FBXL2;VAPA;IFI27
prerank,heterotypic cell-cell adhesion (GO:0034113),0.33822630961880285,0.8961661953172725,0.6025848142164781,0.9699233186478083,1.0,5/25,8.36%,ITGAD;ITGAV;JUP;JAM3;CD200R1
prerank,cellular zinc ion homeostasis (GO:0006882),0.3269689244184592,0.8961367332801644,0.5955766192733017,0.9692782369803739,1.0,3/26,4.66%,SLC30A10;SLC30A5;SLC39A7
prerank,negative regulation of neuron projection development (GO:0010977),-0.24363432286020795,-0.8960291237136668,0.6764705882352942,0.8246716303882922,1.0,11/56,13.30%,EPHA4;DPYSL3;EFNB2;RUFY3;KANK1;PRAG1;APOE;NGEF;ADCY6;GAK;TRPV4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.25174378491349925,0.8959940800522623,0.6485207100591716,0.9688897406893325,1.0,33/146,18.81%,DYNLL1;PSMD1;DCTN3;HAUS3;HAUS1;FBXO5;CDC7;HMMR;DCTN2;PSMD10;PSMA5;PSMB5;HAUS8;PRKACA;CEP192;CEP135;PSMC4;PSMA4;SSNA1;PSMC5;PSMB9;CEP250;CEP152;CSNK1E;CENPF;CLASP1;PSMA7;PSMD14;VPS4B;ALMS1;PCM1;PSMA2;PSMD11
prerank,polyamine metabolic process (GO:0006595),0.37669625068979556,0.8957519094651082,0.5893470790378007,0.9686919264303471,1.0,3/13,13.65%,ODC1;HDAC10;DHPS
prerank,regulation of peptidase activity (GO:0052547),-0.3160203845692531,-0.8954591231296151,0.5962566844919787,0.825273397155513,1.0,6/19,14.01%,CAV1;CST3;ECM1;CTSH;PSMA3;FURIN
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.3359691786465603,-0.8953144851706278,0.5958429561200924,0.8249480630245369,1.0,8/15,22.65%,IGF1;BCL2L1;GPX1;PRELID1;GHITM;AKT1;HGF;PPIF
prerank,negative regulation of neuron death (GO:1901215),-0.2221685547803875,-0.8951872064598099,0.6605504587155964,0.8245522914761212,1.0,35/93,28.08%,CD200;MEF2C;RETREG1;VPS35;SOD2;CD34;SIX1;NGF;NRBP2;APOE;GSK3B;SNX6;MDK;FOXQ1;NENF;PTK2B;CHMP4B;CHMP4A;RASA1;AKT1;ERBB3;CHGA;SIX4;KDM2B;CLCF1;MT3;IKBKG;NTF3;CRLF1;LIG4;PARK7;VSTM2L;BDNF;NDNF;MSH2
prerank,protein mannosylation (GO:0035268),-0.3029880746873459,-0.894714910554037,0.6103542234332425,0.824975461476677,1.0,6/22,14.77%,TMTC2;TMTC1;TMTC4;LARGE1;FKRP;DPY19L4
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.27576649956290256,-0.8944175330537465,0.6162790697674418,0.8249738768010799,1.0,11/31,29.47%,NFS1;GCH1;MOCS1;FDXR;CYP51A1;NOXRED1;PYCR2;STAR;MOCS3;PYCR3;FDFT1
prerank,regulation of mRNA processing (GO:0050684),0.31035246611721373,0.894312340182901,0.6167192429022083,0.9713320163258826,1.0,8/32,18.68%,KHDRBS3;CWC22;SRSF10;DHX9;SAFB2;IWS1;SAFB;KHDRBS1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.31796950373403005,0.8942699337888289,0.599406528189911,0.9707086847532543,1.0,6/30,12.21%,RPN2;OSTC;DAD1;ALG5;MCFD2;TUSC3
prerank,regulation of axon guidance (GO:1902667),0.40929002646211865,0.893932552775613,0.6024518388791593,0.9708097806683222,1.0,2/10,5.13%,MYCBP2;ZSWIM8
prerank,positive chemotaxis (GO:0050918),0.35571000797310914,0.8935142783174439,0.5829228243021346,0.97104619799073,1.0,2/17,3.60%,SEMA5A;SCRIB
prerank,innate immune response (GO:0045087),0.24009092127594603,0.89347456080897,0.6985210466439136,0.9704082058406176,1.0,21/217,10.09%,COLEC12;CLEC4E;CXCL10;CLEC5A;CD40;MASP1;KYNU;MFAP4;DHX58;TLR8;TRIM56;PTK2;IFNLR1;TRIM8;MBL2;SP100;TLR4;CYBA;CR2;IRAK1;FGR
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2710320912935555,0.8932779756088516,0.6195372750642674,0.9701360055909274,1.0,6/85,3.69%,LAMC1;LAMB1;TCF7L2;C5AR1;PEX2;MCC
prerank,regulation of mitochondrion organization (GO:0010821),0.29194503500424585,0.8932346030449558,0.6064610866372981,0.9695210888527624,1.0,10/47,16.74%,TMEM102;LRRK2;OMA1;PINK1;IAPP;HTRA2;GSK3A;SREBF1;CSNK2A2;HAX1
prerank,positive regulation of sodium ion transport (GO:0010765),0.3964947493699955,0.8932273473670759,0.6097560975609756,0.9688168262570902,1.0,2/12,3.99%,CNKSR3;ANK3
prerank,stabilization of membrane potential (GO:0030322),0.36310283473281096,0.8931836298418263,0.5935919055649241,0.9682083497156306,1.0,1/16,0.58%,KCNK2
prerank,response to lipopolysaccharide (GO:0032496),0.251292138989348,0.8927710987846,0.6813725490196079,0.9684521312177558,1.0,19/138,12.41%,GGT5;CXCL10;WNT5A;CXCL1;GGT7;PDE4B;PTPN22;PDCD1LG2;CD68;AXL;TLR4;PLAA;IRAK1;PYCARD;LIAS;MAPKAPK3;IL12A;CD86;PDCD4
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.24662212986563087,0.8927709087229844,0.7012835472578763,0.9677340362199406,1.0,46/186,18.97%,LRP1;PRICKLE1;HDAC1;WNT5A;TCF7L2;BICC1;NKD1;NPHP3;PSMD1;MCC;RBMS3;TLE2;PSMD10;PTPRU;PTPRO;PSMA5;KREMEN1;PSMB5;SOX2;GLI1;TLE1;NKD2;GLI3;PSMC4;PSMA4;SHISA6;JADE1;PSMC5;LMBR1L;SOX9;GSK3A;PSMB9;AXIN1;CTNNBIP1;CHD8;AMER2;DVL3;PSMA7;HECW1;PSMD14;FRZB;BMP2;LZTS2;PSMA2;PSMD11;APCDD1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.36194986792009143,-0.8926736232977805,0.6258351893095768,0.8282491660934281,1.0,4/11,16.40%,CAT;GPX1;PRDX1;PRDX3
prerank,regulation of neurotransmitter transport (GO:0051588),0.3652041748752338,0.8922039874000265,0.5951134380453752,0.9683442584189583,1.0,3/16,4.99%,HCRT;CHRNB4;FMR1
prerank,DNA conformation change (GO:0071103),0.35853880903608476,0.8920345116338536,0.5979557069846678,0.968057537097821,1.0,6/17,22.80%,NAA10;TOP2B;TOP3A;TOP2A;HMGB1;ABL1
prerank,ribosomal large subunit assembly (GO:0000027),-0.284453424206656,-0.8919364104212093,0.6502590673575129,0.8292214602048539,1.0,11/24,29.78%,RPL5;RPL10;RPL11;RPLP0;RPL23A;MRPL20;NOP2;RPF2;RPL24;FASTKD2;NOP53
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.23957902146964224,-0.891908027269556,0.6688741721854304,0.828631470538352,1.0,8/63,6.17%,MEF2C;IL18;ANXA1;IL6ST;SLC7A1;TFRC;CD38;NCK1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2582404022234317,0.891613341296976,0.6562091503267974,0.9682877775209892,1.0,12/107,9.08%,EDN3;SLC24A5;SLC30A10;CD40;RYR2;SLC30A5;SLC39A7;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3383356006530457,0.8916106120678645,0.5818181818181818,0.9675719336230169,1.0,8/21,17.28%,ITGAV;HTR2B;ZFP36L2;MAP2K1;SOX9;MYC;PTGER4;LGALS9
prerank,B cell proliferation (GO:0042100),-0.3254338366739766,-0.8911922385149441,0.6321243523316062,0.8295165840537251,1.0,2/17,3.06%,MEF2C;CTPS1
prerank,negative regulation of immune system process (GO:0002683),-0.3242093507999436,-0.8909017092170629,0.6372795969773299,0.8294819976595106,1.0,1/16,0.41%,CD200
prerank,negative regulation of biomineral tissue development (GO:0070168),0.34415320413269307,0.8905064271858492,0.6113744075829384,0.9693798454403503,1.0,1/21,0.11%,ENPP1
prerank,cellular response to oxygen levels (GO:0071453),-0.3790447137111258,-0.8904646699597377,0.6276595744680851,0.8297990199016347,1.0,5/10,24.98%,ATP6V0A2;ATP6V1G1;CCDC115;TMEM199;NDUFS2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.3992810911783695,0.8902926439623223,0.5711775043936731,0.9691654513139619,1.0,2/10,5.31%,ATP1A2;NEDD4
prerank,negative regulation of DNA metabolic process (GO:0051053),0.3320782314761703,0.8900780398495551,0.5993788819875776,0.9689855363295986,1.0,4/24,7.73%,ERCC1;KMT2A;MSH3;ERCC4
prerank,membrane protein proteolysis (GO:0033619),-0.26257905446576524,-0.8898989716245608,0.658307210031348,0.8304208256383933,1.0,9/37,13.03%,NFKB1;ERAP1;ADAM10;RBMX;CTSH;DAG1;RET;APH1A;APH1B
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3679641639425166,-0.8897247200590965,0.6115879828326181,0.8301147802729769,1.0,4/10,16.47%,PRKAA2;SIRT1;PRKAA1;MYOCD
prerank,rRNA modification (GO:0000154),0.34437027460408604,0.8892622598461503,0.6012965964343598,0.9702190195909277,1.0,10/21,30.64%,NAT10;DIMT1;NSUN3;MTERF4;METTL5;ZCCHC4;NOP10;DKC1;NSUN4;FTSJ3
prerank,regulation of mRNA metabolic process (GO:1903311),0.39502555585497107,0.8891123467871177,0.6090909090909091,0.9698603112286039,1.0,4/11,17.80%,DHX9;SAFB2;IWS1;SAFB
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.37545492273187,-0.8889071064515147,0.5920177383592018,0.8312648486549047,1.0,3/10,12.12%,CCT3;CCT4;CCT7
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3329541399272299,-0.888845403699885,0.6067708333333334,0.8307321508173915,1.0,3/15,6.13%,NEK6;CDC23;PTTG1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.2715628111796513,-0.8887191759670143,0.6318840579710145,0.8303622095538951,1.0,6/33,12.52%,PTPRJ;EZR;RC3H1;PTPN2;CEACAM1;DGKZ
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.26083879947670274,-0.8884635597656716,0.655786350148368,0.8302745171115659,1.0,11/40,18.65%,BCL2L1;ARL6IP5;UBB;VCP;MAPT;BAD;BAX;PRELID1;PRDX3;AKT1;PID1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.38455444669639305,0.8881964386543979,0.5861456483126111,0.9712141677678239,1.0,4/13,11.47%,PLA2R1;SPRED1;SPRED2;MSX1
prerank,positive regulation of glycolytic process (GO:0045821),0.3404000043966302,0.8881933807814093,0.6048780487804878,0.9697936713539337,1.0,3/20,4.54%,ZBTB20;PFKFB1;ENTPD5
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.3404000043966302,0.8881933807814093,0.6048780487804878,0.9697936713539337,1.0,3/20,4.54%,ZBTB20;PFKFB1;ENTPD5
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28656558576656577,0.8880670479657292,0.6328571428571429,0.969374727858089,1.0,17/58,18.77%,ERCC1;LIG3;POLQ;POLA1;ERCC4;POLL;RNF168;UBE2V2;POLB;CYREN;PAXIP1;KDM2A;ZBTB7A;NHEJ1;PSMD14;SMARCAL1;RIF1
prerank,lymphocyte mediated immunity (GO:0002449),-0.363612091278111,-0.8880296102079638,0.6097560975609756,0.8305375483940731,1.0,4/12,20.48%,CD55;GNL1;BTN3A3;CD46
prerank,lysosome organization (GO:0007040),0.3091277682499684,0.8880292970644097,0.6230769230769231,0.9687531259880386,1.0,8/36,15.60%,MYO7A;LRRK2;ZKSCAN3;HPS1;MTOR;TFEB;CLVS1;ACP2
prerank,regulation of neuron migration (GO:2001222),0.3310539073990187,0.8878570546035781,0.5914149443561209,0.9684188643518549,1.0,9/26,18.79%,IGSF10;CTNNA2;PLAA;PLXNB2;NTNG2;NTNG1;COL3A1;CAMK2A;ULK4
prerank,response to UV (GO:0009411),0.2625611682827849,0.8877983412026591,0.6632124352331606,0.967833454643497,1.0,21/95,15.40%,FEN1;POLK;USP1;ERCC5;MFAP4;FMR1;NEDD4;CDKN2D;ERCC4;UVSSA;NOC2L;TP53;POLH;DHX36;IL12A;SPRTN;REV1;EIF2S1;ERCC2;BAK1;MYC
prerank,sodium ion import across plasma membrane (GO:0098719),0.35947447029689056,0.887715139793003,0.6,0.9673109684046524,1.0,3/17,9.46%,SLC9A9;SLC9A1;HCN2
prerank,cellular response to UV (GO:0034644),0.2711244075422381,0.8874882392755196,0.6477732793522267,0.9671255542699287,1.0,15/76,16.02%,PPID;ERCC1;POLK;MFAP4;FMR1;NEDD4;ERCC4;NOC2L;XPC;TP53;DHX36;EIF2S1;BAK1;MYC;IMPACT
prerank,transcription by RNA polymerase II (GO:0006366),0.23259842775024675,0.8867497522434594,0.7441113490364025,0.9681536739873561,1.0,52/305,17.13%,RORA;PPARA;TEAD1;HDAC1;TAF9B;C5AR1;INTS8;TAF12;THRA;NR1H4;MAML3;PGR;PPARD;NR1H2;TEAD2;GTF2A1;RTF1;LSM11;TAF15;NR2C1;TAF3;CDK13;SRRT;TBPL1;NUDT21;NELFA;ZC3H8;SNAPC5;INTS14;SNW1;GTF2H3;ESR2;SSRP1;ELP4;NFIX;ELL2;HDAC10;MED1;TRIP11;ERCC2;NRBF2;SLBP;EAF2;SNRPF;GTF2H1;AR;SYMPK;CCNK;IWS1;MAZ;NR1D2;TAF8
prerank,regulation of proteolysis (GO:0030162),-0.24838482996299976,-0.8866513086125608,0.6627906976744186,0.8328932599565247,1.0,16/48,24.68%,CAV1;LTBP4;CST3;CASP8;BAD;PERP;IST1;SERPINE2;TRAF3;NEDD8;AKT1;CLN8;HDAC6;CAMK2N1;CLN6;CYFIP2
prerank,negative regulation of cell growth (GO:0030308),0.2529031723733456,0.8864594758066253,0.6918158567774936,0.9681007070010114,1.0,18/121,12.54%,ENPP1;HRG;CDKN2A;SIPA1;GJA1;NAIF1;SERTAD2;CDKN2D;CDKL3;BCL6;DCC;NME6;NDRG3;TP53;JADE1;MSX1;ESR2;GSK3A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.29139835442987794,-0.8860103427104808,0.5935828877005348,0.8336341357969668,1.0,4/24,6.17%,RBPJ;NOTCH1;ATF6;KLF2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.37547562071367063,-0.8858333066664381,0.6093023255813953,0.8333673215635473,1.0,2/10,5.89%,EZR;CDC42
prerank,intestinal absorption (GO:0050892),0.37937241093961743,0.8857170734820035,0.6035087719298246,0.9690819503598607,1.0,1/13,0.61%,NPC1L1
prerank,aggrephagy (GO:0035973),-0.2904368789322053,-0.8856320064279936,0.6392045454545454,0.8331300506763177,1.0,13/27,22.28%,VIM;SQSTM1;WDFY3;UBB;DYNC1H1;UBE2N;DYNC1I1;UBC;ARL13B;DYNC1LI1;HDAC6;CFTR;UBA52
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.2618091938124465,0.8856163489683422,0.6705577172503242,0.9686101863401431,1.0,11/93,9.83%,NTRK3;PTEN;CNKSR3;SH2D3C;MTCP1;DOCK7;PINK1;PRKD1;INPP5J;TENM1;NSD1
prerank,female gonad development (GO:0008585),0.3503786611147763,0.8853954339054075,0.6185567010309279,0.9684053893553999,1.0,5/19,23.37%,NR2F2;NUP107;LHCGR;INHBA;EIF2B5
prerank,polyol biosynthetic process (GO:0046173),-0.3207340727962366,-0.8850997067116119,0.6042154566744731,0.8336167878027215,1.0,3/16,6.64%,ACER3;ITPKB;IP6K2
prerank,protein kinase B signaling (GO:0043491),-0.2949723918298015,-0.8849964450788914,0.6351351351351351,0.8331974732111843,1.0,2/23,3.58%,IGF1;KDR
prerank,response to muramyl dipeptide (GO:0032495),-0.3607651369631315,-0.8849656848205179,0.6141552511415526,0.8326064243754644,1.0,1/12,1.09%,VIM
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.3401832772835681,-0.8848409499912364,0.6521739130434783,0.832219527578531,1.0,7/13,33.32%,RUNX1;ZBTB7B;TGFBR2;PNP;NCKAP1L;SOCS1;NKAP
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2963563392098849,-0.8846875710399702,0.6614173228346457,0.8319289681456858,1.0,10/23,25.69%,DIAPH1;CAMK2D;ANK2;NOS1;PTK2B;NOS1AP;CACNB1;CBARP;CASQ2;PSEN2
prerank,regulation of mitochondrial fission (GO:0090140),0.32803667864331804,0.8846641584011543,0.6067415730337079,0.9693798039459539,1.0,3/24,8.27%,DCN;LRRK2;PINK1
prerank,autophagosome organization (GO:1905037),-0.24374553013302785,-0.8842872464488095,0.6950354609929078,0.832158691210586,1.0,17/50,21.26%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;RAB1A;ATG12;ATG2A;MAP1LC3A;AMBRA1;ULK3;RAB1B;ATG101;MAP1LC3B;WDR45
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.33530865458412673,0.8836434895810255,0.6241830065359477,0.9710022511913113,1.0,5/23,18.72%,CECR2;KPNA1;FBH1;REXO4;KPNB1
prerank,establishment of melanosome localization (GO:0032401),-0.3027451119134952,-0.8835895392393969,0.6565656565656566,0.8330407097539761,1.0,7/19,28.52%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,N-glycan processing (GO:0006491),0.3477504608689793,0.8827627496390547,0.5861486486486487,0.9723420174078605,1.0,4/18,10.38%,ST8SIA1;PRKCSH;MAN1C1;MAN1B1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.32570745512988813,-0.882222813452452,0.6075,0.8352989565030179,1.0,2/15,5.26%,CD55;HSPH1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.27352137591957615,-0.8813935492832192,0.6162790697674418,0.8363786106588436,1.0,7/29,13.27%,RPS14;RPS16;RPS19;UTP3;RPS21;NOP9;RPS8
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3267197799162531,0.8811757470407877,0.6147798742138365,0.9753236502181224,1.0,4/26,6.02%,DUSP1;FBXO5;CENPE;CDC16
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.27787701769275236,0.8805465505524271,0.6433666191155493,0.976006473087232,1.0,4/57,3.59%,GHR;CD40;ERBB4;TSLP
prerank,positive regulation of telomere maintenance (GO:0032206),0.3186173063745568,0.8804902736554671,0.6172839506172839,0.975428056611077,1.0,7/31,17.17%,GNL3;ERCC1;SIRT6;HNRNPA2B1;DHX36;HNRNPD;PKIB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.28360185207127464,0.8803214551431324,0.6480117820324006,0.9750849815620162,1.0,8/54,8.66%,HRG;CD40;FGFR1;PDPK1;JUP;NF1;PRKD1;PRKCA
prerank,I-kappaB phosphorylation (GO:0007252),-0.3735077987660478,-0.8801498304913751,0.6038961038961039,0.8383908879308465,1.0,1/10,0.80%,ERC1
prerank,adherens junction organization (GO:0034332),0.2876623451274525,0.8795252910011837,0.6437768240343348,0.9761749827877362,1.0,12/48,14.84%,CDH6;CADM2;JUP;DCHS1;CDH11;CDH15;CDH3;JAM3;CDH10;CADM3;NECTIN3;FERMT2
prerank,regulation of spindle assembly (GO:0090169),-0.28947326238050786,-0.8792934738883748,0.6506666666666666,0.839464521048678,1.0,16/25,38.37%,DRG1;CHMP2B;DYNC1H1;CHMP4B;NUMA1;PDCD6IP;CHMP1A;CHMP4C;HSPA1A;CHMP2A;SPAG5;HSPA1B;TPR;PLK1;HNRNPU;CHMP3
prerank,regulation of mRNA stability (GO:0043488),0.24768287748188728,0.8792677611715848,0.6941457586618877,0.976015394019757,1.0,39/145,19.94%,NUP214;PSMD1;RBM24;YWHAZ;FMR1;DND1;PSMD10;PDE12;TAF15;ZFP36L2;PSMA5;PSMB5;PAIP1;PRKCA;TENT5A;PSMC4;PSMA4;DHX36;PSMC5;CSDC2;TNPO1;EXOSC9;PSMB9;FTO;EIF4ENIF1;HNRNPD;GDNF;RC3H2;EXOSC8;EXOSC5;PSMA7;IGF2BP3;PSMD14;PSMA2;YTHDF1;PSMD11;FXR1;ZC3H14;XPO1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.34074589702452895,0.8792373226994664,0.6091205211726385,0.9753804688818989,1.0,4/21,8.73%,SULF1;HS6ST3;HS6ST2;EXTL3
prerank,liver development (GO:0001889),-0.2672349441546748,-0.8791922101715344,0.6488095238095238,0.8390362232060042,1.0,8/32,15.68%,ARID5B;WNT4;ANXA1;COBL;LSR;CITED2;ZIC3;MET
prerank,mitochondrion disassembly (GO:0061726),-0.26602886033496964,-0.8790629530318151,0.6738461538461539,0.8386624059418566,1.0,14/34,21.26%,BECN1;SQSTM1;GABARAP;GABARAPL1;USP30;ATG2B;FUNDC1;ATG12;ATG2A;MAP1LC3A;AMBRA1;MARK2;MAP1LC3B;WDR45
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.29083606689669206,-0.8786974369120918,0.6481012658227848,0.8387471890440262,1.0,11/23,24.26%,BAD;BAX;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;COX18;NDUFA13;TIMM10B;BCL2L11
prerank,regulation of cellular localization (GO:0060341),0.29039585994586414,0.878428371301935,0.6374269005847953,0.9765373985664596,1.0,10/46,16.45%,ADCY5;TRIM67;NR1H4;LRRK2;PINK1;LYN;EPHA5;CSNK1E;BRSK2;DVL3
prerank,negative regulation of cellular process (GO:0048523),0.22198576256915642,0.877075136476448,0.8204334365325078,0.9788950041582345,1.0,96/521,16.56%,ENPP1;DLC1;CASK;COL18A1;PLXNC1;ATF5;HRG;ROR2;TGFBI;CXCL1;PTEN;SEMA5A;ERBB4;GPLD1;CDKN2A;SIPA1;GLMN;SUSD2;GJA1;DLG3;DUSP1;NR1H2;REST;FBXO5;TMEM115;HTR2B;ADGRB1;DSCAM;NAIF1;SERTAD2;ACTN1;PDE12;CBFA2T3;DUS2;GMNN;NPAS2;CDKN2D;PTPRU;BCL6;MDM4;PRKD1;IFNLR1;P3H1;APPL2;TENM1;SP100;BMP7;NME6;MAP2K1;TNS2;NDRG3;EIF2AK2;TNFRSF21;TP53;FKTN;JADE1;PLXNB2;MSX1;GAS8;SPEG;ESR2;HTRA2;FABP3;HGS;PDCD4;ST18;DIS3L2;TESC;SMYD5;BNIPL;P3H3;MALSU1;CDKN2C;TDRD9;ADAM22;LYN;NME1;THAP12;WNK2;TSPYL2;F2R;FERMT2;FOXM1;TFAP4;CLU;AR;CNOT7;MYC;KLF11;RNF167;IMPACT;CDK10;BRINP1;TSC1;RBM5;CHERP
prerank,mitotic chromosome condensation (GO:0007076),-0.2800373285485821,-0.876970107632396,0.682741116751269,0.8417984904295626,1.0,12/26,31.55%,SMC2;PHF8;TENT4A;PHF13;CSNK2B;CHMP1A;NCAPH2;SMC4;RB1;NCAPG2;TTN;SET
prerank,T cell receptor signaling pathway (GO:0050852),0.24578117888539894,0.8768126219186222,0.7081339712918661,0.9787919628301546,1.0,19/138,11.54%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;ICOSLG;PDPK1;PIK3R2;PTPN22;EIF2B1;CD276;PSMD10;PSMA5;PSMB5;PSMC4;TNFRSF21;PSMA4;FYN;PSMC5
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3252253855224448,0.8767923240206136,0.6245954692556634,0.9781284904740575,1.0,5/26,8.28%,KCNS2;VAMP2;NEDD4;KCNG1;KCNAB1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.32559388296086283,0.8763346414322828,0.6170212765957447,0.9784773168116981,1.0,7/24,19.13%,TMEM204;NEDD4;PRKCB;HGS;ITGA5;HIF1A;ARNT
prerank,tRNA wobble uridine modification (GO:0002098),0.3713547654813857,0.8761045315792748,0.6046901172529313,0.9782960928100705,1.0,4/14,17.74%,CTU1;ELP1;ELP4;TRMU
prerank,regulation of response to external stimulus (GO:0032101),0.25001537051072725,0.875854189411622,0.6914634146341463,0.978154141398506,1.0,17/121,13.07%,PDGFRA;XCL1;HRG;WNT5A;ADGRA2;PTPN22;DHX58;CASP4;ADAMTS12;BCL6;PTGES;APPL2;BIRC2;FGR;P2RX4;CASP12;AREL1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2928102287000059,0.8753432603541788,0.6332842415316642,0.9786185136847132,1.0,11/41,18.74%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,epithelial to mesenchymal transition (GO:0001837),0.28594420363736295,0.875248433081354,0.6412742382271468,0.9781391370337366,1.0,15/47,18.74%,WNT5A;FGFR1;LOXL3;LOXL2;TBX3;AMELX;DDX17;BMP7;TGFBR1;SOX9;OLFM1;CUL7;BMP2;HEY1;HIF1A
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.355385340064567,-0.8748611912694357,0.6112359550561798,0.8457203563720037,1.0,3/10,11.86%,VTN;GRB10;ITGB3
prerank,actin nucleation (GO:0045010),-0.2992236248822101,-0.8744436817716051,0.632,0.8459996779730558,1.0,7/21,23.22%,JMY;LMOD1;TRIM27;IQGAP2;ARPC5L;ARPC5;ARPC4
prerank,inner dynein arm assembly (GO:0036159),0.38882159535973715,0.8740751915201532,0.6370235934664247,0.9801887951049328,1.0,2/11,15.25%,DNAAF4;CCDC39
prerank,regulation of immunoglobulin production (GO:0002637),-0.2901610614948755,-0.8740507071411748,0.6326034063260341,0.8461589128178731,1.0,3/23,10.44%,RBP4;DNAJB9;EPHB2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.36184957870628565,0.8739223653879643,0.6288659793814433,0.979844495726202,1.0,2/15,3.83%,NTRK2;NGFR
prerank,purine-containing compound catabolic process (GO:0072523),-0.33866295816511505,-0.8739002336573541,0.6441860465116279,0.8458233981082205,1.0,5/13,19.98%,XDH;GPX1;NT5E;GDA;NT5C1A
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.21962788118424995,0.8738628072838653,0.8484848484848485,0.9792781263944054,1.0,172/807,19.42%,IL33;ZEB1;ZFHX3;TRPS1;ATF5;XCL1;NRG1;RUNX2;PRICKLE1;PPARA;MIER2;ETV5;HDAC1;L3MBTL1;PPID;WNT5A;TAF9B;NR2F2;TCF7L2;BASP1;SALL1;CDKN2A;THRA;NR1H4;PEX2;PER3;MEIS2;POU3F3;PPARD;NR1H2;LOXL3;LOXL2;REST;TBX3;SCML4;MDFIC;RUNX1T1;ZNF423;ZBTB16;ZFP37;RTF1;SIRT6;TLE2;FOXS1;PSMD10;PRDX5;BCOR;CAPN3;GLIS1;CALCA;DUSP22;TENM2;CBFA2T3;GMNN;BRMS1L;BRMS1;PAX9;ZBTB2;TRIM37;LYAR;BCL6;NR2C1;TAF3;ZKSCAN3;MDM4;PER2;TWIST1;SOX2;MXI1;NOC2L;L3MBTL4;PHF6;SP100;TLE1;DAXX;BMP7;NSD1;GLI3;SOX10;TP53;N4BP2L2;ZC3H8;MPHOSPH8;ZFPM2;ZNF25;SNW1;DAP;EPC1;ZNF318;ESR2;SOX9;MYT1L;TWIST2;PDCD4;IGF2;SAP30;DPF2;KDM1B;HIC2;BTAF1;CNOT1;PHC1;PRDM5;ATN1;ZMYND15;NRIP1;NFIX;HDAC10;PEG3;MED1;CUX2;UBE2D1;MED25;BPTF;KDM5C;CREB3L1;ZBTB32;CHD8;FOXM1;TFAP4;DMAP1;PRMT2;AR;CNOT7;MYC;CRY2;ORC2;CENPF;ZHX3;DCAF1;FGFR2;KLF11;KDM2A;IMPACT;SPINDOC;EFNA1;ZBTB7A;AASS;ZNF3;CBFA2T2;NONO;MBTD1;CIART;MAZ;NR1D2;CALR;DNMT3A;SARS1;CDK5;MBD2;LDB2;LDB1;SUV39H2;BMP2;MBD1;KAT7;SKOR2;HEY1;BRD7;ILF3;KHDRBS1;WWC1;RIF1;DEDD2;PEX14;THAP7;CREBZF;CBFB;EHMT2;NR2C2;NACC1;IKZF4
prerank,response to nutrient levels (GO:0031667),0.3482078338489269,0.8735114746971661,0.61101243339254,0.9793785344408377,1.0,4/17,13.01%,CD68;RPS6KB1;MTOR;MEAK7
prerank,cellular response to heat (GO:0034605),-0.264347138687653,-0.8734656337886652,0.6656346749226006,0.8461287516434565,1.0,8/35,14.33%,THBS1;ANO1;VCP;FGF1;MAPT;BAG3;TRPV4;HIKESHI
prerank,immunoglobulin mediated immune response (GO:0016064),0.3970882248304316,0.8733678019628391,0.5963636363636363,0.9790148997230831,1.0,2/10,12.94%,TLR8;CD81
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.34514635932875654,-0.8729916968361917,0.6014150943396226,0.8464727876692506,1.0,4/13,13.29%,HACD4;HACD1;ELOVL4;ELOVL7
prerank,regulation of intracellular transport (GO:0032386),0.29402185577007833,0.872741502119805,0.6327433628318584,0.9796984065887526,1.0,11/38,19.60%,NUP214;AAAS;NEFH;LRRK2;TTC21B;SCFD1;ATP9A;RINT1;CAPN10;WWC1;ATPSCKMT
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2624694723684462,0.8726355249351914,0.6688918558077437,0.9792512946029185,1.0,27/80,23.69%,KDELR3;COPA;KDELR2;GBF1;TMEM115;COPZ2;DNAJC28;CENPE;COPB1;KIFAP3;SCFD1;ATP9A;RINT1;KIF3C;KIF2A;ERGIC2;TMED3;TMED9;COPG1;COPB2;KIF3A;KIF11;KIF15;BNIP1;KIF23;COPZ1;KDELR1
prerank,zinc ion homeostasis (GO:0055069),0.3169084641458145,0.8722413634199172,0.6242038216560509,0.9793976615923373,1.0,3/28,4.66%,SLC30A10;SLC30A5;SLC39A7
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.36918700766667367,0.8721707137363283,0.6099290780141844,0.9788596408459729,1.0,7/13,27.04%,UBE2G2;YOD1;BRSK2;EDEM2;UBE2J1;OS9;BCAP31
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.22669980086642555,0.8718871755939416,0.7846481876332623,0.9787864999223033,1.0,94/366,22.82%,RORA;CHD7;ZFHX3;MSC;ATF5;NANOS3;RABL3;NCOA2;MYT1;TEAD2;REST;FBXO5;SOX6;ZNF423;MTPN;FOXN2;CXXC1;ZFP37;GMNN;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;DAXX;SRRT;BRCA2;NSD1;TP53;GRM5;NFXL1;TGFBR1;ESR2;SRSF10;IGF2;TFEB;SAP30;NUP107;ZNF628;CARM1;HDAC10;ARNT2;SSBP2;RBM4B;TGFBRAP1;CCNA2;UBE2V1;HNRNPD;MLF1;ATF2;WTIP;MAFB;ZKSCAN5;TSC1;TRIP4;NONO;CYFIP1;USP13;NR1D2;CALR;ZBTB11;LDB1;MLF2;BMP2;KAT7;SKOR2;REXO4;HIF1A;WWC1;THAP7;TERF2IP;EHMT2;NR2C2;SP1;TRAPPC2;CNBP;SMC3;DVL2;ORC5;HCFC2;GON4L;UTP4;APBB3;ASCC1;DDIT3;CREBBP;LIN54;SERTAD3;ATRX;MLLT6;NLK;RREB1;ABL1;HOXB7
prerank,cell proliferation in forebrain (GO:0021846),0.3937520947947316,0.8718301022167669,0.6241007194244604,0.9782210116242672,1.0,4/10,25.77%,DOCK7;PCM1;KIF14;NUMBL
prerank,response to copper ion (GO:0046688),-0.2972964258061169,-0.8712639594520952,0.6370370370370371,0.8493546381708242,1.0,15/20,37.95%,MT2A;ATP5F1D;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;HSF1;ATP7B;AQP1;IL1A
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2621732546601707,0.8712557985843503,0.6666666666666666,0.978765114040636,1.0,20/78,22.24%,PTEN;NR2F2;CDKN2A;CCNJ;PKMYT1;PSMD10;CDKN2D;CCNB2;CDKN2C;CCNA2;TFAP4;GTF2H1;CCNK;CCNE1;LATS2;MEN1;CDK5R1;CCND3;CDK7;CCNT2
prerank,protein maturation (GO:0051604),0.2579950940271237,0.8711069820633743,0.6779448621553885,0.9783834539996105,1.0,9/95,6.96%,ECE1;ECE2;OGT;NAA10;PCSK2;SORL1;ADAM19;CCS;CPM
prerank,regulation of exit from mitosis (GO:0007096),0.3016545097608415,0.8704594106811049,0.6430769230769231,0.9791257108267467,1.0,3/38,6.02%,CDC14B;BUB1B;CDC16
prerank,protein stabilization (GO:0050821),-0.19686001773152315,-0.8704317681484782,0.8376623376623377,0.8504317732658531,1.0,59/168,27.13%,EPHA4;IGF1;PLPP3;PTGES3;HIP1R;ATP1B3;TBL1X;CTNND1;DVL1;RPL5;CRYAB;RPS7;SOX4;RAB21;MTMR9;TBRG1;SOX17;CCT3;ANK2;RPL11;VHL;ATF7IP;GAPDH;CRTAP;NCLN;BAG3;CCT4;CCT7;FLNA;GLMP;HIP1;CDKN1A;CREB1;PRKCD;USP9X;LAMP2;AFM;CREBL2;PIM2;RPL23;RTN4;SMAD7;TYROBP;BAG2;TMEM88;HSPD1;SUGT1;MCM8;TRIM39;MT3;SUMO1;COG3;CHEK2;GOLGA7;HSPA1A;FLOT1;PARK7;ATP1B2;STK3
prerank,mitochondrion transport along microtubule (GO:0047497),0.3748708594841753,0.8703482067847144,0.6363636363636364,0.9786697486152762,1.0,4/13,18.74%,LRPPRC;OPA1;SYBU;HIF1A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.30827202218439864,-0.8702313337901056,0.6658227848101266,0.8501866752860179,1.0,2/19,0.43%,IGF1;PICALM
prerank,response to leucine (GO:0043201),-0.3565157636764961,-0.870167898083135,0.5982339955849889,0.8489850724950893,1.0,3/10,11.78%,SESN1;UBR1;UBR2
prerank,cellular response to leucine (GO:0071233),-0.3565157636764961,-0.870167898083135,0.5982339955849889,0.8489850724950893,1.0,3/10,11.78%,SESN1;UBR1;UBR2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2669125590704607,0.8701326592219246,0.6644021739130435,0.9784454987771689,1.0,12/76,11.85%,CCDC22;CDKN2A;PSMD10;BRMS1;TRIM37;LRRC14;COMMD1;BMP7;IRAK1;PYCARD;DAP;PTGIS
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3004980502111695,-0.8699400455516895,0.613941018766756,0.8487806297383528,1.0,4/18,9.79%,PSMD9;CCN3;KCNB1;SFRP1
prerank,regulation of cytokinesis (GO:0032465),0.266672615007725,0.8696868119572719,0.6846965699208444,0.9787274332248108,1.0,3/78,0.93%,SVIL;CDC14B;RXFP3
prerank,detection of visible light (GO:0009584),0.35239074361922523,0.8694855505937302,0.6299342105263158,0.978488575516109,1.0,3/16,14.50%,GNA11;ABCA4;CEP250
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.2647445170504334,0.8693561922410591,0.664364640883978,0.9780783701686928,1.0,8/75,5.64%,SPRY4;SPRY1;PTEN;NR2F2;CDKN2A;DUSP1;SORL1;NF1
prerank,mitochondrion organization (GO:0007005),-0.19707713345238717,-0.8690415072351974,0.8209876543209876,0.850014586696251,1.0,55/165,26.64%,CXADR;BCL2L1;MEF2A;NOS3;MTM1;ATP5F1B;ALAS1;CAV2;SIRT3;HK2;DNM3;MIEF1;USP30;BAX;BNIP3L;TIMM9;BID;CHCHD2;TERT;PYROXD2;TRAK2;RAB38;ADCK1;MTFR1L;AFG1L;PRDX3;VPS13D;YME1L1;AIFM1;ATP5F1D;MSTO1;TIMM13;CHCHD3;TOMM22;PID1;SIRT5;TIMM8B;MPV17;MIGA1;POLRMT;HIGD1A;FANCG;TWNK;OXA1L;VPS13C;HSPD1;PNPT1;PARP1;TIMM10B;TOMM5;FMC1;MIEF2;SLC25A4;PARK7;HSD17B10
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22443519807370207,-0.8690263306784194,0.7303370786516854,0.849403440050185,1.0,23/64,28.66%,MLLT3;ELOA;GTF2H5;AFF4;POLR2B;POLR2H;POLR2G;POLR2C;ELOC;MLLT1;CDK9;NELFCD;GTF2H4;LEO1;NCBP2;ADRM1;GTF2F2;CTDP1;ELOF1;TCEA1;POLR2I;POLR2K;TCEA2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.3180865849717456,0.8688112775247717,0.6426282051282052,0.978623196494399,1.0,3/27,4.06%,PPARA;ITGAV;NR1H2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2600687182140113,-0.8688070699000836,0.6712328767123288,0.8492313926717682,1.0,10/30,21.86%,CAVIN1;GTF2H5;UBTF;POLR2H;TTF1;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,icosanoid biosynthetic process (GO:0046456),-0.3727244119801232,-0.8683367604823522,0.6188340807174888,0.8495950427538721,1.0,5/10,36.41%,PLA2G4A;MGST3;PLA2G5;ALOX5AP;MGST2
prerank,organelle organization (GO:0006996),0.22338561407668353,0.8677705384593996,0.7976570820021299,0.9802701816882224,1.0,91/388,19.29%,SEC16B;CECR2;PPID;PHIP;RAB34;MTFR2;ABCD2;SIPA1;PEX2;SEC16A;WDPCP;GBF1;DPYSL2;IRAG2;PRKCI;DNAJC28;LRRK2;PEX7;SMPD4;SIPA1L3;EPS15;FMNL2;WASF3;FAM161A;CIDEA;BSCL2;GOLGA2;FGD6;PINK1;PRKD1;PALLD;KIFAP3;RAB30;RAB29;MTX3;OPA1;WDR73;BCS1L;SAR1A;SLC25A33;ARHGAP4;RAB2A;POLG2;LNPK;SH3KBP1;KIF5C;CENPW;PEX11A;SYNE1;KIF9;FAM161B;COG1;LONP1;ATP7A;PCLO;TRIP11;CLASP2;SH3D19;PACSIN3;HACE1;MYC;PEX19;WTIP;TNIK;CLASP1;CEP55;FGD2;USP6NL;HAX1;UBXN2B;TMED3;PAK5;VPS4B;TMED9;GOLGA8B;GOLGA5;MCOLN1;PEX12;PDZD8;CUL7;MAST1;PEX3;SSBP1;YTHDF1;PEX14;PEX6;EIF2AK3;MIA3;TRAPPC12;TBC1D20;NIPSNAP2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.2659104680478429,-0.8677513759981355,0.6781326781326781,0.8501872946373015,1.0,9/28,25.48%,PRKDC;KMT5B;SHLD2;PARP9;SMCHD1;SETMAR;NUDT16L1;DTX3L;KMT5C
prerank,regulation of isotype switching (GO:0045191),-0.33129896634086337,-0.8676590841250066,0.6282352941176471,0.8497453704371177,1.0,3/14,9.89%,KMT5B;TFRC;SHLD2
prerank,receptor signaling pathway via STAT (GO:0097696),0.3202579103165228,0.8674240361946014,0.6366723259762309,0.980346337279007,1.0,1/25,0.31%,GHR
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24172521198475838,-0.8671699397227673,0.705685618729097,0.8500765894931634,1.0,5/50,7.95%,NR3C2;EGFR;APP;NMI;IFI35
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3190057267469991,-0.8669829152497395,0.628361858190709,0.8497894238133064,1.0,4/15,6.99%,KHNYN;NYNRIN;DICER1;RPP30
prerank,neurogenesis (GO:0022008),-0.24912465606169373,-0.8668395020338626,0.7236024844720497,0.8494290621300482,1.0,9/43,13.34%,TGFB2;THOC2;ANXA1;CDK6;SIX1;MAPT;WDR62;CLN5;TRAK2
prerank,protein dephosphorylation (GO:0006470),0.24621221318692063,0.8665151188170485,0.7200488997555012,0.9816436552243302,1.0,21/135,10.69%,CDC14B;PTPRT;PTEN;PTPRR;PTPRN2;DUSP12;DUSP1;MTMR4;PTPN22;DUSP22;PTPRU;PTPRO;PTPN13;SSH2;PPP2R2A;TNS2;PPP2R3A;PPP6C;PPP3CB;PDP1;PTPRA
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.332127009090764,-0.8664972316608832,0.627906976744186,0.84946639011989,1.0,5/13,16.98%,NR3C2;ABHD2;NR3C1;GPER1;ESR1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2881122898291093,0.8664893231146114,0.646551724137931,0.9810022974733495,1.0,14/46,24.01%,TIMM10;DNAJC19;PINK1;PITRM1;TIMM44;DNAJC15;PAM16;GRPEL1;TIMM21;MFN2;GDAP1;CHCHD4;FIS1;TOMM34
prerank,response to interleukin-1 (GO:0070555),-0.21846764250349102,-0.8664393555829866,0.7628458498023716,0.848923961097467,1.0,12/73,10.33%,HDAC4;APP;NFKB1;IRAK2;SIRPA;IL1R1;ANXA1;GBP2;RC3H1;HYAL1;SFRP1;RBMX
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.353838751378809,-0.8664224191679976,0.6487695749440716,0.8483088934111054,1.0,4/11,13.66%,CTPS2;TPK1;DCK;SLC19A3
prerank,stem cell development (GO:0048864),0.3598112857360648,0.8662295829241405,0.63,0.9808716358530994,1.0,2/16,9.37%,NRG1;TAPT1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34353565315486867,0.8657647060287831,0.6409395973154363,0.9811753438520747,1.0,3/18,9.42%,ATP1A2;SLC43A1;COMMD1
prerank,positive regulation of dendritic spine development (GO:0060999),0.3518047174847535,0.8656988741071991,0.6492890995260664,0.980621344204967,1.0,6/20,13.86%,FOXO6;FMR1;CAPRIN1;RELN;DHX36;CUX2
prerank,protein O-linked glycosylation (GO:0006493),0.25271381381036523,0.8656578383331379,0.7133592736705577,0.9800194740336,1.0,12/96,11.10%,GALNTL6;PLOD1;OGT;GALNT18;POMT1;GALNT13;GALNT15;RXYLT1;B3GNT8;GALNT10;POFUT2;FKTN
prerank,response to molecule of bacterial origin (GO:0002237),-0.219927842220414,-0.8655953446034572,0.7472924187725631,0.8493276828958214,1.0,8/69,8.26%,SMAD6;FOXP1;FER;NOS3;LBP;PELI1;IFNAR1;GCH1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.35877570151972565,-0.8653948183266641,0.6383442265795207,0.8490922449380407,1.0,1/10,0.55%,RAPGEF2
prerank,response to unfolded protein (GO:0006986),-0.2418616156599187,-0.8653102991656113,0.7231833910034602,0.8486165947272811,1.0,17/48,25.83%,TMBIM6;HSPA8;HSPH1;HSPB8;BAX;PTPN1;OPTN;HSPB1;BAG3;ERN1;STT3B;DNAJB5;DNAJB1;HSPD1;HSPA14;HSPA1A;HSPB2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.311675027711088,0.864870099612025,0.6579754601226994,0.9810819692155865,1.0,8/30,15.77%,GJA1;RYR2;SCN2B;CACNA1G;FGF12;KCNE4;SCN1A;CACNA2D1
prerank,wound healing (GO:0042060),0.26961631687396936,0.8647222553097574,0.6541666666666667,0.9807272379216021,1.0,9/62,11.50%,PDGFRA;NRG1;WNT5A;NF1;SRF;EVPL;SYT7;ARL8B;TGFBR1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.39474740814554704,0.8641947526757778,0.6222222222222222,0.9812622823885997,1.0,3/10,17.61%,FMR1;GNB5;GPR35
prerank,regulation of regulated secretory pathway (GO:1903305),0.3038837567032285,0.8641436295336511,0.6471494607087828,0.9806794669607243,1.0,10/34,19.47%,LRRK2;RIMS2;SYT3;SYT7;RIMS1;RAB15;SYT5;SYT6;SYT1;RIMS4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.4035353755380631,0.8634070296144327,0.6384479717813051,0.9816599509002233,1.0,2/10,8.66%,PRKACB;PRKACA
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.25216090694899435,-0.8633802621763114,0.6947040498442367,0.8519371664263204,1.0,10/39,17.14%,MYRIP;PSMD9;RBP4;SOX4;NNAT;BAD;ACSL4;SELENOT;GPER1;HFE
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.23308156055792412,-0.8631896396775379,0.7372013651877133,0.8516655640635282,1.0,15/57,16.10%,TNFSF10;HIP1R;KDR;VPS35;GSK3B;RALBP1;MIEF1;BAD;BAX;BID;DDHD1;BOK;ZNF205;ADCK1;GPER1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.27555924170529444,-0.8631044273605937,0.6955307262569832,0.8511918555153528,1.0,9/27,23.88%,MAP3K1;IRAK2;UBB;TAB2;IRAK4;UBC;LY96;UBA52;HSPD1
prerank,defense response to protozoan (GO:0042832),-0.3424887754037351,-0.8630192627921404,0.6431718061674009,0.8507263613490862,1.0,4/12,11.59%,GBP7;GBP4;GBP2;GBP6
prerank,rRNA catabolic process (GO:0016075),0.3467051809676628,0.8629776981941568,0.6072555205047319,0.9818878022170742,1.0,6/16,19.04%,EXOSC9;EXOSC10;EXOSC8;EXOSC5;DEDD2;TRIR
prerank,mRNA transport (GO:0051028),0.2546157653007939,0.862758590940939,0.7036553524804178,0.9816667369820126,1.0,27/101,21.20%,EIF4A3;NUP214;AAAS;FMR1;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;KIF5C;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,regulation of transposition (GO:0010528),-0.339627147785789,-0.8624650180894328,0.6510067114093959,0.8512071002085053,1.0,3/13,11.78%,MYBL1;TEX15;UBR2
prerank,replicative senescence (GO:0090399),0.3800012160771087,0.862450461523123,0.6278659611992945,0.9816450142433841,1.0,3/12,10.60%,PLA2R1;CDKN2A;TP53
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3428617394933226,0.8624272005921217,0.6291946308724832,0.9810033908752841,1.0,5/18,16.69%,PIK3R1;ATXN3;BAK1;BAG6;USP13
prerank,sterol biosynthetic process (GO:0016126),0.3015040180539529,0.8623768661644879,0.6601208459214502,0.9804219879933569,1.0,7/33,11.95%,NPC1L1;DHCR24;SC5D;ACAT2;PLPP6;HMGCS1;ACLY
prerank,mRNA export from nucleus (GO:0006406),0.25617584197144294,0.8619144646345536,0.7038007863695938,0.9807690763729673,1.0,28/102,21.20%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;DDX19A;ENY2;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;IWS1;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3253769271210314,0.861596628933815,0.647887323943662,0.9807700283795676,1.0,2/24,5.64%,EPHA7;NF1
prerank,JNK cascade (GO:0007254),-0.25213590124868934,-0.8614450112190999,0.7455089820359282,0.8526150817389466,1.0,16/40,24.35%,IRAK2;MAP3K5;MINK1;MAPK9;MAP2K4;UBB;MAP2K7;TAB2;UBE2N;UBC;MAP3K10;MAP4K3;GPS1;UBA52;IKBKG;NOD2
prerank,protein localization to condensed chromosome (GO:1903083),-0.33612302510068415,-0.8608412506474821,0.6728538283062645,0.8532170479058416,1.0,6/12,32.58%,MTBP;ZW10;BUB3;IK;TTK;ZWILCH
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2287507974262323,0.8608341598885619,0.7811447811447811,0.9816619604647043,1.0,71/264,22.68%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNUPN;SNRPB2;CDK13;CELF4;SMU1;DDX17;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;SRSF10;SYF2;CLNS1A;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;GEMIN8;CTNNBL1;ZCRB1;RBM6;POLR2L;DDX1;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,fatty acid biosynthetic process (GO:0006633),0.2702595185013742,0.8606901028184093,0.6790633608815427,0.9813104119820079,1.0,18/63,21.94%,LIPC;LIPH;DEGS1;ELOVL2;HSD17B8;ACOT7;LIAS;ACLY;NDUFAB1;ELOVL6;ELOVL1;HACD3;ALOX5;ACSBG1;ABHD3;SCD5;ACACA;ELOVL5
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3532614454811168,-0.8603380102534444,0.6112359550561798,0.8536135481579166,1.0,1/11,4.55%,NFKBIZ
prerank,establishment of mitotic spindle localization (GO:0040001),0.31132398936939065,0.8602905743533052,0.6724409448818898,0.9814785705604382,1.0,9/28,18.72%,GJA1;GPSM2;SPDL1;NUSAP1;INSC;CLASP2;CLASP1;UBXN2B;KPNB1
prerank,protein N-linked glycosylation (GO:0006487),0.2662046711174779,0.8602571697679646,0.6720867208672087,0.9808669973261991,1.0,14/66,14.57%,RPN2;OSTC;ENTPD5;DAD1;ALG6;GFPT2;MAN1C1;ALG13;ALG5;MCFD2;TUSC3;TMEM258;B4GALT7;PMM2
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3650173341312471,0.8598543860148171,0.62751677852349,0.9810601815140133,1.0,3/14,11.24%,EARS2;SLC25A33;TEFM
prerank,positive regulation of organelle assembly (GO:1902117),0.28411209117308145,0.8598026329949883,0.7034795763993948,0.9804850254553086,1.0,9/44,13.02%,PIP4K2A;FSCN1;GPSM2;IL5;TAPT1;ASAP1;ARHGAP35;ENTR1;CNOT1
prerank,regulation of mitotic cell cycle (GO:0007346),0.23699639905272712,0.859791449027421,0.7633410672853829,0.9798219462212208,1.0,38/171,18.28%,BUB1B;L3MBTL1;PSMD1;MEIS2;SCRIB;PKMYT1;GBF1;FBXO5;RNF40;CCDC57;CDC16;PSMD10;PSMA5;PSMB5;RPS6KB1;CDK13;PRKCA;LGMN;XPC;PSMC4;PSMA4;TTC28;RCC1;MKI67;PSMC5;ANAPC5;PSMB9;UBE2D1;ERCC2;TFAP4;CDK10;BRINP1;PSMA7;SRA1;PSMD14;CDC26;CUL7;PSMA2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.3083299593418803,-0.8597269876071654,0.6683291770573566,0.8542726483087616,1.0,6/18,12.78%,RAP1A;SYN1;VPS18;GSK3B;RAB5A;SLC4A8
prerank,regulation of calcium-mediated signaling (GO:0050848),0.31872102561220284,0.8594826863606291,0.6598746081504702,0.9798168728135529,1.0,3/25,11.17%,ITPR1;LRRK2;P2RX4
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.266621658818497,0.8594314339924702,0.7079889807162535,0.9792510664856994,1.0,10/69,15.73%,IL33;WNT5A;TWIST1;TLR4;CYBA;PYCARD;RIPK1;DHX9;CLU;TIRAP
prerank,positive regulation of lyase activity (GO:0051349),0.357586953418346,0.8592682033374703,0.6339285714285714,0.9789134623201411,1.0,3/14,6.98%,AKAP5;NF1;FXN
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.218277196884767,-0.8586306365940249,0.7636986301369864,0.8558083540686594,1.0,12/75,13.30%,SLC12A7;SLC9A2;SLC8A3;KCNJ13;ATP1B3;SLC39A8;SLC39A10;KCNK9;KCNJ2;SLC12A8;KCNJ12;TRPV4
prerank,primary miRNA processing (GO:0031053),-0.3609293468461665,-0.8584964790746287,0.6220657276995305,0.8554201156888908,1.0,4/10,12.84%,DGCR8;DROSHA;SMAD3;SMAD1
prerank,regulation of T cell cytokine production (GO:0002724),0.3561728496961202,0.8583123079944152,0.657487091222031,0.9803271120322183,1.0,1/15,0.79%,XCL1
prerank,microtubule bundle formation (GO:0001578),0.2884202862281928,0.857684528890236,0.6784615384615384,0.9810381220773181,1.0,6/42,11.65%,NCKAP5L;RSPH9;AAAS;MTCL1;CAPN6;GAS8
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2812093039024931,-0.857492874696255,0.6762177650429799,0.8567803618310039,1.0,9/23,23.20%,WNT5B;SMO;SIX1;PIK3CD;MDK;EGF;AGT;SIX4;SOX8
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2123360671410245,-0.8574428768356364,0.8146551724137931,0.8562254134566954,1.0,23/87,20.39%,RBFOX2;SHOC2;TBX1;CD44;FGF1;HNRNPF;ITGB1BP1;HYAL1;SFRP1;NR4A1;FRS2;POLR2B;FGFBP1;POLR2H;HNRNPH1;POLR2G;POLR2C;GRB2;FGFR3;FGFRL1;FLRT1;HNRNPA1;GALNT3
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2475804293246238,-0.8572920812196635,0.6848484848484848,0.8559028255966544,1.0,18/38,30.78%,PTPRJ;MAGI2;XDH;PIK3CB;DAG1;PHLPP2;SIRT1;GPER1;EPHA2;AKT1;PPP2R5B;CIB1;HYAL2;ARRB2;PPP2R5C;TRIB3;NOP53;BANK1
prerank,connective tissue development (GO:0061448),0.2962709226774608,0.857106786783019,0.6476043276661515,0.9816041127845665,1.0,5/35,5.84%,SULF1;PGRMC2;SOX6;ZBTB16;CREB3L2
prerank,DNA repair (GO:0006281),0.22697468008678476,0.856519351632557,0.787117903930131,0.9821777845197927,1.0,66/284,20.54%,FANCI;ERCC6L2;ERCC1;LIG3;FAN1;FEN1;POLK;POLQ;USP1;ERCC5;FANCA;MSH3;ASF1A;NEIL3;POLA1;CDKN2D;RPA1;ERCC4;POLL;XPC;RNF168;FAAP100;COMMD1;BRCA2;RFC3;UBE2V2;TEX264;TP53;POLH;RECQL;FAAP20;GTF2H3;POLN;MUTYH;XRCC1;POLB;SPRTN;RAD52;FTO;ALKBH3;MBD4;ATXN3;POLI;ERCC2;DOT1L;EME2;UBE2V1;GTF2H1;CSNK1E;MMS19;APEX2;SMARCAL1;SMC1A;MSH6;WRN;FBH1;REXO4;TRAIP;POLE;TRIP13;MLH1;MTA1;DDX1;USP45;MEN1;DDB1
prerank,cellular response to amino acid stimulus (GO:0071230),0.2991967310950519,0.8561414461437207,0.6743119266055045,0.9823324598225848,1.0,10/33,18.69%,CPEB1;MTOR;GLRA1;FYN;GLRA2;RRAGA;CASTOR1;KLHL22;RRAGD;CAPN2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.295498478358457,0.8560923442198375,0.6825153374233128,0.9817706745082773,1.0,6/36,14.70%,GHR;ERBB4;OCIAD1;HGS;DOT1L;F2R
prerank,regulation of metal ion transport (GO:0010959),0.35004634956715597,0.8558049845185863,0.6642984014209592,0.9817214347333505,1.0,2/16,2.18%,SLC30A10;IL16
prerank,glycosphingolipid metabolic process (GO:0006687),-0.2532324478449177,-0.8556164700123046,0.7098765432098766,0.8586133568011446,1.0,16/42,24.76%,SMPD3;ST6GALNAC3;LARGE1;HEXB;UGCG;B3GALNT1;ESYT3;ST3GAL5;SMPD1;GM2A;ARSA;PSAP;GLTP;A4GALT;CLN6;ASAH1
prerank,response to nitric oxide (GO:0071731),-0.3290929387201521,-0.8549385740334959,0.6484018264840182,0.8593237135478025,1.0,1/13,0.46%,FOXO1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.31622837278477456,0.8549336806029785,0.6605222734254992,0.9829887904549145,1.0,12/27,25.73%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.2644072418559235,0.8548654341690447,0.6835616438356165,0.9824524260261184,1.0,7/66,5.62%,IL34;EDN3;CD40;FGFR1;HTR2B;TLR6;LRRK2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3409789355991544,-0.854821436717656,0.6566820276497696,0.858916956842162,1.0,2/12,1.13%,CACNA1C;CAV1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.3541962125544443,0.854627480414358,0.6389351081530782,0.9822871855475225,1.0,3/15,12.81%,TAF9B;ARMC10;PTTG1IP
prerank,amino acid transport (GO:0006865),0.28214081058177065,0.854533506091441,0.6894150417827298,0.9818248681857685,1.0,4/49,4.87%,SLC1A5;SLC7A11;SLC43A1;SLC7A8
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.35323647718922346,-0.8542038888399957,0.6750572082379863,0.8594888189191984,1.0,5/10,25.64%,CX3CR1;FZD3;CX3CL1;SMARCD3;KDM1A
prerank,vesicle transport along microtubule (GO:0047496),-0.27881028256756857,-0.854189001600132,0.6934673366834171,0.8588722731317403,1.0,8/23,23.86%,NDEL1;DYNC1H1;TRAK2;RAB1A;DYNC1I1;KIF1C;BICDL1;KIF5B
prerank,photoreceptor cell development (GO:0042461),0.3563686448784218,0.8541576723476808,0.6311188811188811,0.9819513746471631,1.0,3/14,17.63%,MYO7A;AHI1;CDHR1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.3428004967345232,0.8539685585262405,0.6598639455782312,0.981700878297088,1.0,5/18,20.59%,DDX19B;DDX19A;ENY2;IWS1;MCM3AP
prerank,chemical homeostasis (GO:0048878),0.2700445921317672,0.8538939236595244,0.6858288770053476,0.9811762585478813,1.0,10/61,17.02%,ZBTB20;ACOX2;TLCD3B;IRS2;SLC66A1;TENT4B;SLC4A1;WNK2;ABHD4;NR1D2
prerank,protein K63-linked deubiquitination (GO:0070536),0.30543993425317967,0.8535937154412248,0.6832298136645962,0.9811331010123686,1.0,8/31,17.14%,STAMBPL1;USP33;ATXN3;YOD1;USP16;USP13;STAMBP;PSMD14
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2496696190894545,-0.8534805638245457,0.7325581395348837,0.8596515775895779,1.0,14/39,25.48%,ARID2;PRKDC;KMT5B;SHLD2;PARP9;FUS;SMCHD1;DDX11;SETMAR;MGMT;WDR48;PARP1;DTX3L;KMT5C
prerank,eye photoreceptor cell development (GO:0042462),0.3547421824017868,0.8532255801867702,0.6412478336221837,0.9812801271882171,1.0,2/15,10.28%,MYO7A;RPGRIP1
prerank,cell cycle checkpoint signaling (GO:0000075),0.37879401636601184,0.8527406087367331,0.6648351648351648,0.9816858697782225,1.0,1/12,0.92%,BUB1B
prerank,positive regulation of inflammatory response (GO:0050729),0.2570284978922258,0.8523001357044107,0.7204884667571235,0.9819574917388031,1.0,13/86,17.31%,IL33;WNT5A;IL16;TSLP;PLA2G7;TLR4;VAMP7;PDCD4;CD81;RIPK1;DHX9;PTGER4;ADAM8
prerank,cholesterol metabolic process (GO:0008203),0.26661017663562053,0.8522738740134161,0.7086834733893558,0.9813453170311701,1.0,13/68,16.30%,NPC1L1;CEL;PPARD;DHCR24;SOAT2;ACAT2;PLPP6;HMGCS1;ABCA5;ACLY;SCAP;LDLRAP1;IDI1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3045471662250603,0.8520774702523927,0.6793048973143759,0.9811072061903644,1.0,6/29,17.28%,CXCL10;PLA2G7;LGMN;IL12A;CALR;LGALS9
prerank,glycosaminoglycan metabolic process (GO:0030203),0.2755538693055297,0.8520627185898724,0.6837481698389458,0.9804767301687687,1.0,13/54,15.44%,HSPG2;GPC4;GCNT2;GPC5;HS6ST2;GNS;GUSB;B4GALT7;IDUA;HS3ST6;HS3ST5;HEXA;SDC2
prerank,cellular response to amino acid starvation (GO:0034198),0.26299361987076936,0.8518207424428929,0.703601108033241,0.9803207731481401,1.0,19/71,19.01%,NPRL2;SZT2;WDR24;PRKD1;MTOR;EIF2AK2;DAP;TFEB;ATP6V0E1;EIF2S1;ATF2;MIOS;IMPACT;RRAGA;CASTOR1;ATP6V0D1;RRAGD;ATP6V1G2;EIF2AK3
prerank,regulation of protein dephosphorylation (GO:0035304),0.29254095607407343,0.8517884425911487,0.6864784546805349,0.9797239312703133,1.0,9/37,16.59%,DLC1;PPP6R2;PTPA;HSP90B1;ANKLE2;SYMPK;TSC1;PPP1R8;PPP6R3
prerank,regulation of necroptotic process (GO:0060544),-0.27515471615812775,-0.851782189103681,0.7282608695652174,0.8623702307565096,1.0,12/23,26.97%,YBX3;PELI1;CASP8;CYLD;SDCBP;MLKL;PDCD6IP;CFLAR;BIRC3;SLC25A4;FLOT1;ZBP1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.31301758976872657,-0.8516248723028361,0.6440281030444965,0.8620412761726046,1.0,5/17,16.12%,KLF4;ANXA1;TMSB4X;MAP2K5;ANXA4
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.31064328654592643,-0.8516191472678601,0.6592592592592592,0.8614061947685319,1.0,4/16,10.61%,FOXD1;SIX1;FGF1;NPNT
prerank,"phototransduction, visible light (GO:0007603)",0.3596619001689745,0.8515118826360388,0.6405451448040886,0.9796235788997458,1.0,2/14,11.78%,GNA11;ABCA4
prerank,pyroptosis (GO:0070269),0.35611813317862884,0.8514107581450855,0.671353251318102,0.9791865847578151,1.0,4/15,19.67%,CASP4;GSDMD;DHX9;GSDME
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.358589362057999,0.8513927207321823,0.6451612903225806,0.9785518326677726,1.0,4/14,15.02%,NMNAT3;AK4;AK8;AK3
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3319365066999638,0.8513652542230895,0.6508196721311476,0.9779542582692343,1.0,2/21,7.70%,IL34;PTK2
prerank,regulation of transport (GO:0051049),0.29636482558674465,0.8508981750466269,0.6558823529411765,0.9783633884850377,1.0,7/36,11.18%,TMEM102;VAMP2;LRRK2;MYO6;PINK1;POFUT2;SCFD1
prerank,response to amino acid starvation (GO:1990928),0.26180720414351244,0.850299747071601,0.7125171939477304,0.9789930932403871,1.0,19/72,19.01%,NPRL2;SZT2;WDR24;PRKD1;MTOR;EIF2AK2;DAP;TFEB;ATP6V0E1;EIF2S1;ATF2;MIOS;IMPACT;RRAGA;CASTOR1;ATP6V0D1;RRAGD;ATP6V1G2;EIF2AK3
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.34326785317250563,-0.8500882719176073,0.6442953020134228,0.8637418308607125,1.0,6/11,47.98%,SIRT1;TAF7;CIITA;PF4;IL4;TMEM106A
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.33102765933274314,-0.849648738102888,0.6932084309133489,0.8639649694673662,1.0,8/12,37.58%,SMO;SIX1;AGT;SIX4;SOX8;LHX1;PAX8;NOG
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3263614763080904,0.8493605445324048,0.6506410256410257,0.9802712225195996,1.0,2/21,4.06%,LRP1;NR1H2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.369374276494941,0.8490153692416373,0.6341030195381883,0.9803573765752752,1.0,2/12,9.69%,GCNT2;BMP7
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3660030054422133,0.8487691424485788,0.6678571428571428,0.9802375629541551,1.0,4/12,15.21%,SEC63;SEC61B;HSPA5;GET3
prerank,regulation of histone modification (GO:0031056),-0.32930253231844314,-0.848567730396808,0.6822222222222222,0.8654354625094464,1.0,5/13,17.82%,AKAP8;MTHFR;UBE2N;MYOCD;CDK9
prerank,cellular copper ion homeostasis (GO:0006878),0.35294969833462986,0.8485554988559777,0.6470588235294118,0.980030174214342,1.0,3/14,14.03%,CCDC22;ABCB6;ATP7A
prerank,chromosome condensation (GO:0030261),-0.25146304086295185,-0.8473518659131355,0.7098591549295775,0.8671781577368614,1.0,15/36,29.13%,SMC2;PHF8;TENT4A;PHF13;GPER1;AIFM1;CSNK2B;CHMP1A;NCAPH2;BANF1;SMC4;RB1;NCAPG2;DFFB;TTN
prerank,regulation of neurogenesis (GO:0050767),0.26763861345610174,0.8473425472861468,0.7009735744089013,0.9819226117113459,1.0,9/55,11.46%,REST;SORL1;SERPINF1;DOCK7;PER2;APPL2;WNT3;NAP1L1;SNW1
prerank,dendritic cell chemotaxis (GO:0002407),0.35281614589572535,0.8472283453022309,0.6331569664902998,0.9815000488708794,1.0,5/14,25.54%,GPR183;TRPM2;PIK3CG;HMGB1;CCR5
prerank,regulation of dopamine secretion (GO:0014059),0.3199959765578214,0.8470526215156978,0.651685393258427,0.9811969749572061,1.0,6/25,18.61%,SYT3;SYT7;SYT5;GDNF;SYT6;SYT1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.27296713846538717,0.8468374521268871,0.6991525423728814,0.981006052179684,1.0,9/51,15.62%,EPB41L3;CNTNAP2;MAP4K4;LRRK2;BMP7;ATP7A;CTTN;SGK1;TNIK
prerank,defense response to symbiont (GO:0140546),0.2511008117853298,0.8467889293103876,0.7189119170984456,0.9804461285126372,1.0,14/92,15.88%,MAP3K14;RTP4;CD40;IFIT2;TLR8;PDE12;TRIM56;IFNLR1;EIF2AK2;PYCARD;AGBL4;SERINC5;CNOT7;EXOSC5
prerank,regulation of protein transport (GO:0051223),0.31113570188084116,0.846621359862765,0.6534954407294833,0.9801432038103427,1.0,9/27,17.32%,DNAJC1;LLGL1;P3H1;NDFIP2;SCFD1;ARFIP1;SNX12;NDFIP1;STXBP5
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.2794519621059268,0.8462621651086002,0.6804281345565749,0.9802023688645699,1.0,8/42,14.95%,CECR2;HDAC1;CHD4;MBD3;SPTY2D1;SMARCA1;CHD8;DMAP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.24284369641961975,0.8461391811085975,0.7239648682559598,0.9797927088128561,1.0,23/129,15.81%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;SSNA1;MELK;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;BRSK2;CLASP1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.36011668222531845,0.8461370448142992,0.6586620926243568,0.9791343636218839,1.0,2/15,4.54%,KDF1;NCOA3
prerank,regulation of sodium ion transport (GO:0002028),0.2951966339994317,0.8459732169253047,0.6732223903177005,0.9788225452092927,1.0,7/34,11.17%,NKAIN1;CNKSR3;ANK3;NKAIN2;NEDD4;FGF12;P2RX4
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.27784250908386365,-0.8457410819256939,0.7436619718309859,0.8697077069504032,1.0,9/24,21.54%,BCL2L1;ACKR3;CD44;TPT1;SIRT1;SNAI1;CD74;MIF;CCAR2
prerank,homocysteine metabolic process (GO:0050667),0.38414585537649754,0.8456659376846283,0.6327272727272727,0.9787900599388704,1.0,4/11,17.19%,MTRR;BLMH;DPEP1;MMUT
prerank,regulation of TOR signaling (GO:0032006),-0.21732868326833613,-0.8454877330874428,0.8233082706766918,0.8695533686928174,1.0,15/67,16.14%,FNIP1;DEPTOR;RICTOR;PRKAA2;SH3BP4;UBR1;LAMTOR5;RRAGC;HDAC3;UBR2;TBC1D7;LAMTOR3;TBCK;SIRT1;PRKAA1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.30295151188118835,0.8453411789466697,0.678516228748068,0.9781417057370825,1.0,5/29,15.23%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.30295151188118835,0.8453411789466697,0.678516228748068,0.9781417057370825,1.0,5/29,15.23%,ACSF2;ACOT7;ACSL6;ACLY;ACOT2
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.17578650504260723,-0.8448698465230688,0.9583333333333334,0.8701002575694995,1.0,108/336,26.42%,FOXO1;FOXP1;BCL2L1;XIAP;SAMHD1;VCPIP1;MCL1;ACER2;CBX3;PRKDC;UVRAG;KMT5B;APC;TRIP12;MAPK14;CASP2;RNF8;VCP;NRDE2;FNIP2;INTS3;TLK2;UBA6;CRIP1;PAXX;BTG2;DYRK2;BAX;UBE2A;RBBP8;INO80;RECQL5;ATR;CBX1;ZDHHC16;RTEL1;BID;OTUB1;RNF169;HERC2;WDHD1;ETAA1;ATM;BOK;GNL1;LIG1;POLE2;NBN;CDKN2AIP;CCND1;GRB2;PLK5;RAD51D;CDKN1A;NSMCE4A;DDX11;ENDOV;RAD51C;PARP4;SIRT1;NSMCE3;TRRAP;EPHA2;OARD1;APTX;HUS1;MUS81;OGG1;XRCC2;APBB1;USP3;NPM1;GTF2H4;MACROD1;CIB1;CHD1L;E2F1;MCM9;MGMT;PHF1;BATF;FANCG;WDR48;IKBKE;RFWD3;ZRANB3;TAOK2;PARP1;MCM8;PARP2;BCL2L11;IKBKG;ATRIP;SUMO1;RMI2;RAD51;BACH1;DTX3L;BRSK1;HINFP;CHEK2;NCOA6;KMT5C;TIGAR;BRCA1;PCLAF;PARK7;CHRNA4
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.2314493885973125,-0.8448611103367368,0.7736486486486487,0.8694693865286919,1.0,25/54,31.37%,CAV1;NXN;SQSTM1;RPL5;SOX4;SH3RF2;RPL11;HDAC8;ISG15;DCUN1D3;AKT1;COPS9;TNFAIP3;VPS28;SMAD7;BAG2;SENP2;HSPA1A;ARRB2;PARK7;U2AF2;PRR7;HSPA1B;MINAR1;CAMLG
prerank,mitochondrial fission (GO:0000266),0.34404478839519625,0.8448298051526021,0.6702508960573477,0.9785754203087433,1.0,4/16,14.74%,MTFR2;OPA1;DNM1;MTFP1
prerank,protein homooligomerization (GO:0051260),0.24258940820571084,0.8448014775911508,0.7522012578616353,0.977976304343095,1.0,16/114,11.66%,SLC1A5;TRPA1;POLQ;MPP2;ADCY8;CLYBL;ASIC1;GOLGA2;KCNC2;APPL2;HCN1;GLRA3;GSDMD;VSTM5;PYCARD;TRPM2
prerank,positive regulation of cartilage development (GO:0061036),0.33804963057181425,0.8446490800212121,0.6672354948805461,0.9776125715892892,1.0,5/17,12.02%,LOXL2;SOX6;ZBTB16;TAPT1;SOX9
prerank,global genome nucleotide-excision repair (GO:0070911),0.3097155933943611,0.8446450008580044,0.6776212832550861,0.976963922782425,1.0,9/26,20.54%,ERCC1;ERCC4;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;USP45;DDB1
prerank,regulation of epithelial cell migration (GO:0010632),0.2762624906571803,0.8445589884188004,0.6783216783216783,0.9764959415727579,1.0,6/51,7.70%,PTN;PTPRR;RHOJ;MCC;GLIPR2;PTK2
prerank,regulation of cell size (GO:0008361),0.3217161831140867,0.8442998737710531,0.6618589743589743,0.9763879389637955,1.0,4/23,9.11%,PRR16;PTEN;MTPN;MTOR
prerank,synaptic vesicle cycle (GO:0099504),0.3025023849298707,0.8441518325519867,0.6600306278713629,0.9760508131392417,1.0,7/30,17.24%,VAMP2;SYNDIG1;SYT7;RIMS1;DNAJC5;PCLO;CDK5
prerank,striated muscle cell differentiation (GO:0051146),0.3443059756611061,0.8439188821249792,0.664440734557596,0.9758842219155125,1.0,2/16,3.70%,NRG1;MYEF2
prerank,tRNA aminoacylation (GO:0043039),0.2895223748448591,0.8438946683875509,0.6862464183381088,0.9752727821372904,1.0,13/37,26.61%,EPRS1;CARS1;TARS1;YARS1;HARS1;SARS1;SARS2;AIMP1;PPA2;MARS2;AARS1;FARSA;YARS2
prerank,anterior/posterior axis specification (GO:0009948),-0.3210508393359959,-0.8438737296686201,0.6957547169811321,0.8707677697561873,1.0,2/15,6.37%,SKI;WLS
prerank,negative regulation of protein catabolic process (GO:0042177),-0.24417750217355688,-0.8437308978526333,0.7469135802469136,0.8704215142652639,1.0,8/40,20.11%,EGFR;PTPN3;CST3;AZIN1;FLNA;CYP51A1;SNX3;TIMP3
prerank,regulation of axon extension (GO:0030516),-0.2513839221282883,-0.8435878329821476,0.7373417721518988,0.8700446285475422,1.0,8/37,13.68%,NTN1;SEMA7A;RUFY3;APOE;GSK3B;MAPT;GOLGA4;MACF1
prerank,regulation of protein secretion (GO:0050708),0.24353051594397673,0.8434107015246898,0.7420537897310513,0.9756526877770743,1.0,17/119,12.83%,RAPGEF4;PPID;CACNA1E;ITPR1;DNAJC1;LLGL1;IER3IP1;PER2;PRKCA;P3H1;KCNC2;SYT7;GCK;PPP3CB;EXOC1;IL12A;ARFIP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3095618461218021,0.8433349409527603,0.637223974763407,0.975167631412447,1.0,10/27,18.79%,CTNNA2;PTEN;DISC1;GSK3A;NTNG2;NTNG1;BRSK2;NCS1;IL1RAPL1;ULK4
prerank,endomembrane system organization (GO:0010256),0.23101205964170193,0.8433166910230344,0.7679814385150812,0.9745433251349163,1.0,50/178,22.55%,SEC16B;PHETA2;SEC16A;SPTBN1;ANK3;GBF1;DNAJC28;LRRK2;SMPD4;SUN2;SYP;GOLGA2;PRKD1;RAB30;RAB29;RAB2A;DNM1;WASHC5;LNPK;SYNE1;AP3D1;COG1;TRIP11;CLASP2;PHETA1;HACE1;VPS33B;CLASP1;USP6NL;UBXN2B;TMED3;TMED9;GOLGA8B;GOLGA5;CTDNEP1;CUL7;NUP155;EIF2AK3;MIA3;TRAPPC12;TBC1D20;PLEKHM2;ARFGEF2;PI4K2A;ATL1;TLCD1;SERP1;BAG5;BNIP1;RAB22A
prerank,cellular response to retinoic acid (GO:0071300),-0.24447335447581856,-0.8428544354442443,0.739938080495356,0.870839009689119,1.0,10/42,15.29%,WNT5B;WNT9A;FZD4;FZD7;TBX1;WNT6;RET;ATM;PTK2B;CREB1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.3468199750956231,-0.8422959249875027,0.647887323943662,0.8712754988356578,1.0,3/11,12.72%,TGFB2;SOX4;HEY2
prerank,organelle assembly (GO:0070925),0.2182164793259955,0.842184937607857,0.8585106382978723,0.97626683500694,1.0,78/385,18.18%,DYNLL1;CDC14B;ATG9B;TRAF3IP1;CCDC61;DZIP1;NPHP3;WDPCP;WDR35;HAUS3;WDR45B;HAUS1;GBF1;LSM14A;CCDC57;RAB8A;CENPE;STARD9;DISC1;ATP2A2;LSM4;E2F4;CAPN3;IFT81;HAUS8;FAM161A;BSCL2;GOLGA2;HPS1;ABCB6;SNAP29;RB1CC1;CCDC65;AHI1;TCTN2;IFT74;RCC1;BBIP1;EXOC7;EXOC1;TMEM67;ASAP1;EDC3;IQCB1;SSX2IP;RFX2;TUBGCP4;IFT88;CENPC;HGS;RAB11FIP3;CEP126;CENPW;SCLT1;TXNDC15;EIF2S1;ACTR2;ATG9A;TSG101;EIF4ENIF1;DYNLL2;CEP250;ATG14;SNF8;TUBGCP6;PTPDC1;CENPF;ULK2;IFT43;UBXN2B;CLUAP1;VPS4B;GOLGA8B;BBS1;WIPI2;PCM1;ATP6V0D1;WDR90
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.31246525845553375,0.842091053955806,0.6872037914691943,0.9758236718878491,1.0,12/28,25.42%,ITPR1;CASP4;DNAJC10;BAK1;BAG6;BRSK2;BBC3;TNFRSF10B;DDIT3;TMEM117;ATF4;SELENOK
prerank,endocytic recycling (GO:0032456),0.2761698366364723,0.8416776602090333,0.6777456647398844,0.9760553421557402,1.0,10/50,16.12%,CCDC22;MICALL2;EPS15;VPS39;VPS26C;RAB11FIP3;ENTR1;SNF8;SNX12;VPS52
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3304684622956242,-0.8416055854963603,0.6901408450704225,0.8719754799427728,1.0,8/13,38.05%,UPP2;OGG1;NEIL1;NT5M;NTHL1;SMUG1;NEIL2;DCTPP1
prerank,protein glycosylation (GO:0006486),0.23861927889509316,0.8411457301658475,0.772609819121447,0.9765518017840397,1.0,22/125,14.57%,PLOD1;ST8SIA1;OGT;GALNT18;RPN2;GCNT2;ENTPD5;DAD1;POMT1;ALG6;GFPT2;B3GNT8;MAN1C1;GOLGA2;GALNT10;ALG5;FKTN;TUSC3;TMEM258;B4GALT7;B3GALT5;PMM2
prerank,centromere complex assembly (GO:0034508),0.28534335682144485,0.8410996238975387,0.6886503067484663,0.9760099893653885,1.0,7/36,15.58%,MIS18A;CENPU;CENPE;CENPC;CENPW;MIS18BP1;CENPF
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.31468371030280906,0.8410275686949549,0.6769983686786297,0.9755025726175321,1.0,7/24,18.49%,NR1H2;LRRK2;HERPUD1;OPA1;CREB3L1;CLU;ALOX5
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.31557895134432545,-0.8409865527074744,0.6708542713567839,0.872562089164744,1.0,7/16,23.28%,ST8SIA4;ST6GALNAC3;LARGE1;ST8SIA2;ST3GAL5;A4GALT;ST8SIA6
prerank,regulation of mRNA polyadenylation (GO:1900363),0.3415762180214231,0.8408280084451264,0.6683417085427136,0.9752696836154269,1.0,3/17,10.19%,CPEB1;RNF40;NUDT21
prerank,regulation of intracellular pH (GO:0051453),-0.2577287246402307,-0.8404798793825607,0.7327586206896551,0.872842102117625,1.0,10/34,22.36%,SLC4A10;SLC9A2;ATP5F1B;SLC4A3;SLC4A8;SLC9A5;SLC26A6;SLC9B1;CFTR;SLC4A7
prerank,regulation of blood circulation (GO:1903522),0.293047113804813,0.8400131441750659,0.7059724349157733,0.9763335576224024,1.0,3/34,7.97%,ECE1;KCNIP2;PER2
prerank,dendritic cell differentiation (GO:0097028),0.32176601151626544,0.8388032697574306,0.6574675324675324,0.9782350222354439,1.0,6/22,19.87%,AXL;CAMK4;TRPM2;LYN;LGALS9;PRTN3
prerank,reverse cholesterol transport (GO:0043691),0.36225708616963326,0.838476589078249,0.6615905245346869,0.9783105675192507,1.0,3/13,15.09%,LIPC;ABCA5;CLU
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.3139272638054712,0.8384551256509508,0.6534181240063593,0.9776950994997012,1.0,3/26,8.55%,ATP1A2;FMR1;GNB5
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2257908278682787,-0.8378797942620336,0.8214285714285714,0.8771607183267646,1.0,14/64,22.05%,PLA2G4A;CYP1B1;ACOT8;MGLL;AIG1;GPX1;ACSL4;ACSL5;PTGS2;ALOX12;PNPLA3;PLA2G4C;SLC27A2;FAAH
prerank,autophagosome maturation (GO:0097352),-0.2550735115665028,-0.8377383368460826,0.7419354838709677,0.8767753361563505,1.0,6/32,7.75%,UVRAG;GABARAP;EPG5;GABARAPL1;CALM1;VCP
prerank,regulation of cell death (GO:0010941),0.24818710945161115,0.8375404553882934,0.7459893048128342,0.9789401649584574,1.0,13/94,9.69%,LRP1;ACOX2;EPHB1;HTR2B;DHCR24;LRRK2;PDE12;DUS2;NPAS2;PRKD1;DCC;RAB29;BMP7
prerank,toll-like receptor signaling pathway (GO:0002224),0.2527403791041568,0.8375395658924503,0.7356475300400535,0.9782927340527531,1.0,17/84,17.67%,COLEC12;UNC93B1;NR1H4;TLR6;TLR8;LGMN;TLR4;BIRC2;IRAK1;MAPKAPK3;S100A1;HSP90B1;UBE2D1;RIPK1;TIRAP;LGALS9;MYD88
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2662954980902727,-0.8372093237354992,0.7323232323232324,0.8771836570128683,1.0,7/25,16.03%,SLIT2;KANK1;CAPZB;TBC1D7;EVI5L;PRKCD;ARHGAP44
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2997238000361007,0.8369453680441153,0.7006079027355623,0.9788981892165706,1.0,11/33,17.78%,HRG;RAC3;PTK2;JAM3;PLAU;TESC;LYN;EFNA1;FERMT3;PIK3CG;PDE3B
prerank,regulation of cell-cell adhesion (GO:0022407),0.28320684121006695,0.8367704786185591,0.701780415430267,0.9786244639461331,1.0,5/39,7.70%,EPHA7;TENM3;PTPRR;FLOT2;PTK2
prerank,phospholipid metabolic process (GO:0006644),-0.2166542678267705,-0.8367061520650739,0.8,0.8775285904356428,1.0,19/71,23.41%,PLPP3;MBOAT1;PLA2G4A;SMPD3;AGPAT4;TNFAIP8L3;ENPP2;PIP4P1;PGP;PLAAT3;SMPD1;CLN8;PLA2G4E;PNPLA3;PIP5K1A;AGPAT2;PLA2G4C;PLPPR1;FITM2
prerank,ERAD pathway (GO:0036503),0.25212052726081013,0.8364331420561447,0.7278645833333334,0.9786642704148534,1.0,22/83,16.82%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;RCN3;TMEM67;DNAJC10;USP19;HSP90B1;ATXN3;HSPA5;BAG6;YOD1;BRSK2;UBXN6;USP13;DNAJB14
prerank,positive regulation of actin nucleation (GO:0051127),-0.34270765295234973,-0.8363294771705537,0.6666666666666666,0.8776266060889315,1.0,2/11,3.69%,WASF2;GSN
prerank,cell cycle G2/M phase transition (GO:0044839),0.2399371913569944,0.8361704456650949,0.7518796992481203,0.9785414913189914,1.0,23/130,15.81%,DYNLL1;CDK14;DCTN3;HAUS3;PKMYT1;HAUS1;CCDC57;DCTN2;HAUS8;CCNB2;PRKACA;CEP192;PPP2R2A;CEP135;SSNA1;MELK;CCNA2;CEP250;FOXM1;CEP152;CSNK1E;BRSK2;CLASP1
prerank,protein autoubiquitination (GO:0051865),0.2640800846144015,0.8357692827532528,0.7200557103064067,0.9787373897486018,1.0,5/61,7.21%,SH3RF1;SH3RF3;RNF220;BFAR;TRIM37
prerank,mucosal immune response (GO:0002385),0.34660303905563244,0.8356942122782658,0.6555944055944056,0.9782267725296868,1.0,15/15,65.37%,IFNLR1;OTUD7B;PLA2G1B;DEFA6;PIGR;LTF;FFAR2;DEFB1;BPIFB1;CAMP;IL4;RAB17;NOS2;RNASE3;RPL39
prerank,negative regulation of ATPase activity (GO:0032780),0.33909637096304984,0.8354991439987537,0.6683673469387755,0.9779768272672187,1.0,5/16,20.41%,VCPKMT;TP53;PAM16;TSC1;PXK
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.22923594267130162,-0.835354499063954,0.8,0.8788393175584125,1.0,11/46,20.68%,DGKH;PLA2G4A;PLD2;AGPAT4;DGKG;LCLAT1;DGKZ;DDHD1;DDHD2;PNPLA3;AGPAT2
prerank,positive regulation of cell cycle (GO:0045787),-0.22256445783277862,-0.8352437172129128,0.8344827586206897,0.8784041824151974,1.0,17/62,22.16%,EGFR;CCNYL1;APP;CCND2;TGFB2;LRP6;RPS15A;CITED2;CCND1;TAL1;ANKRD17;EIF4EBP1;PKN2;AKT1;RGCC;ASNS;NUPR1
prerank,positive regulation of nuclear division (GO:0051785),0.3122601435691661,0.8347427522008746,0.6768,0.9788849336786214,1.0,4/25,12.42%,EDN3;PHIP;NUSAP1;IGF2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3585959295803652,0.8345653233205801,0.6654676258992805,0.9785992676779474,1.0,4/13,14.78%,GRIN2A;LGMN;ASPH;BAK1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.2851436148462597,0.8341795898426142,0.7029096477794793,0.978768649206468,1.0,7/38,12.73%,IL34;UNC119;DLG3;RELN;GRM5;DLG4;CASS4
prerank,mesenchymal cell development (GO:0014031),-0.2935175583163336,-0.8338581826607813,0.6911392405063291,0.8803385274563732,1.0,6/18,12.82%,FOXC1;NOTCH1;TCOF1;HEYL;HEY2;NOLC1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.32298048772215027,-0.8336729952560265,0.7032710280373832,0.8800216931499553,1.0,8/13,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;GAL3ST3;B3GNT6;B4GAT1
prerank,sphingoid metabolic process (GO:0046519),-0.33717425435194515,-0.8329225129846076,0.680952380952381,0.8808042072293839,1.0,5/12,26.54%,PLPP3;DEGS2;KDSR;SPHK2;ASAH2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.28801920582263724,0.8329043495492214,0.7119402985074627,0.9807920119736618,1.0,6/34,12.59%,EDN3;PHIP;CDC16;NUSAP1;IGF2;ANAPC5
prerank,protein lipidation (GO:0006497),0.26780849110551225,0.8327069742305795,0.7183499288762447,0.9805715874339788,1.0,21/59,27.31%,PIGV;GPLD1;PIGQ;WDR45B;PIGP;PIGA;PIGL;ZDHHC2;HHAT;ZDHHC6;WIPI2;ZDHHC9;ZDHHC8;ATG10;ZDHHC17;PIGN;SELENOK;MPPE1;PIGB;WIPI1;PIK3C3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2586105998583205,0.8324669540068517,0.7355021216407355,0.9804150499014421,1.0,10/63,11.50%,SH3RF1;TCF7L2;PHIP;ITGAV;FGFR1;NOL3;G0S2;SP100;PYCARD;TGFBR1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2119705642954695,0.8323161564983097,0.9019607843137255,0.9800726324957854,1.0,104/572,17.45%,IL33;ZEB1;ZFHX3;TRPS1;PPARA;MIER2;ETV5;HDAC1;PPID;TAF9B;NR2F2;TCF7L2;SALL1;THRA;NR1H4;PEX2;PER3;MEIS2;NFATC3;PPARD;NR1H2;LOXL2;REST;TBX3;ZBTB16;NEDD4;ZFP37;RTF1;SIRT6;PSMD10;BCOR;GLIS1;DUSP22;TENM2;SRF;BRMS1L;BRMS1;ZBTB2;TRIM37;LYAR;BCL6;NR2C1;TAF3;ZKSCAN3;MDM4;PER2;TWIST1;SOX2;MXI1;NOC2L;PHF6;SP100;NSD1;GLI3;SOX10;TP53;N4BP2L2;ZFPM2;ZNF25;SNW1;EPC1;ESR2;SOX9;MYT1L;IGF2;SAP30;DPF2;KDM1B;CNOT1;PRDM5;ATN1;NRIP1;NFIX;HDAC10;PEG3;MED1;CUX2;UBE2D1;MED25;BPTF;ZBTB32;CHD8;FOXM1;DMAP1;AR;MYC;CRY2;ORC2;DCAF1;FGFR2;KLF11;IMPACT;EFNA1;ZBTB7A;AASS;ZNF3;MAZ;NR1D2;CALR;DNMT3A;SARS1;MBD2;LDB2;LDB1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3169365911122691,0.832167607145105,0.6911076443057722,0.979746114018047,1.0,6/25,12.95%,ADK;GMPS;AMPD2;PRPS1L1;PRPS1;DGUOK
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.25737794391116087,0.8316117878928369,0.7337748344370861,0.9802794688830655,1.0,17/67,18.81%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;PSMA7;CALR;PSMD14;PSMA2;PSMD11
prerank,lysine catabolic process (GO:0006554),0.35657203348563293,0.8311377706184904,0.6467391304347826,0.9799472439507244,1.0,3/12,16.27%,SLC25A21;DLST;AASS
prerank,lysine metabolic process (GO:0006553),0.35657203348563293,0.8311377706184904,0.6467391304347826,0.9799472439507244,1.0,3/12,16.27%,SLC25A21;DLST;AASS
prerank,regulation of protein catabolic process (GO:0042176),-0.19705658852265112,-0.8308476747991931,0.8472222222222222,0.8840741249692756,1.0,24/99,20.49%,FOXO1;WWP1;EGFR;WWP2;GPC3;APC;GSK3B;VCP;AZIN1;SMURF2;EEF1A1;ASB5;RNF41;APC2;FLNA;FURIN;OAZ1;CYP51A1;OAZ2;TMEM9;SNX3;WDR91;FZR1;TNFAIP3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.25456000671701867,0.8304378372887302,0.7408854166666666,0.980708268415868,1.0,17/70,18.81%,ITGAV;ITGB5;PSMD1;PSMD10;SNAP23;PSMA5;PSMB5;CYBA;PSMC4;PSMA4;PSMC5;PSMB9;PSMA7;CALR;PSMD14;PSMA2;PSMD11
prerank,regulation of RNA metabolic process (GO:0051252),-0.2220082922677588,-0.8304340585474014,0.7907801418439716,0.8841695526110886,1.0,17/59,18.41%,MBNL1;AHNAK;AHNAK2;NOVA2;CELF1;HNRNPF;PCBP2;PTBP3;RC3H1;MBNL2;FASTK;FUS;HNRNPH1;SRRM4;FAM50A;RASA1;PQBP1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3353050383211708,0.829821073655871,0.688663282571912,0.9813314193329423,1.0,3/16,12.02%,ACADL;APPL2;SOX9
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3756423645222046,0.829798704341206,0.6579861111111112,0.9807323529886516,1.0,2/10,14.03%,KYNU;ATP7A
prerank,cellular response to zinc ion (GO:0071294),-0.30485827371812235,-0.8297641578709247,0.6960556844547564,0.8848035831639514,1.0,11/15,30.91%,MT2A;MT3;HVCN1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.37781704562186524,0.8296768498532625,0.6731448763250883,0.9803425349775514,1.0,3/10,10.42%,TSPAN6;DHX58;SEC14L1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.36683121627687404,0.8294912806751302,0.6871609403254972,0.9800562523279563,1.0,2/11,12.14%,TIMM10;AGK
prerank,oligodendrocyte development (GO:0014003),0.34519884931690054,0.8294458458282666,0.6701030927835051,0.9795149371358526,1.0,4/15,13.88%,EIF2B1;SOX10;PLP1;MYRF
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.32222341132550225,0.8291177556105694,0.7179930795847751,0.9795081144723647,1.0,2/21,1.52%,SPRY4;SPRY1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2734183649439127,-0.8290688272983269,0.7060367454068242,0.8853581010094402,1.0,9/22,24.09%,GTF2H5;UBB;UBC;RAD23B;GTF2H4;CHD1L;UBA52;CETN2;PARP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.23526059018385703,0.8274217031287158,0.7847309136420526,0.9822730213309415,1.0,17/121,12.94%,GHR;IL34;UNC119;CD40;ERBB4;TSLP;DLG3;DGKQ;IL5;RELN;TP53;GRM5;DLG4;IL12A;IGF2;CASS4;CD81
prerank,neural crest cell differentiation (GO:0014033),0.3355536193238799,0.8273847247099864,0.6574225122349103,0.9817114496696178,1.0,3/18,9.37%,NRG1;HTR2B;TAPT1
prerank,positive regulation of developmental growth (GO:0048639),0.27166702600681,0.8265164697636419,0.7165242165242165,0.9828520986116599,1.0,12/49,20.02%,GHR;CDKL5;LIMK1;RIMS2;SYT3;PLAA;RIMS1;UNC13A;CPNE9;SYT1;ZFYVE27;MAP3K13
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3236965673244166,-0.8262596592133343,0.7130620985010707,0.8898246143489841,1.0,7/11,27.18%,SERTAD1;ARID1B;SMARCD1;ELOF1;PADI2;CDCA4;CHEK1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.24462173718441468,0.8262232733524998,0.7722513089005235,0.9827552401030792,1.0,18/91,15.24%,PLD1;ITGAV;VAMP2;LRRK2;RAB8A;RUFY1;RAB3C;RIMS2;MAP2K1;FGR;OPHN1;SYT7;RAB15;SCFD1;ATP9A;RINT1;SNX12;PACSIN3
prerank,cellular calcium ion homeostasis (GO:0006874),0.23401203109509994,0.8257152135778406,0.7925211097708083,0.9830993336046435,1.0,16/133,9.08%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ADCY8;CALCA;HERPUD1;CALB1;ATP13A3;TRPC3;PRKACA;MICU3;HTR2C
prerank,regulation of DNA recombination (GO:0000018),0.2868043361231064,0.8253616574609032,0.7149187592319055,0.9831406044181894,1.0,10/32,22.34%,MSH3;SIRT6;ZCWPW1;SPIDR;KPNA1;FIGNL1;MSH6;TERF2IP;PPP4R2;KPNA2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3341258365359605,-0.8251736449741703,0.691415313225058,0.8912315021824588,1.0,6/12,28.65%,SERINC3;PSAT1;CBS;SEPHS2;CTH;GGT1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.33323408913863184,0.824918597550601,0.685,0.9833923284744489,1.0,4/16,10.89%,HNRNPA2B1;ERCC4;TERF1;DHX36
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.24104508384022688,-0.8248917836438466,0.7854984894259819,0.891096030710619,1.0,12/37,25.88%,NFKB1;RIN3;APOE;OPTN;ITGB3;EDN1;SDCBP;SIRT5;MTMR2;ANKRD13D;MT3;BRCA1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.24814784715553867,0.8247355201861606,0.755359394703657,0.9830861315978411,1.0,28/88,23.38%,FBXO9;PSMD1;FBXO31;DMAC2;PSMD10;PSMA5;PSMB5;AMN1;FBXO17;PSMC4;PSMA4;PSMC5;FBXW5;FBXL13;CUL5;PSMB9;PSMA7;PSMD14;PSMA2;CUL4A;PSMD11;FBXO4;FBXW4;FBXL22;BTRC;FBXL5;FBXL12;KIF14
prerank,keratan sulfate catabolic process (GO:0042340),0.3624557392229659,0.824108272798651,0.6848591549295775,0.9837156462614983,1.0,3/11,15.26%,LUM;GNS;HEXA
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.21618129942955794,0.8237936190720453,0.8745945945945945,0.9837140522825467,1.0,82/327,22.97%,RORA;CHD7;ZFHX3;MSC;ATF5;NCOA2;MYT1;TEAD2;REST;SOX6;ZNF423;FOXN2;CXXC1;ZFP37;HP1BP3;SPIN1;SPTY2D1;SOX2;EDF1;DAXX;SRRT;BRCA2;NSD1;TP53;NFXL1;TGFBR1;ESR2;SRSF10;IGF2;TFEB;SAP30;NUP107;ZNF628;CARM1;HDAC10;ARNT2;SSBP2;TGFBRAP1;UBE2V1;HNRNPD;MLF1;ATF2;WTIP;MAFB;ZKSCAN5;TRIP4;NONO;USP13;NR1D2;CALR;ZBTB11;LDB1;MLF2;BMP2;KAT7;SKOR2;REXO4;HIF1A;WWC1;THAP7;TERF2IP;NR2C2;SP1;TRAPPC2;CNBP;DVL2;HCFC2;GON4L;UTP4;APBB3;ASCC1;DDIT3;CREBBP;LIN54;SERTAD3;ATRX;MLLT6;NLK;RREB1;ABL1;HOXB7;ZMIZ1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.36149361713454164,0.8234854633916405,0.6815834767641996,0.9837062518297508,1.0,1/12,1.00%,PPARA
prerank,cellular response to reactive oxygen species (GO:0034614),0.2620443414862253,0.8234112485640543,0.7321178120617111,0.9832167650949843,1.0,9/59,11.67%,PDGFRA;ERCC6L2;FOS;CAMKK2;PRDX5;FXN;PLEKHA1;TRPM2;PDK2
prerank,ventricular septum development (GO:0003281),0.28203432720750843,0.8233146469979487,0.7195301027900147,0.9827870982463415,1.0,8/37,15.14%,ROBO2;SALL1;MDM4;ZFPM2;TGFBR1;HECTD1;DAND5;GJA5
prerank,somite development (GO:0061053),0.3693612550157389,0.8232253047643509,0.6872909698996655,0.982310668163901,1.0,2/11,10.12%,LOXL3;PPP2R3A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.31545737549403924,0.8226592893381997,0.7030201342281879,0.9827631650473438,1.0,4/22,8.98%,PDE4B;FMR1;GNB5;CACNB4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.26657075781619116,0.8224821958225164,0.7403708987161198,0.9824972119060409,1.0,5/50,7.11%,SH3RF1;NGFR;DHCR24;NOL3;CDKN2D
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.33041015876481017,0.8223076154437049,0.6739495798319328,0.982195057124668,1.0,1/17,0.79%,XCL1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.31420776254794147,-0.8215374016040811,0.665903890160183,0.8965068472662021,1.0,11/14,50.62%,TYROBP;CSF1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;TRAF6;IL12B
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3045760959512598,-0.8214336189777032,0.7113924050632912,0.8960428346987331,1.0,3/16,10.01%,IGF1R;INSR;CLEC16A
prerank,gluconeogenesis (GO:0006094),0.28562409917259196,0.8212006283614278,0.7367624810892587,0.9837547516478666,1.0,6/39,11.24%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.3167389126129392,-0.8209675764482439,0.6951219512195121,0.8962144176540887,1.0,3/13,10.37%,ALG9;ALG12;MPDU1
prerank,mitochondrial genome maintenance (GO:0000002),0.3564980082789361,0.8209084291321542,0.6745886654478976,0.9837082214551593,1.0,4/11,13.98%,OPA1;SLC25A33;TOP3A;LONP1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.34951301366306975,0.8207320276831722,0.6739130434782609,0.9834210213983219,1.0,3/13,10.80%,GRIK2;SYP;SHISA6
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.35766106045650004,0.8204276801486204,0.676950998185118,0.9833596247694669,1.0,6/11,28.96%,JAK1;IL12A;CANX;STAT1;JAK2;STAT3
prerank,rRNA 3'-end processing (GO:0031125),-0.34175643959839097,-0.8201822872340054,0.7178899082568807,0.8970390792995008,1.0,4/10,15.85%,ERI1;RPS21;EXOSC2;EXOSC3
prerank,iron-sulfur cluster assembly (GO:0016226),0.3055954779805767,0.8200207099756909,0.6919191919191919,0.9835370460142329,1.0,6/24,16.72%,NUBP2;FXN;CIAO1;ABCB7;MMS19;ISCA1
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3398351561918616,-0.8197158414921868,0.6682692307692307,0.8965446082988187,1.0,4/11,19.80%,CCT3;CCT4;CCT7;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3398351561918616,-0.8197158414921868,0.6682692307692307,0.8965446082988187,1.0,4/11,19.80%,CCT3;CCT4;CCT7;MEPCE
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3129059093097009,0.818744169336971,0.6871961102106969,0.9854207414283187,1.0,6/22,17.33%,GPLD1;NRDC;SH3D19;PACSIN3;ADAM8;ADRA2A
prerank,negative regulation of autophagy (GO:0010507),0.2631824970946808,0.8182950085466537,0.7395079594790159,0.9856906406137498,1.0,13/54,18.12%,EIF4G3;HTR2B;PTPN22;LRRK2;ZKSCAN3;GOLGA2;PINK1;MTOR;DAP;SNRNP70;TSC1;RRAGA;KLHL22
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.32381453908407853,0.8180110794325345,0.695,0.9856167580453933,1.0,1/19,0.79%,XCL1
prerank,ncRNA 3'-end processing (GO:0043628),0.34151165829686453,0.8179122946397192,0.661641541038526,0.985191929517047,1.0,3/14,15.80%,INTS8;INTS14;PTCD1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.24475146311697446,-0.8178377306302345,0.782967032967033,0.8993713667339593,1.0,10/33,25.14%,AFAP1L2;HIP1R;CCDC88A;HIP1;GPER1;AKT1;EGF;AGT;DOK1;CNOT9
prerank,skeletal muscle contraction (GO:0003009),-0.28325768396157713,-0.8176460485916298,0.7042606516290727,0.8990856103664813,1.0,14/19,54.12%,STAC;TNNT3;TNNI1;STAC2;TNNC1;TNNI3;CCDC78;TCAP;TNNI2;MYH14;TNNC2;JSRP1;TNNT1;CHRNA1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.2787066611120141,0.8174200089494271,0.7127976190476191,0.9854882702799519,1.0,9/39,16.69%,UTRN;ANK3;SCN2B;NEDD4;FXYD4;FGF12;WNK2;FGF14;HECW1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.31973061686687715,-0.8172850786215151,0.7209302325581395,0.8991315678901964,1.0,5/12,36.86%,FDX1;FDXR;STAR;TSPO;FDX2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3164388039374064,0.8170628576989534,0.7030995106035889,0.9849600911653801,1.0,7/20,22.28%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;BCKDK;HIBADH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3164388039374064,0.8170628576989534,0.7030995106035889,0.9849600911653801,1.0,7/20,22.28%,MCCC1;ACADSB;BCAT1;SLC25A44;MCCC2;BCKDK;HIBADH
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.283725312400482,0.8168510187220339,0.7228177641653905,0.9847425064996334,1.0,10/36,17.82%,WNT5A;TCF7L2;AGO4;PPP3CB;AGO3;GNAO1;GNG2;TNRC6B;AGO1;CAMK2A
prerank,icosanoid metabolic process (GO:0006690),-0.2378951143121779,-0.8165924853286135,0.8115942028985508,0.8997304166064292,1.0,5/40,5.00%,PTGS1;PLA2G4A;CYP1B1;MGLL;PON3
prerank,negative regulation of telomere maintenance (GO:0032205),0.33502629059649713,0.8156543464474244,0.6993127147766323,0.9864592240803068,1.0,3/15,7.80%,ERCC1;ERCC4;TERF1
prerank,Rac protein signal transduction (GO:0016601),0.3270939447205602,0.8156080973137648,0.7194492254733219,0.9859230044903616,1.0,5/18,17.40%,ELMO1;HACE1;CYFIP1;HACD3;RHOG
prerank,regulation of Golgi organization (GO:1903358),-0.2945266148590812,-0.8154266042748707,0.7235142118863049,0.9011608095754149,1.0,4/17,18.35%,ARMH3;STX18;MAP2K2;CAMSAP2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.25662243740093926,-0.8153143863483023,0.7734806629834254,0.9006958935306694,1.0,6/29,12.98%,KANK2;RUNX1;VPS18;WBP2;KCTD6;VPS11
prerank,long-chain fatty acid import into cell (GO:0044539),0.3744022301223551,0.8150810138157675,0.6795774647887324,0.9863218054072923,1.0,2/10,7.87%,SPX;RPS6KB1
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3436378875696235,-0.814542872565965,0.6995412844036697,0.9013753418259798,1.0,3/11,11.47%,NSUN2;NRDE2;NUP153
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.22513238933274124,0.8143913773412048,0.8392018779342723,0.987048213024251,1.0,21/163,11.54%,PIK3R1;PAG1;TXK;PDE4B;PSMD1;ICOSLG;PDPK1;PIK3R2;PTPN22;EIF2B1;CD276;PSMD10;PSMA5;PSMB5;PLEKHA1;PRKCB;PSMC4;TNFRSF21;PSMA4;FYN;PSMC5
prerank,epithelial cell-cell adhesion (GO:0090136),0.368736039174248,0.8142826706526639,0.6887755102040817,0.9866276888753929,1.0,2/11,3.95%,ITGB5;JUP
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.2984019910788375,0.8141663732052482,0.7355242566510172,0.986231028382678,1.0,7/30,15.90%,MICALL2;PINK1;SAE1;HTRA2;GSK3A;RNF31;CSNK2A2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.24538341011768502,0.8141365478223279,0.7806451612903226,0.9856594724482436,1.0,20/84,18.81%,BUB1B;PSMD1;FBXO5;FBXO31;CDC16;PSMD10;CDC20B;PSMA5;PSMB5;PSMC4;PSMA4;PSMC5;ANAPC5;PSMB9;UBE2D1;PSMA7;PSMD14;CDC26;PSMA2;PSMD11
prerank,copper ion homeostasis (GO:0055070),0.3242394450201889,0.8140570459467105,0.6968174204355109,0.985173515131792,1.0,4/17,14.03%,CCDC22;ABCB6;COMMD1;ATP7A
prerank,regulation of viral life cycle (GO:1903900),-0.27529440109646225,-0.8139820607263604,0.7282608695652174,0.9017370886435966,1.0,5/21,15.93%,TRIM25;TRIM5;TRIM14;PPIA;TRIM27
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2902845818039249,0.8138764552482434,0.728486646884273,0.9848877454829055,1.0,6/30,10.60%,NAT10;ERCC4;TERF1;PIF1;TENT4B;TP53
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.2823798753559346,-0.8137238533890493,0.7257281553398058,0.9015214984220377,1.0,4/18,12.90%,ANXA1;KLF9;FAM107A;NR3C1
prerank,regulation of leukocyte migration (GO:0002685),-0.2958364869832477,-0.8136785273396955,0.7291139240506329,0.9009382870707114,1.0,2/16,5.15%,ANXA1;RAC1
prerank,neuron projection extension (GO:1990138),0.2904344606671741,0.8134454164743524,0.73125,0.9850527468897782,1.0,10/32,19.08%,AUTS2;SEMA5A;TMEM108;CDKL3;PPP3CB;IMPACT;ULK2;CYFIP1;CDK5;LLPH
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.29315857087543173,0.8133813823056865,0.7014218009478673,0.984545955059617,1.0,5/31,14.06%,GLMN;PDCD1LG2;TNFRSF21;CD86;LYN
prerank,cellular response to nitrogen compound (GO:1901699),0.32331697832050327,0.8132606950993073,0.7095709570957096,0.9841626401572277,1.0,5/20,11.64%,NR1H4;FMR1;PDE12;DAXX;SPIDR
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.24575230009791457,0.8127586450554228,0.7684210526315789,0.9845318270192747,1.0,21/78,19.81%,PRICKLE1;RNF180;LRRK2;SIRT6;PSMD10;HERPUD1;CBFA2T3;CDC20B;NKD2;ZYG11B;HECTD1;GSK3A;DDA1;CLU;CSNK1E;DET1;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,macrophage chemotaxis (GO:0048246),0.3707865168539327,0.8125781058144984,0.697196261682243,0.9842672639945068,1.0,10/10,62.94%,CCL2;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF
prerank,regulation of mast cell degranulation (GO:0043304),0.3386808050740144,0.8125309395472874,0.7109929078014184,0.9837429257723239,1.0,4/14,17.28%,GAB2;FGR;LYN;LGALS9
prerank,histone H2A monoubiquitination (GO:0035518),0.3246051167609368,0.8121843281520866,0.6905158069883528,0.9837849511061353,1.0,3/17,9.24%,BCOR;TRIM37;RNF168
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.19459751311052756,-0.8118065651749,0.902127659574468,0.903711212396471,1.0,24/104,21.77%,SLC8A3;ACTB;TRIB2;UVRAG;CCND2;CALM1;LRP6;CCNG1;CAB39;PPEF2;MAP2K2;RALB;ETAA1;CCND1;EZH2;CDKN1A;SERTAD1;SIRT1;CCNE2;AKT1;ADRB2;CIB1;DUSP19;CSF1R
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.2376134421287778,-0.8117759229969621,0.7957957957957958,0.9031103610051444,1.0,6/38,10.97%,CACNA1C;CAV1;CAMK2D;ANK2;KCNJ2;KCNQ1
prerank,stress granule assembly (GO:0034063),-0.2853365344913039,-0.8117267820523062,0.7578947368421053,0.9025405997645827,1.0,5/20,15.87%,CSDE1;MAPT;UBAP2L;DYNC1H1;RPS23
prerank,autophagosome assembly (GO:0000045),-0.22544026280069424,-0.8115796824113205,0.8517110266159695,0.9021271135292758,1.0,22/52,29.08%,BECN1;RAB23;ATG13;GABARAP;GABARAPL1;TP53INP2;ATG2B;RAB1A;ATG12;ATG2A;MAP1LC3A;AMBRA1;RAB1B;ATG101;MAP1LC3B;WDR45;SMURF1;EMC6;ATG16L1;UBXN2A;RAB19;IRGM
prerank,artery morphogenesis (GO:0048844),-0.2554694223703631,-0.8113752131495265,0.7880434782608695,0.901826956710533,1.0,8/30,14.79%,NRP1;BMPR2;NOTCH1;TGFB2;TBX1;TBX2;HEY2;STRA6
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.2974927452723854,0.8112677476746594,0.7156549520766773,0.9849520904752328,1.0,5/27,10.83%,UTRN;SCN2B;COMMD1;FXYD4;FGF12
prerank,regulation of monocyte chemotaxis (GO:0090025),0.30224565600918823,0.8102224569154434,0.7110754414125201,0.9863696534788033,1.0,4/24,9.06%,CXCL10;DUSP1;PLA2G7;LGMN
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3313195923833743,-0.8095871189742605,0.7093023255813954,0.9043027635259991,1.0,7/11,46.13%,ADRB2;ARRB2;ADM;DRD3;ADRB3;ARR3;ARRB1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3162569629187605,0.8095365830029492,0.704201680672269,0.9870511342797537,1.0,7/20,17.42%,AGO4;AGO3;CNOT1;CNOT7;WTIP;TNRC6B;AGO1
prerank,nuclear envelope organization (GO:0006998),-0.27595423408748687,-0.8094594996357877,0.727735368956743,0.9038640833692653,1.0,7/20,26.12%,LEMD3;REEP3;TOR1A;TMEM170A;TOR1AIP1;EMD;REEP4
prerank,negative regulation of cell cycle process (GO:0010948),-0.21370046601295367,-0.8094387222897712,0.8327526132404182,0.9032550811176079,1.0,24/61,29.55%,PHC3;CBX3;MAX;L3MBTL2;RBBP8;E2F6;RING1;EZH2;GPER1;RBBP7;PPP1R10;E2F1;PCGF2;TOM1L2;APAF1;CHMP4C;RNF2;RAD51;BRCA1;CHMP2A;CHEK1;YAF2;BMI1;E2F7
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.2836169321340608,0.8094109288733827,0.7178683385579937,0.9866979013766167,1.0,4/33,9.09%,PTEN;SUSD2;GLI1;APPL2
prerank,androgen receptor signaling pathway (GO:0030521),-0.33231007788540556,-0.809073475016289,0.7093023255813954,0.9032745068667662,1.0,2/11,7.64%,DDX5;TMF1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2168419090458705,-0.808922535453996,0.8382838283828383,0.9029003060982341,1.0,22/54,29.73%,OTULIN;HIPK1;CASP8;MADD;PTPN2;CYLD;TNFRSF1A;LAPTM5;CCDC3;TRADD;TNFAIP3;CFLAR;TRAF1;RFFL;BIRC3;IKBKB;IKBKG;HSPA1A;PELI3;CASP1;HSPA1B;TRAF2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.34286546434104676,-0.808747386597686,0.7300884955752213,0.9025593441724455,1.0,2/10,9.33%,NFKBIZ;RC3H1
prerank,protein neddylation (GO:0045116),-0.3059652336728608,-0.8086341159634606,0.7333333333333333,0.902095218865123,1.0,3/13,17.00%,UBE2F;NEDD8;DCUN1D3
prerank,cardiac muscle cell contraction (GO:0086003),-0.27875067099878603,-0.8085909910965013,0.742014742014742,0.9015231985620922,1.0,3/19,3.69%,CACNA1C;CAMK2D;GSN
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2723690124442077,0.8082842913340992,0.757754800590842,0.9882866282505639,1.0,8/43,15.27%,ZFYVE28;SPRY1;CBLB;EPS15;HGS;SH3KBP1;TSG101;AREG
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3602240146529493,0.8081413010839231,0.6994535519125683,0.9879270136365509,1.0,2/11,7.80%,CCT5;TERF1
prerank,regulation of endocytic recycling (GO:2001135),-0.3272296275255102,-0.808065394139466,0.7115384615384616,0.9017625195178333,1.0,2/11,5.18%,ACTN2;INPP5F
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.34393308267081363,0.8077659437259891,0.7181663837011885,0.9880656686911954,1.0,7/13,28.50%,RPP40;NOL9;RRS1;UTP20;ABT1;RCL1;TBL3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3244638231605709,0.8077350015337983,0.7118353344768439,0.9875029230793461,1.0,2/18,8.27%,DCN;PINK1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.24690828654617047,-0.8077309288377239,0.7889908256880734,0.9017018455402167,1.0,4/31,4.36%,RBPJ;TPM1;NOTCH1;TGFB2
prerank,cellular protein-containing complex assembly (GO:0034622),0.22250669751993427,0.8071492669834549,0.8495260663507109,0.9880126417635322,1.0,28/160,15.58%,NRG1;STXBP6;TCF4;VAMP2;DNAJC28;CENPE;EPS15;OMA1;DNAAF3;IMMP2L;TTC12;DNAI4;CCDC65;CYBA;DNAJB12;VAMP4;TBCE;CENPC;CENPW;NUP107;AXIN1;LONP1;HSPA4;DHX9;CLU;COX7A2L;CCDC39;CENPF
prerank,maturation of 5.8S rRNA (GO:0000460),0.3254399735683433,0.8070224472314736,0.7197231833910035,0.9876222959776612,1.0,4/17,15.30%,C1D;NOL9;MTREX;EXOSC10
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3229372301656287,0.8068383042839649,0.7124394184168013,0.9873661736108468,1.0,6/18,19.41%,SPTBN1;AR;LDLRAP1;ZDHHC2;CDK5;ABCA2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.2307874633354754,-0.8065495469422588,0.8189910979228486,0.9030521450489696,1.0,11/42,20.68%,LBP;RPS19;DROSHA;SERPINE1;OPTN;RPL30;RNASE7;MPEG1;HMGB2;CHGA;ROMO1
prerank,regulation of DNA replication (GO:0006275),-0.22057151883801868,-0.8065445100463497,0.8050314465408805,0.9024185888726266,1.0,10/49,12.73%,EGFR;S100A11;GLI2;PPP2R1A;ACVRL1;ESCO1;ATR;CCDC88A;PCNA;STN1
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.31527514770137,-0.8063620710711692,0.7361111111111112,0.9021016576580447,1.0,6/13,25.74%,RPS15;NOP9;RAN;NPM1;LTV1;LSG1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3430847780746745,-0.8055343448228879,0.7082352941176471,0.9028933719125537,1.0,5/10,30.12%,NUFIP1;RUVBL2;TAF9;PIH1D2;RUVBL1
prerank,skin development (GO:0043588),0.2517830663181145,0.805122090403119,0.7658402203856749,0.9899613556948559,1.0,11/65,14.03%,KDF1;WNT5A;ITGA3;DHCR24;COL1A2;ABCB6;EVPL;FA2H;MED1;STMN1;ATP7A
prerank,long-chain fatty acid transport (GO:0015909),0.2843240076883573,0.8049686270287795,0.7286585365853658,0.9896165026098692,1.0,7/30,12.16%,ABCD2;FABP5;FABP4;SPX;RPS6KB1;SLC25A20;FABP3
prerank,tRNA processing (GO:0008033),0.25561593432745533,0.8041537313403149,0.7534246575342466,0.9905324891597612,1.0,19/61,23.78%,RPP40;CTU1;POP5;QTRT2;POP7;TSEN15;FAM98B;TRMT61A;WDR4;METTL1;PTCD1;SARS1;RPP21;DDX1;TRMT10A;LCMT2;AARS1;TRMT10C;SSB
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.25330337804624903,-0.803941201693892,0.7542372881355932,0.904948561518965,1.0,6/31,10.44%,KMT5B;RBP4;TFRC;DNAJB9;SHLD2;EPHB2
prerank,membrane fusion (GO:0061025),0.2821875809602758,0.8039125612205239,0.7310664605873262,0.9903298546232492,1.0,10/33,16.86%,VAMP2;SNAP23;OPA1;SNAP29;RIMS1;DNM1;RABIF;HACE1;VPS33B;UBXN2B
prerank,secondary alcohol metabolic process (GO:1902652),-0.2376249474985693,-0.8036758025984817,0.8291139240506329,0.9047884699972982,1.0,12/42,23.36%,FDX1;RXRA;APOE;PIP4P1;SOAT1;IDH3B;CLN8;OSBPL1A;IDH3A;EBP;TSKU;CLN6
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.31582353083613934,0.8036067969105796,0.6938775510204082,0.9902695292169165,1.0,2/18,4.94%,FBXO5;CDC7
prerank,acetyl-CoA metabolic process (GO:0006084),-0.3080853959754328,-0.8033929017215576,0.7759036144578313,0.9046391294129873,1.0,5/15,17.18%,NUDT7;ACAT1;PMVK;ACACB;HMGCS2
prerank,regulation of protein localization to nucleus (GO:1900180),-0.23023875077353087,-0.8032295228036129,0.8082595870206489,0.904272672380501,1.0,14/43,26.32%,TFRC;GSK3B;LAMTOR5;PARP9;SUMO3;CTNNA1;AKT1;MFHAS1;ILRUN;WWTR1;GLUL;DTX3L;CARD10;PARK7
prerank,aminoglycan biosynthetic process (GO:0006023),0.262519965854466,0.8031543627604024,0.7639296187683284,0.9905221507088947,1.0,12/49,15.44%,HSPG2;GPC4;GCNT2;GPC5;B3GNT8;HS6ST2;B4GALT7;B3GALT5;HS3ST6;HS3ST5;HEXA;SDC2
prerank,histone exchange (GO:0043486),0.2694026676189004,0.8031241595264608,0.7605633802816901,0.9899646647666845,1.0,7/37,14.95%,MIS18A;CENPU;SPTY2D1;CENPC;CENPW;MIS18BP1;DMAP1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.21493809669550076,0.8030234793231543,0.8610478359908884,0.9895343953951795,1.0,63/241,22.68%,TRA2B;EIF4A3;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNRPB2;SMU1;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;SRSF10;SYF2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;CTNNBL1;ZCRB1;RBM6;POLR2L;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.25945601603102836,-0.8029223058401451,0.7802197802197802,0.9041510566427552,1.0,12/25,29.64%,PRKDC;MAPK14;ETS1;TAL1;HMGB2;ABCB10;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,regulation of T cell mediated immunity (GO:0002709),-0.33775615830722894,-0.8029174144774275,0.6995515695067265,0.9035176904957476,1.0,6/10,41.55%,TNFRSF1B;AGER;CCR2;TRPM4;ZBTB1;WAS
prerank,intracellular sterol transport (GO:0032366),0.3472232181537023,0.8029015362258928,0.6950354609929078,0.9891313691370575,1.0,5/13,19.35%,RELCH;SERAC1;ARV1;OSBP;NPC2
prerank,membrane lipid metabolic process (GO:0006643),0.2961217139820897,0.8028017486548337,0.7204658901830283,0.9887054263609809,1.0,5/22,12.14%,SERINC1;SPTLC1;AGMO;B4GALT4;AGK
prerank,regulation of chromatin organization (GO:1902275),-0.3066837652561162,-0.8027696651251562,0.715,0.9031318203083235,1.0,3/14,8.35%,MLLT3;TLK1;TLK2
prerank,rRNA transcription (GO:0009303),-0.28986391114068183,-0.802722840383586,0.7764705882352941,0.9025726020394013,1.0,6/17,22.51%,CAVIN1;TCOF1;NIFK;GTF3C6;POLR1G;GTF3A
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2806299272919688,0.802210354287201,0.7423780487804879,0.9886009301915851,1.0,10/32,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,tRNA export from nucleus (GO:0006409),0.2806299272919688,0.802210354287201,0.7423780487804879,0.9886009301915851,1.0,10/32,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.306362742600763,0.8021464064184343,0.7118380062305296,0.9880967441975782,1.0,1/22,0.79%,XCL1
prerank,histone ubiquitination (GO:0016574),-0.26766432606758067,-0.8016468320025675,0.7606382978723404,0.9037929325523755,1.0,7/21,24.94%,RNF8;UBE2A;UBR2;UBE2N;LEO1;RNF20;DTX3L
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3665125567249005,0.8014125930868731,0.699288256227758,0.988829194154735,1.0,2/10,8.21%,HRG;JAM3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.3318311715791567,-0.8013437179788763,0.7084233261339092,0.9036581244318588,1.0,2/10,7.95%,LBP;IFI35
prerank,negative regulation of organelle assembly (GO:1902116),0.2795470836862841,0.8012505909594854,0.7526555386949925,0.9885101010864362,1.0,6/35,11.18%,MDM1;LRRK2;TRIM37;PINK1;KAT2A;SCFD1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3121897437904935,-0.8009742110720268,0.7204545454545455,0.902988247403942,1.0,3/12,11.95%,IGF1;LMCD1;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3121897437904935,-0.8009742110720268,0.7204545454545455,0.902988247403942,1.0,3/12,11.95%,IGF1;LMCD1;CAMTA1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.27868593588483564,0.8009174607286282,0.7586726998491704,0.9885164367630839,1.0,5/39,7.53%,PIK3R1;PIP4K2A;PIK3R2;EFR3A;PI4KA
prerank,myofibril assembly (GO:0030239),0.2706961168011051,0.8006302932691911,0.7594202898550725,0.9884316605641142,1.0,1/42,0.14%,PDGFRA
prerank,anterior/posterior pattern specification (GO:0009952),-0.21665477603397532,-0.8006250455531134,0.8459119496855346,0.9029431099883984,1.0,14/53,19.42%,BMPR2;SKI;WLS;TBX1;HOXC6;HEYL;HEY2;PCSK5;ATP6AP2;ACVR2B;HHEX;BHLHE40;HOXD3;HOXB6
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.2588838832598716,-0.80055516095133,0.7465181058495822,0.902413365520575,1.0,2/27,3.33%,CD200;SIRPA
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.2632303302638243,-0.8002966946125676,0.7643835616438356,0.9022295717830912,1.0,9/22,30.22%,ROCK2;GSK3B;PPP4R4;PPP1R11;MGAT5;IKBKB;NCKAP1L;FKBP1A;PPP1R15A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2941882054959861,0.800293885462259,0.7557251908396947,0.9884472502650504,1.0,5/29,11.37%,NCDN;GRIK2;SYP;SHISA6;DLG4
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.33749216792099,0.7994438157437956,0.703971119133574,0.9894236395527743,1.0,5/13,21.91%,CISD3;CIAO1;MMS19;ISCA1;YAE1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3159400889870143,0.7992699021446467,0.7416666666666667,0.9891398098480048,1.0,7/20,20.70%,SUN2;TAF3;SP100;SYNE1;TAF8;SUPT7L;BBS4
prerank,positive regulation of JNK cascade (GO:0046330),0.2488479323247473,0.7992670886471203,0.7718579234972678,0.9885301461698975,1.0,4/70,2.24%,SH3RF1;EDA2R;TRAF4;SH3RF3
prerank,regulation of ion transport (GO:0043269),0.24506821509842652,0.7990529657964718,0.7880794701986755,0.9883093923049491,1.0,19/76,20.41%,NKAIN1;ANK3;NKAIN2;VAMP2;NEDD4;SYT3;HTR1A;SYT7;P2RX4;SYT5;KCNJ8;GDNF;STC1;KCNJ10;KCNJ3;SYT6;SYT1;KCNJ16;PXK
prerank,acylglycerol biosynthetic process (GO:0046463),0.30191031622073217,0.7990276091138778,0.7319078947368421,0.987741519528151,1.0,5/23,15.43%,LPIN3;AGMO;GK;GPAT3;LPIN2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.29436220996806683,-0.7989661277252608,0.7356608478802993,0.9037864823789015,1.0,5/15,23.20%,SMO;SIX1;AGT;SIX4;SOX8
prerank,vesicle transport along actin filament (GO:0030050),0.31526117122007996,0.7989004111594393,0.738562091503268,0.9873692665142934,1.0,4/19,11.63%,MYO7A;MYO1B;MYO6;MYO1G
prerank,regulation of primary metabolic process (GO:0080090),0.22879789091117037,0.7983785260905645,0.8206388206388207,0.9877593888661861,1.0,27/126,17.14%,PPARA;ODC1;NCOA2;PSMD1;PPARD;C1QTNF2;PSMD10;SC5D;IRS2;CHD9;PSMA5;PSMB5;EDF1;NCOA1;PSMC4;PSMA4;PSMC5;HMGCS1;PSMB9;CARM1;MED1;SREBF1;ELOVL6;IDI1;PSMA7;NR1D2;PSMD14
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2596018444951392,-0.7982465692465107,0.7819148936170213,0.9043252814769913,1.0,11/23,32.73%,VCPIP1;MINDY1;OTUB1;USP25;TNFAIP3;BAP1;USP37;USP20;OTUB2;OTUD4;OTUD5
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.2668208610823688,-0.7981669786026784,0.7605985037406484,0.9038134091020487,1.0,14/23,34.97%,PRCC;INTS3;ZW10;WEE1;PLK5;PABIR1;SETMAR;CHFR;CHMP4C;CHEK1;PLK3;ZWILCH;VPS4A;PLK2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.23064937614532338,-0.7979323080118913,0.7760736196319018,0.9035476419111627,1.0,27/43,38.41%,FOXN3;INTS3;BRCC3;ATM;NBN;CDKN1A;PABIR1;DONSON;HUS1;CHFR;ORC1;FZR1;TAOK2;TRIM39;BRSK1;BRCA1;CHEK1;UIMC1;NOP53;DTL;BABAM2;HUS1B;MRE11;PLK1;CDK1;CDC6;TICRR
prerank,negative regulation of macroautophagy (GO:0016242),-0.2580866710172719,-0.7979262551632593,0.8035714285714286,0.9029200599462514,1.0,15/26,33.92%,MTM1;FEZ2;NRBP2;CLEC16A;TMEM39A;CHMP4B;CHMP4A;AKT1;NUPR1;SMG1;QSOX1;PHF23;LZTS1;FEZ1;PIK3CA
prerank,ureteric bud morphogenesis (GO:0060675),0.32469690152017366,0.7977446716200216,0.7290969899665551,0.9883410069123038,1.0,6/16,24.18%,SALL1;GDNF;MYC;BMP2;PAX2;BMP4
prerank,double-strand break repair (GO:0006302),0.2222897270640428,0.7972671954185927,0.8367103694874851,0.9886271097725046,1.0,37/158,20.19%,MORF4L1;ERCC1;LIG3;FAN1;FEN1;POLQ;ERCC5;POLA1;RPA1;ERCC4;POLL;MMS22L;RNF168;BRCA2;UBE2V2;ZFYVE26;REV3L;RECQL;SPIDR;POLN;XRCC1;POLB;CYREN;RAD52;EME2;PAXIP1;KDM2A;NHEJ1;PSMD14;SMARCAL1;HELQ;WRN;FBH1;RIF1;TRIP13;MTA1;DDX1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2831753832675227,-0.7964523806179893,0.7666666666666667,0.9045472197501382,1.0,1/18,0.46%,PLCB1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.370472663360743,0.7964060828292994,0.7205882352941176,0.9895888006269876,1.0,10/10,62.98%,SAG;PDE6A;GRK1;CNGA1;GNB1;CNGB1;GNAT1;RHO;PDE6B;PDE6G
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.30866695200620814,0.7961793540255601,0.7430441898527005,0.9893710386631253,1.0,8/22,20.43%,RPP40;NOL9;EXOSC9;RRS1;EXOSC10;EXOSC8;URB1;UTP20
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.33639806169654735,0.7956334614350158,0.7328646748681898,0.9897614109417787,1.0,6/15,21.14%,UNC119;SMAP1;NEU3;SCYL2;DGKD;SNAP91
prerank,cardiocyte differentiation (GO:0035051),0.36412820899342,0.795514278349928,0.6948275862068966,0.9893685528758845,1.0,1/10,0.83%,NRG1
prerank,axonal transport of mitochondrion (GO:0019896),0.35149433336047453,0.7954619426816523,0.6913793103448276,0.9888547560469462,1.0,4/11,20.27%,OPA1;SYBU;HIF1A;ACTR10
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2394005924406617,0.7954457765470465,0.8044619422572179,0.988279307363175,1.0,23/88,19.79%,EIF4A3;NANOS3;EPRS1;DNAJC1;LSM14A;FMR1;CAPRIN1;EIF2AK2;DHX36;CNOT1;MALSU1;EIF4ENIF1;PUS7;BAG6;CNOT7;TSC1;IGF2BP3;CALR;CDK5;ILF3;EIF2AK3;FXR1;PLAT
prerank,regulation of DNA metabolic process (GO:0051052),0.2635803281415107,0.795374381875044,0.7565597667638484,0.9877979373299239,1.0,15/44,22.34%,USP1;PIF1;UBE2V2;POLH;MPHOSPH8;KPNA1;CDT1;KDM1B;UBE2V1;HNRNPD;MYC;KAT7;TERF2IP;WDR18;KPNA2
prerank,metal ion transport (GO:0030001),0.2411436747550482,0.7952782238849294,0.8089005235602095,0.9873579169409997,1.0,19/86,20.11%,CACNA1E;CALCRL;ITPR1;CACNG3;RYR2;SLC30A5;TRPC3;NDFIP2;FYN;TRPM2;TUSC3;RYR3;CACNA2D1;NDFIP1;GRIN3A;CAMK2A;ATP2C1;TRPC1;NIPA2
prerank,mRNA metabolic process (GO:0016071),0.2364633991463484,0.7951524052940773,0.8255208333333334,0.9869859673548744,1.0,19/90,16.75%,AGO4;GEMIN2;ZC3H12D;LSM11;ZFP36L2;PCBP3;HNRNPA2B1;SRSF11;PRKACA;NUDT21;TP53;AGO3;PRPF18;DIS3L2;SLBP;SNRPF;SRSF9;NONO;SF3A3
prerank,action potential (GO:0001508),0.2652655165719143,0.7946715695204347,0.7526717557251908,0.9872100839600099,1.0,8/44,13.61%,ANK3;CACNA1G;GNA11;KCND2;KCNE4;AKAP6;SCN1A;SCN2A
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.33376170368488867,0.7945807212154109,0.7317487266553481,0.9867626708596002,1.0,4/15,12.46%,SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.32043518105498875,0.7944250457170755,0.7421487603305785,0.9864458028284833,1.0,2/16,12.10%,PTPN22;IL12A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3154885821891132,-0.7941443415221328,0.7370892018779343,0.9077001524336377,1.0,8/12,30.16%,CD44;RPL26;SIRT1;CD74;MIF;KDM1A;TAF9;TRIAP1
prerank,actin filament-based transport (GO:0099515),0.3053063525578876,0.7940943227656676,0.7269789983844911,0.986391828775695,1.0,5/21,11.63%,MYO7A;MYO1B;SUN2;MYO6;MYO1G
prerank,axonal fasciculation (GO:0007413),0.3403380804624022,0.7937981937375232,0.7068345323741008,0.9863128085271089,1.0,5/12,15.96%,SEMA5A;CNTN4;EPHA3;ARHGAP35;NRCAM
prerank,organelle disassembly (GO:1903008),0.27985141555300874,0.7937782091659975,0.7579908675799086,0.9857458286895626,1.0,10/33,19.53%,GBF1;GOLGA2;RB1CC1;TEX264;KIF9;GFM2;VRK1;ULK2;MTIF2;DDRGK1
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2423934057060944,-0.7932910598579914,0.7952522255192879,0.9084699948482468,1.0,8/32,13.64%,BCL2L1;VPS35;SOD2;HK2;BAD;BAX;BID;BOK
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.24734235222058548,0.7932646658953018,0.772972972972973,0.9860872846152806,1.0,9/65,8.14%,PPARA;SPRY1;PDPK1;SPRED1;HTRA3;MTMR4;IL17RD;CIDEA;SPRED2
prerank,regulation of heart contraction (GO:0008016),0.23660028046138848,0.7930309997172199,0.8189987163029525,0.9858965975759669,1.0,16/90,15.14%,ATP1A2;ITPR1;RYR2;TMEM65;ATP1A3;KCNIP2;ATP2A2;PRKACA;FXYD4;P2RX4;S100A1;GSK3A;RYR3;ASPH;STIM1;GJA5
prerank,photoperiodism (GO:0009648),0.2918710444990206,0.7927959544267611,0.7426356589147287,0.9856928188227538,1.0,12/28,25.73%,PER3;PER2;TP53;RBM4B;CRY2;MTA1;FBXL22;FBXL12;CRY1;USP2;PPP1CA;FBXL3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.2724351313913515,0.7923664494230583,0.760119940029985,0.9858877286028702,1.0,10/39,18.88%,ZFYVE28;SPRY1;EPS15;LGMN;HGS;SH3KBP1;TSG101;AREG;PTPN18;SPRY2
prerank,regulation of chromatin binding (GO:0035561),0.3613389556680623,0.7915483049914517,0.7019400352733686,0.9867664669428362,1.0,4/10,14.16%,GMNN;CDT1;BTAF1;MED25
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.2663171092074586,-0.7915358275490824,0.800524934383202,0.9106748125784718,1.0,6/20,16.10%,ERLIN1;WNT4;SIK1;CEACAM1;ASXL3;GPER1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3346962412672588,-0.790942852438604,0.7315914489311164,0.9109968207946335,1.0,2/10,3.59%,OSR1;CAMK2D
prerank,regulation of pH (GO:0006885),0.35191690406424375,0.790756593034842,0.7356746765249538,0.9876313637993271,1.0,4/11,18.98%,SLC9A1;CLCN3;PDK2;ATP6AP1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24505976743898367,0.7907060512265116,0.8047419804741981,0.9871250194665895,1.0,6/66,5.48%,PIK3R1;NGFR;JUP;PIK3R2;ZIC1;CCT5
prerank,protein alkylation (GO:0008213),0.30167260359826825,0.7906673648800088,0.7341772151898734,0.9865847533291411,1.0,9/22,28.62%,PRMT3;VCPKMT;FAM98B;PRMT2;CAMKMT;ETF1;PCMT1;FAM98A;METTL22
prerank,mitotic nuclear division (GO:0140014),0.24411241070020454,0.7901536130445574,0.7765814266487214,0.9868709284033892,1.0,19/71,21.10%,CCDC61;LSM14A;AAAS;SGO1;GOLGA2;CEP192;NSL1;NUSAP1;MAP9;CLASP2;KIFC2;KIF2A;CLASP1;SMC1A;KLHL22;RHOA;KPNB1;SMC3;KIF11
prerank,cellular response to acid chemical (GO:0071229),0.29094134845343234,0.790103549819814,0.7601957585644372,0.9863500504999017,1.0,7/27,18.69%,CPEB1;MTOR;GLRA1;GLRA2;RRAGA;RRAGD;CAPN2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2467848057985976,0.7897903285722998,0.8026845637583893,0.9863082306663238,1.0,14/62,15.09%,LRRK2;NOL3;HERPUD1;CDKN2D;PINK1;NOC2L;ARMC10;OPA1;RTKN2;BCL2L2;HTRA2;PTTG1IP;CREB3L1;CLU
prerank,macromolecule catabolic process (GO:0009057),0.2870922259516878,0.7895413366744095,0.7455882352941177,0.9861477235796934,1.0,5/26,9.11%,NEDD4;CAPN3;UCHL3;LGMN;MTOR
prerank,BMP signaling pathway (GO:0030509),0.2482155877864063,0.7893270366318633,0.7887323943661971,0.9859513880472429,1.0,4/62,2.78%,RUNX2;RGMB;RGMA;SMAD5
prerank,mitochondrial gene expression (GO:0140053),-0.22372249446515838,-0.7892861581274915,0.8290322580645161,0.9130647728741159,1.0,18/42,29.55%,IARS2;MRPS7;NOA1;MRPS17;MRPL16;MRPS18A;MRPL2;MRPS18B;POLRMT;GATC;TWNK;MRPL57;PTCD3;LARS2;MRPS34;MRPS12;FASTKD2;MRPS2
prerank,cell junction maintenance (GO:0034331),0.32867555512005325,0.789169547960076,0.743103448275862,0.9856171080582005,1.0,5/14,27.43%,CBLN1;F2R;PRTN3;MYADM;DCTN1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.24527434579004975,-0.7886590394439238,0.8035714285714286,0.9134062169116535,1.0,11/30,21.54%,BCL2L1;ACKR3;THOC1;CD44;RTEL1;TPT1;SIRT1;SNAI1;CD74;MIF;CCAR2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.26937930312085867,-0.7886544813470714,0.7896103896103897,0.9127778414252147,1.0,2/23,7.08%,NMT2;CALM1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.35255670454068266,0.7883073674002744,0.7266666666666667,0.9865150146298267,1.0,2/11,7.25%,NOVA1;PCBP3
prerank,DNA duplex unwinding (GO:0032508),0.255923837557,0.7882121968930801,0.7852062588904695,0.9860718666824403,1.0,16/50,20.54%,MCM7;RPA1;PIF1;XPC;MCM4;RECQL;GTF2H3;ERCC2;DHX9;GTF2H1;MCMDC2;WRN;SSBP1;CUL4A;DDX1;DDB1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3160662122901423,0.7880089737325106,0.7180762852404643,0.9858237345137634,1.0,4/17,12.81%,PSMD10;TWIST1;ARMC10;PTTG1IP
prerank,lipid phosphorylation (GO:0046834),-0.330709052815809,-0.7878164914171865,0.7511627906976744,0.913428982334948,1.0,3/10,12.52%,DGKH;DGKG;DGKZ
prerank,cardiac muscle contraction (GO:0060048),0.2693506046608745,0.787765484441208,0.7572519083969466,0.9856604076497433,1.0,3/34,4.25%,ATP1A2;RYR2;SCN2B
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3029817432935312,0.7871143083327483,0.7584541062801933,0.9861829343099464,1.0,5/23,12.46%,SEC16A;SEL1L;HERPUD1;SEC61B;HSP90B1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.353552521021087,0.7869774784377037,0.7259136212624585,0.9858186049284062,1.0,4/11,20.44%,NR1H4;DGKQ;BMP2;BMP5
prerank,mRNA catabolic process (GO:0006402),0.25963003810127006,0.7868377537400904,0.7847919655667145,0.98549531035859,1.0,11/44,17.91%,AGO4;ZC3H12D;PDE12;ZFP36L2;AGO3;EXOSC9;DIS3L2;MRTO4;EXOSC10;AGO1;DXO
prerank,myoblast fusion (GO:0007520),0.3398959898491166,0.7867726927449351,0.7264150943396226,0.9850201395233951,1.0,4/12,18.99%,ADGRB3;ADAM12;CD81;KCNH1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.309735130055767,-0.7860852278512136,0.7619047619047619,0.9154791447661221,1.0,3/12,16.98%,ELAVL1;TERT;ESR1
prerank,mismatch repair (GO:0006298),0.2876667683913086,0.7860112288748743,0.7620481927710844,0.9857297712597968,1.0,9/27,23.02%,ERCC1;MSH3;RPA1;XPC;MUTYH;MSH6;MLH1;ABL1;TDG
prerank,negative regulation of translational initiation (GO:0045947),-0.30635386931534425,-0.785719433732965,0.7328605200945626,0.9154404862978656,1.0,5/13,17.67%,PAIP2;RBM4;EIF4EBP1;EIF3E;AGO2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.32147282412912925,0.785537861908909,0.7219430485762144,0.9859659826433496,1.0,4/15,18.74%,TLR6;TLR4;MYD88;HIF1A
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.27645321148095037,-0.785314070486605,0.7451456310679612,0.9154353919457922,1.0,11/19,30.46%,AMPD3;TERT;DCK;GMPR2;APRT;TYMS;CDA;POLD2;PNP;POLD1;ADA
prerank,positive regulation of monooxygenase activity (GO:0032770),0.28937598919861274,0.7851936401869396,0.7543581616481775,0.9859831252927631,1.0,6/26,15.31%,POR;HTR2B;CDH3;S100A1;ATP7A;GDNF
prerank,positive regulation of viral transcription (GO:0050434),-0.25108704851115593,-0.7847558177907108,0.8125,0.9156801688844247,1.0,10/25,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;CDK9;NELFCD;GTF2F2;CTDP1;POLR2I;POLR2K
prerank,positive regulation of interferon-alpha production (GO:0032727),0.31075183941313744,0.78436898249164,0.7323232323232324,0.9868338567572776,1.0,4/19,14.93%,TLR8;TLR4;DHX36;DHX9
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3205054710075742,-0.7843403378102136,0.740990990990991,0.9156568960420449,1.0,6/10,28.15%,RAPGEF3;SPHK2;BRCA1;SMAD4;CHEK1;HDAC5
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.23084995738706982,-0.7841663228796149,0.8637770897832817,0.915245232290094,1.0,18/40,28.72%,THOC1;ATR;RTEL1;PCNA;ETAA1;PRIMPOL;DDX11;DONSON;ALYREF;CDK9;SETMAR;MCM9;RFWD3;ZRANB3;RAD51;CENPX;GEN1;POLD1
prerank,regulation of autophagosome assembly (GO:2000785),0.2754293167040948,0.7840654682093042,0.7719033232628398,0.9867459232663695,1.0,6/33,12.23%,PIP4K2A;NPRL2;LRRK2;PINK1;SCFD1;IFT88
prerank,positive regulation of neutrophil migration (GO:1902624),0.31173160533637945,0.7836373018735621,0.7323232323232324,0.9869153318613308,1.0,1/18,0.79%,XCL1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.3116622845678856,0.783515355742765,0.7452991452991453,0.9865446657977315,1.0,2/18,5.80%,TMEM102;NAIF1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.29376730650564536,-0.7831772573461877,0.751269035532995,0.9161108483295798,1.0,8/15,26.32%,RPL5;RPS7;RPL11;RPL23;SMAD7;BAG2;DTX3L;PARK7
prerank,regulation of glycogen metabolic process (GO:0070873),-0.31130614099656784,-0.7830655811766207,0.7724137931034483,0.9156814595256083,1.0,7/12,40.71%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3D;GCGR
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.23301180502069893,0.7827597210509072,0.8171052631578948,0.9872619269076103,1.0,25/96,21.20%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.21907205921456102,0.7827104624465273,0.8744019138755981,0.9867442472718053,1.0,20/148,11.13%,HDAC1;L3MBTL1;TAF9B;PIP4K2A;TAF12;PDPK1;PRR5;CHD4;MBD3;TAF15;RPA1;TAF3;MDM4;NOC2L;MTOR;DAXX;RFC3;TP53;TOP3A;RPL37
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.25553770063018366,-0.7808117068147783,0.8041237113402062,0.9185272870790966,1.0,7/24,24.20%,LEPR;COQ10A;COX15;SDHAF4;PID1;MRAP2;MT3
prerank,regulation of sensory perception of pain (GO:0051930),-0.32871597805245584,-0.7806812723591524,0.7464114832535885,0.9180865579792432,1.0,2/11,4.87%,MGLL;CCN3
prerank,negative regulation of cell cycle (GO:0045786),0.2378411561150215,0.7806094930213512,0.8279569892473119,0.9898434057877319,1.0,14/73,16.22%,PTEN;NR2F2;CDKN2A;SIPA1;SCRIB;DUSP1;GMNN;BMP7;HTRA2;PDCD4;TSPYL2;TFAP4;RNF167;BRINP1
prerank,negative regulation of histone modification (GO:0031057),0.3381942915109679,0.7805806114917044,0.7218430034129693,0.9893022915568209,1.0,4/14,18.84%,TWIST1;NOC2L;AASS;THAP7
prerank,positive regulation of intracellular transport (GO:0032388),-0.23051938727810056,-0.7803930987933462,0.8520710059171598,0.9178788571827353,1.0,11/38,19.79%,ACTN2;STX18;RUFY3;PRR5L;CEP290;DYNC1H1;OAZ1;BCAS3;OAZ2;NUMA1;PLA2G4E
prerank,ceramide biosynthetic process (GO:0046513),0.2652590169063678,0.779934076185274,0.7961595273264401,0.9898670972104775,1.0,9/40,12.53%,CERS4;SPTLC3;TLCD3B;SMPD4;SPTLC1;DEGS1;FA2H;AGK;ST6GALNAC6
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.28059156295623633,0.779831215823169,0.7807153965785381,0.9894311714303597,1.0,1/29,0.79%,XCL1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.3257210753319483,0.7798258951471384,0.7344827586206897,0.9888489588060583,1.0,3/15,14.09%,PPARA;CIDEA;PLIN2
prerank,heart contraction (GO:0060047),0.2605413666203201,0.7797827273613053,0.7659259259259259,0.9883290564785838,1.0,3/41,4.25%,ATP1A2;RYR2;SCN2B
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.35370738600936824,0.7797622958882614,0.7360861759425493,0.9877742924727306,1.0,2/10,4.84%,PRKD3;HTR2B
prerank,NIK/NF-kappaB signaling (GO:0038061),0.23936194809321315,0.7792363899317318,0.8302631578947368,0.9881010327954955,1.0,17/72,18.81%,MAP3K14;PSMD1;TLR6;PSMD10;PSMA5;PSMB5;BIRC2;IRAK1;PSMC4;PSMA4;PSMC5;PSMB9;TIRAP;PSMA7;PSMD14;PSMA2;PSMD11
prerank,regulation of cell cycle process (GO:0010564),0.2263642691604435,0.7784524055665737,0.8482587064676617,0.9888599815827658,1.0,17/104,14.50%,ATF5;L3MBTL1;TIPIN;PKMYT1;FBXO5;CDK13;ZFYVE26;RCC1;MKI67;SOX9;USP19;RAB11FIP3;ENTR1;BUB1;MAP9;DBF4;CEP250
prerank,negative regulation of secretion by cell (GO:1903531),0.2653028231715701,0.7783461145602522,0.787701317715959,0.9884590374001345,1.0,6/38,16.32%,STXBP6;PNKD;TRH;IL12A;GRM7;IL1RAPL1
prerank,regulation of interleukin-12 production (GO:0032655),-0.21982516208701178,-0.778331588677211,0.8662613981762918,0.9203646007739481,1.0,3/47,2.21%,PLCB1;FOXP1;THBS1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.24358592839914708,0.7780375572512566,0.8097902097902098,0.9884057999523661,1.0,10/63,12.54%,EIF4G3;GPLD1;HTR2B;PTPN22;SORL1;ZKSCAN3;GOLGA2;MTOR;DAP;GSK3A
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3360338157929068,0.7776951384783582,0.7208480565371025,0.9884259842092251,1.0,3/14,10.21%,SCRIB;FSCN1;OPHN1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.3071132677898848,-0.7771501135488246,0.7540983606557377,0.921509792012694,1.0,6/12,24.44%,CLN5;ATP6AP2;TMEM9;CLN6;CCDC115;TMEM199
prerank,histone H2A acetylation (GO:0043968),0.3201265707514388,0.776966488082727,0.7664359861591695,0.9890789357667841,1.0,8/16,26.17%,MORF4L1;BRD8;EPC1;DMAP1;ING3;ACTL6A;MORF4L2;YEATS4
prerank,prostanoid metabolic process (GO:0006692),0.33320523301317795,0.7768816243827459,0.7425044091710759,0.9886211362077402,1.0,3/13,12.62%,PTGES;PLAA;PTGR2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.34375206914849443,0.7766664310494116,0.7398230088495575,0.9884074529064939,1.0,1/11,1.73%,TAF9B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.2818629685824294,-0.7766067993506307,0.765625,0.9216668196382775,1.0,5/16,21.54%,BCL2L1;ACKR3;TPT1;SNAI1;CCAR2
prerank,phosphatidylcholine catabolic process (GO:0034638),0.35467662053052706,0.7762791886564265,0.7269565217391304,0.9884499064255693,1.0,2/10,8.18%,LIPC;PLA2G7
prerank,establishment of spindle orientation (GO:0051294),0.28135781992450765,0.7761172319547526,0.7693498452012384,0.9881432094618199,1.0,7/28,16.86%,GJA1;LLGL1;GPSM2;SPDL1;INSC;CLASP1;UBXN2B
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.23290364656103182,0.7761098750274844,0.8546666666666667,0.9875698944564651,1.0,23/85,19.81%,PRICKLE1;FMR1;RNF180;LRRK2;PSMD10;CBFA2T3;NKD2;PSMC5;ZYG11B;HECTD1;GSK3A;DDA1;ATXN3;BAG6;CLU;CSNK1E;DET1;USP13;RNF217;RNF19B;DDRGK1;SUMO2;RNF144A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2737580451208569,0.7759530333157244,0.7829581993569131,0.9872397344204474,1.0,6/31,17.28%,CD40;IL16;TLR4;TIRAP;MAPK11;LGALS9
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2581934754798492,0.7757278618368659,0.7996894409937888,0.9870425228701258,1.0,7/38,14.74%,MIS18A;CENPU;ASF1A;UBN1;CENPC;CENPW;MIS18BP1
prerank,actin polymerization or depolymerization (GO:0008154),0.250322769354144,0.7755187161153598,0.8172514619883041,0.9868263984101667,1.0,4/50,6.98%,SVIL;MICALL2;ARHGAP6;WASF3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2514936213358653,0.7755174046313299,0.8045977011494253,0.9862433306753601,1.0,6/50,7.97%,OGT;PRMT3;FBXO5;ADGRB1;LIMK1;PER2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.27726793144201306,-0.7752673146598194,0.7962962962962963,0.9230131857730837,1.0,7/18,23.26%,PET100;COX20;SMIM20;COX14;COA5;COX18;OXA1L
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2684426588507367,-0.7749976881512332,0.8042959427207638,0.9227576706256447,1.0,6/18,23.89%,ASH1L;SMYD2;EEF1AKMT2;SETMAR;SETD1A;KMT2B
prerank,sister chromatid segregation (GO:0000819),0.27779807372601867,0.7749294506182679,0.7836166924265843,0.9866605929158555,1.0,7/31,18.12%,TOP2B;SGO1;NSL1;NUSAP1;TOP2A;SMC1A;KLHL22
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.22834489452848886,-0.7742529335146004,0.8166666666666667,0.9232785667556667,1.0,9/32,21.86%,CAVIN1;GTF2H5;UBTF;POLR2H;POLR1H;TAF1C;GTF2H4;POLR1G;POLR1C
prerank,thyroid hormone generation (GO:0006590),0.3549300037861691,0.7742189408197905,0.7246891651865008,0.9873098168332888,1.0,1/10,4.90%,CPQ
prerank,alcohol catabolic process (GO:0046164),-0.323471361350791,-0.7740779785297248,0.7624434389140271,0.9229109740102507,1.0,3/10,13.08%,SCARF1;APOE;SNX17
prerank,mRNA processing (GO:0006397),0.2044150456881856,0.7740435710953393,0.9223085460599334,0.98700937892743,1.0,74/287,22.68%,TRA2B;EIF4A3;GEMIN2;ISY1;NOVA1;SNRNP35;ZRSR2;SF3B6;PPIH;THOC7;LSM4;BCAS2;HNRNPA2B1;SRSF11;WBP11;SNRPB2;PRKACA;SMU1;SRRT;CWC22;DDX41;SLU7;NUDT21;DBR1;SNW1;MTREX;CWC25;CASC3;SNRNP48;GTF2H3;SRSF10;PRPF18;SYF2;ERCC2;RBM4B;HNRNPUL1;RBM17;HNRNPD;DHX9;SNRPF;GTF2H1;SNRNP70;SYMPK;CWF19L2;SRRM2;SRSF9;RBM5;NONO;CHERP;THOC5;HNRNPL;SF3A3;SNRNP27;DNAJC8;USP49;SRSF6;CTNNBL1;ZCRB1;RBM6;CHTOP;POLR2L;PRPF8;TFIP11;DDX39B;RAVER2;DHX15;RBM15;CDK7;RNGTT;CACTIN;WBP4;HNRNPH3;LSM3;SRSF12
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.3088051688270249,-0.7740134858679087,0.7808219178082192,0.9223705345889511,1.0,7/12,35.25%,B3GALT1;B3GALNT1;B3GNT2;B3GNT9;B3GNT3;B3GNT6;B4GAT1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.29876719752403236,-0.7736921542074735,0.7935779816513762,0.9221951393326677,1.0,2/13,4.78%,PLA2G4A;MGLL
prerank,regulation of activated T cell proliferation (GO:0046006),0.27130138070108184,0.7736466318438442,0.7839116719242902,0.9870807865357047,1.0,7/30,17.28%,SCRIB;ICOSLG;PDCD1LG2;PYCARD;IGF2;PRKAR1A;LGALS9
prerank,pre-replicative complex assembly (GO:0036388),0.24495048468487124,0.7735560370982608,0.8247978436657682,0.9866441917347485,1.0,17/64,18.81%,PSMD1;MCM7;PSMD10;GMNN;PSMA5;PSMB5;PSMC4;MCM4;PSMA4;PSMC5;CDT1;PSMB9;ORC2;PSMA7;PSMD14;PSMA2;PSMD11
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2831270319668965,0.7735224254251459,0.7908082408874801,0.9861220502335498,1.0,7/27,18.14%,MORF4L1;BRD8;KAT2A;NAA50;BAG6;PHF20L1;KAT7
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.3245594804612768,0.7733688406042581,0.75,0.9857921219820015,1.0,4/15,18.56%,KCNIP2;KCNN2;KCNJ8;KCNJ3
prerank,protein polyglutamylation (GO:0018095),0.33307454310254303,0.7730161945161912,0.7444253859348199,0.9858090028034662,1.0,2/11,13.44%,TTLL6;TPGS1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.2612506702924592,-0.772476635719977,0.8062015503875969,0.923392172741605,1.0,3/21,10.66%,CCN3;DAB2;SH2B1
prerank,positive regulation of DNA recombination (GO:0045911),0.28237657067548005,0.7717482133799842,0.8049180327868852,0.9873650535012231,1.0,8/27,18.77%,ZCWPW1;MRNIP;HMCES;ACTR2;ERCC2;PAXIP1;MMS19;RIF1
prerank,negative regulation of cell communication (GO:0010648),-0.26214894587085863,-0.7713270370348324,0.8097560975609757,0.9244433977662039,1.0,7/21,28.49%,IGFBP3;ACVR1;PTPN1;ERBB3;SOCS5;BRAP;KIF26A
prerank,response to alcohol (GO:0097305),0.2796501647315192,0.7713064690627365,0.7811501597444089,0.9875239150043045,1.0,6/27,19.41%,GRIN2B;GRIN2A;GLRA1;TGFBR1;GRIN3A;ABCA2
prerank,regulation of protein modification process (GO:0031399),0.2503276212577842,0.7711131026963282,0.8117647058823529,0.987274609380955,1.0,12/50,16.18%,PHIP;RABL3;SPRED1;PTK2;SPRED2;GRM5;FKTN;PLXNB2;IGF2;LYN;ATG14;NDUFS4
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2985767002971015,-0.7710514388455632,0.7920792079207921,0.9242203313017708,1.0,5/13,19.19%,RNF8;RECQL5;EAPP;NELFCD;HEXIM1
prerank,glial cell development (GO:0021782),0.2855898450582596,0.771034893790665,0.7528830313014827,0.9868207008368234,1.0,5/25,13.88%,MXRA8;EIF2B1;NF1;SOX10;MYRF
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.33051369746088766,0.7708904078696045,0.7472527472527473,0.9864663790159875,1.0,2/13,8.27%,PPARA;PINK1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.27079085893514676,-0.7706891109821894,0.7890625,0.9241093556931417,1.0,5/19,16.40%,CAT;MAOB;GPX1;PRDX1;PRDX3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3123772283838177,0.7704778415072396,0.7520938023450586,0.9865376859319896,1.0,5/15,21.31%,REEP2;LNPK;RTN3;ZFYVE27;ATL1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.25447194894439645,0.7704613373546004,0.8043795620437956,0.9859845384765973,1.0,6/45,10.90%,WNT5A;TLR6;TLR8;TLR4;GSDMD;PYCARD
prerank,NAD biosynthetic process (GO:0009435),0.2944472439427036,0.7704373960870371,0.7495769881556683,0.9854407508076819,1.0,3/20,11.85%,NMNAT3;KYNU;PTGIS
prerank,DNA modification (GO:0006304),0.2918791656918964,0.7703155287088747,0.7761194029850746,0.9850768081115022,1.0,6/22,19.03%,NEIL3;TERF1;MUTYH;MBD4;EXOSC5;TERF2IP
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.30084441800218786,-0.7702642956921102,0.7822014051522248,0.9240848521219979,1.0,6/13,22.16%,MTM1;FEZ2;TMEM39A;CHMP4B;CHMP4A;NUPR1
prerank,neuron projection fasciculation (GO:0106030),0.34346563879840775,0.7701555711659421,0.7316636851520573,0.9847716285000785,1.0,4/10,15.96%,SEMA5A;CNTN4;ARHGAP35;NRCAM
prerank,Golgi to endosome transport (GO:0006895),-0.28115983304700454,-0.7701442438193977,0.7914572864321608,0.923623159072832,1.0,5/16,14.67%,DOP1B;AP2A1;KLHL20;MON2;VPS13A
prerank,negative regulation of DNA replication (GO:0008156),0.32988577388206225,0.7699073074318378,0.7634782608695653,0.9846064236788333,1.0,5/13,24.45%,GMNN;TERF1;TSPYL2;GMNC;GTPBP4
prerank,negative regulation of protein depolymerization (GO:1901880),0.28907931138408427,0.769666014469073,0.76,0.9844204568836902,1.0,6/24,18.52%,PLEKHH2;STMN2;NAV3;CLASP2;CLASP1;SPEF1
prerank,organonitrogen compound catabolic process (GO:1901565),0.24796891702306137,0.7692432171633402,0.8319327731092437,0.984543752122633,1.0,9/57,12.19%,CPQ;LIPC;CAPN3;UCHL3;PLA2G7;MTOR;ADO;TXN2;SGPL1
prerank,spinal cord development (GO:0021510),0.33356289241454695,0.7691643780666281,0.7420494699646644,0.984093591961423,1.0,3/12,8.43%,LOXL3;NF1;RELN
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3279435883410175,-0.7684022600419096,0.7846790890269151,0.9255656008349761,1.0,5/10,35.38%,CX3CR1;CEACAM1;ARRB2;FCGR2B;LILRB1
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2822101744744013,-0.7681974821173323,0.7740259740259741,0.9252420300150176,1.0,4/16,13.26%,BMPR2;ACE;KLK2;DDAH1
prerank,mitochondrial transcription (GO:0006390),0.3547728202149548,0.7681231483684763,0.7583774250440917,0.9852945154911269,1.0,5/10,27.93%,SLC25A33;TEFM;TFAM;FOXO3;MRPL12
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3142288896812042,-0.7679720536687196,0.7839080459770115,0.9249290293232779,1.0,4/10,24.67%,DCLRE1A;RTEL1;DCLRE1B;ACD
prerank,snRNA metabolic process (GO:0016073),-0.2736562599179422,-0.7678910385851312,0.79,0.924426695936618,1.0,6/17,19.80%,INTS3;RBM7;INTS9;INTS10;INTS1;MEPCE
prerank,epidermal cell differentiation (GO:0009913),-0.22201511851224792,-0.7673270625458741,0.884393063583815,0.9246641881625489,1.0,11/41,20.57%,CLIC4;ANXA1;TXNIP;CASP3;UGCG;GATA6;BCR;WNT16;EPHA2;ADAM9;PIP5K1A
prerank,cellular component maintenance (GO:0043954),0.3377451770302202,0.767299586344385,0.7800751879699248,0.9860932365948146,1.0,3/12,12.48%,ITGA3;FYN;LNPK
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.30429464563278963,-0.7669381371708318,0.7867647058823529,0.9245880469790936,1.0,5/12,19.19%,RNF8;RECQL5;EAPP;NELFCD;HEXIM1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.29773874136569783,-0.766705099924612,0.7930283224400871,0.9242906545404523,1.0,4/13,17.56%,EPN2;NIBAN2;PTPN1;HHEX
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2554698949002008,0.765883933067665,0.8014705882352942,0.9878226119307552,1.0,11/42,20.56%,POLQ;SIRT6;MRNIP;SPIDR;FIGNL1;ACTR2;MMS19;FBH1;RIF1;TERF2IP;PPP4R2
prerank,regulation of protein-containing complex assembly (GO:0043254),0.2212256935235024,0.7657280378956134,0.8808933002481389,0.9874943348592055,1.0,20/110,16.02%,NRG1;HRG;TRAF3IP1;SORL1;NAPB;MPP7;PINK1;SLF1;SAR1A;EIF2AK2;IAPP;SPIDR;CDT1;KIF9;HSPA5;BAK1;CLU;SLF2;TIRAP;IMPACT
prerank,mitochondrial translational termination (GO:0070126),0.2282379753263625,0.765700597855588,0.8586387434554974,0.986961303683754,1.0,24/88,23.64%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,embryonic hemopoiesis (GO:0035162),0.33104207607408986,0.764621071909999,0.755834829443447,0.9882094469069795,1.0,2/12,4.58%,FLT3LG;KMT2A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.20642700613166534,-0.7637376657550509,0.8819672131147541,0.9278214261138296,1.0,12/52,15.85%,TUT7;SAMD4A;CNOT10;PARN;PAN3;LSM6;CNOT8;RC3H1;EXOSC2;LSM2;NT5C3B;EXOSC3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.26843148750060525,0.7633252360189521,0.7925925925925926,0.9897845810200842,1.0,8/32,19.31%,CDK14;FBXO5;POLA1;CDT1;KLF11;CDK5;CCNE1;TFDP1
prerank,negative regulation of cellular component organization (GO:0051129),0.2301395781227041,0.762239880638282,0.8467635402906208,0.9909681380140998,1.0,13/74,16.02%,TRAF3IP1;FAP;NR1H4;SORL1;CARMIL2;PRKD1;EPHA3;IAPP;HSPA5;CLU;PACSIN3;AR;IMPACT
prerank,regulation of presynapse organization (GO:0099174),0.31153935333648597,0.762169576815409,0.759016393442623,0.9899234656688696,1.0,5/18,18.74%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,regulation of presynapse assembly (GO:1905606),0.31153935333648597,0.762169576815409,0.759016393442623,0.9899234656688696,1.0,5/18,18.74%,GPC4;LRFN5;IL1RAPL1;SLITRK1;GPC6
prerank,respiratory tube development (GO:0030323),0.28175011607520545,0.7618700180462326,0.7730061349693251,0.9898347246429458,1.0,6/28,15.70%,ITGA3;NPHP3;LOXL3;BAG6;CCDC39;FGFR2
prerank,negative regulation of cilium assembly (GO:1902018),-0.30427437633788307,-0.7618327600486632,0.7916666666666666,0.9298823822356165,1.0,7/12,42.80%,TBC1D7;EVI5L;ODF2L;MAP4;TBC1D30;TCHP;CCP110
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.3478600682534695,0.7615570354568283,0.7464539007092199,0.9897476077247641,1.0,2/10,8.31%,GFPT2;PFKM
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.31090662352176046,0.7609289950595177,0.7703826955074875,0.9901783973491116,1.0,5/17,16.92%,NTRK2;SORL1;RTN2;CLU;RTN3
prerank,positive regulation of protein kinase activity (GO:0045860),0.21114365508519947,0.7606657305086691,0.9131483715319663,0.9900207973320798,1.0,26/148,17.33%,IL34;UNC119;TRAF4;MAP4K4;DLG3;CENPE;MTCP1;CALCA;MRNIP;PTK2;RELN;JTB;DAXX;CACUL1;MAP2K1;GRM5;DLG4;INCENP;CASS4;AXIN1;STRADB;CLU;TNIK;EFNA1;PAK5;ADRA2A
prerank,necroptotic process (GO:0070266),-0.2749295729078079,-0.7605133999423054,0.8152709359605911,0.9311140357371426,1.0,6/16,19.95%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96
prerank,calcium ion import (GO:0070509),0.2793045529345745,0.7604568709923724,0.785031847133758,0.9897829151807505,1.0,4/28,8.94%,CACNA1E;ATP2A2;CACNA1G;MICU3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.3212581665718529,0.7603608748774254,0.8084033613445378,0.9893687931275618,1.0,6/15,24.26%,GRM5;GRM7;GRM1;HOMER3;HOMER2;GRM8
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.23212135606772497,0.7603185160868853,0.8464619492656876,0.9888697248320821,1.0,7/73,9.15%,NTRK3;SH2D3C;MTCP1;DOCK7;PINK1;PRKD1;TENM1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.319200016585127,0.7601504938848838,0.7569444444444444,0.9885394634948416,1.0,3/15,10.89%,GSTO2;DAXX;DHX36
prerank,positive regulation of dephosphorylation (GO:0035306),0.2799883885692316,0.759823057814855,0.8006182380216383,0.9884812196922128,1.0,1/27,0.26%,DLC1
prerank,microtubule nucleation (GO:0007020),0.2947137436439496,0.7598132304378156,0.7615262321144675,0.9879234842659365,1.0,6/20,15.81%,CCDC57;GOLGA2;TUBGCP4;CLASP2;TUBGCP6;CLASP1
prerank,lymphocyte proliferation (GO:0046651),-0.25435242555172816,-0.7593335457604442,0.8402948402948403,0.9321064734297122,1.0,3/22,6.08%,MEF2C;CTPS1;ELF4
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.2807093626404541,0.7593109531146698,0.7693602693602694,0.9881506012511018,1.0,4/23,11.67%,SLC12A6;SLC9A1;CLCN3;PDK2
prerank,synaptic vesicle localization (GO:0097479),0.32231522629483933,0.7587643290822649,0.7378815080789947,0.9884510426501746,1.0,4/13,17.24%,SYNDIG1;KIF5C;TMEM230;CDK5
prerank,positive regulation of cholesterol transport (GO:0032376),0.2786163562376307,0.7586919216483845,0.80248833592535,0.9879869781747186,1.0,2/27,4.06%,LRP1;NR1H2
prerank,TOR signaling (GO:0031929),-0.2475658112846561,-0.7586894946146446,0.833810888252149,0.9324256880572857,1.0,15/26,35.05%,FNIP1;RICTOR;PRR5L;CCDC88A;MAPKAP1;EIF4EBP1;AKT1;NPRL3;RHEBL1;MLST8;EIF4EBP2;SMG1;SYAP1;RPS6KB2;CARD11
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.27755725214679694,0.7584532899724512,0.7947454844006568,0.9877786934949874,1.0,3/26,9.80%,TREML4;PTPN22;CYBA
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24608403203929397,0.7578721639773702,0.829512893982808,0.9881719116828648,1.0,11/48,18.74%,OGT;NUP214;AAAS;POM121;GCK;NUP42;NUP107;ZBTB7A;NUP54;NUP155;HIF1A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2700581243265774,-0.7578590272237063,0.8291457286432161,0.9329934214482377,1.0,5/17,17.85%,SOD2;HSPB1;PPIA;SIRT1;AKT1
prerank,body fluid secretion (GO:0007589),0.3137177624038665,0.7577018454016942,0.7580645161290323,0.9878641947651199,1.0,1/15,2.16%,ERBB4
prerank,protein localization to mitochondrion (GO:0070585),-0.31013930314834165,-0.757655228624877,0.7991071428571429,0.9326465026256378,1.0,5/11,22.02%,HK1;HK2;ISG15;AKT1;COX18
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.3112532665086292,0.757501347929064,0.7534246575342466,0.9876261871640039,1.0,3/14,12.41%,CD40;PRKCI;PDCD4
prerank,retrograde axonal transport (GO:0008090),0.31640642801431496,0.7572055448373645,0.75809199318569,0.9875466716243486,1.0,2/16,6.29%,DLG2;TMEM108
prerank,regulation of viral genome replication (GO:0045069),0.24145082884553873,0.756596016083232,0.8340365682137834,0.9879019702403705,1.0,5/56,7.13%,PPARA;PPID;PPIH;PDE12;STAU1
prerank,L-serine metabolic process (GO:0006563),-0.3164489120972349,-0.7563836884389908,0.7819383259911894,0.9337750009140567,1.0,3/10,17.46%,SERINC3;PSAT1;CBS
prerank,regulation of lipid storage (GO:0010883),-0.25751043784059874,-0.7561096030594188,0.8020565552699229,0.9335208762114421,1.0,5/22,15.99%,NFKB1;NFKBIA;PTPN2;ITGB3;SIRT1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.24386475277268188,-0.7559504000240583,0.824468085106383,0.9331116087373207,1.0,7/25,21.22%,ATXN7;APC;APC2;TRPV4;CAMSAP2;CIB1;KATNB1
prerank,regulation of cellular catabolic process (GO:0031329),0.23601929713604683,0.7558903737992448,0.8469101123595506,0.9884921571029291,1.0,13/62,18.15%,PIP4K2A;ITPR1;PIK3R2;MTMR4;LRRK2;RAB8A;WDR24;USP33;CISD2;USP13;RRAGA;GPR137B;RRAGD
prerank,protein depolymerization (GO:0051261),-0.2379034781800934,-0.7546119772194447,0.862533692722372,0.9343135201321231,1.0,8/27,21.45%,MICAL2;GSN;KIF24;CFL1;DSTN;MICAL3;KATNB1;TWF2
prerank,ncRNA export from nucleus (GO:0097064),0.25570996739339663,0.7544300329541517,0.81089258698941,0.9902579760061421,1.0,11/36,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;TSC1;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.24608005869739766,0.7541865074690643,0.8275862068965517,0.9900864266947067,1.0,13/50,22.24%,CCNJ;PKMYT1;CDKN2D;CCNB2;CDKN2C;CCNA2;GTF2H1;CCNK;CCNE1;CDK5R1;CCND3;CDK7;CCNT2
prerank,regulation of RNA splicing (GO:0043484),0.23142257995277363,0.7526307511557447,0.8674863387978142,0.9919344416389945,1.0,15/69,18.68%,PIK3R1;TRA2B;AFF2;PRX;KHDRBS3;CWC22;SRSF10;RBM20;ZNF326;SNRNP70;HNRNPLL;HNRNPL;HABP4;RRP1B;KHDRBS1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.25876152681150866,-0.7522600329942665,0.80440097799511,0.936754349177424,1.0,4/20,19.11%,PLCB1;RGS10;LYPD1;AGRN
prerank,lipid modification (GO:0030258),0.26456327321260364,0.7522052312804041,0.8164464023494861,0.9920124001730922,1.0,8/37,14.60%,PLPPR3;DGKQ;PLA2G7;PLPPR2;PLPP6;DGKI;MBOAT7;PLPP5
prerank,rRNA methylation (GO:0031167),0.28458258145096826,0.751887761677227,0.7970297029702971,0.9918931667326656,1.0,12/22,31.71%,MRM3;DIMT1;NSUN3;MTERF4;NSUN5;METTL15;METTL5;ZCCHC4;NSUN4;FTSJ3;EMG1;METTL16
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2832457063855975,0.7518379632826278,0.7882736156351792,0.990823132230703,1.0,7/22,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2832457063855975,0.7518379632826278,0.7882736156351792,0.990823132230703,1.0,7/22,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;ZDHHC6;ZDHHC9;ZDHHC8
prerank,regulation of interleukin-8 production (GO:0032677),-0.19316919431478774,-0.7517828459087471,0.9397163120567376,0.9367700307175859,1.0,12/69,17.21%,AFAP1L2;KLF4;LBP;ANXA1;MAVS;LAMTOR5;SERPINE1;TMSB4X;MAP2K5;ANXA4;RAB1A;CD74
prerank,fatty acid oxidation (GO:0019395),0.23844261337484965,0.7517695780453267,0.8696883852691218,0.9903497118837853,1.0,5/57,6.33%,ABCD2;PEX2;PPARD;ACADL;ACADS
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.2955743704202479,0.7512839662460009,0.7724358974358975,0.9905351652003851,1.0,6/19,20.26%,NR1H4;TLR4;IRAK1;TIRAP;LGALS9;RAB11FIP2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.2672725294011156,-0.7511770543747986,0.8120104438642297,0.9369474274881169,1.0,4/18,12.12%,PARN;CCT3;CCT4;CCT7
prerank,histone deubiquitination (GO:0016578),0.3006355066766284,0.7510748277591079,0.7896494156928213,0.9902959033171986,1.0,6/18,18.17%,KAT2A;ENY2;USP21;USP16;USP49;TAF10
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.29915212886196163,0.7510424987653376,0.8247078464106845,0.989786704917703,1.0,5/18,17.82%,TLR4;LRRC17;FBN1;MAFB;GPR137B
prerank,protein localization to vacuole (GO:0072665),0.3204167623861717,0.750802673725862,0.7583892617449665,0.9895775417847319,1.0,3/13,12.94%,SZT2;RNF128;CD81
prerank,protein monoubiquitination (GO:0006513),-0.2238803576784074,-0.7507918754555811,0.8773006134969326,0.9368404873755859,1.0,8/36,24.94%,MGRN1;UBE2D3;TRIM25;UBE3D;CUL3;LEO1;RNF20;DTX3L
prerank,actin filament polymerization (GO:0030041),-0.23838448304042686,-0.750753670232436,0.8601036269430051,0.9362449742810852,1.0,6/29,10.34%,DIAPH1;GSN;RAC1;COBL;GAS7;FAM107A
prerank,neural crest cell development (GO:0014032),0.25248454693426736,0.7504811309182792,0.8176555716353111,0.9894831515250546,1.0,6/44,10.26%,NRG1;SEMA5A;ERBB4;HTR2B;TAPT1;SOX10
prerank,calcium ion homeostasis (GO:0055074),0.22197677560118395,0.7503463367133688,0.8921052631578947,0.9891106610508476,1.0,9/95,9.08%,EDN3;SLC24A5;CD40;RYR2;HTR2B;CCL15;ATP2A2;ATP13A3;HTR2C
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.32900443773096477,0.7500964758145957,0.7723292469352014,0.9889102004190753,1.0,3/11,14.59%,SIRT6;MPHOSPH8;RESF1
prerank,mitochondrial membrane organization (GO:0007006),-0.2281125692483746,-0.7499025078364838,0.8780487804878049,0.9367634888633772,1.0,10/32,25.67%,BCL2L1;APOOL;MICOS10;BAD;SLC25A5;GHITM;CHCHD3;PPIF;APOO;SLC25A4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3012796570505891,-0.7498646647264272,0.7819383259911894,0.9355442297132033,1.0,2/12,9.10%,GSK3B;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3012796570505891,-0.7498646647264272,0.7819383259911894,0.9355442297132033,1.0,2/12,9.10%,GSK3B;DYRK2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3404874361919767,0.7497842873035434,0.7575221238938054,0.9888367343392517,1.0,1/11,1.25%,PTPRT
prerank,miRNA mediated inhibition of translation (GO:0035278),0.32902319915470757,0.7492324389806753,0.7724014336917563,0.9885664112887154,1.0,3/11,17.42%,AGO4;AGO3;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.32902319915470757,0.7492324389806753,0.7724014336917563,0.9885664112887154,1.0,3/11,17.42%,AGO4;AGO3;AGO1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.27283071884702376,0.7489195394641976,0.8422712933753943,0.9884714305466334,1.0,8/26,20.52%,C1QC;TLR4;LRRC17;FBN1;MYC;MAFB;GPR137B;INHBA
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19819227030748218,0.7487559337664231,0.956989247311828,0.9881598106341972,1.0,92/314,24.57%,BUB1B;FBXO9;FBXO45;PSMD1;BFAR;FBXO5;FBXO31;SEL1L;ZSWIM8;NEDD4;DMAC2;CDC16;PSMD10;CRBN;HERPUD1;CDC20B;PSMA5;ECPAS;PSMB5;AMN1;UBE2G2;UBXN4;BIRC2;PLAA;DNAJB12;FBXO17;PSMC4;MAN1B1;SEC61B;PSMA4;TMEM67;PSMC5;DNAJC10;FBXW5;USP19;FBXL13;HSP90B1;CUL5;GSK3A;ANAPC5;PSMB9;AREL1;TRIM2;ATXN3;UBE2D1;HSPA5;RNF122;BAG6;TRIM3;HACE1;YOD1;PSMA7;HECW1;DNAJB14;UBXN2B;PSMD14;FEM1B;CDC26;KLHL22;RNF187;PSMA2;DCAF11;ZFAND2A;CUL4A;PSMD11;FBXO4;FBXW4;SPSB2;UBE2J1;MTA1;DDB1;UBE2K;FBXL22;DDIT3;BTRC;RNF216;RMND5B;UBR3;SPSB3;ANAPC4;FAF1;FBXL5;FBXL12;NHLRC3;KIF14;UBE2J2;UFD1;UBE4A;FBXO44;SPSB1;OS9;MAD2L1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.27546392083213567,-0.748503935696485,0.7980049875311721,0.9367837229677721,1.0,3/14,13.03%,ADAM10;APH1A;APH1B
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.2750746359934654,0.7484936973405586,0.8078817733990148,0.9880294783235047,1.0,7/27,16.44%,PDE4B;RYR2;JUP;ATP2A2;CTNNA3;GJA5;STC1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.34282548535326757,0.748172217206224,0.7992277992277992,0.9879369465225258,1.0,5/10,24.42%,DSE;CSGALNACT2;B3GAT3;DSEL;B3GAT2
prerank,negative regulation of signaling (GO:0023057),-0.2460776414819271,-0.7481618089877742,0.8589743589743589,0.9366275383469121,1.0,4/25,10.53%,IGFBP3;ACVR1;PTPN1;OPTN
prerank,transferrin transport (GO:0033572),0.2575211887250238,0.7477727601321811,0.8202764976958525,0.9880084124623818,1.0,7/33,18.98%,STEAP3;ARHGAP1;ATP6V0E1;MCOLN1;ATP6V0D1;ATP6V1G2;ATP6AP1
prerank,regulation of neuron apoptotic process (GO:0043523),0.221923739732301,0.7477066926528345,0.8703939008894537,0.9875374278190153,1.0,9/96,9.06%,EPHA7;SLC30A10;NTRK2;GRID2;PRKCI;NF1;EGLN2;PINK1;LGMN
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.28226628160135914,0.7474045540296028,0.7831715210355987,0.9874478057292557,1.0,7/22,22.24%,CDK13;CCNK;THOC5;KAT7;CDC73;DDX39B;CCNT2
prerank,hexose biosynthetic process (GO:0019319),0.255829111842896,0.7470142679346118,0.8249258160237388,0.9874966896512863,1.0,6/42,11.24%,MDH1;PFKFB1;CRTC2;ALDOB;PER2;ENO3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.32616844456292526,0.7469305271937328,0.7854477611940298,0.9865184294476403,1.0,1/12,1.17%,SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.32616844456292526,0.7469305271937328,0.7854477611940298,0.9865184294476403,1.0,1/12,1.17%,SPRY4
prerank,macroautophagy (GO:0016236),0.21402677862650676,0.7469173000374633,0.9036755386565273,0.9859765896822529,1.0,25/118,17.76%,DYNLL1;PIP4K2A;VPS39;VIPAS39;PINK1;SNAP29;RB1CC1;PLAA;ARL8B;TMEM74;LIX1L;VAMP7;HGS;MFN1;HDAC10;TSG101;DYNLL2;ATG14;SNF8;YOD1;VPS33B;CSNK2A2;UBXN6;VPS4B;WIPI2
prerank,actin filament network formation (GO:0051639),0.3347851676024876,0.7466770325187457,0.7569060773480663,0.9857766453280881,1.0,7/11,29.22%,ACTN1;CARMIL2;SPIRE1;PLS3;CARMIL1;LCP1;FHOD3
prerank,regulation of p38MAPK cascade (GO:1900744),-0.22011820698319504,-0.7464949315933915,0.8849557522123894,0.9381747623784469,1.0,10/35,20.29%,EZR;MINK1;XDH;GADD45B;CYLD;MAP3K4;PER1;DLG1;MFHAS1;GADD45G
prerank,negative regulation of phosphatase activity (GO:0010923),0.2811526018403942,0.7463889220116813,0.7993874425727412,0.9856528342650669,1.0,6/25,15.54%,BOD1;GPATCH2;PTPA;PPP1R26;ZCCHC9;CRY2
prerank,positive regulation of DNA replication (GO:0045740),-0.27074394145530895,-0.7463600589048808,0.8254364089775561,0.9377079368163934,1.0,5/16,18.27%,EGFR;GLI2;PCNA;STN1;EGF
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2693130441027355,-0.746181161591285,0.8077858880778589,0.9373055013841681,1.0,3/16,11.41%,ST3GAL4;ETS1;MDK
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.26366184250808694,-0.7461321893412906,0.841726618705036,0.9367397524072743,1.0,9/21,26.32%,BCL2L1;TMBIM6;NCK1;BOK;CREB3;SELENOS;BCL2L11;HSPA1A;PARK7
prerank,mitotic cytokinesis (GO:0000281),0.2430425142314646,0.7460114163303505,0.863013698630137,0.9856493636016243,1.0,12/47,17.84%,UNC119;SPTBN1;ANK3;EFHC1;JTB;NUSAP1;INCENP;RTKN;STMN1;CEP55;STAMBP;CUL7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.2454019653481521,-0.7458011820024079,0.8405063291139241,0.9365328474336094,1.0,8/23,23.86%,HOOK1;CCDC88A;CCDC186;CCDC88C;DYNC1I1;KIF1C;TUBA1C;KIF5B
prerank,proton transmembrane transport (GO:1902600),0.25503550956920396,0.7457466944517902,0.8217054263565892,0.9854922847964025,1.0,3/36,6.00%,ATP1A2;ATP1A3;SLC9A1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.24953972148492787,-0.7455277581539266,0.7923076923076923,0.9362609313659446,1.0,11/21,36.05%,NES;CX3CR1;MDK;FZD3;CX3CL1;SMARCD3;KDM1A;DLL4;DISP3;LRP2;FZD9
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.30528353343118686,0.7453452245442544,0.7953020134228188,0.9855277821069388,1.0,8/17,25.81%,SEL1L;HERPUD1;SEC61B;HSP90B1;RHBDD1;UFD1;OS9;AUP1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.2947147539059535,-0.7453155326354778,0.8013856812933026,0.9359084430189204,1.0,5/13,21.96%,PRPF3;LSM2;CD2BP2;PRPF19;DDX20
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.2929574512760411,-0.7450610421580983,0.8017057569296375,0.9356571162543877,1.0,6/11,34.90%,ZC3H3;LEO1;NCBP2;AHCYL1;BARD1;PAPOLA
prerank,neuron apoptotic process (GO:0051402),0.29451395800864805,0.7450223717173996,0.7934426229508197,0.9854506192913085,1.0,6/19,17.24%,NGFR;TNFRSF21;FAM162A;ATN1;SCN2A;CDK5
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.25697374400695017,-0.7449044371167383,0.8759493670886076,0.9352139525885177,1.0,4/18,13.03%,ADAM10;APOE;APH1A;APH1B
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.29088582049381817,0.7441961036445475,0.8006329113924051,0.9861358806209357,1.0,6/22,18.28%,PSMA5;PSMB5;PSMA4;PSMB9;PSMA7;PSMA2
prerank,postreplication repair (GO:0006301),0.2510761889737293,0.7440651489135218,0.8406432748538012,0.9857740362438133,1.0,11/45,14.55%,POLK;RPA1;RFC3;UBE2V2;POLH;FAAP20;POLN;SPRTN;REV1;POLI;UBE2V1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2697012038801004,0.7439587776770982,0.8269525267993875,0.9853679222672582,1.0,9/29,21.60%,ERCC5;RPA1;XPC;GTF2H3;ERCC2;GTF2H1;CUL4A;DDB1;CDK7
prerank,telomere maintenance via telomerase (GO:0007004),0.27135894551663725,0.7439402903970155,0.8204334365325078,0.9848400855530701,1.0,7/28,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,epithelial cell development (GO:0002064),-0.2551189473861881,-0.7436779306581955,0.8353808353808354,0.936202236356667,1.0,13/20,44.96%,WNT5B;ACTA2;DACT2;SLC4A7;EXPH5;TMEM79;WNT7A;PKHD1;POF1B;GRHL2;WNT7B;RAB25;ROS1
prerank,post-translational protein modification (GO:0043687),0.19457069070129274,0.7435631646105783,0.9662447257383966,0.9848459152098068,1.0,86/332,23.17%,LAMC1;LAMB1;CCDC22;FBXO9;MXRA8;PRKCSH;COPS3;PSMD1;VCAN;FBXO31;ZBTB16;SPP1;RAB8A;EPAS1;PSMD10;UCHL3;AMELX;PSMA5;WDR5;PSMB5;APLP2;COMMD1;FBXO17;PSMC4;KCTD7;PSMA4;ASB1;PSMC5;RAB2A;FBXW5;FBXL13;HSP90B1;CUL5;COPS4;CAND1;PSMB9;LGALS1;SPARCL1;DDA1;ASB10;CHML;FBN1;SDC2;SERPINC1;PSMA7;DCAF4;IGFBP7;PSMD14;SOCS6;FEM1B;CUL7;WSB2;KLHL22;CALU;PSMA2;DCAF11;RCN1;HIF1A;CUL4A;PSMD11;ANO8;FBXO4;MIA3;DCAF10;RHBDD1;FBXW4;WSB1;SPSB2;MEN1;SCG2;DDB1;MBTPS1;FBXL22;CHGB;SENP8;WDTC1;RBBP5;BTRC;UBXN7;ASB13;KTN1;SPSB3;FBXO21;KLHL5;FBXL5;FBXL12
prerank,snRNA transcription (GO:0009301),0.22764042603357426,0.7433473663889713,0.9032258064516129,0.9845880477904023,1.0,23/70,26.43%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;USPL1;SP1;TAF11;POLR2L;GTF2B;CDK7;GTF2A2;CCNT2;POLR2D;TAF5;GTF2E1;POU2F1;ELL;RPRD2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.28411309372356225,-0.7430506901710392,0.8461538461538461,0.9363712911569805,1.0,5/14,24.67%,TNKS2;ATR;TERT;TPP1;ACD
prerank,respiratory electron transport chain (GO:0022904),0.31467335799892215,0.7429852970839879,0.7716262975778547,0.9845763777667406,1.0,2/14,8.61%,SDHB;SLC25A22
prerank,programmed necrotic cell death (GO:0097300),-0.2592799772020311,-0.7423621138752157,0.8508557457212714,0.9365713991786528,1.0,7/18,22.65%,PGAM5;CYLD;TICAM1;ITPK1;MLKL;LY96;PPIF
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.25679346651659796,0.7422193347235119,0.8221528861154446,0.9851125612854504,1.0,1/32,0.36%,CDC14B
prerank,lung development (GO:0030324),0.26533700942320765,0.741947557805088,0.8130699088145896,0.9849680080778555,1.0,7/33,15.70%,ITGA3;NPHP3;LOXL3;RCN3;BAG6;CCDC39;FGFR2
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27434335278436744,-0.741078295422098,0.8167053364269141,0.9376209624200755,1.0,5/15,19.74%,SMPD3;SDC4;SDC1;SDCBP;PDCD6IP
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3088724779057549,0.7403552895984613,0.7715736040609137,0.9867019847691307,1.0,2/16,9.92%,NAA10;NAA50
prerank,histone acetylation (GO:0016573),0.23050815517591355,0.7402779906912202,0.8744939271255061,0.9862639370605173,1.0,19/69,21.85%,TAF12;MORF4L1;BRD8;WDR5;BRCA2;KAT2A;NAA50;JADE1;EPC1;POLE3;DMAP1;ATF2;PHF20L1;KAT7;TAF10;MBIP;SUPT7L;ING3;CREBBP
prerank,heterocycle biosynthetic process (GO:0018130),-0.2844421659018779,-0.7402534482532956,0.8119047619047619,0.938076444288458,1.0,7/14,27.93%,NFS1;GCH1;MOCS1;NOXRED1;PYCR2;MOCS3;PYCR3
prerank,mesonephros development (GO:0001823),-0.30055406908536736,-0.7402367640654735,0.8009153318077803,0.9374691438429784,1.0,2/11,7.92%,OSR1;FGF1
prerank,pentose-phosphate shunt (GO:0006098),-0.3014862576125246,-0.7399419389838788,0.7923728813559322,0.9371902046278888,1.0,5/11,24.52%,DERA;TALDO1;PGM2;SHPK;PGLS
prerank,lipid oxidation (GO:0034440),-0.29517791750525857,-0.7396829951603624,0.8023809523809524,0.936890306221196,1.0,1/12,2.57%,ADIPOR2
prerank,RNA export from nucleus (GO:0006405),0.21803668438061752,0.7395229650114848,0.8838709677419355,0.9868204426347379,1.0,25/100,21.20%,EIF4A3;NUP214;AAAS;POM121;THOC7;HNRNPA2B1;GLE1;SRSF11;DDX19B;SLU7;NUP42;CASC3;NUP107;SLBP;SYMPK;FYTTD1;SRSF9;THOC5;NUP54;SRSF6;NUP155;CHTOP;MCM3AP;DDX39B;RANBP2
prerank,pseudouridine synthesis (GO:0001522),-0.290317912259327,-0.7394627835933166,0.800982800982801,0.9365457149209192,1.0,6/13,33.67%,PUS10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,acyl-CoA metabolic process (GO:0006637),0.2583414530655123,0.7391601718307623,0.835820895522388,0.9867665516412809,1.0,7/35,17.51%,ACSF2;DLST;ACOT7;HMGCS1;ACSL6;ACOT2;MCEE
prerank,negative regulation of ion transport (GO:0043271),0.2790236751590058,0.7381707806700245,0.7996870109546166,0.9877007906660905,1.0,6/24,17.33%,GPM6B;NEDD4;WNK2;PACSIN3;STC1;ADRA2A
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3067505821081762,-0.7380309038316203,0.815242494226328,0.9376755015685375,1.0,5/10,24.31%,THOC1;ETAA1;CCAR2;RFWD3;RPA2
prerank,zymogen activation (GO:0031638),0.24981591216757237,0.7380086346621884,0.8590909090909091,0.9873699626571759,1.0,7/39,14.78%,KLKB1;GRIN2A;OMA1;PLAU;LGMN;ASPH;BAK1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.20690477231460672,-0.7369531592623143,0.9249146757679181,0.9383534729607702,1.0,15/45,23.99%,THAP4;GOT2;GPT2;RIMKLB;OAT;MTHFR;NOX4;ASS1;DDAH1;CBS;KYAT3;ASNS;DDAH2;GLUL;PYCR2
prerank,regulation of chromosome segregation (GO:0051983),0.30193671654164367,0.7358102540421065,0.7874149659863946,0.9899823646175001,1.0,3/16,15.90%,MKI67;BUB1;CSNK2A2
prerank,positive regulation of secretion by cell (GO:1903532),0.22942869170772584,0.7354833021390279,0.8943758573388203,0.9898951640620534,1.0,14/70,18.98%,CADPS2;EDN3;PPID;CADPS;IER3IP1;P2RX4;EXOC1;CLASP2;CLASP1;ADAM8;STXBP5;RAB2B;BMP2;ATP6AP1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22821404449251007,0.7354739767654688,0.8803894297635605,0.9893572422076149,1.0,17/62,23.31%,NUP214;AAAS;FMR1;DND1;POM121;NUP42;NUP107;DHX9;WTIP;NUP54;AGO1;NUP155;FXR1;POLR2L;RANBP2;IPO8;NUP35
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.28720283728455376,0.7354298055135485,0.819935691318328,0.9888617663644523,1.0,7/20,18.37%,SPRY1;TBX3;TGFBR1;PDCD4;OLFM1;BMP2;HEY1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2635199085426471,0.7353896854126024,0.8535433070866142,0.9883576037711196,1.0,10/30,22.09%,ENTPD5;SELENOF;DNAJB12;HSPA13;HSPA5;DNAJB14;HSPE1;ST13;HSPA9;CHCHD4
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.28013878239535805,-0.7347675796048287,0.80622009569378,0.9404558725569275,1.0,9/14,31.99%,WNT9A;PTHLH;RFLNA;EFEMP1;CHADL;RFLNB;GREM1;ADAMTS7;SNAI2
prerank,glycerol metabolic process (GO:0006071),0.3353527857628855,0.7339944705049757,0.7844202898550725,0.9897344563389798,1.0,2/10,10.39%,COQ3;GK
prerank,negative regulation of viral release from host cell (GO:1902187),-0.2795135229890241,-0.733967836482225,0.8226950354609929,0.940796675428945,1.0,3/13,15.01%,TRIM5;TRIM11;TRIM35
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2298035416495506,0.7339414975957522,0.8838797814207651,0.9892512570212632,1.0,17/69,16.82%,SEL1L;HERPUD1;ECPAS;UBE2G2;UBXN4;DNAJB12;FBXO17;MAN1B1;SEC61B;TMEM67;DNAJC10;USP19;HSP90B1;HSPA5;BAG6;YOD1;DNAJB14
prerank,regulation of programmed necrotic cell death (GO:0062098),0.27866373969378866,0.7332384919290287,0.7996820349761526,0.9896905400125714,1.0,4/20,14.79%,OGT;FLOT2;BIRC2;RIPK1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.25702499001192364,0.7330673349815018,0.8364485981308412,0.989368025451078,1.0,10/31,20.38%,PTEN;CDKN2A;SUSD2;CDKN2D;JADE1;CDKN2C;PRMT2;BRD7;CDC73;CCL2
prerank,positive regulation of protein processing (GO:0010954),0.2915259646153126,0.7329298588803245,0.7993254637436762,0.9889954351587541,1.0,5/19,19.56%,KLKB1;CLEC3B;NKD2;ADAM8;RHBDD1
prerank,cellular response to radiation (GO:0071478),0.24529541665344706,0.7327528666873008,0.8788774002954209,0.9887012926539628,1.0,5/40,12.57%,GPR88;GPR52;TP53;SPIDR;FIGNL1
prerank,DNA recombination (GO:0006310),0.2509269162052453,0.7322916181115309,0.8534351145038168,0.9888080839786051,1.0,10/37,22.28%,ERCC1;MSH3;RPA1;RECQL;RAD52;HDAC10;WRN;FBH1;RAD54L;HMGB1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.2559930373415163,-0.732226568006227,0.8214285714285714,0.9422752882442788,1.0,7/19,29.92%,PRKDC;MDK;PPP2R3C;RHOH;CD27;NCKAP1L;IL7
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.23225530608244113,0.7316884190468941,0.8632478632478633,0.9890798485855472,1.0,8/57,15.32%,CDC14B;TIPIN;FBXO31;MRNIP;TP53;RINT1;EME2;ATF2
prerank,pigment granule transport (GO:0051904),-0.2546790724578355,-0.7316329256187712,0.853904282115869,0.9417151892337778,1.0,6/18,28.52%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,melanosome transport (GO:0032402),-0.2546790724578355,-0.7316329256187712,0.853904282115869,0.9417151892337778,1.0,6/18,28.52%,ARL6;MKKS;BBS7;BBS2;BBS5;RAB11A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2532543594571054,0.7313993816385884,0.8531684698608965,0.9889453429870582,1.0,7/32,16.57%,NANOS3;NR1H4;MTPN;GRM5;RBM4B;TSC1;CYFIP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.2926692925489695,0.731224112931374,0.8177339901477833,0.9886431763464465,1.0,3/17,8.14%,SPRED1;DGKQ;SPRED2
prerank,DNA dealkylation (GO:0035510),-0.31119663191793456,-0.7311116200827313,0.7982456140350878,0.9411158214794252,1.0,6/10,31.64%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.31119663191793456,-0.7311116200827313,0.7982456140350878,0.9411158214794252,1.0,6/10,31.64%,ASCC2;ALKBH5;ASCC3;MGMT;ALKBH2;ALKBH1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.30764742901591025,0.7309037269638899,0.8086642599277978,0.9885404789186877,1.0,5/14,21.79%,TLR6;IRAK1;TIRAP;TNFRSF10B;MALT1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.23581839534322094,0.7308470946854829,0.8682284040995608,0.98808380716034,1.0,14/49,23.38%,TRAF3IP1;THRA;SORL1;JAM3;IAPP;HSPA5;CLU;IMPACT;PTGER4;TFIP11;HMGB1;ANKRD27;NLRP2B;KIF14
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.2827879381829044,0.730234864436008,0.8252730109204368,0.9884117077566932,1.0,2/20,3.83%,MBTPS2;NGFR
prerank,negative regulation of calcium ion transport (GO:0051926),0.302612063703554,0.7301079617687445,0.8003355704697986,0.9880448814741647,1.0,4/15,17.33%,ATP1A2;PACSIN3;STC1;ADRA2A
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.28626122069259663,0.7300347133278771,0.8036006546644845,0.9875988874544794,1.0,2/20,4.94%,PPID;PPIH
prerank,cellular response to misfolded protein (GO:0071218),-0.2579358646254448,-0.729971301314464,0.8793565683646113,0.9418734574161078,1.0,6/20,21.66%,RNF185;VCP;TOR1A;CUL3;RNF5;UGGT1
prerank,cellular response to BMP stimulus (GO:0071773),0.22752971409062991,0.7295747345291462,0.8935574229691877,0.9876999729420929,1.0,8/66,12.41%,RUNX2;RGMB;RGMA;SMAD5;ADAMTS12;BMP7;SOX9;PDCD4
prerank,regulation of cell division (GO:0051302),0.22286842981693153,0.729565763538231,0.8990825688073395,0.9871693961177298,1.0,12/72,15.70%,KDF1;SUSD2;EFHC1;NCOA3;HTR2B;ZFYVE26;INSC;RAB11FIP3;ENTR1;SMYD5;MYC;FGFR2
prerank,piRNA metabolic process (GO:0034587),0.28613781809692906,0.7294984319297577,0.8236272878535774,0.9867053663772316,1.0,1/19,2.39%,TDRKH
prerank,CENP-A containing chromatin organization (GO:0061641),0.2575279655560796,0.7293181957866246,0.8441558441558441,0.985862525996412,1.0,5/29,14.74%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.2575279655560796,0.7293181957866246,0.8441558441558441,0.985862525996412,1.0,5/29,14.74%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,negative regulation of histone methylation (GO:0031061),0.33148922224211846,0.7292927723953706,0.8003533568904594,0.9853490340031908,1.0,3/10,16.27%,BCOR;WDR5;AASS
prerank,transition metal ion transport (GO:0000041),0.25489082596455404,0.729180684441267,0.848297213622291,0.9849610132214083,1.0,8/35,19.43%,SLC30A10;SLC30A5;TRPC3;TRPC7;HEPH;ATP7A;ATP2C1;TRPC1
prerank,regulation of chromosome organization (GO:0033044),-0.24338158945933402,-0.7287854923514009,0.8623595505617978,0.9425910268520402,1.0,9/22,26.33%,SMG6;MAPT;HDAC8;SMG5;SETMAR;SHCBP1L;RMI2;LIG4;RB1
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.20678035367087214,-0.7286996576571111,0.9,0.9420778515604185,1.0,6/40,10.68%,SLC13A3;SLC38A11;SLC16A1;SLC38A5;SLC38A10;SLC7A5
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.317826867057846,-0.728694020868067,0.8385650224215246,0.9414670007924709,1.0,4/10,11.99%,NCK1;CITED2;VHL;BAG3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.2800321312794713,0.7283274849788464,0.8275290215588723,0.9855701894522215,1.0,3/21,8.79%,PTEN;CNKSR3;INPP5J
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.30209758820973,0.7276674719884487,0.7948717948717948,0.9859171628934464,1.0,5/14,22.88%,NOL9;DDX18;URB1;RPL35;ZNHIT6
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3001956933546306,0.7276181349121851,0.8227194492254734,0.9854340275140161,1.0,2/15,7.16%,REST;ZFP36L2
prerank,regulation of striated muscle contraction (GO:0006942),0.26232266201843846,0.727175602931135,0.8609375,0.9855055488997473,1.0,5/27,15.14%,ATP1A2;RYR2;PRKACA;P2RX4;GJA5
prerank,mitochondrial translation (GO:0032543),0.2118800733331814,0.7270997192444673,0.9222082810539524,0.9850619767869349,1.0,27/104,23.64%,MRPL44;EARS2;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;HARS1;MRPS23;MRPL3;MTIF2;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21
prerank,negative regulation of interleukin-2 production (GO:0032703),0.28924029637322246,0.7270433905912339,0.8236331569664903,0.984597824020238,1.0,2/18,8.85%,XCL1;NAV3
prerank,regulation of centrosome duplication (GO:0010824),0.257001031363252,0.7268382514225533,0.850453172205438,0.9843337394733583,1.0,7/30,19.18%,NAT10;CEP295;TMEM67;FBXW5;VPS4B;ALMS1;CENATAC
prerank,RNA biosynthetic process (GO:0032774),0.2607393156405129,0.726428262923841,0.8183183183183184,0.9843387464656724,1.0,3/31,10.16%,TAF12;POLA1;TBPL1
prerank,nucleotide biosynthetic process (GO:0009165),0.29449138231395844,0.7260837391812068,0.8069883527454242,0.9842753893326743,1.0,3/18,10.63%,NMNAT3;PRPS1L1;PRPS1
prerank,negative regulation of phagocytosis (GO:0050765),-0.2621097259105837,-0.7259419241782978,0.8485639686684073,0.9440598059215659,1.0,5/17,31.67%,SIRPA;DYSF;SNX3;FCGR2B;CD300LF
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.2697983973090563,0.7256706836714903,0.8217821782178217,0.9843000114079352,1.0,6/26,13.74%,PDPK1;DUSP22;ZFP36L2;SOX9;GAREM1;MED1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.20179760497489774,-0.725616865869439,0.9492063492063492,0.9438088735893883,1.0,19/48,32.92%,SLIT2;ROBO1;SAMHD1;PTPN2;NLRC5;ISG15;CCDC3;USP18;RFFL;SIGIRR;YTHDF2;PADI2;PELI3;TTLL12;PPARG;OTUD4;PYDC1;GPS2;TREM2
prerank,tRNA transport (GO:0051031),0.2512132195023885,0.7249516967754301,0.8579970104633782,0.9847180735220097,1.0,10/35,23.78%,NUP214;AAAS;POM121;NUP42;NUP107;NUP54;NUP155;RANBP2;NUP35;SSB
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.21700601658778473,-0.7241520045341405,0.918918918918919,0.9447945703586624,1.0,14/33,29.64%,PRKDC;MAPK14;ETS1;TAL1;HMGB2;ABCB10;PITHD1;FES;ACVR2A;HSPA1A;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,tRNA modification (GO:0006400),0.22898698714308893,0.7234842354321797,0.8987517337031901,0.9861593725871624,1.0,19/62,24.77%,CTU1;DUS2;QTRT2;TRMT13;OSGEP;TYW3;TRMT44;TRMT61A;PUS7;WDR4;METTL1;THUMPD3;TRMT10A;METTL2A;METTL2B;LCMT2;AARS1;SSB;NSUN6
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.19949522695799465,-0.7232673143460193,0.9352750809061489,0.9451401505737568,1.0,13/49,26.32%,AFAP1L2;LBP;MAVS;LAMTOR5;SERPINE1;RAB1A;CD74;TLR7;BCL10;HYAL2;NOD2;HSPA1A;PARK7
prerank,serine family amino acid metabolic process (GO:0009069),0.30296962061825783,0.7230261562226442,0.8073089700996677,0.9862277597075373,1.0,1/16,1.42%,THNSL2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2039336545253635,0.7227787992130724,0.9392466585662211,0.9860195715847518,1.0,20/136,15.41%,XCL1;TCF7L2;CDKN2A;FOXS1;PSMD10;BRMS1;TRIM37;TAF3;LRRC14;SP100;COMMD1;BMP7;IRAK1;PYCARD;DAP;PTGIS;PIM1;CTNNBIP1;PRMT2;PAXIP1
prerank,protein methylation (GO:0006479),0.2477368344599426,0.7221114231135353,0.8729446935724963,0.9863490627506974,1.0,17/40,28.62%,PRMT3;VCPKMT;NSD1;FAM98B;CARM1;PRMT2;N6AMT1;EHMT2;ATPSCKMT;CAMKMT;EHMT1;PRMT6;ETF1;PCMT1;FAM98A;NSD3;METTL22
prerank,spliceosomal snRNP assembly (GO:0000387),0.24811451070060586,0.7213855017511337,0.8730886850152905,0.9867448623565183,1.0,13/38,25.56%,GEMIN2;LSM4;SNUPN;SRSF10;CLNS1A;SNRPF;USP4;GEMIN8;PRPF8;SRSF12;GEMIN5;GEMIN7;SNRPG
prerank,phagosome maturation (GO:0090382),0.24861602388434662,0.7195643825653766,0.8537735849056604,0.9885828152129699,1.0,2/35,2.26%,RAB34;RAB20
prerank,translational termination (GO:0006415),0.2136419121933199,0.7189139020964099,0.9036939313984169,0.9888746913701608,1.0,28/95,25.44%,MRPL44;MRPS31;MRPS24;MTRF1;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;N6AMT1;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MTRF1L;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;ETF1;MRPL14;MRPL32
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.18619290134262498,-0.7186305277796841,0.9611307420494699,0.9497094231569813,1.0,14/63,15.10%,PRKDC;CNOT10;CRADD;SOX4;CASP2;PLAGL1;CNOT8;BTG2;BAX;RPL26;PCNA;ATM;CCND1;CDKN1A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.28767926439076974,0.718586817388689,0.8228476821192053,0.988757859439995,1.0,7/18,22.36%,NOL3;PINK1;HTRA2;NONO;HIF1A;BAG5;MAPK7
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.307848465599947,0.7185833606699749,0.8211805555555556,0.9882230095043513,1.0,2/13,10.04%,UNC93B1;IRAK1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.3087000235615225,0.7182746529311478,0.8006872852233677,0.9880933626751475,1.0,2/13,10.06%,L2HGDH;DLST
prerank,regulation of defense response to virus (GO:0050688),0.3030868517467723,0.7182482433484038,0.8088495575221238,0.9875936319205453,1.0,3/14,14.93%,TRAF3IP1;IFNLR1;DHX9
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23675343770712198,0.7180881205516823,0.8967065868263473,0.9872619046438549,1.0,6/45,9.77%,BUB1B;SCRIB;ZFP36L2;BCL6;BMP7;NME6
prerank,microtubule anchoring at centrosome (GO:0034454),0.3264716207194351,0.7179405043732435,0.8309352517985612,0.9869319607260925,1.0,5/10,20.71%,PCM1;CEP19;KIF3A;BBS4;NIN
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.327548718604948,0.717322699420884,0.8059964726631393,0.9871928218060654,1.0,5/10,24.06%,EMC2;EMC9;EMC8;EMC10;EMC4
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.25697947347874356,-0.7167230604625134,0.8647214854111406,0.9511475544567348,1.0,9/17,32.58%,MTBP;ZW10;BUB3;CTCF;RB1;IK;TTK;CENPA;ZWILCH
prerank,chromatin remodeling at centromere (GO:0031055),0.24982085540557966,0.7166942514059036,0.8421052631578947,0.9874695022782195,1.0,5/31,14.74%,MIS18A;CENPU;CENPC;CENPW;MIS18BP1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.25546153574346875,-0.7165680357224139,0.8578313253012049,0.9506824331980721,1.0,5/17,23.42%,CD55;TRIM5;CX3CL1;LY96;SIGIRR
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.24966435702276443,-0.7165073705273589,0.876993166287016,0.950124128352447,1.0,3/17,16.76%,SLC7A5;PRKCZ;HAVCR2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2998783044171516,0.7163809672866756,0.8214285714285714,0.9873146525540305,1.0,4/14,14.64%,LRRK2;HERPUD1;OPA1;CREB3L1
prerank,cellular response to inorganic substance (GO:0071241),0.2723681775026272,0.7158396694937841,0.8381410256410257,0.9874968192644727,1.0,4/21,11.64%,ADCY10;FMR1;KCNC2;SPIDR
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.22298119101765732,-0.7149313446727357,0.8907103825136612,0.9511341376194344,1.0,8/31,15.33%,TMBIM6;HSPA8;HSPB8;BAX;PTPN1;OPTN;BAG3;ERN1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.300365746773659,0.7145629648191564,0.8297101449275363,0.9885998900509863,1.0,4/15,19.65%,RYR2;SRPRA;ZFAND2A;RAB3GAP2
prerank,positive regulation of cellular senescence (GO:2000774),0.32942290542028074,0.7142804010977558,0.8101933216168717,0.988429556413419,1.0,1/10,2.62%,CDKN2A
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.25569255859665424,0.7130968335406401,0.8368,0.9893887538950956,1.0,11/29,23.83%,ELOVL2;HSD17B8;ACSL6;ACLY;ELOVL6;ELOVL1;ACSBG1;SCD5;ACACA;ELOVL5;TECR
prerank,regulation of biosynthetic process (GO:0009889),0.3170521757714453,0.7129743712279134,0.8292682926829268,0.9890184891428829,1.0,2/11,18.49%,SLC25A33;ALOX5
prerank,snRNA processing (GO:0016180),0.2873849503828336,0.7129618464729643,0.8221476510067114,0.9884971708442484,1.0,2/16,11.40%,INTS8;INTS14
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.2179287789839836,0.7122207939444235,0.9226594301221167,0.988878993118365,1.0,3/72,4.21%,FLRT2;FGFR1;SPRED1
prerank,negative regulation by host of viral process (GO:0044793),-0.29474731804719745,-0.7120761671453114,0.8501118568232662,0.9535236560227175,1.0,7/10,46.02%,VAPA;PSMC3;CRP;ZC3H12A;CCL8;PRKN;PTX3
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.21886568286843894,0.7120010872228272,0.9349593495934959,0.9886406291252304,1.0,22/69,26.43%,INTS8;GTF2A1;SRRT;ZC3H8;SNAPC5;INTS14;ELL2;CCNK;TAF8;SP1;TAF11;POLR2L;GTF2B;CDK7;GTF2A2;CCNT2;POLR2D;TAF5;GTF2E1;POU2F1;ELL;RPRD2
prerank,positive regulation of T cell activation (GO:0050870),-0.18796566744705834,-0.7114894784649165,0.9903846153846154,0.9534745968788755,1.0,6/62,6.17%,SIRPA;ANXA1;IL6ST;SLC7A1;TFRC;NCK1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2186666454559989,0.7114367111876625,0.9296148738379814,0.9888170518423083,1.0,15/76,17.95%,C5AR1;P2RY1;HTR2B;CALCA;TRHR;CCKBR;HTR2C;GNA11;LPAR1;GRM5;F2R;LHCGR;ADRA2A;GPR35;GRM1
prerank,peptidyl-methionine modification (GO:0018206),0.3059038326209005,0.7112106801977675,0.8197879858657244,0.9885615592194235,1.0,1/12,6.10%,METAP1D
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.24072219756110114,0.7109655990160906,0.8705035971223022,0.9883157534465868,1.0,12/42,23.52%,EPRS1;CARS1;TARS1;EARS2;YARS1;HARS1;SARS1;SARS2;AIMP1;PPA2;MARS2;AARS1
prerank,negative regulation of bone remodeling (GO:0046851),-0.29125288385367776,-0.7103743567210853,0.832967032967033,0.9540683409439049,1.0,6/11,25.13%,SFRP1;TMEM119;P2RX7;GPR137;TNFAIP3;GREM1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.2653097498560845,-0.7096894346316932,0.865909090909091,0.9541616381842262,1.0,3/14,18.36%,MOXD1;NOS1;SLC22A2
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.28616272798117226,-0.7093565678534421,0.8375870069605569,0.9538803048469661,1.0,5/12,25.16%,CRYAB;APOE;PFDN4;PFDN6;PFDN2
prerank,positive regulation of protein maturation (GO:1903319),-0.28661492420014284,-0.7092604930623645,0.8351648351648352,0.9533570727202655,1.0,2/11,7.88%,SOX4;CCBE1
prerank,potassium ion import across plasma membrane (GO:1990573),0.237383151447462,0.7090651068428456,0.897125567322239,0.9901799476756737,1.0,10/41,21.25%,ATP1A2;SLC12A6;ATP1A3;HCN2;KCNJ8;KCNJ10;KCNJ3;KCNJ16;ABCC9;SLC12A9
prerank,melanosome localization (GO:0032400),-0.23893543626272712,-0.7090406062522051,0.8994845360824743,0.9529809135938675,1.0,8/21,31.77%,ARL6;SHROOM2;MKKS;BBS7;BBS2;BBS5;RAB11A;VPS33A
prerank,positive regulation of type I interferon production (GO:0032481),-0.18248034227201868,-0.7088647294633637,0.967741935483871,0.9525449579898813,1.0,23/73,27.47%,NFKB1;PRKDC;POLR3E;MAVS;CRCP;IRF1;GAPDH;RIOK3;POLR2H;POLR3G;POLR3D;TBK1;NFKB2;ISG15;PQBP1;POLR1C;POLR3K;TLR7;HSPD1;IRF5;FLOT1;ZBP1;POLR2K
prerank,RNA methylation (GO:0001510),-0.18907834628017314,-0.7079144317868862,0.9671532846715328,0.9528582436247784,1.0,17/60,26.00%,VIRMA;NSUN2;TRMT61B;CMTR1;FTSJ1;TRDMT1;TRMT5;THUMPD2;METTL6;GTPBP3;RBM15B;MEPCE;TRMT6;MRM2;TRMT12;TRMT112;NOP2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.27522238856893916,0.7076968459287536,0.8344481605351171,0.9912914779820162,1.0,3/19,10.06%,SLC25A21;ASPA;DLST
prerank,iron ion transport (GO:0006826),0.2292471441538486,0.7075085675473243,0.8898678414096917,0.990978358256727,1.0,10/47,18.98%,STEAP3;ARHGAP1;HEPH;ATP6V0E1;ABCB7;MCOLN1;SLC39A14;ATP6V0D1;ATP6V1G2;ATP6AP1
prerank,protein sumoylation (GO:0016925),0.23017365890932953,0.7068538120881094,0.8985915492957747,0.9912332412143685,1.0,18/49,26.97%,NUP214;AAAS;POM121;PIAS2;SAE1;NUP42;NUP107;NUP54;NUP155;SUMO2;RANBP2;NUP35;TRIM28;UBA2;NSMCE2;IFIH1;NUP210;NUP88
prerank,histone mRNA metabolic process (GO:0008334),0.26358423591861296,0.7060942797426397,0.8693009118541033,0.9916215944757002,1.0,6/27,15.30%,LSM11;TENT4B;TENT2;SLBP;SNRPF;EXOSC10
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.25281679897243764,0.7060733821571307,0.8763693270735524,0.9911165013872753,1.0,6/29,14.79%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,cellular response to chemical stress (GO:0062197),0.2063386576339436,0.7059800023794573,0.9413298565840938,0.9906949249080006,1.0,19/96,17.24%,ETV5;PRDX6;ALDH3B1;LRRK2;PRDX5;CCS;PYCR1;PINK1;PRKD1;CYBA;ERMP1;HTRA2;EIF2S1;RAD52;LONP1;VKORC1L1;TXNRD2;NOX1;NUDT2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.25093979287878304,0.7059499915841994,0.8681818181818182,0.990196026894478,1.0,5/32,15.72%,DLC1;MTOR;PTPA;ANKLE2;SYMPK
prerank,translesion synthesis (GO:0019985),0.23913265641366388,0.7059081126719153,0.8760932944606414,0.9897178007118367,1.0,10/42,14.01%,POLK;RPA1;RFC3;REV3L;POLH;FAAP20;POLN;SPRTN;REV1;POLI
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.2382809629915088,-0.7057638242426264,0.8564102564102564,0.9543969593337341,1.0,6/21,21.22%,ATXN7;APC;APC2;CAMSAP2;CIB1;KATNB1
prerank,membrane repolarization during action potential (GO:0086011),0.3014009191196041,0.7053447736513179,0.8108108108108109,0.9898709790225819,1.0,2/13,10.97%,KCNIP2;KCNE4
prerank,error-free translesion synthesis (GO:0070987),-0.23930420189771873,-0.7053101974944307,0.8967391304347826,0.9542481400526256,1.0,5/22,12.60%,NPLOC4;UBB;VCP;RCHY1;PCNA
prerank,protein targeting to membrane (GO:0006612),0.2111330713615853,0.7051750037096064,0.9365079365079365,0.9895744671885321,1.0,21/83,20.14%,RTP4;ABCD2;PEX2;PRKCI;SEC63;ZDHHC24;SRPRA;SLC25A17;GET3;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;PEX3;ZDHHC9;ALDH3A2;PEX14;SSR1;RABGEF1;MICALL1
prerank,cellular macromolecule catabolic process (GO:0044265),0.2291889234562798,0.704734148554729,0.8928571428571429,0.9895639268343865,1.0,10/49,16.58%,RNASEH2C;UBE2G2;FBXO17;MTREX;RNASEH2B;HTRA2;RIPK1;HNRNPD;RNASEH1;PPP1R8
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.20632276730370308,-0.7046602330859401,0.9323943661971831,0.954275093467882,1.0,9/36,20.75%,ITGB1;SHANK3;NRP1;EPHB2;EDN1;HFE;EGF;ADRB2;HDAC6
prerank,macrophage migration (GO:1905517),0.3016072325464588,0.7043664058492094,0.8240574506283662,0.9894870458621716,1.0,13/13,69.86%,P2RX4;CCL2;P2RY12;CXCL17;TAFA4;SAA1;EDN2;LGALS3;CCL3;EDNRB;CCL5;CKLF;CCR2
prerank,positive regulation of viral life cycle (GO:1903902),0.26778505015391135,0.7040320331695282,0.848966613672496,0.9893373926958552,1.0,7/22,22.34%,FMR1;AXL;LGALS1;TSG101;LGALS9;DDB1;KPNA2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.26440802370265176,0.7033296249945544,0.848531684698609,0.9896373959813699,1.0,5/23,20.54%,COPS3;XPC;COPS4;CUL4A;DDB1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.2665030851505624,0.7030180476597129,0.8355932203389831,0.989461697625167,1.0,2/21,4.94%,FBXO5;CDC7
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.25785016877105355,0.7017247997236249,0.8624595469255664,0.990468174166746,1.0,4/26,9.55%,FLOT2;LRRC14;APPL2;BIRC2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2769982053752788,0.7007610940243757,0.8309608540925267,0.9910732650800393,1.0,8/18,23.89%,LYAR;UTP15;EIF2AK3;POLR2L;HEATR1;DHX33;MAF1;ATF4
prerank,protein complex oligomerization (GO:0051259),0.20886213045072186,0.7003612421223344,0.9421265141318977,0.9910288935221974,1.0,13/85,11.72%,POLQ;MPP2;NOL3;SLC9A1;ADCY8;KCNC2;OPA1;GLRA3;NUDT21;GSDMD;VSTM5;PYCARD;WDCP
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.23280628354431132,0.6998393440373898,0.9114658925979681,0.9911121217930996,1.0,7/45,15.27%,PIK3R1;SLC30A10;PDPK1;PTK2;SOX9;GAREM1;AREG
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.18174897053261502,-0.6996061401724852,0.9717741935483871,0.9586678125449312,1.0,22/68,28.51%,CAVIN1;GTF2H5;WDR33;UBTF;SNRPE;POLR2H;TTF1;POLR1H;CLP1;TAF1C;GTF2H4;POLR1G;POLR1C;NCBP2;POLR3K;LSM10;SMN1;SSU72;CPSF7;POLR2K;MED18;MTERF2
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.25447819384150633,-0.6994723762419812,0.8579088471849866,0.9581714134979157,1.0,2/18,2.06%,NPLOC4;DDX60
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2488143478779547,0.6994657521335707,0.888208269525268,0.9910058957934339,1.0,6/30,14.79%,CD40;TLR6;TLR4;BIRC2;UBE2D1;RIPK1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.3015524982305422,0.6991700110510164,0.8284734133790738,0.9908160790267508,1.0,5/13,24.18%,CAMK4;ZC3H8;ADAM8;TOX;BMP4
prerank,synaptic vesicle membrane organization (GO:0048499),0.27907896742729343,0.6990072458801906,0.853781512605042,0.990469370794415,1.0,4/17,13.39%,SNAP23;SYP;SNAP29;AP3D1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.25560340344300336,0.6980280790058839,0.8644628099173554,0.9910530156681037,1.0,5/25,15.36%,NCKAP5L;STMN2;STMN4;STMN1;KIF2A
prerank,maintenance of protein localization in organelle (GO:0072595),0.2748921104232378,0.6978016015390561,0.847682119205298,0.9907720140741155,1.0,7/19,20.70%,TAF3;PINK1;TAPT1;HSPA5;TAF8;SUPT7L;BBS4
prerank,positive regulation of ruffle assembly (GO:1900029),0.2997682144341708,0.6974105240165459,0.8294314381270903,0.9906871334552086,1.0,2/13,8.92%,CARMIL2;EPS8L1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.242069909980536,0.697217857656768,0.8646153846153846,0.9903862191156674,1.0,6/30,19.53%,OGT;EIF3H;FHIT;BAG6;USP14;DDRGK1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.20930379580664063,0.6971078858497165,0.9278215223097113,0.9899947712816871,1.0,15/76,18.44%,NTRK3;SEMA5A;FCHSD2;LIMK1;GPSM2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;HAX1;CDK5;VASP;CDC42EP3
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2665257927418987,-0.6970996645560799,0.8735632183908046,0.9598233203905631,1.0,1/14,2.21%,THBS1
prerank,positive regulation of transporter activity (GO:0032411),0.3011690560440986,0.6970506319239446,0.8330404217926186,0.9895286862872691,1.0,3/13,15.57%,KMT2A;KCTD7;SGK1
prerank,regulation of programmed cell death (GO:0043067),0.1943582439294339,0.6966769943972367,0.9647473560517039,0.9894765969068648,1.0,32/161,17.24%,CXCL10;STEAP3;HS1BP3;CASP6;LRRK2;TM7SF3;ACTN1;OMA1;BRMS1;BCL6;USP42;CIDEA;PINK1;BIRC2;DAXX;TMEM219;TP53;SLK;PSMC5;SOX9;RTKN;LGALS1;NME1;RIPK1;CLU;AIFM2;SGK1;ZBTB7A;SRA1;HAX1;CALR;CDK5
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3207160078112407,0.6962371325377505,0.8435754189944135,0.9894384468627992,1.0,3/10,19.29%,PDE4B;CACNA2D1;NIPSNAP2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.24803203980421656,0.6956826201214225,0.8930232558139535,0.9895668570092154,1.0,11/33,21.21%,NCOA2;DNAAF4;AXIN1;CARM1;SAFB2;PRMT2;AR;CALR;CBFB;DDRGK1;TRIM68
prerank,establishment of vesicle localization (GO:0051650),-0.2470384489682147,-0.6952889011897587,0.8729016786570744,0.9609173268777446,1.0,9/18,34.41%,CCDC186;TOR1A;SYNJ1;SPG11;KIF5B;IKBKG;RAB11A;F8A1;DNM2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2356126541921459,0.6933683798495123,0.9081481481481481,0.9916923071370994,1.0,5/39,10.83%,UTRN;SCN2B;NEDD4;FXYD4;FGF12
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21432469444972257,0.6929336777795595,0.930939226519337,0.9916170019508456,1.0,14/72,15.41%,ARID3A;CNOT11;E2F4;RPS6KA6;MYO6;MDM4;SP100;TP53;CNOT1;CARM1;FOXM1;TFAP4;CNOT7;PAXIP1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.22621238839878324,0.6923922989455716,0.9035460992907801,0.9917177297392858,1.0,8/52,11.95%,MDH1;L2HGDH;MTRR;MTHFD1L;DLST;HOGA1;ALDH5A1;ACLY
prerank,sulfur amino acid metabolic process (GO:0000096),0.2651416664255133,0.6923052177297303,0.8731942215088283,0.9913041565978055,1.0,7/24,22.78%,MTRR;ADO;TXN2;DPEP1;MMUT;MSRA;MTHFD1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.25614088549427894,-0.6920058833423494,0.8707482993197279,0.9633564598731528,1.0,10/15,43.15%,MAPK14;RAPGEF3;ADAM9;TYROBP;FLOT1;TREM2;EHD2;SCGB3A1;EHD1;IL4
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2551136449204819,0.6915931775260568,0.8837920489296636,0.9915608730158955,1.0,10/25,27.62%,CDK13;RNF168;NELFA;EAF2;LDB1;CDC73;NELFB;EAF1;ELL;WDR43
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.23676246630738057,0.689531515481885,0.9043348281016442,0.9933033988277932,1.0,6/39,11.63%,MYO7A;MYO1B;MYO6;PPFIA2;TANC2;MYO1G
prerank,protein acylation (GO:0043543),-0.1999270775256295,-0.689406363219301,0.9525316455696202,0.9651223945464685,1.0,17/38,30.47%,FOXO1;ZDHHC21;ZDHHC16;ZDHHC14;ING4;ZDHHC18;ING5;CLOCK;NAA80;ZDHHC3;NAT9;GLUL;ZDHHC5;PORCN;KAT6A;ZDHHC23;ZDHHC12
prerank,cellular response to leucine starvation (GO:1990253),0.3118427219232869,0.688015898170373,0.839924670433145,0.994409962476071,1.0,3/10,18.15%,MTOR;IMPACT;RRAGD
prerank,positive regulation of rRNA processing (GO:2000234),0.3073471701627636,0.6874490711179233,0.8511029411764706,0.9945140144632992,1.0,5/10,27.62%,UTP15;DIMT1;HEATR1;RIOK2;WDR43
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.23118145391878542,-0.687294442584667,0.9268929503916449,0.9663928177457382,1.0,3/22,9.86%,PPM1E;PPM1F;PPM1D
prerank,cellular response to lectin (GO:1990858),0.20019594352166675,0.6872006111531407,0.9549436795994993,0.9937302464000879,1.0,14/104,14.06%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.20019594352166675,0.6872006111531407,0.9549436795994993,0.9937302464000879,1.0,14/104,14.06%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,regulation of protein acetylation (GO:1901983),0.3021683189191411,0.6871525061096564,0.8284734133790738,0.9932527571995184,1.0,2/12,7.99%,CEP295;FAM161A
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.28063129192839675,-0.6871117352919135,0.8848039215686274,0.9659380152444388,1.0,3/12,13.81%,DIAPH1;ANK2;PTK2B
prerank,response to histamine (GO:0034776),-0.2904095424101128,-0.6865894786838007,0.8776824034334764,0.9657954549973451,1.0,1/10,2.26%,DIAPH1
prerank,tRNA methylation (GO:0030488),0.24029168699475753,0.6860645337158208,0.878234398782344,0.9939018581657258,1.0,13/34,24.77%,PRORP;TRMT13;TYW3;TRMT44;TRMT61A;METTL1;THUMPD3;TRMT10A;METTL2A;METTL2B;LCMT2;TRMT10C;NSUN6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.19945569256883694,0.68602298431277,0.9613466334164589,0.9934234037608755,1.0,14/105,14.06%,CLEC4E;PSMD1;PDPK1;PSMD10;PSMA5;PRKACB;PSMB5;PRKACA;PSMC4;PSMA4;FYN;PSMC5;PSMB9;LYN
prerank,regulation of JUN kinase activity (GO:0043506),-0.20461700588154788,-0.6851809759286233,0.9137931034482759,0.9664002484914515,1.0,7/33,17.50%,MAP3K5;HIPK3;PPEF2;MAP3K4;MAPK8IP1;EDN1;MAP3K10
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.22914189040996077,0.6847596842524556,0.906060606060606,0.9942622751001889,1.0,6/37,15.90%,OGT;EIF3H;PDCL3;FHIT;BAG6;CSNK2A2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.2433247634986176,-0.6846325942373582,0.8976190476190476,0.9662758829497737,1.0,5/17,21.03%,ALG9;ALG12;MPDU1;NUS1;DOLPP1
prerank,protein insertion into membrane (GO:0051205),0.24208837611148912,0.6839035386641837,0.8877086494688923,0.9946152045654537,1.0,4/32,11.32%,RTP4;VAMP2;SEC61B;TRAM2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.2491876910678145,0.6835339384003403,0.9086687306501547,0.9944861700498209,1.0,7/29,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23169685110755672,0.6835214448366475,0.889055472263868,0.9939754089042968,1.0,14/38,26.69%,NDUFS7;NDUFS5;NDUFV2;NDUFV3;NDUFC2;NDUFA12;NDUFAB1;NDUFS4;NDUFB3;NDUFA10;NDUFS1;NDUFB6;NDUFB8;NDUFB10
prerank,positive regulation of interferon-beta production (GO:0032728),0.24055089064797613,0.6832080592842644,0.8961832061068702,0.9937863670604865,1.0,6/33,16.13%,DHX58;TLR8;TRIM56;TLR4;DHX9;POLR3A
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2615355738952083,-0.683015972267322,0.8711217183770883,0.9670665361305067,1.0,6/14,32.75%,PTPN2;CCDC3;RFFL;PELI3;PYDC1;GPS2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.2567516837346147,-0.6825513733127629,0.875,0.9668536547219766,1.0,5/13,24.35%,ECSIT;HDAC6;OXA1L;MT3;NOD2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2519397605293776,-0.682511019439373,0.8880208333333334,0.9662684248591679,1.0,4/16,16.15%,AMPD3;ADSS2;LHPP;PFAS
prerank,regulation of interferon-alpha production (GO:0032647),0.2619211245873495,0.6811781906583655,0.8543046357615894,0.9953596633293531,1.0,4/23,14.93%,TLR8;TLR4;DHX36;DHX9
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.23952335628027943,-0.6803252780639437,0.9034653465346535,0.9675085446382556,1.0,4/17,15.56%,STX1A;KCNB1;SLC4A8;RAB3D
prerank,negative regulation of dephosphorylation (GO:0035305),0.27245073601770037,0.6799073912001814,0.871404399323181,0.9961980780950116,1.0,5/18,16.58%,GPATCH2;PTPA;PPP1R26;ZCCHC9;PPP1R8
prerank,mitochondrial translational elongation (GO:0070125),0.20201023153168754,0.6789994458567528,0.95,0.996549794713199,1.0,30/88,28.51%,MRPL44;MRPS31;MRPS24;MRPS26;MRPL28;MRPL30;MRPS30;MRPL10;DAP3;ERAL1;GFM2;MRPS23;MRPL3;MRPL49;MRPL51;MRPS5;MRPS27;MRPL52;MRPS15;MRPL19;MRPS6;MRPS21;MRPL14;MRPL32;GFM1;CHCHD1;MRPL12;MRPL1;MRPL47;MRPS11
prerank,positive regulation of myelination (GO:0031643),-0.2764891389588301,-0.678977279594212,0.8807339449541285,0.9680924462408712,1.0,2/11,6.77%,PARD3;DICER1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.249814451032143,0.6778577645143778,0.8848484848484849,0.9971864448420453,1.0,6/27,17.95%,CALCA;HTR2C;LPAR1;F2R;GPR35;GRM1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.19591558578602558,0.6775920798099374,0.9640564826700898,0.9969221847385762,1.0,9/112,10.90%,IL33;WNT5A;NR1H4;PTPN22;CIDEA;TWIST1;TLR4;CYBA;PYCARD
prerank,secretory granule organization (GO:0033363),-0.2855793292908026,-0.6760996349011139,0.8435374149659864,0.9699641779266426,1.0,1/10,3.41%,SRGN
prerank,response to interferon-alpha (GO:0035455),0.2732029383080502,0.675870596720036,0.8499184339314845,0.998138027574953,1.0,5/16,19.64%,PDE12;AXL;EIF2AK2;ADAR;RO60
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.2872814622431128,0.6754072529895154,0.856401384083045,0.9980684701381936,1.0,3/13,12.81%,PSMD10;TWIST1;PTTG1IP
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.23418640698590093,0.6751425361684206,0.8995568685376661,0.9978224136353008,1.0,9/38,19.62%,DHX58;TLR8;AKIRIN2;PRKCA;CYBA;DHX9;ZCCHC3;ADAM8;CD180
prerank,B cell activation involved in immune response (GO:0002312),0.2881904170313656,0.6746139279122398,0.8514190317195326,0.9978497702623155,1.0,4/13,19.62%,GPR183;RNF168;MSH6;CD180
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.2245556784958494,-0.6745875514250014,0.9287531806615776,0.970605979555168,1.0,3/23,5.15%,SLIT2;DPP4;RAC1
prerank,response to UV-A (GO:0070141),0.2816483939772786,0.6745811468630888,0.8647686832740213,0.9973597869691091,1.0,1/14,1.67%,PPID
prerank,proteasomal protein catabolic process (GO:0010498),0.18509165439612624,0.674403733805903,0.9874285714285714,0.9970083453598508,1.0,68/201,26.63%,FBXO45;PSMD1;BFAR;SEL1L;ZSWIM8;NEDD4;PSMD10;CRBN;PSMA5;PSMB5;BIRC2;PLAA;DNAJB12;PSMC4;PSMA4;RCN3;PSMC5;FBXW5;GSK3A;PSMB9;AREL1;TRIM2;ATXN3;RNF122;BAG6;TRIM3;HACE1;BRSK2;UBXN6;PSMA7;HECW1;UBXN2B;PSMD14;SOCS6;FEM1B;KLHL22;RNF187;PSMA2;DCAF11;ZFAND2A;CUL4A;PSMD11;RHBDD1;SPSB2;MTA1;DDB1;UBE2K;FBXL22;DDIT3;BTRC;RNF216;RMND5B;SPSB3;FAF1;NHLRC3;KIF14;CCDC47;FBXO44;SPSB1;CTNNB1;AGAP3;PSMB2;RMND5A;COP1;NR1D1;UBE4B;SKP2;KLHL42
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.20809950052317777,-0.6741904717651789,0.9159663865546218,0.9703164104855228,1.0,14/29,40.06%,PLA2G4A;PLA2G6;PLAAT3;PLA2G4E;DBI;PLA2G4C;LPCAT2;PLA2G4F;LPCAT3;PLA2G4B;PLA2G5;LPCAT4;PLBD1;PLB1
prerank,non-motile cilium assembly (GO:1905515),0.24405449060868428,0.6732644218773278,0.9192546583850931,0.9976229720927365,1.0,11/30,25.19%,DISC1;RPGRIP1;IFT88;CEP250;BBS1;PCM1;BBS4;RPGRIP1L;IFT122;TOGARAM1;TMEM216
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.19983452971870355,-0.6731647381631347,0.9289940828402367,0.9705028723937021,1.0,14/35,29.64%,PRKDC;CDK6;MAPK14;ETS1;TAL1;HMGB2;ABCB10;ACVR2A;HSPA1A;SPI1;FAM210B;STAT5B;NCKAP1L;HSPA1B
prerank,regulation of gene silencing by RNA (GO:0060966),0.21560748990625078,0.6714148409603687,0.9449152542372882,0.9984173032902096,1.0,13/50,23.31%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;NUP54;AGO1;NUP155;POLR2L;RANBP2;IPO8;NUP35
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21560748990625078,0.6714148409603687,0.9449152542372882,0.9984173032902096,1.0,13/50,23.31%,NUP214;AAAS;FMR1;POM121;NUP42;NUP107;NUP54;AGO1;NUP155;POLR2L;RANBP2;IPO8;NUP35
prerank,lysosome localization (GO:0032418),0.2308942590434765,0.6709201569091748,0.9167950693374423,0.9983778935244059,1.0,7/37,19.53%,RAB34;KXD1;ARL8B;TFEB;VPS33B;PIK3CG;PLEKHM2
prerank,glycine transport (GO:0015816),0.3094199698204635,0.6705403433741298,0.8527272727272728,0.9982231186617726,1.0,4/10,25.71%,SLC7A8;SLC25A38;SLC6A5;SLC36A1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.27981205754003935,-0.6703872426949643,0.8698630136986302,0.9721056677372892,1.0,3/11,17.56%,RENBP;UAP1;UAP1L1
prerank,methylguanosine-cap decapping (GO:0110156),0.30052334414875553,0.6700257493424805,0.848816029143898,0.9982210888618039,1.0,2/10,13.47%,EDC3;EDC4
prerank,protein targeting (GO:0006605),0.1927669086619527,0.6694782396490655,0.9752781211372065,0.9982426630297064,1.0,28/118,21.72%,RTP4;TIMM10;DNAJC19;CACNG3;SORL1;PRKCI;SEC63;ZDHHC24;SRPRA;PITRM1;TIMM44;AKAP6;PEX19;ZDHHC19;ZDHHC2;ZDHHC6;PEX12;LTBP2;ZFAND2A;ZDHHC9;PEX6;KIF13B;HOMER3;RABGEF1;MICALL1;MFN2;FUT10;GDAP1
prerank,histone H3 acetylation (GO:0043966),0.2274202456637985,0.6693967596449735,0.9284671532846716,0.9978210030589819,1.0,11/40,20.15%,TAF12;WDR5;BRCA2;KAT2A;JADE1;POLE3;LDB1;KAT7;TAF10;MBIP;SUPT7L
prerank,positive regulation of calcium ion import (GO:0090280),0.29148593591898664,0.6692831094572994,0.8654545454545455,0.9974083966407717,1.0,3/12,20.38%,STC1;PDGFRB;CCL2
prerank,cholesterol efflux (GO:0033344),-0.22937969117244433,-0.6688247231747378,0.9164420485175202,0.9727547285297966,1.0,3/20,12.83%,SCARB1;APOE;SOAT1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.2812189703418,-0.6679431545425644,0.860730593607306,0.9728602786247647,1.0,2/10,7.12%,PDGFA;TBX1
prerank,early endosome to Golgi transport (GO:0034498),-0.2696237535785325,-0.6677934578451781,0.8835616438356164,0.9723499450484364,1.0,5/11,28.34%,SURF4;LMAN1;RAB6A;SNX2;STX5
prerank,RNA destabilization (GO:0050779),0.26063715210555605,0.6675276053295347,0.8680781758957655,0.9985818741759507,1.0,5/18,18.68%,RBM24;LIN28B;FTO;DXO;YTHDF1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2501413157612502,-0.6671657574728003,0.9061728395061729,0.97223156668154,1.0,6/15,30.12%,CCT3;CCT4;CCT7;RUVBL2;NHP2;RUVBL1
prerank,RNA 3'-end processing (GO:0031123),0.20825378209891848,0.6663779585150582,0.9510869565217391,0.9991159419888982,1.0,13/69,17.43%,EIF4A3;LIN28B;THOC7;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SYMPK;SRSF9;THOC5;SRSF6
prerank,calcium ion import across plasma membrane (GO:0098703),0.2796459903731944,0.6662242567876144,0.8568840579710145,0.9987291099625312,1.0,3/14,15.77%,TRPV3;TRPM2;CACNA2D1
prerank,intracellular pH reduction (GO:0051452),0.23084593720502958,0.6661040010802991,0.8993610223642172,0.998320056239095,1.0,9/33,23.56%,RAB20;CLCN3;ATP6V0E1;ATP6V0D1;ATP6V1G2;GPR89A;GPR89B;ATP6V0B;DMXL1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.24319690712887465,-0.6656123046409776,0.9116883116883117,0.9727976816037369,1.0,9/15,47.10%,SYN3;ZDHHC3;ZDHHC12;ADRA1A;HAP1;STXBP1;NPAS4;NPS;DRD2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.23263204464143358,0.6654488325066465,0.9203539823008849,0.9984414441786509,1.0,6/33,17.00%,LSM11;NUDT21;SLBP;SNRPF;SYMPK;MAZ
prerank,insulin secretion (GO:0030073),0.2614586624713077,0.6651748182960637,0.8842281879194631,0.9981726315165995,1.0,2/19,6.62%,PTPRN2;RIMS2
prerank,myeloid dendritic cell activation (GO:0001773),0.2910895288828317,0.6647588756373068,0.8621908127208481,0.9980586009018085,1.0,2/12,10.90%,CAMK4;PYCARD
prerank,peptide hormone secretion (GO:0030072),0.24462872687495923,0.6645894200350758,0.9054263565891473,0.9977013137409615,1.0,2/26,6.62%,EDN3;RIMS2
prerank,smoothened signaling pathway (GO:0007224),0.2392332870458649,0.6644107478953188,0.896551724137931,0.9973480070041117,1.0,5/32,10.58%,PTCH2;PTCHD1;GLI1;GLI3;TCTN2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2845806908300086,0.6639293561258393,0.8779174147217235,0.9972715674175994,1.0,4/11,22.51%,ASF1A;UBN1;ATRX;IPO4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.22134906124140616,-0.6638353179058739,0.93,0.9735403530420306,1.0,5/23,15.11%,HACD1;FAR2;ACSL4;ELOVL7;ACSL5
prerank,cellular response to interferon-beta (GO:0035458),-0.25023557432105853,-0.6637232756912966,0.8880778588807786,0.9729993919229462,1.0,7/14,29.08%,IRF1;CDC34;IFITM2;NDUFA13;PNPT1;TRIM6;IRGM
prerank,intracellular cholesterol transport (GO:0032367),0.2789265746472153,0.6630123589956325,0.8585858585858586,0.9975932891990312,1.0,5/15,19.35%,RELCH;SERAC1;LDLRAP1;OSBP;NPC2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.2610439852873725,-0.6629984104928677,0.8816425120772947,0.9729548703303815,1.0,2/13,5.89%,EZR;CDC42
prerank,response to iron ion (GO:0010039),-0.26507995541617646,-0.662632909866274,0.883177570093458,0.9726162909633855,1.0,4/12,24.08%,B2M;ACO1;HFE;SLC11A2
prerank,mitotic metaphase plate congression (GO:0007080),0.21601757750474435,0.6623381373580759,0.9432314410480349,0.9976880283905961,1.0,11/51,18.72%,BOD1;DCTN2;CENPE;SPDL1;RMDN1;CENPC;CDT1;RRS1;CEP55;VPS4B;KPNB1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.2980386839554312,0.662209561040097,0.8594306049822064,0.9972890714459556,1.0,2/11,13.23%,KCNIP2;AKAP6
prerank,regulation of vasculature development (GO:1901342),0.24449295378594918,0.6621678612027588,0.8973143759873617,0.9968099532500503,1.0,3/26,9.31%,ADGRA2;NF1;SP100
prerank,regulation of trophoblast cell migration (GO:1901163),0.2782895445924505,0.6620551017518345,0.8637137989778535,0.9964006140972144,1.0,3/14,18.21%,GJA1;CALR;SYDE1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23716396532858025,0.6620129799656546,0.9140625,0.9959264957832544,1.0,8/31,15.88%,LSM4;EDC3;EXOSC9;DIS3L2;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,axonal transport (GO:0098930),0.22231893777243086,0.6605178214676062,0.9266467065868264,0.9967373496506867,1.0,10/36,22.83%,TMEM108;AP3M1;OPA1;SYBU;AP3D1;HIF1A;KIF3A;KIF1B;AP3B2;BLOC1S6
prerank,ubiquinone metabolic process (GO:0006743),0.2767163746275423,0.6603959290897335,0.8833333333333333,0.9963345205549313,1.0,5/15,19.09%,COQ3;AIFM2;PDSS2;COQ8B;COQ7
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.23057421361723604,0.6603802426943426,0.9441930618401206,0.9958360267013335,1.0,13/35,25.53%,BOD1;PPP6R2;MTOR;PTPA;HSP90B1;CRY2;TSC1;PPP6R3;PDGFRB;BOD1L1;NUAK1;STYXL1;CALM2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.23655358770524093,0.6601682849650143,0.9203821656050956,0.9955063237242906,1.0,7/32,18.52%,CLIP3;STMN2;NAV3;STMN1;CLASP2;CLASP1;SPEF1
prerank,B cell mediated immunity (GO:0019724),0.2946893952261831,0.6600803806230899,0.8599290780141844,0.9950769426079378,1.0,1/10,6.37%,TLR8
prerank,modulation by host of symbiont process (GO:0051851),0.2383466561339436,0.6600443049027893,0.9184615384615384,0.9945915201735087,1.0,8/31,20.00%,HDAC1;REST;SNW1;SAP30;TFAP4;RRP1B;SP1;TAF11
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.2968984723205009,0.6595433923060058,0.8714788732394366,0.9945259696679725,1.0,2/11,9.11%,PWP1;MTOR
prerank,response to acidic pH (GO:0010447),0.2843470227671201,0.6595305983971796,0.8485370051635112,0.9940314772698544,1.0,3/13,16.02%,SLC9A1;LGMN;IMPACT
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.26477437999365283,-0.6593624639628698,0.8848758465011287,0.9744354427519089,1.0,6/12,32.75%,ERLIN1;CEACAM1;SIRT1;BRCA1;TRIB3;APOC1
prerank,positive regulation of isotype switching (GO:0045830),0.27380040932683025,0.6590778465851905,0.8758503401360545,0.9939488258269171,1.0,4/15,18.77%,CD40;HMCES;PAXIP1;RIF1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.2970321992495888,0.6590286107876608,0.8726333907056799,0.9934828735817106,1.0,3/10,17.14%,IGF2;KDM1B;DNMT3A
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.26939120536359235,-0.6582862263546829,0.8806306306306306,0.9746194292659475,1.0,2/11,6.64%,ITPKB;IP6K2
prerank,protein tetramerization (GO:0051262),0.2025872342797956,0.6576181957567835,0.9511533242876526,0.9942613104055741,1.0,13/67,18.60%,TRPA1;GRIN2B;GOLGA2;APPL2;HSD17B8;HCN1;NUDT21;TRPM2;RYR3;USP16;MCOLN1;ALDH9A1;SSBP1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2244800145066308,0.6572492274559155,0.9274924471299094,0.9940834787683198,1.0,4/36,10.27%,OGT;EIF3H;OPHN1;FHIT
prerank,melanosome organization (GO:0032438),0.2393437398642267,0.6567442900561836,0.9314194577352473,0.9940375970611851,1.0,4/26,13.39%,HPS1;RAB29;ABCB6;AP3D1
prerank,mRNA 3'-end processing (GO:0031124),0.20317055050120603,0.6563297017385278,0.9562334217506632,0.9938792592035733,1.0,18/78,20.64%,EIF4A3;THOC7;LSM11;SRSF11;TENT4B;SLU7;NUDT21;CASC3;TENT2;SLBP;SYMPK;SRSF9;THOC5;SRSF6;PAPOLB;CHTOP;CDC73;DDX39B
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.2459633747233923,-0.6560438228964889,0.9082125603864735,0.9756752074978267,1.0,9/16,35.46%,TRIB2;TYROBP;JAK3;VSIR;FCGR2B;DLL1;AGER;LILRB1;CD274
prerank,monosaccharide transmembrane transport (GO:0015749),0.2690109890109891,0.655824310637097,0.8847457627118644,0.9938210350988547,1.0,16/16,73.13%,SLC2A9;SLC45A3;SLC2A7;SLC2A8;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A10;SLC2A6;SLC5A3;SLC50A1;SLC23A1;SLC23A2;SLC2A2;SLC2A12
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.2469281020282459,-0.6557772503730127,0.9043062200956937,0.9752722230933493,1.0,2/14,15.21%,IL6ST;PTGS2
prerank,regulation of T cell proliferation (GO:0042129),-0.17128757544664924,-0.6546705339428369,0.9828178694158075,0.9754420009332311,1.0,7/61,11.76%,ANXA1;IL6ST;SLC7A1;TFRC;NCK1;SDC4;DLG5
prerank,histone H2A ubiquitination (GO:0033522),0.270122218812121,0.6545647030539502,0.8941368078175895,0.9944198052592592,1.0,3/17,9.24%,BCOR;TRIM37;RNF168
prerank,DNA replication checkpoint signaling (GO:0000076),0.2720247243601557,0.6541957398293377,0.9052287581699346,0.9942289746817325,1.0,2/16,12.29%,TIPIN;CDT1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.24213522097904508,0.65396230472451,0.8872785829307569,0.993926957191176,1.0,5/23,20.78%,ACOT7;ELOVL6;ALOX5;ACSBG1;GSTM1
prerank,phosphatidylserine metabolic process (GO:0006658),0.230512000326336,0.6536548131188309,0.9207317073170732,0.993684028018385,1.0,6/32,14.68%,SERINC1;ABHD16A;ABHD12;PTDSS2;SERINC5;PLA2G12A
prerank,negative regulation of innate immune response (GO:0045824),0.22879974583844673,0.6533142311351909,0.9253499222395023,0.9934662710770887,1.0,6/34,17.51%,SUSD4;DHX58;LYAR;FAM3A;CNOT7;A2M
prerank,Golgi ribbon formation (GO:0090161),-0.2551311629455851,-0.6525790518707236,0.8846153846153846,0.9763510990663526,1.0,4/13,22.18%,VTI1A;OPTN;FHDC1;MYO18A
prerank,glutathione derivative metabolic process (GO:1901685),0.25303126905556683,0.6523802336273308,0.9050736497545008,0.9932550671061736,1.0,2/20,7.44%,GSTO2;GSTA3
prerank,glutathione derivative biosynthetic process (GO:1901687),0.25303126905556683,0.6523802336273308,0.9050736497545008,0.9932550671061736,1.0,2/20,7.44%,GSTO2;GSTA3
prerank,striated muscle contraction (GO:0006941),0.20959901415687504,0.6521889753308884,0.9525179856115108,0.9929152098024797,1.0,3/53,4.25%,ATP1A2;RYR2;SCN2B
prerank,peptidyl-lysine methylation (GO:0018022),-0.20661331354860596,-0.6521589466109526,0.924119241192412,0.9760157831221082,1.0,3/26,11.45%,SMYD3;SMYD2;EEF2KMT
prerank,protein localization to centrosome (GO:0071539),0.2605616247697081,0.6513501133402027,0.8788927335640139,0.9931149160665418,1.0,7/17,25.80%,DCTN2;CEP192;PCM1;NUDCD3;BBS4;GOLGB1;CCDC14
prerank,positive regulation of cellular protein localization (GO:1903829),0.20042002635166345,0.65086227843869,0.9710344827586207,0.9930453915806596,1.0,16/69,19.53%,GNL3;NGFR;NECAB2;FYN;GAS8;CDT1;ENTR1;MEAK7;CEP250;FERMT2;GPR137B;KAT7;ORMDL3;EIF2AK3;TRAPPC12;DDRGK1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2714497589927164,-0.6506180413045368,0.8701594533029613,0.9764797362277945,1.0,2/10,17.53%,SMYD2;EEF1AKMT2
prerank,regulation of protein neddylation (GO:2000434),-0.2713818697509518,-0.6501891745318782,0.9049881235154394,0.9761721308581319,1.0,4/10,20.00%,RPL5;RPL11;DCUN1D3;COPS9
prerank,regulation of defense response to virus by host (GO:0050691),0.2281123818389568,0.6493995179224866,0.9198113207547169,0.9937360188907716,1.0,8/30,25.31%,PTPN22;IFNLR1;TRIM44;DHX9;RNF216;STAT1;TRAF3IP2;AIM2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.20978735013081518,-0.6489883427914234,0.936231884057971,0.9763861236449086,1.0,9/27,30.15%,SIRPA;CD44;ETS1;MDK;SKAP1;HSPD1;ITGB2;HAS2;CCR2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.24776206259563524,0.6470799607291067,0.9077669902912622,0.9951155664255649,1.0,8/22,23.89%,PWP1;LYAR;MTOR;UTP15;EIF2AK3;HEATR1;DHX33;ATF4
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.2884795460435515,0.6467152693748496,0.860036832412523,0.9949121518112232,1.0,3/12,21.94%,ELOVL2;ELOVL1;ELOVL5
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2468906617042244,-0.6459678569146026,0.941320293398533,0.9777860744605757,1.0,3/13,10.43%,NCK1;DNAJB9;PTPN1
prerank,negative regulation of cartilage development (GO:0061037),-0.2537515468386458,-0.6456633337731347,0.9060240963855422,0.9773596006052749,1.0,8/13,31.99%,WNT9A;PTHLH;EFEMP1;WNT11;CHADL;GREM1;ADAMTS7;SNAI2
prerank,negative regulation of cation channel activity (GO:2001258),0.23811498535344372,0.6456437651890028,0.8987138263665595,0.9952361576144243,1.0,3/26,8.55%,FMR1;KCNAB1;GNB5
prerank,positive regulation of protein acetylation (GO:1901985),0.2853981334463385,0.6456305319113177,0.8765652951699463,0.9947406328494778,1.0,2/12,7.99%,CEP295;FAM161A
prerank,relaxation of muscle (GO:0090075),0.2808794947029221,0.6454488675624112,0.9048442906574394,0.9943898946485417,1.0,2/13,11.17%,ATP1A2;P2RX4
prerank,glycoprotein catabolic process (GO:0006516),-0.23162480462403595,-0.6450356621463632,0.9353233830845771,0.977162188402768,1.0,5/17,19.05%,OGA;MANBA;NGLY1;EDEM1;STT3B
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.25933028937282243,0.6445981195671519,0.8962585034013606,0.9945730010452271,1.0,3/17,12.64%,RYR2;KCNE4;KCNJ8
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2233301404883809,-0.6442706882111495,0.9475,0.9770398525811418,1.0,5/19,16.30%,HIPK1;DYRK2;HIPK2;SIRT1;TMEM109
prerank,RNA modification (GO:0009451),0.20866661924664714,0.6441762483320188,0.9564606741573034,0.9944070751380298,1.0,15/54,24.77%,NAT10;CTU1;QTRT2;TRMT61A;PUS7;WDR4;METTL1;ADAR;NSUN3;RBM15;LCMT2;NSUN5;AARS1;SSB;NSUN6
prerank,protein destabilization (GO:0031648),-0.19659612854579073,-0.6439896371064033,0.9467455621301775,0.9766068679863199,1.0,6/32,16.67%,GSN;SOX17;CTSH;CCDC88C;SIRT1;CUL3
prerank,cellular respiration (GO:0045333),0.21899611454933163,0.6438197490123525,0.9357249626307922,0.9941940327882528,1.0,7/41,16.18%,MTFR2;SDHB;NDUFS7;SURF1;UQCRH;SLC25A14;NDUFS4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2740198468054326,0.6435566145150522,0.8894230769230769,0.9938884516365216,1.0,2/15,10.60%,TCF7L2;TP53
prerank,regulation of actin filament-based movement (GO:1903115),0.2918578707259204,0.6435248036484841,0.8690909090909091,0.9934110085151646,1.0,1/10,2.74%,PDE4B
prerank,aspartate family amino acid metabolic process (GO:0009066),0.25743033315870445,0.6431269621354853,0.9107438016528926,0.9932314460233788,1.0,8/18,25.73%,ASPA;NAT8L;FOLH1;MSRA;ASPG;MTHFD1;NAALAD2;SMS
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.24815339212768367,-0.6430085574232819,0.9198113207547169,0.9766329450569003,1.0,8/14,39.86%,DDX60;ANKRD17;ZDHHC5;PUM1;OASL;TLR5;TLR3;TLR2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.25132576193996137,-0.6428347092315874,0.9116279069767442,0.9761338573378868,1.0,3/13,17.56%,RENBP;UAP1;UAP1L1
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2021362965019885,-0.6427899236551436,0.9619883040935673,0.9755537628763066,1.0,8/28,30.15%,SIRPA;PRKDC;TICAM1;TYROBP;HSPD1;NOD2;NCKAP1L;CCR2
prerank,negative regulation of protein metabolic process (GO:0051248),0.21064497033003127,0.6421708138251166,0.9549418604651163,0.9935058735698837,1.0,8/48,15.09%,ITGAV;ADGRB1;FLOT2;MDM4;EIF2AK1;IAPP;SNX12;CLU
prerank,anterograde synaptic vesicle transport (GO:0048490),0.2629579552907709,0.6417443510245505,0.9192439862542955,0.9928233763171002,1.0,8/15,30.60%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1;SNAPIN;BLOC1S5;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.2629579552907709,0.6417443510245505,0.9192439862542955,0.9928233763171002,1.0,8/15,30.60%,AP3M1;AP3D1;AP3B2;BLOC1S6;AP3S1;SNAPIN;BLOC1S5;AP3M2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.300511859328072,0.6415812944125711,0.864963503649635,0.9924529213566294,1.0,2/10,12.41%,PTPN22;PDCD4
prerank,calcium ion import into cytosol (GO:1902656),0.26403143820909347,0.6414395654765437,0.8842676311030742,0.9920639150975111,1.0,3/15,15.77%,TRPV3;TRPM2;CACNA2D1
prerank,negative regulation of locomotion (GO:0040013),0.28286807492514665,0.6410731441062781,0.8972125435540069,0.9918490642993338,1.0,3/12,18.39%,SPOCK3;CRK;FBLN1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.26656480346289346,0.640633209836882,0.9081632653061225,0.9917082971612777,1.0,3/15,15.04%,ADGRV1;SCN1A;PDZD7
prerank,positive regulation of cell aging (GO:0090343),0.2871286030077529,0.6382122649462039,0.892226148409894,0.9930974390544206,1.0,1/11,2.62%,CDKN2A
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.2192777195418003,-0.6369090015581579,0.9532467532467532,0.9786589016119871,1.0,4/22,11.41%,SLC16A2;NES;GATA2;MDK
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.22942749387306438,0.636600955869374,0.906396255850234,0.9937964515778138,1.0,5/28,16.74%,ABITRAM;FCHSD2;ARHGAP35;CTTN;HAX1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.23085736798498163,0.635113223441698,0.9206349206349206,0.9944657845412627,1.0,5/28,15.81%,STMN2;STMN4;STMN1;CLASP2;CLASP1
prerank,response to UV-B (GO:0010224),-0.2513238835989594,-0.6350400677300918,0.9118329466357309,0.9791285586579047,1.0,8/12,36.06%,CRIP1;HYAL1;CDKN1A;MME;HYAL2;MSH2;HYAL3;RELA
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.2775455333992368,0.6345923585712286,0.9008695652173913,0.9943288101181532,1.0,1/12,6.05%,LIN28B
prerank,regulation of catecholamine secretion (GO:0050433),-0.1928242424526584,-0.6342175961295721,0.9666666666666667,0.979043549496181,1.0,3/29,7.77%,SYT9;STX1A;KCNB1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.21216713584397418,-0.6334283471688376,0.9361702127659575,0.9789206463115626,1.0,9/21,30.22%,YWHAB;GSK3B;PPP1R16B;PPP4R4;PPP1R11;MFHAS1;ENSA;FKBP1A;PPP1R15A
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2108997394732386,0.6330106469616825,0.95,0.9949849212849599,1.0,11/44,18.44%,FCHSD2;CARMIL2;TENM1;PYCARD;CDC42EP1;CDC42EP4;CTTN;EVL;SPIRE1;VASP;CDC42EP3
prerank,nucleosome organization (GO:0034728),0.20230700210738442,0.6327965439749752,0.9576642335766423,0.9946417958948406,1.0,15/55,22.19%,NAP1L3;ASF1A;CHAF1B;SPTY2D1;DAXX;NAP1L1;SOX9;POLE3;BPTF;DMAP1;SMARCD2;MCM3AP;LIN54;ATRX;ZNHIT1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.28904059651714664,0.6327346488718405,0.8863636363636364,0.9941820331421529,1.0,4/10,24.38%,UBE2G2;YOD1;UBE2J1;OS9
prerank,nuclear transport (GO:0051169),0.2621000822399978,0.6325693442376593,0.8887015177065767,0.9938050606906276,1.0,2/16,5.60%,AAAS;NUTF2
prerank,regulation of microglial cell activation (GO:1903978),-0.23634308677634058,-0.6323477304602524,0.926605504587156,0.9789831323588578,1.0,15/15,76.39%,CX3CL1;TTBK1;TREM2;STAP1;CST7;TAFA3;IL6;CCL3;GRN;SYT11;LDLR;MMP8;SPHK1;NR1D1;PTPRC
prerank,lung epithelium development (GO:0060428),-0.2647518890483162,-0.6314810950997728,0.8930957683741648,0.9788898544799044,1.0,2/10,14.79%,ERRFI1;STRA6
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.26696793374867045,0.6313938263764886,0.9,0.9941532917545671,1.0,2/14,9.66%,DUSP1;PPP2R2A
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.2082204200657965,-0.631344351385432,0.9597989949748744,0.9783608929672534,1.0,13/23,43.85%,MAP3K5;MAP3K4;EDN1;MAP3K10;DUSP19;TRAF2;FZD10;SASH1;RPS3;MAP3K7;DAB2IP;ARHGEF5;TAOK3
prerank,amino sugar biosynthetic process (GO:0046349),-0.2550757408306196,-0.6310600831139648,0.9181818181818182,0.9779246511509669,1.0,3/12,17.56%,RENBP;UAP1;UAP1L1
prerank,peptidyl-lysine acetylation (GO:0018394),0.28941017579359773,0.6303073017344721,0.8989547038327527,0.9944530507814252,1.0,4/10,21.85%,KAT2A;BAG6;KAT7;CREBBP
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.27597660528474416,0.6301377117081327,0.886654478976234,0.9940738862483155,1.0,2/12,12.02%,TLR4;SOX9
prerank,positive regulation of immune response (GO:0050778),0.1976951793933282,0.629921882107697,0.9745042492917847,0.9937204502037171,1.0,9/64,17.31%,HRG;TLR8;AKIRIN2;CYBA;PYCARD;CD81;DHX9;LGALS9;ADAM8
prerank,nucleocytoplasmic transport (GO:0006913),0.21348078588852215,0.6295061118807492,0.9535232383808095,0.9935246231670732,1.0,12/40,25.56%,GEMIN2;AAAS;NUTF2;SNUPN;NXT2;SNRPF;GEMIN8;XPO1;MALT1;GEMIN5;GEMIN7;SNRPG
prerank,anterograde axonal transport (GO:0008089),-0.18083367561781863,-0.6294374569516104,0.9791666666666666,0.9782643739742551,1.0,6/37,13.34%,MAPK8IP3;RAB21;AP3B1;HSPB1;AP3S2;TRAK2
prerank,acute-phase response (GO:0006953),-0.2522314451789385,-0.6280749199436791,0.9114832535885168,0.9784761899405503,1.0,3/12,23.42%,LBP;IL22;SIGIRR
prerank,histone mRNA catabolic process (GO:0071044),-0.23289096848586585,-0.6279466584761446,0.9443037974683545,0.9779395457775701,1.0,3/15,13.12%,TUT7;ERI1;ATM
prerank,negative regulation of DNA recombination (GO:0045910),0.20771134223718724,0.627866995980508,0.9497041420118343,0.9942218387886226,1.0,10/43,22.12%,POLQ;MSH3;TERF1;DAXX;MSH6;FBH1;RIF1;TERF2IP;POLR2L;ATRX
prerank,establishment of mitotic spindle orientation (GO:0000132),0.23674181819328033,0.6277597735795571,0.9438202247191011,0.9938034024424562,1.0,4/23,11.84%,GJA1;GPSM2;SPDL1;INSC
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.2657394069177524,0.6269571280865325,0.9054290718038529,0.9938307070567274,1.0,3/14,9.23%,ERH;DHODH;DPYS
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.2416601126657873,-0.626585982373336,0.9186046511627907,0.9780803083177703,1.0,2/13,7.77%,STX1A;KCNB1
prerank,vitamin D metabolic process (GO:0042359),0.26560075988029364,0.6265329439760495,0.9053356282271945,0.993629549435599,1.0,2/13,16.48%,LGMN;CYP2R1
prerank,transcription by RNA polymerase III (GO:0006383),-0.19852047045395493,-0.6264438111956395,0.9664804469273743,0.9775538363771431,1.0,10/27,32.21%,SNAPC3;CRCP;POLR3G;GTF3C6;POLR3K;GTF3A;ICE1;POLR2K;SNAPC2;GTF3C5
prerank,cellular response to hydroxyurea (GO:0072711),-0.26959747219338376,-0.6257208431173448,0.9097387173396675,0.9773463147107518,1.0,3/10,16.19%,DDI2;DDX11;NSMCE3
prerank,regulation of rRNA processing (GO:2000232),0.2521485193824267,0.6251183687618065,0.9128113879003559,0.9941200909689857,1.0,7/16,27.62%,UTP15;DIMT1;SHQ1;HEATR1;RIOK2;USP36;WDR43
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20380325746417643,-0.6245100386408413,0.961139896373057,0.9773839767319132,1.0,12/25,35.61%,TNFSF10;BAD;BAX;BID;GPER1;PPIF;BCL2L11;BIK;DNM1L;BMF;HRK;PMAIP1
prerank,detection of mechanical stimulus (GO:0050982),0.24683677120243602,0.6239223799717042,0.9252032520325203,0.9944259219955593,1.0,2/19,7.70%,JUP;PTK2
prerank,negative regulation of transmembrane transport (GO:0034763),0.28363652676013645,0.6219216548219034,0.9074733096085409,0.9953099495477453,1.0,2/10,9.17%,IRS2;PRKCB
prerank,DNA geometric change (GO:0032392),0.23443914010885156,0.621605940654323,0.931637519872814,0.9950349276341443,1.0,8/24,22.28%,HNRNPA2B1;PIF1;DHX36;RECQL;DHX9;WRN;DDX1;HMGB1
prerank,relaxation of cardiac muscle (GO:0055119),0.2683158091233634,0.6214228008999931,0.9122203098106713,0.9946562494153335,1.0,2/13,11.17%,ATP1A2;P2RX4
prerank,acyl-CoA biosynthetic process (GO:0071616),0.25283058433940114,0.6209330886379225,0.9032258064516129,0.9944804911360473,1.0,7/16,28.19%,HSD17B8;ACLY;SCD5;ACACA;DIP2A;PPT1;SLC25A1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.24214161045664254,-0.6204336447481346,0.9244851258581236,0.9790018324623662,1.0,5/12,26.57%,NINL;BICD2;CCDC68;CCDC120;BICD1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.23345735023215625,0.6196647416589889,0.9345637583892618,0.994830560229483,1.0,4/22,15.73%,PTPN22;APPL2;LYN;TIRAP
prerank,erythrocyte development (GO:0048821),0.28800868071880187,0.6190933475282319,0.9040590405904059,0.9947239291256025,1.0,3/10,16.24%,LYAR;MED1;ZBTB7A
prerank,natural killer cell mediated immunity (GO:0002228),0.25378560786270876,0.6184214256483561,0.9258010118043845,0.9946881446899045,1.0,3/15,22.59%,ARL8B;PLEKHM2;ULBP1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.23790745943414776,0.618147320421989,0.9461172741679873,0.9943821543395087,1.0,5/22,17.34%,NEDD4;PLAA;TSG101;SNF8;VPS4B
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.26009154224588804,0.6181174047095555,0.9154135338345865,0.9939078141102112,1.0,3/14,16.00%,MRNIP;ACTR2;MMS19
prerank,regulation of interferon-beta production (GO:0032648),0.20417269842120137,0.617842351106087,0.9596541786743515,0.9935964493035998,1.0,18/46,28.85%,DHX58;TLR8;TRIM56;TLR4;PYCARD;DHX9;TIRAP;POLR3A;PTPN11;RNF216;CACTIN;PPM1B;POLR3F;IFIH1;POLR3B;RELB;PTPRS;POLR3C
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.24213594212074008,0.6168061943265107,0.9363484087102177,0.9937761277562912,1.0,4/20,14.06%,PTPN22;TLR4;IRAK1;LYN
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.24308231232489072,0.6151594954833732,0.9390625,0.9943262008715504,1.0,8/20,27.04%,ATP2A2;HERPUD1;BAK1;PACS2;FIS1;CCDC47;SELENOK;BCAP31
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2634555980136524,0.6143699570200465,0.9209138840070299,0.9943114900115092,1.0,1/13,3.37%,JAK1
prerank,response to hydroxyurea (GO:0072710),0.2734142808518292,0.6143397111102977,0.9198606271777003,0.9938439841520146,1.0,4/11,22.12%,FMR1;SPIDR;KAT7;ATRX
prerank,steroid hormone biosynthetic process (GO:0120178),0.2225663524847062,0.614166472344085,0.9350850077279753,0.9934586408116562,1.0,5/29,17.79%,HSD17B8;MED1;AKR1B1;HSD17B11;HSD17B2
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.23289927301326238,0.6139330527739811,0.9317803660565723,0.9931142926490788,1.0,1/22,1.70%,WNT5A
prerank,regulation of histone methylation (GO:0031060),0.26322276222811664,0.613792579352108,0.9492119089316988,0.9927150102474765,1.0,3/13,19.18%,NSD1;AASS;CHTOP
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2235635374233304,0.6131272665824254,0.9513343799058085,0.9926299155297418,1.0,7/29,15.88%,LSM4;EDC3;EXOSC9;EDC4;CNOT7;EXOSC8;EXOSC5
prerank,lipoprotein biosynthetic process (GO:0042158),0.27514070938221036,0.6129882489075636,0.9063604240282686,0.9922217771750578,1.0,6/11,29.03%,WDR45B;WIPI2;ATG10;WIPI1;PIK3C3;ATG7
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.21677970151251216,-0.6126371339821318,0.9462915601023018,0.9825238546264615,1.0,7/18,38.71%,PRKDC;PRELID1;PRDM1;NCKAP1L;CCR2;IL4I1;IKZF3
prerank,negative regulation of T cell differentiation (GO:0045581),0.2847276833211471,0.6118571893483453,0.9112318840579711,0.9924500611502377,1.0,2/10,10.74%,GLI3;ZC3H8
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2109671835671011,-0.611061896563034,0.9682151589242054,0.9827081292604157,1.0,2/20,4.60%,GCLC;GATM
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.25413627867295985,0.6104599557946242,0.9440677966101695,0.9927992263023258,1.0,4/14,19.53%,BFAR;HSPA5;BAK1;DDRGK1
prerank,tRNA wobble base modification (GO:0002097),-0.23000818644722928,-0.6104165760106193,0.9558823529411765,0.9824450326232935,1.0,9/14,34.97%,TRMT9B;GTPBP3;ELP3;MOCS3;KTI12;URM1;ALKBH1;ADAT2;CTU2
prerank,protein localization to chromosome (GO:0034502),0.21230403177812174,0.6098411042914496,0.9470499243570348,0.9926802271711925,1.0,4/34,10.29%,BOD1;RPA1;MRNIP;SLF1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.20260227904240588,-0.6096169882382415,0.9795918367346939,0.9822421523527419,1.0,15/23,48.45%,PVR;PIK3R6;RAET1E;ARRB2;LAMP1;AP1G1;RASGRP1;LILRB1;SLAMF6;CD226;CRTAM;NCR1;KLRD1;CD160;KLRK1
prerank,mitochondrial fusion (GO:0008053),-0.21620943108880752,-0.6095711609221522,0.9347319347319347,0.9816550924507967,1.0,6/18,25.58%,MIEF1;USP30;BAX;CHCHD3;MIGA1;MIEF2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19832621023601038,-0.6094893880566706,0.9681697612732095,0.9810733633833524,1.0,11/25,32.54%,PTGES3;HSPA8;GAK;DNAJB5;DNAJB1;HSPA14;HSPA1A;HSPA1B;DNAJB4;HSPA2;SDF2L1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.23638894045028241,-0.608309749779344,0.9534883720930233,0.9810065953086731,1.0,2/13,10.66%,DAB2;SH2B1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.22973214339010176,0.6076991119987832,0.94,0.9934207430056652,1.0,6/25,18.37%,PER2;TWIST1;NSD1;DOT1L;ZBTB7A;HEY1
prerank,histone H2B ubiquitination (GO:0033523),0.27799360040930143,0.6062893956906064,0.9223826714801444,0.9937516976395319,1.0,1/10,4.62%,RNF40
prerank,folic acid metabolic process (GO:0046655),0.24135780277505292,0.6061861807499775,0.9384116693679092,0.9933231376898144,1.0,6/18,24.36%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.2154561680908768,-0.6050495416788119,0.9577114427860697,0.9819233261902144,1.0,2/18,5.51%,FER;IL6ST
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.2707470896442743,0.6038110665435105,0.9132075471698113,0.9942092738922294,1.0,4/10,21.50%,MAP2K1;LYN;RNF13;MAPK1
prerank,translational elongation (GO:0006414),-0.14330845533857203,-0.6032854430835867,1.0,0.9821607529271,1.0,37/101,33.21%,EEF1G;MRPL39;EEF1A1;EEF2K;EEFSEC;EEF1D;MRPS7;GTPBP1;MRPS17;MRPL15;MRPL20;MRPL16;MRPS18A;MRPL2;GADD45GIP1;MRPS18B;MRPL58;MRPL24;OXA1L;MRPL57;MRPL55;PTCD3;MRPS34;MRPL36;MRPL35;MRPS12;MRPL34;MRPL38;MRPS9;MRPS2;MRPL18;GTPBP2;TUFM;MRPL11;MRPS14;MRPL9;MRPS33
prerank,microglial cell activation (GO:0001774),0.23146379465159916,0.6029864855979502,0.9298531810766721,0.9941805417936764,1.0,2/21,7.19%,C5AR1;C1QA
prerank,purine-containing compound salvage (GO:0043101),0.2648612042898157,0.6025598764633114,0.9178321678321678,0.993920767665617,1.0,3/12,12.95%,ADK;AMPD2;DGUOK
prerank,regulation of interleukin-17 production (GO:0032660),0.21064654722089568,0.6024204064396542,0.9625585023400937,0.9935058474998097,1.0,3/31,12.10%,NR1H4;TLR4;IL12A
prerank,regulation of calcium ion transport (GO:0051924),0.19267374290375056,0.6014861019181496,0.972027972027972,0.9935354294262349,1.0,12/54,19.25%,IL16;GRAMD2A;P2RX4;STIM1;F2R;PACSIN3;CACNA2D1;STC1;ADRA2A;CAMK2A;CRACR2A;HOMER3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.2787200478924091,0.6005391865209567,0.9224283305227656,0.9935641245072087,1.0,3/10,23.58%,AREG;ADRA2A;ADAM17
prerank,mesenchyme development (GO:0060485),0.24571972760600047,0.6001498193616768,0.9228130360205832,0.9933004495086253,1.0,4/15,18.02%,BMP7;TGFBR1;FGFR2;BMP2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.21572475966614957,0.5996656279906741,0.9618441971383148,0.9930974442398124,1.0,5/29,13.42%,FBXO5;LIMK1;PINK1;DCUN1D5;AXIN1
prerank,regulation of B cell proliferation (GO:0030888),0.19972521593072506,0.5994461476385589,0.9703588143525741,0.9927357642428342,1.0,7/44,15.73%,CD40;IRS2;GPR183;TNFRSF21;CD81;LYN;TIRAP
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.2390473238762414,0.5991318517338674,0.9236111111111112,0.9924129615222258,1.0,7/18,23.83%,ELOVL2;ACSL6;ELOVL6;ELOVL1;ACSBG1;ELOVL5;TECR
prerank,peptidyl-proline modification (GO:0018208),0.22748214976808911,0.5990652126110547,0.9496062992125984,0.9919634155757694,1.0,2/25,4.94%,PPID;PPIH
prerank,reticulophagy (GO:0061709),-0.23776745998567508,-0.5989316247572556,0.9325581395348838,0.9835705547008935,1.0,4/12,22.49%,RETREG1;ATG2B;ATG2A;UFM1
prerank,mitochondrial transport (GO:0006839),0.19195356814825942,0.5987702371430905,0.9886201991465149,0.9916314737648314,1.0,13/53,24.01%,TIMM10;DNAJC19;BCS1L;PITRM1;TIMM44;BAK1;MFN2;SLC25A16;GDAP1;SLC25A24;FIS1;BNIP3;TOMM34
prerank,regulation of actin nucleation (GO:0051125),-0.23763666981530054,-0.598689813532881,0.9447004608294931,0.983072768954959,1.0,5/12,29.88%,GSN;ARPIN;CORO1B;ARF1;WHAMM
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.260649892821354,0.5982171886671915,0.9412724306688418,0.9914310670057017,1.0,1/13,3.91%,DUSP1
prerank,negative regulation of cell division (GO:0051782),0.2681824292892005,0.5974981652246046,0.9237588652482269,0.9913346621608832,1.0,1/11,3.06%,SUSD2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.2549442271934559,0.5973189988939688,0.9396984924623115,0.990947155810975,1.0,2/14,6.12%,ADK;GMPS
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2643417641195779,0.597311651716589,0.9119266055045872,0.9904669943422262,1.0,1/10,3.59%,TSLP
prerank,spliceosomal complex assembly (GO:0000245),0.1990307907533737,0.5952651663485035,0.9806835066864784,0.9910404686584685,1.0,12/46,20.64%,ZRSR2;NOL3;CELF4;LUC7L2;SRSF10;SRSF9;RBM5;SF3A3;SRSF6;DDX1;LUC7L3;DDX39B
prerank,regulation of histone acetylation (GO:0035065),0.21285922259538534,0.5950955611251488,0.9647239263803681,0.9906460007418347,1.0,7/33,18.84%,KMT2A;SETD5;NOC2L;PAXIP1;IWS1;BRD7;THAP7
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.2529949008020389,0.5927519351923654,0.9209138840070299,0.9913645660061497,1.0,2/12,9.43%,SNAP23;SNAP29
prerank,protein palmitoylation (GO:0018345),0.20904280206585157,0.592618205277332,0.9596899224806201,0.9909456213355864,1.0,8/30,20.03%,CLIP3;ZDHHC24;ZDHHC19;ZDHHC2;HHAT;ZDHHC6;ZDHHC9;ZDHHC8
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.25506806357044454,0.5922642169545539,0.9333333333333333,0.9906386251696683,1.0,4/13,24.06%,SAE1;SENP6;ATG10;UBA2
prerank,positive regulation of chromatin organization (GO:1905269),0.25537374186630757,0.5918740774673412,0.9366852886405959,0.9903570341416456,1.0,4/12,22.12%,TERF1;DAXX;TERF2IP;ATRX
prerank,folic acid-containing compound metabolic process (GO:0006760),0.23640956715166503,0.5912241392602492,0.9602649006622517,0.9902011833930007,1.0,6/19,24.36%,MTRR;MTHFD1L;MTHFD2L;SLC19A1;MTHFD1;MTHFS
prerank,mitotic sister chromatid segregation (GO:0000070),0.17419215793830678,0.5879388256100561,0.9973924380704041,0.9913029276832853,1.0,18/98,18.72%,BOD1;DCTN2;SGO1;CENPE;TEX14;NAA50;NSL1;SPDL1;NUSAP1;DIS3L2;NCAPH;RRS1;CEP55;CSNK2A2;VPS4B;SMC1A;KLHL22;KPNB1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2476703259369501,0.5873024000995578,0.9229508196721311,0.9911399694549333,1.0,3/15,15.32%,TIPIN;EME2;ATF2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.23294032823288718,-0.5865739955364045,0.9343065693430657,0.9876348301508241,1.0,6/12,30.20%,ADSS2;LHPP;PFAS;ATIC;PPAT;PAICS
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21677645736672613,-0.5859176751543169,0.9530864197530864,0.9872931962931131,1.0,6/15,27.04%,ERN1;CLP1;TSEN34;TRPT1;ZBTB8OS;TSEN54
prerank,microtubule anchoring (GO:0034453),0.2542958126388103,0.5855071247349514,0.924956369982548,0.991522465239953,1.0,4/12,18.83%,CLASP2;CLASP1;PCM1;PEX14
prerank,purine nucleotide metabolic process (GO:0006163),0.221170722338133,0.5845000239065662,0.9675850891410048,0.9915119463806357,1.0,4/24,10.63%,ITPA;FHIT;PRPS1L1;PRPS1
prerank,glucose transmembrane transport (GO:1904659),0.23519931118714324,0.584373975411733,0.9482470784641068,0.9910873490689346,1.0,1/18,4.00%,PPARD
prerank,positive regulation of B cell proliferation (GO:0030890),0.208885394115416,0.5841614536487584,0.9606299212598425,0.9907017548824748,1.0,5/29,15.73%,CD40;IRS2;GPR183;CD81;TIRAP
prerank,regulation of spindle organization (GO:0090224),0.23128197919426538,0.5834604094807458,0.9544715447154472,0.9905560158335863,1.0,3/18,14.37%,GPSM2;MAP9;SENP6
prerank,C4-dicarboxylate transport (GO:0015740),0.24279758321661626,0.5787748598842309,0.9425675675675675,0.9921952661803591,1.0,3/14,15.03%,SLC25A22;SLC25A30;SLC25A14
prerank,Golgi to lysosome transport (GO:0090160),-0.2377728969225937,-0.5777620867949349,0.9595238095238096,0.9897287546224438,1.0,5/11,33.55%,GAK;LAPTM5;AP4M1;LAMP1;AP1G1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.20450063609712393,0.5763599974360922,0.9829984544049459,0.9927734601436461,1.0,7/33,19.03%,RPA1;TERF1;PIF1;PPP6C;PPP6R3;SHQ1;TERF2IP
prerank,negative regulation of interferon-beta production (GO:0032688),-0.2420246855744642,-0.5741991318321639,0.9467849223946785,0.9904004893913466,1.0,1/10,3.33%,SIRPA
prerank,regulation of exosomal secretion (GO:1903541),0.2236642788610194,0.5732383310638433,0.9622331691297209,0.9936926479025483,1.0,5/19,17.34%,HGS;ATP9A;TSG101;SNF8;VPS4B
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.18389446529787673,0.5724052122627106,0.9903314917127072,0.9935656226190129,1.0,8/54,15.37%,ARID3A;CNOT11;E2F4;MDM4;TP53;CNOT1;CARM1;CNOT7
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.19898636282885324,-0.5720481423982889,0.9622166246851386,0.9899516044244617,1.0,7/19,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;ACD;POLR2I;POLR2K
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.19898636282885324,-0.5720481423982889,0.9622166246851386,0.9899516044244617,1.0,7/19,27.47%,POLR2B;POLR2H;POLR2G;POLR2C;ACD;POLR2I;POLR2K
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.24288053027680667,0.5711270127145563,0.9461400359066428,0.993608275513297,1.0,2/12,10.60%,FBXO31;TP53
prerank,negative regulation of gluconeogenesis (GO:0045721),0.2518481088808863,0.570458736225698,0.9376114081996435,0.9934074549527623,1.0,2/11,11.19%,GCK;ERFE
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.1978588686400901,-0.569572485218052,0.9820051413881749,0.9902002673040257,1.0,8/20,32.83%,MGRN1;YWHAB;MET;MRAP2;BICD1;ADA;PLEK;RGS2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.22435891958130297,-0.5661824001734558,0.9878934624697336,0.9907026994475366,1.0,1/13,1.78%,IL18
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.2289301430043023,-0.565461678871642,0.9345794392523364,0.9903241574101849,1.0,4/11,26.35%,EGLN3;CRTAP;P4HA3;P4HB
prerank,response to peptide (GO:1901652),0.19426540392918587,0.5653859883097455,0.9740680713128039,0.9949607181119154,1.0,7/33,23.88%,EIF2B1;IRS1;FYN;KAT7;CACNA1A;EIF2B5;STAT1
prerank,regulation of sister chromatid cohesion (GO:0007063),0.24518504053472606,0.5644270580120817,0.9400352733686067,0.994867946307645,1.0,2/12,13.61%,FEN1;BUB1
prerank,V(D)J recombination (GO:0033151),0.2527285862463168,0.5634064342263381,0.9498207885304659,0.9947786404443071,1.0,1/11,3.43%,LIG3
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.2255315271012599,0.5625513869732632,0.9660194174757282,0.9946324771025975,1.0,6/20,19.38%,GMPS;AMPD2;AK4;AK3;ADSS1;IMPDH2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.21432446790450585,0.562026379493127,0.9640062597809077,0.994348591060658,1.0,2/22,6.00%,RYR2;SLC9A1
prerank,membrane raft organization (GO:0031579),0.23269949913190022,0.5619810344266802,0.9452054794520548,0.9938922059958443,1.0,2/15,9.79%,FLOT2;FA2H
prerank,positive regulation of catalytic activity (GO:0043085),0.19227387534884074,0.5616029428310744,0.9777448071216617,0.9935563027531653,1.0,11/37,22.80%,MSH3;FXN;IGF2;ATP7A;NHEJ1;MSH6;WRN;SSBP1;CHTOP;B3GAT3;ABL1
prerank,positive regulation of B cell activation (GO:0050871),0.18444856447579602,0.5610402290691743,0.9896296296296296,0.9932855567938288,1.0,8/50,15.73%,CD40;IRS2;HMCES;GPR183;SH3KBP1;CD81;PAXIP1;TIRAP
prerank,positive regulation of interleukin-17 production (GO:0032740),0.20929856547600598,0.5605017403807324,0.9660194174757282,0.9929965576030213,1.0,1/22,2.85%,NR1H4
prerank,nuclear body organization (GO:0030575),0.24957840956324853,0.5585212722070233,0.9496402877697842,0.9932621689919131,1.0,3/12,19.34%,AFF2;HABP4;USPL1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.20492415651303603,-0.557625756418294,0.981042654028436,0.9921463737026929,1.0,11/16,48.45%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.22673678416538093,-0.5556731582811097,0.9589322381930184,0.9921280775207503,1.0,4/11,28.63%,RC3H1;ATM;TYROBP;FCGR2B
prerank,regulation of response to interferon-gamma (GO:0060330),0.2349214457231893,0.5551900422840631,0.9609929078014184,0.9939773334647607,1.0,1/14,3.37%,JAK1
prerank,protein localization to microtubule organizing center (GO:1905508),0.2278364686018279,0.5551811370325364,0.941696113074205,0.9935010185360723,1.0,4/15,20.70%,DCTN2;CEP192;PCM1;BBS4
prerank,regulation of mitochondrial fusion (GO:0010635),-0.23197556562286492,-0.5539089430564851,0.9599056603773585,0.9920399910360858,1.0,3/11,18.65%,TFRC;ADCK1;PID1
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.20707184643158133,-0.5533674546488384,0.9678217821782178,0.9915819290237309,1.0,5/16,21.44%,SIX1;PTGS2;SIRT1;ZBTB7B;SOX13
prerank,negative regulation of histone acetylation (GO:0035067),-0.22770384827344667,-0.550990455737871,0.9630541871921182,0.9916519299728983,1.0,5/11,31.55%,SIRT1;BRCA1;SPI1;TAF7;SET
prerank,phagosome acidification (GO:0090383),-0.1795924553115446,-0.5507695342186736,0.9949367088607595,0.9911045335175797,1.0,7/26,23.54%,ATP6V0A4;RAB38;ATP6V0E2;ATP6V0A2;ATP6V0D2;ATP6V0A1;ATP6V1G1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.18168536524300022,0.5498183889546102,0.9908536585365854,0.9948810427241941,1.0,10/47,20.76%,PPARD;ZBTB16;BMP7;WDFY2;CARM1;PIM1;FRZB;BMP2;CMKLR1;RARRES2
prerank,lipid biosynthetic process (GO:0008610),0.1682883251526155,0.5496421974987187,1.0,0.9944521859436237,1.0,8/77,14.56%,PAM;LIPC;LIPH;HSD17B8;ACSL6;ACLY;SREBF1;NDUFAB1
prerank,regulation of myoblast fusion (GO:1901739),0.24383321321671397,0.5496333304226088,0.9310344827586207,0.9939746520838322,1.0,1/11,5.41%,ADGRB1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.21933074175540704,-0.5491889343117056,0.9762470308788599,0.9909302392778256,1.0,5/12,32.75%,SOAT1;MFSD2A;P4HB;LPCAT3;APOC1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.2338795755635084,0.5469993503219388,0.9572192513368984,0.9943639984326524,1.0,14/14,76.63%,RAB29;CD81;NECTIN2;PRKD2;LCK;TESPA1;CD226;TRAT1;RELA;RPS3;CARD11;KCNN4;IKBKG;BCL10
prerank,negative regulation of inclusion body assembly (GO:0090084),0.2479673328572803,0.5453423236172603,0.9584775086505191,0.9944063171879954,1.0,1/10,5.25%,SORL1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2463017026597355,0.5399971201966516,0.9446428571428571,0.9955806462844168,1.0,3/11,15.88%,TENT4B;EXOSC10;EXOSC5
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2501086874399714,0.5369331932604605,0.9659284497444633,0.9959895979284611,1.0,2/10,18.84%,NOC2L;THAP7
prerank,quinone biosynthetic process (GO:1901663),0.2277152208729039,0.5360633485088232,0.9781512605042016,0.9957657044883981,1.0,4/14,19.09%,COQ3;PDSS2;COQ8B;COQ7
prerank,hexose transmembrane transport (GO:0008645),0.20949683083339946,0.5348996524185734,0.9836601307189542,0.9956265356299087,1.0,1/21,4.00%,PPARD
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.20682205855875507,0.5348329136008927,0.9761092150170648,0.9951688596274489,1.0,6/20,24.68%,GCK;ERFE;GSK3A;BCKDK;CRY1;CLK2
prerank,negative regulation of double-strand break repair (GO:2000780),-0.16340249348355798,-0.5333333308542775,0.9972067039106145,0.9942943493668895,1.0,12/30,33.24%,TRIP12;SHLD2;OTUB1;RNF169;SMCHD1;OGG1;NUDT16L1;RMI2;PARPBP;OTUB2;SHLD3;HSF1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.19125985211681149,-0.5327550186688381,0.9837209302325581,0.993828748933508,1.0,12/17,50.62%,PVR;RAET1E;LAMP1;AP1G1;RASGRP1;SLAMF6;CD226;CRTAM;KLRD1;CD160;KLRK1;IL12B
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.21572943023116734,-0.5305395470681941,0.983451536643026,0.9937195978841733,1.0,7/11,42.14%,PLCG2;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,regulation of integrin activation (GO:0033623),-0.200378344164139,-0.5288267948815536,0.9927007299270073,0.9934905164125836,1.0,7/15,33.06%,RASIP1;SKAP1;PIEZO1;RAP1B;SRC;PLEK;SELP
prerank,eosinophil migration (GO:0072677),-0.2031142085766309,-0.5283542595653044,0.9882903981264637,0.9923770426608239,1.0,14/14,79.71%,CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL13;CCL1;CCL3;LGALS3;CCL24;CCL26;CCL2;SCG2
prerank,eosinophil chemotaxis (GO:0048245),-0.2031142085766309,-0.5283542595653044,0.9882903981264637,0.9923770426608239,1.0,14/14,79.71%,CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL13;CCL1;CCL3;LGALS3;CCL24;CCL26;CCL2;SCG2
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.19915866139260377,-0.5282843829863447,0.9854368932038835,0.9917851467546224,1.0,14/14,80.11%,NGRN;MPV17L2;FASTKD2;RPUSD3;COA3;C1QBP;RMND1;FASTKD3;TRUB2;RPUSD4;TRMT10C;RCC1L;MRPS27;UQCC2
prerank,regulation of mitochondrial translation (GO:0070129),0.20613069141920504,0.5273405855545615,0.9769736842105263,0.9967404155037524,1.0,7/21,23.65%,MALSU1;UQCC2;NSUN3;MRPS27;MTG1;RCC1L;TRMT10C
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.23366654886757893,0.5255325801812945,0.9605488850771869,0.9967329925513246,1.0,3/13,21.56%,PER2;HEY1;DDIT3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.21726088147324196,0.5249141062628002,0.9794520547945206,0.9964161628591984,1.0,3/16,18.77%,POLQ;FBH1;RIF1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.2064985845373274,-0.5238517155767524,0.9700460829493087,0.9921197493053666,1.0,6/13,31.80%,SIX1;PTGS2;ZBTB7B;SOX13;FNDC5;VSTM2A
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.18254045165044558,-0.5234471362298487,0.9875,0.9915889579287208,1.0,3/20,12.17%,FAR2;CBR4;ACSL4
prerank,ubiquinone biosynthetic process (GO:0006744),0.21700278178499535,0.5211361691884269,0.9703459637561779,0.996870505315892,1.0,4/15,19.09%,COQ3;PDSS2;COQ8B;COQ7
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.21961325966850814,0.5180588324847325,0.9762308998302207,0.9970933046056093,1.0,13/13,78.06%,NUDT21;TUT1;CPSF2;CSTF2T;NCBP1;CPSF1;CSTF2;CPSF4;FIP1L1;CPSF4L;CPSF7;CPSF6;NCBP2
prerank,negative regulation of receptor internalization (GO:0002091),0.2264362208016133,0.5179012714706022,0.9597902097902098,0.9966508344136115,1.0,2/12,11.37%,NECAB2;DLG4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.1784094137412065,0.5149302528869248,0.9855305466237942,0.9968418516088084,1.0,10/34,26.10%,TLR6;LRRC14;TLR4;LYN;NFKBIL1;CACTIN;NLRP2B;RAB7B;GRAMD4;NR1D1
prerank,T cell proliferation (GO:0042098),0.2216579622377983,0.5145004152500304,0.9747899159663865,0.9964653252612516,1.0,3/13,16.96%,PPP3CB;LMBR1L;PIK3CG
prerank,regulation of calcium ion import (GO:0090279),-0.17349343831504951,-0.5144647394662829,0.9862385321100917,0.9927493600440364,1.0,6/21,25.69%,TRIM27;EGF;SPHK2;PLN;PLPP4;PSEN2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2140040190505604,0.5101543818661974,0.980701754385965,0.9969785154794486,1.0,5/15,23.47%,GLI1;ATAD5;DDRGK1;CDC73;STXBP4
prerank,synaptic vesicle transport (GO:0048489),0.22364502988122725,0.5095475135878905,0.9749552772808586,0.9966268373262099,1.0,3/11,17.24%,KIF5C;TMEM230;CDK5
prerank,aminoglycan metabolic process (GO:0006022),0.23363254033017394,0.5087266315716883,0.9655831739961759,0.9963324825259323,1.0,10/10,76.65%,B4GALT7;B3GAT3;B3GAT2;CHST9;B3GAT1;XYLT1;GAL3ST3;B3GALT6;XYLT2;CLN6
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2342099309510466,0.5058370918449382,0.9637023593466425,0.9964454470232079,1.0,4/10,24.36%,MTHFD1L;MTHFD2L;MTHFD1;MTHFS
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.22898750863097111,0.5010397449284761,0.9703832752613241,0.9964313825963654,1.0,10/10,77.12%,CEP250;RPE65;GRM6;CACNA1F;GNAT2;CNGB1;REEP6;GNAT1;CACNA2D4;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.22898750863097111,0.5010397449284761,0.9703832752613241,0.9964313825963654,1.0,10/10,77.12%,CEP250;RPE65;GRM6;CACNA1F;GNAT2;CNGB1;REEP6;GNAT1;CACNA2D4;TULP1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.18405924250232608,-0.49406138143652634,0.9974747474747475,0.9954963575886037,1.0,8/14,46.29%,ERN1;NCBP2;CPSF6;CPSF7;CPSF4L;FIP1L1;CPSF4;CSTF2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.21270470388668308,0.4917848090897113,0.978984238178634,0.9966838836577225,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.21270470388668308,0.4917848090897113,0.978984238178634,0.9966838836577225,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.21270470388668308,0.4917848090897113,0.978984238178634,0.9966838836577225,1.0,2/12,12.59%,CDC16;ANAPC5
prerank,superoxide anion generation (GO:0042554),-0.19240439724425726,-0.49138813436809503,0.9931192660550459,0.995290604815,1.0,4/13,26.70%,NOX4;ALOX12;CYBB;NCF2
prerank,estrogen metabolic process (GO:0008210),0.2073240890671174,0.48811808928444145,0.9870759289176091,0.9968133564266554,1.0,3/15,17.79%,HSD17B8;HSD17B11;HSD17B2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.21808058704324856,0.4865172831755984,0.9813084112149533,0.9966049817476311,1.0,1/11,5.86%,KCNIP2
prerank,ether lipid biosynthetic process (GO:0008611),0.22156601191465936,0.48313814048828546,0.9760589318600368,0.9966875656199276,1.0,1/10,5.67%,PEX7
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2061459771700181,0.48056416954137954,0.9758203799654577,0.996577564771558,1.0,3/14,20.19%,TSEN15;FAM98B;DDX1
prerank,sulfation (GO:0051923),0.21181596738065153,0.47181196384786694,0.9853747714808044,0.997312638535829,1.0,2/11,15.14%,HS3ST5;SULT6B1
prerank,regulation of cilium movement (GO:0003352),0.21199358422311787,0.4654482410749686,0.9819168173598554,0.9976466507424228,1.0,2/10,15.25%,CCDC65;CCDC39
prerank,regulation of B cell activation (GO:0050864),0.17391304347826095,0.4640788583170038,0.9900826446280991,0.9973379181352215,1.0,25/25,82.64%,ZFP36L2;SH3KBP1;TNIP2;ZFP36L1;AHR;TLR9;MZB1;IGLL1;TNFSF4;IL10;CD19;SLAMF8;IL6;CD22;IL4;THEMIS2;IKZF3;IL4I1;FOXJ1;SAMSN1;BANK1;FCGR2B;NOD2;TNFAIP3;LAPTM5
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.2039810795406518,0.45373601631284316,0.9856887298747764,0.998003406632416,1.0,2/10,19.84%,DLGAP3;NPTX2
prerank,negative regulation of mRNA processing (GO:0050686),-0.16624320295118278,-0.45184287879907925,1.0,0.998876816945638,1.0,3/15,16.15%,RBMX;SRSF4;SRSF7
prerank,DNA catabolic process (GO:0006308),-0.18210922787193973,-0.4512566330965099,0.9912472647702407,0.9983105065957057,1.0,11/11,81.81%,SETMAR;MUS81;DFFB;DNASE1L1;DNASE1;XRN2;DNASE1L3;ISG20;DNASE1L2;REXO4;FBH1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.187706907538352,0.4483911599960884,0.9933884297520661,0.9980508130016567,1.0,5/14,25.34%,SRSF10;SRSF9;SRSF6;SRSF12;RNPS1
prerank,ovarian follicle development (GO:0001541),-0.17151939877771713,-0.4441423438949485,0.9907621247113164,0.9982136786461514,1.0,5/13,37.95%,EIF2B4;INHBB;FOXL2;CEBPB;EIF2B2
prerank,organophosphate catabolic process (GO:0046434),-0.17583438018939906,-0.44156191709237924,0.9952830188679245,0.9977594022274046,1.0,1/11,9.76%,ENPP2
prerank,regulation of neutrophil migration (GO:1902622),0.19719409469266555,0.4369600332405896,0.9910873440285205,0.9985526840784749,1.0,2/10,17.40%,JAM3;RHOG
prerank,exit from mitosis (GO:0010458),0.17019273024044193,0.39581052093022867,0.9982788296041308,1.0,1.0,12/12,82.99%,CLASP2;CLASP1;PPP2R2D;SIRT7;SPAST;EPS8;UBE2C;UBE2S;CHMP2A;CTDP1;CHMP7;CHMP4B
prerank,regulation of B cell differentiation (GO:0045577),0.15353874212042098,0.37702500545413425,0.9965870307167235,1.0,1.0,1/17,7.16%,ZFP36L2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.13565169887997586,0.3644191520856401,1.0,1.0,1.0,2/24,13.25%,PTPN22;TRIM44
prerank,megakaryocyte differentiation (GO:0030219),0.14714375392341508,0.32690978805217297,1.0,0.9999468475443359,1.0,11/11,85.30%,MED1;UBA5;SH2B3;KIT;MPIG6B;GATA1;ZFPM1;THPO;IL11;CDKN2B;TAL1
